sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.5,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness serve as a predictor for neuropsychological decline after a concussion? Loss of consciousness may indicate neuropsychological impairments post-concussion, but it is not the only factor. Other elements such as the severity of the concussion, the individual's health condition, and the time elapsed since the injury also play crucial roles. Hence, a thorough neuropsychological evaluation is essential following a concussion.",1.8948778188548325e-07,0.17044751893701537,0.02314109957708576,0.014507411718254981,0.14401231093327116,0.0024720578566732355,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
0,0.5,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness forecast neuropsychological deficits after a concussion? While loss of consciousness can signal neuropsychological issues after a concussion, it is not the sole predictor. The severity of the concussion, the person's overall health, and the time since injury also significantly affect cognitive outcomes. Thus, a detailed neuropsychological assessment is necessary after a concussion.",2.3685972735685406e-08,0.014969518631601453,0.05613225682429833,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
0,0.5,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a reliable predictor of neuropsychological impairments following a concussion? Loss of consciousness might indicate neuropsychological decline after a concussion, but it alone does not determine the outcome. Factors including the concussion's severity, the individual's health status, and how long ago the injury occurred also influence cognitive effects. Therefore, comprehensive neuropsychological testing is important post-concussion.",7.105791820705622e-08,0.08244166725810942,0.020321999485258355,0.005440279394345618,0.056461018114079664,0.001009707076140641,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
0,0.5,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does experiencing loss of consciousness predict neuropsychological deficits after a concussion? Loss of consciousness can be an indicator of neuropsychological decline after a concussion; however, it is not the only factor involved. The severity of the concussion, the individual's health, and the time since injury also play significant roles. Consequently, thorough neuropsychological assessments are crucial following a concussion.",7.105791820705622e-08,0.05812071355425186,0.002894185996838848,0.005440279394345618,0.056461018114079664,0.001009707076140641,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
0,0.5,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness an indicator of neuropsychological decline after a concussion? Loss of consciousness may suggest neuropsychological impairments after a concussion, but it is not the exclusive predictor. Other factors such as concussion severity, the individual's health condition, and the duration since the injury also greatly impact cognitive outcomes. Therefore, a comprehensive neuropsychological evaluation is essential after a concussion.",1.1842986367842703e-07,0.06271507974980706,0.04843833109325407,0.009067132323909363,0.09240596745805885,0.0016248741078274467,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
0,0.5,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness predict cognitive impairments following a concussion? Loss of consciousness can indicate neuropsychological deficits post-concussion, but it is not the only determinant. The severity of the concussion, the person's health status, and the time elapsed since injury also significantly influence cognitive effects. Hence, a detailed neuropsychological assessment is vital after a concussion.",0.0,0.025672117798516858,0.018381073278597906,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.5,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does losing consciousness predict neuropsychological problems after a concussion? Loss of consciousness can be a sign of neuropsychological decline following a concussion, but it is not the sole predictor. The severity of the concussion, the individual's health, and the time since the injury also play important roles. Therefore, comprehensive neuropsychological testing is necessary post-concussion.",2.3685972735685406e-08,0.05832422038339624,0.05536332179930796,0.0018134264647818726,0.007108302408927791,0.018860946745562133,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
0,0.5,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is the loss of consciousness a predictor of neuropsychological deficits after a concussion? Loss of consciousness might indicate neuropsychological impairments following a concussion, but it is not the only factor. Factors like concussion severity, individual health status, and time since injury also significantly affect cognitive outcomes. Thus, thorough neuropsychological assessment is essential after a concussion.",0.0,4.440892098500626e-16,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.5,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does the occurrence of loss of consciousness forecast neuropsychological decline after a concussion? Loss of consciousness can signal neuropsychological issues post-concussion, but it is not the sole predictor. The severity of the concussion, the individual's health condition, and the duration since injury also influence cognitive effects. Therefore, comprehensive neuropsychological evaluation is important following a concussion.",0.0,0.025672117798516858,0.018381073278597906,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.5,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a sole predictor of neuropsychological impairments after a concussion? While loss of consciousness can indicate neuropsychological decline after a concussion, it is not the only factor involved. The severity of the concussion, the individual's health, and the time since injury also play significant roles. Hence, a detailed neuropsychological assessment is necessary post-concussion.",2.3685972735685406e-08,0.019749436002661103,0.000999416473864173,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
1,0.5,1,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Is transgastric endoscopic splenectomy feasible? Yes, it can be performed using an endoscope to excise the spleen.",1.6580180914979737e-07,0.30263182581459036,0.04338842975206613,0.012693985253473147,0.3829922522561051,0.0,0.012675610786670111,0.4054651081081633,0.0,1.6580180914979747e-07,0.4307829160924532,0.0
1,0.5,2,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Can a transgastric endoscopic splenectomy be done? Yes, this technique uses an endoscope to remove the spleen.",1.6580180914979737e-07,0.30263182581459036,0.04338842975206613,0.012693985253473147,0.3829922522561051,0.0,0.012675610786670111,0.4054651081081633,0.0,1.6580180914979747e-07,0.4307829160924532,0.0
1,0.5,3,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Is it possible to do a transgastric endoscopic splenectomy? Yes, the spleen can be removed via an endoscopic approach through the stomach.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.5,4,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Can transgastric endoscopic splenectomy be achieved? Yes, it involves the use of an endoscope to extract the spleen.",1.42115836414112e-07,0.24200720399815534,0.04338842975206613,0.01088055878869127,0.3184537311185345,0.0,0.010864809245717238,0.3364722366212112,0.0,1.4211583641411212e-07,0.356674943938732,0.0
1,0.5,5,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Is transgastric endoscopic splenectomy achievable? Yes, it entails using an endoscope to perform spleen removal.",2.1317375462116807e-07,0.4361632184391131,0.04338842975206613,0.0163208381830369,0.5260930958967784,0.0,0.01629721386857586,0.5596157879354209,0.0,2.1317375462116818e-07,0.5978370007556197,0.0
1,0.5,6,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Is a transgastric endoscopic splenectomy doable? Yes, this procedure uses an endoscope to take out the spleen.",1.6580180914979737e-07,0.30263182581459036,0.04338842975206613,0.012693985253473147,0.3829922522561051,0.0,0.012675610786670111,0.4054651081081633,0.0,1.6580180914979747e-07,0.4307829160924532,0.0
1,0.5,7,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Can splenectomy be done endoscopically through the stomach? Yes, it is possible to remove the spleen using a transgastric endoscopic method.",7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
1,0.5,8,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Is it feasible to conduct a transgastric endoscopic splenectomy? Yes, this involves spleen removal using an endoscope inserted via the stomach.",7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
1,0.5,9,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Is performing a transgastric endoscopic splenectomy possible? Yes, the spleen can be endoscopically removed through the stomach.",1.6580180914979737e-07,0.30263182581459036,0.04338842975206613,0.012693985253473147,0.3829922522561051,0.0,0.012675610786670111,0.4054651081081633,0.0,1.6580180914979747e-07,0.4307829160924532,0.0
1,0.5,10,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Is a spleen removal via transgastric endoscopy possible? Yes, the procedure uses an endoscope to excise the spleen.",1.42115836414112e-07,0.24200720399815534,0.04338842975206613,0.01088055878869127,0.3184537311185345,0.0,0.010864809245717238,0.3364722366212112,0.0,1.4211583641411212e-07,0.356674943938732,0.0
2,0.5,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does blood pressure vary in treated hypertensive patients depending on whether a physician or nurse takes the measurement? Yes, blood pressure readings can differ based on the person measuring them, as 'white coat hypertension' may cause higher readings with physicians due to patient anxiety, making nurse measurements potentially lower and more accurate.",4.263475092423373e-07,0.16115002681705715,0.12713474872346153,0.03264167636607371,0.22593797262326287,0.05859375,0.0325944277371516,0.27149040005287883,0.029822485207100586,4.263475092423373e-07,0.31845373111853315,0.0
2,0.5,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does blood pressure change when measured by a physician versus a nurse? Yes, because of 'white coat hypertension,' readings taken by physicians may be higher due to anxiety, whereas nurse measurements might be lower and more reliable.",6.868932093348768e-07,0.37691396305254665,0.1467347487234615,0.052589367478674306,0.47439933192176387,0.05859375,0.05251324468763313,0.5257245384371192,0.029822485207100586,6.868932093348768e-07,0.5787368293821986,0.0
2,0.5,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is there a difference in blood pressure readings in treated hypertensive patients when measured by a physician compared to a nurse? Yes, blood pressure can vary, with higher readings often recorded by physicians due to 'white coat hypertension,' while nurse measurements tend to be lower and more precise.",5.210914001850789e-07,0.2451414401611034,0.1254682080807394,0.0398953822252012,0.30931958156231376,0.05859375,0.039837633900963065,0.3566482083931861,0.029822485207100586,5.210914001850789e-07,0.4054651081081624,0.0
2,0.5,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Do blood pressure readings in treated hypertensive patients differ depending on whether a physician or nurse measures them? Yes, the phenomenon called 'white coat hypertension' can lead to elevated readings by physicians, while nurse measurements are generally lower and more accurate.",6.868932093348768e-07,0.37691396305254665,0.1467347487234615,0.052589367478674306,0.47439933192176387,0.05859375,0.05251324468763313,0.5257245384371192,0.029822485207100586,6.868932093348768e-07,0.5787368293821986,0.0
2,0.5,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Can blood pressure readings in treated hypertensive patients change based on whether a physician or nurse takes the measurement? Yes, due to 'white coat hypertension,' readings by physicians may be higher because of patient anxiety, making nurse measurements typically lower and more accurate.",6.39521263863506e-07,0.32812379888311494,0.1467347487234615,0.04896251454911056,0.42438891134710044,0.05859375,0.0488916416057274,0.4744312440495695,0.029822485207100586,6.39521263863506e-07,0.5260930958967798,0.0
2,0.5,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does who measures blood pressure affect the readings? Yes, 'white coat hypertension' can cause higher readings when measured by physicians, while nurse measurements tend to be lower and more accurate.",8.526950184846739e-07,0.5692858557000027,0.1467347487234615,0.06528335273214744,0.6722250752516818,0.05859375,0.06518885547430323,0.729323493678359,0.029822485207100586,8.526950184846746e-07,0.7884573603642693,0.0
2,0.5,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does the person measuring blood pressure affect readings in treated hypertensive patients? Yes, patients may exhibit 'white coat hypertension' with physicians, causing higher readings, whereas nurse measurements are often lower and more accurate.",8.763809912203592e-07,0.6000575143667564,0.1467347487234615,0.06709677919692932,0.7039737735662617,0.05859375,0.06699965701525609,0.7621133165013507,0.029822485207100586,8.7638099122036e-07,0.822358912039951,0.0
2,0.5,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Are blood pressure readings in treated hypertensive patients influenced by whether a physician or nurse measures them? Yes, due to 'white coat hypertension,' physician measurements may be elevated, while nurse measurements tend to be lower and more reliable.",7.579511275419327e-07,0.4548755045222572,0.1467347487234615,0.058029646873019924,0.554442039595298,0.05859375,0.05794564931049173,0.6079626366740922,0.029822485207100586,7.57951127541933e-07,0.6632942174102623,0.0
2,0.5,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does blood pressure in treated hypertensive patients differ when measured by a physician versus a nurse? Yes, because of 'white coat hypertension,' readings taken by physicians can be higher due to anxiety, with nurse measurements being lower and more accurate.",7.105791820705621e-07,0.4022317710368384,0.1467347487234615,0.05440279394345618,0.5003748183250218,0.05859375,0.054324046228586,0.5523927855192801,0.029822485207100586,7.105791820705622e-07,0.6061358035703139,0.0
2,0.5,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is there a change in blood pressure readings in treated hypertensive patients depending on if a physician or nurse measures it? Yes, 'white coat hypertension' may cause higher readings with physicians, making nurse measurements generally lower and more accurate.",7.342651548062474e-07,0.42820725744009636,0.1467347487234615,0.05621622040823805,0.5270430654071827,0.05859375,0.056134847769538865,0.5797917597073954,0.029822485207100586,7.342651548062476e-07,0.6343066805370108,0.0
3,0.5,1,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are we overlooking any prognostic indicators? Answer: We identify ESLD etiology as a novel prognostic factor for survival. Renal function, measured by serum creatinine, and urinary sodium (<5 mEq/l) at diagnosis correlate with survival, indicating early intervention could improve outcomes.",2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
3,0.5,2,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: could we be missing key prognostic factors? Answer: For the first time, we highlight ESLD etiology as a survival predictor. Renal function (serum creatinine) and urinary Na levels (<5 mEq/l) at diagnosis associate with survival, implying early treatment may enhance survival.",2.6054570009253947e-07,0.22778393087071303,0.0,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
3,0.5,3,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are there undiscovered prognostic factors? Answer: We report ESLD etiology as a new prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary sodium below 5 mEq/l at diagnosis are linked to survival, suggesting early therapy might boost survival chances.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.5,4,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: might we be missing some prognostic markers? Answer: This is the first report identifying ESLD etiology as a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were associated with survival, indicating early treatment could improve survival.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.5,5,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are certain prognostic factors overlooked? Answer: We present ESLD etiology as a prognostic factor for survival for the first time. Renal function, expressed by serum creatinine, and urinary sodium (<5 mEq/l) at diagnosis correlate with survival, suggesting early intervention may increase survival.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.5,6,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: could some prognostic factors be missed? Answer: We report ESLD etiology as a novel survival prognostic factor. Renal function, measured by serum creatinine, and urinary Na less than 5 mEq/l at diagnosis are linked to survival, implying that early treatment might improve survival.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.5,7,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are prognostic factors being missed? Answer: For the first time, ESLD etiology is reported as a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis associate with survival, indicating early therapy could enhance survival.",2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
3,0.5,8,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: is there a chance we missed prognostic factors? Answer: We identify ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary sodium under 5 mEq/l at diagnosis associate with survival, suggesting early treatment may improve survival.",1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
3,0.5,9,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: are some prognostic factors unknown? Answer: This study reports ESLD etiology as a prognostic factor for survival for the first time. Renal function, expressed as serum creatinine, and urinary Na below 5 mEq/l at diagnosis correlate with survival, implying early intervention might increase survival.",1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
3,0.5,10,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Question: Hepatorenal syndrome: could we be missing important prognostic factors? Answer: We report ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary sodium less than 5 mEq/l at diagnosis are associated with survival, suggesting early treatment may improve survival outcomes.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
4,0.5,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is Aripiprazole a novel risk factor for pathological gambling? Answer: Recent research indicates a potential association between Aripiprazole, an antipsychotic drug, and a heightened risk of pathological gambling. Nevertheless, more studies are required to",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
4,0.5,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be a new risk factor for pathological gambling? Answer: Current studies suggest there might be a connection between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, additional research is necessary to",9.47438909427412e-08,0.07694293601234303,0.027006172839506164,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
4,0.5,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Does Aripiprazole represent a new risk factor for pathological gambling? Answer: Recent findings imply a possible link between Aripiprazole, used as an antipsychotic, and a greater risk of pathological gambling. Still, further investigation is needed to",7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
4,0.5,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: Is it a new risk factor for pathological gambling? Answer: Some recent studies point to a potential correlation between Aripiprazole, an antipsychotic drug, and elevated pathological gambling risk. Further research is needed to",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
4,0.5,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is there a new risk factor for pathological gambling in Aripiprazole? Answer: Emerging studies suggest Aripiprazole, an antipsychotic medication, may be linked to an increased risk of pathological gambling. More research is required to",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
4,0.5,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole and pathological gambling: a new risk factor? Answer: Recent investigations indicate a possible association between Aripiprazole, an antipsychotic agent, and a higher risk of pathological gambling. However, further studies are needed to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.5,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be linked to pathological gambling as a new risk factor? Answer: Studies recently have suggested a potential connection between Aripiprazole, an antipsychotic drug, and increased pathological gambling risk. Additional research is necessary to",4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.5,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is Aripiprazole a potential new risk factor for pathological gambling? Answer: Recent research points to a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. Further investigation is required to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.5,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a potential new risk factor for pathological gambling? Answer: Recent studies have suggested a possible association between Aripiprazole, an antipsychotic drug, and a heightened risk of pathological gambling. More research is needed to",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
4,0.5,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Does Aripiprazole pose a new risk factor for pathological gambling? Answer: Recent evidence suggests a possible connection between Aripiprazole, used as an antipsychotic medication, and increased pathological gambling risk. Still, further research is needed to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
5,0.5,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there varying degrees of risk for transitioning to psychosis within the Ultra High Risk (UHR) criteria? Yes, the risk levels differ based on factors like age, symptom frequency and intensity, and family history. Nevertheless, UHR criteria do not guarantee that all individuals identified as UHR will develop psychosis.",5.684633456564497e-07,0.23217831296817826,0.12244897959183675,0.043522235154764985,0.27585536648845155,0.097412109375,0.04345923698286881,0.32083281976598643,0.07100591715976333,5.684633456564497e-07,0.367170346952161,0.04338842975206613
5,0.5,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within the Ultra High Risk (UHR) criteria, are there distinct levels of risk for psychosis transition? Indeed, risk varies depending on age, symptom severity and frequency, and family history. However, it’s crucial to understand that UHR criteria are not absolute predictors, and not everyone labeled as UHR will experience psychosis.",5.447773729207643e-07,0.2115590257654425,0.12244897959183675,0.04170880868998311,0.2548019572906184,0.097412109375,0.041648435441915946,0.2993266145450231,0.07100591715976333,5.447773729207643e-07,0.345191440233386,0.04338842975206613
5,0.5,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Does the Ultra High Risk (UHR) criteria indicate different risk levels for developing psychosis? Yes, risk levels differ according to factors such as age, how often and how severe symptoms are, and family history. Still, UHR criteria are not definitive, meaning not all individuals identified as UHR will go on to develop psychosis.",4.737194547137081e-07,0.17879511223925482,0.10322560396707703,0.036268529295637494,0.19417733547418425,0.097412109375,0.036216030819057346,0.23745121082693554,0.07100591715976333,4.737194547137081e-07,0.2820125386118537,0.04338842975206613
5,0.5,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there multiple risk levels for psychosis transition within the Ultra High Risk (UHR) criteria? Yes, risk depends on factors including age, symptom frequency and intensity, and family history. It’s important to note that UHR criteria are not conclusive predictors, so not all who meet UHR criteria will develop psychosis.",5.447773729207643e-07,0.23985074742095058,0.1020496740362812,0.04170880868998311,0.2548019572906184,0.097412109375,0.041648435441915946,0.2993266145450231,0.07100591715976333,5.447773729207643e-07,0.345191440233386,0.04338842975206613
5,0.5,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within the Ultra High Risk (UHR) framework, do different levels of risk for psychosis exist? Yes, risk varies based on age, symptom frequency and intensity, and family history. However, UHR criteria are not definitive, and not all individuals classified as UHR will necessarily develop psychosis.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
5,0.5,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is there a range of risk levels for psychosis transition in the Ultra High Risk (UHR) criteria? Yes, factors such as age, symptom severity and frequency, and family history influence the risk. Nonetheless, UHR criteria do not definitively predict psychosis onset for all individuals identified as UHR.",6.158352911278206e-07,0.2747379273869748,0.12244897959183675,0.04714908808432873,0.3193404784281899,0.097412109375,0.047080840064774546,0.36528458233681915,0.07100591715976333,6.158352911278206e-07,0.41263272102891824,0.04338842975206613
5,0.5,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do the Ultra High Risk (UHR) criteria reflect varying degrees of risk for developing psychosis? Yes, risk levels are influenced by age, how often and how intense symptoms are, and family history. However, it's important to remember that UHR criteria are not definitive predictors, and not everyone classified as UHR will develop psychosis.",4.737194547137081e-07,0.15213560529464143,0.12244897959183675,0.036268529295637494,0.19417733547418425,0.097412109375,0.036216030819057346,0.23745121082693554,0.07100591715976333,4.737194547137081e-07,0.2820125386118537,0.04338842975206613
5,0.5,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are different risk levels for transition to psychosis recognized in the Ultra High Risk (UHR) criteria? Yes, risk is determined by factors like age, symptom frequency and intensity, and family history. Still, UHR criteria are not absolute, and not all individuals meeting UHR criteria will develop psychosis.",6.158352911278206e-07,0.3048747613243634,0.10072058453010835,0.04714908808432873,0.3193404784281899,0.097412109375,0.047080840064774546,0.36528458233681915,0.07100591715976333,6.158352911278206e-07,0.41263272102891824,0.04338842975206613
5,0.5,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Does the Ultra High Risk (UHR) criteria categorize different levels of risk for psychosis transition? Yes, the risk levels vary according to age, symptom frequency and intensity, and family history. However, UHR criteria are not definitive, so not all individuals identified as UHR will develop psychosis.",6.39521263863506e-07,0.2967168341057498,0.12244897959183675,0.0489625145491106,0.3418133342802476,0.097412109375,0.04889164160572741,0.3882741005615187,0.07100591715976333,6.39521263863506e-07,0.43616321843911265,0.04338842975206613
5,0.5,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within the Ultra High Risk (UHR) criteria, are there varying levels of risk for psychosis? Yes, risk depends on factors such as age, frequency and intensity of symptoms, and family history. It is important to note that UHR criteria are not definitive predictors, and not all classified as UHR will develop psychosis.",4.974054274493935e-07,0.17155369115174413,0.12244897959183675,0.03808195576041937,0.21397996277036402,0.097412109375,0.03802683236001021,0.25765391814445415,0.07100591715976333,4.974054274493935e-07,0.3026318258145895,0.04338842975206613
6,0.5,1,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","A model for healing Los Angeles grades C and D reflux oesophagitis: is there an ideal duration of acid suppression for the best healing? Yes, optimal healing for these grades is possible with timely and sufficient acid suppression, though the exact timing depends on individual factors such as severity.",3.316036182995957e-07,0.07705668237979424,0.1262002743484225,0.025387970506946217,0.10164330299047775,0.11282578875171474,0.025351221573340132,0.1270737296210167,0.09876543209876548,3.316036182995957e-07,0.15339238115913867,0.08401920438957469
6,0.5,2,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Does a model exist for healing Los Angeles grades C and D reflux oesophagitis that identifies the best acid suppression period for maximum healing? Indeed, effective healing can be achieved with appropriate and timely acid suppression, but the ideal timing varies based on individual severity and other factors.",3.552895910352811e-07,0.0981100915776274,0.1262002743484225,0.02720139697172809,0.1231495082114411,0.11282578875171474,0.027162023114293,0.1490526363397917,0.09876543209876548,3.552895910352811e-07,0.17586523701119638,0.08401920438957469
6,0.5,3,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Is there an optimal acid suppression timeframe for maximal healing in Los Angeles grades C and D reflux oesophagitis? Yes, healing is best achieved through timely and adequate acid suppression, though the optimal timing differs among patients depending on severity.",5.447773729207642e-07,0.28469604715804087,0.1262002743484225,0.04170880868998307,0.3142047449741492,0.11282578875171474,0.04164843544191593,0.34479721346588565,0.09876543209876548,5.447773729207643e-07,0.37653593247334793,0.08401920438957469
6,0.5,4,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","A healing model for Los Angeles grades C and D reflux oesophagitis: can maximal healing be attained with optimal acid suppression timing? Yes, timely and sufficient acid suppression leads to optimal healing, but the perfect timing varies with individual severity.",5.447773729207642e-07,0.3202420564175248,0.10057700565036154,0.04170880868998307,0.3142047449741492,0.11282578875171474,0.04164843544191593,0.34479721346588565,0.09876543209876548,5.447773729207643e-07,0.37653593247334793,0.08401920438957469
6,0.5,5,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Regarding healing of Los Angeles grades C and D reflux oesophagitis, is there a best time for acid suppression to maximize healing? Yes, optimal healing occurs with timely and adequate acid suppression, though timing depends on factors like disease severity.",5.447773729207642e-07,0.28469604715804087,0.1262002743484225,0.04170880868998307,0.3142047449741492,0.11282578875171474,0.04164843544191593,0.34479721346588565,0.09876543209876548,5.447773729207643e-07,0.37653593247334793,0.08401920438957469
6,0.5,6,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Is there an ideal acid suppression duration for optimal healing of Los Angeles grades C and D reflux oesophagitis? Yes, timely and adequate acid suppression ensures optimal healing, but the exact timing is influenced by individual severity and other factors.",5.447773729207642e-07,0.3202420564175248,0.10057700565036154,0.04170880868998307,0.3142047449741492,0.11282578875171474,0.04164843544191593,0.34479721346588565,0.09876543209876548,5.447773729207643e-07,0.37653593247334793,0.08401920438957469
6,0.5,7,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","A model addressing healing of Los Angeles grades C and D reflux oesophagitis: is there a perfect acid suppression period for maximal healing? Yes, optimal healing can be achieved by timely and sufficient acid suppression, with timing varying by individual severity.",5.210914001850789e-07,0.25937823917374914,0.1262002743484225,0.0398953822252012,0.2882292585708912,0.11282578875171474,0.039837633900963065,0.3181289663837248,0.09876543209876548,5.210914001850789e-07,0.3491369582852326,0.08401920438957469
6,0.5,8,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","For Los Angeles grades C and D reflux oesophagitis, is there an optimal time frame for acid suppression to maximize healing? Yes, healing is maximized with timely and adequate acid suppression, although the ideal timing depends on severity and individual factors.",5.210914001850789e-07,0.25937823917374914,0.1262002743484225,0.0398953822252012,0.2882292585708912,0.11282578875171474,0.039837633900963065,0.3181289663837248,0.09876543209876548,5.210914001850789e-07,0.3491369582852326,0.08401920438957469
6,0.5,9,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Is there a model for healing Los Angeles grades C and D reflux oesophagitis that defines the best acid suppression timing for maximal healing? Yes, optimal healing is possible with appropriate and timely acid suppression, but timing varies according to severity and patient-specific factors.",4.500334819780227e-07,0.187057577594123,0.1262002743484225,0.03445510283085558,0.21412128641716777,0.11282578875171474,0.034405229278104466,0.24214305940580338,0.09876543209876548,4.500334819780227e-07,0.27117541681552204,0.08401920438957469
6,0.5,10,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Can maximal healing of Los Angeles grades C and D reflux oesophagitis be achieved with optimal acid suppression timing? Yes, timely and adequate acid suppression leads to optimal healing, though the ideal timing is dependent on the severity and individual patient factors.",4.974054274493935e-07,0.2684976841716673,0.10182527434842248,0.038081955760419325,0.2629114505865995,0.11282578875171474,0.0380268323600102,0.2921534799804668,0.09876543209876548,4.974054274493935e-07,0.32246871120307175,0.08401920438957469
7,0.5,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening technologies, some degree of discordance between TEOAE and AABR may be unavoidable in certain types of hearing loss among seemingly healthy newborns whose mothers had prenatal care. The limitations of using perinatal morbidities as criteria for targeted screening in these cases should be considered.",1.6580180914979784e-07,0.08562668083250946,0.02903801652892562,0.012693985253473108,0.08409473944941182,0.031970247933884303,0.012675610786670066,0.08238635499868874,0.035041322314049606,1.6580180914979784e-07,0.10877613617595294,0.017851239669421492
7,0.5,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance in TEOAE and AABR outcomes be anticipated in newborns? With the screening methods available, discordant results between TEOAE and AABR may be inevitable for certain hearing loss categories in apparently healthy newborns whose mothers underwent prenatal care. The potential shortcomings of relying on perinatal morbidities for targeted screening need to be acknowledged.",2.3685972735685406e-08,0.020054214100678536,0.0007221837754709942,0.0018134264647818726,0.019940821287388832,0.0003766243752402823,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
7,0.5,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is discordance between TEOAE and AABR test results predictable in newborns? Considering existing screening technologies, some discordance between TEOAE and AABR may be unavoidable in specific hearing loss types among healthy-appearing newborns whose mothers received prenatal care. The limitations of using perinatal morbidities as a basis for targeted screening in such cases should be noted.",4.737194547137081e-08,0.011629129321992782,0.035199999999999974,0.0036268529295637453,0.012820968936166466,0.036800000000000034,0.003621603081905733,0.014098300735944314,0.03840000000000001,4.737194547137081e-08,0.01282309223879885,0.019599999999999992
7,0.5,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we predict discordant outcomes between TEOAE and AABR in newborns? Given the current screening tools, discordance in TEOAE and AABR may be inevitable for some hearing loss categories in apparently healthy newborns with mothers who had prenatal care. The possible limitations of using perinatal morbidities as the basis for targeted screening in these instances must be considered.",1.1842986367842703e-07,0.09648465573463305,0.003358677685950405,0.009067132323909363,0.09595304393715409,0.0017487603305785006,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
7,0.5,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it feasible to foresee discordance in TEOAE and AABR results among newborns? Based on the screening technologies available, discordant TEOAE and AABR outcomes may be unavoidable in certain hearing loss categories among apparently healthy newborns whose mothers received prenatal care. The potential drawbacks of using perinatal morbidities as criteria for targeted screening in such cases should be recognized.",1.4211583641411244e-07,0.11471505202249777,0.003961224489795918,0.010880558788691236,0.11408692378126695,0.002061734693877538,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
7,0.5,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Are discordant TEOAE and AABR outcomes predictable in newborns? With the screening technologies currently available, some discordance between TEOAE and AABR may be inevitable for certain types of hearing loss in apparently healthy newborns whose mothers had prenatal care. The limitations of perinatal morbidities as a basis for targeted screening in these cases must be acknowledged.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.058668538416332794,0.001088074047703811,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
7,0.5,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance in TEOAE and AABR outcomes be predicted in newborns? Given the screening methods at hand, discordant results between TEOAE and AABR might be unavoidable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of using perinatal morbidities as a foundation for targeted screening should be kept in mind.",1.4211583641411244e-07,0.11471505202249777,0.003961224489795918,0.010880558788691236,0.11408692378126695,0.002061734693877538,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
7,0.5,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discordance in TEOAE and AABR outcomes among newborns? Considering available screening technologies, discordant TEOAE and AABR results may be inevitable for some hearing loss categories in apparently healthy newborns whose mothers had prenatal care. The limitations of perinatal morbidities as a basis for targeted screening in these cases should be taken into account.",1.1842986367842703e-07,0.09648465573463305,0.003358677685950405,0.009067132323909363,0.09595304393715409,0.0017487603305785006,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
7,0.5,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we anticipate discordance between TEOAE and AABR outcomes in newborns? Given current screening technologies, discordant results may be unavoidable for certain hearing loss categories among apparently healthy newborns whose mothers underwent prenatal care. The potential limitations of using perinatal morbidities for targeted screening in such cases should be considered.",7.105791820705622e-08,0.006104406581574295,0.03840000000000001,0.005440279394345618,0.03344237944153461,0.019599999999999992,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
7,0.5,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is discordance between TEOAE and AABR outcomes predictable in newborns? Based on available screening technologies, discordant TEOAE and AABR results may be inevitable in some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The possible limitations of perinatal morbidities as a basis for targeted screening in these cases should be acknowledged.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.058668538416332794,0.001088074047703811,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
8,0.5,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article explores whether culture, attitudes, and faith have a role in recovery outcome measures, focusing on the cultural suitability of the RAQ in Australia and emphasizing the necessity for comprehensive and inclusive recovery metrics.",4.73719454713706e-08,0.01865023714217351,0.02775510204081633,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
8,0.5,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper examines the relevance of cultural factors, attitudes, and faith in recovery outcome assessments, highlighting the appropriateness of the RAQ in Australian contexts and the importance of creating rigorous, inclusive measures.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.5,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Investigating the place of culture, attitudes, and faith in recovery outcomes, this study reviews the RAQ's cultural fit in Australia and calls for the development of thorough and inclusive recovery measures.",1.421158364141118e-07,0.1438133800961805,0.02775510204081633,0.010880558788691277,0.18805223150294026,0.0,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
8,0.5,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research addresses the cultural relevance of the RAQ within Australian settings and underscores the need for robust, inclusive recovery outcome measures that consider culture, attitudes, and faith.",2.131737546211677e-07,0.24917389575400595,0.02775510204081633,0.016320838183036916,0.29725152346793093,0.0,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
8,0.5,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Focusing on recovery outcome measures, the paper questions the role of culture, attitudes, and faith, analyzing the RAQ's cultural appropriateness in Australia and advocating for rigorous, inclusive tools.",2.131737546211677e-07,0.24917389575400595,0.02775510204081633,0.016320838183036916,0.29725152346793093,0.0,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
8,0.5,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study discusses whether culture, attitudes, and faith should be included in recovery outcome measures, particularly assessing the RAQ's suitability in Australia and the demand for comprehensive, inclusive metrics.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.5,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper evaluates the inclusion of cultural, attitudinal, and faith-based factors in recovery outcome measures, reviewing the RAQ's cultural relevance in Australian settings and highlighting the need for inclusive and rigorous measures.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.5,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Exploring the significance of culture, attitudes, and faith in recovery outcomes, the article assesses the RAQ's appropriateness in Australia and stresses the importance of developing inclusive, rigorous recovery measures.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.5,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The article considers the role of culture, attitudes, and faith in recovery outcome measures, focusing on the RAQ's cultural fit in Australia and the necessity for rigorous, inclusive recovery metrics.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.5,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper investigates the cultural appropriateness of the RAQ in Australian contexts and identifies a need to create thorough, inclusive recovery outcome measures that incorporate culture, attitudes, and faith.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
9,0.5,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging enable prediction of various histologic subtypes of primary parotid gland tumors? Yes, it does, by evaluating apparent diffusion coefficient values to differentiate between benign and malignant tumors, facilitating precise diagnosis and treatment planning.",4.974054274493932e-07,0.2105088287435919,0.16493055555555555,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.37098260345145784,0.07100591715976332,4.974054274493935e-07,0.4557673085959473,0.0181755829903978
9,0.5,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Yes, this imaging technique helps distinguish benign from malignant tumors through apparent diffusion coefficient measurements, supporting accurate diagnosis and therapy decisions.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.5,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is it possible to predict histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Yes, the method allows differentiation between benign and malignant tumors by analyzing apparent diffusion coefficient values, aiding diagnosis and treatment.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.5,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging provide predictions for various histologic subtypes of primary parotid gland tumors? Yes, by assessing apparent diffusion coefficient values, it helps differentiate benign and malignant tumors, improving diagnostic accuracy and treatment planning.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.5,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can different histologic subtypes of primary parotid gland tumors be predicted with diffusion-weighted echo-planar MR imaging? Yes, this imaging modality uses apparent diffusion coefficient values to distinguish benign from malignant tumors, assisting in accurate diagnosis and therapeutic planning.",4.974054274493932e-07,0.2105088287435919,0.16493055555555555,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.37098260345145784,0.07100591715976332,4.974054274493935e-07,0.4557673085959473,0.0181755829903978
9,0.5,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is diffusion-weighted echo-planar MR imaging effective in predicting different histologic subtypes of primary parotid gland tumors? Yes, it enables differentiation between benign and malignant tumors through apparent diffusion coefficient evaluation, aiding precise diagnosis and treatment.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.5,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging allow for prediction of histologic subtypes in primary parotid gland tumors? Yes, by analyzing apparent diffusion coefficient values, it can distinguish benign from malignant tumors, facilitating accurate diagnosis and treatment planning.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.5,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging be used to predict various histologic subtypes of primary parotid gland tumors? Yes, it differentiates benign and malignant tumors by assessing apparent diffusion coefficient values, which supports correct diagnosis and treatment.",5.447773729207638e-07,0.26607867989840406,0.16493055555555555,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.4298231034743911,0.07100591715976332,5.447773729207643e-07,0.5163919304123827,0.0181755829903978
9,0.5,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is it feasible to predict different histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Yes, the technique assesses apparent diffusion coefficient values to differentiate tumor types, aiding diagnosis and treatment planning.",5.684633456564491e-07,0.29506621677165557,0.16493055555555555,0.04352223515476496,0.3762970304410662,0.1204,0.04345923698286882,0.4605947621411448,0.07100591715976332,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
9,0.5,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging assist in predicting histologic subtypes of primary parotid gland tumors? Yes, by evaluating apparent diffusion coefficient values, it helps distinguish between benign and malignant tumors, which supports accurate diagnosis and treatment planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
10,0.5,1,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does measuring end-tidal carbon dioxide correlate with arterial carbon dioxide levels in extremely low birth weight infants during their first week? Yes, end-tidal carbon dioxide readings can correspond with arterial carbon dioxide in extremely low birth weight infants in the initial week of life, though the strength of this correlation may differ depending on disease severity and ventilation type.",1.8948778188548325e-07,0.016946514147936576,0.05244878904481659,0.014507411718254981,0.024323805764113082,0.06710000000000002,0.014486412327622933,0.01594392449381843,0.07988571521335061,1.8948778188548325e-07,0.03217953840868537,0.07306314524741901
10,0.5,2,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a correlation between end-tidal and arterial carbon dioxide measurements in extremely low birth weight infants within the first week? End-tidal carbon dioxide can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life, but the accuracy of this correlation may be influenced by factors like disease severity and ventilation mode.",1.8948778188548325e-07,0.04573684687956625,0.16862114743856726,0.014507411718254981,0.024318101643601153,0.1005917159763313,0.014486412327622933,0.008811331954750923,0.09749184597225952,1.8948778188548325e-07,0.03217953840868537,0.07306314524741901
10,0.5,3,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide levels reflect arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, in extremely low birth weight infants, end-tidal carbon dioxide measurement can correspond to arterial carbon dioxide in the first week, although the correlation may vary due to disease severity and ventilation settings.",3.552895910352811e-07,0.15774903510360527,0.02861949732302216,0.02720139697172809,0.15146071557790064,0.0697314049586777,0.027162023114293,0.13532945629058668,0.08992754919731055,3.552895910352811e-07,0.14678214121587274,0.08855109778180172
10,0.5,4,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement align with arterial carbon dioxide in extremely low birth weight infants in the first week of life? End-tidal carbon dioxide can correlate with arterial carbon dioxide in these infants during their first week, but the correlation may be affected by the severity of illness and the ventilation method used.",3.079176455639103e-07,0.02953006718887652,0.0999232041587903,0.023574544042164344,0.0525227068686851,0.11111111111111112,0.023540420032387266,0.06481344146016399,0.11174127835395523,3.079176455639103e-07,0.10480490139468568,0.08938332986255726
10,0.5,5,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a relationship between end-tidal and arterial carbon dioxide in extremely low birth weight infants during their initial week? Yes, end-tidal carbon dioxide measurements can correspond with arterial carbon dioxide levels in extremely low birth weight infants in the first week, though the correlation can vary with disease severity and ventilation type.",3.316036182995957e-07,0.0626648029826753,0.16516012396694213,0.025387970506946217,0.10121397682183364,0.09061909262759923,0.025351221573340132,0.11342924567373736,0.0911360868774145,3.316036182995957e-07,0.15386516480082202,0.06863258261656857
10,0.5,6,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide measurements be used to estimate arterial carbon dioxide in extremely low birth weight infants during the first week? Yes, they can correlate, but the accuracy depends on factors such as the severity of disease and the ventilation mode.",5.921493183921352e-07,0.1108099925880146,0.335,0.045335661619546816,0.20824894355772328,0.1875,0.045270038523821665,0.27871294330504526,0.15089163237311393,5.921493183921352e-07,0.35151585987404665,0.109375
10,0.5,7,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Do end-tidal carbon dioxide readings correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, there is a correlation, but it may vary based on disease severity and ventilation methods.",7.342651548062471e-07,0.2748303505323304,0.33082828719723184,0.05621622040823806,0.3707678730554975,0.1875,0.05613484776953888,0.44576702796820955,0.15089163237311393,7.342651548062476e-07,0.5233661168007067,0.109375
10,0.5,8,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is end-tidal carbon dioxide measurement a reliable indicator of arterial carbon dioxide in extremely low birth weight infants within the first week? It can be, but the correlation varies and is influenced by disease severity and ventilation mode.",6.868932093348765e-07,0.21711950422520943,0.3323688271604938,0.052589367478674306,0.31360945921554917,0.1875,0.05251324468763313,0.38692652794527627,0.15089163237311393,6.868932093348768e-07,0.4627414949842712,0.109375
10,0.5,9,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does the measurement of end-tidal carbon dioxide correlate with arterial carbon dioxide in extremely low birth weight infants in their first week? Yes, it can correlate, although the strength of this correlation may be affected by factors like disease severity and ventilation technique.",5.684633456564497e-07,0.0859073920187563,0.33557964009518143,0.04352223515476494,0.18355633096735158,0.1875,0.0434592369828688,0.25339513532075353,0.15089163237311393,5.684633456564497e-07,0.3255403734707887,0.109375
10,0.5,10,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide levels correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life? Yes, correlation exists but varies depending on disease severity and the mode of ventilation.",7.342651548062471e-07,0.2748303505323304,0.33082828719723184,0.05621622040823806,0.3707678730554975,0.1875,0.05613484776953888,0.44576702796820955,0.15089163237311393,7.342651548062476e-07,0.5233661168007067,0.109375
11,0.5,1,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does the coexistence of major depression and alcohol use disorder in adolescence result in worse depression outcomes? Findings indicate that slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are due to greater exposure to adverse childhood experiences in this group. Adolescent MD/AUD comorbidity probably serves as a risk indicator rather than a causal factor.,1.6580180914979784e-07,0.09261665379352646,0.015380859375,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
11,0.5,2,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does having both major depression and alcohol use disorder during adolescence lead to poorer depression outcomes? Analysis shows that the modestly higher depression rates by age 35 in the comorbid MD/AUD group can be attributed to more frequent adverse childhood experiences among these individuals. Comorbid adolescent MD/AUD is likely a marker of risk instead of a direct cause.,1.8948778188548325e-07,0.11000839650539529,0.015380859375,0.014507411718254981,0.13353139262452185,0.0,0.014486412327622933,0.13580154115906407,0.0,1.8948778188548325e-07,0.13815033848081626,0.0
11,0.5,3,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Is comorbidity of major depression and alcohol use disorder in adolescence associated with worse depression outcomes? The data suggest that the slightly increased depression rates through age 35 in the comorbid MD/AUD group stem from increased exposure to negative childhood environments. Adolescent MD/AUD comorbidity probably indicates risk rather than causes it.,3.552895910352811e-07,0.24103665891180004,0.015380859375,0.02720139697172809,0.2670627852490446,0.0,0.027162023114293,0.2719337154836441,0.0,3.552895910352811e-07,0.2769867833350337,0.0
11,0.5,4,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does the combination of major depression and alcohol use disorder in adolescence lead to poorer depression prognosis? Results imply that marginally higher depression rates by age 35 in the comorbid MD/AUD group are explained by greater exposure to adverse childhood conditions. Comorbid adolescent MD/AUD is more likely a risk marker than a causal factor.,2.8423167282822487e-07,0.18276775078782448,0.015380859375,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
11,0.5,5,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Is the coexistence of major depression and alcohol use disorder in adolescence linked to worse depression outcomes? Findings reveal that the slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are due to increased adverse childhood experiences. Adolescent MD/AUD comorbidity seems to be a risk indicator rather than a direct cause.,2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.5,6,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does adolescent comorbidity of major depression and alcohol use disorder result in poorer depression outcomes? Analysis suggests that the modestly higher depression rates by age 35 in the comorbid MD/AUD group are explained by greater exposure to adverse childhood circumstances. This comorbidity is likely a marker of risk rather than a cause.,3.316036182995957e-07,0.22123403161562027,0.015380859375,0.025387970506946217,0.24686007793152598,0.0,0.025351221573340132,0.25131442828090833,0.0,3.316036182995957e-07,0.2559333741372005,0.0
11,0.5,7,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Are depression outcomes worse when major depression and alcohol use disorder co-occur in adolescence? The results indicate that the marginally higher depression rates through age 35 in the comorbid MD/AUD group are due to increased exposure to adverse childhood environments. Adolescent MD/AUD comorbidity is probably a risk marker rather than a causal factor.,3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.5,8,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does having both major depression and alcohol use disorder during adolescence predict poorer depression outcomes? Findings suggest that the slightly elevated depression rates by age 35 among the comorbid MD/AUD group are explained by increased adverse childhood experiences. Comorbid adolescent MD/AUD likely serves as a risk indicator, not a direct cause.",3.552895910352811e-07,0.24103665891180004,0.015380859375,0.02720139697172809,0.2670627852490446,0.0,0.027162023114293,0.2719337154836441,0.0,3.552895910352811e-07,0.2769867833350337,0.0
11,0.5,9,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Is the presence of major depression and alcohol use disorder in adolescence associated with worse depression outcomes? The analysis shows that the marginally higher depression rates up to age 35 in the comorbid MD/AUD group result from greater exposure to adverse childhood conditions. Adolescent MD/AUD comorbidity is probably a risk marker rather than a causal factor.,2.3685972735685406e-07,0.14572647910747438,0.015380859375,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
11,0.5,10,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does comorbidity of major depression and alcohol use disorder in adolescence lead to worse outcomes for depression? The results suggest that slightly higher depression rates by age 35 in the comorbid MD/AUD group are explained by increased exposure to adverse childhood circumstances. This comorbidity is likely a risk marker rather than a cause.,3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
12,0.5,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does having an optimistic perspective lead to improved survival rates in older age? Answer: Yes, optimism is associated with better survival in advanced age. Studies show that optimism may contribute to longevity by affecting how people cope with challenges.",1.1842986367842692e-07,0.06841215236409459,0.13296398891966763,0.009067132323909363,0.005343659020720537,0.09204470742932283,0.009054007704764333,0.06073768844295824,0.047500000000000014,1.1842986367842703e-07,0.09624107065990772,0.024375
12,0.5,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can an optimistic attitude forecast greater survival among the elderly? Answer: Yes, an optimistic attitude is predictive of enhanced survival at older ages. Research suggests that optimism supports longevity through its impact on coping mechanisms.",2.1317375462116813e-07,0.11901825291155843,0.07603102289579253,0.01632083818303686,0.14665533965185373,0.06265995077183889,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
12,0.5,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is there a link between optimism and increased survival in later life? Answer: Yes, optimism can be a predictor of better survival outcomes in advanced age. Evidence points to optimism influencing coping strategies that promote longevity.",1.8948778188548283e-07,0.011630555309439572,0.13296398891966763,0.014507411718254981,0.0768944392162525,0.09204470742932283,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
12,0.5,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does an optimistic outlook correlate with longer life expectancy in the elderly? Answer: Yes, having an optimistic outlook is connected to improved survival at older ages. Studies indicate optimism helps individuals manage stress, thereby enhancing longevity.",1.8948778188548283e-07,0.08864690870498926,0.07760066712035965,0.014507411718254981,0.11650284953396373,0.06349799462655467,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
12,0.5,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can optimism improve survival chances in advanced age? Answer: Yes, an optimistic mindset is associated with better survival rates among the elderly. Research reveals optimism’s role in shaping effective coping strategies that support longevity.",2.3685972735685343e-07,0.06878896914938792,0.13296398891966763,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.5,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is optimism a predictor of survival in older adults? Answer: Yes, optimism can predict greater survival in advanced age. Scientific findings link optimism to longevity through its positive influence on coping behaviors.",2.84231672828224e-07,0.17273528975082098,0.10174650712986533,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
12,0.5,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does maintaining optimism influence survival at advanced ages? Answer: Yes, maintaining an optimistic perspective is linked to better survival outcomes in older adults. Research suggests optimism aids longevity by improving coping methods.",2.84231672828224e-07,0.1294135909658234,0.13296398891966763,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
12,0.5,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can a positive outlook enhance survival prospects in elderly populations? Answer: Yes, a positive outlook is predictive of improved survival at advanced ages. Studies associate optimism with longevity due to its effect on coping strategies.",2.1317375462116813e-07,0.11901825291155843,0.07603102289579253,0.01632083818303686,0.14665533965185373,0.06265995077183889,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
12,0.5,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is an optimistic viewpoint associated with increased longevity in later years? Answer: Yes, optimism is associated with longer survival in advanced age. Research indicates that optimism affects how individuals cope, contributing to greater longevity.",2.3685972735685343e-07,0.10956233271173765,0.10357923226218368,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.5,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does optimism predict better survival rates among the aged? Answer: Yes, optimism can forecast improved survival in older individuals. Evidence shows optimism influences coping mechanisms that are beneficial for longevity.",3.3160361829959463e-07,0.1939521121033949,0.13296398891966763,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.33945109091197967,0.047500000000000014,3.316036182995957e-07,0.3839231431116885,0.024375
13,0.5,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? ACR independently predicts negative outcomes for both mother and baby in suspected preeclampsia cases and could enhance risk prediction models.,2.3685972735685396e-07,0.03021660039242624,0.13888888888888887,0.018134264647818726,0.08920918856484938,0.10275824770146022,0.018108015409528666,0.12124719024711839,0.08436992969172526,2.3685972735685406e-07,0.15471195622081746,0.06489994591671175
13,0.5,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia serve as a prognostic indicator for adverse maternal and neonatal outcomes? ACR is an independent prognostic marker for poor outcomes in these women and may improve risk assessment models.,1.8948778188548325e-07,0.019793820182237187,0.13888888888888887,0.014507411718254981,0.03791589417729968,0.10275824770146022,0.014486412327622933,0.06860345676169954,0.08436992969172526,1.8948778188548325e-07,0.10064473495054127,0.06489994591671175
13,0.5,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia forecast adverse maternal and neonatal results? ACR acts as an independent prognostic factor for unfavorable outcomes and may aid in refining risk prediction within prognostic frameworks.,2.8423167282822456e-07,0.08286033387784508,0.13888888888888887,0.02176111757738247,0.14327640983512557,0.10275824770146022,0.0217296184914344,0.17681704140193055,0.08436992969172526,2.8423167282822487e-07,0.2118703700607658,0.06489994591671175
13,0.5,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in suspected preeclampsia cases among women a predictor for maternal and neonatal complications? ACR independently forecasts adverse maternal and neonatal outcomes and could be valuable in risk prediction models.,3.3160361829959516e-07,0.21764700566807926,0.08195592286501376,0.025387970506946224,0.24120818723742365,0.07337349104397628,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.2724949918772013,0.06489994591671175
13,0.5,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predict maternal and neonatal adverse outcomes? ACR is an independent prognostic factor and may help improve risk prediction models for such outcomes.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
13,0.5,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) a prognostic factor for adverse maternal and neonatal outcomes in women suspected of preeclampsia? ACR independently predicts these adverse outcomes and may be useful for risk prediction within prognostic models.,3.0791764556390986e-07,0.1102593080659604,0.13888888888888887,0.023574544042164344,0.17144728680182242,0.10275824770146022,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2417233332104476,0.06489994591671175
13,0.5,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic indicator for maternal and neonatal adverse outcomes? ACR is an independent predictor and may inform risk predictions in prognostic models.,3.3160361829959516e-07,0.13843018503265725,0.13888888888888887,0.025387970506946224,0.20043482367507393,0.10275824770146022,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.2724949918772013,0.06489994591671175
13,0.5,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia an independent prognostic factor for poor maternal and neonatal outcomes? ACR may be helpful in risk prediction models for these adverse events.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
13,0.5,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does measuring the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia provide prognostic information about maternal and neonatal adverse outcomes? ACR independently predicts such outcomes and may be useful in risk prediction models.,3.5528959103528046e-07,0.16741772190590876,0.13888888888888887,0.027201396971728103,0.2302877868247557,0.10275824770146022,0.02716202311429302,0.2664292000916175,0.08436992969172526,3.552895910352811e-07,0.3042436901917811,0.06489994591671175
13,0.5,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) an independent prognostic factor for maternal and neonatal adverse outcomes in women suspected of preeclampsia? ACR may assist in improving risk prediction within prognostic models.,4.2634750924233636e-07,0.25979104203692405,0.13888888888888887,0.03264167636607374,0.3255979666290809,0.10275824770146022,0.03259442773715164,0.3648692729048708,0.08436992969172526,4.263475092423373e-07,0.40602638450172357,0.06489994591671175
14,0.5,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Question: Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Answer: Rapid prescreening might not reliably identify glandular cell abnormalities in Pap smears. Conventional techniques, like manual examination by a cytotechnologist or pathologist, are generally more dependable for spotting these abnormalities.",1.1842986367842703e-07,0.21501039311438275,0.07291628484204242,0.009067132323909363,0.21650550254965673,0.07271468144044323,0.009054007704764333,0.18709775371237747,0.049861495844875335,1.1842986367842703e-07,0.1561739970481013,0.025623268698060954
14,0.5,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Can rapid prescreening detect glandular cell abnormalities in Pap smears? Answer: Rapid prescreening often fails to effectively detect glandular cell abnormalities in Pap smears. Manual slide review by a cytotechnologist or pathologist remains the more trusted method for identifying such abnormalities.,1.4211583641411244e-07,0.3099522558308112,0.12077427568380855,0.010880558788691236,0.27839137848714657,0.09876543209876545,0.0108648092457172,0.24973887141912732,0.0763888888888889,1.4211583641411244e-07,0.2195663353034485,0.05246913580246914
14,0.5,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Is rapid prescreening effective for detecting glandular cell abnormalities in Pap smears? Answer: Rapid prescreening may not be efficient in detecting glandular cell abnormalities in Pap smears. Traditional manual review by specialists such as cytotechnologists or pathologists is usually more accurate.,1.4211583641411244e-07,0.3099522558308112,0.12077427568380855,0.010880558788691236,0.27839137848714657,0.09876543209876545,0.0108648092457172,0.24973887141912732,0.0763888888888889,1.4211583641411244e-07,0.2195663353034485,0.05246913580246914
14,0.5,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Do glandular cell abnormalities in Pap smears get detected through rapid prescreening? Answer: Rapid prescreening might not be sufficient to detect glandular cell abnormalities in Pap smears. More reliable detection typically comes from manual slide reviews conducted by cytotechnologists or pathologists.,1.4211583641411244e-07,0.24232814065423103,0.07515420442667164,0.010880558788691236,0.2437340194591493,0.07450693937180423,0.0108648092457172,0.2141928621596434,0.05113221329437545,1.4211583641411244e-07,0.1830849047476617,0.026296566837107373
14,0.5,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Are Pap smear glandular cell abnormalities identified by rapid prescreening? Answer: Rapid prescreening may not effectively identify glandular cell abnormalities in Pap smears. Manual examination by a cytotechnologist or pathologist is generally considered more reliable for this purpose.,2.1317375462116844e-07,0.2560286783905661,0.031202595159747038,0.016320838183036854,0.25519089901027137,0.027006172839506164,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
14,0.5,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Does rapid prescreening detect glandular cell abnormalities in Pap smears? Answer: Rapid prescreening is not always effective at detecting glandular cell abnormalities in Pap smears. Manual review by trained cytotechnologists or pathologists remains the preferred method for detection.,2.1317375462116844e-07,0.36547297005792645,0.10729176973377008,0.016320838183036854,0.33012572934107753,0.08044982698961935,0.0162972138685758,0.30015990470975895,0.055363321799307974,2.1317375462116866e-07,0.2684499827465596,0.02854671280276816
14,0.5,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Can glandular cell abnormalities in Pap smears be found by rapid prescreening? Answer: Rapid prescreening might not accurately detect glandular cell abnormalities in Pap smears. Traditional manual review by cytotechnologists or pathologists is typically more reliable for identifying these abnormalities.,1.6580180914979784e-07,0.27040195900343145,0.07749889145604336,0.012693985253473108,0.2717177781379023,0.0763888888888889,0.012675610786670066,0.2420391911555062,0.05246913580246914,1.6580180914979784e-07,0.21073913643943865,0.027006172839506164
14,0.5,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Is rapid prescreening a reliable method for detecting glandular cell abnormalities in Pap smears? Answer: Rapid prescreening may not reliably detect glandular cell abnormalities in Pap smears. Manual slide review by cytotechnologists or pathologists is usually more dependable.,2.1317375462116844e-07,0.36547297005792645,0.10729176973377008,0.016320838183036854,0.33012572934107753,0.08044982698961935,0.0162972138685758,0.30015990470975895,0.055363321799307974,2.1317375462116866e-07,0.2684499827465596,0.02854671280276816
14,0.5,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Are glandular cell abnormalities in Pap smears effectively detected by rapid prescreening? Answer: Rapid prescreening may not be effective in detecting glandular cell abnormalities in Pap smears. Manual review by cytotechnologists or pathologists is generally more reliable.,2.3685972735685374e-07,0.35960372502276483,0.08525320224065713,0.018134264647818726,0.3606469881263088,0.08264462809917354,0.018108015409528666,0.3305312489163281,0.056932966023875105,2.3685972735685406e-07,0.29860247286444963,0.029384756657483937
14,0.5,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Question: Does rapid prescreening successfully identify glandular cell abnormalities in Pap smears? Answer: Rapid prescreening may not successfully identify glandular cell abnormalities in Pap smears. Manual examination by a cytotechnologist or pathologist is typically more reliable.,2.8423167282822434e-07,0.5425627877399437,0.1662334593572779,0.02176111757738248,0.5061476896846808,0.14268727705112957,0.021729618491434413,0.4781906084395837,0.1189060642092747,2.8423167282822487e-07,0.4484188274735259,0.09274673008323425
15,0.5,1,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do Provider Service Networks (PSNs) in Florida's Medicaid program lead to reduced costs compared to HMOs or primary care case management? PSNs may offer lower expenditures, but savings vary based on factors like PSN efficiency.",5.684633456564491e-07,0.29506621677165557,0.16493055555555558,0.04352223515476496,0.4006179841449238,0.10380622837370242,0.04345923698286882,0.5101052750382835,0.03566529492455417,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
15,0.5,2,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida's Medicaid program, do Provider Service Networks result in cost savings compared to HMOs or primary care case management? PSNs could lower expenses, though actual savings depend on elements such as how efficiently the PSN operates.",5.210914001850785e-07,0.2379078029317072,0.16493055555555558,0.0398953822252012,0.3417774841219905,0.10380622837370242,0.03983763390096307,0.44948065322184805,0.03566529492455417,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
15,0.5,3,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are expenditures lower with Provider Service Networks than with HMOs or primary care case management in Florida's Medicaid program? PSNs might reduce costs, but the extent of savings relies on factors including PSN efficiency.",5.921493183921344e-07,0.32491917992133734,0.16493055555555558,0.04533566161954684,0.43138964281167747,0.10380622837370242,0.04527003852382169,0.5418539733528633,0.03566529492455417,5.921493183921352e-07,0.5809304515499543,0.0181755829903978
15,0.5,4,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Within Florida's Medicaid program, do Provider Service Networks yield lower costs compared to HMOs or primary care case management? Potentially yes, but savings are influenced by factors like the effectiveness of the PSN.",6.158352911278197e-07,0.35569083858809103,0.16493055555555558,0.047149088084328716,0.4631383411262573,0.10380622837370242,0.047080840064774566,0.574643796175855,0.03566529492455417,6.158352911278206e-07,0.614832003225636,0.0181755829903978
15,0.5,5,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do Provider Service Networks in Florida's Medicaid program reduce spending relative to HMOs or primary care case management? They can, although actual cost reductions depend on aspects such as the PSN's operational efficiency.",6.158352911278197e-07,0.35569083858809103,0.16493055555555558,0.047149088084328716,0.4631383411262573,0.10380622837370242,0.047080840064774566,0.574643796175855,0.03566529492455417,6.158352911278206e-07,0.614832003225636,0.0181755829903978
15,0.5,6,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In the context of Florida's Medicaid program, do PSNs lead to lower expenditures than HMOs or primary care case management? PSNs may achieve cost savings, but the precise amount depends on factors including PSN efficiency.",5.684633456564491e-07,0.29506621677165557,0.16493055555555558,0.04352223515476496,0.4006179841449238,0.10380622837370242,0.04345923698286882,0.5101052750382835,0.03566529492455417,5.684633456564497e-07,0.5481406287269626,0.0181755829903978
15,0.5,7,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do Provider Service Networks result in decreased costs compared to HMOs or primary care case management within Florida's Medicaid program? They have the potential to do so, but savings are contingent on factors like the PSN's efficiency.",5.210914001850785e-07,0.2379078029317072,0.16493055555555558,0.0398953822252012,0.3417774841219905,0.10380622837370242,0.03983763390096307,0.44948065322184805,0.03566529492455417,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
15,0.5,8,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are costs lower with Provider Service Networks than with HMOs or primary care case management in Florida's Medicaid program? PSNs might reduce expenditures, though actual savings depend on the efficiency of the PSN.",6.158352911278197e-07,0.35569083858809103,0.16493055555555558,0.047149088084328716,0.4631383411262573,0.10380622837370242,0.047080840064774566,0.574643796175855,0.03566529492455417,6.158352911278206e-07,0.614832003225636,0.0181755829903978
15,0.5,9,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida's Medicaid program, do Provider Service Networks lead to lower expenditures relative to HMOs or primary care case management? They can, but the savings depend on various factors such as PSN efficiency.",6.158352911278197e-07,0.35569083858809103,0.16493055555555558,0.047149088084328716,0.4631383411262573,0.10380622837370242,0.047080840064774566,0.574643796175855,0.03566529492455417,6.158352911278206e-07,0.614832003225636,0.0181755829903978
15,0.5,10,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do Provider Service Networks in Florida's Medicaid program potentially lower costs compared with HMOs or primary care case management? Yes, but the exact savings depend on factors like the efficiency of the PSN.",6.158352911278197e-07,0.35569083858809103,0.16493055555555558,0.047149088084328716,0.4631383411262573,0.10380622837370242,0.047080840064774566,0.574643796175855,0.03566529492455417,6.158352911278206e-07,0.614832003225636,0.0181755829903978
16,0.5,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage effective for treating postoperative cerebrospinal fluid fistula following spine surgery? Yes, lumbar drainage is typically an effective approach for managing cerebrospinal fluid (CSF) fistulas after spine surgery, providing a dependable way to control CSF leaks.",7.10579182070559e-08,0.12436250042346186,0.13362244897959183,0.005440279394345618,0.13323334788337027,0.14876033057851237,0.0054324046228586,0.06368762398617411,0.10380622837370242,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
16,0.5,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage work for postoperative cerebrospinal fluid fistulas after spine surgery? Yes, lumbar drainage is commonly successful in treating postoperative CSF fistulas after spine surgery and is a trusted method to handle CSF leaks.",1.421158364141118e-07,0.007580147960844386,0.10009105098855357,0.01088055878869125,0.00421305085980439,0.11848689307851237,0.01086480924571722,0.025924534703512858,0.10380622837370242,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
16,0.5,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a successful treatment for cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is generally effective for postoperative CSF fistulas following spine surgery, offering a reliable solution for managing CSF leaks.",1.658018091497971e-07,0.04287805954258639,0.1572265625,0.01269398525347313,0.015450312226986451,0.14876033057851237,0.012675610786670094,0.057673233018092684,0.10380622837370242,1.6580180914979784e-07,0.13478570065126494,0.05387755102040818
16,0.5,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Can lumbar drainage effectively treat postoperative cerebrospinal fluid fistulas after spine surgery? Yes, lumbar drainage is usually an effective technique to manage CSF fistulas after spine surgery and is a dependable method for controlling CSF leaks.",1.184298636784265e-07,0.024902248646321734,0.1025390625,0.00906713232390937,0.035301570481072186,0.11937557392102843,0.009054007704764347,0.004847123963240829,0.10380622837370242,1.1842986367842703e-07,0.07024717951369341,0.05387755102040818
16,0.5,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage effective in managing postoperative cerebrospinal fluid fistulas after spine surgery? Yes, lumbar drainage is widely regarded as an effective treatment for CSF fistulas following spine surgery and serves as a reliable way to handle CSF leaks.",4.73719454713706e-08,0.1894841472806421,0.16120343316289262,0.0036268529295637453,0.1606323220714856,0.14876033057851237,0.003621603081905733,0.09185850095287096,0.10380622837370242,4.737194547137081e-08,0.019364979175993557,0.05387755102040818
16,0.5,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage effectively address postoperative cerebrospinal fluid fistulas after spine surgery? Yes, lumbar drainage is generally an effective method for treating CSF fistulas after spine surgery and provides a dependable approach to managing CSF leaks.",1.184298636784265e-07,0.024902248646321734,0.1025390625,0.00906713232390937,0.035301570481072186,0.11937557392102843,0.009054007704764347,0.004847123963240829,0.10380622837370242,1.1842986367842703e-07,0.07024717951369341,0.05387755102040818
16,0.5,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a reliable treatment for postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is typically effective in managing postoperative CSF fistulas after spine surgery and is a trusted method to control CSF leaks.",9.47438909427412e-08,0.09488200317060258,0.13213667820069203,0.0072537058591274906,0.10506247091667342,0.14876033057851237,0.007243206163811473,0.034700087112922606,0.10380622837370242,9.474389094274162e-08,0.03947552084693973,0.05387755102040818
16,0.5,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage treatment effective for postoperative cerebrospinal fluid fistulas following spine surgery? Yes, lumbar drainage is commonly effective in treating CSF fistulas after spine surgery and serves as a reliable method to manage CSF leaks.",1.184298636784265e-07,0.10411906928174419,0.15895328719723184,0.00906713232390937,0.07607493404342192,0.14876033057851237,0.009054007704764347,0.004847123963240829,0.10380622837370242,1.1842986367842703e-07,0.07024717951369341,0.05387755102040818
16,0.5,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Can lumbar drainage successfully treat postoperative cerebrospinal fluid fistulas after spine surgery? Yes, lumbar drainage is generally a successful approach for managing CSF fistulas post-spine surgery and is a dependable method for controlling CSF leaks.",1.421158364141118e-07,0.07396657916385418,0.15811524334251606,0.01088055878869125,0.04622197089374014,0.14876033057851237,0.01086480924571722,0.025924534703512858,0.10380622837370242,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
16,0.5,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage an effective method for postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is usually effective in treating CSF fistulas following spine surgery and provides a reliable way to manage CSF leaks.",1.184298636784265e-07,0.10411906928174419,0.15895328719723184,0.00906713232390937,0.07607493404342192,0.14876033057851237,0.009054007704764347,0.004847123963240829,0.10380622837370242,1.1842986367842703e-07,0.07024717951369341,0.05387755102040818
17,0.5,1,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Does differential symptom reporting explain the higher depression rates in women? Differential symptom reporting partly explains the increased depression rates in women since women may be more inclined to report symptoms or seek assistance. However, it",1.184298636784265e-07,0.11867823875538175,0.010066045148548516,0.00906713232390937,0.1121098208597302,0.017795138888888895,0.009054007704764347,0.06811573714833319,0.05246913580246914,1.1842986367842703e-07,0.10771459467909672,0.027006172839506164
17,0.5,2,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the elevated depression rate in women due to differences in symptom reporting? Differences in symptom reporting do play a role in the higher depression prevalence among women, as they might be more prone to report symptoms or pursue help. However, it",2.3685972735685406e-08,0.13035529255377742,0.0737967770934804,0.0018134264647818726,0.09729847673474756,0.051405325443786974,0.0018108015409528666,0.0989383475148311,0.05246913580246914,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
17,0.5,3,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are women's higher depression rates explained by how symptoms are reported differently? Reporting differences contribute to the higher depression rates in women because women are potentially more likely to disclose symptoms or seek treatment. However, it",1.184298636784265e-07,0.03946141811995929,0.06551601356796163,0.00906713232390937,0.07133645729738003,0.047004132231404955,0.009054007704764347,0.06811573714833319,0.05246913580246914,1.1842986367842703e-07,0.10771459467909672,0.027006172839506164
17,0.5,4,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Can the higher incidence of depression in women be attributed to variations in symptom reporting? Variations in symptom reporting do contribute to women's higher depression rates, as women may be more likely to express symptoms or seek medical help. However, it",0.0,0.10397207708399137,0.07258748374696139,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914,0.0,0.03746741516540242,0.027006172839506164
17,0.5,5,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the increased depression rate in women due to differential symptom reporting? Differential symptom reporting partially accounts for the elevated depression rates in women, since women might be more inclined to report symptoms or look for help. However, it",4.73719454713706e-08,0.08551207019664941,0.09615241275472936,0.0036268529295637453,0.053994294293033374,0.0763888888888889,0.003621603081905733,0.01889563984129694,0.05246913580246914,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
17,0.5,6,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Do differences in symptom reporting explain why depression rates are higher in women? Differences in symptom reporting do contribute to the higher depression rates among women because women may be more willing to report symptoms or seek assistance. However, it",2.36859727356853e-08,0.005784950117757592,0.02122448979591833,0.0018134264647818726,0.0076996802636211115,0.023919753086419755,0.0018108015409528666,0.008827198864009844,0.025462962962962975,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
17,0.5,7,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are higher depression rates in women a result of differential symptom reporting? Differential symptom reporting contributes to higher depression rates in women, as women might be more likely to report symptoms or seek help. However, it",1.184298636784265e-07,0.11867823875538175,0.010066045148548516,0.00906713232390937,0.1121098208597302,0.017795138888888895,0.009054007704764347,0.11012465718226894,0.02219569830246914,1.1842986367842703e-07,0.10771459467909672,0.027006172839506164
17,0.5,8,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the disparity in depression rates between genders explained by symptom reporting differences? Symptom reporting differences do contribute to the higher depression rates in women, as women may be more likely to report symptoms or seek help. However, it",4.73719454713706e-08,0.04903063964086263,0.06997984378936759,0.0036268529295637453,0.053994294293033374,0.0763888888888889,0.003621603081905733,0.01889563984129694,0.05246913580246914,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
17,0.5,9,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Could the greater prevalence of depression in women be due to differences in how symptoms are reported? Differences in symptom reporting do play a role in women's higher depression rates, since women might be more likely to report symptoms or seek help. However, it",7.105791820705622e-08,0.2133680529726374,0.09920634920634921,0.005440279394345618,0.18074599993217566,0.0763888888888889,0.0054324046228586,0.14894876808949453,0.05246913580246914,7.105791820705622e-08,0.11542895663511299,0.027006172839506164
17,0.5,10,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are women's elevated depression rates explained by differential symptom reporting? Differential symptom reporting contributes to the higher depression rates in women because women may be more likely to report symptoms or seek help. However, it",1.421158364141118e-07,0.07077886148248869,0.06385522959183673,0.01088055878869125,0.06041605688471208,0.0763888888888889,0.01086480924571722,0.09888739581508688,0.05246913580246914,1.4211583641411244e-07,0.13946329299367655,0.027006172839506164
18,0.5,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a link between crime and over-the-counter pharmacy syringe sales? Our research shows that OTC pharmacy syringe sales did not correlate with a rise in reported crime in Los Angeles communities from 2006 to 2008.,4.73719454713706e-08,0.10324992977309444,0.03180708532418292,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.5,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does crime relate to the sale of syringes over the counter in pharmacies? Findings indicate no association between OTC syringe sales and increased crime reports in Los Angeles neighborhoods during 2006-2008.,7.10579182070559e-08,0.011292339736452828,0.06035379812695108,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
18,0.5,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales connected to crime rates? The data reveal that OTC syringe sales were not linked to higher crime reports in Los Angeles localities between 2006 and 2008.,7.10579182070559e-08,0.05750215177378237,0.027060100148354166,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
18,0.5,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime influenced by the availability of syringes sold over the counter in pharmacies? Our study found no evidence that OTC syringe sales led to more reported crime in Los Angeles communities from 2006 through 2008.,4.73719454713706e-08,0.14285834009080567,0.06035379812695108,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.5,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Do over-the-counter pharmacy syringe sales contribute to crime? Results demonstrate no connection between OTC syringe sales and increased crime incidents reported in Los Angeles areas during 2006-2008.,1.658018091497971e-07,0.20771219726635204,0.02195379812695107,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
18,0.5,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there an association between crime and OTC pharmacy syringe sales? The analysis shows that selling syringes OTC in pharmacies did not increase reported crime in Los Angeles communities from 2006 to 2008.,2.36859727356853e-08,0.0532461814011187,0.06035379812695108,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
18,0.5,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are crime rates affected by over-the-counter sales of syringes in pharmacies? Our findings indicate no rise in reported crime linked to OTC syringe sales in Los Angeles between 2006 and 2008.,7.10579182070559e-08,0.011292339736452828,0.06035379812695108,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
18,0.5,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does the sale of syringes over the counter at pharmacies correlate with crime? Evidence from 2006-2008 in Los Angeles suggests no increase in crime reports due to OTC syringe sales.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.5,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime correlated with OTC pharmacy syringe sales? The study results show no association between OTC syringe sales and increased crime reports in Los Angeles communities during 2006-2008.,1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
18,0.5,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales related to crime levels? Our findings confirm that OTC syringe sales did not lead to an increase in reported crime in local Los Angeles communities from 2006 to 2008.,0.0,0.042008920033936636,0.030080360626951082,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
19,0.5,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology evaluation required for the treatment of ductal carcinoma in situ? Answer: Yes, expert breast pathology evaluation is crucial for the treatment of ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.09676491279688726,0.07680498163452701,0.003626852929563759,0.10594427408294083,0.10612022684310021,0.003621603081905747,0.11621306957942412,0.1279483070348455,4.737194547137081e-08,0.07442356653769577,0.10560000000000003
19,0.5,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is it necessary to have expert breast pathology assessment in managing ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is vital for managing ductal carcinoma in situ (DCIS).",2.36859727356853e-08,0.004341051389695316,0.022569444444444448,0.0018134264647818796,0.007590156824194949,0.028799999999999937,0.0018108015409528735,0.011309146026370787,0.03402366863905328,2.3685972735685406e-08,0.03774032798284699,0.0
19,0.5,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is specialized breast pathology review important for the management of ductal carcinoma in situ? Answer: Yes, specialized breast pathology review is important for managing ductal carcinoma in situ (DCIS).",0.0,0.047803253831721015,0.027886079605124875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
19,0.5,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Does managing ductal carcinoma in situ require expert breast pathology analysis? Answer: Yes, expert breast pathology analysis is necessary for managing ductal carcinoma in situ (DCIS).",7.10579182070559e-08,0.19009710614174846,0.04506944444444441,0.005440279394345639,0.18660424439477064,0.04859501133786848,0.005432404622858621,0.18196333015267374,0.045662379578463495,7.105791820705622e-08,0.18287598996711107,0.04338842975206613
19,0.5,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology consultation needed for ductal carcinoma in situ management? Answer: Yes, expert breast pathology consultation is needed for effective management of ductal carcinoma in situ (DCIS).",0.0,0.09560650766344159,0.05201159320477505,0.0,0.049510512897140035,0.03328888888888884,0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0
19,0.5,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is professional breast pathology assessment essential for treating ductal carcinoma in situ? Answer: Yes, professional breast pathology assessment is essential in the treatment of ductal carcinoma in situ (DCIS).",0.0,0.0,0.0,0.0,0.0,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0
19,0.5,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert evaluation by a breast pathologist necessary for the management of ductal carcinoma in situ? Answer: Yes, expert evaluation by a breast pathologist is necessary for managing ductal carcinoma in situ (DCIS).",9.47438909427412e-08,0.032156640367119405,0.05266944444444446,0.007253705859127518,0.06545443739095536,0.04529163237311387,0.007243206163811494,0.055337055259796486,0.058681016785412425,9.474389094274162e-08,0.05068121956601335,0.06632653061224487
19,0.5,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is it critical to have expert breast pathology assessment for managing ductal carcinoma in situ? Answer: Yes, it is critical to have expert breast pathology assessment for the management of ductal carcinoma in situ (DCIS).",1.421158364141118e-07,0.07059280780214117,0.06140080539119,0.010880558788691277,0.05727400819592621,0.08644389574759942,0.010864809245717241,0.041970330889503416,0.10970142494867766,1.4211583641411244e-07,0.034352569638256725,0.12244897959183673
19,0.5,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology review required for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology review is required to manage ductal carcinoma in situ (DCIS).",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
19,0.5,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology examination indispensable for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology examination is indispensable for managing ductal carcinoma in situ (DCIS).",0.0,0.047803253831721015,0.027886079605124875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20,0.5,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an initial night impact on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, a single night of sleep recording may suffice for patients with moderate to high frequency SB. Nonetheless, low RMMA frequency observed during the first night can be verified.",4.737194547137081e-08,0.1478218899304342,0.11323023120531728,0.0036268529295637453,0.11338399756642437,0.05536332179930796,0.003621603081905733,0.06319776905997099,0.018860946745562133,4.737194547137081e-08,0.03774032798284743,0.0
20,0.5,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does sleep bruxism exhibit a first night effect? Results revealed no significant first night impact on RMMA frequency severity in young, healthy patients with SB. In practice, one night of sleep monitoring might be adequate for those with moderate to high frequency SB. However, low RMMA frequency detected on the first night could be confirmed.",2.3685972735685406e-08,0.055690442232240844,0.05369254544554915,0.0018134264647818726,0.0583242203833958,0.05536332179930796,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
20,0.5,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night influence on sleep bruxism? The study showed no overall first night effect on the severity of RMMA frequency among young, healthy SB patients. For clinical purposes, a single night sleep recording may be enough for patients with moderate to high SB frequency. Still, low RMMA frequency on the initial night can be confirmed.",4.737194547137081e-08,0.12350093622657665,0.09580241771689776,0.0036268529295637453,0.11338399756642437,0.05536332179930796,0.003621603081905733,0.06319776905997099,0.018860946745562133,4.737194547137081e-08,0.03774032798284743,0.0
20,0.5,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night affect sleep bruxism? Findings demonstrated no overall first night effect on RMMA frequency severity in young, healthy patients with SB. Clinically, one night of sleep recording may be sufficient for those with moderate to high frequency SB, although low RMMA frequency on the first night could be confirmed.",9.474389094274162e-08,0.03375057479646948,0.02785507547500285,0.0072537058591274906,0.027670574962977756,0.035371651661865226,0.007243206163811466,0.05231511806187328,0.018860946745562133,9.474389094274162e-08,0.08004270767353683,0.0
20,0.5,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on sleep bruxism severity? The results indicated no overall first night effect on RMMA frequency in young, healthy SB patients. In clinical settings, a single night sleep study may be adequate for moderate to high frequency SB patients, but low RMMA frequency on the first night can be confirmed.",2.3685972735685406e-08,0.004346206635207572,0.01582673885880878,0.0018134264647818726,0.006011225624154459,0.017685505574778944,0.0018108015409528666,0.019551204535685596,0.0003624288791975773,2.3685972735685406e-08,0.019418085857102696,0.0
20,0.5,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an initial night effect on sleep bruxism? The data showed no significant first night effect on RMMA frequency severity in young, healthy individuals with SB. For clinical practice, one night of sleep recording might be sufficient for moderate to high frequency SB patients. However, low RMMA frequency during the first night can be confirmed.",0.0,0.059924306654624004,0.0759916611702704,0.0,0.05134423559703327,0.036851395847011775,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
20,0.5,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night impact sleep bruxism? The study found no overall first night effect on the severity of RMMA frequency in young, healthy patients with SB. Clinically, one night of sleep recording may be enough for patients with moderate to high frequency SB, while low RMMA frequency on the first night can be confirmed.",2.3685972735685406e-08,0.02132591116330973,0.002770113147299774,0.0018134264647818726,0.032167723003774906,0.03650237505374583,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
20,0.5,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on sleep bruxism? Results showed no overall first night impact on RMMA frequency severity in young, healthy SB patients. In clinical practice, a single night sleep recording might be sufficient for moderate to high frequency SB patients. However, low RMMA frequency on the first night could be confirmed.",4.737194547137081e-08,0.009205847051115157,0.03248646397334437,0.0036268529295637453,0.0392760254127027,0.05536332179930796,0.003621603081905733,0.012309783448174905,0.018860946745562133,4.737194547137081e-08,0.03922071315328246,0.0
20,0.5,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does a first night effect exist in sleep bruxism? The findings revealed no overall first night effect on the severity of RMMA frequency in young, healthy patients with SB. Clinically, one night of sleep recording may be enough for moderate to high frequency SB cases, but low RMMA frequency on the first night can be confirmed.",0.0,0.025205352020361893,0.01827155351936688,0.0,0.05134423559703327,0.036851395847011775,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
20,0.5,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on sleep bruxism? The results indicated no overall first night effect on RMMA frequency severity in young and healthy SB patients. For clinical use, one night of sleep recording may suffice for moderate to high frequency SB patients, though low RMMA frequency on the first night could be confirmed.",2.3685972735685406e-08,0.004346206635207572,0.01582673885880878,0.0018134264647818726,0.006011225624154459,0.017685505574778944,0.0018108015409528666,0.019551204535685596,0.0003624288791975773,2.3685972735685406e-08,0.019418085857102696,0.0
21,0.5,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns cause less pain? Minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia does not result in lower total opioid usage.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced in newborns undergoing minimal access major surgery? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia repairs do not lead to decreased cumulative opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns lead to less pain? Repairing esophageal atresia or congenital diaphragmatic hernia via minimal access methods is not linked to reduced overall opioid consumption.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain with minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia does not correspond to lower total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns result in less pain? The use of minimal access techniques for esophageal atresia or congenital diaphragmatic hernia repair is not associated with reduced cumulative opioid administration.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,0.5,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain lessened by minimal access major surgery in newborns? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia does not show a decrease in total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery reduce pain in newborns? Repairing esophageal atresia or congenital diaphragmatic hernia through minimal access surgery does not correlate with less cumulative opioid use.,1.421158364141118e-07,0.2709556937716999,0.045171407099086576,0.010880558788691277,0.2705631540617417,0.03993055555555556,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.5,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there a reduction in pain with minimal access major surgery in newborns? Minimal access surgical repair for esophageal atresia or congenital diaphragmatic hernia does not equate to lower opioid dose requirements.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,0.5,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery cause less pain in newborns? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia repair are not linked to decreased overall opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.5,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain alleviated by minimal access major surgery in newborns? Using minimal access techniques for esophageal atresia or congenital diaphragmatic hernia repair does not reduce cumulative opioid dosage.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
22,0.5,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites representative of community practice? Answer: Yes, family practice at residency teaching sites typically mirrors community practice. Residency programs aim to ready physicians for community practice by familiarizing them with common health concerns.",2.36859727356853e-08,0.029761059141726776,0.0029835463597203127,0.0018134264647818726,0.029717171588468982,0.002581738577784029,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.5,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites align with community practice? Answer: Yes, family practice at residency teaching sites frequently reflects community practice. Residency programs are structured to prepare physicians for community practice by exposing them to prevalent health issues.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.5,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is the family practice at residency teaching sites similar to community practice? Answer: Yes, family practice at residency teaching sites often resembles community practice. Residency programs intend to equip physicians for community practice by introducing them to usual health problems.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.5,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites correspond to community practice? Answer: Yes, family practice at residency teaching sites commonly reflects community practice. Residency programs prepare physicians for community practice by providing exposure to typical health issues.",7.10579182070559e-08,0.09201182215673853,0.009386957908163268,0.005440279394345618,0.0918913774266974,0.008150510204081599,0.0054324046228586,0.09161903752274592,0.006593590561224494,7.105791820705622e-08,0.09116928482195785,0.004716198979591822
22,0.5,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites indicative of community practice? Answer: Yes, family practice at residency teaching sites generally reflects community practice. Residency programs are designed to train physicians for community practice by exposing them to common health challenges.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22,0.5,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites represent community practice? Answer: Yes, family practice at residency teaching sites often represents community practice. Residency programs focus on preparing physicians for community practice by familiarizing them with frequent health issues.",4.73719454713706e-08,0.06041365202649773,0.006109330784655448,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.5,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites consistent with community practice? Answer: Yes, family practice at residency teaching sites usually reflects community practice. Residency programs aim to prepare physicians for community practice through exposure to common health concerns.",4.73719454713706e-08,0.06041365202649773,0.006109330784655448,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.5,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites reflect the nature of community practice? Answer: Yes, family practice at residency teaching sites often reflects the nature of community practice. Residency programs are designed to prepare physicians for community practice by exposing them to typical health issues.",1.1842986367842703e-07,0.04461749993061037,0.047017784469521956,0.009067132323909363,0.07377188467384155,0.031739499123749224,0.009054007704764333,0.10410063264663982,0.013677360490547325,1.1842986367842703e-07,0.13567251877376396,0.006377551020408163
22,0.5,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites aligned with community practice? Answer: Yes, family practice at residency teaching sites often aligns with community practice. Residency programs prepare physicians for community practice by exposing them to common health conditions.",4.73719454713706e-08,0.09689508258228452,0.029894770408163268,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.5,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites mirror community practice? Answer: Yes, family practice at residency teaching sites frequently mirrors community practice. Residency programs are intended to prepare physicians for community practice by introducing them to common health problems.",2.36859727356853e-08,0.029761059141726776,0.0029835463597203127,0.0018134264647818726,0.029717171588468982,0.002581738577784029,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
23,0.5,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the length of psychological treatment for depression connected to the likelihood of returning to treatment? Yes, the duration of psychological treatment for depression may be linked to a return to treatment. Extended treatment periods might reflect more severe or chronic cases that require repeated therapy sessions. Nonetheless, this relationship can vary based on individual patient responses and other factors.",4.737194547137081e-08,0.11074679361716422,0.05296198347107435,0.0036268529295637453,0.062407464857966666,0.019435669225879006,0.003621603081905733,0.06269223125544832,0.019322583011394202,4.737194547137081e-08,0.06295662331933816,0.019131008851288562
23,0.5,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the duration of psychological treatment for depression influence the chances of resuming treatment? Indeed, the length of psychological treatment for depression can be associated with a return to treatment. Longer treatments may suggest more serious or persistent conditions needing ongoing therapy. However, individual patient differences and other variables also play a role.",1.1842986367842703e-07,0.028198901104572016,0.0440111111111111,0.009067132323909363,0.07605175934124508,0.012412167159763315,0.009054007704764333,0.07514589818803596,0.014433349769888242,1.1842986367842703e-07,0.07411123451212287,0.016582942965154498
23,0.5,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a relationship between the duration of psychological treatment for depression and the likelihood of returning to treatment? Yes, the duration of treatment for depression can relate to returning for further therapy. Prolonged treatment might indicate chronic or severe depression requiring multiple therapy sessions. Still, this depends on the patient's response and other influencing elements.",4.737194547137081e-08,0.0337071852434776,0.04812010765090349,0.0036268529295637453,0.011309146026370342,0.03402366863905326,0.003621603081905733,0.03857478438073514,0.05436390532544381,4.737194547137081e-08,0.013603907614186284,0.036982248520710054
23,0.5,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Can the length of psychological treatment for depression be related to the probability of returning to treatment? Yes, treatment duration for depression may correlate with returning to therapy. Longer durations often reflect more severe or chronic depression that needs repeated treatment. However, this is influenced by individual patient factors and other considerations.",1.4211583641411244e-07,0.004656556066979345,0.08124964598084128,0.010880558788691236,0.014307659512725834,0.07100591715976332,0.0108648092457172,0.03989683106075903,0.05436390532544381,1.4211583641411244e-07,0.06643880005935054,0.036982248520710054
23,0.5,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the time spent in psychological treatment for depression connected to the chance of returning to treatment? Yes, the duration of psychological treatment can be related to a return to therapy. Extended treatment may signal severe or ongoing conditions requiring recurrent sessions. This, however, can depend on individual patient responses and other factors.",1.1842986367842703e-07,0.051779619729268145,0.10117662437524028,0.009067132323909363,0.00549496778345393,0.07100591715976332,0.009054007704764333,0.01969412374324042,0.05436390532544381,1.1842986367842703e-07,0.045819512856614786,0.036982248520710054
23,0.5,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does how long psychological treatment for depression lasts affect the likelihood of a patient returning for treatment? Yes, the duration of treatment might be related to returning to therapy. Longer treatment durations could indicate more severe or chronic depression needing repeated therapy. Yet, this also depends on individual patient factors and other influences.",1.1842986367842703e-07,0.07843912667388153,0.12039999999999998,0.009067132323909363,0.00549496778345393,0.07100591715976332,0.009054007704764333,0.01969412374324042,0.05436390532544381,1.1842986367842703e-07,0.045819512856614786,0.036982248520710054
23,0.5,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the length of psychological treatment for depression associated with the risk of returning to treatment? Yes, the duration of treatment can be linked to return visits for therapy. Longer treatment periods may reflect more severe or persistent depression requiring additional sessions. Individual patient responses and other factors also affect this relationship.",1.4211583641411244e-07,0.059021040816778836,0.12039999999999998,0.010880558788691236,0.014307659512725834,0.07100591715976332,0.0108648092457172,0.03989683106075903,0.05436390532544381,1.4211583641411244e-07,0.06643880005935054,0.036982248520710054
23,0.5,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a connection between the duration of psychological treatment for depression and the likelihood of returning to treatment? Yes, the length of treatment for depression may relate to returning to therapy. Extended treatments might indicate chronic or severe cases needing repeated therapy. Still, individual patient differences and other influences matter.",1.6580180914979784e-07,0.04395924814659402,0.060644454504300546,0.012693985253473108,0.06280208848575253,0.05060661160420776,0.012675610786670066,0.06051611826349479,0.05436390532544381,1.6580180914979784e-07,0.0874922092571837,0.036982248520710054
23,0.5,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Can the duration of psychological treatment for depression influence the chance of returning to treatment? Yes, the time spent in treatment can be related to returning for further therapy. Longer durations often suggest severe or chronic depression requiring multiple sessions. However, this depends on individual patient responses and other factors.",1.8948778188548325e-07,0.019015706203080462,0.12039999999999998,0.014507411718254981,0.0551296540329802,0.07100591715976332,0.014486412327622933,0.08156952746132795,0.05436390532544381,1.8948778188548325e-07,0.10899841447814707,0.036982248520710054
23,0.5,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the period of psychological treatment for depression linked to the probability of returning to treatment? Yes, the duration of depression treatment may be associated with returning to therapy. Prolonged treatment can indicate chronic or severe conditions needing recurrent sessions. This relationship varies based on patient response and other variables.",1.8948778188548325e-07,0.009276015452427622,0.10000069444444443,0.014507411718254981,0.0551296540329802,0.07100591715976332,0.014486412327622933,0.08156952746132795,0.05436390532544381,1.8948778188548325e-07,0.10899841447814707,0.036982248520710054
24,0.5,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can a new surgical technique for the temporomandibular joint enhance access and minimize complications? The VMPA offers direct access and excellent visibility to the TMJ area, resulting in favorable aesthetic and functional outcomes. It may be regarded as the preferred method for standard TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is it possible that a novel surgical method for the temporomandibular joint improves accessibility and lowers complication rates? The VMPA provides straightforward access and clear visualization of the TMJ region, delivering good cosmetic and functional results. This approach can be considered the best choice for routine TMJ operations.",2.3685972735685406e-08,0.09447112089549092,0.08264462809917356,0.0018134264647818726,0.007989419483715121,0.021266540642722105,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
24,0.5,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Could an innovative surgical approach to the temporomandibular joint enhance access and reduce the risk of complications? The VMPA grants direct access and optimal visibility to the TMJ area, yielding positive esthetic and functional outcomes. It is often deemed the preferred technique for common TMJ procedures.",7.105791820705622e-08,0.010627073760686834,0.038296331722753874,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.5,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does a new surgical approach to the temporomandibular joint improve access and decrease complications? The VMPA allows direct access and favorable visualization of the TMJ region, producing good esthetic and functional results. It can be regarded as the approach of choice for typical TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Might a novel surgical technique for the temporomandibular joint enhance access and lessen complications? The VMPA provides direct entry and excellent visibility to the TMJ area, offering beneficial cosmetic and functional outcomes. It is considered the preferred approach for common TMJ surgical interventions.",1.4211583641411244e-07,0.018006862531199097,0.08264462809917356,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
24,0.5,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can an innovative surgical approach to the temporomandibular joint improve access and reduce complications? The VMPA facilitates direct access and clear visibility of the TMJ region, resulting in good esthetic and functional results. This method is often the favored choice for routine TMJ surgeries.",1.1842986367842703e-07,0.026715768867978884,0.05940199771368603,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.5,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is a new surgical approach to the temporomandibular joint able to improve access and reduce complications? The VMPA ensures direct access and favorable visualization of the TMJ area, leading to positive esthetic and functional outcomes. It is considered the preferred approach for common TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Could a novel surgical technique for the temporomandibular joint improve access and minimize complications? The VMPA offers direct access and good visibility of the TMJ region, yielding favorable cosmetic and functional results. It can be regarded as the approach of choice for typical TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does an innovative surgical method for the temporomandibular joint enhance access and reduce complications? The VMPA provides direct access and optimal visualization of the TMJ area, producing beneficial esthetic and functional outcomes. This approach is often preferred for common TMJ surgical procedures.",1.6580180914979784e-07,0.07591647169854898,0.058269628099173555,0.012693985253473108,0.13177252289144326,0.021266540642722105,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
24,0.5,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Might a new surgical approach to the temporomandibular joint improve access and lower the risk of complications? The VMPA allows direct access and clear visibility of the TMJ region, resulting in good cosmetic and functional results. It is considered the favored approach for standard TMJ surgeries.",7.105791820705622e-08,0.020179467597532863,0.06043388429752067,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
25,0.5,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare professionals consider it acceptable to break confidentiality to safeguard a patient's wife from a sexually transmitted infection? Most individuals in France are influenced by the specific circumstances when determining if a doctor should violate confidentiality to protect the spouse of a patient with an STD.,4.737194547137081e-08,0.013249670855493001,0.03819444444444445,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.5,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Are French non-experts and medical practitioners okay with breaching confidentiality to protect a patient's wife from a sexually transmitted disease? In France, the majority of people base their decision on situational factors regarding whether a physician should breach confidentiality to shield the patient's spouse from an STD.",1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
25,0.5,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable for French laypersons and health professionals to breach confidentiality to protect a patient's wife from an STD? Most people in France take situational factors into account when deciding if a doctor should disclose confidential information to protect the spouse of a patient infected with a sexually transmitted disease.,2.3685972735685406e-08,0.0340182126061217,0.038602079862557266,0.0018134264647818726,0.035249067127276934,0.039930555555555566,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
25,0.5,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do health professionals and laypeople in France find it acceptable to breach patient confidentiality to protect the wife from a sexually transmitted disease? Most French individuals are influenced by the context when deciding if a physician should break confidentiality to safeguard the patient's spouse from an STD.,1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
25,0.5,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French healthcare workers and laypeople agree on breaching confidentiality to protect a patient's wife from a sexually transmitted disease? In France, most people consider situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient with an STD.",1.6580180914979784e-07,0.12910265173226865,0.013242276077097506,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.5,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease acceptable to French laypeople and health professionals? Most French people are influenced by the situation when deciding if a doctor should break confidentiality to protect the spouse of an STD-infected patient.,1.8948778188548325e-07,0.15355759740001185,0.012192798185603794,0.014507411718254981,0.1519086212980736,0.01613519565073701,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.5,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypersons and medical professionals find it acceptable to violate confidentiality to protect a patient's wife from an STD? Most individuals in France rely on situational considerations when deciding if a physician should breach confidentiality to protect the spouse of a patient with a sexually transmitted disease.,9.474389094274162e-08,0.059122553298924796,0.01612461419753087,0.0072537058591274906,0.058066668431643986,0.01820216049382717,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,0.5,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and laypeople consider it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted infection? Most people in France are swayed by the circumstances when deciding if a physician should break confidentiality to safeguard the spouse of a patient infected with an STD.,4.737194547137081e-08,0.013249670855493001,0.03819444444444445,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.5,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French laypeople and healthcare providers comfortable breaching confidentiality to protect a patient's wife from a sexually transmitted disease? The majority of French people are influenced by situational factors when determining if a doctor should disclose confidential information to protect the spouse of a patient with an STD.,9.474389094274162e-08,0.029626928594246316,0.0373272093572779,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,0.5,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and medical professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Most people in France are influenced by the specific situation when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with an STD.,2.3685972735685406e-08,0.0214335618386734,0.001161795495699433,0.0018134264647818726,0.02133437618373879,0.0008118618278758691,0.0018108015409528666,0.021208698070558363,0.0004245966626427282,2.3685972735685406e-08,0.02105340919783316,0.0
26,0.5,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Yes, research suggests that the insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance due to its association with increased risk.",9.474389094274162e-08,0.13762791002635089,0.028010204081632656,0.0072537058591274906,0.1335680876175096,0.030577875172469793,0.007243206163811466,0.1290202970235641,0.029123945207861282,9.474389094274162e-08,0.1266744478480617,0.02690586419753086
26,0.5,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism is considered a potential candidate gene for insulin resistance based on studies indicating a connection with higher risk.",1.1842986367842703e-07,0.0437474329413865,0.03722299168975071,0.009067132323909363,0.06712206273106824,0.027120315581854043,0.009054007704764333,0.09119457636192774,0.013269628099173578,1.1842986367842703e-07,0.11950075121351711,0.0050308641975308835
26,0.5,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the ACE gene I/D polymorphism's insertion allele a potential candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) in the ACE gene I/D polymorphism has been identified as a candidate gene for insulin resistance, supported by evidence of its association with increased risk.",9.474389094274162e-08,0.01708057427679588,0.040228468113083504,0.0072537058591274906,0.010341922184629926,0.05084605724106023,0.007243206163811466,0.03450022694720989,0.037293154176271076,9.474389094274162e-08,0.029956236607138642,0.04246913580246913
26,0.5,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be linked to insulin resistance, as research shows it is associated with a greater risk.",9.474389094274162e-08,0.01708057427679588,0.040228468113083504,0.0072537058591274906,0.04114846354284962,0.029513888888888895,0.007243206163811466,0.06600691697266203,0.014827852370440639,9.474389094274162e-08,0.09443504410108705,0.003931816011927075
26,0.5,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: The insertion allele of the ACE gene I/D polymorphism: is it a candidate gene for insulin resistance? Answer: Yes, studies have shown that the insertion allele (I) of the ACE gene I/D polymorphism might be a candidate gene for insulin resistance due to its association with elevated risk.",4.737194547137081e-08,0.05237444752958709,0.0064058171745152714,0.0036268529295637453,0.05010001774476125,0.005486111111111136,0.003621603081905733,0.04758242007502789,0.0035231723543411725,4.737194547137081e-08,0.046106945246820796,0.0018791605739505585
26,0.5,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele (I) of the ACE gene I/D polymorphism implicated in insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism is considered a candidate gene for insulin resistance, supported by research highlighting its link to increased risk.",1.4211583641411244e-07,0.1341347095149743,0.003520408163265376,0.010880558788691236,0.19049336080430201,0.03743764172335601,0.0108648092457172,0.2490559227178477,0.07735537190082646,1.4211583641411244e-07,0.2804566311261327,0.09957168052406151
26,0.5,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Could the ACE gene I/D polymorphism's insertion allele be related to insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may represent a candidate gene for insulin resistance, as indicated by studies showing its association with higher risk.",1.6580180914979784e-07,0.002521632498501347,0.09545529257067717,0.012693985253473108,0.022122645434886845,0.09138888888888888,0.012675610786670066,0.07591647169854898,0.05826962809917357,1.6580180914979784e-07,0.10227689818676478,0.04246913580246913
26,0.5,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele of the ACE gene I/D polymorphism associated with insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism is a potential candidate gene for insulin resistance, based on research demonstrating an increased risk linked to the I allele.",9.474389094274162e-08,0.01708057427679588,0.040228468113083504,0.0072537058591274906,0.04114846354284962,0.029513888888888895,0.007243206163811466,0.06600691697266203,0.014827852370440639,9.474389094274162e-08,0.09443504410108705,0.003931816011927075
26,0.5,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Does research support the insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance? Answer: Yes, evidence suggests that the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance because of its association with increased risk.",2.3685972735685406e-08,0.05415277330412804,0.01817867036011081,0.0018134264647818726,0.05362629580082823,0.021111111111111164,0.0018108015409528666,0.05300700262790148,0.02223065534753846,2.3685972735685406e-08,0.05292545762377321,0.022430810114242618
26,0.5,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Question: Is the insertion allele (I) of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Yes, research indicates that the insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance, given its association with elevated risk.",9.474389094274162e-08,0.1979015779011286,0.05125114784205692,0.0072537058591274906,0.2259877116921687,0.07996924259900037,0.007243206163811466,0.255047057125374,0.1083757800640918,9.474389094274162e-08,0.25563206283595763,0.11416666666666664
27,0.5,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a link between androgens and sexual desire in women? Yes, androgens like testosterone significantly influence female sexual desire and responsiveness. Lower androgen levels can result in reduced sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.5,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does a relationship exist between androgens and sexual desire in women? Indeed, androgens such as testosterone are crucial for female sexual desire and responsiveness. Decreased androgen levels may cause diminished sexual desire, showing a positive correlation.",4.97405427449393e-07,0.19992935121742894,0.3339224229997011,0.03808195576041933,0.26030263922561403,0.22634676324128575,0.03802683236001021,0.3287539978666105,0.15104166666666666,4.974054274493935e-07,0.3999300212339123,0.07496876301541024
27,0.5,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens associated with sexual desire in women? Yes, androgens including testosterone play an important role in female sexual desire and responsiveness. Low androgen concentrations can lead to lower sexual desire, demonstrating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.5,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is sexual desire in women correlated with androgens? Yes, androgens like testosterone are key to female sexual desire and responsiveness. Reduced levels of these hormones may lead to less sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.5,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Do androgens affect sexual desire in women? Yes, there is a correlation between androgens such as testosterone and female sexual desire. Lower androgen levels may result in decreased sexual desire, suggesting a positive link.",5.447773729207636e-07,0.219161440922651,0.36246913580246926,0.04170880868998309,0.3209272610420495,0.22634676324128575,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
27,0.5,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a connection between androgens and sexual desire in women? Yes, androgens including testosterone have a significant impact on female sexual desire and responsiveness. Low androgen levels can cause reduced sexual desire, showing a positive correlation.",4.737194547137077e-07,0.1706582406307957,0.33471403376165293,0.03626852929563745,0.23131510235236252,0.22634676324128575,0.03621603081905734,0.29890103471692875,0.15104166666666666,4.737194547137081e-07,0.3691583625671586,0.07496876301541024
27,0.5,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens linked to sexual desire in women? Yes, androgens like testosterone play a vital role in female sexual desire and responsiveness. Decreased androgen levels may lead to diminished sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.5,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does sexual desire in women correlate with androgen levels? Yes, androgens such as testosterone are important for female sexual desire and responsiveness. Low levels of these hormones may reduce sexual desire, suggesting a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.5,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a correlation between androgen levels and sexual desire in women? Yes, androgens including testosterone significantly influence female sexual desire and responsiveness. Lower androgen levels may decrease sexual desire, demonstrating a positive correlation.",5.447773729207636e-07,0.3031792809905234,0.3021153376755182,0.04170880868998309,0.3209272610420495,0.22634676324128575,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
27,0.5,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens related to sexual desire in women? Yes, androgens like testosterone play a crucial role in female sexual desire and responsiveness. Reduced androgen levels can lead to lower sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
28,0.5,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals pertinent and useful for practitioners and athletes? Indeed, sports medicine journals are very pertinent to both practitioners and athletes. They deliver the latest research, treatment progress, and prevention strategies for sports injuries. They also provide important knowledge on improving athletic performance and nutrition.",4.737194547137081e-08,0.08006802086047538,0.025100054083288248,0.0036268529295637453,0.07913464021248595,0.024190208012743315,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.5,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Do sports medicine journals hold relevance and applicability for practitioners and athletes? Yes, these journals are extremely relevant to practitioners and athletes alike. They present current research findings, advancements in treatment, and preventive approaches for sports injuries. Additionally, they offer key insights into enhancing athletic performance and nutrition.",7.105791820705622e-08,0.16248910318892662,0.0687334593572779,0.005440279394345618,0.13192008828948065,0.046400951814396206,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
28,0.5,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals applicable and significant for practitioners and athletes? Absolutely, sports medicine journals are highly significant for both practitioners and athletes. They supply updated research, new treatment methods, and preventive techniques for sports-related injuries. They also share valuable information on boosting athletic performance and nutrition.",4.737194547137081e-08,0.04993118692308629,0.0038321995464852404,0.0036268529295637453,0.07913464021248595,0.024190208012743315,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.5,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Is the content of sports medicine journals relevant and practical for practitioners and athletes? Yes, sports medicine journals are very practical and relevant for practitioners and athletes. They provide the newest research, treatment innovations, and injury prevention strategies in sports medicine. They further offer essential insights into athletic performance improvement and nutrition.",1.6580180914979784e-07,0.16493378940827252,0.012136713444997713,0.012693985253473108,0.159849922783736,0.00647039625884064,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
28,0.5,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals useful and relevant to practitioners and athletes? Yes, these journals are very useful and relevant to both practitioners and athletes. They offer updated studies, treatment developments, and preventive measures for sports injuries. They also provide important guidance on enhancing athletic performance and nutrition.",4.737194547137081e-08,0.04993118692308629,0.0038321995464852404,0.0036268529295637453,0.048328098854266255,0.0020526554379765236,0.003621603081905733,0.015013325609441353,0.02271498107084911,4.737194547137081e-08,0.047628048989254435,0.0
28,0.5,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Do practitioners and athletes find sports medicine journals applicable and relevant? Yes, sports medicine journals are highly applicable and relevant to practitioners and athletes. They include the latest research, advances in treatment, and prevention techniques for sports injuries. They also give valuable insights on athletic performance enhancement and nutrition.",9.474389094274162e-08,0.09751360699811418,0.007355371900826427,0.0072537058591274906,0.12393066880576553,0.025134411171674104,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
28,0.5,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals significant and relevant to athletes and practitioners? Indeed, sports medicine journals hold great significance and relevance for athletes and practitioners. They present current research, treatment advancements, and preventive strategies for sports injuries. They also provide useful information on improving athletic performance and nutrition.",4.737194547137081e-08,0.08006802086047538,0.025100054083288248,0.0036268529295637453,0.07913464021248595,0.024190208012743315,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.5,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals pertinent and beneficial for athletes and practitioners? Yes, these journals are both pertinent and beneficial for athletes and practitioners. They provide up-to-date research, treatment innovations, and preventive measures for sports injuries. They also offer valuable insights into athletic performance and nutrition enhancement.",2.3685972735685406e-08,0.005533090837231747,0.019375000000000003,0.0018134264647818726,0.03855843438316109,0.04359904818560379,0.0018108015409528666,0.07318771383072864,0.06937499999999999,2.3685972735685406e-08,0.04191646561712403,0.047500000000000014
28,0.5,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Do sports medicine journals serve as relevant and applicable resources for practitioners and athletes? Yes, sports medicine journals serve as highly relevant and applicable resources for practitioners and athletes. They share the latest research, treatment progress, and injury prevention methods in sports medicine. They also offer important information on enhancing athletic performance and nutrition.",2.1317375462116866e-07,0.05056406593946239,0.08847485127095728,0.016320838183036854,0.041246354824907794,0.10235937876411616,0.0162972138685758,0.031062560191557953,0.11555555555555556,2.1317375462116866e-07,0.08754738983424648,0.07939508506616257
28,0.5,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Are sports medicine journals relevant and useful to practitioners and athletes? Yes, sports medicine journals are very relevant and useful to both practitioners and athletes. They provide current research, treatment improvements, and preventive measures for sports-related injuries. They also offer valuable insights into improving athletic performance and nutrition.",7.105791820705622e-08,0.015010979665534219,0.034925639500297465,0.005440279394345618,0.04150958647731384,0.018498994102315543,0.0054324046228586,0.03818633012873196,0.02221074380165289,7.105791820705622e-08,0.07061756721395396,0.0
29,0.5,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the quantity of needles impact acupuncture treatment for neck pain? Yes, it can. The number of needles depends on how severe and where the pain is located. More needles may be applied for severe or extensive pain.",2.1317375462116834e-07,0.10450672932332639,0.08007294673217737,0.016320838183036854,0.13072392723955018,0.06632653061224489,0.0162972138685758,0.1973348824033958,0.02271498107084911,2.1317375462116866e-07,0.23483959107740038,0.0
29,0.5,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In acupuncture for neck pain, does the needle count matter? Yes, it does. The amount of needles used varies based on the pain's intensity and location. Severe or broad pain may require more needles.",3.0791764556390954e-07,0.18144966533566942,0.10707911957168353,0.023574544042164365,0.248506962895934,0.06632653061224489,0.023540420032387294,0.3186957394076626,0.02271498107084911,3.079176455639103e-07,0.36000273403140737,0.0
29,0.5,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the number of needles important in acupuncture for treating neck pain? Yes, it can influence the treatment. The needle count is determined by the pain's severity and position, with more needles used for stronger or widespread pain.",2.1317375462116834e-07,0.06703931415792397,0.10707911957168353,0.016320838183036854,0.13072392723955018,0.06632653061224489,0.0162972138685758,0.1973348824033958,0.02271498107084911,2.1317375462116866e-07,0.23483959107740038,0.0
29,0.5,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Regarding acupuncture for neck pain, does the number of needles make a difference? Yes, it does. The severity and area of pain dictate needle quantity, with more needles used for intense or large-area pain.",3.0791764556390954e-07,0.18144966533566942,0.10707911957168353,0.023574544042164365,0.248506962895934,0.06632653061224489,0.023540420032387294,0.3186957394076626,0.02271498107084911,3.079176455639103e-07,0.36000273403140737,0.0
29,0.5,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does acupuncture needle quantity affect neck pain treatment? Yes, it matters. The number of needles depends on pain severity and location, with increased needles for more severe or extensive pain.",4.0266153650665074e-07,0.3106613968156764,0.10707911957168353,0.030828249901291883,0.3820383555204563,0.06632653061224489,0.030783626196198788,0.45684607788847975,0.02271498107084911,4.026615365066519e-07,0.5031035776720798,0.0
29,0.5,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In treating neck pain with acupuncture, is the needle number significant? Yes, it is. Needle usage is based on how severe and where the pain is, with more needles for intense or widespread discomfort.",3.0791764556390954e-07,0.18144966533566942,0.10707911957168353,0.023574544042164365,0.248506962895934,0.06632653061224489,0.023540420032387294,0.3186957394076626,0.02271498107084911,3.079176455639103e-07,0.36000273403140737,0.0
29,0.5,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","When using acupuncture for neck pain, does the number of needles count? Yes, it can be important. Needle quantity depends on the pain's intensity and location, with more needles for severe or broad pain.",3.0791764556390954e-07,0.18144966533566942,0.10707911957168353,0.023574544042164365,0.248506962895934,0.06632653061224489,0.023540420032387294,0.3186957394076626,0.02271498107084911,3.079176455639103e-07,0.36000273403140737,0.0
29,0.5,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the number of acupuncture needles relevant in neck pain therapy? Yes, it matters. The severity and location of the pain influence needle count, often requiring more needles for intense or widespread pain.",3.3160361829959484e-07,0.2122213240024231,0.10707911957168353,0.025387970506946245,0.2802556612105138,0.06632653061224489,0.025351221573340167,0.3514855622306543,0.02271498107084911,3.316036182995957e-07,0.39390428570708913,0.0
29,0.5,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the amount of needles used in acupuncture affect neck pain treatment? Yes, it does. The needle number depends on pain severity and location, with more needles used in cases of intense or extensive pain.",2.8423167282822424e-07,0.23314342931068754,0.048485369571683534,0.021761117577382486,0.25974422426311605,0.03605309311224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
29,0.5,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In acupuncture treatment for neck pain, does needle count matter? Yes, it can. The number of needles depends on how severe and where the pain is, with more needles applied for intense or widespread pain.",2.8423167282822424e-07,0.15159670218598764,0.10707911957168353,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
30,0.5,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines followed when preparing high fall-risk patients for discharge post-rehabilitation? Answer: Evidence suggests that systematic falls risk assessments are rarely conducted for high fall-risk individuals during rehabilitation. When risks are detected, strategies are typically applied. However, neglecting to assess certain risk factors may have restricted the fall prevention measures provided. Failure to adequately",2.1317375462116866e-07,0.06979943563213364,0.06026334158634829,0.016320838183036854,0.08976371208394296,0.048261993679977015,0.0162972138685758,0.11417787145680425,0.03274920999712727,2.1317375462116866e-07,0.1394140234791097,0.016661878770468257
30,0.5,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we adhere to guidelines in preparing patients at high risk of falls for discharge after rehabilitation? Answer: There is minimal evidence supporting that systematic falls risk assessments are performed on high-risk patients during rehabilitation. When risks are identified, appropriate strategies are usually implemented. Nevertheless, overlooking some risk factors might have limited the effectiveness of fall prevention strategies offered. Failure to adequately",2.3685972735685406e-08,0.09402302064719947,0.07877526753864447,0.0018134264647818726,0.05081823853724643,0.048261993679977015,0.0018108015409528666,0.0289229721838673,0.03274920999712727,2.3685972735685406e-08,0.006297787702283841,0.016661878770468257
30,0.5,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is the preparation of high fall-risk patients for discharge from rehabilitation in line with guidelines? Answer: Little evidence shows that patients at high risk of falls undergo systematic risk assessments during rehabilitation. When risks are found, strategies are generally put in place. However, not assessing some risk factors may have constrained the fall prevention efforts provided. Failure to adequately",9.474389094274162e-08,0.04442607950782662,0.07877526753864447,0.0072537058591274906,0.00038738491035505973,0.048261993679977015,0.007243206163811466,0.022370322203681958,0.03274920999712727,9.474389094274162e-08,0.04588796546828533,0.016661878770468257
30,0.5,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are patients at high risk of falls properly assessed before discharge after rehabilitation according to guidelines? Answer: There is scant evidence that systematic falls risk assessments are conducted for high-risk patients during rehabilitation. When a risk is identified, a strategy is usually implemented. Yet, failure to evaluate some risk factors might have limited the fall prevention options offered. Failure to adequately",4.737194547137081e-08,0.05503636270787915,0.062386378649755575,0.0036268529295637453,0.03428893658603549,0.048261993679977015,0.003621603081905733,0.012115853867486592,0.03274920999712727,4.737194547137081e-08,0.01079664565701588,0.016661878770468257
30,0.5,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do rehabilitation practices meet guidelines for discharging patients at high risk of falls? Answer: Evidence indicates that systematic falls risk assessments are seldom performed on high-risk patients during rehabilitation. When risks are detected, strategies are typically applied. However, missing some risk factor assessments may have restricted fall prevention strategies. Failure to adequately",2.6054570009253947e-07,0.08186764581646422,0.07877526753864447,0.0199476911126006,0.12822999291173875,0.048261993679977015,0.019918816950481533,0.1533985846100867,0.03274920999712727,2.6054570009253947e-07,0.17941935809280807,0.016661878770468257
30,0.5,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines met when preparing patients at high risk of falls for discharge after rehabilitation? Answer: There is limited evidence that systematic falls risk assessments are carried out for high fall-risk individuals during rehabilitation. When risks are identified, strategies are generally implemented. Nonetheless, failure to assess certain risk factors might have limited the fall prevention strategies offered. Failure to adequately",7.105791820705622e-08,0.03812829180554278,0.062113388768176216,0.005440279394345618,0.01748181826965478,0.048261993679977015,0.0054324046228586,0.004978579491813129,0.03274920999712727,7.105791820705622e-08,0.02818838836888471,0.016661878770468257
30,0.5,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is there compliance with guidelines in assessing fall risk for patients at high risk before discharge from rehabilitation? Answer: Little evidence exists that systematic falls risk assessments are performed during rehabilitation for high-risk patients. When a risk is found, strategies are usually implemented. However, failure to assess some risk factors may have limited the fall prevention strategies provided. Failure to adequately",4.737194547137081e-08,0.05503636270787915,0.062386378649755575,0.0036268529295637453,0.03428893658603549,0.048261993679977015,0.003621603081905733,0.012115853867486592,0.03274920999712727,4.737194547137081e-08,0.01079664565701588,0.016661878770468257
30,0.5,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: How well do rehabilitation services follow guidelines in preparing high fall-risk patients for discharge? Answer: Evidence is scarce that systematic falls risk assessments occur for high-risk patients during rehabilitation. When risks are identified, strategies are generally employed. Yet, failure to assess certain risk factors might have limited the offered fall prevention strategies. Failure to adequately",1.8948778188548325e-07,0.050983531185782915,0.06059968454824667,0.014507411718254981,0.07107157907178863,0.048261993679977015,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
30,0.5,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are fall risk assessments systematically conducted for high-risk patients before discharge after rehabilitation as per guidelines? Answer: There is little evidence that systematic falls risk assessment is done for high fall-risk patients during rehabilitation. When risks are identified, strategies are usually implemented. However, failure to assess some risk factors might have limited the fall prevention strategies offered. Failure to adequately",7.105791820705622e-08,0.03812829180554278,0.062113388768176216,0.005440279394345618,0.01748181826965478,0.048261993679977015,0.0054324046228586,0.004978579491813129,0.03274920999712727,7.105791820705622e-08,0.02818838836888471,0.016661878770468257
30,0.5,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do patients at high risk of falls receive guideline-compliant preparation for discharge after rehabilitation? Answer: There is minimal evidence that systematic falls risk assessments are conducted during rehabilitation for high-risk patients. When risks are detected, strategies are generally implemented. Nonetheless, failure to assess certain risk factors may have limited the fall prevention strategies provided. Failure to adequately",1.4211583641411244e-07,0.014381050267199491,0.06123700223252202,0.010880558788691236,0.03470393490091439,0.048261993679977015,0.0108648092457172,0.05808840480576105,0.03274920999712727,1.4211583641411244e-07,0.08225560963915957,0.016661878770468257
31,0.5,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Yes, symptoms are important when selecting patients for Phase I clinical trials. The nature",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
31,0.5,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Should symptoms be considered when enrolling patients in phase I clinical trials? Answer: Yes, symptoms should be taken into account when enrolling patients in Phase I clinical trials. The nature",9.47438909427412e-08,0.23907506864127992,0.04518698060941831,0.007253705859127518,0.24211438262844576,0.05113592643890422,0.007243206163811494,0.2449199534720119,0.055016928285626404,9.474389094274162e-08,0.24740461478319142,0.05682998614958451
31,0.5,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Do symptoms play a role in the selection of patients for phase I clinical trials? Answer: Yes, symptoms play a role in the selection of patients for Phase I clinical trials. The nature",1.658018091497971e-07,0.10753708026234987,0.01221097857425521,0.012693985253473157,0.103032037965336,0.033366624581503884,0.012675610786670115,0.0975529699769977,0.05552728940144841,1.6580180914979784e-07,0.090909528896149,0.07869297303408898
31,0.5,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Is it important to consider symptoms in patients for phase I clinical trials? Answer: Yes, it is important to consider symptoms in patients for Phase I clinical trials. The nature",9.47438909427412e-08,0.1004456325292904,0.012210978574255182,0.007253705859127518,0.0987046211332836,0.01976118240463315,0.007243206163811494,0.09638841478059623,0.028316405047706827,9.474389094274162e-08,0.09337190799209338,0.037876646503476746
31,0.5,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Are symptoms a factor when choosing patients for phase I clinical trials? Answer: Yes, symptoms are a factor when choosing patients for Phase I clinical trials. The nature",4.73719454713706e-08,0.05125696620119591,0.0073130193905817376,0.003626852929563759,0.05026203862567158,0.011433518005540294,0.003621603081905747,0.04893994957148795,0.016094182825484693,4.737194547137081e-08,0.04721740821418363,0.02129501385041549
31,0.5,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Does symptom presence influence patient consideration for phase I clinical trials? Answer: Yes, symptom presence influences patient consideration for Phase I clinical trials. The nature",2.36859727356853e-08,0.0013017374025299233,0.016620498614958512,0.0018134264647818796,0.060839591961871164,0.056066481994459766,0.0018108015409528735,0.06543070719018029,0.06640581717451527,2.3685972735685406e-08,0.07061614882646916,0.07620498614958451
31,0.5,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Should the symptoms of patients be evaluated for phase I clinical trial eligibility? Answer: Yes, the symptoms of patients should be evaluated for phase I clinical trial eligibility. The nature",9.47438909427412e-08,0.10044563252929084,0.012210978574255182,0.007253705859127518,0.14650787496500373,0.0008756667658708084,0.007243206163811494,0.19540944057487364,0.02377349203273829,9.474389094274162e-08,0.24740461478319142,0.05682998614958451
31,0.5,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Is symptom assessment necessary when considering patients for phase I clinical trials? Answer: Yes, symptom assessment is necessary when considering patients for Phase I clinical trials. The nature",4.73719454713706e-08,0.05125696620119591,0.0073130193905817376,0.003626852929563759,0.10160627422270485,0.01198484934139854,0.003621603081905747,0.10225896346071472,0.012499921482905324,4.737194547137081e-08,0.10266918265897873,0.012009974811716007
31,0.5,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Do symptoms impact the decision to include patients in phase I clinical trials? Answer: Yes, symptoms impact the decision to include patients in Phase I clinical trials. The nature",7.10579182070559e-08,0.004399850872373268,0.0166204986149584,0.005440279394345639,0.0004447159015268376,0.033240997229916996,0.005432404622858621,0.004159523886570149,0.049861495844875314,7.105791820705622e-08,0.00953610363314139,0.0664819944598338
31,0.5,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Question: Are symptoms relevant in the evaluation of patients for phase I clinical trials? Answer: Yes, symptoms are relevant in the evaluation of patients for Phase I clinical trials. The nature",9.47438909427412e-08,0.1004456325292904,0.012210978574255182,0.007253705859127518,0.0987046211332836,0.01976118240463315,0.007243206163811494,0.09638841478059623,0.028316405047706827,9.474389094274162e-08,0.09337190799209338,0.037876646503476746
32,0.5,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might enhance blood lipid profiles in OSA patients, particularly those with dyslipidemia before surgery, potentially offering significant metabolic and cardiovascular benefits. Future prospective studies should investigate this metabolic impact of airway surgery in OSA.",1.1842986367842703e-07,0.0027057931470175767,0.0737990999186179,0.009067132323909363,0.04881975148543116,0.039150354019158694,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
32,0.5,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery decrease serum lipid levels in obstructive sleep apnea sufferers? Surgical intervention may improve lipid levels in the blood among OSA patients, especially those with preoperative dyslipidemia, which could lead to important metabolic and cardiovascular advantages. Prospective research is needed to explore this metabolic effect of airway surgery for OSA.",2.3685972735685406e-08,0.032332721741264336,0.036471890561339995,0.0018134264647818726,0.006835970231221733,0.01915868388171596,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
32,0.5,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is airway surgery effective in lowering serum lipid levels in patients with obstructive sleep apnea? Surgery has the potential to improve blood lipid concentrations in OSA patients, particularly those exhibiting dyslipidemia before the procedure, possibly resulting in significant metabolic and cardiovascular benefits. Prospective studies should evaluate this metabolic effect of airway surgery in OSA.",2.3685972735685406e-08,0.12618923231413826,0.07620469381577787,0.0018134264647818726,0.07378257060690219,0.039150354019158694,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
32,0.5,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does performing airway surgery reduce serum lipid levels in obstructive sleep apnea patients? Airway surgery may positively affect blood lipid levels in OSA patients, especially in those with dyslipidemia prior to surgery, potentially providing major metabolic and cardiovascular benefits. This potential metabolic impact warrants investigation through prospective studies.",1.1842986367842703e-07,0.056285456262339384,0.03153258271010034,0.009067132323909363,0.0789565854228198,0.017421958957430296,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
32,0.5,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can serum lipid levels be lowered by airway surgery in patients with obstructive sleep apnea? Surgery might improve lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, potentially leading to significant metabolic and cardiovascular outcomes. Prospective studies should assess this metabolic effect of airway surgery in OSA.",1.1842986367842703e-07,0.026789831557660904,0.052596504758870864,0.009067132323909363,0.0789565854228198,0.017421958957430296,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
32,0.5,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is there a reduction in serum lipid levels after airway surgery in obstructive sleep apnea patients? Airway surgery may enhance blood lipid levels in OSA patients, especially those with pre-existing dyslipidemia, which could yield important metabolic and cardiovascular benefits. This potential effect should be studied prospectively.",1.6580180914979784e-07,0.0728967768044817,0.05071734418492031,0.012693985253473108,0.09327151405626388,0.039150354019158694,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
32,0.5,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery have an impact on serum lipid levels in patients with obstructive sleep apnea? Surgery may improve lipid levels in OSA patients, particularly those with dyslipidemia before the operation, possibly resulting in significant metabolic and cardiovascular benefits. Prospective studies should further explore this metabolic effect.",1.4211583641411244e-07,0.04957845524404503,0.05167721080927387,0.010880558788691236,0.10160519956242586,0.016939610217505802,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.5,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Could airway surgery lower serum lipid levels in obstructive sleep apnea patients? Surgery might improve blood lipid profiles in OSA patients, especially those with preoperative dyslipidemia, potentially providing major metabolic and cardiovascular advantages. This metabolic effect should be examined in prospective studies.",2.6054570009253947e-07,0.10437411715405398,0.09506564056134,0.0199476911126006,0.18858169386058954,0.039150354019158694,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
32,0.5,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is serum lipid reduction observed following airway surgery in patients with obstructive sleep apnea? Airway surgery may improve lipid levels in the blood among OSA patients, particularly those with dyslipidemia before surgery, potentially leading to significant metabolic and cardiovascular benefits. Prospective research should investigate this effect.",1.6580180914979784e-07,0.042090235446262,0.07285489675968711,0.012693985253473108,0.09327151405626388,0.039150354019158694,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
32,0.5,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Surgery may enhance blood lipid parameters in OSA patients, especially those with preoperative dyslipidemia, potentially yielding important metabolic and cardiovascular benefits. Prospective studies are recommended to examine this potential metabolic effect.",1.8948778188548325e-07,0.03375654994010002,0.09506564056134,0.014507411718254981,0.1162610322809634,0.039150354019158694,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
33,0.5,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerised tomography a viable substitute for bone scintigraphy in identifying bone metastases in breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy for detecting bone metastases from breast cancer? Answer: Our study suggests that routine bone scintigraphy is not needed in metastatic breast cancer patients when CT imaging of the thorax, abdomen, and pelvis is performed.",1.184298636784265e-07,0.09887403359652636,0.02498356344510192,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
33,0.5,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible to use computerised tomography instead of bone scintigraphy to detect bone metastases in breast cancer? Answer: Our findings imply that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are done.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.5,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be replaced by computerised tomography in the detection of bone metastases from breast cancer? Answer: Our data suggest that routine bone scintigraphy is not required for metastatic breast cancer patients when CT of the thorax, abdomen, and pelvis is available.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerised tomography serve as an alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our evidence shows that routine bone scintigraphy is not needed if CT imaging of the thorax, abdomen, and pelvis is performed in patients with metastatic breast cancer.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.5,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT imaging substitute bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our findings suggest that routine bone scintigraphy is unnecessary for metastatic breast cancer patients if CT scans of the thorax, abdomen, and pelvis are carried out.",1.184298636784265e-07,0.09887403359652636,0.02498356344510192,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
33,0.5,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerised tomography effective enough to replace bone scintigraphy for bone metastasis detection in breast cancer? Answer: Our research indicates that routine bone scintigraphy is not required for metastatic breast cancer patients when CT of the thorax, abdomen, and pelvis is performed.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.5,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can routine bone scintigraphy be omitted if computerised tomography is used to detect bone metastases from breast cancer? Answer: Our findings suggest that bone scintigraphy is not necessary for metastatic breast cancer patients if CT imaging of the thorax, abdomen, and pelvis has been done.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.5,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is CT scan a sufficient replacement for bone scintigraphy in detecting bone metastases in breast cancer patients? Answer: Our results indicate that routine bone scintigraphy is not needed when CT of the thorax, abdomen, and pelvis is performed in metastatic breast cancer cases.",1.8948778188548272e-07,0.14137324671020046,0.046400951814396206,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be avoided in favor of computerised tomography for detecting bone metastases in breast cancer? Answer: Our findings suggest that routine bone scintigraphy is not required if CT scans of the thorax, abdomen, and pelvis are conducted in patients with metastatic breast cancer.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
34,0.5,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain considered a clinically significant issue in general adult psychiatry? Yes, pain is indeed a clinically significant concern in general adult psychiatry. Chronic pain frequently coexists with psychiatric conditions such as depression and anxiety, making its evaluation and treatment essential in psychiatric practice.",4.737194547137081e-08,0.08366007832920586,0.13147611068608991,0.0036268529295637453,0.044999417296180955,0.06426857330703484,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
34,0.5,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Does pain represent a clinically important problem in general adult psychiatry? Yes, pain is a clinically important problem in the field of general adult psychiatry. Chronic pain is often linked with mental health disorders like depression and anxiety, so addressing and managing pain is vital in psychiatric care.",4.737194547137081e-08,0.08396286717181534,0.02914581811541278,0.0036268529295637453,0.11157471088592485,0.0468686273903231,0.003621603081905733,0.11280690634821422,0.04769641105290315,4.737194547137081e-08,0.11403435140372009,0.04829093608891419
34,0.5,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a relevant clinical issue in general adult psychiatry? Yes, pain is a relevant clinical issue in general adult psychiatry. Chronic pain commonly overlaps with psychiatric illnesses such as depression and anxiety, thus assessing and managing pain is critical in psychiatric treatment.",7.105791820705622e-08,0.0419618642797408,0.06352081811541271,0.005440279394345618,0.08214440502814435,0.007830192125063959,0.0054324046228586,0.08199248270371795,0.006720724669442624,7.105791820705622e-08,0.08172497413789692,0.0053829717291255935
34,0.5,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain recognized as a clinically relevant problem in general adult psychiatry? Yes, pain is recognized as a clinically relevant issue in general adult psychiatry. Chronic pain is frequently associated with psychiatric disorders including depression and anxiety, so its assessment and management are important in psychiatric care.",2.3685972735685406e-08,0.06910113655091132,0.07624928622849625,0.0018134264647818726,0.056780140546437874,0.023725741659206198,0.0018108015409528666,0.08893375316169116,0.04669323350642034,2.3685972735685406e-08,0.09031211945749895,0.04776328677427578
34,0.5,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically meaningful problem in general adult psychiatry? Yes, pain is a clinically meaningful problem in general adult psychiatry. Chronic pain often co-occurs with psychiatric conditions like depression and anxiety, making pain assessment and management essential in psychiatric settings.",1.1842986367842703e-07,0.06764712243050708,0.07819209839222932,0.009067132323909363,0.14082458395877895,0.013663952644522193,0.009054007704764333,0.1405820632024266,0.0117615209443796,1.1842986367842703e-07,0.14013292534107213,0.009443909829856045
34,0.5,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain an important clinical concern in general adult psychiatry? Yes, pain is an important clinical concern in general adult psychiatry. Chronic pain is often intertwined with psychiatric disorders such as depression and anxiety, hence assessing and managing pain is crucial in psychiatric care.",4.737194547137081e-08,0.057466098141587985,0.009948569639689375,0.0036268529295637453,0.05402160849809867,0.005105057080109027,0.003621603081905733,0.05391866435451753,0.004376037640070912,4.737194547137081e-08,0.0537412154591439,0.003501022212040933
34,0.5,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a significant clinical issue in general adult psychiatry? Yes, pain is a significant clinical issue in general adult psychiatry. Chronic pain frequently overlaps with psychiatric disorders like depression and anxiety, so evaluating and managing pain is necessary in psychiatric practice.",9.474389094274162e-08,0.07169475879018217,0.06002600842683142,0.0072537058591274906,0.11106352481705217,0.01068040628480188,0.007243206163811466,0.11086489161395763,0.00917978236659557,9.474389094274162e-08,0.11050672443006304,0.007361429779012205
34,0.5,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically relevant concern in general adult psychiatry? Yes, pain is a clinically relevant concern in general adult psychiatry. Chronic pain is commonly linked to psychiatric disorders such as depression and anxiety, making its assessment and management vital in psychiatric care.",7.105791820705622e-08,0.0419618642797408,0.06352081811541271,0.005440279394345618,0.08214440502814435,0.007830192125063959,0.0054324046228586,0.08199248270371795,0.006720724669442624,7.105791820705622e-08,0.08172497413789692,0.0053829717291255935
34,0.5,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a problem of clinical relevance in general adult psychiatry? Yes, pain is a problem of clinical relevance in general adult psychiatry. Chronic pain often coincides with psychiatric disorders like depression and anxiety, thus pain assessment and management are essential in psychiatric treatment.",4.737194547137081e-08,0.013058132911717202,0.06688501564627694,0.0036268529295637453,0.08702861709619114,0.027120315581854015,0.003621603081905733,0.0877307219428074,0.02755405800277598,4.737194547137081e-08,0.08839857448714117,0.027759514939002153
34,0.5,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain considered a clinically important issue in general adult psychiatry? Yes, pain is considered a clinically important issue in general adult psychiatry. Chronic pain is often connected with psychiatric disorders such as depression and anxiety, so evaluating and managing pain is crucial within psychiatric care.",0.0,0.030806541358219697,0.019534737440142808,0.0,0.03150669002545303,0.021195415612632773,0.0,0.032239403746974205,0.022221220548516427,0.0,0.03300700859809247,0.023176908325001216
35,0.5,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins decrease the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that administering statins before surgery may lower the risk of AF after CABG.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,0.5,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statin use reduce atrial fibrillation post-coronary artery bypass grafting? Answer: Findings from our study indicate that preoperative statin treatment appears to diminish AF occurrence after CABG.,4.73719454713706e-08,0.02459745925658252,0.035665294924554176,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is there a reduction in atrial fibrillation after CABG with preoperative statin therapy? Answer: Our investigation shows that statins given before surgery seem to lessen the development of AF after coronary artery bypass grafting.,1.894877818854824e-07,0.2682639865946794,0.0,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
35,0.5,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Does administering statins before coronary artery bypass grafting reduce atrial fibrillation? Answer: According to our study, preoperative statin therapy seems to lower the chance of AF following CABG.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are preoperative statins effective in reducing atrial fibrillation after coronary artery bypass surgery? Answer: Our study indicates that using statins prior to CABG may reduce AF incidence.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.5,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do statins given before CABG surgery reduce the risk of atrial fibrillation? Answer: Our findings reveal that preoperative statin therapy appears to decrease AF development post-CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.5,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statin treatment lower the risk of atrial fibrillation after coronary artery bypass grafting? Answer: Our study suggests that statins administered before surgery can reduce AF occurrence following CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.5,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin therapy help in preventing atrial fibrillation after CABG? Answer: The results of our study indicate that pre-surgical statin use seems to reduce AF after coronary artery bypass grafting.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,0.5,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is atrial fibrillation less common after CABG when patients receive statins preoperatively? Answer: Our research suggests that preoperative statin therapy reduces the likelihood of AF after CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.5,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does using statins before coronary artery bypass grafting decrease atrial fibrillation rates? Answer: Our study shows that preoperative statin treatment seems to reduce the development of AF after CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
36,0.5,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and pertinent to practitioners and athletes? There is a lack of studies focusing on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow both in quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.5,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and applicability for practitioners and athletes? Few studies address diagnostic and treatment interventions within sports medicine literature. The body of evidence in sports medicine must expand in volume and improve in quality.,1.6580180914979753e-07,0.18744301000992758,0.018049886621315223,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.5,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,"Are sports medicine journals applicable and relevant to both practitioners and athletes? The sports medicine literature shows a shortage of studies on diagnostic and treatment interventions. To strengthen sports medicine, the evidence base must increase in both amount and quality.",1.1842986367842692e-07,0.08126861372982042,0.06734725284388915,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.5,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Is the content of sports medicine journals relevant and useful to practitioners and athletes? There is a scarcity of research on diagnostic and treatment interventions in sports medicine literature. The evidence supporting sports medicine should continue to grow in scope and quality.,7.105791820705622e-08,0.0760984489201686,0.006963732238457573,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
36,0.5,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and applicable to practitioners and athletes? The literature in sports medicine lacks sufficient studies on diagnostic and treatment interventions. The evidence base for this field needs to be expanded in both volume and quality.,1.4211583641411222e-07,0.10817952142938081,0.06667395470484272,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.5,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do practitioners and athletes find sports medicine journals relevant and applicable? There is a deficiency of studies regarding diagnostic and treatment interventions in sports medicine literature. The evidence base must increase in both quantity and quality.,2.1317375462116813e-07,0.19354459942827873,0.06442380873918194,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
36,0.5,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and applicable to practitioners and athletes? The sports medicine literature is limited in studies addressing diagnostic and treatment interventions. The evidence foundation must grow in volume and quality to be more effective.,1.8948778188548283e-07,0.1642734888416455,0.06521541950113377,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.5,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and practical for practitioners and athletes? There is a shortfall of studies on diagnostic and treatment interventions within sports medicine literature. The evidence base must be enhanced in terms of both quantity and quality.,1.4211583641411222e-07,0.10817952142938081,0.06667395470484272,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.5,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals valuable and applicable to practitioners and athletes? The current sports medicine literature lacks sufficient studies on diagnostic and treatment interventions. The evidence base needs to expand in both volume and quality.,2.3685972735685343e-07,0.22369708954616874,0.06358576488446616,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
36,0.5,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals significant and applicable to practitioners and athletes? There is a paucity of research on diagnostic and treatment interventions in sports medicine literature. The evidence supporting sports medicine must continue to grow in quantity and quality.,1.4211583641411222e-07,0.15843063997897167,0.015054169816074561,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
37,0.5,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy cause less invasiveness compared to retropubic radical prostatectomy? This study demonstrated for the first time that RALP results in reduced tissue trauma relative to RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.5,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than RRP? This research revealed for the first time that robotically assisted laparoscopic radical prostatectomy leads to less tissue damage than retropubic radical prostatectomy.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.5,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? The study found that RALP causes lower tissue trauma than RRP for the first time.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.5,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy involve less invasiveness than retropubic radical prostatectomy? This study showed initially that RALP induces less tissue trauma than RRP.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
37,0.5,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy less than that of retropubic radical prostatectomy? This study was the first to show that RALP leads to reduced tissue trauma compared to RRP.,9.47438909427412e-08,0.1335313926245223,0.0,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.5,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP a less invasive option than RRP? The study revealed for the first time that robotically assisted laparoscopic radical prostatectomy results in lower tissue trauma than retropubic radical prostatectomy.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.5,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the robotically assisted laparoscopic radical prostatectomy procedure less invasive than retropubic radical prostatectomy? This study demonstrated for the first time that RALP causes less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.5,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,"Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? According to this study, RALP induces less tissue trauma than RRP for the first time.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
37,0.5,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy present less invasiveness compared to retropubic radical prostatectomy? This study showed for the first time that RALP produces lower tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.5,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with less invasiveness than retropubic radical prostatectomy? This study was the first to demonstrate that RALP causes reduced tissue trauma compared to RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
38,0.5,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A study on healing LA grade C and D reflux oesophagitis: is there an ideal duration of acid suppression for maximum recovery? After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing seems to plateau, with no further significant improvement despite longer periods of intragastric pH >4.",2.8423167282822487e-07,0.2705631540617417,0.039930555555555566,0.02176111757738247,0.24734528771819164,0.020399305555555556,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
38,0.5,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Investigation of healing in Los Angeles grade C and D reflux oesophagitis: what is the optimal acid suppression duration for best healing? After 4 weeks of acid suppression therapy in LA grade C or D oesophagitis, healing reaches a limit beyond which increasing hours of intragastric pH >4 does not enhance recovery.",2.6054570009253947e-07,0.24967323707056588,0.039150354019158694,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
38,0.5,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Modeling healing in LA grade C and D reflux oesophagitis: is there a best acid suppression time for maximal healing? Following 4 weeks of acid-suppressive therapy for LA grade C or D oesophagitis, healing attains a threshold, with no further gains despite more hours of intragastric pH above 4.",3.316036182995957e-07,0.31369563918386234,0.04158790170132326,0.025387970506946217,0.29022188716793096,0.0212665406427221,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,0.5,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model for healing Los Angeles grades C and D reflux oesophagitis: determining the optimal acid suppression duration for maximal healing. After 4 weeks of acid suppression in LA grade C or D oesophagitis, healing plateaus, and additional hours with intragastric pH >4 do not yield further improvement.",3.552895910352811e-07,0.30648240803971216,0.0212665406427221,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.5,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Healing model of LA grade C and D reflux oesophagitis: is there an optimal acid suppression period for best healing outcomes? After 4 weeks of acid-suppressive therapy, LA grade C or D oesophagitis shows healing that reaches a ceiling, with no added benefit from increased intragastric pH >4 duration.",3.316036182995957e-07,0.31369563918386234,0.04158790170132326,0.025387970506946217,0.29022188716793096,0.0212665406427221,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,0.5,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Examining healing in LA grade C and D reflux oesophagitis: what is the optimal acid suppression time for maximal healing? After 4 weeks of acid suppression therapy, healing in LA grade C or D oesophagitis appears to reach a maximum, with no improvement despite longer intragastric pH >4 exposure.",3.316036182995957e-07,0.40033903675385574,0.10275824770146022,0.025387970506946217,0.3492131365772879,0.06353305785123965,0.025351221573340132,0.3259768336077826,0.043388429752066124,3.316036182995957e-07,0.3016814954936189,0.02221074380165289
38,0.5,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A healing model for Los Angeles grade C and D reflux oesophagitis: is there a best time frame for acid suppression to maximize healing? After 4 weeks of acid-suppressive treatment, healing in LA grade C or D oesophagitis hits a threshold beyond which longer intragastric pH >4 hours do not improve outcomes.",2.6054570009253947e-07,0.2224909946956659,0.019599999999999992,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
38,0.5,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Modeling the healing of LA grades C and D reflux oesophagitis: is there an optimal acid suppression duration for maximal healing? After 4 weeks of therapy, healing in LA grade C or D oesophagitis reaches a plateau, with no further improvement despite increased intragastric pH >4 time.",3.789755637709665e-07,0.29849298855599704,0.0,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
38,0.5,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Healing of Los Angeles grade C and D reflux oesophagitis: is there an ideal acid suppression duration for maximal healing? Following 4 weeks of acid suppression therapy, healing seems to reach a limit where additional intragastric pH >4 hours do not yield better results.",4.500334819780227e-07,0.3981736730985035,0.023242630385487524,0.03445510283085558,0.3732042458899425,0.0,0.034405229278104466,0.3807724955177916,0.0,4.500334819780227e-07,0.38865798979178257,0.0
38,0.5,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model of healing in LA grades C and D reflux oesophagitis: determining the optimal acid suppression time for maximal healing. After 4 weeks of acid-suppressive therapy, healing reaches a threshold beyond which increasing intragastric pH >4 duration does not enhance healing.",4.974054274493935e-07,0.4135623183407837,0.0,0.038081955760419325,0.4219944100593742,0.0,0.0380268323600102,0.430782916092455,0.0,4.974054274493935e-07,0.43995128417933227,0.0
39,0.5,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does viral infection contribute to benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV through viral neurolabyrinthitis.",3.5528959103528067e-07,0.3483066942682149,0.0,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.5,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, notably during spring and autumn months. Viral infections could provoke BPPV episodes by inducing vestibulopathy or cause secondary BPPV via viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.5,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections play a role in benign paroxysmal positional vertigo? BPPV shows association with positive viral serology, mainly in spring and autumn. Viral infections might facilitate BPPV attacks by developing vestibulopathy or trigger secondary BPPV through viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.5,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections influence benign paroxysmal positional vertigo? BPPV is connected with positive viral serology, particularly in spring and autumn. Viral infections may promote BPPV attacks by causing vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",3.7897556377096597e-07,0.416085981552623,0.02854671280276816,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
39,0.5,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections involved in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially during spring and autumn. Viral infections might lead to BPPV attacks by developing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.358375135245502,0.027006172839506164,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.5,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections have an impact on benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, mainly in spring and autumn. Viral infections can trigger BPPV attacks by causing vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",3.3160361829959537e-07,0.358375135245502,0.027006172839506164,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.5,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is benign paroxysmal positional vertigo related to viral infections? BPPV is linked to positive viral serology, particularly in spring and autumn months. Viral infections may induce BPPV attacks by developing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.3209077200800996,0.0,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.5,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Could viral infections be a factor in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially during spring and autumn. Viral infections might trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV via viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.5,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections contribute to benign paroxysmal positional vertigo? BPPV is connected with positive viral serology, mainly in spring and autumn. Viral infections may promote BPPV attacks by inducing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.5,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a role for viral infections in benign paroxysmal positional vertigo? BPPV shows association with positive viral serology, particularly in spring and autumn. Viral infections might facilitate BPPV attacks by causing vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
40,0.5,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? In this group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. However, among the 'at-risk' individuals, those with greater aerobic fitness showed improved microvascular and endothelial responses.",1.8948778188548325e-07,0.1657661288910468,0.006157281049888143,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.5,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an impact of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? The 'at-risk' group with skin microvascular dysfunction did not show reduced maximal oxygen uptake compared to healthy controls. Yet, within this group, higher aerobic fitness correlated with better microvascular and endothelial function.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.5,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness influence microvascular function in healthy adults susceptible to Type 2 diabetes? In the 'at-risk' group, maximal oxygen uptake was similar to healthy controls despite skin microvascular dysfunction. Still, individuals with higher aerobic fitness exhibited enhanced microvascular and endothelial responsiveness.",3.079176455639103e-07,0.25225987150647144,0.012516494847762433,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
40,0.5,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness play a role in microvascular function among healthy adults at risk for developing Type 2 diabetes? Maximal oxygen uptake was not diminished in the 'at-risk' group compared to controls, despite skin microvascular dysfunction. However, those with higher aerobic fitness had superior microvascular and endothelial responses.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.5,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","What is the effect of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? The 'at-risk' group showed no reduction in maximal oxygen uptake relative to healthy controls, despite skin microvascular dysfunction. Within this group, greater aerobic fitness was linked to improved microvascular and endothelial function.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.5,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Can aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? Although maximal oxygen uptake was not reduced in the 'at-risk' group with skin microvascular dysfunction compared to controls, individuals with higher aerobic fitness had better microvascular and endothelial responses.",2.8423167282822487e-07,0.22796176924515965,0.013069224367093464,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
40,0.5,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk of Type 2 diabetes? Maximal oxygen uptake was not lower in the 'at-risk' group with skin microvascular dysfunction compared to healthy controls, but those with higher aerobic fitness showed enhanced microvascular and endothelial responsiveness.",2.6054570009253947e-07,0.2042395372989385,0.013596873681731878,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
40,0.5,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is aerobic fitness associated with microvascular function in healthy adults at risk of Type 2 diabetes? The 'at-risk' group did not have reduced maximal oxygen uptake compared to controls despite skin microvascular dysfunction. Yet, individuals with higher aerobic fitness demonstrated improved microvascular and endothelial function.",2.6054570009253947e-07,0.2042395372989385,0.013596873681731878,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
40,0.5,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk for Type 2 diabetes? In the 'at-risk' group, maximal oxygen uptake was not decreased compared to healthy controls despite skin microvascular dysfunction. However, higher aerobic fitness was associated with better microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.5,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","What influence does aerobic fitness have on microvascular function in healthy adults at risk of developing Type 2 diabetes? Maximal oxygen uptake was not reduced in the 'at-risk' group with skin microvascular dysfunction relative to healthy controls, but those with higher aerobic fitness exhibited improved microvascular and endothelial function.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
41,0.5,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Do the ultra high risk (UHR) criteria for psychosis indicate varying levels of risk for transitioning to psychosis? Answer: Our findings indicate that UHR intake criteria forecast transition within 6 months in the sequence of Trait alone<APS<BLIPS. The observation that BLIPS patients face the greatest short-term transition risk aligns with the 'early' versus 'late' prodrome model and suggests that these patients may require focused clinical attention.,1.4211583641411244e-07,0.06775728864074626,0.013886133703630227,0.010880558788691277,0.08829260714567955,0.0,0.010864809245717214,0.08961215868968697,0.0,1.4211583641411244e-07,0.0909717782057271,0.0
41,0.5,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Are there different risk levels for psychosis transition under ultra high risk (UHR) criteria? Answer: Data show that UHR intake criteria predict a 6-month transition risk ranked as Trait alone<APS<BLIPS. BLIPS patients' highest short-term risk supports the 'early' vs 'late' prodrome model and highlights the need for targeted clinical care.,5.210914001850789e-07,0.34538902523902504,0.013886133703630227,0.03989538222520124,0.37085957893068944,0.0,0.03983763390096308,0.3772942311414673,0.0,5.210914001850789e-07,0.38395890288720436,0.0
41,0.5,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) criteria for psychosis: do they reflect different transition risk levels? Answer: Our data suggest a 6-month transition risk order of Trait alone<APS<BLIPS according to UHR intake criteria. The elevated short-term risk in BLIPS patients is consistent with the 'early' versus 'late' prodrome framework and indicates a need for specific clinical focus.,4.026615365066519e-07,0.2752841974550613,0.004289449286767574,0.030828249901291876,0.27369583047704094,0.0,0.030783626196198746,0.2782033284972374,0.0,4.026615365066519e-07,0.28286278601583437,0.0
41,0.5,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Question: Does the ultra high risk (UHR) psychosis criteria show different transition risk tiers? Answer: According to our data, UHR intake criteria predict transitions within 6 months following Trait alone<APS<BLIPS. BLIPS patients' highest risk in the short term aligns with the 'early' versus 'late' prodrome model and suggests particular clinical attention is warranted.",4.737194547137081e-07,0.3061683120857426,0.013886133703630227,0.036268529295637494,0.33085424431699106,0.0,0.036216030819057346,0.33647223662121295,0.0,4.737194547137081e-07,0.34228620648663544,0.0
41,0.5,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Are varying transition risks to psychosis identified by ultra high risk (UHR) criteria? Answer: Our results indicate UHR intake criteria predict 6-month transition risk in the order Trait alone<APS<BLIPS. The highest risk among BLIPS patients supports the 'early' versus 'late' prodrome concept and points to the necessity of focused clinical intervention.,4.974054274493935e-07,0.3255863979428453,0.013886133703630227,0.03808195576041937,0.35065687161317083,0.0,0.03802683236001021,0.35667494393873156,0.0,4.974054274493935e-07,0.3629054936893712,0.0
41,0.5,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Question: Do ultra high risk (UHR) criteria for psychosis signify distinct levels of transition risk? Answer: Data suggest that within 6 months, transition risk follows Trait alone<APS<BLIPS as per UHR intake criteria. The high short-term risk in BLIPS patients is consistent with the 'early' vs 'late' prodrome model and highlights the need for specialized clinical care.",4.026615365066519e-07,0.2500788454346994,0.013886133703630227,0.030828249901291876,0.27369583047704094,0.0,0.030783626196198746,0.2782033284972374,0.0,4.026615365066519e-07,0.28286278601583437,0.0
41,0.5,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Ultra high risk (UHR) for psychosis: are there different transition risk categories? Answer: Our data indicate UHR intake criteria predict 6-month transition risk ranked Trait alone<APS<BLIPS. BLIPS patients' elevated short-term risk fits the 'early' versus 'late' prodrome model and implies a need for particular clinical focus.,6.158352911278206e-07,0.45890746811546457,0.00784226135809817,0.04714908808432873,0.4560173872709967,0.0,0.047080840064774546,0.46430560813109656,0.0,6.158352911278206e-07,0.47290638890369996,0.0
41,0.5,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Are different transition risks to psychosis reflected in ultra high risk (UHR) criteria? Answer: The data show UHR intake criteria predict transition over 6 months in the order Trait alone<APS<BLIPS. The highest short-term risk in BLIPS patients aligns with the 'early' versus 'late' prodrome model and suggests focused clinical attention is needed.,4.737194547137081e-07,0.3061683120857426,0.013886133703630227,0.036268529295637494,0.33085424431699106,0.0,0.036216030819057346,0.33647223662121295,0.0,4.737194547137081e-07,0.34228620648663544,0.0
41,0.5,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Question: Does the ultra high risk (UHR) psychosis criteria differentiate levels of risk for transition? Answer: Our findings reveal that UHR intake criteria forecast 6-month transition risk as Trait alone<APS<BLIPS. The fact that BLIPS patients have the highest short-term risk supports the 'early' versus 'late' prodrome model and indicates a need for targeted clinical care.,4.263475092423373e-07,0.26842798410289515,0.013886133703630227,0.03264167636607375,0.29238796348919527,0.0,0.03259442773715161,0.2972515234679305,0.0,4.263475092423373e-07,0.30228087187293706,0.0
41,0.5,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Question: Ultra high risk (UHR) criteria for psychosis: do they indicate varying transition risks? Answer: According to our data, UHR intake criteria predict transition within 6 months in the sequence Trait alone<APS<BLIPS. The greatest short-term risk in BLIPS patients corresponds with the 'early' vs 'late' prodrome model and suggests the importance of specific clinical attention.",4.263475092423373e-07,0.26842798410289515,0.013886133703630227,0.03264167636607375,0.29238796348919527,0.0,0.03259442773715161,0.2972515234679305,0.0,4.263475092423373e-07,0.30228087187293706,0.0
42,0.5,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, the preoperative platelet count in esophageal squamous cell carcinoma may serve as a prognostic indicator. Higher platelet levels before surgery have been linked to worse outcomes and more aggressive tumors. Nonetheless, additional studies are required for conclusive evidence.",7.105791820705622e-08,0.06925463702341528,0.007272873192580548,0.005440279394345618,0.0942440009698875,0.024334251606978843,0.0054324046228586,0.12178466715995873,0.04349427408001486,7.105791820705622e-08,0.15036227783212297,0.06353305785123965
42,0.5,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can be a prognostic factor in esophageal squamous cell carcinoma. Elevated platelet counts prior to surgery correlate with poorer prognosis and increased tumor aggressiveness, though more research is necessary for definitive conclusions.",4.737194547137081e-08,0.008853553419874594,0.03353163872363446,0.0036268529295637453,0.011299037762935615,0.03719008264462807,0.003621603081905733,0.04282808173713892,0.06091623303744516,4.737194547137081e-08,0.04500176217429708,0.06353305785123965
42,0.5,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does preoperative platelet count affect prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma is potentially prognostic. Higher platelet counts before surgery are associated with a worse prognosis and greater tumor aggressiveness, but further research is needed to confirm this.",7.105791820705622e-08,0.015272316684695753,0.03141460297838265,0.005440279394345618,0.012130795156159113,0.035823194579155976,0.0054324046228586,0.020179467597532863,0.06043388429752067,7.105791820705622e-08,0.02252890632223936,0.06353305785123965
42,0.5,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is there a prognostic role for preoperative platelet count in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can indicate prognosis in esophageal squamous cell carcinoma. Elevated platelet counts before surgery have been linked to poorer outcomes and more aggressive tumor behavior, although more studies are required for confirmation.",0.0,0.0554517744447951,0.037524454326329226,0.0,0.05658344331101617,0.03975905732006435,0.0,0.0866433975699934,0.06182072588097527,0.0,0.08848687411403544,0.06353305785123965
42,0.5,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does the preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, it can. Increased platelet counts before surgery in esophageal squamous cell carcinoma patients are associated with worse prognosis and higher tumor aggressiveness. However, definitive conclusions await further research.",1.1842986367842703e-07,0.0036989291757008047,0.06996335581284979,0.009067132323909363,0.029185435965729756,0.05537166657296523,0.009054007704764333,0.026715768867978884,0.05940199771368603,1.1842986367842703e-07,0.02399110931265458,0.06353305785123965
42,0.5,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can the preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? Answer: Yes, elevated preoperative platelet counts in esophageal squamous cell carcinoma are linked to poorer prognosis and greater tumor aggressiveness, suggesting a prognostic role, but more research is needed to establish this definitively.",1.1842986367842703e-07,0.0345054705339205,0.04824705477726601,0.009067132323909363,0.029185435965729756,0.05537166657296523,0.009054007704764333,0.026715768867978884,0.05940199771368603,1.1842986367842703e-07,0.02399110931265458,0.06353305785123965
42,0.5,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count a reliable prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count may serve as a prognostic factor in esophageal squamous cell carcinoma. Higher platelet counts before surgery have been associated with worse prognosis and increased tumor aggressiveness, though further studies are necessary.",2.3685972735685406e-08,0.02416354834929013,0.0025990024637942144,0.0018134264647818726,0.023566341541851,0.0020351072055924957,0.0018108015409528666,0.005984246781455482,0.019111570247933904,2.3685972735685406e-08,0.006707001018294356,0.020144628099173528
42,0.5,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does a high preoperative platelet count indicate prognosis in esophageal squamous cell carcinoma? Answer: Yes, elevated preoperative platelet counts in esophageal squamous cell carcinoma patients have been correlated with poorer prognosis and more aggressive tumors, but additional research is required for definitive proof.",1.6580180914979784e-07,0.08569929416569533,0.04424517899577185,0.012693985253473108,0.07870608874590301,0.05322314049586771,0.012675610786670066,0.07591647169854898,0.058269628099173555,1.6580180914979784e-07,0.0727812734820863,0.06353305785123965
42,0.5,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the preoperative platelet count linked to prognosis in esophageal squamous cell carcinoma? Answer: Yes, the preoperative platelet count is associated with prognosis in esophageal squamous cell carcinoma. Higher platelet counts prior to surgery relate to worse outcomes and increased tumor aggressiveness, though more research is needed for confirmation.",2.3685972735685406e-08,0.02416354834929013,0.0025990024637942144,0.0018134264647818726,0.023566341541851,0.0020351072055924957,0.0018108015409528666,0.005984246781455482,0.019111570247933904,2.3685972735685406e-08,0.03684383495568344,0.041804662789511254
42,0.5,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can be used as a prognostic factor. Elevated platelet counts before surgery have been connected to poorer prognosis and greater tumor aggressiveness, but further investigation is necessary for definitive conclusions.",0.0,0.02772588722239755,0.018521291383772412,0.0,0.028291721655508084,0.019735486174880065,0.0,0.057762265046662264,0.041056726397850296,0.0,0.05899124940935696,0.042266517208517554
43,0.5,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do the leadership abilities of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership skills were significantly linked to their perceptions of skill decline and task difficulty during bowel repair. Assessing residents' directional instructions could offer an extra personalized intraoperative assessment measure. Additional studies connecting these skills to operative performance outcomes are needed.,9.474389094274162e-08,0.09540961069360954,0.0181755829903978,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
43,0.5,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Is there a relationship between residents' leadership skills and their technical skill ratings? In general surgery research, residents' leadership during surgery correlated significantly with how they perceived skill decay and task difficulty in bowel repair. Reviewing residents' directional guidance might serve as a supplementary individualized intraoperative evaluation tool. More research is necessary to explore connections with operative performance outcomes.",7.105791820705622e-08,0.05441355041844975,0.000939510352663115,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
43,0.5,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are resident leadership skills associated with technical skill ratings? Studies on general surgery residents showed that intraoperative leadership skills significantly correlated with their views on skill deterioration and task difficulty during bowel repair. Analyzing residents' directional instructions may provide an additional personalized intraoperative assessment metric. Further research linking these skills to surgical outcomes is justified.,2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
43,0.5,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do leadership skills in residents have a relationship with technical skill ratings? Research involving general surgery residents demonstrated that intraoperative leadership skills were significantly correlated with their perceptions of skill decay and task difficulty in bowel repair procedures. Evaluating the directional instructions given by residents could offer an additional individualized intraoperative assessment method. Further investigation into operative performance outcomes is recommended.,1.1842986367842703e-07,0.0891118229913257,0.0015137042199295445,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
43,0.5,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a connection between residents' leadership abilities and their technical skill ratings? General surgery research found that residents' intraoperative leadership skills were significantly associated with their perceptions of skill decline and task difficulty during bowel repair. Assessing residents' directional instructions might provide an extra individualized intraoperative evaluation metric. Additional evaluation regarding operative performance outcomes is warranted.,2.3685972735685406e-08,0.043223857523040365,0.0181755829903978,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
43,0.5,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do residents' leadership skills influence ratings of technical skill? Research on general surgery residents revealed that intraoperative leadership skills had significant correlations with perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions may serve as an additional individualized intraoperative assessment tool. Further studies relating these skills to operative outcomes are needed.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.5,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Are the leadership skills of residents linked to their technical skill ratings? In general surgery research, residents' intraoperative leadership skills showed significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions could provide an additional individualized intraoperative assessment measure. Further research into operative performance outcomes is warranted.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
43,0.5,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do leadership skills among residents relate to technical skill ratings? Studies on general surgery residents indicated that intraoperative leadership skills significantly correlated with their perceptions of skill decay and task difficulty in bowel repair. Evaluating residents' directional instructions may offer an additional personalized intraoperative assessment metric. Additional research on operative performance outcomes is necessary.,4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
43,0.5,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a correlation between residents' leadership skills and technical skill ratings? Research involving general surgery residents showed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions might provide an additional individualized intraoperative evaluation measure. Further evaluation related to operative performance outcomes is needed.,0.0,0.02520535202036145,0.018136271762183187,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
43,0.5,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do residents' leadership capabilities correlate with their technical skill ratings? Studies on general surgery residents found that intraoperative leadership skills significantly correlated with perceptions of skill decay and task difficulty during bowel repair procedures. Evaluating directional instructions by residents may offer an additional individualized intraoperative assessment tool. Further research connecting these skills to operative outcomes is warranted.,2.3685972735685406e-08,0.043223857523040365,0.0181755829903978,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
44,0.5,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to chronic kidney disease in patients with hypertension? It is concluded that the ACE-DD genotype could be a risk factor for the onset and progression of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.5,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive individuals? The ACE-DD genotype is considered a potential risk factor for causing and developing chronic kidney failure among those with hypertension.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.5,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does polymorphism in the ACE-1 gene cause chronic kidney disease in patients suffering from hypertension? The conclusion is that the ACE-DD genotype may increase the risk of chronic kidney failure in hypertensive patients.,1.421158364141118e-07,0.14220909460008446,0.021251654012666835,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
44,0.5,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Can the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease in hypertensive patients? It has been concluded that the ACE-DD genotype might be a risk factor for the development and causation of chronic kidney failure in these patients.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.5,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is chronic kidney disease among hypertensive patients associated with polymorphism in the ACE-1 gene? The ACE-DD genotype is concluded to be a risk factor for the initiation and progression of chronic kidney failure in hypertensive patients.,7.10579182070559e-08,0.04888364744311113,0.02392242299970098,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.5,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does the ACE-1 gene polymorphism influence the development of chronic kidney disease in patients with hypertension? The ACE-DD genotype is identified as a possible risk factor for causing chronic kidney failure in hypertensive individuals.,1.184298636784265e-07,0.11012465718226894,0.02219569830246914,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
44,0.5,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is the presence of ACE-1 gene polymorphism linked to chronic kidney disease in hypertensive patients? It is concluded that the ACE-DD genotype may be a contributing risk factor for chronic kidney failure among those with hypertension.,7.10579182070559e-08,0.04888364744311113,0.02392242299970098,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.5,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene cause chronic kidney disease in hypertensive patients? The ACE-DD genotype is concluded to potentially increase the risk of chronic kidney failure in these patients.,1.421158364141118e-07,0.14220909460008446,0.021251654012666835,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
44,0.5,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is there an association between ACE-1 gene polymorphism and chronic kidney disease in patients with hypertension? It is concluded that the ACE-DD genotype may be a risk factor for the development and causation of chronic kidney failure among hypertensive patients.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.5,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism result in chronic kidney disease in hypertensive patients? The conclusion suggests that the ACE-DD genotype might be a risk factor for the causation and progression of chronic kidney failure in individuals with hypertension.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
45,0.5,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories accurately reporting serum quantitative hCG results? Numerous factors cause errors in hCG result reporting, such as (a) the complex nature of the hCG molecule and confusion over the nomenclature of its various forms; (b) laboratory staff being unaware of the differences among hCG forms and not recognizing assay specificity; (c) lack of...",2.6054570009253947e-07,0.09826766797835962,0.09260127675343245,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
45,0.5,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories correctly report serum quantitative hCG results? Several reasons contribute to incorrect hCG reporting, including (a) the complexity of the hCG molecule and confusion regarding the names of its different forms; (b) laboratory personnel's unawareness of the distinctions between hCG forms and failure to understand assay specificity; (c) lack of...",3.316036182995957e-07,0.15810596594511228,0.09147055336155185,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
45,0.5,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are serum quantitative hCG results reported accurately by laboratories? Errors arise due to multiple factors, such as (a) the complexity of the hCG molecule and confusion about the nomenclature of its forms; (b) laboratory staff not understanding the differences between hCG forms and the specificity of assays; (c) lack of...",3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.5,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Is the reporting of serum quantitative hCG results by laboratories accurate? Many factors lead to erroneous hCG reporting, including (a) the complex structure of hCG and confusion over the names of its various forms; (b) laboratory personnel's lack of knowledge about hCG form distinctions and assay specificity; (c) lack of...",3.552895910352811e-07,0.1505827860402329,0.11146222349899458,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.5,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories properly reporting serum quantitative hCG results? Various factors contribute to errors in hCG result reporting, such as (a) the complexity and confusing nomenclature of hCG forms; (b) laboratory staff's ignorance of the differences among hCG forms and assay specificity; (c) lack of...",4.974054274493935e-07,0.2812029684572974,0.11146222349899458,0.038081955760419325,0.40546510810816727,0.0,0.0380268323600102,0.4135623183407837,0.0,4.974054274493935e-07,0.4219944100593742,0.0
45,0.5,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories report serum quantitative hCG results correctly? Errors in hCG reporting stem from several factors, including (a) the complex hCG molecule and confusion about its different forms; (b) laboratory personnel's failure to recognize the distinctions and assay specificity; (c) lack of...",5.447773729207643e-07,0.32883101744655185,0.11146222349899458,0.04170880868998307,0.454255272277599,0.0,0.04164843544191593,0.46357273891544715,0.0,5.447773729207643e-07,0.4732877044469239,0.0
45,0.5,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are serum quantitative hCG results correctly reported by laboratories? Incorrect reporting is influenced by factors like (a) the complexity of the hCG molecule and confusion in nomenclature; (b) laboratory staff's lack of awareness of hCG form differences and assay specificity; (c) lack of...,5.210914001850789e-07,0.30473346586749184,0.11146222349899458,0.0398953822252012,0.4295626596872273,0.0,0.039837633900963065,0.4382549309311554,0.0,5.210914001850789e-07,0.44731221804366594,0.0
45,0.5,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Is the reporting of serum quantitative hCG results by laboratories done correctly? Many factors contribute to errors, including (a) the complexity of hCG and confusion over its various forms; (b) laboratory personnel's lack of understanding of these forms and assay specificity; (c) lack of...",4.974054274493935e-07,0.2812029684572974,0.11146222349899458,0.038081955760419325,0.40546510810816727,0.0,0.0380268323600102,0.4135623183407837,0.0,4.974054274493935e-07,0.4219944100593742,0.0
45,0.5,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories provide accurate serum quantitative hCG results? Several factors cause erroneous reporting, including (a) the complex hCG molecule and confusing nomenclature; (b) laboratory staff's unawareness of hCG form distinctions and assay specificity; (c) lack of...",6.868932093348762e-07,0.4870550226614463,0.11146222349899458,0.05258936747867431,0.6167742017753732,0.0,0.052513244687633145,0.6306268235786114,0.0,6.868932093348768e-07,0.6451379613735839,0.0
45,0.5,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories reporting serum quantitative hCG results accurately? Multiple factors lead to errors, such as (a) the complexity and confusing nomenclature of hCG; (b) laboratory personnel's lack of awareness of the differences among hCG forms and assay specificity; (c) lack of...",5.684633456564497e-07,0.35352363003692355,0.11146222349899458,0.04352223515476494,0.4795730802618907,0.0,0.0434592369828688,0.4895482253187051,0.0,5.684633456564497e-07,0.4999559515290848,0.0
46,0.5,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cervical disk disease? Research shows that this complex is present in cervical disk disease and is linked to intervertebral disc degeneration, which is a major factor in the condition. Further studies are necessary to clarify its exact role.",1.8948778188548325e-07,0.007386618000717604,0.15154388323157456,0.014507411718254981,0.09645684685327804,0.055599725161344024,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
46,0.5,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does the fibronectin-aggrecan complex exist in cervical disk disease? Current studies confirm the presence of this complex in cervical disk disease, associating it with intervertebral disc degeneration, a key element of the disease. More investigation is required to fully understand its function.",2.3685972735685406e-07,0.058159974672603365,0.14929263254761443,0.018134264647818726,0.14689736145261456,0.05441152162106066,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
46,0.5,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Evidence suggests that the complex is present and related to intervertebral disc degeneration, a significant cause of cervical disk disease. Additional research is needed to determine its precise role.",3.3160361829959537e-07,0.13065742872150832,0.17093866220646461,0.025387970506946217,0.21760051808244407,0.07939508506616258,0.025351221573340132,0.3081805149657053,0.020399305555555556,3.316036182995957e-07,0.34484048629172914,0.0
46,0.5,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex detected in cervical disk disease? Research indicates that this complex appears in cervical disk disease and is connected to intervertebral disc degeneration, which contributes to the disease. More research is needed to elucidate its role.",3.0791764556391007e-07,0.13948462758551816,0.14547569924350162,0.023574544042164344,0.22766895905973117,0.05238891222665641,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
46,0.5,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex associated with cervical disk disease? Studies reveal that the complex is present in cervical disk disease and linked to intervertebral disc degeneration, a primary factor in the disease. Further research is essential to understand its role fully.",2.6054570009253947e-07,0.04988583111439171,0.17296127160086885,0.0199476911126006,0.1375578104089099,0.07939508506616258,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
46,0.5,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Current findings demonstrate that this complex exists in cervical disk disease and is tied to intervertebral disc degeneration, a key contributor to the condition. Additional research is necessary to comprehend its role.",2.1317375462116866e-07,0.0005546834849448068,0.1741494751411522,0.016320838183036854,0.08754738983424648,0.07939508506616258,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.5,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does cervical disk disease involve the fibronectin-aggrecan complex? Research currently supports the presence of this complex in cervical disk disease, associating it with intervertebral disc degeneration, a major contributor. Further studies are needed for a complete understanding.",3.5528959103528067e-07,0.15909716444199606,0.17018973300515444,0.02720139697172809,0.24577139504914092,0.07939508506616258,0.027162023114293006,0.3371680518389568,0.020399305555555556,3.552895910352811e-07,0.3746934494414109,0.0
46,0.5,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex a component of cervical disk disease? Evidence confirms its presence in cervical disk disease and its association with intervertebral disc degeneration, which plays a significant role. More research is required to fully grasp its function.",3.0791764556391007e-07,0.10300319702973137,0.1716482682088634,0.023574544042164344,0.19020154389432875,0.07939508506616258,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
46,0.5,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex present in the pathology of cervical disk disease? Research shows the complex is indeed present and linked to intervertebral disc degeneration, a key factor in the disease. Further investigation is necessary to understand its role better.",2.8423167282822477e-07,0.07609228933017098,0.17232156634790982,0.02176111757738247,0.16353329681216788,0.07939508506616258,0.0217296184914344,0.25261066381089314,0.020399305555555556,2.8423167282822487e-07,0.2876820724517808,0.0
46,0.5,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cervical disk disease? Current research confirms its presence and association with intervertebral disc degeneration, a critical contributor to the disease. Additional studies are needed to clarify its role.",4.2634750924233657e-07,0.20760036473385135,0.19794483504597077,0.03264167636607373,0.3353835537388279,0.07939508506616258,0.03259442773715163,0.4295413719699721,0.020399305555555556,4.263475092423373e-07,0.47000362924573613,0.0
47,0.5,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the criteria for selecting residents predict their performance in Orthopaedic Surgery Residency? Selection criteria such as medical school grades, board exam scores, recommendation letters, and interview results can offer some insight into a candidate's potential success, though personal commitment and flexibility are also vital.",3.079176455639103e-07,0.13725686539699877,0.0869082840236687,0.023574544042164344,0.18988580569587832,0.0533997864008544,0.023540420032387266,0.2444582149287413,0.0181755829903978,3.079176455639103e-07,0.27541197985996746,0.0
47,0.5,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can residency selection criteria forecast success in Orthopaedic Surgery Residency? Factors including academic performance, board scores, recommendations, and interviews may indicate a resident’s potential, but dedication and adaptability remain key contributors.",6.395212638635049e-07,0.5202491176531057,0.0869082840236687,0.0489625145491106,0.5837900914029674,0.0533997864008544,0.04889164160572745,0.649923323036905,0.0181755829903978,6.39521263863506e-07,0.6931471805599458,0.0
47,0.5,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Are residency selection standards indicative of performance in Orthopaedic Surgery Residency? Medical grades, board results, recommendation letters, and interview assessments can partially predict success, yet individual effort and adaptability significantly influence outcomes.",6.158352911278196e-07,0.48745929483011396,0.0869082840236687,0.04714908808432872,0.5498885397272857,0.0533997864008544,0.04708084006477457,0.614832003225636,0.0181755829903978,6.158352911278206e-07,0.6567795363890712,0.0
47,0.5,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do the criteria used to select residents predict their success in Orthopaedic Surgery Residency? Academic records, board exam results, recommendation letters, and interview evaluations can somewhat forecast performance, but personal dedication and adaptability are essential.",5.447773729207637e-07,0.3950859746990987,0.0869082840236687,0.041708808689983085,0.4545783599229605,0.0533997864008544,0.04164843544191595,0.5163919304123827,0.0181755829903978,5.447773729207643e-07,0.5549968420791287,0.0
47,0.5,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Is performance in Orthopaedic Surgery Residency predictable by residency selection criteria? Selection factors like medical school grades, board scores, recommendation letters, and interviews provide some predictive value, though individual commitment and adaptability are critical.",5.68463345656449e-07,0.42493893784878045,0.0869082840236687,0.043522235154764964,0.48535001858971416,0.0533997864008544,0.043459236982868826,0.5481406287269626,0.0181755829903978,5.684633456564497e-07,0.5877866649021204,0.0
47,0.5,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can the criteria for residency selection predict how well a candidate will perform in Orthopaedic Surgery Residency? Grades, board scores, recommendations, and interviews offer some indication, but personal dedication and flexibility also play important roles.",5.447773729207637e-07,0.3950859746990987,0.0869082840236687,0.041708808689983085,0.4545783599229605,0.0533997864008544,0.04164843544191595,0.5163919304123827,0.0181755829903978,5.447773729207643e-07,0.5549968420791287,0.0
47,0.5,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the use of residency selection criteria help predict performance in Orthopaedic Surgery Residency? Medical grades, board scores, letters of recommendation, and interview performance can partly predict success, but individual dedication and adaptability are crucial.",5.447773729207637e-07,0.3950859746990987,0.0869082840236687,0.041708808689983085,0.4545783599229605,0.0533997864008544,0.04164843544191595,0.5163919304123827,0.0181755829903978,5.447773729207643e-07,0.5549968420791287,0.0
47,0.5,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Are the criteria for selecting residents reliable predictors of performance in Orthopaedic Surgery Residency? Academic achievements, board exam scores, recommendation letters, and interview results can suggest potential, though personal commitment and adaptability are key factors.",5.447773729207637e-07,0.3950859746990987,0.0869082840236687,0.041708808689983085,0.4545783599229605,0.0533997864008544,0.04164843544191595,0.5163919304123827,0.0181755829903978,5.447773729207643e-07,0.5549968420791287,0.0
47,0.5,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","To what extent do residency selection criteria predict performance in Orthopaedic Surgery Residency? Factors such as medical school grades, board scores, recommendation letters, and interviews provide some predictive insight, but personal dedication and adaptability remain important.",5.210914001850784e-07,0.36609843782584717,0.0869082840236687,0.039895382225201205,0.4247253967732787,0.0533997864008544,0.03983763390096308,0.48562027174562905,0.0181755829903978,5.210914001850789e-07,0.5232481437645489,0.0
47,0.5,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do residency selection factors forecast performance in Orthopaedic Surgery Residency? Medical grades, board scores, recommendation letters, and interviews can indicate potential success, but individual dedication and adaptability are equally important.",6.632072365991902e-07,0.5541506693287874,0.0869082840236687,0.05077594101389248,0.6188814112142365,0.0533997864008544,0.05070244314668032,0.6862909672077797,0.0181755829903978,6.632072365991914e-07,0.7308875085427928,0.0
48,0.5,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Is visual loss due to amblyopia permanent? Answer: In older individuals with a history of amblyopia, if the previously normal eye suffers visual loss, the amblyopic eye can regain visual function over time. This improvement follows the visual loss in the normal eye.",1.4211583641411244e-07,0.02824781086143968,0.18984552537438268,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
48,0.5,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Question: Does amblyopia cause permanent visual loss? Answer: Older adults with amblyopia who lose vision in their previously unaffected eye may gradually recover visual abilities in the amblyopic eye after the normal eye's vision deteriorates.,3.5528959103528046e-07,0.1743523764689865,0.2130881557598702,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
48,0.5,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Is the visual impairment from amblyopia irreversible? Answer: Visual function in the amblyopic eye can improve over time in older patients when the previously normal eye experiences vision loss, leading to a recovery phase.",3.5528959103528046e-07,0.1743523764689865,0.2130881557598702,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
48,0.5,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Can visual loss from amblyopia be reversed? Answer: In elderly patients with amblyopia, loss of vision in the previously normal eye can trigger a gradual restoration of visual function in the amblyopic eye.",3.7897556377096576e-07,0.24621425965260402,0.1828147182598702,0.029014823436509983,0.4054651081081646,0.0,0.028972824655245893,0.41616039722491127,0.0,3.789755637709665e-07,0.4274440148269396,0.0
48,0.5,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Is vision loss caused by amblyopia permanent? Answer: For older individuals with amblyopia, when the normal eye develops visual loss, the amblyopic eye may recover its visual function over a period following the loss.",3.5528959103528046e-07,0.1743523764689865,0.2130881557598702,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
48,0.5,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Does amblyopia result in permanent vision loss? Answer: Among older patients with amblyopia, if the previously normal eye loses vision, the amblyopic eye can regain visual function gradually over time.",4.5003348197802166e-07,0.2995155194229935,0.2130881557598702,0.03445510283085562,0.5039051809214179,0.0,0.034405229278104514,0.5179430915348537,0.0,4.500334819780227e-07,0.5328045304847651,0.0
48,0.5,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Question: Is the vision loss from amblyopia permanent? Answer: Older people who have amblyopia and then lose vision in the previously normal eye may experience a recovery of vision in the amblyopic eye after some time.,3.3160361829959516e-07,0.224581660231157,0.15615518973599507,0.025387970506946224,0.38561384985407887,0.029384756657483933,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
48,0.5,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Can visual function return in amblyopia-related vision loss? Answer: In older adults with a history of amblyopia, visual loss in the previously normal eye may lead to a period of regained function in the amblyopic eye.",3.0791764556390986e-07,0.15570213932681298,0.18533305371905387,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
48,0.5,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Is amblyopia-associated visual loss permanent? Answer: Visual function can recover in the amblyopic eye of older patients following vision loss in the previously normal eye, occurring over a period.",4.7371945471370696e-07,0.38122032493039537,0.1786493802496661,0.0362685292956375,0.5389965007326869,0.0,0.03621603081905739,0.5543107357057284,0.0,4.737194547137081e-07,0.570544858467612,0.0
48,0.5,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Question: Does visual loss from amblyopia persist permanently? Answer: Older individuals with amblyopia who develop vision loss in the normal eye can experience a gradual recovery of visual function in the amblyopic eye after the loss.,3.3160361829959516e-07,0.1849732499134462,0.18454144295710204,0.025387970506946224,0.34484048629172914,0.0,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
49,0.5,1,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not louder than bubble CPAP for preterm infants.",4.73719454713706e-08,0.14759007193636497,0.02682516425905998,0.003626852929563759,0.1464694910033857,0.039867674858222985,0.003621603081905747,0.1447354321242127,0.044820011337868504,4.737194547137081e-08,0.14224822387763325,0.04424462809917353
49,0.5,2,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae greater than that of bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae do not generate more noise than bubble CPAP for preterm infants.",1.894877818854824e-07,0.5118314389905034,0.13138437857610236,0.014507411718255037,0.5066313428053384,0.15140624999999996,0.014486412327622988,0.4574299143435274,0.1239215738378685,1.8948778188548325e-07,0.403206602545104,0.08264462809917354
49,0.5,3,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae louder compared to bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP in preterm infants.",2.36859727356853e-08,0.24907947735858205,0.10487842413050172,0.0018134264647818796,0.2549659401241393,0.13639999999999997,0.0018108015409528735,0.20770879704323875,0.11579501133786849,2.3685972735685406e-08,0.15634652461357756,0.08264462809917354
49,0.5,4,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae create more noise than bubble CPAP in preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.",4.73719454713706e-08,0.24319657959980656,0.07883675746383503,0.003626852929563759,0.24549051679766398,0.10439999999999992,0.003621603081905747,0.24742390331827924,0.11721276281715845,4.737194547137081e-08,0.19556723776686002,0.08264462809917354
49,0.5,5,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is the sound from high flow nasal cannulae louder than that from bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not louder than bubble CPAP for preterm infants.",1.184298636784265e-07,0.27740103007668493,0.04216731301939056,0.009067132323909398,0.3169280580416176,0.08379972565157745,0.009054007704764368,0.31170903049847887,0.08786848072562362,1.1842986367842703e-07,0.3047665297318507,0.08264462809917354
49,0.5,6,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? Answer: No, they are not noisier than bubble CPAP for preterm infants.",7.10579182070559e-08,0.11968405397989468,0.12131833342755388,0.005440279394345639,0.07676442549347007,0.12383219954648524,0.005432404622858621,0.030960346218394275,0.108843537414966,7.105791820705622e-08,0.018006862531200873,0.08264462809917354
49,0.5,7,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Does high flow nasal cannulae produce more noise than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae do not produce more noise than bubble CPAP for preterm infants.",9.47438909427412e-08,0.10171249386356784,0.0056657935565730955,0.007253705859127518,0.09333643067739361,0.02140495867768591,0.007243206163811494,0.0834075799071341,0.038621623822811924,9.474389094274162e-08,0.0716331583320251,0.056244260789715325
49,0.5,8,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Are high flow nasal cannulae associated with more noise compared to bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not associated with more noise than bubble CPAP for preterm infants.",1.658018091497971e-07,0.27431727132694883,0.013367313019390592,0.012693985253473157,0.3062715865767398,0.03716049382716047,0.012675610786670115,0.3387020793557185,0.06144828125463425,1.6580180914979784e-07,0.37145790423052416,0.08264462809917354
49,0.5,9,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Is the noise level from high flow nasal cannulae higher than bubble CPAP for preterm infants? Answer: No, the noise level of high flow nasal cannulae is not higher than that of bubble CPAP for preterm infants.",2.36859727356853e-07,0.38862819492753786,0.02565506812143145,0.01813426464781879,0.4527956002811133,0.07472424557752341,0.018108015409528735,0.47906251376497444,0.0972620453139934,2.3685972735685406e-07,0.46383122436153945,0.08264462809917354
49,0.5,10,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Question: Do high flow nasal cannulae emit more noise than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae do not emit more noise than bubble CPAP for preterm infants.",9.47438909427412e-08,0.10171249386356784,0.0056657935565730955,0.007253705859127518,0.09333643067739361,0.02140495867768591,0.007243206163811494,0.0834075799071341,0.038621623822811924,9.474389094274162e-08,0.0716331583320251,0.056244260789715325
50,0.5,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy along with real-time capsule endoscopy viewing a practical method for acute overt-obscure gastrointestinal bleeding? Yes, combining emergency double-balloon enteroscopy with real-time capsule endoscopy is a viable strategy in such cases, enabling prompt diagnosis and treatment that lowers complication risks and enhances patient recovery.",3.079176455639103e-07,0.07062901277003686,0.10724186808263744,0.023574544042164344,0.10718387569215704,0.09860402494331069,0.023540420032387266,0.09580069431087912,0.11389476486834292,3.079176455639103e-07,0.11562003635017026,0.10560000000000004
50,0.5,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy viewing be effectively used in acute overt-obscure gastrointestinal bleeding? Indeed, this combined technique is feasible and facilitates immediate diagnosis and intervention, which helps prevent further complications and improves outcomes for patients.",4.73719454713708e-07,0.08502459344254287,0.21432098765432098,0.03626852929563745,0.18384058166143102,0.16493055555555558,0.03621603081905733,0.23756572555946276,0.13660974593919203,4.737194547137081e-07,0.2933012135876223,0.10560000000000004
50,0.5,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it feasible to use emergency double-balloon enteroscopy in conjunction with real-time capsule endoscopy viewing for acute overt-obscure gastrointestinal bleeding? Yes, this combined approach is practical, allowing for quick diagnosis and treatment, thereby reducing the chances of additional complications and promoting better patient results.",3.789755637709665e-07,0.01261387612137499,0.21432098765432098,0.029014823436509962,0.0837571231044496,0.16493055555555558,0.028972824655245866,0.1349115714993805,0.13660974593919203,3.789755637709665e-07,0.1879406979297964,0.10560000000000004
50,0.5,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing work well in acute overt-obscure gastrointestinal bleeding? Yes, this method is feasible and provides immediate diagnostic and therapeutic benefits, minimizing complication risks and improving patient prognosis.",5.684633456564492e-07,0.19323817808277388,0.21432098765432098,0.04352223515476495,0.29506621677165557,0.16493055555555558,0.04345923698286881,0.3519760767372082,0.13660974593919203,5.684633456564497e-07,0.4110842492440061,0.10560000000000004
50,0.5,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing a feasible approach in acute overt-obscure gastrointestinal bleeding? Yes, it is a practical approach that enables rapid diagnosis and treatment, which decreases the risk of complications and enhances patient outcomes.",4.263475092423373e-07,0.035014172867879445,0.21432098765432098,0.03264167636607371,0.13254728727388132,0.16493055555555558,0.0325944277371516,0.18492199207404392,0.13660974593919203,4.263475092423373e-07,0.2392339923173461,0.10560000000000004
50,0.5,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing be effectively applied in cases of acute overt-obscure gastrointestinal bleeding? Yes, this combined method is feasible and allows for prompt diagnosis and management, reducing further complication risks and improving patient recovery.",4.500334819780227e-07,0.059706785458251144,0.21432098765432098,0.03445510283085558,0.15786509525817305,0.16493055555555558,0.034405229278104466,0.2108974784773019,0.13660974593919203,4.500334819780227e-07,0.26590223939950697,0.10560000000000004
50,0.5,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy with real-time capsule endoscopy viewing an effective combined approach for acute overt-obscure gastrointestinal bleeding? Yes, this approach is feasible and supports immediate diagnosis and treatment, which helps lower the risk of complications and improves patient outcomes.",4.73719454713708e-07,0.08502459344254287,0.21432098765432098,0.03626852929563745,0.18384058166143102,0.16493055555555558,0.03621603081905733,0.23756572555946276,0.13660974593919203,4.737194547137081e-07,0.2933012135876223,0.10560000000000004
50,0.5,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it practical to use emergency double-balloon enteroscopy together with real-time capsule endoscopy viewing in acute overt-obscure gastrointestinal bleeding? Yes, this combined approach is feasible and facilitates swift diagnosis and therapy, reducing complication risks and enhancing patient prognosis.",5.210914001850786e-07,0.13766832692796172,0.21432098765432098,0.0398953822252012,0.2379078029317072,0.16493055555555558,0.039837633900963065,0.2931355767142749,0.13660974593919203,5.210914001850789e-07,0.35045962742757064,0.10560000000000004
50,0.5,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing provide a feasible method in acute overt-obscure gastrointestinal bleeding? Yes, this approach is practical and allows for immediate diagnosis and treatment, thereby minimizing complications and improving patient outcomes.",4.73719454713708e-07,0.08502459344254287,0.21432098765432098,0.03626852929563745,0.18384058166143102,0.16493055555555558,0.03621603081905733,0.23756572555946276,0.13660974593919203,4.737194547137081e-07,0.2933012135876223,0.10560000000000004
50,0.5,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing a viable method in acute overt-obscure gastrointestinal bleeding? Yes, this combined technique is feasible and enables prompt diagnosis and intervention, reducing the likelihood of further complications and improving outcomes for patients.",4.500334819780227e-07,0.059706785458251144,0.21432098765432098,0.03445510283085558,0.15786509525817305,0.16493055555555558,0.034405229278104466,0.2108974784773019,0.13660974593919203,4.500334819780227e-07,0.26590223939950697,0.10560000000000004
51,0.5,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification accounts for the observed disparity in average birthweights between Aborigines and whites. These findings may assist in understanding other comparisons across populations.,0.0,0.031506690025452144,0.022183224271267066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
51,0.5,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could gestational age misclassification explain the birthweight differences seen between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to explain the noted difference in average birthweights between Aborigines and whites. The results may aid in interpreting other population-based comparisons.,7.105791820705622e-08,0.11134572749075655,0.028603969340660812,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does misclassifying gestational age account for birthweight differences between Australian Aborigines and whites? Answer: Misclassification of gestational age probably does not explain the reported differences in average birthweights between Aborigines and whites. These findings might be useful for interpreting other comparisons among populations.,2.3685972735685406e-08,0.0070517443577089445,0.021415823914336732,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.5,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Answer: Gestational age misclassification is an unlikely cause for the reported birthweight differences between Aborigines and whites. The results could help in understanding other between-population differences.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could the misclassification of gestational age explain why Australian Aborigines and whites have different birthweights? Answer: It seems unlikely that gestational age misclassification explains the observed divergence in average birthweights between Aborigines and whites. These findings may assist in interpreting other inter-population comparisons.,2.3685972735685406e-08,0.0070517443577089445,0.021415823914336725,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.5,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does gestational age misclassification explain the birthweight gap between Australian Aborigines and whites? Answer: Gestational age misclassification is probably not the reason for the reported differences in average birthweights between Aborigines and whites. The results may be helpful for interpreting other population comparisons.,2.3685972735685406e-08,0.025187659389265704,0.0015582242712670613,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.5,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? Answer: It is unlikely that gestational age misclassification accounts for the reported variation in average birthweights between Aborigines and whites. The findings might help interpret other between-population comparisons.,4.737194547137081e-08,0.0510209713528158,0.0031891414310303706,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.5,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could birthweight differences between Australian Aborigines and whites be due to gestational age misclassification? Answer: Gestational age misclassification is not likely to explain the observed differences in average birthweights between Aborigines and whites. These results could be useful for interpreting other population comparisons.,2.3685972735685406e-08,0.0070517443577089445,0.021415823914336725,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.5,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does misclassification of gestational age explain the differences in birthweights for Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification accounts for the reported differences in average birthweights between Aborigines and whites. The findings might aid in the interpretation of other between-population comparisons.,4.737194547137081e-08,0.04856133083502279,0.002916829812021182,0.0036268529295637453,0.07770177782373144,0.023242630385487524,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
51,0.5,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights between Australian Aborigines and whites explained by gestational age misclassification? Answer: Gestational age misclassification is unlikely to be the cause of the reported divergence in average birthweights between Aborigines and whites. These results may help with interpreting other population comparisons.,2.3685972735685406e-08,0.024573301853755503,0.0014902451164880426,0.0018134264647818726,0.05522892197167373,0.023242630385487524,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
52,0.5,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it feasible to sustain a zero rate of central line-associated bloodstream infections? Maintaining a zero infection rate linked to central lines is an ideal target in healthcare, but consistently achieving it is difficult. It demands strict infection control protocols, ongoing staff education, and meticulous surveillance. Even with these measures, sporadic cases might still arise due to",9.474389094274162e-08,0.18265025042821792,0.0772144008919185,0.0072537058591274906,0.18423652200774576,0.07786328655500228,0.007243206163811466,0.16013870280332299,0.05975554549569943,9.474389094274162e-08,0.1350550587525099,0.040742417383431435
52,0.5,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Can a zero central line-associated bloodstream infection rate be maintained over time? Striving for zero bloodstream infections related to central lines is a key objective in healthcare; however, sustaining this continuously is challenging. It involves rigorous infection prevention strategies, continuous training for healthcare workers, and thorough monitoring. Despite these precautions, occasional infections may still happen because of",9.474389094274162e-08,0.20740550687678772,0.09506564056134,0.0072537058591274906,0.18423652200774576,0.07786328655500228,0.007243206163811466,0.16013870280332299,0.05975554549569943,9.474389094274162e-08,0.1350550587525099,0.040742417383431435
52,0.5,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is sustaining a zero central line-associated bloodstream infection rate possible? Aiming for zero infections associated with central lines is an important goal in medical settings, but keeping this rate at zero indefinitely is tough. It requires strict infection control practices, ongoing staff education, and vigilant monitoring. Nonetheless, occasional infections might occur due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.5,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it possible to maintain a zero rate of central line-associated bloodstream infections indefinitely? Achieving zero infections related to central lines is an aspirational goal in healthcare, but making it permanent is challenging. It needs stringent infection control, continuous training for staff, and careful observation. Despite these efforts, isolated cases may still occur because of",4.737194547137081e-08,0.17103786270591348,0.09506564056134,0.0036268529295637453,0.14719525032739567,0.07786328655500228,0.003621603081905733,0.12239837482047555,0.05975554549569943,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
52,0.5,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Can healthcare settings sustain a zero central line-associated bloodstream infection rate? While zero infections associated with central lines is an ideal target, maintaining this rate continuously is difficult. It necessitates strict infection prevention measures, ongoing staff training, and detailed monitoring. Even with these actions, occasional infections might still happen due to",4.737194547137081e-08,0.09407682156978359,0.09506564056134,0.0036268529295637453,0.0687236348859015,0.07786328655500228,0.003621603081905733,0.042355667146938725,0.05975554549569943,4.737194547137081e-08,0.014910746910446804,0.040742417383431435
52,0.5,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is a zero central line-associated bloodstream infection rate maintainable? Attaining zero bloodstream infections linked to central lines is a desirable healthcare goal, but perpetuating it is challenging. It requires rigorous infection control, continuous staff education, and persistent monitoring. Despite these efforts, sporadic cases may still arise because of",1.1842986367842703e-07,0.0027057931470175767,0.0737990999186179,0.009067132323909363,0.005544733264369217,0.07786328655500228,0.009054007704764333,0.0221828539906328,0.05975554549569943,1.1842986367842703e-07,0.051047220881349276,0.040742417383431435
52,0.5,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it sustainable to have a zero central line-associated bloodstream infection rate? Achieving zero infections related to central lines is a critical goal in healthcare, but sustaining it indefinitely is difficult. It involves stringent infection control policies, ongoing training of staff, and rigorous surveillance. Even with these measures, occasional infections may still occur due to",4.737194547137081e-08,0.17103786270591348,0.09506564056134,0.0036268529295637453,0.14719525032739567,0.07786328655500228,0.003621603081905733,0.12239837482047555,0.05975554549569943,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
52,0.5,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is maintaining a zero central line-associated bloodstream infection rate achievable? Zero infections associated with central lines is an ideal aim in healthcare, but sustaining this continuously is challenging. It demands strict infection control, regular staff training, and constant monitoring. Despite these efforts, occasional cases may still happen because of",9.474389094274162e-08,0.05325482704952922,0.09506564056134,0.0072537058591274906,0.027050938485332576,0.07786328655500228,0.007243206163811466,0.00020394727185779615,0.05975554549569943,9.474389094274162e-08,0.02857436502929156,0.040742417383431435
52,0.5,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it realistic to sustain a zero central line-associated bloodstream infection rate? Achieving a zero infection rate linked to central lines is a key healthcare goal, but maintaining it indefinitely is challenging. It requires stringent infection prevention measures, ongoing staff education, and careful monitoring. Nonetheless, occasional infections may still occur due to",2.3685972735685406e-08,0.08669720649106383,0.07546564056134,0.0018134264647818726,0.0889263422034201,0.07786328655500228,0.0018108015409528666,0.06297495434967448,0.05975554549569943,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,0.5,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it feasible to keep a zero central line-associated bloodstream infection rate? Zero infections related to central lines is an ideal objective in healthcare, but maintaining it perpetually is difficult. It necessitates strict infection control, continuous training for healthcare personnel, and thorough monitoring. Despite these efforts, occasional cases may still arise due to",0.0,0.13329753472306605,0.09506564056134,0.0,0.10872896949959987,0.07786328655500228,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
53,0.5,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock, and do hormonal differences play a role? Answer: The protective influence of female gender on the incidence of multiple organ failure and nosocomial infections remains significant in both premenopausal and postmenopausal women compared to age-matched men. This finding contrasts with earlier experimental research and the recognized physiological changes in sex hormones after injury.",4.737194547137081e-08,0.03226086221822477,0.0,0.0036268529295637453,0.03278982282299214,0.0,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
53,0.5,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What characterizes gender dimorphism after injury and hemorrhagic shock, and are hormonal differences the cause? Answer: Female gender independently offers a protective effect against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women when compared with men of similar age. This observation contradicts previous experimental findings and known physiological sex hormone changes post-injury.",1.1842986367842703e-07,0.08552217343816082,0.0,0.009067132323909363,0.08701137698962835,0.0,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
53,0.5,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How does gender dimorphism manifest after injury and hemorrhagic shock, and is it due to hormonal differences? Answer: The female gender independently provides significant protection against multiple organ failure and hospital-acquired infections in both premenopausal and postmenopausal women relative to men of the same age. This is in contrast to earlier experimental studies and the documented physiological sex hormone alterations that occur after injury.",7.105791820705622e-08,0.04800921918636103,0.0,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
53,0.5,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: In the context of injury and hemorrhagic shock, how is gender dimorphism characterized, and are hormones responsible? Answer: Female gender exerts an independent protective effect on the rates of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to similarly aged men. This finding opposes previous experimental data and known physiological changes in sex hormones following injury.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
53,0.5,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the characterization of gender dimorphism after injury and hemorrhagic shock, and do hormonal differences explain it? Answer: The protective effect of being female on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women compared to men of a similar age. This result contradicts earlier experimental studies and known physiological sex hormone changes after injury.",2.3685972735685406e-08,0.016260520871781203,0.0,0.0018134264647818726,0.01652930195121094,0.0,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
53,0.5,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism after injury and hemorrhagic shock characterized, and are hormonal differences the cause? Answer: Female gender independently protects against multiple organ failure and nosocomial infections in both pre- and postmenopausal women when compared with age-matched men. This finding is contrary to previous experimental research and the known physiological sex hormone changes post-injury.",1.4211583641411244e-07,0.10354067894083929,0.0,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
53,0.5,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormones responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates is significant in both premenopausal and postmenopausal women compared to men of similar age, which contradicts prior experimental studies and known physiological sex hormone changes after injury.",1.1842986367842703e-07,0.08552217343816082,0.0,0.009067132323909363,0.08701137698962835,0.0,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
53,0.5,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How do hormonal differences relate to gender dimorphism after injury and hemorrhagic shock? Answer: Female gender independently confers protection against multiple organ failure and hospital-acquired infections in both pre- and postmenopausal women relative to similarly aged men, opposing previous experimental findings and known physiological sex hormone changes post-injury.",3.079176455639103e-07,0.23967285326541932,0.0,0.023574544042164344,0.24419696051204154,0.0,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
53,0.5,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the role of hormonal differences in gender dimorphism after injury and hemorrhagic shock? Answer: The female gender shows a significant independent protective effect against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to men of similar age, which contradicts earlier experimental studies and the known physiological sex hormone changes following injury.",7.105791820705622e-08,0.05043085362689137,0.0,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
53,0.5,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism after injury and hemorrhagic shock characterized, and do hormones play a role? Answer: Female gender independently provides significant protection against multiple organ failure and nosocomial infections in both pre- and postmenopausal women compared to age-matched men, a finding that contrasts with previous experimental studies and the known physiological changes in sex hormones after injury.",7.105791820705622e-08,0.05043085362689137,0.0,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
54,0.5,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women need fewer calories to keep their weight stable? Answer: The number of calories needed to maintain weight depends on individual factors such as age, height, weight, and activity level, rather than race or ethnicity.",7.10579182070559e-08,0.08223809823697303,0.0,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
54,0.5,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is it true that African American women require fewer calories to maintain their weight? Answer: Caloric needs for weight maintenance are influenced by personal characteristics like age, height, weight, and physical activity, not by racial or ethnic identity.",7.10579182070559e-08,0.08223809823697303,0.0,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
54,0.5,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women have lower calorie requirements for weight maintenance? Answer: Weight maintenance calorie needs are based on individual factors including age, height, weight, and exercise habits, not on race or ethnicity.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.5,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Are fewer calories needed by African American women to sustain their weight? Answer: The amount of calories necessary to maintain weight depends on personal factors such as age, height, weight, and physical activity rather than racial or ethnic background.",9.47438909427412e-08,0.10821358464023101,0.0,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
54,0.5,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women require a reduced caloric intake to maintain weight? Answer: Caloric intake for maintaining weight is determined by individual characteristics like age, height, weight, and activity level, not by race or ethnicity.",0.0,0.03960841031771123,0.02854671280276816,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
54,0.5,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is the caloric requirement for weight maintenance lower in African American women? Answer: Calorie needs to maintain weight are influenced by factors such as age, height, weight, and physical activity level, not by racial or ethnic group.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
54,0.5,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women need fewer calories to maintain their weight? Answer: The calories needed to keep weight stable depend on individual factors including age, height, weight, and activity level, rather than racial or ethnic background.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
54,0.5,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Are calorie needs for weight maintenance less in African American women? Answer: Caloric needs for maintaining weight are based on individual factors like age, height, weight, and physical activity, not on race or ethnicity.",2.36859727356853e-08,0.06976090043560124,0.029384756657483937,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.5,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women require fewer calories to keep their weight steady? Answer: The amount of calories needed to maintain weight depends on personal factors such as age, height, weight, and physical activity, not on racial or ethnic identity.",9.47438909427412e-08,0.10821358464023101,0.0,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
54,0.5,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is there a lower caloric requirement for weight maintenance in African American women? Answer: Caloric intake for weight maintenance is influenced by individual factors including age, height, weight, and physical activity level, rather than by race or ethnicity.",7.10579182070559e-08,0.009275237125399904,0.05246913580246914,0.005440279394345625,0.047089972862661256,0.027006172839506164,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
55,0.5,1,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Yes, heightened neutrophil migration post-major trauma may play a role in causing ARDS by promoting lung inflammation and releasing damaging agents.",5.921493183921348e-07,0.1947427756356559,0.24826388888888892,0.045335661619546816,0.27736741797426934,0.17159999999999997,0.045270038523821665,0.3310523465647033,0.14532871972318342,5.921493183921352e-07,0.3867013171227902,0.11649408284023667
55,0.5,2,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is increased neutrophil migratory activity after major trauma a contributing factor to acute respiratory distress syndrome? Indeed, elevated neutrophil movement after severe injury can lead to ARDS through lung inflammation and harmful substance release.",6.86893209334876e-07,0.30915312681340135,0.24826388888888892,0.05258936747867433,0.39515045363065315,0.17159999999999997,0.05251324468763316,0.4524132035689701,0.14532871972318342,6.868932093348768e-07,0.5118644600767972,0.11649408284023667
55,0.5,3,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can increased neutrophil migratory activity after major trauma be involved in the onset of acute respiratory distress syndrome? Yes, because increased neutrophil activity can cause lung inflammation and the release of toxic substances that may result in ARDS.",5.921493183921348e-07,0.2322101908010583,0.22125771604938277,0.045335661619546816,0.27736741797426934,0.17159999999999997,0.045270038523821665,0.3310523465647033,0.14532871972318342,5.921493183921352e-07,0.3867013171227902,0.11649408284023667
55,0.5,4,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does major trauma-induced neutrophil migratory activity increase contribute to acute respiratory distress syndrome? Yes, as enhanced neutrophil migration can trigger lung inflammation and release harmful factors, potentially causing ARDS.",8.053230730133025e-07,0.4734561781046773,0.24826388888888892,0.061656499802583725,0.5650494904260501,0.17159999999999997,0.06156725239239753,0.6283038700326342,0.14532871972318342,8.053230730133038e-07,0.6941860168707521,0.11649408284023667
55,0.5,5,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is heightened neutrophil migratory activity following major trauma a factor in acute respiratory distress syndrome development? Yes, increased neutrophil activity can lead to lung inflammation and the secretion of damaging substances, which may cause ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.5,6,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can the increased migration of neutrophils after major trauma be a factor in acute respiratory distress syndrome? Yes, because this increased activity can promote lung inflammation and the release of harmful agents that contribute to ARDS.",6.395212638635054e-07,0.25031262679046806,0.24826388888888892,0.04896251454911057,0.3345258318142177,0.17159999999999997,0.04889164160572741,0.38989284658763657,0.14532871972318342,6.39521263863506e-07,0.4473259389392257,0.11649408284023667
55,0.5,7,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does an increase in neutrophil migratory activity after major trauma play a role in the etiology of acute respiratory distress syndrome? Yes, as this heightened activity can induce lung inflammation and harmful substance release, leading to ARDS.",6.158352911278201e-07,0.22214174982377122,0.24826388888888892,0.04714908808432869,0.3055382949409662,0.17159999999999997,0.04708084006477454,0.3600398834379548,0.14532871972318342,6.158352911278206e-07,0.416554280272472,0.11649408284023667
55,0.5,8,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is the rise in neutrophil migratory activity post-major trauma a contributing factor to acute respiratory distress syndrome? Yes, since increased neutrophil migration can cause lung inflammation and the discharge of damaging substances, potentially resulting in ARDS.",6.395212638635054e-07,0.25031262679046806,0.24826388888888892,0.04896251454911057,0.3345258318142177,0.17159999999999997,0.04889164160572741,0.38989284658763657,0.14532871972318342,6.39521263863506e-07,0.4473259389392257,0.11649408284023667
55,0.5,9,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can increased neutrophil migratory activity following major trauma contribute to the cause of acute respiratory distress syndrome? Yes, because it can enhance lung inflammation and the release of harmful substances that may cause ARDS.",6.86893209334876e-07,0.30915312681340135,0.24826388888888892,0.05258936747867433,0.39515045363065315,0.17159999999999997,0.05251324468763316,0.4524132035689701,0.14532871972318342,6.868932093348768e-07,0.5118644600767972,0.11649408284023667
55,0.5,10,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migratory activity after major trauma contribute to the etiology of acute respiratory distress syndrome? Yes, as this increased activity can lead to lung inflammation and the release of toxic substances, potentially causing ARDS.",6.395212638635054e-07,0.25031262679046806,0.24826388888888892,0.04896251454911057,0.3345258318142177,0.17159999999999997,0.04889164160572741,0.38989284658763657,0.14532871972318342,6.39521263863506e-07,0.4473259389392257,0.11649408284023667
56,0.5,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in such cases was unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment is essential.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.5,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The impact of decompression wasn't apparent. Prompt diagnosis of sarcoidosis in other organs and steroid therapy is necessary.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression were not evident. Early detection of sarcoidosis in other organs and steroid treatment are required.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.5,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not obvious. Early diagnosis of sarcoidosis in other organs and steroid therapy is important.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The results of decompression were inconclusive. Early identification of sarcoidosis in other organs and steroid treatment should be pursued.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery show benefits for spinal cord sarcoidosis with compressive cervical myelopathy? The effect was not clear. Early diagnosis of sarcoidosis from other organs and steroid therapy are needed.,2.842316728282237e-07,0.21102800636467522,0.09642074506939374,0.02176111757738252,0.2873602258827379,0.049861495844875335,0.021729618491434455,0.33217877086583103,0.025623268698060954,2.8423167282822487e-07,0.37948962170490397,0.0
56,0.5,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a useful intervention for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness was not demonstrated. Early diagnosis of sarcoidosis in other organs and steroid therapy is required.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in cases of spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression was uncertain. Early diagnosis from other organ sarcoidosis and steroid treatment is necessary.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.5,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is surgical decompression effective for spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression were not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy should be initiated.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.5,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The effect of decompression was unclear. Early diagnosis of sarcoidosis in other organs and steroid therapy is required.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
57,0.5,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery remains a safe and effective option for treating GERD in elderly patients, showing low morbidity and mortality and symptom improvement similar to younger individuals.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.5,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is both safe and effective for GERD treatment in older patients, with low risks and symptom relief comparable to that seen in younger patients.",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.5,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is being elderly a contraindication for laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom improvement on par with younger patients.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.5,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age prevent laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is safe and effective in elderly GERD patients, with low complication rates and symptom improvement similar to younger patients.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
57,0.5,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD contraindicated in elderly patients? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, with low morbidity, mortality, and symptom improvement comparable to younger patients.",1.42115836414112e-07,0.2311670332228073,0.055363321799307974,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.5,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Can elderly patients safely undergo laparoscopic surgery for GERD? Answer: Yes, laparoscopic antireflux surgery is safe and effective in elderly patients, showing low morbidity and mortality and symptom relief similar to younger patients.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.5,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a limiting factor for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for elderly GERD patients, with low risks and symptom improvement comparable to younger individuals.",2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
57,0.5,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is age a contraindication for laparoscopic antireflux surgery in GERD patients? Answer: No, laparoscopic antireflux surgery is safe and effective for elderly patients with GERD, demonstrating low morbidity and mortality and symptom improvement like younger patients.",1.42115836414112e-07,0.2311670332228073,0.055363321799307974,0.010880558788691236,0.19783241553260567,0.02854671280276816,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.5,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does elderly age contraindicate laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is safe and effective for GERD treatment in elderly patients, with low complication rates and symptom improvement comparable to younger patients.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.5,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a barrier to laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom improvement similar to younger patients.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
58,0.5,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Research indicates that both French laypersons and healthcare professionals consider it acceptable to violate confidentiality to safeguard a patient's wife from a sexually transmitted infection.,6.395212638635043e-07,0.21012695487838284,0.22892819979188353,0.048962514549110644,0.24973693227343752,0.23725286160249745,0.04889164160572749,0.291526854953168,0.2434963579604579,6.39521263863506e-07,0.33569932028784155,0.24765868886576478
58,0.5,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Studies show that French lay people and medical professionals alike find breaching confidentiality acceptable when protecting a patient's wife from an STD.,7.105791820705602e-07,0.34365834750290647,0.22892819979188353,0.05440279394345628,0.3894988746485968,0.23725286160249745,0.05432404622858611,0.43813032914504335,0.2434963579604579,7.10579182070562e-07,0.48985000011509827,0.24765868886576478
58,0.5,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Evidence suggests that both the French general public and health workers approve of breaking confidentiality to protect a patient's wife from a sexually transmitted disease.,6.395212638635043e-07,0.21012695487838284,0.22892819979188353,0.048962514549110644,0.24973693227343752,0.23725286160249745,0.04889164160572749,0.291526854953168,0.2434963579604579,6.39521263863506e-07,0.33569932028784155,0.24765868886576478
58,0.5,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Findings reveal that French non-professionals and health experts agree on the acceptability of breaching confidentiality to shield a patient's wife from an STD.,6.868932093348749e-07,0.29713833186801253,0.22892819979188353,0.052589367478674404,0.3407087104791655,0.23725286160249745,0.052513244687633236,0.3868370347574932,0.2434963579604579,6.868932093348767e-07,0.43578277884482297,0.24765868886576478
58,0.5,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Research demonstrates that French lay individuals and healthcare providers deem it permissible to breach confidentiality to protect a patient's wife from sexually transmitted infections.,6.632072365991896e-07,0.2526865692971785,0.22892819979188353,0.050775941013892524,0.29418869484427157,0.23725286160249745,0.05070244314668036,0.33804687058806193,0.2434963579604579,6.632072365991914e-07,0.3844894844572728,0.24765868886576478
58,0.5,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Data suggests that both French laypeople and health professionals accept confidentiality breaches to defend a patient's wife against an STD.,7.579511275419309e-07,0.4437418060598879,0.22892819979188353,0.05802964687302004,0.49485939030642223,0.23725286160249745,0.057945649310491856,0.5493559642552674,0.2434963579604579,7.579511275419328e-07,0.6076330357714821,0.24765868886576478
58,0.5,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,French laypersons and health professionals reportedly find it acceptable to compromise confidentiality to protect a patient's wife from sexually transmitted diseases.,7.342651548062455e-07,0.39244851167233774,0.22892819979188353,0.05621622040823816,0.44079216903614693,0.23725286160249745,0.05613484776953898,0.49219755041531865,0.2434963579604579,7.342651548062474e-07,0.5470084139550471,0.24765868886576478
58,0.5,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Studies suggest that both French non-medical individuals and health professionals approve of breaking confidentiality to safeguard a patient's wife from an STD.,7.105791820705602e-07,0.34365834750290647,0.22892819979188353,0.05440279394345628,0.3894988746485968,0.23725286160249745,0.05432404622858611,0.43813032914504335,0.2434963579604579,7.10579182070562e-07,0.48985000011509827,0.24765868886576478
58,0.5,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Research findings indicate that French lay people and health care professionals find it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted disease.,5.921493183921337e-07,0.13008424720484557,0.22892819979188353,0.045335661619546885,0.16635532333438707,0.23725286160249745,0.04527003852382174,0.2045154779635383,0.2434963579604579,5.921493183921352e-07,0.24472754208211356,0.24765868886576478
58,0.5,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Evidence shows that both French laypersons and health professionals agree on the acceptability of breaching confidentiality to protect a patient's wife from an STD.,6.632072365991896e-07,0.2526865692971785,0.22892819979188353,0.050775941013892524,0.29418869484427157,0.23725286160249745,0.05070244314668036,0.33804687058806193,0.2434963579604579,6.632072365991914e-07,0.3844894844572728,0.24765868886576478
59,0.5,1,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Diffusion-weighted echo-planar MR imaging (epiDWI) may help distinguish pleomorphic adenoma and myoepithelial adenomas from other primary parotid gland tumor types, but due to overlaps within benign and malignant groups as well as between them, definitive diagnoses should be approached with caution.",4.263475092423373e-07,0.37156355643248284,0.0,0.03264167636607371,0.37948962170490574,0.0,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
59,0.5,2,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","EpiDWI shows promise in differentiating pleomorphic adenoma and myoepithelial adenomas from other parotid gland tumors; however, because of overlapping features within and between benign and malignant lesions, diagnosis should not rely solely on this method.",5.684633456564491e-07,0.5340824859302571,0.0,0.04352223515476496,0.54654370636807,0.0,0.04345923698286882,0.5596157879354231,0.0,5.684633456564497e-07,0.5733459807473245,0.0
59,0.5,3,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Primary parotid gland tumors can potentially be differentiated into pleomorphic adenoma and myoepithelial adenomas using diffusion-weighted echo-planar MR imaging, but overlapping characteristics among benign and malignant lesions limit definitive diagnostic conclusions.",6.632072365991903e-07,0.6592456288842641,0.0,0.050775941013892475,0.675755437848077,0.0,0.050702443146680314,0.6931471805599454,0.0,6.632072365991914e-07,0.7114963192281416,0.0
59,0.5,4,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Using diffusion-weighted echo-planar MR imaging, pleomorphic adenoma and myoepithelial adenomas can be distinguished from other tumor entities in the parotid gland, yet overlaps within benign and malignant groups suggest that diagnosis should not be solely based on this imaging.",4.737194547137079e-07,0.42285685082003255,0.0,0.03626852929563745,0.4321333551903246,0.0,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
59,0.5,5,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","EpiDWI has the capability to separate pleomorphic adenoma and myoepithelial adenomas from other examined parotid gland tumors, but due to overlapping imaging features among benign and malignant lesions, diagnosis should be made cautiously.",6.158352911278197e-07,0.5947071077466926,0.0,0.047149088084328716,0.6090640633494036,0.0,0.047080840064774566,0.6241543090729946,0.0,6.158352911278206e-07,0.6400373552459979,0.0
59,0.5,6,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Diffusion-weighted echo-planar MR imaging can differentiate pleomorphic adenoma and myoepithelial adenomas from other tumor types in the parotid gland; however, due to overlaps within and between benign and malignant lesions, diagnosis should not be solely dependent on this technique.",4.737194547137079e-07,0.42285685082003255,0.0,0.03626852929563745,0.4321333551903246,0.0,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
59,0.5,7,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","The potential of epiDWI to distinguish pleomorphic adenoma and myoepithelial adenomas from other parotid tumors exists, but overlap among benign and malignant lesions means diagnosis should not rely exclusively on this imaging.",6.39521263863505e-07,0.6264558060612724,0.0,0.048962514549110596,0.6418538861723952,0.0,0.04889164160572744,0.6580558607486764,0.0,6.39521263863506e-07,0.6751286750572669,0.0
59,0.5,8,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Pleomorphic adenoma and myoepithelial adenomas may be differentiated from other parotid gland tumors using diffusion-weighted echo-planar MR imaging, though overlapping features within benign and malignant groups limit definitive diagnosis.",7.105791820705609e-07,0.7282385003712148,0.0,0.054402793943456235,0.7472144018302207,0.0,0.05432404622858606,0.7672551527136671,0.0,7.105791820705622e-07,0.788457360364271,0.0
59,0.5,9,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Diffusion-weighted echo-planar MR imaging offers potential in differentiating pleomorphic adenoma and myoepithelial adenomas from other entities in the parotid gland, but overlapping characteristics between benign and malignant lesions suggest careful diagnosis.",6.632072365991903e-07,0.6592456288842641,0.0,0.050775941013892475,0.675755437848077,0.0,0.050702443146680314,0.6931471805599454,0.0,6.632072365991914e-07,0.7114963192281416,0.0
59,0.5,10,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","EpiDWI can potentially identify pleomorphic adenoma and myoepithelial adenomas among primary parotid gland tumors, but because of overlaps within and between benign and malignant groups, diagnoses should be made cautiously.",6.868932093348756e-07,0.6931471805599458,0.0,0.052589367478674355,0.710846757659346,0.0,0.05251324468763319,0.7295148247308201,0.0,6.868932093348768e-07,0.7492366472109886,0.0
60,0.5,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it feasible to achieve correlated results in BCRABL transcript detection using quantitative real-time PCR with homebrew assays? Yes, correlated outcomes can be obtained from homebrew assays for BCRABL transcript detection via quantitative real-time PCR. With careful design and precise execution, these assays can match the accuracy and sensitivity of commercial kits. Maintaining consistency in methods and quality control is essential for dependable results.",7.105791820705622e-08,0.007511732746235289,0.02774858908895453,0.005440279394345618,0.04828486576453006,0.0007438382869188465,0.0054324046228586,0.04800921918636103,0.0,7.105791820705622e-08,0.04879016416943571,0.0
60,0.5,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew assays yield correlated results for BCRABL transcript detection by quantitative real-time PCR? Yes, it is possible to get correlated results from homebrew assays when detecting BCRABL transcripts using quantitative real-time PCR. These assays, if properly designed and rigorously performed, can achieve precision and sensitivity comparable to commercial kits. Ensuring consistent procedures and quality control is crucial for reliable outcomes.",1.4211583641411244e-07,0.05960259777547883,0.025387093244079208,0.010880558788691236,0.07552222043422674,0.015380859375,0.0108648092457172,0.0984400728132524,0.0,1.4211583641411244e-07,0.10008345855698497,0.0
60,0.5,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results achievable from homebrew assays in BCRABL transcript detection via quantitative real-time PCR? Yes, homebrew assays can produce correlated results for BCRABL transcript detection using quantitative real-time PCR. When these assays are carefully designed and executed with attention to detail, they can deliver precision and sensitivity on par with commercial kits. Consistent protocols and quality control measures are key to ensuring reliable results.",4.737194547137081e-08,0.034053605544404064,0.002315329325294241,0.0036268529295637453,0.03192961034713804,0.00048802720148283935,0.003621603081905733,0.031748698314579826,0.0,4.737194547137081e-08,0.03226086221822477,0.0
60,0.5,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible to obtain correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR? Yes, correlated results can be obtained using homebrew assays for BCRABL transcript detection through quantitative real-time PCR. Properly designed and meticulously conducted, these assays can offer precision and sensitivity comparable to commercial kits. Consistency in procedures and quality control is vital for reliable findings.",1.1842986367842703e-07,0.13284153724104897,0.0375771996627602,0.009067132323909363,0.15113472619250423,0.050945671237244874,0.009054007704764333,0.1518351832397098,0.0507015306122449,1.1842986367842703e-07,0.13049496967683627,0.03443877551020409
60,0.5,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can quantitative real-time PCR homebrew assays provide correlated results for BCRABL transcript detection? Yes, it is possible to achieve correlated results using homebrew assays for BCRABL transcript detection with quantitative real-time PCR. These assays, when designed accurately and executed carefully, can match the precision and sensitivity of commercial kits. Consistent methodology and stringent quality control are essential for reliable results.",1.6580180914979784e-07,0.12457757101212596,0.008770615300620177,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
60,0.5,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are homebrew assays capable of delivering correlated results in BCRABL transcript detection via quantitative real-time PCR? Yes, homebrew assays can yield correlated results for BCRABL transcript detection using quantitative real-time PCR. With accurate design and thorough execution, these assays can provide precision and sensitivity similar to commercial kits. Maintaining consistency in procedures and quality control is critical for dependable results.",1.6580180914979784e-07,0.14807408560737834,0.025143009344651704,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
60,0.5,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it achievable to get correlated results from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? Yes, correlated results are achievable from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, if designed carefully and executed precisely, can offer comparable precision and sensitivity to commercial kits. Consistent procedures and quality control are necessary for reliable outcomes.",1.4211583641411244e-07,0.12891731583147337,0.02351684300981094,0.010880558788691236,0.12251524962473148,0.018475711877693125,0.0108648092457172,0.0984400728132524,0.0,1.4211583641411244e-07,0.10008345855698497,0.0
60,0.5,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew assays produce correlated results in quantitative real-time PCR for BCRABL transcript detection? Yes, it is feasible for homebrew assays to produce correlated results in quantitative real-time PCR for BCRABL transcript detection. When designed and performed with accuracy, these assays can achieve precision and sensitivity similar to commercial kits. Consistency and quality control are essential for dependable results.",1.8948778188548325e-07,0.26320570055376713,0.08968196646660104,0.014507411718254981,0.3045760261362571,0.12122888656419203,0.014486412327622933,0.3068181877645082,0.12244897959183677,1.8948778188548325e-07,0.28703365328123454,0.10745522698875466
60,0.5,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible for homebrew assays to yield correlated results in BCRABL transcript detection by quantitative real-time PCR? Yes, homebrew assays can yield correlated results for BCRABL transcript detection using quantitative real-time PCR. With meticulous design and execution, these assays can provide precision and sensitivity comparable to commercial kits. Ensuring consistent procedures and quality control measures is crucial for reliable results.",1.4211583641411244e-07,0.15202222185013836,0.03938295238487956,0.010880558788691236,0.12251524962473148,0.018475711877693125,0.0108648092457172,0.0984400728132524,0.0,1.4211583641411244e-07,0.10008345855698497,0.0
60,0.5,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results from homebrew assays feasible in BCRABL transcript detection by quantitative real-time PCR? Yes, correlated results are feasible from homebrew assays for BCRABL transcript detection via quantitative real-time PCR. These assays, when accurately designed and carefully conducted, can deliver precision and sensitivity equivalent to commercial kits. Consistency in methodology and quality control is vital to ensure dependable results.",1.6580180914979784e-07,0.14807408560737834,0.025143009344651704,0.012693985253473108,0.1404199076252466,0.019057916135204092,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
61,0.5,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosing appendicitis. However, for girls over 10 years old, selective imaging is recommended to prevent unnecessary surgeries. In uncertain cases, ultrasonography is the preferred imaging technique.",1.1842986367842703e-07,0.05616995293994398,0.04434829637641969,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
61,0.5,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we require imaging to identify appendicitis in pediatric patients? Diagnosis mainly depends on clinical examination. That said, in girls older than 10, imaging should be selectively used to avoid unwarranted appendectomies. Ultrasonography is the imaging method of choice when the diagnosis is unclear.",4.737194547137081e-08,0.016150708639682154,0.04434829637641969,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
61,0.5,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging essential for diagnosing appendicitis in children? The diagnosis primarily relies on clinical assessment. Still, for girls above 10 years, imaging should be selectively applied to prevent needless appendectomies. Ultrasonography is preferred in ambiguous cases.",2.3685972735685353e-07,0.18970134556446672,0.04434829637641969,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
61,0.5,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should imaging be used to diagnose appendicitis in children? Clinical assessment is crucial for diagnosis. However, in girls older than 10, selective imaging is advised to reduce unnecessary appendectomies. Ultrasonography is the recommended imaging in doubtful cases.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.5,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is it necessary to use imaging to diagnose appendicitis in children? Diagnosis depends mainly on clinical evaluation. Nonetheless, in girls over 10 years old, selective imaging is advised to avoid unnecessary surgeries. Ultrasonography is the preferred choice for uncertain cases.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.5,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do children with suspected appendicitis need imaging for diagnosis? Clinical assessment is fundamental for diagnosis. Yet, in girls older than 10, imaging should be selectively used to prevent unnecessary appendectomies. Ultrasonography is the imaging modality of choice in equivocal situations.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.5,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging required to diagnose appendicitis in pediatric patients? Clinical examination is key to diagnosis. However, selective imaging is recommended for girls over 10 to avoid unnecessary appendectomies. Ultrasonography should be used in unclear cases.",2.6054570009253883e-07,0.21868888243771822,0.04434829637641969,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
61,0.5,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary for diagnosing appendicitis in children? Clinical assessment is the cornerstone of diagnosis. Still, in girls older than 10 years, selective imaging is warranted to prevent unnecessary appendectomies. Ultrasonography is the preferred imaging in ambiguous cases.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913525,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
61,0.5,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we need to perform imaging to diagnose appendicitis in children? The diagnosis mainly relies on clinical assessment. However, in girls older than 10, selective imaging is advised to avoid unnecessary surgeries. Ultrasonography is the imaging choice when the diagnosis is uncertain.",9.474389094274162e-08,0.06528939793786215,0.01997329637641969,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
61,0.5,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging a requirement for diagnosing appendicitis in children? Clinical evaluation is fundamental for diagnosis. Nonetheless, selective imaging is recommended in girls over 10 to prevent unnecessary appendectomies. Ultrasonography is preferred in equivocal cases.",2.8423167282822413e-07,0.2485418455874,0.04434829637641969,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
62,0.5,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with",Question: Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair unnecessary? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low rates of immediate and delayed paraplegia. This indicates routine reimplantation of segmental vessels is not needed.,2.1317375462116866e-07,0.15415067982725983,0.0,0.016320838183036854,0.1568424714929706,0.0,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
62,0.5,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should spinal cord arteries be reimplanted during thoracic and thoracoabdominal aneurysm aneurysm repair? Answer: Using MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation in TAA/A repair is safe and results in acceptably low immediate and delayed paraplegia rates. This suggests routine surgical reimplantation of segmental vessels is unnecessary.",2.1317375462116866e-07,0.15415067982725983,0.0,0.016320838183036854,0.1568424714929706,0.0,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
62,0.5,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair beneficial? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low rates of paraplegia, implying routine reimplantation is not required.",3.552895910352811e-07,0.2719337154836441,0.0,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
62,0.5,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair provide benefits? Answer: Monitoring MEP and SSEP indicates that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low immediate and delayed paraplegia rates, suggesting routine reimplantation is unnecessary.",3.316036182995957e-07,0.25131442828090833,0.0,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
62,0.5,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: In thoracic and thoracoabdominal aneurysm repair, is spinal artery reimplantation necessary? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and yields acceptably low paraplegia rates, indicating routine segmental vessel reimplantation is not indicated.",3.789755637709665e-07,0.29298712468147725,0.0,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
62,0.5,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should spinal cord arteries be reimplanted in thoracic and thoracoabdominal aneurysm repair? Answer: Using MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low rates of immediate and delayed paraplegia, suggesting routine reimplantation is not needed.",3.316036182995957e-07,0.25131442828090833,0.0,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
62,0.5,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is it worthwhile to reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm repair? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low paraplegia rates, implying routine reimplantation is unnecessary.",3.789755637709665e-07,0.29298712468147725,0.0,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
62,0.5,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does reimplanting spinal cord arteries during TAA/A repair reduce paraplegia risk? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation is safe and results in acceptably low paraplegia rates, suggesting routine reimplantation is not required.",4.737194547137081e-07,0.41417401444494706,0.023242630385487524,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
62,0.5,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is routine reimplantation of spinal cord arteries necessary in thoracic and thoracoabdominal aneurysm repair? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low rates of immediate and delayed paraplegia, indicating routine reimplantation is not recommended.",2.6054570009253947e-07,0.21855051475472065,0.01922337562475971,0.0199476911126006,0.1953087523207664,0.0,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
62,0.5,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does sacrificing spinal cord arteries without reimplantation during TAA/A repair pose risks? Answer: Monitoring MEP and SSEP indicates that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to acceptably low immediate and delayed paraplegia rates, suggesting routine reimplantation is unnecessary.",3.316036182995957e-07,0.3927730365584483,0.10072314049586772,0.025387970506946217,0.3714579042305246,0.08264462809917356,0.025351221573340132,0.3492131365772879,0.06353305785123965,3.316036182995957e-07,0.3259768336077826,0.043388429752066124
63,0.5,1,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, such a connection exists.",2.8423167282822376e-07,0.17195366882557162,0.18953463738436552,0.02176111757738255,0.1516564552764943,0.23582766439909295,0.02172961849143448,0.21304219765545085,0.2222222222222221,2.8423167282822456e-07,0.2797212513199212,0.20408163265306126
63,0.5,2,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do cervical cord plaques relate to discopathy in patients with multiple sclerosis? Yes, there is a relationship.",3.3160361829959447e-07,0.2127203510864062,0.2448979591836735,0.025387970506946304,0.27681959823049995,0.23582766439909295,0.025351221573340226,0.3465735902799736,0.2222222222222221,3.3160361829959526e-07,0.42282209496059453,0.20408163265306126
63,0.5,3,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques associated with discopathy in individuals with multiple sclerosis? Yes, an association is present.",3.3160361829959447e-07,0.2127203510864062,0.2448979591836735,0.025387970506946304,0.27681959823049995,0.23582766439909295,0.025351221573340226,0.3465735902799736,0.2222222222222221,3.3160361829959526e-07,0.42282209496059453,0.20408163265306126
63,0.5,4,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there an association between cervical cord plaques and discopathy in multiple sclerosis sufferers? Yes, a link is evident.",2.8423167282822376e-07,0.09493731543002237,0.2448979591836735,0.02176111757738255,0.1516564552764943,0.23582766439909295,0.02172961849143448,0.21304219765545085,0.2222222222222221,2.8423167282822456e-07,0.2797212513199212,0.20408163265306126
63,0.5,5,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Does a relationship exist between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, it does.",3.3160361829959447e-07,0.2127203510864062,0.2448979591836735,0.025387970506946304,0.27681959823049995,0.23582766439909295,0.025351221573340226,0.3465735902799736,0.2222222222222221,3.3160361829959526e-07,0.42282209496059453,0.20408163265306126
63,0.5,6,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there any link between cervical cord plaques and discopathy in patients who have multiple sclerosis? Yes, a link exists.",2.605457000925384e-07,0.04087009415974707,0.2448979591836735,0.019947691112600675,0.0944980414365455,0.23582766439909295,0.019918816950481606,0.15241757583901583,0.2222222222222221,2.605457000925392e-07,0.21518273018235057,0.20408163265306126
63,0.5,7,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques connected to discopathy in patients with multiple sclerosis? Yes, they are related.",3.552895910352798e-07,0.2772588722239768,0.2448979591836735,0.02720139697172818,0.34581246971745205,0.23582766439909295,0.0271620231142931,0.4206815624336948,0.2222222222222221,3.552895910352806e-07,0.5028648026341309,0.20408163265306126
63,0.5,8,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a correlation between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, a correlation is found.",2.8423167282822376e-07,0.17195366882557162,0.18953463738436552,0.02176111757738255,0.1516564552764943,0.23582766439909295,0.02172961849143448,0.21304219765545085,0.2222222222222221,2.8423167282822456e-07,0.2797212513199212,0.20408163265306126
63,0.5,9,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do cervical cord plaques have any relation to discopathy in multiple sclerosis patients? Yes, there is a relation.",3.079176455639091e-07,0.15209572926997117,0.2448979591836735,0.023574544042164428,0.21228107709292932,0.23582766439909295,0.023540420032387353,0.2775807187930215,0.2222222222222221,3.079176455639099e-07,0.3487141228068733,0.20408163265306126
63,0.5,10,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a tie between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, a tie exists.",3.079176455639091e-07,0.23364245639467063,0.1863042091836735,0.023574544042164428,0.21228107709292932,0.23582766439909295,0.023540420032387353,0.2775807187930215,0.2222222222222221,3.079176455639099e-07,0.3487141228068733,0.20408163265306126
64,0.5,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is the 30-day and 1-year mortality following emergency general surgery laparotomies a significant concern that requires improvement? Answer: Mortality rates at 30 days and 1 year after emergency general surgery laparotomies continue to be problematic. The elevated mortality highlights the necessity for advancements in perioperative management. Improvements in surgical methods, patient selection, and postoperative care may help lower these rates.",2.3685972735685406e-08,0.005060528262953667,0.01538935056940597,0.0018134264647818726,0.0406952414882209,0.01719469248222487,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
64,0.5,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are 30-day and 1-year mortality rates after emergency general surgery laparotomies areas needing attention and enhancement? Answer: Mortality within 30 days and 1 year following emergency general surgery laparotomies remains a critical issue. High mortality rates suggest the need for better perioperative care. Optimizing surgical techniques, patient selection, and postoperative management could reduce these mortality rates.",1.1842986367842703e-07,0.09363865096228263,0.0057550707454820105,0.009067132323909363,0.11431717501168714,0.01964997598211273,0.009054007704764333,0.11422551513996027,0.01851192595229618,1.1842986367842703e-07,0.09015109699429802,0.0
64,0.5,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Does the 30-day and 1-year mortality in emergency general surgery laparotomies represent a concern and an area for improvement? Answer: Mortality rates at 30 days and 1 year post-emergency general surgery laparotomies are still concerning. The high rates indicate a pressing need to improve perioperative care. Enhanced surgical approaches, refined patient selection, and improved postoperative care might decrease these mortality figures.",0.0,0.04545227413507824,0.032501636417154034,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
64,0.5,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are the 30-day and 1-year mortality statistics after emergency general surgery laparotomies a cause for concern and improvement? Answer: Mortality rates at 30 days and 1 year following emergency general surgery laparotomies remain troubling. These elevated mortality figures point to the necessity for better perioperative care. Advancements in surgical technique, patient selection, and postoperative care could potentially lessen mortality.",4.737194547137081e-08,0.01292141578319228,0.014549315802036403,0.0036268529295637453,0.05859989948873601,0.017776896739735835,0.003621603081905733,0.05880712977502611,0.017538265306122455,4.737194547137081e-08,0.03509131981126945,0.0
64,0.5,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is there a need to address 30-day and 1-year mortality rates in emergency general surgery laparotomies? Answer: Mortality rates within 30 days and 1 year after emergency general surgery laparotomies continue to be high. This concern signals a requirement for improved perioperative care. Enhanced surgical procedures, better patient selection, and superior postoperative care may reduce these mortality rates.",7.105791820705622e-08,0.031231186104315967,0.013680598480396995,0.005440279394345618,0.05250934207274227,0.0008763865356541979,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
64,0.5,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: How concerning are 30-day and 1-year mortality rates in emergency general surgery laparotomies, and is improvement needed? Answer: Mortality at 30 days and 1 year post-emergency general surgery laparotomies remains a significant concern. The high mortality rates indicate a need for improved perioperative care. Better surgical techniques, patient selection, and postoperative management could help lower these rates.",9.474389094274162e-08,0.02555995547631973,0.0302095241002317,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
64,0.5,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is the mortality at 30 days and 1 year after emergency general surgery laparotomies an area that needs improvement? Answer: Mortality rates within 30 days and 1 year following emergency general surgery laparotomies remain problematic. The elevated mortality highlights the importance of enhancing perioperative care. Improvements in surgery, patient selection, and postoperative care could reduce mortality.",1.1842986367842703e-07,0.16790442030799113,0.057198133177555455,0.009067132323909363,0.18993323107277238,0.07333812122953173,0.009054007704764333,0.16556975073699398,0.05536332179930796,1.1842986367842703e-07,0.11630759437391891,0.018860946745562133
64,0.5,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Does emergency general surgery laparotomy mortality at 30 days and 1 year require attention and improvement? Answer: Mortality rates at 30 days and 1 year post-emergency general surgery laparotomies are still a concern. The high rates suggest the need for better perioperative care. Refining surgical techniques, patient selection, and postoperative care may reduce these mortality rates.",1.1842986367842703e-07,0.14314916385942178,0.04034915358571872,0.009067132323909363,0.16472787905241093,0.05561801357862823,0.009054007704764333,0.16556975073699398,0.05536332179930796,1.1842986367842703e-07,0.14246409175353936,0.037677816224529016
64,0.5,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are 30-day and 1-year mortality rates after emergency general surgery laparotomies a concern that warrants improvement? Answer: Mortality rates within 30 days and 1 year after emergency general surgery laparotomies remain high. This indicates a need for enhanced perioperative care. Improved surgical methods, patient selection, and postoperative care could help decrease mortality.",2.1317375462116866e-07,0.20202313204479205,0.02981479414705869,0.016320838183036854,0.2209607506038087,0.04193187122953174,0.0162972138685758,0.22096621292236884,0.039930555555555566,2.1317375462116866e-07,0.19691443409130027,0.020399305555555556
64,0.5,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Should 30-day and 1-year mortality following emergency general surgery laparotomies be considered an area for improvement? Answer: Mortality rates at 30 days and 1 year after emergency general surgery laparotomies continue to be elevated. This raises concerns and highlights the necessity for better perioperative care. Advancing surgical techniques, patient selection, and postoperative care could reduce these mortality rates.",7.105791820705622e-08,0.031231186104315967,0.013680598480396995,0.005440279394345618,0.07683029577660072,0.01837944354358135,0.0054324046228586,0.07694100961913897,0.017851239669421492,7.105791820705622e-08,0.05310982531394792,0.0
65,0.5,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing a viable method for acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is practical, safe, and effective for acute OGIB, potentially preventing major surgery by diagnosing and treating most cases successfully. The combined approach with real-time CE viewing is particularly beneficial for detecting recurrent bleeding vascular lesions.",7.105791820705622e-08,0.05470323687720402,0.001808723671861051,0.005440279394345618,0.05310982531394792,0.0,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
65,0.5,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Can emergency double-balloon enteroscopy with real-time capsule endoscopy viewing be effectively used in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe, and effective in acute OGIB, often avoiding the need for major surgery by diagnosing and treating most patients. The combined method with real-time CE viewing is especially helpful in identifying recurrent bleeding vascular lesions.",4.737194547137081e-08,0.03613505428837982,0.0011847510613564732,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
65,0.5,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing a feasible approach for acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is a safe and effective procedure in acute OGIB, which may prevent major surgery by diagnosing and treating most patients successfully. The combined use with real-time capsule endoscopy is particularly useful in detecting recurrent bleeding vascular lesions.",2.3685972735685406e-08,0.01759033546955635,0.0005628732740962095,0.0018134264647818726,0.00640208123595265,0.01694411414982164,0.0018108015409528666,0.01739174271186883,0.0,2.3685972735685406e-08,0.01769957709940062,0.0
65,0.5,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Does emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing provide a feasible solution for acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is a safe, effective, and feasible method in acute OGIB that may help avoid major surgery by diagnosing and successfully treating most cases. The combined approach with real-time CE viewing is especially valuable for identifying recurrent bleeding vascular lesions.",4.737194547137081e-08,0.05760331239055727,0.017467682363804228,0.0036268529295637453,0.03390155167568043,0.0,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
65,0.5,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Is emergency double-balloon enteroscopy along with real-time capsule endoscopy viewing a viable combined technique for acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is effective, safe, and feasible in acute OGIB and can often prevent major surgery by diagnosing and treating most patients. The combined approach with real-time CE viewing is particularly useful for detecting recurrent bleeding vascular lesions.",2.3685972735685406e-08,0.005996968915344958,0.01662049861495844,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
65,0.5,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Can emergency double-balloon enteroscopy with real-time capsule endoscopy be a feasible combined approach to acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is safe, effective, and feasible for acute OGIB, potentially avoiding major surgery by diagnosing and treating most patients. The combined method with real-time CE viewing is especially useful for identifying recurrent bleeding vascular lesions.",9.474389094274162e-08,0.048416581503104794,0.015680988262295324,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
65,0.5,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Is the use of emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing feasible in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is a safe and effective approach in acute OGIB, which may help avoid major surgery by diagnosing and successfully treating most patients. The combined use with real-time CE viewing is especially helpful in detecting recurrent bleeding vascular lesions.",2.3685972735685406e-08,0.01759033546955635,0.0005628732740962095,0.0018134264647818726,0.01709443335929972,0.0,0.0018108015409528666,0.01739174271186883,0.0,2.3685972735685406e-08,0.01769957709940062,0.0
65,0.5,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing offer a feasible approach for acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe, and effective in acute OGIB and may avoid the need for major surgery by diagnosing and treating most patients successfully. The combined approach with real-time CE viewing is particularly useful for identifying recurrent bleeding vascular lesions.",4.737194547137081e-08,0.05760331239055727,0.017467682363804228,0.0036268529295637453,0.03390155167568043,0.0,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
65,0.5,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Is emergency double-balloon enteroscopy together with real-time capsule endoscopy viewing a feasible combined method for acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is effective, safe, and feasible in acute OGIB, often preventing major surgery by diagnosing and treating most cases. The combined approach with real-time CE viewing is especially valuable for detecting recurrent bleeding vascular lesions.",7.105791820705622e-08,0.029947980428634224,0.016005331583271633,0.005440279394345618,0.05310982531394792,0.0,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
65,0.5,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Question: Can emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing be effectively used as a combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is a feasible, safe, and effective procedure in acute OGIB that may avoid major surgery by diagnosing and successfully treating most patients. The combined use with real-time CE viewing is especially useful to identify recurrent bleeding vascular lesions.",9.474389094274162e-08,0.06858096687886395,0.0021446658509194083,0.0072537058591274906,0.06669137449867257,0.0,0.007243206163811466,0.0678225963387602,0.0,9.474389094274162e-08,0.06899287148694988,0.0
66,0.5,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does gender affect the outcome of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the typical survival and recovery benefits seen in men during ischemic stroke, potentially providing a greater positive effect in women.",2.3685972735685406e-07,0.19422150524599857,0.003587829580463598,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
66,0.5,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis could change the usual survival and recovery advantage observed in men, possibly offering a stronger treatment benefit for women.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.5,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex impact how patients respond to intravenous thrombolysis in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may modify the expected survival and recovery advantage typically seen in men, with women potentially experiencing a larger treatment benefit.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.5,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is there a sex difference in response to intravenous thrombolysis for ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis might alter the natural survival and recovery advantage in men, suggesting a possibly greater beneficial effect in women.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.5,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","How does sex influence the effectiveness of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register reveal that intravenous thrombolysis may change the survival and recovery advantage usually observed in men, with women potentially receiving a more substantial treatment benefit.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.5,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does intravenous thrombolysis response in ischemic stroke vary by sex? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data indicate that intravenous thrombolysis could modify the natural survival and recovery benefits in men, possibly leading to a larger positive effect in women.",3.552895910352811e-07,0.30758067168397085,0.006006557747752838,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
66,0.5,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the survival and recovery response to intravenous thrombolysis in ischemic stroke affected by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the expected outcomes in men, with women potentially gaining a greater therapeutic benefit.",3.079176455639103e-07,0.2606854352184591,0.004974671163918205,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
66,0.5,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex play a role in the response to intravenous thrombolysis during ischemic stroke? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis might change the survival and recovery advantage typically seen in men, with a possible enhanced benefit for women.",3.079176455639103e-07,0.2606854352184591,0.004974671163918205,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
66,0.5,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the treatment effect of intravenous thrombolysis in ischemic stroke influenced by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the survival and recovery advantage normally expected in men, showing a potential larger benefit in women.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.5,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex affect the benefits of intravenous thrombolysis in ischemic stroke? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicates that intravenous thrombolysis might alter the natural survival and recovery advantage in men, with women possibly experiencing a greater beneficial effect.",3.316036182995957e-07,0.2838584397377497,0.005478908433114424,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
67,0.5,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers release GABA? Answer: No, mossy fibers in the cerebellar neuronal circuit do not release GABA. Instead, they mainly release glutamate, an excitatory neurotransmitter. GABA, an inhibitory neurotransmitter, is generally not linked to mossy fibers.",1.8948778188548293e-07,0.20240545093327666,0.004795429037853273,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
67,0.5,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Are GABA neurotransmitters released by mossy fibers? Answer: No, mossy fibers, which are components of the cerebellum's neuronal pathways, do not release GABA. They predominantly release glutamate, an excitatory neurotransmitter, whereas GABA is inhibitory and not typically released by these fibers.",9.474389094274162e-08,0.09609593929608184,0.0021642561983471094,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
67,0.5,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers secrete GABA? Answer: No, mossy fibers found in the cerebellum's neural circuit do not secrete GABA. Their primary neurotransmitter is glutamate, which excites neurons, while GABA, an inhibitory neurotransmitter, is not usually associated with them.",1.6580180914979763e-07,0.17475121924149972,0.004085823035454482,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.5,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Is GABA released by mossy fibers? Answer: No, mossy fibers within the cerebellum's neuronal network do not release GABA. They mainly release glutamate, an excitatory neurotransmitter, whereas GABA is an inhibitory chemical not commonly linked to mossy fibers.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.5,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers emit GABA? Answer: No, mossy fibers, which are part of the cerebellar circuitry, do not emit GABA. They primarily release glutamate, an excitatory neurotransmitter, and GABA, an inhibitory neurotransmitter, is not typically produced by them.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.5,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Are mossy fibers responsible for releasing GABA? Answer: No, mossy fibers in the cerebellum do not release GABA. They mainly release glutamate, an excitatory neurotransmitter, while GABA, known for its inhibitory effects, is generally not released by mossy fibers.",1.4211583641411233e-07,0.14784031154193933,0.0034125248964080625,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
67,0.5,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers discharge GABA? Answer: No, mossy fibers, integral to the cerebellar neuronal circuit, do not discharge GABA. Their main neurotransmitter is glutamate, which excites neurons, and GABA, an inhibitory neurotransmitter, is not typically associated with them.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
67,0.5,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Does GABA come from mossy fibers? Answer: No, mossy fibers in the cerebellum do not produce GABA. They primarily release glutamate, an excitatory neurotransmitter, and GABA, which inhibits neuronal activity, is not commonly linked to mossy fibers.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
67,0.5,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Are mossy fibers a source of GABA? Answer: No, mossy fibers, part of the cerebellar neural circuit, do not release GABA. Instead, their main neurotransmitter is glutamate, which excites neurons, while GABA is an inhibitory neurotransmitter not usually connected to mossy fibers.",7.105791820705622e-08,0.03818633012873196,0.02221074380165289,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
67,0.5,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Question: Do mossy fibers produce GABA? Answer: No, mossy fibers within the cerebellum do not produce GABA. They primarily release glutamate, an excitatory neurotransmitter, and GABA, an inhibitory neurotransmitter, is not typically associated with mossy fibers.",2.3685972735685353e-07,0.26011629724039764,0.006335969001115268,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
68,0.5,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is key to understanding and clarifying gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to differ between men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.5,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements is essential for identifying and explaining gender-specific differences in mortality risk associated with marital status. The influence of living alone and cohabiting with a partner seems to vary between males and females.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.5,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is vital to uncover and interpret gender variations in mortality risks tied to marital status. The consequences of living alone compared to living with a partner differ between men and women.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
68,0.5,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating how people live is important to recognize and explain gender differences in mortality risks based on marital status. The impact of solitary living versus living with a partner appears distinct for men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.5,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Considering living arrangements is crucial to identify and elucidate gender-specific mortality risk differences related to marital status. The effects of living alone and living with a partner seem to vary by gender.",9.474389094274162e-08,0.0876726280430189,0.0018114382460973355,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
68,0.5,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Studying living arrangements plays a key role in revealing and explaining gender disparities in mortality risks linked to marital status. The impact of living alone versus with a partner appears to differ between men and women.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.5,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The assessment of living arrangements is important for detecting and explaining gender differences in mortality risks associated with marital status. The influence of living alone and living with a partner seems to be different for men and women.",4.737194547137081e-08,0.041114813894306934,0.00079930555555556,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
68,0.5,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living conditions is essential for understanding and clarifying gender differences in mortality risks by marital status. The effects of living alone and cohabiting with a partner appear to differ in men and women.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
68,0.5,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing how individuals live is fundamental to identifying and explaining gender-based differences in mortality risk related to marital status. The impact of solitary living and living with a partner seems to differ between men and women.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.5,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements is critical for recognizing and explaining gender-specific mortality risk variations by marital status. The consequences of living alone versus living with a partner appear to differ between men and women.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
69,0.5,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are aromatase inhibitor-related musculoskeletal symptoms primarily addressed by preventing osteoporosis? While osteoporosis prevention aids in symptom relief, other elements like lifestyle, health status, and concurrent therapies are also important in symptom management.",7.105791820705612e-07,0.6534274214248974,0.016826529264103593,0.054402793943456214,0.67004227454128,0.016661878770468257,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
69,0.5,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the prevention of osteoporosis the main strategy to eliminate musculoskeletal symptoms caused by aromatase inhibitors? Although osteoporosis prevention helps, managing these symptoms also depends on patient lifestyle, overall health, and other medical treatments.",6.632072365991906e-07,0.5461878915042129,0.049048751486325794,0.050775941013892455,0.6055037534037084,0.016661878770468257,0.05070244314668029,0.6435502394205721,0.0,6.632072365991914e-07,0.6592456288842641,0.0
69,0.5,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does preventing osteoporosis hold the key to resolving musculoskeletal symptoms related to aromatase inhibitors? Preventing osteoporosis can reduce symptoms, but factors such as lifestyle, health, and additional treatments are equally vital.",7.342651548062465e-07,0.6877078833458676,0.015755053507728878,0.05621622040823809,0.7039438262169617,0.016661878770468257,0.05613484776953891,0.7453329337305146,0.0,7.342651548062476e-07,0.7646061445420895,0.0
69,0.5,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are musculoskeletal symptoms from aromatase inhibitors best managed by focusing on osteoporosis prevention? Osteoporosis prevention is beneficial, yet lifestyle, general health, and concurrent medical care also significantly influence symptom control.",7.579511275419318e-07,0.6753996229842198,0.049048751486325794,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
69,0.5,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is stopping osteoporosis the essential approach to eliminate aromatase inhibitor-induced musculoskeletal symptoms? Preventing osteoporosis contributes to symptom improvement but must be combined with attention to lifestyle, health, and other treatments.",7.579511275419318e-07,0.6753996229842198,0.049048751486325794,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
69,0.5,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Can musculoskeletal symptoms linked to aromatase inhibitors be eliminated solely by preventing osteoporosis? While osteoporosis prevention helps, patient lifestyle, overall health, and other ongoing treatments are also critical.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.5,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is preventing osteoporosis the key factor in managing musculoskeletal symptoms caused by aromatase inhibitors? It is helpful but not sufficient alone; lifestyle, health condition, and concurrent therapies also matter.",7.816371002776171e-07,0.7104909427954889,0.049048751486325794,0.05984307333780185,0.7754027901991054,0.016661878770468257,0.05975645085144466,0.8194409058842362,0.0,7.816371002776184e-07,0.841567185678219,0.0
69,0.5,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does addressing osteoporosis prevent musculoskeletal symptoms related to aromatase inhibitors completely? It aids symptom relief but other factors like patient lifestyle, health, and additional treatments play important roles.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.5,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is osteoporosis prevention the main solution to aromatase inhibitor-associated musculoskeletal symptoms? It supports symptom reduction, but lifestyle, overall health, and other treatments are also crucial.",8.763809912203583e-07,0.8646416226227478,0.049048751486325794,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
69,0.5,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are aromatase inhibitor-induced musculoskeletal symptoms mainly controlled by osteoporosis prevention? Preventing osteoporosis can alleviate symptoms, but managing lifestyle, health, and concurrent medical treatments is also necessary.",8.52695018484673e-07,0.823819628102493,0.049048751486325794,0.0652833527321475,0.8931858258554897,0.016661878770468257,0.06518885547430328,0.9420432279765691,0.0,8.526950184846746e-07,0.9694005571881035,0.0
70,0.5,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in younger individuals might represent a distinct clinical condition. Additional studies are required to confirm our observations and establish the best management strategy for this group.,0.0,0.03554600925948437,0.025256675594513445,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
70,0.5,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Colorectal cancer occurring in young patients could be considered a distinct clinical entity. More research is necessary to validate these findings and determine the optimal treatment approach for this population.,7.105791820705611e-08,0.08172497413789737,0.0053829717291255935,0.005440279394345618,0.07865527994541788,0.0019215668371073726,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
70,0.5,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Colorectal cancer among young individuals may be a unique clinical entity. Further investigation is needed to confirm our results and to define the best management strategy for this group.,2.36859727356853e-08,0.09729847673474801,0.051405325443786974,0.0018134264647818726,0.06245691695904432,0.026296566837107373,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.5,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be a distinct clinical entity? Answer: Colorectal cancer in younger patients might constitute a distinct clinical entity. Additional research is needed to validate our findings and to identify the optimal approach for this population.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.008635101559923974,0.024835646457268077,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.5,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a distinct clinical condition? Answer: Colorectal cancer in young patients may represent a unique clinical entity. Further studies are required to confirm these findings and to establish the best treatment protocol for this group.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.0441811108194079,0.05009232205178152,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
70,0.5,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients form a unique clinical entity? Answer: Colorectal cancer among young patients might be a distinct clinical condition. More research is necessary to validate our findings and to define the optimal management approach for this population.,4.7371945471370706e-08,0.08902433317653635,0.027736686390532554,0.0036268529295637453,0.08777472494333605,0.026296566837107373,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
70,0.5,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a clinically distinct entity? Answer: Colorectal cancer in young individuals may be a distinct clinical entity. Further research is needed to confirm our observations and to determine the optimal treatment approach for this group.,2.36859727356853e-08,0.027983758678753468,0.0018819495170846606,0.0018134264647818726,0.008635101559923974,0.024835646457268077,0.0018108015409528666,0.009813183473625475,0.026296566837107373,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.5,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Can colorectal cancer in young patients be considered a distinct clinical entity? Answer: Colorectal cancer among young patients might represent a unique clinical entity. Additional studies are necessary to validate these findings and to establish the best approach for this population.,4.7371945471370706e-08,0.08902433317653635,0.027736686390532554,0.0036268529295637453,0.08777472494333605,0.026296566837107373,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
70,0.5,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in young patients may constitute a distinct clinical condition. Further research is required to confirm our findings and to define the optimal management strategy for this group.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.0441811108194079,0.05009232205178152,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
70,0.5,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a separate clinical condition? Answer: Colorectal cancer in younger patients might be a distinct clinical entity. More studies are needed to validate these observations and to determine the best treatment approach for this population.,2.36859727356853e-08,0.0626411177067503,0.02652739304401356,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
71,0.5,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: Findings from this study indicate that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.5,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: The results of the current study suggest that septoplasty does not affect compensatory hypertrophy of the middle turbinate, even after a year.",0.0,0.056163014849542225,0.09609723873695335,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
71,0.5,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty influence the dimensions of compensatory hypertrophy in the middle turbinate? Answer: According to the present study, compensatory hypertrophy of the middle turbinate remains unchanged following septoplasty, even after one year.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.5,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Can septoplasty modify the size of compensatory hypertrophy in the middle turbinate? Answer: This study's findings imply that septoplasty does not alter compensatory hypertrophy of the middle turbinate, even after one year.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.5,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does the size of compensatory hypertrophy of the middle turbinate change after septoplasty? Answer: The current study suggests that septoplasty has no effect on compensatory hypertrophy of the middle turbinate, even one year post-procedure.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
71,0.5,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is there a change in compensatory hypertrophy of the middle turbinate after septoplasty? Answer: Findings indicate that compensatory hypertrophy of the middle turbinate is unaffected by septoplasty, even after one year.",7.10579182070559e-08,0.15287573057837367,0.039769888231426645,0.005440279394345639,0.1541226678518357,0.040177514792899396,0.005432404622858621,0.15520643673841938,0.039848783694937544,7.105791820705622e-08,0.1560845471648702,0.03878369493754113
71,0.5,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty affect the dimensions of the middle turbinate's compensatory hypertrophy? Answer: The study shows that compensatory hypertrophy of the middle turbinate does not change after septoplasty, even one year later.",7.10579182070559e-08,0.018718211760319292,0.05134628088254728,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,0.5,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty impact compensatory hypertrophy size in the middle turbinate? Answer: Present study results suggest no effect of septoplasty on compensatory hypertrophy of the middle turbinate, even after one year.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.5,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is compensatory hypertrophy of the middle turbinate altered by septoplasty? Answer: According to the study, septoplasty does not influence compensatory hypertrophy of the middle turbinate, even after one year.",1.184298636784265e-07,0.1871842557071708,0.018844444444444372,0.009067132323909398,0.1868078298808853,0.015599999999999989,0.009054007704764368,0.18594411041946923,0.011377777777777758,1.1842986367842703e-07,0.1844905074135399,0.00617777777777781
71,0.5,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: After septoplasty, does the compensatory hypertrophy of the middle turbinate change in size? Answer: The findings suggest that septoplasty does not affect the size of compensatory hypertrophy of the middle turbinate, even one year post-surgery.",2.36859727356853e-08,0.03364734985180551,0.0031726211122673764,0.0018134264647818796,0.03355963256444161,0.0025910509885536254,0.0018108015409528735,0.03339721616887559,0.0018684240952711456,2.3685972735685406e-08,0.033146172468933255,0.0010047404324198955
72,0.5,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the nature of general practices affect the adoption of IT innovations in primary care? Yes, characteristics like practice size, staff tech skills, leadership, openness to change, and infrastructure greatly affect how IT innovations are embraced in primary care.",4.737194547137079e-07,0.3524099504364444,0.049601870114690604,0.03626852929563745,0.359170494078751,0.05246913580246911,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
72,0.5,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do features of general practices impact the uptake of IT innovations in primary care? Indeed, attributes such as the size of the practice, technological proficiency of staff, leadership approach, readiness for change, and existing infrastructure influence IT adoption.",4.974054274493932e-07,0.30611533640703215,0.10207100591715974,0.038081955760419325,0.38656946826686633,0.05246913580246911,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
72,0.5,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are general practice traits influential in the adoption of IT innovations in primary care? Yes, factors including the practice's size, staff's tech literacy, leadership style, willingness to adapt, and infrastructure play a significant role in IT uptake.",5.210914001850785e-07,0.33351431059514747,0.10207100591715974,0.0398953822252012,0.4147403452335632,0.05246913580246911,0.03983763390096307,0.49899116611898764,0.0,5.210914001850789e-07,0.5108256237659909,0.0
72,0.5,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Can general practice characteristics affect the acceptance of IT innovations in primary care? Absolutely, elements like practice scale, staff technology skills, leadership, change readiness, and infrastructure impact the integration of IT systems.",6.39521263863505e-07,0.5277652175054621,0.06984878369493755,0.048962514549110596,0.5688910250608217,0.05246913580246911,0.04889164160572744,0.6580558607486764,0.0,6.39521263863506e-07,0.6751286750572669,0.0
72,0.5,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do general practice attributes determine the adoption of IT innovations in primary care? Yes, aspects such as the size of the practice, technological literacy among staff, leadership style, openness to change, and infrastructure affect IT innovation uptake.",5.210914001850785e-07,0.33351431059514747,0.10207100591715974,0.0398953822252012,0.4147403452335632,0.05246913580246911,0.03983763390096307,0.49899116611898764,0.0,5.210914001850789e-07,0.5108256237659909,0.0
72,0.5,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Is the uptake of IT innovations in primary care influenced by general practice characteristics? Yes, factors like practice size, staff's tech knowledge, leadership, willingness to change, and infrastructure significantly influence adoption rates.",6.39521263863505e-07,0.4830460445661111,0.10207100591715974,0.048962514549110596,0.5688910250608217,0.05246913580246911,0.04889164160572744,0.6580558607486764,0.0,6.39521263863506e-07,0.6751286750572669,0.0
72,0.5,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do general practice factors influence the integration of IT innovations in primary care? Indeed, practice size, staff's technological skills, leadership approach, readiness to change, and infrastructure affect how IT innovations are adopted.",6.39521263863505e-07,0.5277652175054621,0.06984878369493755,0.048962514549110596,0.5688910250608217,0.05246913580246911,0.04889164160572744,0.6580558607486764,0.0,6.39521263863506e-07,0.6751286750572669,0.0
72,0.5,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are the characteristics of general practices key to IT innovation uptake in primary care? Yes, variables such as practice size, staff tech literacy, leadership style, openness to change, and infrastructure impact the adoption and integration of IT systems.",4.974054274493932e-07,0.30611533640703215,0.10207100591715974,0.038081955760419325,0.38656946826686633,0.05246913580246911,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
72,0.5,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the uptake of IT innovations in primary care depend on general practice characteristics? Yes, factors including practice size, technological proficiency of staff, leadership, willingness to change, and infrastructure play a crucial role.",6.158352911278197e-07,0.4512973462515313,0.10207100591715974,0.047149088084328716,0.53610120223783,0.05246913580246911,0.047080840064774566,0.6241543090729946,0.0,6.158352911278206e-07,0.6400373552459979,0.0
72,0.5,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are general practice features significant in the adoption of IT innovations in primary care? Yes, elements like practice size, staff technology literacy, leadership style, readiness for change, and infrastructure influence the rate and success of IT system adoption.",4.974054274493932e-07,0.34358275157243456,0.07506483307765358,0.038081955760419325,0.38656946826686633,0.05246913580246911,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
73,0.5,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragility of the esophageal mucosa a definitive endoscopic sign of primary eosinophilic esophagitis? Yes; this fragility is a hallmark endoscopic feature of primary eosinophilic esophagitis, characterized by a delicate esophageal lining prone to tearing or a crepe-paper appearance during endoscopy, reflecting high eosinophil infiltration.",3.079176455639103e-07,0.06735581461385864,0.16224892584580256,0.023574544042164344,0.12012164801473713,0.09768501892915088,0.023540420032387266,0.14037529279873961,0.08842752787389467,3.079176455639103e-07,0.19404751088801797,0.05436390532544381
73,0.5,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does fragility of the esophageal mucosa serve as a pathognomonic endoscopic indicator for primary eosinophilic esophagitis? Indeed, the fragile nature of the esophageal lining is a diagnostic endoscopic sign of this condition, showing susceptibility to tearing or a crepe-paper esophagus due to elevated eosinophil levels.",3.316036182995957e-07,0.0912289678003817,0.16124574829931976,0.025387970506946217,0.14384387996095827,0.09715736961451246,0.025351221573340132,0.16390579020893403,0.08842752787389467,3.316036182995957e-07,0.218145062467078,0.05436390532544381
73,0.5,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is esophageal mucosal fragility a distinctive endoscopic sign of primary eosinophilic esophagitis? Yes, the fragile mucosa seen during endoscopy is indicative of primary eosinophilic esophagitis, presenting as an easily torn lining or crepe-paper esophagus linked to eosinophil accumulation.",4.974054274493932e-07,0.2764221393543189,0.15271967120181407,0.038081955760419325,0.32779383014921093,0.09264489795918367,0.0380268323600102,0.3462273470028885,0.08842752787389467,4.974054274493935e-07,0.40535660455522393,0.05436390532544381
73,0.5,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can the fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Yes, this fragility is a key endoscopic hallmark of the disease, where the esophageal lining is delicate and prone to tearing or a crepe-paper texture, signifying high eosinophil presence.",3.079176455639103e-07,0.06735581461385864,0.16224892584580256,0.023574544042164344,0.08861495798928454,0.1204,0.023540420032387266,0.14037529279873961,0.08842752787389467,3.079176455639103e-07,0.19404751088801797,0.05436390532544381
73,0.5,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragile state of the esophageal mucosa a pathognomonic endoscopic feature of primary eosinophilic esophagitis? Affirmative; this fragility is a characteristic endoscopic sign, with the mucosa showing vulnerability to tearing or crepe-paper changes due to eosinophilic infiltration.",4.974054274493932e-07,0.2014873090235132,0.20659722222222224,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.3462273470028885,0.08842752787389467,4.974054274493935e-07,0.40535660455522393,0.05436390532544381
73,0.5,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does primary eosinophilic esophagitis exhibit fragility of the esophageal mucosa as a pathognomonic endoscopic sign? Yes, the condition is marked by a fragile esophageal lining that may tear or resemble crepe-paper during endoscopy, indicating elevated eosinophils.",5.447773729207638e-07,0.25705716017832536,0.20659722222222224,0.04170880868998308,0.34644406729138444,0.1204,0.041648435441915946,0.40506784702582177,0.08842752787389467,5.447773729207643e-07,0.4659812263716594,0.05436390532544381
73,0.5,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragility of the esophageal mucosa an endoscopic hallmark of primary eosinophilic esophagitis? Yes, this fragility is pathognomonic, demonstrated by a delicate mucosa prone to tearing or crepe-paper esophagus in endoscopic exams, correlating with high eosinophil counts.",4.974054274493932e-07,0.2014873090235132,0.20659722222222224,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.3462273470028885,0.08842752787389467,4.974054274493935e-07,0.40535660455522393,0.05436390532544381
73,0.5,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is a fragile esophageal mucosa a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Yes, this condition is characterized by mucosal fragility, which can cause tearing or a crepe-paper appearance during endoscopy, reflecting eosinophil accumulation.",5.921493183921344e-07,0.31589766020125865,0.20659722222222224,0.04533566161954684,0.4070686891078199,0.1204,0.04527003852382169,0.4675882040071553,0.08842752787389467,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
73,0.5,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can fragility of the esophageal mucosa be identified as a pathognomonic endoscopic sign in primary eosinophilic esophagitis? Yes, this fragility is a defining endoscopic feature, with the esophageal lining showing susceptibility to tearing or crepe-paper changes due to eosinophilic infiltration.",4.500334819780226e-07,0.18438958479757828,0.1809739535241613,0.03445510283085558,0.2352184321811599,0.1204,0.034405229278104466,0.2906574958480763,0.08842752787389467,4.500334819780227e-07,0.3481981907152756,0.05436390532544381
73,0.5,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragile esophageal mucosa a definitive endoscopic sign of primary eosinophilic esophagitis? Yes, fragility of the mucosa is a pathognomonic sign seen during endoscopy, where the lining is prone to tearing or crepe-paper appearance, indicating a high eosinophil count.",4.500334819780226e-07,0.14884357553809435,0.20659722222222224,0.03445510283085558,0.2352184321811599,0.1204,0.034405229278104466,0.2906574958480763,0.08842752787389467,4.500334819780227e-07,0.3481981907152756,0.05436390532544381
74,0.5,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering required before scoliosis correction in a patient with myelomeningocele? The study indicates that spinal cord untethering might not be needed for MM patients undergoing scoliosis surgery if they lack clinical signs of tethered cord, despite radiographic evidence of tethering.",2.3685972735685406e-07,0.22314355131420927,0.0,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
74,0.5,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a patient with myelomeningocele, is spinal cord untethering necessary prior to scoliosis correction? Findings suggest untethering may be unnecessary in MM patients having scoliosis surgery who show no clinical symptoms of tethered cord, even if imaging shows tethering.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.5,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele need untethering before scoliosis correction? According to the study, untethering might not be required for MM patients undergoing scoliosis correction without clinical signs of tethered cord, despite radiographic tethering.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.5,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering of the spinal cord essential before scoliosis surgery in myelomeningocele patients? The research suggests that untethering is likely unnecessary in MM patients having scoliosis correction if they do not have clinical symptoms of tethered cord, even when tethering is visible on imaging.",1.6580180914979784e-07,0.15082288973458313,0.0,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
74,0.5,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should patients with myelomeningocele undergo untethering prior to scoliosis corrective surgery? The study results imply that spinal cord untethering may be unnecessary in MM patients without clinical tethered cord symptoms, despite radiographic evidence of tethering.",3.7897556377096586e-07,0.3856624808119835,0.0,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
74,0.5,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In myelomeningocele patients, is untethering required before scoliosis correction? The study suggests spinal cord untethering may not be necessary for those undergoing scoliosis surgery who lack clinical signs of tethered cord, even if tethering appears on imaging.",3.3160361829959526e-07,0.32850406697203516,0.0,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
74,0.5,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a patient with myelomeningocele undergoing scoliosis correction, is untethering needed? Study findings indicate untethering may be unnecessary when no clinical symptoms of tethered cord are present, despite radiographic tethering.",4.974054274493924e-07,0.5447271754416723,0.0,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
74,0.5,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to untether the spinal cord before scoliosis correction in patients with myelomeningocele? According to the study, untethering may not be required if the patient has no clinical symptoms of tethered cord, even if imaging shows tethering.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.5,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does spinal cord untethering need to precede scoliosis surgery in myelomeningocele patients? The study suggests it may be unnecessary when clinical signs of tethered cord are absent, despite radiographic evidence of tethering.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.5,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering mandatory before scoliosis correction in a patient with myelomeningocele? Study results indicate that untethering might not be needed if the patient shows no clinical symptoms of tethered cord, even if tethering is seen on radiographs.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
75,0.5,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What is the clinical importance of bile duct sludge compared to bile duct stones? Answer: Although bile duct sludge and stones are alike, their clinical implications differ. Bile duct sludge, which is thickened bile fluid, typically leads to temporary blockage and usually resolves on its own. However, bile duct",1.4211583641411244e-07,0.12524404565620362,0.02628660189849008,0.010880558788691236,0.1046502601011925,0.020823902218198284,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.5,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How does the clinical significance of bile duct sludge differ from that of bile duct stones? Answer: Bile duct sludge and stones share similarities but differ in clinical impact. Bile duct sludge, a viscous bile fluid, often causes transient obstruction and tends to resolve spontaneously. However, bile duct",1.1842986367842703e-07,0.07173279092873797,0.008426250184491835,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
75,0.5,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Can the clinical importance of bile duct sludge be distinguished from bile duct stones? Answer: While bile duct sludge and stones are similar, they have distinct clinical significances. Bile duct sludge, characterized by thickened bile fluid, frequently results in temporary blockage that resolves without intervention. However, bile duct",1.1842986367842703e-07,0.1006139234520691,0.017908999978310136,0.009067132323909363,0.08298235872201154,0.0212665406427221,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
75,0.5,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What distinguishes the clinical significance of bile duct sludge from bile duct stones? Answer: Bile duct sludge and stones, though comparable, differ clinically. Bile duct sludge, a thick bile fluid, often causes short-term obstruction and usually clears up on its own. However, bile duct",2.3685972735685406e-08,0.004263900361972439,0.019723865877711633,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
75,0.5,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Is the clinical relevance of bile duct sludge different from that of bile duct stones? Answer: Bile duct sludge and stones are similar but have different clinical consequences. Bile duct sludge, which consists of thickened bile fluid, commonly leads to temporary blockage that resolves spontaneously. However, bile duct",1.1842986367842703e-07,0.07173279092873797,0.008426250184491835,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
75,0.5,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: Although bile duct sludge and stones are alike, their clinical importance varies. Bile duct sludge, a dense bile fluid, often causes temporary obstruction and typically resolves by itself. However, bile duct",2.3685972735685406e-08,0.004263900361972439,0.019723865877711633,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
75,0.5,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What is the clinical difference between bile duct sludge and bile duct stones? Answer: Bile duct sludge and stones share similarities but differ in clinical significance. Bile duct sludge, a thickened bile fluid, frequently causes transient blockage and tends to resolve spontaneously. However, bile duct",4.737194547137081e-08,0.007833200048292355,0.03813280736357649,0.0036268529295637453,0.01649336441601079,0.045351473922902494,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
75,0.5,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How does bile duct sludge's clinical significance compare to that of bile duct stones? Answer: While bile duct sludge and stones are similar, their clinical implications are distinct. Bile duct sludge, a viscous bile fluid, often results in temporary obstruction and usually resolves on its own. However, bile duct",1.4211583641411244e-07,0.15353576731171215,0.05208269413397626,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.5,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: In clinical terms, how does bile duct sludge differ from bile duct stones? Answer: Bile duct sludge and stones are similar but have differing clinical significance. Bile duct sludge, characterized by thickened bile fluid, often causes temporary blockage that resolves without treatment. However, bile duct",4.737194547137081e-08,0.02297334130992823,0.00963798487836931,0.0036268529295637453,0.015013325609441353,0.02271498107084911,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
75,0.5,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What clinical differences exist between bile duct sludge and bile duct stones? Answer: Although bile duct sludge and stones are alike, their clinical significance differs. Bile duct sludge, a thick bile fluid, often leads to temporary obstruction and tends to resolve spontaneously. However, bile duct",4.737194547137081e-08,0.007833200048292355,0.03813280736357649,0.0036268529295637453,0.01649336441601079,0.045351473922902494,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
76,0.5,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for",Do quantitative real-time PCR assays for BCRABL detection yield comparable results across different labs despite methodological differences if the same positive control cell line and quality control gene are utilized?,8.763809912203589e-07,0.7803499920060157,0.0302734375,0.06709677919692933,0.8208551541647413,0.015380859375,0.06699965701525612,0.8630462173553419,0.0,8.7638099122036e-07,0.8850381883700527,0.0
76,0.5,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Quantitative real-time PCR assays for detecting BCRABL can produce consistent results between laboratories even with varying methodologies, provided the same positive control cell line and quality control gene are employed.",8.763809912203589e-07,0.7803499920060157,0.0302734375,0.06709677919692933,0.8208551541647413,0.015380859375,0.06699965701525612,0.8630462173553419,0.0,8.7638099122036e-07,0.8850381883700527,0.0
76,0.5,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for",Are results from homebrew quantitative real-time PCR assays for BCRABL detection correlated? Evidence suggests comparability between labs if identical positive control cell lines and quality control genes are used.,9.000669639560442e-07,0.8154413118172847,0.0302734375,0.06891020566171122,0.857222798335616,0.015380859375,0.06881045855620899,0.9007865453381889,0.0,9.000669639560454e-07,0.9242589015233351,0.0
76,0.5,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for",Can quantitative real-time PCR assays for BCRABL transcript detection be comparable across labs with different methods if the same positive control cell line and quality control gene are applied?,9.000669639560442e-07,0.8154413118172847,0.0302734375,0.06891020566171122,0.857222798335616,0.015380859375,0.06881045855620899,0.9007865453381889,0.0,9.000669639560454e-07,0.9242589015233351,0.0
76,0.5,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","The findings indicate that quantitative real-time PCR assays for BCRABL detection may be comparable between different laboratories despite methodological differences, as long as the same positive control cell line and quality control gene are used.",7.579511275419324e-07,0.621285297376327,0.0302734375,0.05802964687301994,0.6565521028734653,0.015380859375,0.05794564931049175,0.693147180559945,0.0,7.57951127541933e-07,0.7091475219063885,0.0
76,0.5,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Quantitative real-time PCR assays targeting BCRABL transcripts can yield correlated results between laboratories, even with significant methodological variations, provided standardized positive control cell lines and quality control genes are used.",8.763809912203589e-07,0.7803499920060157,0.0302734375,0.06709677919692933,0.8208551541647413,0.015380859375,0.06699965701525612,0.8630462173553419,0.0,8.7638099122036e-07,0.8850381883700527,0.0
76,0.5,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Is it possible to achieve correlated quantitative real-time PCR results for BCRABL detection from homebrew assays? The data suggests yes, if the same positive control cell line and quality control gene are consistently applied.",7.816371002776177e-07,0.6511382605260088,0.0302734375,0.05984307333780182,0.687323761540219,0.015380859375,0.059756450851444626,0.7248958788745248,0.0,7.816371002776184e-07,0.7419373447293802,0.0
76,0.5,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Despite methodological differences, quantitative real-time PCR assays for BCRABL detection can be comparable between labs if the same positive control cell line and quality control gene are utilized.",9.237529366917295e-07,0.8518089559881594,0.0302734375,0.0707236321264931,0.894963126318463,0.015380859375,0.07062126009716187,0.9400072584914714,0.0,9.237529366917308e-07,0.9650808960435899,0.0
76,0.5,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Quantitative real-time PCR assays for BCRABL transcript detection can produce comparable results across laboratories, given that the same positive control cell line and quality control gene are consistently used.",9.000669639560442e-07,0.8154413118172847,0.0302734375,0.06891020566171122,0.857222798335616,0.015380859375,0.06881045855620899,0.9007865453381889,0.0,9.000669639560454e-07,0.9242589015233351,0.0
76,0.5,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","The results imply that quantitative real-time PCR assays for detecting BCRABL transcripts can be standardized between laboratories, achieving comparability even with methodological differences, if the same positive control cell line and quality control gene are employed.",7.342651548062471e-07,0.5922977605030755,0.0302734375,0.05621622040823806,0.6266991397237835,0.015380859375,0.05613484776953888,0.6623755218931913,0.0,7.342651548062476e-07,0.6773988235918087,0.0
77,0.5,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Does the fibronectin-aggrecan complex exist in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link with pH. Further research on FAC as a diagnostic marker or treatment is ongoing.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.5,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex found in cervical disk disease? Analysis of injured cervical disks indicates inflammatory markers including MCP, fragments of structural matrix proteins like FAC, and an association with pH. Additional investigation into FAC for diagnostic or therapeutic use is needed.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999996,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
77,0.5,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex detected in cervical disk disease? Biochemical examination of affected cervical intervertebral disks uncovers inflammatory markers such as MCP, fragments of matrix proteins including FAC, and a correlation with pH. Further assessment of FAC as a diagnostic biomarker or therapy is warranted.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.5,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Does cervical disk disease involve the fibronectin-aggrecan complex? Injured cervical intervertebral disks show biochemical signs of inflammation with markers like MCP, fragments of structural proteins such as FAC, and a relationship with pH. FAC is being further evaluated as a potential diagnostic or therapeutic target.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.5,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Biochemical analysis of injured cervical disks reveals inflammatory markers like MCP, fragments of matrix proteins including FAC, and a pH correlation. FAC is under further study as a diagnostic biomarker or treatment option.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999996,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
77,0.5,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Can the fibronectin-aggrecan complex be found in cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks identifies inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a connection with pH. FAC is being further evaluated for diagnostic and therapeutic potential.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.5,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex associated with cervical disk disease? Biochemical studies of injured cervical disks detect inflammatory markers including MCP, fragments of matrix proteins such as FAC, and a pH correlation. Further evaluation of FAC as a diagnostic or therapeutic biomarker is ongoing.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999996,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
77,0.5,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Does the fibronectin-aggrecan complex appear in cervical disk disease? Analysis of injured cervical intervertebral disks shows inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and an association with pH levels. FAC is being further studied as a diagnostic biomarker or therapy.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.5,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex involved in cervical disk disease? Biochemical examination of injured cervical disks reveals inflammatory markers including MCP, fragments of matrix proteins like FAC, and a correlation with pH. FAC is under further investigation as a diagnostic or therapeutic marker.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999996,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
77,0.5,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Is the fibronectin-aggrecan complex detectable in cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks finds inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a link with pH. FAC is being further assessed for its potential as a diagnostic biomarker or treatment.",9.474389094274162e-08,0.05449578863936777,0.019599999999999996,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
78,0.5,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be a precursor to bronchiectasis? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis. It is still unclear if this mechanism drives the progression from PBB to bronchiectasis.,7.105791820705622e-08,0.05571727552295114,0.001873079242376896,0.005440279394345618,0.05541838536493415,0.0009736606461737268,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
78,0.5,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Question: Is alveolar macrophage phagocytic impairment in children with protracted bacterial bronchitis an early indicator of bronchiectasis? Answer: A weakened alveolar macrophage phagocytic activity against apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis alike. However, its role in advancing PBB to bronchiectasis is not yet determined.",4.737194547137081e-08,0.03894356239886809,0.0013659614719480281,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.5,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis precede bronchiectasis? Answer: Reduced phagocytic function of alveolar macrophages toward apoptotic cells or NTHi could underlie neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this contributes to PBB progressing into bronchiectasis is still unknown.,1.8948778188548325e-07,0.10677487948168984,0.03631185475258099,0.014507411718254981,0.13467053227666392,0.01851192595229618,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
78,0.5,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is the phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis a potential forerunner to bronchiectasis? Answer: A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi may be associated with neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. The contribution of this mechanism to the progression from PBB to bronchiectasis remains uncertain.,4.737194547137081e-08,0.08612878664280244,0.03631185475258099,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.5,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could the impaired phagocytic function of alveolar macrophages in children with protracted bacterial bronchitis signal the onset of bronchiectasis? Answer: A lowered phagocytic host response by alveolar macrophages to apoptotic cells or NTHi might facilitate neutrophilic inflammation and NTHi colonization seen in both conditions. Whether this leads to the development of bronchiectasis from PBB is not yet known.,7.105791820705622e-08,0.0796189024388112,0.019075782114846302,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
78,0.5,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis an early sign of bronchiectasis? Answer: The reduced phagocytic activity of alveolar macrophages toward apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Its role in the progression from PBB to bronchiectasis remains unclear.,2.3685972735685406e-08,0.03206156537252758,0.03631185475258099,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.5,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis act as a precursor to bronchiectasis? Answer: A compromised phagocytic host response by alveolar macrophages to apoptotic cells or NTHi may be involved in neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism promotes the progression from PBB to bronchiectasis is still unknown.,2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.5,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is reduced alveolar macrophage phagocytic function in children with protracted bacterial bronchitis a forerunner to bronchiectasis? Answer: A diminished phagocytic response to apoptotic cells or NTHi by alveolar macrophages might contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The impact of this on progression to bronchiectasis remains to be determined.,2.3685972735685406e-08,0.03206156537252758,0.03631185475258099,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.5,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede the development of bronchiectasis? Answer: A lower phagocytic activity by alveolar macrophages against apoptotic cells or NTHi may facilitate neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism drives PBB towards bronchiectasis is currently unknown.,1.1842986367842703e-07,0.044899475763602315,0.03631185475258099,0.009067132323909363,0.07149163065513164,0.01851192595229618,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
78,0.5,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is the impaired phagocytic function of alveolar macrophages in children with protracted bacterial bronchitis a potential early step towards bronchiectasis? Answer: Reduced alveolar macrophage phagocytosis of apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The role of this dysfunction in the progression from PBB to bronchiectasis remains unclear.,4.737194547137081e-08,0.08612878664280244,0.03631185475258099,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
79,0.5,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Biochemical markers of bone turnover might not consistently reflect bone histomorphometry in postmenopausal women. Differences can arise from age, hormone levels, and lifestyle factors. Thus,",1.4211583641411222e-07,0.18330434263064488,0.031883333117970564,0.010880558788691236,0.17119424872305133,0.0144750354540564,0.0108648092457172,0.16515301602662324,0.00786332179930796,1.4211583641411244e-07,0.1640203579443158,0.0041717128027681585
79,0.5,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? These markers may not always precisely mirror bone histomorphometry in postmenopausal women due to influences like age, hormonal changes, and lifestyle. Hence,",2.1317375462116813e-07,0.07561955961873013,0.15051772791330525,0.01632083818303686,0.14665533965185373,0.06265995077183889,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
79,0.5,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Can biochemical markers of bone turnover serve as reliable indicators of bone histomorphometry in 370 postmenopausal women? They may not reliably reflect bone histomorphometry in postmenopausal women because of variations caused by age, hormone levels, and lifestyle. Consequently,",1.6580180914979753e-07,0.05323513332470453,0.12700086694756096,0.012693985253473108,0.0872317389473305,0.0642896053885065,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
79,0.5,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Such markers may not consistently represent bone histomorphometry in postmenopausal women, as factors like age, hormones, and lifestyle can cause variability. Therefore,",2.1317375462116813e-07,0.11522796993644135,0.12248975643718035,0.01632083818303686,0.14665533965185373,0.06265995077183889,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
79,0.5,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Is there a correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Biochemical markers may not always correspond accurately to bone histomorphometry in postmenopausal women due to age, hormonal status, and lifestyle differences. Thus,",1.4211583641411222e-07,0.023608932413695438,0.12908334699840485,0.010880558788691236,0.05879200322684275,0.06503853458981666,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
79,0.5,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover accurately reflect bone histomorphometry in 370 postmenopausal women? These markers might not always be representative of bone histomorphometry in postmenopausal women because of factors such as age, hormone levels, and lifestyle. Hence,",1.6580180914979753e-07,0.05323513332470453,0.12700086694756102,0.012693985253473108,0.0872317389473305,0.0642896053885065,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
79,0.5,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Are biochemical markers of bone turnover good indicators of bone histomorphometry in 370 postmenopausal women? They may not consistently indicate bone histomorphometry in postmenopausal women due to age, hormonal fluctuations, and lifestyle factors. Therefore,",2.605457000925387e-07,0.18126999910804953,0.11745069393718031,0.01994769111260062,0.20982829669093706,0.060827225639520525,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
79,0.5,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Can biochemical markers of bone turnover reliably represent bone histomorphometry in 370 postmenopausal women? They might not always reliably represent bone histomorphometry in postmenopausal women because of variations in age, hormones, and lifestyle. Consequently,",2.605457000925387e-07,0.22327891914198572,0.08854462972790565,0.01994769111260062,0.29647169426093045,0.0007020226539114216,0.01991881695048156,0.3271067424807397,0.016709274673008298,2.6054570009253947e-07,0.3247724394911926,0.008918697978596915
79,0.5,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Do biochemical markers of bone turnover provide an accurate representation of bone histomorphometry in 370 postmenopausal women? These markers may not always provide an accurate reflection of bone histomorphometry in postmenopausal women owing to factors like age, hormonal changes, and lifestyle. Thus,",7.105791820705622e-08,0.05381322914606912,0.00826702046779254,0.005440279394345618,0.04733512367572068,0.017537768057518596,0.0054324046228586,0.04363996421702332,0.02187673130193906,7.105791820705622e-08,0.042173849389631535,0.024375
79,0.5,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,","Is the representation of bone histomorphometry by biochemical markers of bone turnover accurate in 370 postmenopausal women? Biochemical markers may not consistently provide an accurate representation of bone histomorphometry in postmenopausal women due to influences such as age, hormonal levels, and lifestyle. Therefore,",4.737194547137081e-08,0.008425485682931555,0.03652300949598242,0.0036268529295637453,0.013705450822062204,0.04339250493096649,0.003621603081905733,0.017433506001244048,0.022516436554898094,4.737194547137081e-08,0.01619836298637356,0.024375
80,0.5,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, opioid dependence and methadone maintenance treatment (MMT) are usually documented in the medical record, including diagnosis, treatment plans, medication information, and monitoring of the patient's response, offering essential data for healthcare providers involved in the patient's care.",1.8948778188548325e-07,0.18810605133886282,0.03090277777777775,0.014507411718254981,0.1507346237299676,0.00033510005408328436,0.014486412327622933,0.14589892767773494,0.005782899774721101,1.8948778188548325e-07,0.1700564015753634,0.009169152525795844
80,0.5,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is documentation of opioid dependence and methadone maintenance treatment (MMT) found in the medical record? Yes, both opioid dependence and methadone maintenance treatment (MMT) are generally recorded in the medical record, covering diagnosis, treatment strategies, medication details, and patient monitoring, which is vital for current and future healthcare professionals.",2.3685972735685406e-07,0.17225327094649678,0.04659722222222218,0.018134264647818726,0.19963073842555934,0.004525639500297482,0.018108015409528666,0.19348134775276282,0.0022597274203799006,2.3685972735685406e-07,0.2174742634757254,0.01196262528680108
80,0.5,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Yes, opioid dependence and methadone maintenance treatment (MMT) are commonly documented in the medical record, including the diagnosis, treatment plans, medication specifics, and monitoring of patient response, providing important information for healthcare providers.",3.079176455639103e-07,0.25219506276317816,0.03713045816086355,0.023574544042164344,0.2776550981419965,0.012563988919667646,0.023540420032387266,0.269332907786636,0.003617179555428174,3.079176455639103e-07,0.2930685366822967,0.016642011834319494
80,0.5,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically noted in the medical record, with details on diagnosis, treatment plans, medication, and patient monitoring, supplying crucial information for healthcare professionals involved in patient care.",2.3685972735685406e-07,0.17225327094649678,0.04659722222222221,0.018134264647818726,0.19963073842555934,0.004525639500297482,0.018108015409528666,0.19348134775276282,0.0022597274203799006,2.3685972735685406e-07,0.2174742634757254,0.01196262528680108
80,0.5,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Yes, opioid dependence and methadone maintenance treatment (MMT) are usually included in the medical record, detailing diagnosis, treatment plans, medication data, and monitoring of the patient's response, which is essential for healthcare providers.",3.079176455639103e-07,0.28300160412139785,0.019097222222222238,0.023574544042164344,0.30916178816744866,0.032996639883126344,0.023540420032387266,0.3015723115336102,0.0258384001039446,3.079176455639103e-07,0.2930685366822967,0.016642011834319494
80,0.5,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Yes, both opioid dependence and methadone maintenance treatment (MMT) are documented in the medical record, encompassing diagnosis, treatment plans, medication details, and patient response monitoring, providing key information for healthcare professionals.",3.079176455639103e-07,0.25219506276317816,0.03713045816086355,0.023574544042164344,0.2776550981419965,0.012563988919667646,0.023540420032387266,0.269332907786636,0.003617179555428174,3.079176455639103e-07,0.2930685366822967,0.016642011834319494
80,0.5,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in medical records? Yes, opioid dependence and methadone maintenance treatment (MMT) are typically recorded in medical records, including diagnosis, treatment plans, medication information, and monitoring of patient response, which is critical for healthcare providers.",3.789755637709665e-07,0.33879167216911243,0.026666426374471336,0.029014823436509962,0.36210487073297815,0.02164081632653067,0.028972824655245866,0.35132539049035394,0.010337904224870811,3.789755637709665e-07,0.37479351082019363,0.022024983563445087
80,0.5,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) documented in the patient's medical record? Yes, both opioid dependence and methadone maintenance treatment (MMT) are documented in the patient's medical record, detailing diagnosis, treatment plans, medication details, and monitoring of the patient's response, offering vital information for healthcare professionals.",2.6054570009253947e-07,0.29784243093817775,0.061149691358024644,0.0199476911126006,0.2852578669175636,0.045804986149584476,0.019918816950481533,0.27975216687130144,0.041749986919004806,2.6054570009253947e-07,0.27355425535493305,0.03563609467455619
80,0.5,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) found in the medical record? Yes, opioid dependence and methadone maintenance treatment (MMT) are generally found in the medical record, including diagnosis, treatment plans, medication details, and patient response monitoring, important for healthcare providers.",4.026615365066519e-07,0.40314167325804107,0.004448784722222238,0.030828249901291835,0.4265266509895911,0.04672580348943989,0.030783626196198732,0.415743808660078,0.037004998077662415,4.026615365066519e-07,0.40357526111235975,0.0240034416133317
80,0.5,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) listed in the medical record? Yes, both opioid dependence and methadone maintenance treatment (MMT) are listed in the medical record, with documentation of diagnosis, treatment plans, medication information, and monitoring of the patient's response, essential for healthcare professionals.",3.079176455639103e-07,0.28300160412139785,0.019097222222222238,0.023574544042164344,0.30916178816744866,0.032996639883126344,0.023540420032387266,0.3015723115336102,0.0258384001039446,3.079176455639103e-07,0.2930685366822967,0.016642011834319494
81,0.5,1,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The existing prediction formulas for basal metabolic rate (BMR) might not fully apply to the Chinese population because of specific genetic, environmental, and lifestyle influences. Hence, developing a",7.105791820705622e-08,0.019025818107962778,0.061874999999999986,0.005440279394345618,0.009909554725886949,0.04344177572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
81,0.5,2,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is it appropriate to use current basal metabolic rate prediction equations for the Chinese population? Answer: Due to particular genetic, environmental, and lifestyle factors, the current BMR prediction equations may not be completely suitable for Chinese individuals. Thus, there is a need to create a",0.0,0.12322616543287879,0.08716425619834711,0.0,0.09452007007635688,0.06781677572873293,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
81,0.5,3,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Can the current basal metabolic rate prediction equations be used for Chinese people? Answer: The current BMR estimation equations might not be fully relevant for the Chinese population owing to unique genetic, environmental, and lifestyle characteristics. Therefore, it is necessary to develop a",4.737194547137081e-08,0.07633092896736704,0.08613236961451248,0.0036268529295637453,0.048000054441462936,0.06781677572873293,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.5,4,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the existing basal metabolic rate prediction models valid for the Chinese population? Answer: Because of distinct genetic, environmental, and lifestyle factors, the current BMR prediction models may not be entirely accurate for Chinese individuals. Consequently, formulating a",1.6580180914979763e-07,0.051525053808620935,0.08307843316289262,0.012693985253473108,0.07875165119767935,0.06781677572873293,0.012675610786670066,0.14544177349047782,0.023242630385487524,1.6580180914979784e-07,0.18232155679395445,0.0
81,0.5,5,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Does the current basal metabolic rate prediction equation work for Chinese individuals? Answer: Given certain genetic, environmental, and lifestyle differences, the presently used BMR prediction equations may not be wholly applicable to the Chinese population. Hence, there is a requirement to establish a",4.737194547137081e-08,0.10857033271434124,0.109375,0.0036268529295637453,0.048000054441462936,0.06781677572873293,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.5,6,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is the basal metabolic rate estimation equation applicable to the Chinese population? Answer: The current equations for predicting BMR might not be completely appropriate for Chinese people due to specific genetic, environmental, and lifestyle factors. Therefore, it is important to develop a",7.105791820705622e-08,0.08503983530414683,0.109375,0.005440279394345618,0.02390250286240292,0.06781677572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
81,0.5,7,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are current basal metabolic rate prediction formulas suitable for use in the Chinese population? Answer: Owing to some genetic, environmental, and lifestyle variations, the existing BMR prediction formulas may not fully suit the Chinese demographic. Thus, creating a",1.6580180914979763e-07,0.08800648436440772,0.05690586419753086,0.012693985253473108,0.07875165119767935,0.06781677572873293,0.012675610786670066,0.14544177349047782,0.023242630385487524,1.6580180914979784e-07,0.18232155679395445,0.0
81,0.5,8,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Can existing basal metabolic rate prediction equations be applied to the Chinese population? Answer: The current BMR prediction equations may lack full applicability to Chinese individuals because of unique genetic, environmental, and lifestyle factors. As a result, developing a",1.4211583641411233e-07,0.024614146109060542,0.08375173130193905,0.010880558788691236,0.052083404115518483,0.06781677572873293,0.0108648092457172,0.1180427993023625,0.023242630385487524,1.4211583641411244e-07,0.1541506798272576,0.0
81,0.5,9,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is it valid to use current basal metabolic rate prediction equations for Chinese people? Answer: Due to certain genetic, environmental, and lifestyle differences, the current BMR estimation equations may not be entirely valid for the Chinese population. Therefore, formulating a",1.1842986367842703e-07,0.03624967113471511,0.109375,0.009067132323909363,0.02610791771226051,0.06781677572873293,0.009054007704764333,0.09137455222020163,0.023242630385487524,1.1842986367842703e-07,0.1267517056391423,0.0
81,0.5,10,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the current basal metabolic rate prediction equations appropriate for the Chinese population? Answer: Because of specific genetic, environmental, and lifestyle influences, the existing BMR prediction equations may not be fully appropriate for Chinese individuals. Hence, there is a need to create a",4.737194547137081e-08,0.044091525220392835,0.06297404818560379,0.0036268529295637453,0.048000054441462936,0.06781677572873293,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
82,0.5,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Is the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer in coronary artery disease patients? Answer: Our findings from coronary artery disease patients suggest that bezafibrate may have a preventive role against colon cancer development.",7.105791820705622e-08,0.079574527422694,0.005131939371804242,0.005440279394345618,0.04363996421702332,0.021876731301939064,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
82,0.5,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Can bezafibrate, a peroxisome proliferator-activated receptor ligand used for lipid lowering, prevent colon cancer in individuals with coronary artery disease? Answer: Data from patients with coronary artery disease support the theory that bezafibrate might help prevent colon cancer.",1.1842986367842682e-07,0.13634003639361314,0.008992346938775514,0.009067132323909363,0.09820510360836066,0.020493827160493847,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.5,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Does the lipid-lowering drug bezafibrate, which acts as a peroxisome proliferator-activated receptor ligand, reduce the risk of colon cancer in patients with coronary artery disease? Answer: Our results from coronary artery disease patients indicate a potential preventive effect of bezafibrate on colon cancer.",0.0,0.06447880749394885,0.04613236961451247,0.0,0.06601401719618405,0.047500000000000014,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
82,0.5,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Is there evidence that bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, can prevent colon cancer in those with coronary artery disease? Answer: Data obtained from patients with coronary artery disease support the hypothesis that bezafibrate may prevent colon cancer development.",0.0,0.032239403746973316,0.022669707429322852,0.0,0.0,6.938893903907228e-18,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
82,0.5,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Does bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, have a preventive effect on colon cancer in coronary artery disease patients? Answer: Our data from coronary artery disease patients back the possibility that bezafibrate prevents colon cancer.",1.6580180914979742e-07,0.15797931939207865,0.014011678200692025,0.012693985253473108,0.15591594991548163,0.01895328719723185,0.012675610786670073,0.15339948449985608,0.024375,1.6580180914979784e-07,0.19237189264745602,0.0
82,0.5,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Can the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, inhibit colon cancer in patients suffering from coronary artery disease? Answer: Evidence from coronary artery disease patients supports the idea that bezafibrate might prevent colon cancer.",1.6580180914979742e-07,0.15797931939207865,0.014011678200692025,0.012693985253473108,0.15591594991548163,0.01895328719723185,0.012675610786670073,0.15339948449985608,0.024375,1.6580180914979784e-07,0.19237189264745602,0.0
82,0.5,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Is bezafibrate, a peroxisome proliferator-activated receptor ligand used for lipid reduction, effective in preventing colon cancer among patients with coronary artery disease? Answer: Our data from these patients support the hypothesis of bezafibrate's preventive role against colon cancer.",1.1842986367842682e-07,0.02689574472625278,0.06937499999999999,0.009067132323909363,0.06073768844295824,0.047500000000000014,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.5,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Does the use of bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevent colon cancer in coronary artery disease patients? Answer: Findings from patients with coronary artery disease suggest that bezafibrate could have a protective effect against colon cancer.",1.1842986367842682e-07,0.09985860583782591,0.016905864197530852,0.009067132323909363,0.09820510360836066,0.020493827160493847,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.5,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Question: Is there a preventive effect of the peroxisome proliferator-activated receptor ligand bezafibrate on colon cancer in patients with coronary artery disease? Answer: Our data derived from coronary artery disease patients support the hypothesis that bezafibrate may prevent colon cancer development.,7.105791820705622e-08,0.04491716839469717,0.019513504155124657,0.005440279394345618,0.008093954957539395,0.047500000000000014,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
82,0.5,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Question: Does bezafibrate, which lowers lipids as a peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease? Answer: Data from these patients support the hypothesis that bezafibrate has a possible preventive effect on colon cancer.",1.1842986367842682e-07,0.02689574472625278,0.06937499999999999,0.009067132323909363,0.06073768844295824,0.047500000000000014,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
83,0.5,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","The survey reveals considerable dissatisfaction among UK consultant radiologists regarding training and support in suspected child abuse, highlights a low count of paediatric radiologists handling such cases, and indicates a 27% potential rise in radiology child abuse specialists with better training.",3.789755637709665e-07,0.3117169801726436,0.017851239669421492,0.029014823436509962,0.34377153910282665,0.0,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
83,0.5,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","UK consultant radiologists express notable dissatisfaction with current training and support for suspected child abuse cases, with few paediatric radiologists involved, and an opportunity to boost expert numbers by 27% through enhanced training.",5.684633456564489e-07,0.5348605314868533,0.017851239669421492,0.04352223515476497,0.5733459807473245,0.0,0.04345923698286883,0.5877866649021204,0.0,5.684633456564497e-07,0.6029960835656478,0.0
83,0.5,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Consultant radiologists in the UK show significant unhappiness with the available training and support for suspected child abuse, report a limited number of paediatric radiologists managing these cases, and identify a 27% potential increase in specialists if training improves.",4.263475092423371e-07,0.3630102745601933,0.017851239669421492,0.03264167636607371,0.3964152725882455,0.0,0.0325944277371516,0.40546510810816505,0.0,4.263475092423373e-07,0.41494385206270756,0.0
83,0.5,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","The findings indicate UK consultant radiologists are largely dissatisfied with training and support in suspected child abuse, that few paediatric radiologists undertake this work, and that expert numbers could grow by 27% with better training.",5.210914001850783e-07,0.47423590967041784,0.017851239669421492,0.03989538222520121,0.5108256237659909,0.0,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
83,0.5,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","There is marked dissatisfaction among UK consultant radiologists about their training and support in suspected child abuse, alongside a low involvement of paediatric radiologists, with a possible 27% increase in experts if training is enhanced.",5.210914001850783e-07,0.47423590967041784,0.017851239669421492,0.03989538222520121,0.5108256237659909,0.0,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
83,0.5,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","UK consultant radiologists report significant dissatisfaction with the current training and support for suspected child abuse, a scarcity of paediatric radiologists in this area, and a potential 27% growth in specialists through improved training.",5.447773729207636e-07,0.5040888728200996,0.017851239669421492,0.04170880868998309,0.5415972824327446,0.0,0.04164843544191596,0.5549968420791287,0.0,5.447773729207643e-07,0.5690945318899661,0.0
83,0.5,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","The survey highlights considerable discontent among UK consultant radiologists regarding training and support for suspected child abuse, a limited number of paediatric radiologists working in this field, and a 27% potential increase in experts given better training.",4.737194547137077e-07,0.4170774958304695,0.017851239669421492,0.03626852929563745,0.45198512374305766,0.0,0.03621603081905734,0.4626235219481134,0.0,4.737194547137081e-07,0.47378435208564085,0.0
83,0.5,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Consultant radiologists in the UK are notably dissatisfied with the training and support they receive for suspected child abuse, few paediatric radiologists are involved, and expert numbers could rise by 27% with improved training.",5.447773729207636e-07,0.5040888728200996,0.017851239669421492,0.04170880868998309,0.5415972824327446,0.0,0.04164843544191596,0.5549968420791287,0.0,5.447773729207643e-07,0.5690945318899661,0.0
83,0.5,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","UK consultant radiologists demonstrate significant dissatisfaction with the current service for suspected child abuse training and support, with few paediatric radiologists engaged, and a chance to increase specialists by 27% if training improves.",5.684633456564489e-07,0.5348605314868533,0.017851239669421492,0.04352223515476497,0.5733459807473245,0.0,0.04345923698286883,0.5877866649021204,0.0,5.684633456564497e-07,0.6029960835656478,0.0
83,0.5,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","The survey shows UK consultant radiologists are largely unhappy with training and support in suspected child abuse, that few paediatric radiologists participate in this work, and that expert numbers might increase by 27% with enhanced training.",4.97405427449393e-07,0.44524837279716634,0.017851239669421492,0.03808195576041933,0.48097266061630917,0.0,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
84,0.5,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Criteria Forecast Success in Orthopaedic Surgery Residency? Answer: Our findings indicate that USMLE Step 2 scores, the count of honors earned during medical school clerkships, and AOA membership show the strongest links to resident performance. The purpose of analyzing these data was to offer residency programs a clearer understanding of which criteria might be most predictive.",4.737194547137081e-08,0.03448617607116855,0.0,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
84,0.5,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Residency Selection Criteria Predict Outcomes in Orthopaedic Surgery Residency? Answer: We discovered that USMLE Step 2 results, the number of honors received in medical school clerkships, and AOA membership have the most significant correlations with resident performance. Our aim in reviewing these data was to help residency programs identify which criteria are most valuable.",4.737194547137081e-08,0.03571808260207909,0.0,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
84,0.5,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Is Resident Performance in Orthopaedic Surgery Residency Predicted by Selection Criteria? Answer: We found that USMLE Step 2 scores, honors earned during medical school clerkships, and AOA membership were the strongest predictors of resident performance. Our goal in analyzing these results was to inform residency programs about which criteria could be considered high yield.",7.105791820705622e-08,0.05406722127027486,0.0,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
84,0.5,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does the Selection Process for Residency Predict Performance in Orthopaedic Surgery Residency? Answer: We observed that USMLE Step 2 scores, the number of medical school clerkship honors, and AOA membership correlated most strongly with resident success. Our objective in examining these data was to provide residency programs insight into which criteria may be most effective.",4.737194547137081e-08,0.03571808260207909,0.0,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
84,0.5,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Residency Selection Criteria Indicative of Performance in Orthopaedic Surgery Residency? Answer: Our analysis revealed that USMLE Step 2, quantity of honors in medical school clerkships, and AOA membership had the strongest association with resident performance. The intent of this analysis was to guide residency programs toward criteria that might be high yield.",9.474389094274162e-08,0.07275935428242919,0.0,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
84,0.5,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Performance in Orthopaedic Surgery Residency Be Predicted by Selection Criteria? Answer: We identified USMLE Step 2 scores, number of honors in medical school clerkships, and AOA membership as the strongest correlates of resident performance. The purpose of analyzing these findings was to assist residency programs in recognizing which criteria are most predictive.",9.474389094274162e-08,0.07275935428242919,0.0,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
84,0.5,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Criteria Used for Residency Selection Predict Success in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, honors earned during medical school clerkships, and AOA membership showed the strongest correlations with resident outcomes. Our goal was to provide residency programs with insight on which criteria might be most useful.",1.4211583641411244e-07,0.11122563511022499,0.0,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
84,0.5,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Is There a Predictive Relationship Between Residency Selection Criteria and Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2 scores, number of honors in clerkships, and AOA membership were most strongly linked to resident performance. Our aim was to help residency programs identify which criteria have the highest yield.",1.1842986367842703e-07,0.09180754925312229,0.0,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
84,0.5,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: How Well Do Residency Selection Criteria Predict Orthopaedic Surgery Residency Performance? Answer: Our study found that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership had the strongest correlations with resident performance. The goal was to inform residency programs about the most predictive criteria.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.5,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does the Use of Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We demonstrated that USMLE Step 2 results, honors in medical school clerkships, and AOA membership were most strongly associated with resident performance. The objective was to provide residency programs with guidance on high-yield selection criteria.",2.1317375462116866e-07,0.17185025692665912,0.0,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
85,0.5,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective for treating gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma. Nevertheless, additional research is needed to clarify the role of radiotherapy in palliative or adjuvant therapy for this cancer.",7.105791820705622e-08,0.007604187163049225,0.045351473922902494,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
85,0.5,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work for gallbladder carcinoma? External radiotherapy seems to be a safe and effective approach for palliating gallbladder carcinoma, but further studies are required to define its role in palliative or adjuvant care.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.5,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy an effective palliative treatment for gallbladder carcinoma? External radiotherapy is apparently a safe and effective palliative option for gallbladder carcinoma; however, more research is needed to establish its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.25318184550457135,0.03729315417627105,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.5,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative method for gallbladder carcinoma, though further studies are necessary to determine its role in palliative or adjuvant therapy.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.5,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is the use of external palliative radiotherapy effective for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma, but additional studies are essential to understand its role in palliative or adjuvant treatment.",1.4211583641411222e-07,0.12007152469675697,0.01905490708579512,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.5,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy seems to provide a safe and effective palliative approach for gallbladder carcinoma; however, more research is needed to clarify its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.5,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective option for palliative management of gallbladder carcinoma, yet further studies are required to define its role in palliative or adjuvant treatment.",7.105791820705622e-08,0.1428524175162087,0.05106927114649125,0.005440279394345618,0.10939597588864602,0.02661886545938781,0.0054324046228586,0.10965398141320737,0.025623268698060954,7.105791820705622e-08,0.0759859069779214,0.0
85,0.5,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy serve as an effective palliative treatment for gallbladder carcinoma? External radiotherapy seems to be a safe and effective method for palliative care in gallbladder carcinoma, although additional research is necessary to confirm its role in palliative or adjuvant therapy.",7.105791820705622e-08,0.04141624475133909,0.020976473922902493,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
85,0.5,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy a good treatment option for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, but more studies are needed to determine its role in palliative or adjuvant therapy.",1.4211583641411222e-07,0.12007152469675697,0.01905490708579512,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.5,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy effective as palliative care for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative approach for gallbladder carcinoma; however, further research is needed to establish its role in palliative or adjuvant treatment.",1.6580180914979753e-07,0.18519317155393722,0.008526077097505684,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
86,0.5,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure an indicator of fluid responsiveness? Answer: Current evidence does not support the common use of central venous pressure for guiding fluid therapy. This method of fluid resuscitation should be discontinued.,2.36859727356853e-08,0.07209080692487779,0.030475982987571308,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.5,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure predict fluid responsiveness? Answer: There is no data backing the routine use of central venous pressure to direct fluid therapy. This practice in fluid resuscitation ought to be stopped.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.5,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: No evidence supports using central venous pressure widely to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.5,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: Data do not support the prevalent use of central venous pressure for fluid management. This fluid resuscitation strategy should be discontinued.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.5,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure effectively predict fluid responsiveness? Answer: There is no supportive data for the common practice of using central venous pressure to guide fluid therapy. This method should be abandoned.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.5,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to predict fluid responsiveness? Answer: The widespread practice of using central venous pressure to guide fluid therapy lacks supporting data and should be stopped.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.5,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a valid tool for predicting fluid responsiveness? Answer: No data justify the routine use of central venous pressure in guiding fluid therapy. This approach should be discontinued.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.5,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does central venous pressure serve as a predictor for fluid responsiveness? Answer: There is no evidence to support the broad use of central venous pressure for guiding fluid therapy, and this practice should be abandoned.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
86,0.5,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure measurement predictive of fluid responsiveness? Answer: The current data do not support using central venous pressure widely to guide fluid therapy. This practice should be discontinued.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.5,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure guide fluid responsiveness prediction? Answer: There is no data supporting the widespread use of central venous pressure for fluid therapy guidance. This approach should be abandoned.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
87,0.5,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This research demonstrated that FDG is unsuitable as a surrogate tracer for tumor hypoxia in both normal and hypoxic environments. Measurement of tumor hypoxia should rely exclusively on specialized hypoxia tracers.,2.3685972735685406e-08,0.027228516909493017,0.0017922579313610076,0.0018134264647818726,0.02620645821577927,0.000639705252959033,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
87,0.5,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG serve as a surrogate tracer for tumor hypoxia? The study found that FDG does not effectively act as a surrogate tracer for tumor hypoxia under ambient or low-oxygen conditions. Tumor hypoxia assessment requires dedicated hypoxia tracers.,9.474389094274131e-08,0.22602247228762717,0.08337272750856826,0.0072537058591274906,0.22473586342092888,0.08439143655489809,0.007243206163811466,0.22703881559336425,0.0849609375,9.474389094274162e-08,0.19277236223492444,0.05859375
87,0.5,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG function as a surrogate tracer to evaluate tumor hypoxia? Findings indicate that FDG is not a reliable surrogate tracer for tumor hypoxia when tested in ambient or hypoxic states. Only specific hypoxia tracers are appropriate for measuring tumor hypoxia.,2.3685972735685406e-08,0.04208620114650152,0.047731117995341306,0.0018134264647818726,0.009339551043704652,0.02498356344510192,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
87,0.5,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG a valid surrogate tracer for tumor hypoxia measurement? The investigation revealed that FDG fails as a surrogate tracer for tumor hypoxia in both normal and hypoxic conditions. Measurement should be performed using only specialized hypoxia tracers.,9.474389094274131e-08,0.15108764195682367,0.033805061442936005,0.0072537058591274906,0.18622768672315404,0.05766106465407162,0.007243206163811466,0.18743040527565302,0.056932966023875105,9.474389094274162e-08,0.15199899867257427,0.029384756657483937
87,0.5,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Could (18)F-FDG be used as a surrogate tracer to detect tumor hypoxia? This study demonstrated that FDG is ineffective as a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Specific hypoxia tracers must be employed for accurate measurement.,2.3685972735685406e-08,0.027228516909493017,0.0017922579313610076,0.0018134264647818726,0.06175246747526364,0.02614864984927353,0.0018108015409528666,0.06245691695904432,0.026296566837107373,2.3685972735685406e-08,0.026668247082160867,0.0
87,0.5,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia? The research showed that FDG does not serve well as a surrogate tracer for tumor hypoxia in either ambient or hypoxic environments. Only dedicated hypoxia tracers should be utilized to measure tumor hypoxia.,2.3685972735685406e-08,0.039501318646534056,0.04415894894670065,0.0018134264647818726,0.07589825873479139,0.07143718162429183,0.0018108015409528666,0.07865426909969919,0.07450693937180423,2.3685972735685406e-08,0.04511653211571032,0.05113221329437545
87,0.5,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? Results indicate that FDG is not an appropriate surrogate tracer for tumor hypoxia under normal or hypoxic conditions. Tumor hypoxia should be measured exclusively with specific hypoxia tracers.,9.474389094274131e-08,0.15108764195682367,0.033805061442936005,0.0072537058591274906,0.1477195100253792,0.030379758354206053,0.007243206163811466,0.14782199495794224,0.02854671280276816,9.474389094274162e-08,0.11122563511022454,0.0
87,0.5,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia? The study concluded that FDG is not a suitable surrogate tracer for tumor hypoxia in ambient or hypoxic settings. Measurement of tumor hypoxia requires the use of specialized hypoxia tracers.,4.7371945471370706e-08,0.09075828484772996,0.028509808355475175,0.0036268529295637453,0.08959879647112645,0.02748557235736722,0.003621603081905733,0.09011114865082126,0.027006172839506164,4.737194547137081e-08,0.05406722127027619,0.0
87,0.5,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG act as a surrogate tracer to measure tumor hypoxia? Findings from the study suggest that FDG is not effective as a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only hypoxia-specific tracers are recommended for this purpose.,0.0,4.440892098500626e-16,0.0,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
87,0.5,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG a reliable surrogate tracer for tumor hypoxia? The study demonstrated that FDG is not a good surrogate tracer for tumor hypoxia in both ambient and hypoxic conditions. The use of specific hypoxia tracers is necessary to measure tumor hypoxia.,2.3685972735685406e-08,0.027228516909493017,0.0017922579313610076,0.0018134264647818726,0.06175246747526364,0.02614864984927353,0.0018108015409528666,0.06245691695904432,0.026296566837107373,2.3685972735685406e-08,0.026668247082160867,0.0
88,0.5,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is it essential to have expert breast pathology evaluation for managing ductal carcinoma in situ? Answer: Expert breast pathology evaluations remain essential in managing DCIS.,9.47438909427412e-08,0.0681105386809846,0.05500491493383737,0.007253705859127518,0.11289191907964069,0.02941801545844007,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.5,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Does managing ductal carcinoma in situ require expert breast pathology assessment? Answer: Expert breast pathology assessments are still necessary for the management of DCIS.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology assessment required for the treatment of ductal carcinoma in situ? Answer: The management of DCIS continues to require expert breast pathology assessment.,7.10579182070559e-08,0.024624304416563714,0.05801111111111108,0.005440279394345639,0.06975943395752049,0.03107536160420777,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.5,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is specialized breast pathology evaluation crucial for managing ductal carcinoma in situ? Answer: Specialized breast pathology evaluations remain crucial in the management of DCIS.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is the involvement of expert breast pathologists necessary in managing ductal carcinoma in situ? Answer: Expert breast pathology involvement is still necessary for managing DCIS.,9.47438909427412e-08,0.012658764236187725,0.09446944444444441,0.007253705859127518,0.0551296540329802,0.07100591715976333,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.5,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Does the management of ductal carcinoma in situ depend on expert breast pathology assessment? Answer: Managing DCIS still depends on expert breast pathology assessment.,1.184298636784265e-07,0.17131577945163246,0.01195102040816326,0.009067132323909398,0.21823660420133173,0.0151618832937514,0.009054007704764368,0.26780779269691823,0.04535147392290251,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology evaluation indispensable in the management of ductal carcinoma in situ? Answer: Expert breast pathology evaluation remains indispensable for managing DCIS.,1.184298636784265e-07,0.17131577945163246,0.01195102040816326,0.009067132323909398,0.21823660420133173,0.0151618832937514,0.009054007704764368,0.26780779269691823,0.04535147392290251,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology review vital for the treatment of ductal carcinoma in situ? Answer: Expert breast pathology review continues to be vital in DCIS management.,7.10579182070559e-08,0.07794331830578871,0.02097844990548202,0.005440279394345639,0.12521120840231736,0.008389167906399264,0.005432404622858621,0.17554530070304475,0.04158790170132326,7.105791820705622e-08,0.1226023220923329,0.0
88,0.5,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology assessment a necessary component in managing ductal carcinoma in situ? Answer: Expert breast pathology assessment continues to be a necessary component in managing DCIS.,2.36859727356853e-08,0.19045189476436075,0.08782222222222213,0.0018134264647818796,0.19406779636176053,0.10461391755098053,0.0018108015409528735,0.19769736965052553,0.11342155009451795,2.3685972735685406e-08,0.09467248759807756,0.03993055555555556
88,0.5,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Question: Is expert breast pathology analysis required for proper management of ductal carcinoma in situ? Answer: Proper management of DCIS still requires expert breast pathology analysis.,9.47438909427412e-08,0.1790140875705757,0.01979501133786854,0.007253705859127518,0.17065418412630295,0.011638710939410213,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
89,0.5,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys in women with multiple births? Our research indicates that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys in women with higher parity. Pregnancy might offer protective effects on the kidneys against the harmful consequences of glomerular hyperfiltration.,1.4211583641411244e-07,0.15853667338202637,0.06590401051939519,0.010880558788691236,0.1391757799190474,0.008061230233033498,0.0108648092457172,0.1385155465999972,0.005658534430964771,1.4211583641411244e-07,0.13765726869928407,0.0029714576866202713
89,0.5,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had several pregnancies? According to our study, glomerular hyperfiltration from pregnancy does not adversely affect the kidneys in women with multiple pregnancies. Pregnancy may provide protective mechanisms for the kidneys against the negative effects of glomerular hyperfiltration.",7.105791820705622e-08,0.04470656738630341,0.07396765385423232,0.005440279394345618,0.021302257949105563,0.05975554549569943,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
89,0.5,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy lead to kidney damage in women with many childbirths? Our findings suggest that pregnancy-related glomerular hyperfiltration does not harm the kidneys in women with more parities. Pregnancy might have protective roles for the kidneys against the detrimental effects of glomerular hyperfiltration.,1.4211583641411244e-07,0.08529585413748508,0.027512723907726896,0.010880558788691236,0.0761623998681431,0.03704056442485032,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.5,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy cause kidney damage in women with higher parity? Our study proposes that pregnancy-induced glomerular hyperfiltration does not cause kidney damage in women with multiple births. Pregnancy could have protective mechanisms that shield the kidneys from adverse effects of glomerular hyperfiltration.,1.6580180914979784e-07,0.173582684709376,0.01740843336411206,0.012693985253473108,0.1966028430552864,0.0322891619336234,0.012675610786670066,0.19658826231052196,0.030263499776331866,1.6580180914979784e-07,0.19637192685683225,0.027828300280158057
89,0.5,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does pregnancy-related glomerular hyperfiltration damage kidneys in women with a greater number of parities? Our research suggests that glomerular hyperfiltration caused by pregnancy does not have harmful effects on the kidneys in women with more childbirths. Pregnancy may protect the kidneys from the negative impact of glomerular hyperfiltration.,9.474389094274162e-08,0.06606270028826033,0.010680272108843536,0.0072537058591274906,0.06047761514663552,0.01636711574363331,0.007243206163811466,0.059380906387511256,0.018531673581778544,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.5,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage from glomerular hyperfiltration in pregnant women with many parities? Our study indicates that pregnancy-induced glomerular hyperfiltration does not adversely affect kidney function in women with multiple pregnancies. Pregnancy might provide protective benefits to the kidneys against glomerular hyperfiltration’s harmful effects.,1.8948778188548325e-07,0.07201087027531194,0.06915460374115937,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.5,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Our findings suggest that glomerular hyperfiltration caused by pregnancy does not damage the kidneys in women with higher parity. Pregnancy may offer protective mechanisms to prevent kidney damage from glomerular hyperfiltration.,1.8948778188548325e-07,0.1042502740222866,0.04618055555555557,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.5,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","In women with more parities, does glomerular hyperfiltration during pregnancy cause kidney damage? Our study suggests that the hyperfiltration associated with pregnancy does not negatively impact kidney health in these women. Pregnancy may have protective effects against the harmful consequences of glomerular hyperfiltration on the kidneys.",1.4211583641411244e-07,0.007123769937174007,0.09334481175390268,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.5,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration from pregnancy cause kidney harm in women with increased parity? Our research indicates that this form of hyperfiltration does not adversely affect kidneys in women with multiple births. Pregnancy might have protective mechanisms that guard the kidneys against the adverse effects of glomerular hyperfiltration.,1.1842986367842703e-07,0.0003644498606090174,0.07216712580348944,0.009067132323909363,0.0529893953488525,0.037544801694046545,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.5,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage due to glomerular hyperfiltration during pregnancy a concern for women with many parities? According to our study, pregnancy-related glomerular hyperfiltration does not harm the kidneys in women with higher parity. Pregnancy may provide protective mechanisms to shield the kidneys from the negative effects of glomerular hyperfiltration.",7.105791820705622e-08,0.015825434862972276,0.05333333333333336,0.005440279394345618,0.021302257949105563,0.05975554549569943,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
90,0.5,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are stroke patients' self-reported home blood pressure readings dependable? They can be reliable when measurements are taken properly, but factors like using the wrong cuff size, poor technique, or cognitive issues may affect accuracy. Hence, it is important to ensure patients know how to measure and report their blood pressure correctly.",1.8948778188548325e-07,0.00883450392965024,0.09842432371107707,0.014507411718254981,0.005305247500777099,0.10380622837370242,0.014486412327622933,0.03037439758441085,0.08842752787389466,1.8948778188548325e-07,0.05636417544096606,0.07227989234909649
90,0.5,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients' home blood pressure readings be trusted? These reports are reliable if the readings are done correctly, though accuracy might be impacted by incorrect cuff size, improper measurement methods, or cognitive impairments. Therefore, educating patients on proper measurement and reporting is essential.",3.552895910352811e-07,0.13193150644183538,0.1184159938485198,0.02720139697172809,0.15945592732803604,0.10380622837370242,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
90,0.5,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients provide reliable home blood pressure readings? Their reports can be accurate if taken properly, but factors such as wrong cuff size, incorrect technique, or cognitive deficits may influence the results. Thus, it is vital to teach patients how to measure and report blood pressure accurately.",2.6054570009253947e-07,0.07247964513001826,0.0971494532057977,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
90,0.5,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is the reliability of home blood pressure readings reported by stroke patients consistent? These readings can be trustworthy if performed correctly, but accuracy can be compromised by factors like inappropriate cuff size, poor technique, or cognitive challenges. It is therefore important to ensure patients understand proper measurement and reporting procedures.",2.1317375462116866e-07,0.02960304568027894,0.09801668829296424,0.016320838183036854,0.025924534703512858,0.10380622837370242,0.0162972138685758,0.05142780678224401,0.08842752787389466,2.1317375462116866e-07,0.07787038066192942,0.07227989234909649
90,0.5,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are home blood pressure readings reported by stroke patients accurate? They can be reliable if the measurements are done correctly, although factors such as using an incorrect cuff size, improper technique, or cognitive impairment may affect accuracy. Consequently, it is crucial to instruct patients on how to measure and report blood pressure accurately.",1.4211583641411244e-07,0.03145258950141683,0.09919261822376008,0.010880558788691236,0.034700087112921274,0.10380622837370242,0.0108648092457172,0.010447596935843517,0.08842752787389466,1.4211583641411244e-07,0.014691479040397137,0.07227989234909649
90,0.5,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can the home blood pressure readings reported by stroke patients be considered reliable? Yes, when taken properly, but accuracy may be influenced by incorrect cuff size, faulty technique, or cognitive impairment. Therefore, ensuring patients are well-informed on accurate measurement and reporting is critical.",3.789755637709665e-07,0.1554620038520298,0.1184159938485198,0.029014823436509962,0.18355347890709606,0.10380622837370242,0.028972824655245866,0.21269595437836575,0.08842752787389466,3.789755637709665e-07,0.24295013102137952,0.07227989234909649
90,0.5,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","How reliable are home blood pressure readings reported by stroke patients? These readings can be dependable if taken correctly; however, factors like wrong cuff size, improper technique, or cognitive impairment can affect accuracy. Thus, it is essential to educate patients on proper measurement and reporting.",3.316036182995957e-07,0.10894198821713585,0.1184159938485198,0.025387970506946217,0.13592542991784162,0.10380622837370242,0.025351221573340132,0.16390579020893403,0.08842752787389466,3.316036182995957e-07,0.1929397104467161,0.07227989234909649
90,0.5,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are reports of home blood pressure readings from stroke patients trustworthy? They can be, provided the readings are taken correctly. Accuracy may be affected by factors such as incorrect cuff size, improper technique, or cognitive impairment, so it is important to ensure patients know how to measure and report blood pressure accurately.",1.6580180914979784e-07,0.011511768214027995,0.0988159938485198,0.012693985253473108,0.01489745981674151,0.10380622837370242,0.012675610786670066,0.009755110381675092,0.08842752787389466,1.6580180914979784e-07,0.035310766243132896,0.07227989234909649
90,0.5,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is it reliable to trust stroke patients' home blood pressure readings? These readings can be accurate if measured correctly, but factors like incorrect cuff size, improper technique, or cognitive impairment may impact reliability. Therefore, teaching patients proper measurement and reporting is important.",4.026615365066519e-07,0.1795595554310898,0.1184159938485198,0.030828249901291835,0.20824609149746776,0.10380622837370242,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2689256174246375,0.07227989234909649
90,0.5,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients provide trustworthy home blood pressure readings? Their reports can be reliable if the measurements are done properly, though accuracy might be influenced by factors such as using the wrong cuff size, improper technique, or cognitive impairment. Hence, it is vital to ensure patients understand how to measure and report blood pressure correctly.",9.474389094274162e-08,0.07018030663036079,0.09990406789622361,0.0072537058591274906,0.07316636794071707,0.10380622837370242,0.007243206163811466,0.04966831008912598,0.08842752787389466,9.474389094274162e-08,0.025313855573301236,0.07227989234909649
91,0.5,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Our findings indicate that reduced vessel compliance and heightened vascular resistance characterize young, obese, normotensive individuals independently of cardiovascular risk factors. Alterations in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.5,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes signal early vascular abnormalities in young obese males? The results show that young, obese, normotensive subjects exhibit decreased vessel compliance and increased vascular resistance, regardless of cardiovascular risk factors. Changes in arterial wall properties might...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.5,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is an increase in carotid artery pulsatility and resistance indexes an early marker of vascular abnormalities in young obese males? Our data suggest that diminished vessel compliance and elevated vascular resistance are present in young, obese, normotensive subjects, independent of cardiovascular risk factors. Alterations in arterial wall properties could...",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
91,0.5,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can higher carotid artery pulsatility and resistance indexes serve as early signs of vascular abnormalities in young obese males? Findings suggest that reduced vessel compliance and increased vascular resistance occur in young, obese, normotensive subjects, beyond cardiovascular risk factors. Changes in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.5,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are increased carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Our study suggests that young, obese, normotensive individuals display decreased vessel compliance and increased vascular resistance independently of cardiovascular risk factors. Modifications in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.5,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do elevated carotid artery pulsatility and resistance indexes represent early signs of vascular abnormalities in young obese males? Results indicate that young, obese, normotensive subjects have impaired vessel compliance and heightened vascular resistance, irrespective of cardiovascular risk factors. Changes in arterial wall properties might...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.5,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is increased carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Our findings suggest that young, obese, normotensive individuals show reduced vessel compliance and increased vascular resistance independently of cardiovascular risk factors. Alterations in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.5,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are higher carotid artery pulsatility and resistance indexes early markers of vascular abnormalities in young obese males? The data indicate that depressed vessel compliance and increased vascular resistance characterize young, obese, normotensive subjects, independent of cardiovascular risk factors. Changes in arterial wall properties might...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.5,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Our results suggest that young, obese, normotensive individuals have decreased vessel compliance and increased vascular resistance, beyond cardiovascular risk factors. Alterations in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.5,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes in young obese males indicate early vascular abnormalities? Findings suggest that depressed vessel compliance and elevated vascular resistance are features of young, obese, normotensive subjects, independently of cardiovascular risk factors. Changes in arterial wall properties might...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
92,0.5,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having an optimistic outlook predict better survival rates in advanced age? It seems optimism is a strong survival predictor for the oldest-old women and potentially for men, though the male sample is small.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.5,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is an optimistic attitude linked to improved survival among the very elderly? Optimism appears to significantly predict survival in the oldest-old women and possibly men, but the male sample size is limited.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.5,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can optimism forecast better longevity in advanced age? An optimistic outlook is a notable survival predictor for the oldest-old women and may also predict survival in men, though the male sample is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.5,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does optimism influence survival chances at very old ages? Optimism is a significant predictor of survival among the oldest-old women and might be for men, but the male sample is small.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.2971860744661661,0.06937499999999999,0.02535122157334018,0.37245809951007214,0.023795359904818555,3.316036182995957e-07,0.4177352006999784,0.0
92,0.5,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is there a connection between optimism and survival in advanced age? Optimistic outlooks significantly predict survival in oldest-old women and possibly men, though the male sample size is limited.",3.7897556377096523e-07,0.3439621865129374,0.07610327838248068,0.029014823436510018,0.36864503844830976,0.06937499999999999,0.028972824655245928,0.4465660716637938,0.023795359904818555,3.789755637709665e-07,0.49469624183610783,0.0
92,0.5,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does a positive outlook improve survival for the very elderly? Optimism appears to be a key survival predictor among oldest-old women and may be for men, albeit with a small male sample.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.5,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can an optimistic perspective predict longer survival at advanced ages? Optimism is a significant survival predictor in oldest-old women and potentially men, but the sample size for men is small.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.3322773942774351,0.06937499999999999,0.027162023114293055,0.4088257436809468,0.023795359904818555,3.552895910352811e-07,0.45547552868282537,0.0
92,0.5,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is optimism a predictor of survival in the oldest-old? Optimistic outlooks significantly forecast survival in oldest-old women and might do so for men, though the male sample is small.",3.7897556377096523e-07,0.3439621865129374,0.07610327838248068,0.029014823436510018,0.36864503844830976,0.06937499999999999,0.028972824655245928,0.4465660716637938,0.023795359904818555,3.789755637709665e-07,0.49469624183610783,0.0
92,0.5,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having an optimistic mindset predict better survival outcomes in advanced age? It seems optimism significantly predicts survival among oldest-old women and possibly men, with a small male sample size.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.3322773942774351,0.06937499999999999,0.027162023114293055,0.4088257436809468,0.023795359904818555,3.552895910352811e-07,0.45547552868282537,0.0
92,0.5,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is an optimistic viewpoint associated with greater survival at advanced ages? Optimism is a significant survival predictor in oldest-old women and may be for men, but the male sample is limited.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.2971860744661661,0.06937499999999999,0.02535122157334018,0.37245809951007214,0.023795359904818555,3.316036182995957e-07,0.4177352006999784,0.0
93,0.5,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone generally correlates with the aganglionosis level in Hirschsprung's disease specimens, but it is not always precise or definitive.",4.737194547137081e-08,0.16652522168006811,0.11750136961285614,0.0036268529295637453,0.173329815715618,0.1384882570352225,0.003621603081905733,0.18060854558731299,0.154947232402649,4.737194547137081e-08,0.15286192495507622,0.14204081632653065
93,0.5,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correspond to the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, it often corresponds, though it is not always exact or conclusive.",4.0266153650665053e-07,0.11027248760850661,0.234375,0.030828249901291897,0.18070954020233776,0.21120293847566574,0.0307836261961988,0.25473772463042677,0.1799307958477509,4.026615365066519e-07,0.332645890826623,0.14204081632653065
93,0.5,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: In Hirschsprung's disease, does the radiographic transition zone match the aganglionosis level on the specimen? Answer: Yes, typically it matches, but this correlation is not always reliable or definitive.",3.5528959103527993e-07,0.03881352362636292,0.234375,0.027201396971728138,0.10660156804861609,0.21120293847566574,0.027162023114293055,0.17777668349429732,0.1799307958477509,3.552895910352811e-07,0.2526031831530857,0.14204081632653065
93,0.5,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the level of aganglionosis in Hirschsprung's disease specimens reflected by the radiographic transition zone? Answer: Yes, the transition zone often reflects the aganglionosis level, although it is not consistently accurate or conclusive.",2.605457000925387e-07,0.09039820785364405,0.234375,0.01994769111260062,0.026929824575906203,0.21120293847566574,0.01991881695048156,0.03962634501348017,0.1799307958477509,2.6054570009253947e-07,0.10950233951241328,0.14204081632653065
93,0.5,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone accurately indicate the aganglionosis level in Hirschsprung's disease specimens? Answer: It often indicates the level, but it is not always accurate or definitive.",3.7897556377096523e-07,0.07390484343763193,0.234375,0.029014823436510018,0.14296921221949077,0.21120293847566574,0.028972824655245928,0.2155170114771443,0.1799307958477509,3.789755637709665e-07,0.2918238963063682,0.14204081632653065
93,0.5,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: In Hirschsprung's disease, does the radiographic transition zone align with the specimen's aganglionosis level? Answer: Yes, it frequently aligns, but this is not always precise or conclusive.",4.0266153650665053e-07,0.11027248760850661,0.234375,0.030828249901291897,0.18070954020233776,0.21120293847566574,0.0307836261961988,0.25473772463042677,0.1799307958477509,4.026615365066519e-07,0.332645890826623,0.14204081632653065
93,0.5,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a relationship between the radiographic transition zone and aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, a relationship often exists, though it is not always exact or definitive.",3.3160361829959463e-07,0.051121783988010705,0.2010813020214031,0.02538797050694626,0.07151024823734708,0.21120293847566574,0.02535122157334018,0.14140903932342264,0.1799307958477509,3.316036182995957e-07,0.21486285517023873,0.14204081632653065
93,0.5,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correlate with the extent of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, it often correlates, but it is not always definitive or entirely accurate.",3.5528959103527993e-07,0.03881352362636292,0.234375,0.027201396971728138,0.10660156804861609,0.21120293847566574,0.027162023114293055,0.17777668349429732,0.1799307958477509,3.552895910352811e-07,0.2526031831530857,0.14204081632653065
93,0.5,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: In Hirschsprung's disease, can the radiographic transition zone be used to identify the aganglionosis level on the specimen? Answer: Yes, it can often be used, though it is not always a definitive or precise indicator.",2.1317375462116813e-07,0.14923870787657734,0.234375,0.01632083818303686,0.08755444639234167,0.21120293847566574,0.016297213868575813,0.022894011967853345,0.1799307958477509,2.1317375462116866e-07,0.04496381837484176,0.14204081632653065
93,0.5,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone serve as a reliable marker for the level of aganglionosis in Hirschsprung's disease specimens? Answer: It often serves as a marker, but it is not always reliable or definitive.",2.3685972735685343e-07,0.0794778074409761,0.20499024334251606,0.01813426464781874,0.05770148324265989,0.21120293847566574,0.018108015409528687,0.007877646698900342,0.1799307958477509,2.3685972735685406e-07,0.07671251668942158,0.14204081632653065
94,0.5,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic criterion for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.5,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: Increased levels of D-dimer are not reliable as a diagnostic parameter for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.5,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be adopted as a new diagnostic indicator for acute appendicitis? Answer: High D-dimer levels should not be regarded as a diagnostic marker for acute appendicitis.,0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.5,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be utilized as a diagnostic parameter for acute appendicitis? Answer: Raised D-dimer levels do not qualify as a diagnostic criterion in acute appendicitis diagnosis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.09467248759807756,0.03993055555555556,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.5,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic parameter for acute appendicitis? Answer: Elevated D-dimer should not be considered a diagnostic marker in diagnosing acute appendicitis.,7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.5,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels be used as a new diagnostic measure for acute appendicitis? Answer: Increased D-dimer values should not be used for diagnosing acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.5,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer become a diagnostic parameter for acute appendicitis? Answer: D-dimer elevation should not be interpreted as a diagnostic factor for acute appendicitis.,9.47438909427412e-08,0.22954575022770252,0.04918555193280468,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.5,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to be a new diagnostic parameter in acute appendicitis? Answer: Elevated D-dimer levels are not appropriate for diagnosing acute appendicitis.,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.5,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer act as a new diagnostic marker for acute appendicitis? Answer: High D-dimer levels should not be considered diagnostic for acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.5,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Might D-dimer be introduced as a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer concentrations are not sufficient for diagnosing acute appendicitis.,1.184298636784265e-07,0.15345017704898067,0.03698224852071005,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
95,0.5,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Studies showed higher expression of TGF-β1 and VEGF in polyps versus nearby normal endometrial tissue, implying these cytokines could contribute to polyp development.",2.6054570009253947e-07,0.13103362409866648,0.07638888888888888,0.0199476911126006,0.2157639362354895,0.019599999999999992,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
95,0.5,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does the development of endometrial polyps correlate with increased expression of VEGF and TGF-β1? Research indicated that TGF-β1 and VEGF were more highly expressed in polyps than in adjacent normal endometrium, suggesting these cytokines may be involved in polyp formation.",3.079176455639102e-07,0.1810440446733299,0.07638888888888888,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
95,0.5,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there an association between endometrial polyp formation and heightened expression of vascular endothelial growth factor and transforming growth factor-beta1? Findings revealed elevated TGF-β1 and VEGF levels in polyps compared to normal surrounding endometrial tissue, hinting at their role in polyp development.",2.6054570009253947e-07,0.13103362409866648,0.07638888888888888,0.0199476911126006,0.2157639362354895,0.019599999999999992,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
95,0.5,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are vascular endothelial growth factor and transforming growth factor-beta1 expressed at higher levels in endometrial polyps? Increased expression of TGF-β1 and VEGF was observed in polyps relative to adjacent normal endometrium, indicating these cytokines might influence polyp formation.",3.552895910352808e-07,0.23368777815874875,0.07638888888888888,0.02720139697172809,0.3211244518933154,0.019599999999999992,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
95,0.5,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does endometrial polyp formation involve increased expression of TGF-β1 and VEGF? The data showed that polyps exhibited higher TGF-β1 and VEGF expression than nearby normal endometrial tissue, suggesting a possible role for these cytokines in polyp development.",3.789755637709661e-07,0.2995949290446389,0.048633786848072555,0.029014823436509962,0.34929532886001224,0.019599999999999992,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
95,0.5,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is increased expression of vascular endothelial growth factor and transforming growth factor-beta1 associated with the formation of endometrial polyps? Elevated levels of TGF-β1 and VEGF were detected in polyps compared to adjacent normal tissue, implying these cytokines may contribute to polyp formation.",2.6054570009253947e-07,0.13103362409866648,0.07638888888888888,0.0199476911126006,0.2157639362354895,0.019599999999999992,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
95,0.5,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there a link between endometrial polyp formation and increased levels of VEGF and TGF-β1? Studies found that polyps had greater expression of TGF-β1 and VEGF than surrounding normal endometrium, suggesting these factors play a role in polyp development.",3.316036182995955e-07,0.20701953107658788,0.07638888888888888,0.025387970506946217,0.2937254777052001,0.019599999999999992,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
95,0.5,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are higher expressions of vascular endothelial growth factor and transforming growth factor-beta1 found in endometrial polyps? Research demonstrated increased TGF-β1 and VEGF in polyps relative to normal adjacent tissue, indicating these cytokines might be involved in polyp formation.",3.552895910352808e-07,0.23368777815874875,0.07638888888888888,0.02720139697172809,0.3211244518933154,0.019599999999999992,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
95,0.5,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does the presence of endometrial polyps correspond with elevated expression of TGF-β1 and VEGF? Evidence showed increased TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue, suggesting these cytokines could be implicated in polyp formation.",3.789755637709661e-07,0.2995949290446389,0.048633786848072555,0.029014823436509962,0.34929532886001224,0.019599999999999992,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
95,0.5,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the occurrence of endometrial polyps associated with increased expression of transforming growth factor-beta1 and vascular endothelial growth factor? Findings indicated higher TGF-β1 and VEGF expression in polyps than in nearby normal endometrium, implying these cytokines may contribute to polyp formation.",2.8423167282822487e-07,0.15572623668903818,0.07638888888888888,0.02176111757738247,0.24108174421978124,0.019599999999999992,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
96,0.5,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is sternal fracture a rare and frequently missed injury in growing children? Answer: Yes, sternal fractures are uncommon and frequently overlooked in growing children. They may result from direct chest trauma but are often not detected initially because of their rarity and the focus on other injuries.",7.105791820705622e-08,0.01776278298454459,0.05629629629629632,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.5,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures rare and often unnoticed in children who are still growing? Answer: Indeed, sternal fractures are rare and commonly missed in growing children. These fractures can happen from direct chest trauma but tend to be overlooked during initial assessments due to their uncommon nature and the presence of other injuries.",4.737194547137081e-08,0.12453113537604477,0.060365432098765444,0.0036268529295637453,0.0965887779247141,0.040742417383431435,0.003621603081905733,0.06970312704358506,0.020823902218198284,4.737194547137081e-08,0.04167269640056892,0.0
96,0.5,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Sternal fracture in children: Is it an uncommon and frequently ignored injury? Answer: Yes, sternal fractures are uncommon and frequently ignored in growing children. They can arise from direct trauma to the chest but are often missed during early evaluations because they are rare and other injuries are prioritized.",2.3685972735685406e-08,0.03355156382794666,0.03780134892296208,0.0018134264647818726,0.021798108938381855,0.0008454843178918245,0.0018108015409528666,0.021667901379180954,0.00044263842452381755,2.3685972735685406e-08,0.02150620522096336,0.0
96,0.5,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children rare and often not diagnosed initially? Answer: Yes, sternal fractures are rare and often go unnoticed in growing children. They occur due to direct chest trauma but are frequently missed in initial examinations due to their rarity and the presence of more obvious injuries.",0.0,0.0,0.0,0.0,0.02829172165550764,0.02034311182787588,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0
96,0.5,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is a sternal fracture a rare and commonly overlooked injury in children who are still developing? Answer: Yes, sternal fractures are infrequent and often overlooked in growing children. They result from direct trauma to the chest but are frequently missed during the first evaluation because of their rarity and other more apparent injuries.",7.105791820705622e-08,0.19689834423596464,0.09876543209876545,0.005440279394345618,0.1160068637818168,0.040742417383431435,0.0054324046228586,0.08950575433976482,0.020823902218198284,7.105791820705622e-08,0.06187540371808753,0.0
96,0.5,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Question: Are sternal fractures uncommon and often missed in children during growth? Answer: Yes, sternal fractures are uncommon and often overlooked in growing children. They can be caused by direct chest trauma but are frequently undetected in early assessments due to their rarity and other more pressing injuries.",4.737194547137081e-08,0.01116404402174176,0.036543209876543234,0.0036268529295637453,0.014584877794231677,0.019475876740709334,0.003621603081905733,0.013678481895465833,0.020823902218198284,4.737194547137081e-08,0.04348511193973836,0.0
96,0.5,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children rare and frequently missed? Answer: Yes, sternal fractures are rare and frequently missed in growing children. They may occur from direct chest trauma but are often overlooked initially because they are uncommon and other injuries take precedence.",1.6580180914979784e-07,0.14115106861049043,0.006720724669442624,0.012693985253473108,0.1305742451143348,0.01694705747861288,0.012675610786670066,0.1287478116802525,0.020823902218198284,1.6580180914979784e-07,0.16126814759612174,0.0
96,0.5,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is sternal fracture a rare and often overlooked injury in growing children? Answer: Yes, sternal fractures are rare and often overlooked in children who are still growing. They can happen as a result of direct trauma to the chest but are frequently missed during initial evaluations due to their infrequency and the presence of more obvious injuries.",1.6580180914979784e-07,0.19669483740682026,0.04629629629629634,0.012693985253473108,0.14060432303839887,0.005077122458877266,0.012675610786670066,0.13980795482754882,0.002648319227800483,1.6580180914979784e-07,0.13883644485421742,0.0
96,0.5,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Sternal fracture in growing children: Is it an uncommon and often missed injury? Answer: Yes, sternal fractures are uncommon and often missed in growing children. They happen due to direct chest trauma but are frequently overlooked in early examinations because of their rarity and other injuries.",9.474389094274162e-08,0.06529950857661726,0.012597631645250698,0.0072537058591274906,0.09018744774573095,0.003605878992988247,0.007243206163811466,0.08963693449175114,0.0018910788526508258,9.474389094274162e-08,0.0889474860164956,0.0
96,0.5,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children rare and often unnoticed? Answer: Yes, sternal fractures are rare and often unnoticed in children who are growing. They occur from direct trauma to the chest but tend to be missed in initial evaluations due to their uncommon occurrence and the presence of other more evident injuries.",7.105791820705622e-08,0.11842885209710285,0.04236543209876543,0.005440279394345618,0.0893473568372034,0.021519041758671725,0.0054324046228586,0.08950575433976482,0.020823902218198284,7.105791820705622e-08,0.06187540371808753,0.0
97,0.5,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women have a higher obesity risk due to needing fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.5,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require fewer calories to maintain their weight? Answer: The data does not support the claim that African American women are more prone to obesity because of lower calorie needs for weight upkeep.,9.47438909427412e-08,0.16000919813262326,0.03599404555439932,0.0072537058591274975,0.1605828646856997,0.03493981320897727,0.00724320616381148,0.16096077608021542,0.03334762528744492,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.5,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower caloric requirements to sustain their weight? Answer: These results do not confirm that African American women face increased obesity risk from needing fewer calories to maintain weight.,4.73719454713706e-08,0.015575301180038803,0.052029136316337134,0.003626852929563759,0.01837377008561525,0.05619146722164411,0.003621603081905747,0.02149748308653887,0.06035379812695108,4.737194547137081e-08,0.02121682235257394,0.031217481789802305
97,0.5,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories necessary for African American women to maintain their weight? Answer: The evidence does not endorse the notion that African American women are at greater obesity risk due to lower calorie requirements for weight maintenance.,4.73719454713706e-08,0.13906866209485091,0.05850538342288004,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.5,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need less caloric intake to keep their weight steady? Answer: The results do not support the perspective that African American women are more vulnerable to obesity because they require fewer calories to maintain weight.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.5,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement for weight maintenance lower in African American women? Answer: The findings do not uphold the belief that African American women are at higher risk of obesity due to reduced calorie needs.,0.0,0.11882523095313324,0.08383622164052006,0.0,0.1223200906870483,0.08740894901144641,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.5,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require fewer calories for weight maintenance? Answer: The results do not back the theory that African American women are at increased risk of obesity because they need fewer calories to maintain their weight.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.5,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are African American women's calorie needs for maintaining weight lower? Answer: These findings do not support the idea that African American women are more susceptible to obesity due to needing fewer calories for weight maintenance.,0.0,0.11882523095313324,0.08383622164052006,0.0,0.1223200906870483,0.08740894901144641,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.5,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it accurate that African American women require fewer calories to maintain their weight? Answer: The data does not substantiate the claim that African American women have a greater risk of obesity because they require fewer calories for weight upkeep.,1.184298636784265e-07,0.11867823875538175,0.010066045148548516,0.00906713232390937,0.1528831844220786,0.011020060122557518,0.009054007704764347,0.18861500777199236,0.03405723128984371,1.1842986367842703e-07,0.18850370862949672,0.031217481789802305
97,0.5,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have a lower caloric need to sustain their weight? Answer: The results do not validate the view that African American women are at higher obesity risk as a result of needing fewer calories to maintain weight.,1.184298636784265e-07,0.22265031583937311,0.06252143859841289,0.00906713232390937,0.2239752029410469,0.06178568031338546,0.009054007704764347,0.2250964383277787,0.06035379812695108,1.1842986367842703e-07,0.18850370862949672,0.031217481789802305
98,0.5,1,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Research shows mixed satisfaction among UK radiologists concerning the training and support for suspected child abuse cases, with some feeling well-prepared and others calling for enhanced training and support.",6.632072365991901e-07,0.48576141211845014,0.17794529108678797,0.05077594101389249,0.5602642071059711,0.10745522698875466,0.05070244314668033,0.6281990373487258,0.07359999999999998,6.632072365991914e-07,0.6729465965450592,0.056400000000000027
98,0.5,2,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Among UK radiologists, satisfaction with training and support in suspected child abuse varies, as some consider their preparation adequate while others see a need for better resources.",7.105791820705607e-07,0.5103588713750327,0.21361058601134214,0.05440279394345625,0.6372252482421006,0.10745522698875466,0.054324046228586075,0.7082417450222631,0.07359999999999998,7.105791820705622e-07,0.7563282054841096,0.056400000000000027
98,0.5,3,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","UK radiologists report differing levels of contentment with the training and support provided for suspected child abuse, with a portion feeling sufficiently trained and others advocating for more thorough preparation.",6.395212638635048e-07,0.401159579410042,0.21361058601134214,0.04896251454911061,0.5238965629350965,0.10745522698875466,0.048891641605727454,0.5904587093658789,0.07359999999999998,6.39521263863506e-07,0.6337258833917767,0.056400000000000027
98,0.5,4,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","There is a range of satisfaction among UK radiologists about the training and support they receive for suspected child abuse, with some expressing confidence and others requesting improved training.",6.632072365991901e-07,0.436250899221311,0.21361058601134214,0.05077594101389249,0.5602642071059711,0.10745522698875466,0.05070244314668033,0.6281990373487258,0.07359999999999998,6.632072365991914e-07,0.6729465965450592,0.056400000000000027
98,0.5,5,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","UK radiologists have varied opinions on the adequacy of training and support in suspected child abuse, where some feel prepared and others highlight the necessity for more comprehensive education.",6.632072365991901e-07,0.436250899221311,0.21361058601134214,0.05077594101389249,0.5602642071059711,0.10745522698875466,0.05070244314668033,0.6281990373487258,0.07359999999999998,6.632072365991914e-07,0.6729465965450592,0.056400000000000027
98,0.5,6,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Satisfaction levels among UK radiologists regarding training and support in suspected child abuse are mixed, with some feeling ready and others emphasizing the need for enhanced training.",7.105791820705607e-07,0.5103588713750327,0.21361058601134214,0.05440279394345625,0.6372252482421006,0.10745522698875466,0.054324046228586075,0.7082417450222631,0.07359999999999998,7.105791820705622e-07,0.7563282054841096,0.056400000000000027
98,0.5,7,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","The training and support for suspected child abuse among UK radiologists elicits diverse satisfaction, as some feel equipped while others suggest improvements are necessary.",7.816371002776166e-07,0.6329611934673656,0.21361058601134214,0.05984307333780189,0.7650586197519851,0.10745522698875466,0.059756450851444695,0.8417731376467867,0.07359999999999998,7.816371002776184e-07,0.8960901478592689,0.056400000000000027
98,0.5,8,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","UK radiologists show diverse satisfaction regarding their training and support in suspected child abuse, with some feeling competent and others desiring more extensive training.",7.816371002776166e-07,0.6329611934673656,0.21361058601134214,0.05984307333780189,0.7650586197519851,0.10745522698875466,0.059756450851444695,0.8417731376467867,0.07359999999999998,7.816371002776184e-07,0.8960901478592689,0.056400000000000027
98,0.5,9,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Opinions among UK radiologists differ on the sufficiency of training and support for suspected child abuse, with some satisfied and others advocating for better preparation.",7.579511275419313e-07,0.5904015790485699,0.21361058601134214,0.05802964687302001,0.720606857181151,0.10745522698875466,0.05794564931049182,0.7952531220118928,0.07359999999999998,7.57951127541933e-07,0.8472999836898376,0.056400000000000027
98,0.5,10,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Research reflects varied satisfaction among UK radiologists about training and support in suspected child abuse, with some feeling adequately trained and others indicating a need for improvement.",7.105791820705607e-07,0.5103588713750327,0.21361058601134214,0.05440279394345625,0.6372252482421006,0.10745522698875466,0.054324046228586075,0.7082417450222631,0.07359999999999998,7.105791820705622e-07,0.7563282054841096,0.056400000000000027
99,0.5,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Enhancing hospital efficiency by reducing length of stay seems not to increase readmission rates or physician visits within 30 days post-discharge. Further research is necessary to determine ideal lengths of stay and anticipated readmission rates.,2.3685972735685406e-07,0.1980783371253132,0.003728275336599654,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.5,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge from Winnipeg hospitals compromise care quality? Shortening hospital stays to improve efficiency does not appear to raise readmission or physician visit rates within 30 days after discharge. Additional studies are needed to find optimal stay durations and expected readmission rates.,3.552895910352811e-07,0.28106069584732474,0.01753826530612245,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
99,0.5,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is the quality of care affected by earlier patient discharge from Winnipeg hospitals? Improving efficiency by decreasing hospital length of stay does not seem to increase readmissions or physician visits within 30 days post-discharge. Research should focus on identifying optimal stay lengths and expected readmission rates.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,0.5,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does early discharge from Winnipeg hospitals adversely affect care quality? Reducing hospital stay length to boost efficiency does not seem to lead to higher readmission or physician visit rates within 30 days after discharge. More research is required to establish optimal stay lengths and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.5,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does releasing patients sooner from Winnipeg hospitals harm the quality of care? Enhancing hospital efficiency by shortening stays does not appear to increase readmission or physician visit rates within 30 days of discharge. Research is needed to determine the best length of stay and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.5,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients earlier in Winnipeg hospitals impact care quality negatively? Improving hospital efficiency through shorter stays does not seem to cause increased readmissions or physician visits within 30 days after discharge. Further investigation is necessary to identify optimal stay durations and expected readmission rates.,3.079176455639103e-07,0.2345406802124308,0.01753826530612245,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
99,0.5,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier patient discharge from Winnipeg hospitals affect quality of care? Shortening hospital stays to improve efficiency does not appear to increase rates of readmission or physician visits within 30 days post-discharge. Research is needed to find optimal stay lengths and expected readmission rates.,3.316036182995957e-07,0.2575301984371303,0.01753826530612245,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
99,0.5,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Is the quality of care compromised by earlier discharge from Winnipeg hospitals? Reducing length of hospital stay to enhance efficiency does not seem to raise readmission or physician visit rates within 30 days after discharge. Additional research is needed to determine optimal lengths of stay and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.5,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does earlier discharge from Winnipeg hospitals lead to poorer quality of care? Improving efficiency by shortening hospital stays does not appear to increase readmissions or physician visits within 30 days post-discharge. Research is required to identify optimal stay durations and expected readmission rates.,3.552895910352811e-07,0.28106069584732474,0.01753826530612245,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
99,0.5,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Does discharging patients sooner from Winnipeg hospitals negatively affect care quality? Enhancing hospital efficiency by reducing length of stay does not seem to increase readmission rates or physician visits within 30 days after discharge. Further research is necessary to establish optimal lengths of stay and expected readmission rates.,2.3685972735685406e-07,0.1980783371253132,0.003728275336599654,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
100,0.5,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect on sleep bruxism? Yes, sleep bruxism does exhibit a 'first night effect,' characterized by an increase in bruxism episodes during the initial night in a new setting, often caused by elevated arousal and anxiety, leading to more teeth grinding or clenching.",2.1317375462116866e-07,0.1282810847026532,0.03631185475258099,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
100,0.5,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism show a first night effect? Indeed, there is a 'first night effect' in sleep bruxism, where bruxism events increase on the first night sleeping in an unfamiliar environment, typically due to higher arousal and anxiety, resulting in more teeth grinding or clenching.",2.6054570009253947e-07,0.2042395372989385,0.013596873681731878,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
100,0.5,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism affected by a first night effect? Yes, the 'first night effect' in sleep bruxism means that bruxism occurrences rise during the first night in a new place, usually because of increased arousal and anxiety, which causes more teeth grinding or clenching.",2.8423167282822487e-07,0.26020117299213386,0.010089097061815218,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
100,0.5,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does the first night effect influence sleep bruxism? Yes, there is a 'first night effect' on sleep bruxism, marked by an uptick in bruxism episodes on the first night in a novel environment, generally due to heightened arousal and anxiety, leading to more teeth grinding or clenching.",2.1317375462116866e-07,0.18855475257743093,0.007076574999485136,0.016320838183036854,0.21312809815217548,0.02221074380165289,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
100,0.5,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect impacting sleep bruxism? Yes, sleep bruxism experiences a 'first night effect,' where the number of bruxism events goes up during the first night in an unfamiliar setting, often linked to increased arousal and anxiety, causing more teeth grinding or clenching.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
100,0.5,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Can sleep bruxism be influenced by a first night effect? Yes, the 'first night effect' causes an increase in sleep bruxism episodes during the initial night in a new environment, usually because of elevated arousal and anxiety, resulting in more teeth grinding or clenching.",2.8423167282822487e-07,0.22796176924515965,0.013069224367093464,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
100,0.5,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is the first night effect present in sleep bruxism? Yes, sleep bruxism shows a 'first night effect,' which is an increase in bruxism events on the first night in a different environment, typically due to heightened arousal and anxiety, leading to more teeth grinding or clenching.",2.3685972735685406e-07,0.2118730741378676,0.008036441623838694,0.018134264647818726,0.2363011026714661,0.02271498107084911,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
100,0.5,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism have a first night effect? Yes, there is a 'first night effect' characterized by increased bruxism activity during the first night in a new environment, often caused by increased arousal and anxiety, resulting in more teeth grinding or clenching.",3.316036182995957e-07,0.3109745296640196,0.012340347745775346,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
100,0.5,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is a first night effect observed in sleep bruxism? Yes, sleep bruxism demonstrates a 'first night effect,' meaning bruxism events rise on the first night in an unfamiliar setting, usually due to elevated arousal and anxiety, which leads to more teeth grinding or clenching.",2.8423167282822487e-07,0.22796176924515965,0.013069224367093464,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
100,0.5,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there an impact of the first night effect on sleep bruxism? Yes, the 'first night effect' leads to more frequent bruxism episodes during the first night in a new environment, typically because of increased arousal and anxiety, causing more teeth grinding or clenching.",2.8423167282822487e-07,0.26020117299213386,0.010089097061815218,0.02176111757738247,0.284321436878999,0.023795359904818555,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
101,0.5,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Grandmultiparous women experienced higher maternal and neonatal morbidity and neonatal mortality rates, even after adjusting for confounding factors, indicating the necessity for more intensive monitoring compared to regular multiparous patients during labor and delivery.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,0.5,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Even when controlling for confounders, grandmultiparous women showed elevated maternal and neonatal morbidity and neonatal mortality, suggesting they require closer observation than typical multiparous women during labor and delivery.",7.1057918207056e-08,0.07865527994541788,0.0019215668371073726,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
101,0.5,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for negative perinatal results? Grandmultiparous women had greater maternal and neonatal health complications and neonatal death rates despite controlling for confounders, implying the need for heightened surveillance compared to regular multiparous patients during childbirth.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.5,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with higher risk of adverse perinatal outcomes? After adjusting for confounding variables, grandmultiparous women still exhibited increased maternal and neonatal morbidity and neonatal mortality, indicating a need for more careful monitoring than usual multiparous women during labor and delivery.",2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.5,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does being grandmultiparous independently contribute to adverse perinatal outcomes? Grandmultiparous women had increased rates of maternal and neonatal morbidity and neonatal mortality even after accounting for confounders, suggesting they require closer monitoring than standard multiparous patients during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.5,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of adverse perinatal outcomes? Grandmultiparous women showed higher maternal and neonatal morbidity and neonatal mortality rates after controlling for confounding factors, highlighting the need for more vigilant observation compared to regular multiparous women during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.5,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a distinct risk factor for negative perinatal outcomes? Even after adjusting for confounders, grandmultiparous women experienced increased maternal and neonatal morbidity and neonatal mortality, indicating a need for enhanced monitoring relative to regular multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019166,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.5,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently linked to adverse perinatal outcomes? Grandmultiparous women had elevated maternal and neonatal morbidity and neonatal mortality despite controlling for confounders, suggesting closer observation than typical multiparous women during labor and delivery is necessary.",1.421158364141119e-07,0.1640203579443158,0.0041717128027681585,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
101,0.5,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently elevate the risk of adverse perinatal outcomes? After controlling for confounding variables, grandmultiparous women still faced increased maternal and neonatal morbidity and neonatal mortality, implying the need for more intensive monitoring than regular multiparous patients during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.5,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Grandmultiparous women showed increased maternal and neonatal morbidity and neonatal mortality even after adjusting for confounders, indicating they should be observed more closely than usual multiparous women during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
102,0.5,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors adequately addressing the needs of family members who care for frail elderly individuals? Various reasons for dissatisfaction are discussed. Physicians might lack interest in assisting caregivers; even if they are open to advising caregivers, they might receive insufficient compensation for the typical counseling sessions caregivers require; moreover, acting as a professional caregiver to family caregivers is challenging on its own.",2.3685972735685406e-08,0.00609906559789497,0.016124697661918846,0.0018134264647818726,0.01652930195121094,0.0,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
102,0.5,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians fulfill the requirements of family caregivers for the frail elderly? Several hypotheses explaining this dissatisfaction are offered. Doctors may be uninterested in supporting caregivers; even if willing to counsel them, they might be poorly paid for the usual types of counseling sessions caregivers need; additionally, serving as a professional caregiver to family caregivers is demanding.",1.4211583641411244e-07,0.12893362073740544,0.019540597262635323,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
102,0.5,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are medical professionals meeting the needs of family caregivers who look after frail elderly patients? Theories for this dissatisfaction are proposed. Physicians may show little interest in helping caregivers; even if they are willing to provide counseling, they might not be adequately compensated for the typical counseling sessions given to caregivers; furthermore, being a professional caregiver to family caregivers is itself a demanding role.",2.3685972735685406e-08,0.016355255417392023,0.0002558110854360071,0.0018134264647818726,0.016260520871781203,0.0,0.0018108015409528666,0.01652930195121094,0.0,2.3685972735685406e-08,0.01680711831638071,0.0
102,0.5,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians adequately meet the needs of family caregivers of frail elderly individuals? Hypotheses explaining this dissatisfaction are presented. Physicians might be disinterested in assisting caregivers; even if they are open to counseling, they might receive poor remuneration for the common counseling sessions caregivers undergo; and being a professional caregiver to family caregivers is a demanding job.",1.4211583641411244e-07,0.10417836428883565,0.0017265420075026454,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
102,0.5,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors addressing the needs of family caregivers of the frail elderly? Possible reasons for this dissatisfaction are discussed. Physicians may lack interest in aiding caregivers; even if they are receptive to counseling, they might be underpaid for the usual counseling sessions caregivers require; and acting as a professional caregiver to family caregivers is demanding in itself.",1.4211583641411244e-07,0.10417836428883565,0.0017265420075026454,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
102,0.5,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians fulfilling the needs of family caregivers of frail elderly patients? Hypotheses for this dissatisfaction are offered. Doctors may be uninterested in assisting caregivers; even if they are willing to counsel caregivers, they may receive inadequate compensation for typical caregiver counseling sessions; and being a professional caregiver to family caregivers is itself challenging.",2.1317375462116866e-07,0.1606393824029153,0.0027362490836432864,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
102,0.5,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians adequately support family caregivers of the frail elderly? Possible explanations for dissatisfaction are presented. Physicians might not be interested in helping caregivers; even if they are receptive to counseling, they may be poorly compensated for the usual counseling sessions caregivers need; and being a professional caregiver to family caregivers is demanding.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
102,0.5,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are medical doctors meeting the needs of family caregivers for frail elderly individuals? Hypotheses for this discontent are discussed. Physicians may be uninterested in assisting caregivers; even if they are willing to provide counseling, they might be poorly paid for the standard counseling sessions caregivers typically receive; and being a professional caregiver to family caregivers is demanding.",1.4211583641411244e-07,0.10417836428883565,0.0017265420075026454,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
102,0.5,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians meet the needs of family caregivers caring for frail elderly patients? Reasons for this dissatisfaction are presented. Physicians may lack interest in supporting caregivers; even if they are open to counseling, they may receive insufficient remuneration for typical caregiver counseling sessions; and serving as a professional caregiver to family caregivers is demanding.",2.1317375462116866e-07,0.1606393824029153,0.0027362490836432864,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
102,0.5,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors meeting the requirements of family caregivers of frail elderly individuals? Hypotheses explaining this dissatisfaction are offered. Physicians might be uninterested in helping caregivers; even if they are receptive to counseling, they might be poorly compensated for the usual counseling sessions caregivers attend; and being a professional caregiver to family caregivers is challenging.",2.1317375462116866e-07,0.18679587978253576,0.021553118562610177,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
103,0.5,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Studies suggest that airway surgery may improve serum lipid profiles in obstructive sleep apnea patients, but more research is needed to confirm this due to influencing factors such as lifestyle and postoperative conditions.",1.6580180914979784e-07,0.15702233205192728,0.008850478967097022,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
103,0.5,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery lower serum lipid levels in individuals with obstructive sleep apnea? Evidence points to the possibility that airway surgery improves serum lipid levels, though definitive conclusions await further study considering lifestyle and postoperative influences.",4.026615365066514e-07,0.3951339568935963,0.0005430856212727611,0.030828249901291842,0.4054651081081633,0.0,0.030783626196198746,0.4155154439616653,0.0,4.026615365066519e-07,0.42608439531090037,0.0
103,0.5,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there an effect of airway surgery on serum lipid levels in obstructive sleep apnea patients? Research shows airway surgery might enhance serum lipid profiles in these patients, but additional investigation is necessary due to factors like lifestyle and postoperative care.",2.8423167282822487e-07,0.25170046168964566,0.007614555800272531,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
103,0.5,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does undergoing airway surgery affect serum lipid levels in obstructive sleep apnea sufferers? Findings indicate a potential improvement in serum lipid profiles post-surgery, yet more research is required because of variables like patient lifestyle and recovery.",4.026615365066514e-07,0.35552554657588553,0.028929338842379707,0.030828249901291842,0.4054651081081633,0.0,0.030783626196198746,0.4155154439616653,0.0,4.026615365066519e-07,0.42608439531090037,0.0
103,0.5,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery lead to lower serum lipid levels in obstructive sleep apnea patients? Research suggests a possible positive impact on serum lipid profiles, but further studies are essential as outcomes may be affected by lifestyle and postoperative factors.",3.316036182995955e-07,0.2701604685769876,0.031179484808040493,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
103,0.5,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is airway surgery effective in reducing serum lipid levels among obstructive sleep apnea patients? Studies indicate it might improve lipid profiles, but a conclusive answer demands more research, considering lifestyle and postoperative influences.",4.737194547137073e-07,0.4055292949478613,0.057476051645147866,0.03626852929563748,0.49783842823917857,0.0,0.03621603081905737,0.5108256237659905,0.0,4.737194547137081e-07,0.5245244681241537,0.0
103,0.5,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? There is evidence suggesting improvement in serum lipid profiles, but a firm conclusion is pending further research due to lifestyle and postoperative variables.",3.789755637709661e-07,0.3262544359892523,0.029720949604331536,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
103,0.5,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery improve serum lipid levels in patients with obstructive sleep apnea? Research suggests it may, although definitive conclusions require more investigation because of factors such as patient lifestyle and postoperative recovery.",4.737194547137073e-07,0.4055292949478613,0.057476051645147866,0.03626852929563748,0.49783842823917857,0.0,0.03621603081905737,0.5108256237659905,0.0,4.737194547137081e-07,0.5245244681241537,0.0
103,0.5,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there a link between airway surgery and serum lipid level reduction in obstructive sleep apnea patients? Studies imply airway surgery could enhance serum lipid profiles, but further research is needed given the impact of lifestyle and postoperative factors.",3.316036182995955e-07,0.3066418991327744,0.005006915842678726,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
103,0.5,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery have an effect on serum lipid levels in obstructive sleep apnea patients? Research indicates a potential benefit in lipid profiles, yet more research is necessary to confirm this due to influences like lifestyle and postoperative care.",3.316036182995955e-07,0.23367903802120127,0.057476051645147866,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
104,0.5,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the use of audits to identify maternal mortality simply a distinction between wealthy and impoverished areas? No, auditing maternal mortality transcends the divide between rich and poor. Although resources and healthcare access impact maternal mortality rates, audits also reveal factors such as care quality, medical protocols, cultural beliefs, and education, influencing these rates in various contexts.",3.552895910352811e-07,0.1521358150477412,0.05595977741340878,0.027201396971728117,0.18174944134032067,0.042771218534194695,0.027162023114293,0.20494001278313068,0.028959679215860994,3.552895910352811e-07,0.2288291098428128,0.014702606371129419
104,0.5,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Does auditing maternal mortality only differ between affluent and poor regions? No, the identification of maternal mortality through audits is not solely about economic status. While resource availability and healthcare access play roles, audits also uncover elements like care quality, medical practices, cultural norms, and education that affect maternal mortality across different environments.",4.500334819780227e-07,0.23077103564377577,0.05026210937500003,0.03445510283085561,0.25725699384846656,0.042771218534194695,0.034405229278104466,0.28190105391926057,0.028959679215860994,4.500334819780227e-07,0.30730072528430696,0.014702606371129419
104,0.5,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the application of audits to detect maternal mortality merely a contrast between rich and poor settings? No, audits for maternal mortality identification go beyond economic disparities. Though resources and healthcare access matter, audits also bring to light issues like quality of care, medical standards, cultural perspectives, and education affecting maternal mortality in diverse settings.",4.026615365066519e-07,0.19068324550565485,0.05321832239275147,0.030828249901291863,0.21879071302067077,0.042771218534194695,0.030783626196198732,0.2426803407659781,0.028959679215860994,4.026615365066519e-07,0.2672953906706086,0.014702606371129419
104,0.5,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is using audits to identify maternal mortality just a matter of distinguishing between wealthy and poor areas? No, audits do more than highlight economic differences. While access to resources and healthcare influences maternal mortality rates, audits also expose factors including care quality, medical procedures, cultural attitudes, and education levels that impact rates across various settings.",4.026615365066519e-07,0.15532134726705404,0.11015018342270382,0.030828249901291863,0.21879071302067077,0.042771218534194695,0.030783626196198732,0.2426803407659781,0.028959679215860994,4.026615365066519e-07,0.2672953906706086,0.014702606371129419
104,0.5,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Does auditing maternal mortality reflect only the difference between rich and poor environments? No, the use of audits to identify maternal mortality is not limited to economic contrasts. Besides resource availability and healthcare, audits reveal other influences such as quality of care, medical practices, cultural values, and education affecting maternal mortality in different contexts.",4.263475092423373e-07,0.2105269637260565,0.05176860687596116,0.032641676366073735,0.23783890799136387,0.042771218534194695,0.0325944277371516,0.2620984266230808,0.028959679215860994,4.263475092423373e-07,0.28709801796678835,0.014702606371129419
104,0.5,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the identification of maternal mortality through audits merely a difference between rich and poor settings? No, audits reveal more than just economic disparities. Although healthcare access and resources are factors, audits also highlight quality of care, medical protocols, cultural attitudes, and education, all of which influence maternal mortality across different settings.",4.737194547137081e-07,0.21398988568338684,0.10906210937500001,0.03626852929563748,0.27705962114464633,0.042771218534194695,0.03621603081905733,0.3021037612367792,0.028959679215860994,4.737194547137081e-07,0.3279200124870427,0.014702606371129419
104,0.5,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is auditing maternal mortality just about the contrast between wealthy and poor settings? No, the process involves more than economic status. While resources and healthcare access affect maternal mortality, audits also identify factors like care quality, medical practices, cultural beliefs, and education levels that impact rates in diverse environments.",5.447773729207643e-07,0.24743226512492145,0.128662109375,0.0417088086899831,0.33893502486273386,0.042771218534194695,0.04164843544191593,0.36528266285831146,0.028959679215860994,5.447773729207643e-07,0.39245853362461425,0.014702606371129419
104,0.5,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Does the use of audits to identify maternal mortality only reflect the difference between rich and poor areas? No, audits go beyond economic distinctions. Besides resource availability and healthcare access, they uncover factors such as quality of care, medical standards, cultural attitudes, and education influencing maternal mortality across various settings.",5.210914001850789e-07,0.25510469957769377,0.10826280381944445,0.039895382225201226,0.3178816156649007,0.042771218534194695,0.039837633900963065,0.3437764576373481,0.028959679215860994,5.210914001850789e-07,0.37047962690583924,0.014702606371129419
104,0.5,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the role of audits in identifying maternal mortality confined to differences between rich and poor settings? No, audits highlight more than just economic factors. While resources and healthcare access contribute, audits also reveal quality of care, medical practices, cultural perspectives, and education levels affecting maternal mortality in diverse settings.",5.210914001850789e-07,0.25510469957769377,0.10826280381944445,0.039895382225201226,0.3178816156649007,0.042771218534194695,0.039837633900963065,0.3437764576373481,0.028959679215860994,5.210914001850789e-07,0.37047962690583924,0.014702606371129419
104,0.5,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is auditing maternal mortality simply a matter of rich versus poor environments? No, audits encompass more than economic differences. Although resource availability and healthcare access impact maternal mortality, audits also expose factors like care quality, medical protocols, cultural attitudes, and education that influence rates across different settings.",5.921493183921352e-07,0.28999187954371797,0.128662109375,0.045335661619546844,0.3824201368024722,0.042771218534194695,0.045270038523821665,0.4097344254291442,0.028959679215860994,5.921493183921352e-07,0.4379209077013715,0.014702606371129419
105,0.5,1,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","How is gender dimorphism characterized after injury and hemorrhagic shock, and are hormonal differences the cause?",1.0895547458415264e-06,1.3119191148009435,0.0652508464142813,0.08341761737996628,1.4321823265881766,0.016661878770468257,0.08329687088383202,1.5125880864441816,0.0,1.0895547458415283e-06,1.5755363607584183,0.0
105,0.5,2,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Does hormonal variation explain the gender dimorphism observed after injury and hemorrhagic shock?,1.1606126640485824e-06,1.5350626661151532,0.0652508464142813,0.0888578967743119,1.6733443834050643,0.016661878770468257,0.08872927550669063,1.7749523509116734,0.0,1.1606126640485843e-06,1.8632184332101995,0.0
105,0.5,3,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",What role do hormonal differences play in the gender dimorphism seen following injury and hemorrhagic shock?,1.0895547458415264e-06,1.3119191148009435,0.0652508464142813,0.08341761737996628,1.4321823265881766,0.016661878770468257,0.08329687088383202,1.5125880864441816,0.0,1.0895547458415283e-06,1.5755363607584183,0.0
105,0.5,4,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Is the gender dimorphism after injury and hemorrhagic shock attributable to hormonal differences?,1.1606126640485824e-06,1.5350626661151532,0.0652508464142813,0.0888578967743119,1.6733443834050643,0.016661878770468257,0.08872927550669063,1.7749523509116734,0.0,1.1606126640485843e-06,1.8632184332101995,0.0
105,0.5,5,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Are hormonal factors responsible for the gender dimorphism observed post-injury and hemorrhagic shock?,1.1606126640485824e-06,1.5350626661151532,0.0652508464142813,0.0888578967743119,1.6733443834050643,0.016661878770468257,0.08872927550669063,1.7749523509116734,0.0,1.1606126640485843e-06,1.8632184332101995,0.0
105,0.5,6,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",To what extent do hormonal differences account for gender dimorphism after injury and hemorrhagic shock?,1.1132407185772118e-06,1.3809119862878956,0.0652508464142813,0.08523104384474815,1.5062902987418978,0.016661878770468257,0.08510767242478488,1.592630794117718,0.0,1.1132407185772135e-06,1.6625477377480484,0.0
105,0.5,7,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Can hormonal disparities explain the gender dimorphism following injury and hemorrhagic shock?,1.1842986367842678e-06,1.6220740431047833,0.0652508464142813,0.09067132323909377,1.7686545632093895,0.016661878770468257,0.09054007704764351,1.8803128665694993,0.0,1.1842986367842697e-06,1.9810014688665833,0.0
105,0.5,8,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Are the observed gender differences after injury and hemorrhagic shock linked to hormonal variations?,1.136926691312897e-06,1.4550199584416168,0.0652508464142813,0.08704447030953003,1.5863330064154342,0.016661878770468257,0.08691847396573776,1.6796421711073481,0.0,1.1369266913128989e-06,1.7578579175523736,0.0
105,0.5,9,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",Is there a connection between hormonal differences and gender dimorphism after injury and hemorrhagic shock?,1.1132407185772118e-06,1.3809119862878956,0.0652508464142813,0.08523104384474815,1.5062902987418978,0.016661878770468257,0.08510767242478488,1.592630794117718,0.0,1.1132407185772135e-06,1.6625477377480484,0.0
105,0.5,10,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.",How do hormonal differences influence gender dimorphism after injury and hemorrhagic shock?,1.1842986367842678e-06,1.6220740431047833,0.0652508464142813,0.09067132323909377,1.7686545632093895,0.016661878770468257,0.09054007704764351,1.8803128665694993,0.0,1.1842986367842697e-06,1.9810014688665833,0.0
106,0.5,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The programs have had a notable effect on multiple levels; graduates are seen as valuable contributors to their workplaces and frequently hold influence nationally. The described impact aligns well with public health education goals. Qualitative research provided deeper insights into graduates' influence and career trajectories.,2.6054570009253947e-07,0.16833531481921682,0.0,0.019947691112600627,0.17095779814363965,0.0,0.019918816950481533,0.17366349405084325,0.0,2.6054570009253947e-07,0.17645643734155847,0.0
106,0.5,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs contribute to health system strengthening in low- and middle-income countries? The impact is significant across various levels; graduates are recognized for their substantial contributions at work and often possess national-level influence. Much of the observed impact corresponds with public health education objectives. Qualitative studies offered a more detailed understanding of graduates' effects and career paths.,3.079176455639103e-07,0.20223686649489725,0.0,0.023574544042164372,0.2054439742148082,0.0,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
106,0.5,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,"What is the role of MPH programs in enhancing health systems in low- and middle-income countries? There is considerable impact at many levels, with graduates perceived as key contributors to their workplaces and often influential at the national level. The impact largely aligns with the goals of public health education. Qualitative methods revealed deeper insights into the graduates' impact and career development.",2.3685972735685406e-07,0.15180601286800588,0.0,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
106,0.5,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How have MPH programs influenced health system strengthening in low- and middle-income countries? The influence is substantial across multiple levels; graduates are viewed as making significant contributions to their workplaces and frequently have national influence. The impact aligns with public health educational aims. Qualitative research provided a deeper understanding of graduates' impact and career progression.,4.026615365066519e-07,0.27369583047704094,0.0,0.030828249901291863,0.2782033284972374,0.0,0.030783626196198732,0.28286278601583437,0.0,4.026615365066519e-07,0.28768207245178345,0.0
106,0.5,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What impact do MPH programs have on health systems in low- and middle-income countries? There is considerable influence at various levels; graduates are regarded as significant contributors to their workplaces and often have national-level impact. The impact described matches public health education goals. Qualitative studies gave an in-depth view of graduates' influence and career paths.,4.026615365066519e-07,0.27369583047704094,0.0,0.030828249901291863,0.2782033284972374,0.0,0.030783626196198732,0.28286278601583437,0.0,4.026615365066519e-07,0.28768207245178345,0.0
106,0.5,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,In what ways do MPH programs strengthen health systems in low- and middle-income countries? The programs have a considerable impact on many levels; graduates are perceived as valuable contributors to their workplaces and often hold influence nationally. The impact described aligns with public health educational objectives. Qualitative methods revealed more detailed insights into graduates' impact and careers.,3.552895910352811e-07,0.2373281863061667,0.0,0.027201396971728117,0.2411620568168873,0.0,0.027162023114293,0.24512245803298693,0.0,3.552895910352811e-07,0.24921579162398766,0.0
106,0.5,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the effect of MPH programs on health system strengthening in low- and middle-income countries? The impact is notable at many levels; graduates are seen as significant contributors to their workplaces and often influential nationally. Much of the impact corresponds with public health education goals. Qualitative research provided deeper understanding of graduates' impact and career development.,3.552895910352811e-07,0.2620834427547365,0.017851239669421492,0.027201396971728117,0.2411620568168873,0.0,0.027162023114293,0.24512245803298693,0.0,3.552895910352811e-07,0.24921579162398766,0.0
106,0.5,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How do MPH programs affect health system strengthening in low- and middle-income countries? There is considerable impact at multiple levels; graduates are perceived as important contributors to their workplaces and often have national influence. The impact largely aligns with public health educational aims. Qualitative studies offered more in-depth insights into graduates' impact and career trajectories.,4.026615365066519e-07,0.27369583047704094,0.0,0.030828249901291863,0.2782033284972374,0.0,0.030783626196198732,0.28286278601583437,0.0,4.026615365066519e-07,0.28768207245178345,0.0
106,0.5,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What contribution do MPH programs make to health system strengthening in low- and middle-income countries? The impact is significant across many levels; graduates are regarded as key contributors to their workplaces and often have national-level influence. The described impact is consistent with public health education goals. Qualitative methods revealed deeper understanding of graduates' influence and careers.,3.789755637709665e-07,0.28055204382920707,0.0181755829903978,0.02901482343650999,0.25951119548508306,0.0,0.028972824655245866,0.26381459104514127,0.0,3.789755637709665e-07,0.26826398659468076,0.0
106,0.5,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How significant is the impact of MPH programs on health system strengthening in low- and middle-income countries? There is considerable influence at various levels; graduates are perceived as making meaningful contributions to their workplaces and often hold national influence. The impact aligns with public health educational aims. Qualitative research provided more detailed insights into graduates' impact and career paths.,3.079176455639103e-07,0.2261384934107573,0.017236072637734686,0.023574544042164372,0.2054439742148082,0.0,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
107,0.5,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can neoadjuvant chemotherapy alter the scope of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged by neoadjuvant chemotherapy, with clinical non-responders exhibiting more affected lymph nodes. Therefore, a thorough and systemic lymphadenectomy is recommended for patients undergoing neoadjuvant chemotherapy followed by surgery, irrespective of their response to the chemotherapy.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
107,0.5,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it possible to adjust the extent of lymphadenectomy based on neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not affect the frequency or distribution of lymph node metastases, and patients who do not respond clinically have more involved lymph nodes. Consequently, an extensive and systemic lymphadenectomy should be conducted in patients treated with neoadjuvant chemotherapy plus surgery, regardless of their therapeutic response.",1.8948778188548325e-07,0.11066379715023089,0.04704362960325939,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
107,0.5,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer? The rate and anatomical spread of lymph node metastases are not altered by neoadjuvant chemotherapy, and clinical non-responders tend to have more lymph nodes involved. Hence, a comprehensive systemic lymphadenectomy is advised for patients receiving neoadjuvant chemotherapy and surgery, no matter their response to treatment.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
107,0.5,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer patients? The frequency and topographic distribution of lymph node metastases remain unaffected by neoadjuvant chemotherapy, with clinical non-responders showing a higher number of involved lymph nodes. A systemic and extensive lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy plus surgery, regardless of their response to the chemotherapy.",1.1842986367842703e-07,0.0907290005447079,0.0015678118024745405,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
107,0.5,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? Neoadjuvant chemotherapy does not modify the frequency or location of lymph node metastases, and patients who do not respond clinically have more involved lymph nodes. Therefore, systemic and extensive lymphadenectomy is necessary for patients treated with neoadjuvant chemotherapy and surgery, irrespective of the response.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
107,0.5,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can the scope of lymphadenectomy be altered by neoadjuvant chemotherapy in cases of cervical cancer? The occurrence and distribution pattern of lymph node metastases are not changed by neoadjuvant chemotherapy, and non-responders clinically show more lymph node involvement. As a result, a systemic and thorough lymphadenectomy should be carried out in patients treated with neoadjuvant chemotherapy plus surgery regardless of their response.",1.6580180914979784e-07,0.07938352420493455,0.030536825534029612,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
107,0.5,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy affect the extent of lymphadenectomy in cervical cancer? The frequency and anatomical distribution of lymph node metastases are not influenced by neoadjuvant chemotherapy, and clinical non-responders have more involved lymph nodes. Hence, a systemic and extensive lymphadenectomy is recommended for patients undergoing neoadjuvant chemotherapy and surgery, regardless of their response.",4.737194547137081e-08,0.03872771712894396,0.0007114496724635287,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
107,0.5,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it feasible to modify lymphadenectomy extent by neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not alter the frequency or topographic distribution of lymph node metastases, with clinical non-responders exhibiting more involved lymph nodes. Thus, systemic and extensive lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy plus surgery irrespective of response.",2.3685972735685406e-08,0.05520561645900246,0.058381576546742656,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
107,0.5,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could the extent of lymphadenectomy be influenced by neoadjuvant chemotherapy in cervical cancer treatment? The frequency and distribution of lymph node metastases remain unchanged despite neoadjuvant chemotherapy, and clinical non-responders show increased lymph node involvement. Therefore, a systemic and comprehensive lymphadenectomy is necessary in patients treated with neoadjuvant chemotherapy and surgery, regardless of their response.",0.0,0.025672117798516414,0.018470322568413872,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
107,0.5,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is the extent of lymphadenectomy in cervical cancer patients affected by neoadjuvant chemotherapy? The frequency and topographic distribution of lymph node metastases are not modified by neoadjuvant chemotherapy, and those who do not respond clinically have more involved lymph nodes. Consequently, a systemic and extensive lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy plus surgery, regardless of response.",1.1842986367842703e-07,0.0907290005447079,0.0015678118024745405,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
108,0.5,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are doctors effectively addressing the needs of family caregivers for frail elderly patients? While some physicians do meet these needs, it is not uniformly the case. Constraints such as limited appointment time, insufficient resources, and knowledge gaps hinder their capacity to fully support caregivers. Improvements in training and policy are necessary.",2.8423167282822487e-07,0.10331344726856706,0.08002462296091106,0.02176111757738247,0.1508751548600662,0.049048751486325794,0.0217296184914344,0.17693373927687928,0.033293697978596916,2.8423167282822487e-07,0.20389332760040846,0.01694411414982164
108,0.5,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians adequately support family caregivers of the frail elderly? Although some physicians manage to meet these needs, this is not consistent. Factors like time restrictions during visits, lack of resources, and knowledge deficiencies limit their ability to assist caregivers fully. Enhanced training and policy reform are needed.",3.552895910352811e-07,0.1651888509866546,0.08002462296091106,0.02720139697172809,0.21405405648159848,0.049048751486325794,0.027162023114293,0.2414722604144508,0.033293697978596916,3.552895910352811e-07,0.26985129539220454,0.01694411414982164
108,0.5,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are medical professionals fulfilling the needs of family caregivers for frail elderly individuals? Some physicians address these needs well, but this is not always consistent. Challenges including limited time in consultations, resource shortages, and knowledge gaps reduce their ability to support caregivers comprehensively. Training and policy updates are essential.",3.316036182995957e-07,0.14413544178882143,0.08002462296091106,0.025387970506946217,0.19254785126063512,0.049048751486325794,0.025351221573340132,0.2194933536956758,0.033293697978596916,3.316036182995957e-07,0.24737843954014682,0.01694411414982164
108,0.5,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are family caregivers of the frail elderly receiving adequate support from physicians? While certain physicians do meet their needs, this is not consistent across all cases. Time constraints during appointments, inadequate resources, and knowledge limitations can impede their support. There is a need for improved training and policy changes.",3.316036182995957e-07,0.14413544178882143,0.08002462296091106,0.025387970506946217,0.19254785126063512,0.049048751486325794,0.025351221573340132,0.2194933536956758,0.033293697978596916,3.316036182995957e-07,0.24737843954014682,0.01694411414982164
108,0.5,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians meeting the expectations of family caregivers caring for frail elderly patients? Some do, but consistency is lacking. Obstacles such as brief appointment times, resource inadequacies, and gaps in knowledge restrict their support capabilities. Policy reforms and better training are required.",4.974054274493935e-07,0.3017643859924046,0.08002462296091106,0.038081955760419325,0.35381599885675685,0.049048751486325794,0.0380268323600102,0.3845731040551259,0.033293697978596916,4.974054274493935e-07,0.4164547695840799,0.01694411414982164
108,0.5,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do doctors meet the needs of family caregivers for the frail elderly? Although some physicians provide adequate support, this is not consistent. Limited time during appointments, lack of resources, and knowledge gaps hinder their ability to fully assist caregivers. Training improvements and policy adjustments are necessary.",4.026615365066519e-07,0.20867396292639295,0.08002462296091106,0.030828249901291835,0.2585058190524312,0.049048751486325794,0.030783626196198732,0.28693463449120804,0.033293697978596916,4.026615365066519e-07,0.3163713110270985,0.01694411414982164
108,0.5,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are the needs of family caregivers of frail elderly patients being met by physicians? Some physicians do meet these needs, but not consistently. Challenges like time limitations, resource scarcity, and knowledge gaps can limit their support. Enhanced training and policy changes are needed.",4.737194547137081e-07,0.2776668344133446,0.08002462296091106,0.03626852929563745,0.32912338626638515,0.049048751486325794,0.03621603081905733,0.3592552960708342,0.033293697978596916,4.737194547137081e-07,0.3904792831808219,0.01694411414982164
108,0.5,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians adequately addressing the needs of family caregivers for the frail elderly? While some do, this is not consistent across the board. Constraints such as limited appointment time, inadequate resources, and knowledge gaps can restrict their support. Training and policy improvements are required.",4.500334819780227e-07,0.2541363370031502,0.08002462296091106,0.03445510283085558,0.30502583468732514,0.049048751486325794,0.034405229278104466,0.3345626834804625,0.033293697978596916,4.500334819780227e-07,0.3651614751965302,0.01694411414982164
108,0.5,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are family caregivers of frail elderly individuals receiving sufficient support from physicians? Some physicians meet these needs well, but this is not consistent. Time limitations during appointments, insufficient resources, and knowledge gaps can hinder their assistance. Policy changes and better training are necessary.",4.737194547137081e-07,0.2776668344133446,0.08002462296091106,0.03626852929563745,0.32912338626638515,0.049048751486325794,0.03621603081905733,0.3592552960708342,0.033293697978596916,4.737194547137081e-07,0.3904792831808219,0.01694411414982164
108,0.5,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians fulfilling the needs of family caregivers caring for frail elderly patients? Some do so adequately, but this is not always consistent. Challenges include limited time during appointments, inadequate resources, and knowledge gaps that restrict their support. Training enhancements and policy reforms are needed.",4.263475092423373e-07,0.23114681877845067,0.08002462296091106,0.03264167636607371,0.2814953372771307,0.049048751486325794,0.0325944277371516,0.31046513190140246,0.033293697978596916,4.263475092423373e-07,0.3404688626061585,0.01694411414982164
109,0.5,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain linked to a decline in health-related quality of life six months later? Our findings indicate that neck pain negatively affects physical health-related quality of life but does not impact mental health. This suggests that neck pain could be a factor leading to poorer physical HRQoL over time. Increasing awareness about the potential future effects of neck pain is important.,1.4211583641411244e-07,0.03206659309587323,0.11244132123921938,0.010880558788691236,0.0617179154003491,0.03134956989257915,0.0108648092457172,0.08374901575834537,0.01694411414982164,1.4211583641411244e-07,0.10919929196499112,0.0
109,0.5,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does neck pain correlate with worse health-related quality of life after six months? We discovered that neck pain is associated with reduced physical, but not mental, health-related quality of life. This implies that neck pain might contribute to future declines in physical HRQoL within the population. It's crucial to raise awareness about the possible long-term consequences of neck pain.",7.105791820705622e-08,0.03491518170991581,0.011679928674364515,0.005440279394345618,0.031097431661075703,0.01652939636175342,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
109,0.5,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is there an association between neck pain and diminished health-related quality of life six months later? Our study shows neck pain is linked to poorer physical health-related quality of life, though it does not affect mental health-related quality of life. These results suggest neck pain may lead to future physical HRQoL decline. Educating people about the potential future impact of neck pain is essential.",1.8948778188548325e-07,0.031483448082854526,0.19462012385573266,0.014507411718254981,0.08830421068055472,0.06364837281242658,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
109,0.5,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Does neck pain result in worse health-related quality of life after six months? We found a negative relationship between neck pain and physical HRQoL, but no significant effect on mental HRQoL. This analysis suggests neck pain could be a predictor of future physical health quality decline. Raising awareness about neck pain's potential future effects is important.",0.0,0.05041070404072334,0.037447874814421564,0.0,0.025672117798516858,0.018511925952296185,0.0,0.0,0.0,0.0,0.0,0.0
109,0.5,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain associated with a decline in health-related quality of life six months later? The data revealed neck pain adversely affects physical HRQoL but not mental HRQoL. This suggests neck pain may contribute to poorer physical health outcomes in the future. It's important to increase awareness about the possible long-term impact of neck pain.,2.3685972735685406e-08,0.03095185599003436,0.03605179164135776,0.0018134264647818726,0.006979984786362525,0.018511925952296185,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
109,0.5,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Is neck pain linked to poorer health-related quality of life six months later? Our findings highlight a negative association between neck pain and physical, but not mental, HRQoL. This indicates neck pain might be a factor in future physical HRQoL deterioration. Raising awareness about the potential future consequences of neck pain is necessary.",7.105791820705622e-08,0.052392483734148954,0.0684294526133783,0.005440279394345618,0.03148629604143327,0.018511925952296185,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
109,0.5,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Does neck pain predict worse health-related quality of life after six months? We observed that neck pain negatively impacts physical HRQoL without affecting mental HRQoL. This suggests neck pain could contribute to future declines in physical health quality. It's important to inform people about the possible future effects of neck pain.,1.1842986367842703e-07,0.05089190642906427,0.029898356401384066,0.009067132323909363,0.07149163065513164,0.018511925952296185,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
109,0.5,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is there a connection between neck pain and reduced health-related quality of life six months later? Our analysis found neck pain negatively correlates with physical HRQoL but not mental HRQoL. This points to neck pain as a possible contributor to future poor physical health quality. Increasing awareness of neck pain's potential future impact is vital.,2.3685972735685406e-08,0.03095185599003436,0.03605179164135776,0.0018134264647818726,0.006979984786362525,0.018511925952296185,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
109,0.5,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Does experiencing neck pain associate with poorer health-related quality of life six months later? We found neck pain linked to lower physical HRQoL but no effect on mental HRQoL. This suggests neck pain may be a factor in future physical health decline. Promoting awareness about the possible long-term impact of neck pain is important.,4.737194547137081e-08,0.03133225050348454,0.06490442137639374,0.0036268529295637453,0.012068210184330574,0.018511925952296185,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
109,0.5,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Is neck pain related to worse health-related quality of life six months later? Our study indicates neck pain negatively affects physical HRQoL but not mental HRQoL. This implies neck pain may contribute to future physical health quality deterioration. Raising awareness about the potential future impact of neck pain is essential.,1.4211583641411244e-07,0.11834476304852837,0.07990328716089301,0.010880558788691236,0.0921109178578674,0.018511925952296185,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
110,0.5,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: What is the clinical importance of bile duct sludge, and how does it compare to bile duct stones? Answer: The results suggest that symptomatic bile duct sludge (BDS) has clinical significance comparable to that of common bile duct (CBD) stones. Bile duct sludge appears to represent an initial phase of choledocholithiasis.",1.8948778188548325e-07,0.1590208242428357,0.19085296566458435,0.014507411718254981,0.2126415171185636,0.02750832986255728,0.014486412327622933,0.21206028899460883,0.024375,1.8948778188548325e-07,0.1823215567939549,0.0
110,0.5,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical relevance of bile duct sludge differ from that of bile duct stones? Answer: Findings show that symptomatic BDS shares similar clinical significance with CBD stones. Bile duct sludge is likely an early form of choledocholithiasis.,9.474389094274152e-08,0.07987354545497327,0.00853015998643214,0.0072537058591274906,0.1070323024723705,0.004969135802469125,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,0.5,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical significance of bile duct sludge compared to bile duct stones? Answer: The evidence indicates that symptomatic bile duct sludge has clinical implications akin to those of common bile duct stones. It appears to be an early stage in the development of choledocholithiasis.,7.105791820705622e-08,0.09012269132635531,0.0621274363854499,0.005440279394345618,0.10420034732491601,0.025289256198347123,0.0054324046228586,0.10442962480224383,0.024375,7.105791820705622e-08,0.07232066157962613,0.0
110,0.5,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: Is the clinical importance of bile duct sludge distinct from that of bile duct stones? Answer: The data reveal that symptomatic bile duct sludge carries clinical significance similar to that of common bile duct stones, suggesting bile duct sludge is an early stage of choledocholithiasis.",4.737194547137081e-08,0.09485238238135585,0.38094763551452904,0.0036268529295637453,0.006121959487344952,0.06909726353361093,0.003621603081905733,0.0814401065775443,0.024375,4.737194547137081e-08,0.048790164169431716,0.0
110,0.5,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How significant is bile duct sludge clinically, and is it different from bile duct stones? Answer: The findings demonstrate that symptomatic bile duct sludge has clinical significance comparable to CBD stones and likely represents an early stage of choledocholithiasis.",9.474389094274152e-08,0.044327536195488904,0.034953062480763186,0.0072537058591274906,0.07055087191658371,0.02120343316289264,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,0.5,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: What clinical role does bile duct sludge play compared to bile duct stones? Answer: Symptomatic bile duct sludge shows clinical significance similar to that of common bile duct stones, indicating it may be an early phase of choledocholithiasis.",1.1842986367842682e-07,0.13265552852834217,0.11337930968378881,0.009067132323909363,0.09820510360836066,0.02049382716049385,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
110,0.5,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: Does bile duct sludge have a different clinical significance than bile duct stones? Answer: The findings indicate that symptomatic bile duct sludge’s clinical significance is comparable to that of CBD stones, and it may signify an early stage of choledocholithiasis.",7.105791820705622e-08,0.016008362039963586,0.03833651349934941,0.005440279394345618,0.008093954957539395,0.047500000000000014,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.5,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical impact of bile duct sludge relative to bile duct stones? Answer: Symptomatic bile duct sludge is clinically significant in a way similar to common bile duct stones and is considered an early form of choledocholithiasis.,9.474389094274152e-08,0.10200293564357166,0.1057555542992821,0.0072537058591274906,0.07055087191658371,0.02120343316289264,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,0.5,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How does the clinical significance of bile duct sludge compare with that of bile duct stones? Answer: Findings suggest that symptomatic bile duct sludge has clinical importance akin to common bile duct stones, representing an early stage in choledocholithiasis.",9.474389094274152e-08,0.13754894490305603,0.1350056072616436,0.0072537058591274906,0.1070323024723705,0.004969135802469125,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,0.5,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical significance of bile duct sludge different from that of bile duct stones? Answer: The data suggest that symptomatic bile duct sludge is clinically significant like common bile duct stones and may be an initial stage of choledocholithiasis.,7.105791820705622e-08,0.10689923552984215,0.1269800440952006,0.005440279394345618,0.07918597347650769,0.003632213294375436,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
111,0.5,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy predict the outcomes for patients undergoing radical perineal prostatectomy? Prior benign prostate biopsy does not directly determine the outcome for those treated with radical perineal prostatectomy, although it offers useful patient information.",9.474389094274131e-08,0.08925211873831884,0.12169861051038064,0.0072537058591274906,0.09873282084038015,0.13937070144862354,0.007243206163811466,0.0695164616571895,0.12543252595155707,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
111,0.5,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can prior benign prostate biopsy forecast the results for patients treated with radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict outcomes in patients receiving radical perineal prostatectomy, but it can give important insights about the patient.",7.1057918207056e-08,0.08239688909354115,0.09834220912629758,0.005440279394345618,0.0897051413954646,0.1132482524690317,0.0054324046228586,0.0591791619261115,0.09767742391074075,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
111,0.5,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is the outcome for patients treated with radical perineal prostatectomy influenced by prior benign prostate biopsy? Prior benign prostate biopsy does not directly influence the outcome for such patients, though it provides valuable information about the patient.",1.1842986367842661e-07,0.020222683255312734,0.0927734375,0.009067132323909363,0.029853299936036137,0.11019283746556477,0.00905400770476434,0.04052892478393799,0.12543252595155707,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
111,0.5,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does undergoing a benign prostate biopsy beforehand predict the results of radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict the treatment outcome for radical perineal prostatectomy patients, but it can supply useful patient data.",1.1842986367842661e-07,0.02022268325531229,0.0927734375,0.009067132323909363,0.06946171025374692,0.1385790906866717,0.00905400770476434,0.04052892478393799,0.12543252595155707,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
111,0.5,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can prior benign prostate biopsy serve as a predictor for outcomes in patients treated with radical perineal prostatectomy? Prior benign prostate biopsy itself does not directly predict outcomes for these patients, though it offers useful patient information.",1.1842986367842661e-07,0.05873085995308758,0.11950380940082646,0.009067132323909363,0.029853299936036137,0.11019283746556477,0.00905400770476434,0.00024443877841173745,0.09604776929407313,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
111,0.5,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does having a prior benign prostate biopsy affect the outcome of radical perineal prostatectomy? A prior benign prostate biopsy does not directly forecast the outcome for patients undergoing radical perineal prostatectomy, but it provides valuable patient insights.",1.1842986367842661e-07,0.05679367014023606,0.04214843749999997,0.009067132323909363,0.009755110381675092,0.08216486598943987,0.00905400770476434,0.04101780234076191,0.06683877595155707,1.1842986367842703e-07,0.0736432266264817,0.048093909438775506
111,0.5,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is prior benign prostate biopsy a predictor of treatment outcomes in radical perineal prostatectomy patients? Prior benign prostate biopsy does not directly predict outcomes for these patients, though it can provide important patient information.",1.894877818854825e-07,0.038782747045026156,0.11214843749999996,0.014507411718255002,0.0671854356882231,0.10490358126721763,0.01448641232762296,0.09656356828642831,0.09321030372933486,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
111,0.5,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a history of benign prostate biopsy predict the success of radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict outcomes in patients treated with radical perineal prostatectomy, but it offers useful information about the patient.",9.474389094274131e-08,0.08925211873831884,0.12169861051038065,0.0072537058591274906,0.09873282084038015,0.13937070144862354,0.007243206163811466,0.0695164616571895,0.12543252595155707,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
111,0.5,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does prior benign prostate biopsy have predictive value for outcomes after radical perineal prostatectomy? Prior benign prostate biopsy does not directly determine the outcome for patients treated with radical perineal prostatectomy, although it provides valuable patient information.",1.1842986367842661e-07,0.02022268325531229,0.0927734375,0.009067132323909363,0.029853299936036137,0.11019283746556477,0.00905400770476434,0.00024443877841173745,0.09604776929407313,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
111,0.5,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can the results of a prior benign prostate biopsy predict outcomes in patients undergoing radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict the outcome for these patients, but it can provide important information about the patient.",7.1057918207056e-08,0.11887831964932793,0.1237810905612245,0.005440279394345618,0.0897051413954646,0.1132482524690317,0.0054324046228586,0.0591791619261115,0.09767742391074075,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
112,0.5,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy still be recommended? Answer: Second-look laparotomy does not improve overall or disease-free survival. Tumor grade remains the sole independent prognostic factor for patient survival.,1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.5,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still advisable? Answer: Second-look laparotomy shows no beneficial effect on overall or disease-free survival. Tumor grade is the only independent predictor of survival.",1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.5,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy continue to be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: There is no positive impact of second-look laparotomy on overall or disease-free survival. Tumor grade is the only independent prognostic factor for survival.,4.7371945471370706e-08,0.08555642983414735,0.025623268698060954,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
112,0.5,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In Thai women with advanced epithelial ovarian carcinoma, is it necessary to proceed with second-look laparotomy? Answer: Second-look laparotomy does not favorably affect overall or disease-free survival. Tumor grade stands as the sole independent prognostic variable for survival.",7.1057918207056e-08,0.0759859069779214,0.0,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
112,0.5,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still warranted? Answer: The procedure does not improve overall or disease-free survival rates. Tumor grade is the only independent prognostic indicator for survival.,1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.5,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy be continued for advanced epithelial ovarian carcinoma in Thai women? Answer: Second-look laparotomy has no beneficial impact on overall or disease-free survival. Tumor grade is the only independent prognostic factor influencing survival.,1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.5,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women with advanced epithelial ovarian carcinoma, is offering second-look laparotomy justified? Answer: Second-look laparotomy does not positively affect overall or disease-free survival. Tumor grade is the only independent prognostic variable for patient survival.",1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.5,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still recommended? Answer: The second-look laparotomy does not improve overall or disease-free survival. Tumor grade is the sole independent prognostic factor for survival.,1.894877818854825e-07,0.25907342527176347,0.0302734375,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.5,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In cases of advanced epithelial ovarian carcinoma among Thai women, should second-look laparotomy be offered? Answer: Second-look laparotomy lacks a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic factor for patient survival.",7.1057918207056e-08,0.11246733753370775,0.026296566837107373,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
112,0.5,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy remain a treatment option for advanced epithelial ovarian carcinoma in Thai women? Answer: Second-look laparotomy does not enhance overall or disease-free survival. Tumor grade is the only independent prognostic variable affecting survival.,1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
113,0.5,1,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Can bedside assessment alone definitively rule out aspiration after an acute stroke? It cannot. Although helpful as a preliminary screening, bedside assessment must be supplemented with instrumental swallowing tests for thorough and accurate detection of aspiration risk.",4.026615365066515e-07,0.32065516227530333,0.04721366097459391,0.030828249901291835,0.3425766432027877,0.03840000000000001,0.03078362619619874,0.37828286573326375,0.019599999999999992,4.026615365066519e-07,0.4155154439616653,0.0
113,0.5,2,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Is bedside assessment sufficient to exclude aspiration after an acute stroke? No, it is not reliable on its own. It acts mainly as an initial screen and should be combined with other diagnostic tools such as instrumental evaluations for precise identification of aspiration.",2.6054570009253947e-07,0.12799630575027088,0.07496876301541024,0.0199476911126006,0.18435263798789325,0.03840000000000001,0.019918816950481533,0.2157639362354895,0.019599999999999992,2.6054570009253947e-07,0.248461359298501,0.0
113,0.5,3,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Does bedside assessment reliably exclude aspiration following an acute stroke? Bedside assessment by itself cannot reliably rule out aspiration. It is a useful first step but requires additional diagnostic methods like instrumental swallowing assessments for a comprehensive evaluation.,3.789755637709662e-07,0.2922154265548156,0.04796259017590407,0.029014823436509962,0.31440576623609084,0.03840000000000001,0.028972824655245866,0.34929532886001224,0.019599999999999992,3.789755637709665e-07,0.3856624808119835,0.0
113,0.5,4,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can aspiration be confidently excluded with bedside assessment after an acute stroke? Bedside assessment alone is not dependable for this purpose. It serves as an initial screening tool and must be used alongside other diagnostic techniques including instrumental swallowing tests to accurately identify aspiration risk.,2.1317375462116866e-07,0.11298298014082953,0.05225378194456112,0.016320838183036854,0.13672458899863882,0.03840000000000001,0.0162972138685758,0.1669737720660578,0.019599999999999992,2.1317375462116866e-07,0.19845093872383757,0.0
113,0.5,5,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Is bedside assessment alone adequate to exclude aspiration post-acute stroke? No, it cannot reliably exclude aspiration. It is valuable as a first-line screening but needs to be combined with instrumental swallowing evaluations for complete and accurate diagnosis.",4.026615365066515e-07,0.2821469855775285,0.07496876301541024,0.030828249901291835,0.3425766432027877,0.03840000000000001,0.03078362619619874,0.37828286573326375,0.019599999999999992,4.026615365066519e-07,0.4155154439616653,0.0
113,0.5,6,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Can bedside assessment alone reliably detect the absence of aspiration following an acute stroke? It cannot. While it is a useful initial screening method, it should be complemented with instrumental swallowing assessments for comprehensive and accurate aspiration risk identification.",3.552895910352809e-07,0.2280797643072523,0.07496876301541024,0.02720139697172809,0.2870067920479755,0.03840000000000001,0.027162023114293,0.3211244518933154,0.019599999999999992,3.552895910352811e-07,0.356674943938732,0.0
113,0.5,7,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Does bedside assessment provide a reliable exclusion of aspiration after an acute stroke? Bedside evaluation alone is insufficient. It is helpful as an initial screening but requires combination with other diagnostic methods, such as instrumental swallowing tests, for accurate detection.",3.316036182995956e-07,0.20210427790399432,0.07496876301541024,0.025387970506946217,0.26033854496581466,0.03840000000000001,0.025351221573340132,0.2937254777052001,0.019599999999999992,3.316036182995957e-07,0.32850406697203516,0.0
113,0.5,8,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is it possible to exclude aspiration solely through bedside assessment following an acute stroke? Bedside assessment alone cannot reliably exclude aspiration. It functions as an initial screening tool and must be supplemented with instrumental swallowing evaluations for thorough and accurate identification.,3.079176455639103e-07,0.21144382894769898,0.049985199570308315,0.023574544042164344,0.23436305856255668,0.03840000000000001,0.023540420032387266,0.2670572306230392,0.019599999999999992,3.079176455639103e-07,0.30110509278391984,0.0
113,0.5,9,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Can aspiration be excluded reliably just by bedside assessment after an acute stroke? No, bedside assessment alone is not reliable for exclusion. It serves primarily as an initial screening and needs to be paired with other diagnostic approaches like instrumental swallowing evaluations for comprehensive assessment.",2.1317375462116866e-07,0.11298298014082953,0.05225378194456112,0.016320838183036854,0.13672458899863882,0.03840000000000001,0.0162972138685758,0.1669737720660578,0.019599999999999992,2.1317375462116866e-07,0.19845093872383757,0.0
113,0.5,10,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.","Is bedside assessment by itself a reliable method to exclude aspiration following an acute stroke? It is not. While useful as an initial screening tool, it must be combined with other diagnostic techniques such as instrumental swallowing assessments for accurate and comprehensive identification of aspiration risk.",1.8948778188548325e-07,0.05900343426331922,0.07496876301541024,0.014507411718254981,0.1137350707739393,0.03840000000000001,0.014486412327622933,0.14344327465586337,0.019599999999999992,1.8948778188548325e-07,0.17435338714477755,0.0
114,0.5,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call impact polio vaccination coverage in Kenya in 2015? Yes, their boycott call notably reduced polio vaccination rates in Kenya in 2015, causing lower immunization and increased vaccine skepticism, which contributed to a public health crisis.",3.789755637709665e-07,0.17803859535036715,0.09958167533925102,0.029014823436509962,0.1776747321994172,0.11561711156450127,0.028972824655245866,0.1973651800467886,0.109375,3.789755637709665e-07,0.25474801138941316,0.07496876301541025
114,0.5,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott call? Indeed, the boycott urged by Catholic bishops greatly lowered polio vaccination coverage in Kenya in 2015, resulting in decreased immunization and more vaccine hesitancy, leading to a public health crisis.",2.8423167282822487e-07,0.10163242956131269,0.08657853413098163,0.02176111757738247,0.1734478683639118,0.04919567283323939,0.0217296184914344,0.19630274728408592,0.0383690828402367,2.8423167282822487e-07,0.21971797250591063,0.02631656051705391
114,0.5,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' call for a boycott influence the polio vaccination coverage in Kenya during 2015? Yes, the boycott call by Catholic bishops significantly reduced polio vaccination coverage in Kenya in 2015, causing a drop in immunization rates and increased doubts about vaccines, which contributed to a public health crisis.",1.4211583641411244e-07,0.07283084318623922,0.11895202237185391,0.010880558788691236,0.0012547640745252941,0.08027629708675885,0.0108648092457172,0.02151259391194582,0.06778709829867674,1.4211583641411244e-07,0.04501394702825934,0.05370222237268815
114,0.5,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the boycott call from Catholic bishops affect Kenya's polio vaccination coverage in 2015? Yes, the boycott call from Catholic bishops had a significant negative impact on polio vaccination coverage in Kenya in 2015, leading to reduced immunization and heightened vaccine skepticism, contributing to a public health crisis.",2.1317375462116866e-07,0.11410600927968506,0.035296482848930416,0.016320838183036854,0.1578699762048159,0.013740380262562218,0.0162972138685758,0.1515150154357343,0.021332168352171332,2.1317375462116866e-07,0.14448967016628167,0.029617289092507756
114,0.5,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the polio vaccination coverage in Kenya in 2015 impacted by the Catholic bishops' boycott? Yes, the boycott called by Catholic bishops substantially affected polio vaccination coverage in Kenya in 2015, leading to decreased immunization rates and greater skepticism about vaccines, which contributed to a public health crisis.",2.1317375462116866e-07,0.02561913516564962,0.09347182399130445,0.016320838183036854,0.09759630833003863,0.055072579809047464,0.0162972138685758,0.12070847407751462,0.04304846938775511,2.1317375462116866e-07,0.14448967016628167,0.029617289092507756
114,0.5,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the 2015 boycott call by Catholic bishops influence polio vaccination coverage in Kenya? Yes, the 2015 boycott call by Catholic bishops significantly influenced polio vaccination coverage in Kenya, causing a decline in immunization rates and increased vaccine hesitancy, which led to a public health crisis.",2.6054570009253947e-07,0.19888499580597374,0.010847107438016479,0.0199476911126006,0.24204756532948002,0.01215625962056413,0.019918816950481533,0.23494824281448334,0.004890927977839257,2.6054570009253947e-07,0.22701733154454962,0.003962845855646949
114,0.5,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call have an effect on polio vaccination coverage in Kenya in 2015? Yes, the boycott call by Catholic bishops notably affected polio vaccination coverage in Kenya in 2015, resulting in lower immunization and increased skepticism towards vaccines, contributing to a public health crisis.",2.1317375462116866e-07,0.0551147598703281,0.07342146793771902,0.016320838183036854,0.09759630833003863,0.055072579809047464,0.0162972138685758,0.12070847407751462,0.04304846938775511,2.1317375462116866e-07,0.14448967016628167,0.029617289092507756
114,0.5,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the polio vaccination coverage in Kenya in 2015 suffer due to the Catholic bishops' boycott call? Yes, the boycott call from Catholic bishops in 2015 significantly reduced polio vaccination coverage in Kenya, causing decreased immunization rates and greater vaccine skepticism, which contributed to a public health crisis.",2.1317375462116866e-07,0.00387648953902886,0.11397717774629122,0.016320838183036854,0.0373226404552609,0.0978519505104961,0.0162972138685758,0.05909539136107522,0.08716425619834711,2.1317375462116866e-07,0.08147629011537694,0.07496876301541025
114,0.5,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the call for boycott by Catholic bishops impact polio vaccination coverage in Kenya in 2015? Yes, the boycott call by Catholic bishops had a significant impact on polio vaccination coverage in Kenya in 2015, leading to reduced immunization and increased doubts about vaccines, contributing to a public health crisis.",1.6580180914979784e-07,0.03451036683024444,0.059458218549127584,0.012693985253473108,0.07889502077834187,0.038482132561102,0.012675610786670066,0.0732906121771526,0.04584194214876035,1.6580180914979784e-07,0.09729819541932194,0.031580333263344126
114,0.5,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott call? Yes, the boycott call by Catholic bishops in 2015 significantly affected polio vaccination coverage in Kenya, resulting in lower immunization rates and heightened skepticism about vaccines, which contributed to a public health crisis.",1.8948778188548325e-07,0.027387867462251858,0.11570247933884291,0.014507411718254981,0.014534016768876779,0.09877124446009308,0.014486412327622933,0.03644677722146916,0.0876466049382716,1.8948778188548325e-07,0.05900343426331922,0.07496876301541025
115,0.5,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy achievable? Answer: Performing transgastric endoscopic splenectomy in a porcine model seems technically possible. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.5,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy in pigs appears to be technically feasible. Additional experiments focusing on long-term survival are planned.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.5,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to perform transgastric endoscopic splenectomy? Answer: In a porcine model, transgastric endoscopic splenectomy seems technically viable. More long-term survival experiments will be conducted.",7.10579182070559e-08,0.1295569760778843,0.00498842975206612,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
115,0.5,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy feasible? Answer: Transgastric endoscopic splenectomy in a pig model appears to be technically achievable. Further long-term survival research is planned.,2.36859727356853e-08,0.01269124779974895,0.03925619834710741,0.0018134264647818796,0.015821905303944117,0.04338842975206613,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,0.5,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be performed successfully? Answer: It appears technically feasible to perform transgastric endoscopic splenectomy in a porcine model. Additional long-term survival studies are planned.,9.47438909427412e-08,0.11792784675589152,0.030211570247933854,0.007253705859127518,0.11373507077394018,0.03840000000000001,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
115,0.5,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy possible? Answer: The procedure seems technically feasible in a porcine model, with plans for further long-term survival experiments.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.5,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Does transgastric endoscopic splenectomy work? Answer: Transgastric endoscopic splenectomy in pigs looks technically feasible, and more long-term survival experiments are planned.",4.73719454713706e-08,0.1627261447233197,0.05079439573269843,0.003626852929563759,0.16462489786031975,0.049861495844875335,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.5,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it feasible to carry out transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy in a porcine model appears to be technically feasible. Additional long-term survival tests are planned.,1.184298636784265e-07,0.2074734492236936,0.007723134827511954,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
115,0.5,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Could transgastric endoscopic splenectomy be performed? Answer: The technique seems technically feasible in a porcine model, with further long-term survival experiments planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.5,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy achievable in practice? Answer: Transgastric endoscopic splenectomy in a pig model appears technically feasible, and additional long-term survival experiments are planned.",4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
116,0.5,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging therapy remains unestablished, with notable limitations preventing its routine use as a bridging agent.",1.421158364141118e-07,0.1515150154357352,0.022069623820711058,0.010880558788691277,0.14844382118522903,0.02854671280276816,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
116,0.5,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux used in perioperative bridging? Answer: Fondaparinux's role in perioperative bridge therapy has not been clearly defined, and it has significant limitations that hinder its regular use as a bridging agent.",9.47438909427412e-08,0.08408838104583172,0.02414584000950567,0.007253705859127518,0.08175244668655557,0.02854671280276816,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
116,0.5,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Can fondaparinux be used for perioperative bridging? Answer: The use of fondaparinux in perioperative bridge therapy is not established and is limited by important factors that restrict its routine application.,1.421158364141118e-07,0.10530520339840566,0.055363321799307974,0.010880558788691277,0.14844382118522903,0.02854671280276816,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
116,0.5,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: What is the role of fondaparinux in perioperative bridging? Answer: Fondaparinux has not been established as a standard agent for perioperative bridging and has key limitations that affect its routine use.,1.184298636784265e-07,0.07251538057541396,0.055363321799307974,0.009067132323909398,0.11454226950954727,0.02854671280276816,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
116,0.5,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux appropriate for perioperative bridging? Answer: The role of fondaparinux in perioperative bridging therapy is uncertain, with significant drawbacks that prevent its common use as a bridging agent.",1.658018091497971e-07,0.13920675507408742,0.055363321799307974,0.012693985253473157,0.18353514099649804,0.02854671280276816,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
116,0.5,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux play a part in perioperative bridging? Answer: Its role in perioperative bridge therapy has not been established, and there are important limitations to using fondaparinux routinely as a bridging agent.",9.47438909427412e-08,0.08408838104583172,0.02414584000950567,0.007253705859127518,0.08175244668655557,0.02854671280276816,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
116,0.5,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux recommended for perioperative bridging? Answer: Fondaparinux’s role in perioperative bridging therapy has not been confirmed, and it faces important limitations for routine bridging use.",2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.5,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is there an established role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging has not been established, with significant limitations restricting its routine use as a bridging agent.",7.10579182070559e-08,0.09401286366195283,0.004990476327643108,0.005440279394345639,0.09332544715697333,0.002670768987034146,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
116,0.5,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: How is fondaparinux used in perioperative bridging? Answer: Fondaparinux has not been established for perioperative bridging therapy, and important limitations exist that prevent its routine use.",2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.5,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux serve in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging is not established, and there are notable limitations to its routine use as a bridging agent.",1.421158364141118e-07,0.1515150154357352,0.022069623820711058,0.010880558788691277,0.14844382118522903,0.02854671280276816,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
117,0.5,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do individuals with episodic migraines focus specifically on visual stimuli related to headaches? Studies suggest that people with episodic migraines tend to pay more attention to headache-related visual cues due to a cognitive bias, which may influence the frequency and severity of their migraines. However, experiences differ widely among individuals.",0.0,0.08487516496652425,0.05998072311243629,0.0,0.057762265046662264,0.041398320004023936,0.0,0.05899124940935696,0.04246913580246913,0.0,0.03013683393738864,0.021728395061728398
117,0.5,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraine sufferers more likely to notice visual stimuli associated with headaches? Research shows that episodic migraineurs often exhibit selective attention to headache-related visuals, driven by a cognitive bias that might affect how often and how intensely migraines occur. Nonetheless, personal experiences vary greatly.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
117,0.5,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people experiencing episodic migraines selectively focus on headache-related visual stimuli? Evidence points to a tendency among episodic migraineurs to attend more to headache-related visual cues, influenced by a cognitive bias that could contribute to migraine frequency and intensity. Individual reactions, however, can differ substantially.",1.1842986367842703e-07,0.0023212540597223885,0.07800815942501861,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
117,0.5,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is there selective attention to headache-related visual stimuli among episodic migraine patients? Research findings indicate that episodic migraineurs may have a cognitive bias that causes them to focus on headache-related visual stimuli, potentially impacting the occurrence and severity of migraines. Still, individual experiences vary considerably.",1.1842986367842703e-07,0.0023212540597223885,0.07800815942501861,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
117,0.5,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do those with episodic migraines show selective attention to headache-related visual cues? Studies suggest that episodic migraineurs might be biased towards noticing headache-related visuals, which could play a role in the frequency and intensity of their migraine attacks. However, this varies from person to person.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
117,0.5,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraine sufferers selectively attentive to visual stimuli linked to headaches? Research indicates a cognitive bias in episodic migraineurs towards headache-related visual cues, which may influence migraine frequency and severity. Individual experiences, though, can vary widely.",3.0791764556390986e-07,0.16684275137697657,0.10072314049586772,0.023574544042164344,0.22920955184848468,0.06222222222222222,0.023540420032387273,0.264795827684539,0.04246913580246913,3.079176455639103e-07,0.30199700108522576,0.021728395061728398
117,0.5,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraineurs demonstrate selective attention to headache-related visual stimuli? Evidence suggests a cognitive bias in these individuals that leads to increased focus on headache-related cues, potentially affecting migraine frequency and intensity. Nonetheless, individual experiences differ significantly.",3.0791764556390986e-07,0.16684275137697657,0.10072314049586772,0.023574544042164344,0.22920955184848468,0.06222222222222222,0.023540420032387273,0.264795827684539,0.04246913580246913,3.079176455639103e-07,0.30199700108522576,0.021728395061728398
117,0.5,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is there evidence that episodic migraine patients selectively attend to headache-related visual stimuli? Research suggests that due to a cognitive bias, episodic migraineurs may focus more on headache-related visuals, which might contribute to migraine frequency and severity. However, individual experiences vary.",2.1317375462116866e-07,0.06148223571915068,0.10072314049586772,0.016320838183036854,0.12099596720825367,0.06222222222222222,0.0162972138685758,0.15357019257431448,0.04246913580246913,2.1317375462116866e-07,0.1875866499074803,0.021728395061728398
117,0.5,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do individuals with episodic migraines selectively attend to visual stimuli associated with headaches? Studies indicate a cognitive bias towards headache-related cues in episodic migraineurs, potentially influencing the intensity and frequency of migraines. Individual differences, however, are notable.",3.0791764556390986e-07,0.16684275137697657,0.10072314049586772,0.023574544042164344,0.22920955184848468,0.06222222222222222,0.023540420032387273,0.264795827684539,0.04246913580246913,3.079176455639103e-07,0.30199700108522576,0.021728395061728398
117,0.5,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are people with episodic migraines selectively focused on headache-related visual stimuli? Research shows that episodic migraineurs may have a cognitive bias that causes selective attention to headache-related visuals, potentially affecting migraine frequency and severity. Individual experiences can vary significantly.",2.6054570009253926e-07,0.11277553010670038,0.10072314049586772,0.0199476911126006,0.17363970069367252,0.06222222222222222,0.019918816950481533,0.20763741384459067,0.04246913580246913,2.6054570009253947e-07,0.24315650106229247,0.021728395061728398
118,0.5,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is a surgeon's prior experience a factor in their ability to perform transurethral resection of the prostate? Yes, prior experience significantly impacts a surgeon's capability to perform this procedure effectively. Repeated practice improves skill, reduces complications, and enhances patient results. Hence, previous experience is vital for successful surgeries.",2.8423167282822487e-07,0.03391854116666915,0.12659822327144032,0.02176111757738247,0.0072146551012770566,0.16493055555555555,0.0217296184914344,0.041821148433368815,0.136609745939192,2.8423167282822487e-07,0.09263051812547074,0.10560000000000003
118,0.5,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does a surgeon's experience affect their skill in performing transurethral resection of the prostate? Indeed, the surgeon's past experience plays a crucial role in their proficiency. With more practice, surgeons achieve better outcomes and fewer complications. Thus, prior experience is essential for success.",4.026615365066519e-07,0.05790965047932373,0.19013128112267996,0.030828249901291835,0.10785467468350962,0.16493055555555555,0.030783626196198732,0.1596041840897522,0.136609745939192,4.026615365066519e-07,0.21325850591408813,0.10560000000000003
118,0.5,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the ability to carry out transurethral resection of the prostate dependent on the surgeon's experience? Yes, experience directly influences the surgeon's competence. Increased practice leads to improved proficiency, reduced risks, and better patient outcomes. Therefore, previous experience is key to successful procedures.",4.026615365066519e-07,0.09091665907741531,0.1663359212178614,0.030828249901291835,0.10785467468350962,0.16493055555555555,0.030783626196198732,0.1596041840897522,0.136609745939192,4.026615365066519e-07,0.21325850591408813,0.10560000000000003
118,0.5,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's previous experience influence their ability to perform transurethral resection of the prostate? Yes, a surgeon’s experience is a determining factor in their skill level. More experience results in greater proficiency, fewer complications, and improved outcomes for patients. Hence, prior experience is critical.",3.552895910352811e-07,0.042896324869882374,0.16741630005183086,0.02720139697172809,0.06022662569425519,0.16493055555555555,0.027162023114293,0.11081401992032047,0.136609745939192,3.552895910352811e-07,0.1632480853394247,0.10560000000000003
118,0.5,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is performing transurethral resection of the prostate affected by the surgeon's earlier experience? Yes, the surgeon’s ability improves with experience. Practice enhances skill, minimizes complications, and leads to better patient results. Therefore, prior experience is important for successful operations.",4.974054274493933e-07,0.15799310903630515,0.19013128112267996,0.038081955760419325,0.2105088287435919,0.16493055555555555,0.0380268323600102,0.2649646997475781,0.136609745939192,4.974054274493935e-07,0.32147209055431913,0.10560000000000003
118,0.5,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon's previous experience a factor in their ability to perform transurethral resection of the prostate? Yes, experience enhances the surgeon's proficiency. With practice, complications decrease and patient outcomes improve. Thus, prior experience is essential for effective surgery.",4.974054274493933e-07,0.1944745395920915,0.16383471428557259,0.038081955760419325,0.2105088287435919,0.16493055555555555,0.0380268323600102,0.2649646997475781,0.136609745939192,4.974054274493935e-07,0.32147209055431913,0.10560000000000003
118,0.5,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does prior experience influence a surgeon’s ability to perform transurethral resection of the prostate? Yes, it does. Experience improves the surgeon's skill, reduces complications, and leads to better patient outcomes. Hence, previous experience is crucial for success.",5.447773729207639e-07,0.21206033030658133,0.19013128112267996,0.04170880868998307,0.26607867989840406,0.16493055555555555,0.04164843544191594,0.32212311358752643,0.136609745939192,5.447773729207643e-07,0.3803125905772524,0.10560000000000003
118,0.5,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the capability to perform transurethral resection of the prostate affected by the surgeon's past experience? Yes, the surgeon’s skill in this procedure grows with experience. Increased practice results in fewer complications and improved outcomes. Therefore, prior experience is vital.",4.73719454713708e-07,0.13201762263304717,0.19013128112267996,0.03626852929563745,0.18384058166143102,0.16493055555555555,0.03621603081905733,0.23756572555946276,0.136609745939192,4.737194547137081e-07,0.2933012135876223,0.10560000000000003
118,0.5,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is a surgeon’s ability to perform transurethral resection of the prostate impacted by their previous experience? Yes, the surgeon’s competence improves with experience. More practice leads to better outcomes and fewer complications. Thus, prior experience is important for successful surgeries.",4.73719454713708e-07,0.13201762263304717,0.19013128112267996,0.03626852929563745,0.18384058166143102,0.16493055555555555,0.03621603081905733,0.23756572555946276,0.136609745939192,4.737194547137081e-07,0.2933012135876223,0.10560000000000003
118,0.5,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's previous experience affect their ability to perform transurethral resection of the prostate? Yes, experience positively influences the surgeon’s proficiency. With more practice, complications are reduced and patient outcomes are enhanced. Therefore, prior experience is essential.",5.210914001850786e-07,0.184661356118466,0.19013128112267996,0.0398953822252012,0.2379078029317072,0.16493055555555555,0.039837633900963065,0.2931355767142749,0.136609745939192,5.210914001850789e-07,0.35045962742757064,0.10560000000000003
119,0.5,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
119,0.5,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the relationship between marital status, living arrangement, and mortality differ by gender? Answer: Indeed, the link between marital status, living situation, and mortality varies by gender. Research indicates that men usually experience higher mortality rates when they live alone or are unmarried, whereas women often exhibit increased",2.3685972735685406e-08,0.02297693067402795,0.0016569737781858968,0.0018134264647818726,0.051163526083859434,0.021645233584270847,0.0018108015409528666,0.051643039158352,0.021728395061728398,2.3685972735685406e-08,0.021978906718775004,0.0
119,0.5,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is there a gender difference in how marital status and living arrangements relate to mortality? Answer: Yes, gender influences the association between marital status, living arrangements, and mortality. Findings suggest men have higher mortality risks when living alone or unmarried, while women tend to have higher",7.105791820705622e-08,0.019851151063110972,0.05925925925925926,0.005440279394345618,0.03565738861424084,0.020823902218198284,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
119,0.5,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does gender affect the association between marital status, living arrangement, and mortality? Answer: Gender does affect this association. Men generally face higher mortality rates if they are unmarried or living alone, whereas women frequently show elevated",2.8423167282822456e-07,0.16773549884436934,0.08098765432098766,0.02176111757738247,0.2588009399284501,0.020823902218198284,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
119,0.5,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender impact the link between marital status, living arrangements, and mortality? Answer: Yes, the connection between marital status, living arrangements, and mortality varies by gender. Men are more likely to have higher mortality rates when unmarried or living alone, while women often have higher",9.474389094274162e-08,0.15683016986759446,0.0491898604719118,0.0072537058591274906,0.18415700456810757,0.06917609778180171,0.007243206163811466,0.18566569725741866,0.06937499999999999,9.474389094274162e-08,0.1569857954019107,0.047500000000000014
119,0.5,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is the association between marital status, living arrangement, and mortality influenced by gender? Answer: Yes, gender influences this association. Men tend to have increased mortality rates when living alone or unmarried, while women often show higher",3.0791764556390986e-07,0.19513447303248466,0.08098765432098766,0.023574544042164344,0.28697181689514695,0.020823902218198284,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
119,0.5,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the correlation between marital status, living arrangements, and mortality change according to gender? Answer: Yes, this correlation varies by gender. Men generally have higher mortality rates when unmarried or living alone, whereas women tend to have higher",2.6054570009253926e-07,0.1775486823179948,0.05469108748388028,0.0199476911126006,0.23140196574033478,0.020823902218198284,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
119,0.5,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Are there gender differences in the association between marital status, living arrangement, and mortality? Answer: Yes, gender differences exist in this association. Men typically experience higher mortality rates when living alone or unmarried, while women often have higher",2.6054570009253926e-07,0.1775486823179948,0.05469108748388028,0.0199476911126006,0.23140196574033478,0.020823902218198284,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
119,0.5,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the link between marital status, living arrangement, and mortality differ between men and women? Answer: Yes, the link differs by gender. Men tend to have greater mortality rates when living alone or unmarried, while women often present higher",2.3685972735685396e-07,0.15063777461843442,0.055364385622926705,0.018134264647818726,0.2047337186581739,0.020823902218198284,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
119,0.5,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does the association between marital status, living arrangement, and mortality vary by gender? Answer: The association does vary by gender, with men showing higher mortality rates when living alone or unmarried, and women often exhibiting higher",2.8423167282822456e-07,0.24267032917517506,0.02711010330057948,0.02176111757738247,0.2588009399284501,0.020823902218198284,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
120,0.5,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Living in urban areas and the risk of non-communicable diseases in Thailand: Is timing important? Urban living was linked to higher behavioral and physiological risk factors, but these did not necessarily lead directly to increased biological risk factors. These biological risks likely stem from a complex interplay involving long-term accumulation.",2.3685972735685406e-07,0.1152276020093348,0.0507015306122449,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
120,0.5,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Does the timing of living in an urban setting affect non-communicable disease risk in Thailand? Urbanicity correlated with rises in behavioral and physiological risk factors, though this did not always result in higher biological risk factors. The biological risks probably arise from a complicated interaction including long-term buildup.",2.8423167282822487e-07,0.15690029840990372,0.0507015306122449,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
120,0.5,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","In Thailand, does the timing of urban living influence non-communicable disease risk? Urban environments were associated with elevated behavioral and physiological risks, but these associations might not directly cause increased biological risk factors. The biological risks are likely due to a complex interaction involving long-term accumulation.",3.316036182995957e-07,0.20038541034964208,0.0507015306122449,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
120,0.5,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Questioning if timing matters for non-communicable disease risk linked to urban living in Thailand: Urbanicity was tied to increased behavioral and physiological risk factors; however, these increases may not directly cause higher biological risk factors. Such biological risks probably come from a complex interaction and long-term accumulation.",3.079176455639103e-07,0.17840650363086707,0.0507015306122449,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
120,0.5,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Does living in an urban environment at certain times affect non-communicable disease risk in Thailand? Urbanicity was connected to higher behavioral and physiological risk factors, but this may not directly increase biological risk factors. These biological risks likely result from a complex interaction involving long-term accumulation.",3.316036182995957e-07,0.20038541034964208,0.0507015306122449,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
120,0.5,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","How does timing influence the risk of non-communicable diseases associated with urban living in Thailand? Urbanicity was linked to increased behavioral and physiological risk factors, yet these links may not directly raise biological risk factors. Biological risks probably result from a complex interaction and long-term accumulation.",3.316036182995957e-07,0.20038541034964208,0.0507015306122449,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
120,0.5,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Is the timing of urban residence important for non-communicable disease risk in Thailand? Urban living was associated with rises in behavioral and physiological risks, but these may not directly cause increased biological risk factors. The biological risks likely come from complex interactions and long-term buildup.",3.552895910352811e-07,0.2228582662016998,0.0507015306122449,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
120,0.5,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","In Thailand, does the timing of living in urban areas impact non-communicable disease risk? Urbanicity correlated with increased behavioral and physiological risk factors, but these may not translate directly into biological risk factors. The biological risks likely stem from complex interactions and long-term accumulation.",3.789755637709665e-07,0.24584778442639932,0.0507015306122449,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
120,0.5,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Does the timing of residing in urban environments affect non-communicable disease risk in Thailand? Urbanicity was related to increased behavioral and physiological risk factors, though this might not directly lead to higher biological risk factors. Such biological risks probably arise from complex interactions and long-term accumulation.",3.316036182995957e-07,0.20038541034964208,0.0507015306122449,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
120,0.5,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Is timing a factor in the relationship between urban living and non-communicable disease risk in Thailand? Urbanicity was linked to elevated behavioral and physiological risk factors, but these associations may not directly increase biological risk factors. The biological risks are likely due to complex interactions and long-term accumulation.",2.8423167282822487e-07,0.15690029840990372,0.0507015306122449,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
121,0.5,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex affect how patients respond to intravenous thrombolysis in ischemic stroke? Yes, sex can impact the response to intravenous thrombolysis in ischemic stroke. Research shows women might face a greater risk of symptomatic intracranial hemorrhage after treatment. Nonetheless, functional outcomes after thrombolysis are generally comparable between males and females. More studies are necessary for a full understanding.",2.3685972735685406e-08,0.052635830883720924,0.048640272951403385,0.0018134264647818726,0.053960375778036695,0.050406441972848014,0.0018108015409528666,0.05534707269944583,0.05211567312131367,2.3685972735685406e-08,0.056800151614734506,0.0537679663968003
121,0.5,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Indeed, sex may influence the response to intravenous thrombolysis in ischemic stroke. Evidence suggests that women could have an increased risk of symptomatic intracranial hemorrhage following treatment. However, both men and women tend to have similar functional results post-thrombolysis. Additional research is required for a thorough comprehension.",0.0,0.023901626915860064,0.01634498793136005,0.0,0.024320953703856674,0.016897944350033722,0.0,0.02475525644856935,0.01742161071413134,0.0,0.025205352020361893,0.017915987023652685
121,0.5,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does gender play a role in the effectiveness of intravenous thrombolysis for ischemic stroke? Yes, gender can affect the response to intravenous thrombolysis in ischemic stroke. Studies reveal that women might experience a higher risk of symptomatic intracranial hemorrhage after treatment. Despite this, functional outcomes after thrombolysis are largely similar between sexes. Further investigation is needed to fully understand the implications.",4.737194547137081e-08,0.1781080340680372,0.10175411507805154,0.0036268529295637453,0.1804118982943148,0.10380622837370242,0.003621603081905733,0.1588676020541171,0.08842752787389466,4.737194547137081e-08,0.13653949068352622,0.07227989234909649
121,0.5,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can sex impact the outcomes of intravenous thrombolysis in ischemic stroke patients? Yes, sex can influence the outcomes of intravenous thrombolysis in ischemic stroke. Research indicates that women may have an elevated risk of symptomatic intracranial hemorrhage post-treatment. However, functional recovery after thrombolysis is generally alike in both males and females. More research is essential for comprehensive insights.",2.3685972735685406e-08,0.003993923476006245,0.014609765474817377,0.0018134264647818726,0.004449862880897992,0.01537870049980776,0.0018108015409528666,0.004936368658722046,0.01614763552479817,2.3685972735685406e-08,0.00545591601770079,0.016916570549788526
121,0.5,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does intravenous thrombolysis response in ischemic stroke vary by sex? Yes, the response to intravenous thrombolysis in ischemic stroke can vary by sex. Studies suggest that women might be at higher risk for symptomatic intracranial hemorrhage following treatment. Still, males and females usually show similar functional outcomes after thrombolysis. Further studies are needed for a complete understanding.",4.737194547137081e-08,0.03319904280547359,0.04741007668875648,0.0036268529295637453,0.08500228760070527,0.08563064538330462,0.003621603081905733,0.08740863807197341,0.08842752787389466,4.737194547137081e-08,0.06378013640109703,0.07227989234909649
121,0.5,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is there a sex-based difference in response to intravenous thrombolysis for ischemic stroke? Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Research points out that women may face a greater risk of symptomatic intracranial hemorrhage after treatment. Nonetheless, functional outcomes post-thrombolysis are generally comparable between sexes. Additional research is required for full clarity.",4.737194547137081e-08,0.05795429925404294,0.0650162074476654,0.0036268529295637453,0.059796935580343824,0.06749437362112143,0.003621603081905733,0.06173652027345655,0.06991560192159847,4.737194547137081e-08,0.06378013640109703,0.07227989234909649
121,0.5,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","How does sex affect the response to intravenous thrombolysis in ischemic stroke? Sex can indeed influence the response to intravenous thrombolysis in ischemic stroke. Studies have found that women may have an increased risk of symptomatic intracranial hemorrhage post-treatment. However, functional recovery is typically similar for both males and females after thrombolysis. More research is necessary to gain a complete understanding.",4.737194547137081e-08,0.06258350397471357,0.01965056174975431,0.0036268529295637453,0.06292932531805429,0.019787023984127725,0.003621603081905733,0.06326109439067595,0.019840422249752007,4.737194547137081e-08,0.06357662957195265,0.019810756546627374
121,0.5,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does patient sex influence outcomes after intravenous thrombolysis in ischemic stroke? Yes, patient sex can influence outcomes following intravenous thrombolysis in ischemic stroke. Evidence shows that women might have a higher chance of symptomatic intracranial hemorrhage after treatment. Despite this, functional outcomes after thrombolysis tend to be similar between men and women. Further research is needed to fully elucidate these effects.",4.737194547137081e-08,0.06258350397471357,0.01965056174975431,0.0036268529295637453,0.13341886910381007,0.06994965712100928,0.003621603081905733,0.13496597513825703,0.07119145523615997,4.737194547137081e-08,0.13653949068352622,0.07227989234909649
121,0.5,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the effectiveness of intravenous thrombolysis in ischemic stroke affected by sex? Yes, the effectiveness of intravenous thrombolysis in ischemic stroke can be affected by sex. Studies indicate women may be at greater risk for symptomatic intracranial hemorrhage post-treatment. However, functional outcomes after thrombolysis are generally alike for both sexes. Continued research is important for a deeper understanding.",2.3685972735685406e-08,0.04464798393170977,0.01819375209067224,0.0018134264647818726,0.02030539356767136,0.0017937716262976244,0.0018108015409528666,0.020268983361639403,0.001572472126105326,2.3685972735685406e-08,0.020216201780815624,0.0013201076509034987
121,0.5,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Are there sex differences in response to intravenous thrombolysis for ischemic stroke? Yes, sex differences exist in the response to intravenous thrombolysis in ischemic stroke. Research suggests women may have a higher risk of symptomatic intracranial hemorrhage following treatment. Nonetheless, functional outcomes after thrombolysis are usually similar between males and females. More research is needed for comprehensive knowledge.",2.3685972735685406e-08,0.052635830883720924,0.048640272951403385,0.0018134264647818726,0.07871563222660605,0.06814093344914825,0.0018108015409528666,0.08055242471980728,0.07025194488349686,2.3685972735685406e-08,0.08247226941325136,0.07227989234909649
122,0.5,1,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal-induced anxiety in alcoholism caused by a deficiency in beta-endorphin? Yes, anxiety during alcohol withdrawal is linked to a lack of beta-endorphin, a peptide that helps regulate stress and pain.",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
122,0.5,2,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Indeed, withdrawal anxiety in alcoholics is connected to reduced beta-endorphin levels, a peptide that modulates stress and pain.",1.894877818854824e-07,0.20705675094126708,0.05006944444444448,0.014507411718255037,0.20103867488178695,0.06222222222222223,0.014486412327622988,0.253773815616646,0.0322222222222222,1.8948778188548325e-07,0.3101549283038394,0.0
122,0.5,3,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety experienced during alcohol withdrawal due to beta-endorphin deficiency? Yes, withdrawal anxiety in alcoholism is associated with a shortage of beta-endorphin, a peptide important in controlling stress and pain.",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
122,0.5,4,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal anxiety in alcoholics related to a deficiency of beta-endorphin? Yes, the anxiety caused by alcohol withdrawal corresponds to beta-endorphin deficiency, a peptide that manages pain and stress.",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
122,0.5,5,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is beta-endorphin deficiency responsible for withdrawal-induced anxiety in alcoholism? Yes, the anxiety during alcohol withdrawal is linked to a deficiency in beta-endorphin, a peptide involved in stress and pain regulation.",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
122,0.5,6,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety seen in alcohol withdrawal a result of beta-endorphin deficiency? Yes, withdrawal-induced anxiety in alcoholism is connected to a lack of beta-endorphin, a peptide that helps regulate pain and stress.",4.73719454713706e-08,0.06350640312047462,0.09000000000000004,0.003626852929563759,0.02210487643242276,0.06222222222222223,0.003621603081905747,0.021972201559322446,0.0322222222222222,4.737194547137081e-08,0.06899287148695077,0.0
122,0.5,7,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does withdrawal anxiety in alcoholism stem from beta-endorphin deficiency? Yes, beta-endorphin deficiency is indeed associated with the anxiety experienced during alcohol withdrawal; this peptide plays a role in stress and pain control.",4.73719454713706e-08,0.06350640312047462,0.09000000000000004,0.003626852929563759,0.02210487643242276,0.06222222222222223,0.003621603081905747,0.021972201559322446,0.0322222222222222,4.737194547137081e-08,0.06899287148695077,0.0
122,0.5,8,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety from alcohol withdrawal caused by a deficit in beta-endorphin? Yes, withdrawal-induced anxiety in alcoholism is related to beta-endorphin deficiency, a peptide involved in managing pain and stress.",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
122,0.5,9,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is beta-endorphin deficiency linked to withdrawal anxiety in alcoholism? Yes, the anxiety during alcohol withdrawal is connected to a shortage of beta-endorphin, a peptide that regulates stress and pain.",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
122,0.5,10,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal anxiety in alcoholism due to beta-endorphin deficiency? Yes, anxiety induced by alcohol withdrawal is associated with a deficiency of beta-endorphin, a peptide that controls stress and pain.",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
123,0.5,1,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are we adhering to guidelines when preparing high-fall-risk patients for discharge home after rehabilitation? Compliance with these guidelines varies, emphasizing the importance of thorough assessments, individualized care plans, patient education, and home safety precautions. However, research indicates inconsistent application, suggesting a need for enhancement.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.5,2,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we follow the recommended protocols for discharging patients at high risk of falls after rehabilitation? Guideline adherence is variable, underscoring the necessity of complete evaluations, tailored care strategies, patient instruction, and ensuring home safety. Studies show uneven execution, pointing to areas for improvement.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.5,3,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","When preparing high-risk fall patients for discharge post-rehabilitation, do we meet the established guidelines? Compliance is inconsistent, though it is essential to conduct comprehensive assessments, develop personalized care plans, provide education, and implement home safety measures. Evidence reveals gaps in guideline application, indicating a need for better adherence.",3.789755637709665e-07,0.29298712468147725,0.0,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
123,0.5,4,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is guideline compliance achieved in preparing patients prone to falls for home discharge following rehabilitation? The level of adherence varies, with critical steps including full assessments, customized care plans, patient education, and home safety interventions. Research highlights inconsistent implementation, demonstrating the need for improvement.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.5,5,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are guidelines consistently met when preparing high fall-risk patients for discharge from rehabilitation to home? Compliance fluctuates; key components include thorough assessments, individualized care plans, education, and home safety measures. Studies reveal inconsistent adherence, emphasizing the need for enhanced implementation.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
123,0.5,6,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we successfully follow guidelines in preparing patients at high risk of falls for discharge after rehabilitation? Compliance varies widely, but comprehensive assessments, personalized care, patient education, and home safety are vital. Research suggests inconsistent guideline use, highlighting the need for better practice.",4.974054274493935e-07,0.40546510810816727,0.0,0.038081955760419325,0.4135623183407837,0.0,0.0380268323600102,0.4219944100593742,0.0,4.974054274493935e-07,0.430782916092455,0.0
123,0.5,7,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is the preparation of high fall-risk patients for home discharge after rehabilitation aligned with guidelines? Adherence is variable, requiring thorough assessments, tailored care plans, education, and home safety precautions. Evidence points to inconsistent implementation, underscoring the need for improvement.",5.921493183921349e-07,0.5055485666651487,0.0,0.045335661619546816,0.516216472400866,0.0,0.045270038523821665,0.5273549257172001,0.0,5.921493183921352e-07,0.538996500732686,0.0
123,0.5,8,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are we meeting the guidelines for discharging patients at high risk of falls to home after rehabilitation? Compliance is inconsistent, despite the importance of comprehensive evaluations, individualized care plans, patient education, and home safety measures. Studies indicate gaps in adherence, calling for improved practices.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.5,9,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do healthcare providers comply with guidelines when preparing high-risk fall patients for discharge home post-rehabilitation? Compliance varies, with essential elements including thorough assessments, personalized care plans, education, and home safety interventions. Research shows inconsistent application, highlighting the need for enhancement.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
123,0.5,10,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is guideline adherence achieved in the process of preparing patients at high risk of falls for home discharge after rehabilitation? Compliance levels vary; critical factors include comprehensive assessments, individualized care plans, patient education, and home safety measures. Studies suggest inconsistent implementation, indicating a need for improvement.",4.263475092423373e-07,0.3364722366212156,0.0,0.03264167636607371,0.34294475112682976,0.0,0.0325944277371516,0.3496737484797481,0.0,4.263475092423373e-07,0.35667494393873156,0.0
124,0.5,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be both effective and safe in preventing CSF fistulas in cases of significant dural tears and in patients who are debilitated or have undergone irradiation, as well as in treating existing CSF leaks.",2.6054570009253947e-07,0.2504212952634859,0.0053835634451019285,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
124,0.5,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistula after spine surgery? It seems that lumbar drainage is a safe and effective approach for preventing CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, and it also helps in managing CSF leaks.",1.6580180914979784e-07,0.16642988191943964,0.0037170228023798192,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.5,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage prevent and treat postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is considered effective and safe for preventing CSF fistulas in cases involving large dural tears and in debilitated or irradiated patients, as well as for treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.5,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a reliable treatment for postoperative cerebrospinal fluid fistula after spine surgery? The evidence suggests lumbar drainage is both safe and effective in preventing CSF fistulas in patients with major dural tears and those who are debilitated or irradiated, along with treating CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.5,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How effective is lumbar drainage for postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be a safe and effective method to prevent CSF fistulas in cases of large dural tears and in debilitated or irradiated patients, as well as to treat CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.5,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide effective management for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage seems to be both effective and safe in preventing CSF fistulas in patients with significant dural tears and those debilitated or irradiated, and in treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.5,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage beneficial in treating postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is considered an effective and safe option for preventing CSF fistulas in cases of large dural tears and in debilitated or irradiated patients, as well as for treating CSF leaks.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
124,0.5,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage appears to be safe and effective in preventing CSF fistulas in patients with large dural tears and those debilitated or irradiated, and also in managing CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.5,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a safe and effective approach for postoperative cerebrospinal fluid fistula after spine surgery? It seems lumbar drainage effectively prevents CSF fistulas in cases of large dural tears and debilitated or irradiated patients, and also treats CSF leaks.",2.36859727356853e-08,0.02620645821577927,0.000639705252959033,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
124,0.5,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How safe and effective is lumbar drainage in managing postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is reported to be effective and safe in preventing CSF fistulas in patients with large dural tears and those debilitated or irradiated, as well as in treating CSF leaks.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
125,0.5,1,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? The use of a neuroendoscope at the same time does not directly impact the incidence of infections related to ventriculoperitoneal shunts. However, it enables",0.0,0.35647569285939973,0.21145328719723183,0.0,0.32618690849879783,0.21301775147928986,0.0,0.25205352020361627,0.1728395061728395,0.0,0.17328679513998724,0.12244897959183673
125,0.5,2,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is the incidence of ventriculoperitoneal shunt infection influenced by the concurrent use of a neuroendoscope? Concurrent use of a neuroendoscope does not have a direct effect on the rate of ventriculoperitoneal shunt infections. Nevertheless, it permits",0.0,0.19804205158855526,0.10111111111111112,0.0,0.20386681781174953,0.12560880246784345,0.0,0.21004460016968052,0.1425660686728395,0.0,0.17328679513998724,0.12244897959183673
125,0.5,3,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the simultaneous application of a neuroendoscope affect ventriculoperitoneal shunt infection rates? The simultaneous application of a neuroendoscope does not directly alter the incidence of infections in ventriculoperitoneal shunts. Still, it facilitates",9.47438909427412e-08,0.05112738147608731,0.08467455621301775,0.007253705859127518,0.01618451739547222,0.08284023668639043,0.007243206163811494,0.02056797277155109,0.07076850025567973,9.474389094274162e-08,0.059265623278813795,0.0514430624320734
125,0.5,4,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does using a neuroendoscope at the same time impact the frequency of ventriculoperitoneal shunt infections? Using a neuroendoscope simultaneously does not directly change the infection rate of ventriculoperitoneal shunts. However, it allows for",7.10579182070559e-08,0.17650684813243345,0.14725326991676574,0.005440279394345639,0.18909441542843153,0.18079552925706766,0.005432404622858621,0.15674334039929105,0.1728395061728395,7.105791820705622e-08,0.07484672232673395,0.12244897959183673
125,0.5,5,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the combined use of a neuroendoscope influence the occurrence of ventriculoperitoneal shunt infections? The combined use of a neuroendoscope does not directly affect the occurrence of ventriculoperitoneal shunt infections. Yet, it enables",7.10579182070559e-08,0.0834233445775463,0.001814744801512308,0.005440279394345639,0.07922062220767634,0.006420529257067625,0.005432404622858621,0.07430571978735712,0.012839506172839465,7.105791820705622e-08,0.06856303916842643,0.02037797367467696
125,0.5,6,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is the incidence of ventriculoperitoneal shunt infections affected by the simultaneous use of a neuroendoscope? The simultaneous use of a neuroendoscope does not directly impact the incidence of ventriculoperitoneal shunt infections. However, it allows for",2.36859727356853e-08,0.04090965780506162,0.026982248520710128,0.0018134264647818796,0.04428042514549979,0.04017824530645034,0.0018108015409528735,0.04799506639687534,0.05039052658100278,2.3685972735685406e-08,0.05209975094670494,0.05823970491882842
125,0.5,7,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the use of a neuroendoscope simultaneously alter the risk of ventriculoperitoneal shunt infection? Using a neuroendoscope at the same time does not directly influence the risk of ventriculoperitoneal shunt infections. Nonetheless, it facilitates",4.73719454713706e-08,0.12719900298449716,0.09331632653061228,0.003626852929563759,0.13559719032737183,0.12027102139605561,0.003621603081905747,0.10009481734358028,0.10863023149983118,4.737194547137081e-08,0.06253846196508617,0.08915528161323982
125,0.5,8,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the simultaneous employment of a neuroendoscope have an effect on ventriculoperitoneal shunt infection rates? Employing a neuroendoscope simultaneously does not directly affect the infection rates of ventriculoperitoneal shunts. However, it allows for",7.10579182070559e-08,0.2631502457024264,0.2087825182101977,0.005440279394345639,0.23381358836778254,0.21301775147928986,0.005432404622858621,0.15674334039929105,0.1728395061728395,7.105791820705622e-08,0.07484672232673395,0.12244897959183673
125,0.5,9,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the concurrent use of a neuroendoscope change the incidence of ventriculoperitoneal shunt infections? Concurrent use of a neuroendoscope does not directly change the incidence of infections related to ventriculoperitoneal shunts. Still, it enables",4.73719454713706e-08,0.04318116291662477,0.0432544378698225,0.003626852929563759,0.04895379275737888,0.062126119106175964,0.003621603081905747,0.05537564440422882,0.07717624086671702,4.737194547137081e-08,0.06253846196508617,0.08915528161323982
125,0.5,10,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the simultaneous utilization of a neuroendoscope impact ventriculoperitoneal shunt infection incidence? Utilizing a neuroendoscope simultaneously does not directly influence the incidence of ventriculoperitoneal shunt infections. However, it allows for",1.421158364141118e-07,0.11242536401073044,0.17141289437585733,0.010880558788691277,0.13203089405784008,0.21301775147928986,0.010864809245717241,0.051382824741465605,0.1728395061728395,1.4211583641411244e-07,0.034352569638256725,0.12244897959183673
126,0.5,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does using automatic transmission enhance driving habits in elderly drivers? Switching to automatic transmission is often advised for older drivers to help ensure safe driving and preserve their transportation mobility quality.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.5,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can automatic transmission lead to better driving behavior among senior drivers? It is recommended that older drivers switch to automatic transmission to maintain safe driving and sustain their transport mobility.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.5,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is driving behavior improved in older drivers by automatic transmission? Older drivers may be encouraged to use automatic transmission to promote safe driving and uphold their transportation mobility.,1.894877818854824e-07,0.271247020764406,0.008435535717941887,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
126,0.5,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Does automatic transmission aid in improving the driving conduct of elderly drivers? For older drivers, moving to automatic transmission can be suggested to keep driving safe and maintain the quality of their mobility.",7.10579182070559e-08,0.09332544715697333,0.002670768987034146,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.5,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Will automatic transmission enhance driving performance in senior drivers? Recommending automatic transmission for older drivers can help them drive safely and preserve their transport mobility.,2.605457000925383e-07,0.39544808587041747,0.0130411888985551,0.019947691112600675,0.39086630868701233,0.0,0.01991881695048161,0.4054651081081646,0.0,2.6054570009253947e-07,0.42121346507630486,0.0
126,0.5,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does switching to automatic transmission benefit the driving behavior of older adults? It is often recommended for older drivers to adopt automatic transmission to ensure safe driving and maintain transportation mobility.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.5,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can older drivers improve their driving behavior by using automatic transmission? Advising older drivers to switch to automatic transmission may help maintain safe driving and the quality of their transport mobility.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.5,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Is it beneficial for older drivers to use automatic transmission for better driving behavior? Older drivers might be encouraged to switch to automatic transmission to support safe driving and sustain their mobility quality.,7.10579182070559e-08,0.13664714594197003,0.03367550941945407,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.5,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Does the use of automatic transmission improve driving safety in elderly drivers? Switching to automatic transmission is recommended for older drivers to help maintain safe driving and the quality of their transportation.,9.47438909427412e-08,0.12647161962590658,0.0036755094194540414,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
126,0.5,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Can automatic transmission help older drivers maintain safe driving habits? It is suggested that older drivers switch to automatic transmission to preserve safe driving and their transport mobility quality.,1.658018091497971e-07,0.3320666796879155,0.07705328719723187,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
127,0.5,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact outcomes in colon and rectal surgeries? Answer: This extensive multicenter database study indicates that severe, moderate, and even mild preoperative anemia independently increase the risk of complications and prolong hospital stays following colon surgery.",1.1842986367842692e-07,0.12466730702264872,0.002908287627211844,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.5,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia associated with worse outcomes in colon and rectal surgery? Answer: Analysis of a large multicenter database shows that severe, moderate, and mild preoperative anemia are independent risk factors for postoperative complications and extended hospitalization after colon surgery.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.5,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having anemia before surgery affect the results of colon and rectal operations? Answer: Findings from a large multicenter database reveal that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays post-colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.5,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia linked to poorer colon and rectal surgery outcomes? Answer: This large-scale multicenter database analysis demonstrates that severe, moderate, and mild anemia before surgery are independent predictors of complications and increased hospital length of stay after colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.5,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does anemia prior to surgery impact the success of colon and rectal procedures? Answer: Evidence from a multicenter database study suggests that even mild preoperative anemia, along with moderate and severe forms, independently raises the risk of complications and prolongs hospitalization after colon surgery.",0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
127,0.5,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia influence postoperative outcomes in colon and rectal surgery? Answer: According to a large multicenter database analysis, the presence of mild, moderate, or severe anemia before surgery independently increases the likelihood of complications and longer hospital stays following colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.5,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia affect colon and rectal surgery outcomes? Answer: This analysis of a large multicenter database indicates that mild, moderate, and severe preoperative anemia are independent risk factors for complications and extended hospitalization after colon surgery.",1.4211583641411222e-07,0.15157821472220911,0.0035815857662582634,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.5,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there a negative effect of preoperative anemia on colon and rectal surgery results? Answer: Data from a large multicenter database analysis suggest that severe, moderate, and mild anemia before surgery independently contribute to higher complication rates and longer hospital stays after colon surgery.",0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
127,0.5,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does the presence of preoperative anemia worsen outcomes in colon and rectal surgery? Answer: This large multicenter database study finds that mild, moderate, and severe preoperative anemia independently increase the risk of postoperative complications and lengthen hospital stays following colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.5,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Can preoperative anemia affect the recovery and complications of colon and rectal surgery? Answer: Analysis from a large multicenter database shows that even mild preoperative anemia, along with moderate and severe anemia, is an independent risk factor for complications and prolonged hospitalization after colon surgery.",2.3685972735685406e-08,0.053979545877510304,0.02271498107084911,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
128,0.5,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict maternal and neonatal adverse outcomes? Research suggests that the first ACR measurement might be a prognostic indicator for such outcomes.,4.0266153650665106e-07,0.05487487283273529,0.2490234375,0.030828249901291863,0.003996818572778782,0.24793388429752067,0.030783626196198767,0.06550709888708273,0.23615916955017302,4.026615365066519e-07,0.12984039319134366,0.21551020408163268
128,0.5,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predictive of maternal and neonatal adverse outcomes? Studies show that the initial ACR can serve as a prognostic factor for these outcomes.,3.7897556377096576e-07,0.08564653149948898,0.2490234375,0.029014823436509983,0.027751879741801044,0.24793388429752067,0.028972824655245893,0.03271727606409103,0.23615916955017302,3.789755637709665e-07,0.0959388415156619,0.21551020408163268
128,0.5,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected to have preeclampsia predict adverse maternal and neonatal outcomes? Evidence indicates that the first ACR level may be a useful prognostic marker.,4.2634750924233636e-07,0.023126174518155462,0.2490234375,0.03264167636607374,0.03678664139577048,0.24793388429752067,0.03259442773715164,0.09940865056276449,0.23615916955017302,4.263475092423373e-07,0.16493171300261267,0.21551020408163268
128,0.5,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia act as a prognostic factor for negative maternal and neonatal outcomes? Research supports that the initial ACR may forecast such complications.,4.0266153650665106e-07,0.05487487283273529,0.2490234375,0.030828249901291863,0.003996818572778782,0.24793388429752067,0.030783626196198767,0.06550709888708273,0.23615916955017302,4.026615365066519e-07,0.12984039319134366,0.21551020408163268
128,0.5,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia an indicator of maternal and neonatal adverse outcomes? Findings suggest that the first ACR measurement could predict these outcomes.,4.5003348197802166e-07,0.009663648304836236,0.2490234375,0.03445510283085562,0.07068819307145224,0.24793388429752067,0.034405229278104514,0.1344999703740335,0.23615916955017302,4.500334819780227e-07,0.20129935717348735,0.21551020408163268
128,0.5,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic marker for maternal and neonatal complications? Research indicates it might be predictive.,5.210914001850776e-07,0.11502416396266169,0.2490234375,0.03989538222520126,0.17988748503644292,0.24793388429752067,0.039837633900963135,0.24782865568103762,0.23615916955017302,5.210914001850789e-07,0.3190823928298716,0.21551020408163268
128,0.5,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a predictor of maternal and neonatal adverse outcomes? Studies indicate the initial ACR may be a prognostic factor.,4.7371945471370696e-07,0.043565199980518,0.2490234375,0.0362685292956375,0.10577951288272125,0.24793388429752067,0.03621603081905739,0.17086761454490818,0.23615916955017302,4.737194547137081e-07,0.23903968515633434,0.21551020408163268
128,0.5,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia provide prognostic information about maternal and neonatal adverse outcomes? Evidence suggests it can.,5.921493183921335e-07,0.23280719961904595,0.2490234375,0.0453356616195469,0.3024898071287758,0.24793388429752067,0.045270038523821755,0.3756620271909221,0.23615916955017302,5.921493183921352e-07,0.45261378545439523,0.21551020408163268
128,0.5,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia linked to predicting maternal and neonatal adverse outcomes? Research indicates it may be a useful prognostic factor.,4.974054274493923e-07,0.078656519791787,0.2490234375,0.03808195576041938,0.14214715705359593,0.24793388429752067,0.03802683236001026,0.20860794252775516,0.23615916955017302,4.974054274493935e-07,0.2782603983096168,0.21551020408163268
128,0.5,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the first urinary albumin/creatinine ratio (ACR) measurement in women suspected of preeclampsia predict adverse outcomes for mother and newborn? Studies suggest it serves as a prognostic factor.,5.210914001850776e-07,0.11502416396266169,0.2490234375,0.03989538222520126,0.17988748503644292,0.24793388429752067,0.039837633900963135,0.24782865568103762,0.23615916955017302,5.210914001850789e-07,0.3190823928298716,0.21551020408163268
129,0.5,1,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT truly enhance multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Yes, PET/CT offers valuable metabolic insights that complement multidetector CT, improving tumor extent assessment, lesion detection, and treatment planning.",7.579511275419321e-07,0.47653868663496324,0.15089163237311393,0.05802964687301995,0.5331101427165614,0.124297520661157,0.057945649310491766,0.5694198980952057,0.11107438016528923,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
129,0.5,2,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In the preoperative staging of liver metastases from colorectal cancer, does PET/CT contribute beyond multidetector CT? Indeed, PET/CT provides crucial metabolic data that enhances tumor evaluation, identifies additional lesions, and aids in treatment decisions.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.5,3,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is there added benefit of PET/CT over multidetector CT for preoperative staging of colorectal carcinoma liver metastases? Yes, PET/CT supplies detailed metabolic information that refines tumor staging, uncovers more lesions, and supports better treatment strategies.",7.105791820705615e-07,0.4159140648185278,0.15089163237311393,0.05440279394345619,0.4705897857352279,0.124297520661157,0.05432404622858602,0.5048813769576341,0.11107438016528923,7.105791820705622e-07,0.5405298372829281,0.09719008264462808
129,0.5,4,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For patients with colorectal carcinoma liver metastases, does PET/CT offer more than multidetector CT in preoperative staging? Absolutely, PET/CT delivers significant metabolic details that improve tumor extent determination, detect extra lesions, and guide treatment planning.",7.105791820705615e-07,0.4159140648185278,0.15089163237311393,0.05440279394345619,0.4705897857352279,0.124297520661157,0.05432404622858602,0.5048813769576341,0.11107438016528923,7.105791820705622e-07,0.5405298372829281,0.09719008264462808
129,0.5,5,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT add value to multidetector CT in the preoperative staging of liver metastases from colorectal carcinoma? Yes, it provides enhanced metabolic insights that lead to more precise tumor assessment, lesion identification, and optimized treatment planning.",6.868932093348762e-07,0.38692652794527627,0.15089163237311393,0.05258936747867431,0.44073682258554614,0.124297520661157,0.052513244687633145,0.47410971829088044,0.11107438016528923,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
129,0.5,6,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In preoperative staging of colorectal liver metastases, is PET/CT beneficial beyond multidetector CT? Yes, PET/CT contributes detailed metabolic information that aids in accurate tumor extent evaluation, reveals additional lesions, and assists in treatment planning.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.5,7,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is the addition of PET/CT to multidetector CT worthwhile for preoperative staging of colorectal carcinoma liver metastases? Yes, PET/CT offers important metabolic data that enhances tumor staging, detects more lesions, and improves treatment guidance.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.5,8,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT improve upon multidetector CT in preoperative staging for liver metastases of colorectal cancer? Yes, it provides valuable metabolic details that refine tumor extent assessment, find extra lesions, and help plan treatment effectively.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.5,9,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For preoperative staging of colorectal carcinoma liver metastases, does PET/CT provide added benefit over multidetector CT? Yes, PET/CT supplies critical metabolic information that enhances tumor evaluation, uncovers additional lesions, and supports effective treatment planning.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.5,10,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is PET/CT a meaningful addition to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Yes, it offers significant metabolic insights that improve tumor extent determination, detect further lesions, and guide treatment decisions.",7.105791820705615e-07,0.4159140648185278,0.15089163237311393,0.05440279394345619,0.4705897857352279,0.124297520661157,0.05432404622858602,0.5048813769576341,0.11107438016528923,7.105791820705622e-07,0.5405298372829281,0.09719008264462808
130,0.5,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? A history of PIPE might increase the risk of developing IPE, but multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.5,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How significant are postictal psychotic episodes II in the long term? Are they indicative of interictal psychotic episodes? While a history of PIPE could be a risk factor for IPE, multivariate analysis reveals it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.5,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term relevance of postictal psychotic episodes II? Can they forecast interictal psychotic episodes? Although PIPE history may pose a risk for IPE, multivariate analysis suggests it is not an independent predictor.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
130,0.5,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the lasting significance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? A history of PIPE may increase the risk of IPE, but multivariate analysis indicates it is not independently predictive.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.5,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What long-term role do postictal psychotic episodes II play? Do they predict interictal psychotic episodes? A history of PIPE might be a risk factor for IPE, yet multivariate analysis shows it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.5,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How important are postictal psychotic episodes II over the long term? Are they predictive of interictal psychotic episodes? History of PIPE could be a risk factor for IPE, but multivariate analysis indicates it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.5,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term impact of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? A history of PIPE may pose a risk for IPE, but multivariate analysis reveals it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.5,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the enduring significance of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Though PIPE history might increase risk for IPE, multivariate analysis shows it is not an independent predictor.",3.0791764556390943e-07,0.3409265869705931,0.0,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
130,0.5,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term predictive value of postictal psychotic episodes II? Do they forecast interictal psychotic episodes? A history of PIPE may be linked to IPE risk, but multivariate analysis indicates it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.5,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term significance of postictal psychotic episodes II? Are they indicators of interictal psychotic episodes? A history of PIPE may be a risk factor for IPE, yet multivariate analysis suggests it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
131,0.5,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a previous benign prostate biopsy forecast the results for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy might independently correlate with better surgical and biochemical results post-prostatectomy. Further research is necessary to validate these observations.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.5,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a history of benign prostate biopsy predict outcomes in patients treated with radical perineal prostatectomy? Having had a benign prostate biopsy before could be independently linked to improved surgical and biochemical outcomes following prostatectomy. More studies are required to confirm these findings.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.5,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is prior benign prostate biopsy an indicator of outcomes for patients receiving radical perineal prostatectomy? A previous benign biopsy may be independently associated with more favorable surgical and biochemical results after prostatectomy. Additional research is needed to verify these results.,4.7371945471370706e-08,0.05142575219020662,0.07271468144044323,0.0036268529295637453,0.018021423668444392,0.049861495844875335,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.5,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a benign prostate biopsy performed earlier predict the outcome for patients treated with radical perineal prostatectomy? Prior benign biopsy might independently predict better surgical and biochemical outcomes after prostatectomy. Further studies are essential to confirm these findings.,9.474389094274131e-08,0.0012179812952122226,0.07271468144044323,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.5,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can prior benign prostate biopsy serve as a predictor for outcomes in patients undergoing radical perineal prostatectomy? A history of benign prostate biopsy may independently be linked to more positive surgical and biochemical outcomes post-prostatectomy. More research is needed to confirm this.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.5,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does having a prior benign prostate biopsy predict patient outcomes following radical perineal prostatectomy? Such a biopsy might be independently associated with improved surgical and biochemical outcomes after prostatectomy. Additional studies are necessary to confirm these findings.,1.1842986367842661e-07,0.028616955483327544,0.07271468144044323,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
131,0.5,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is a previous benign prostate biopsy predictive of outcomes in patients treated with radical perineal prostatectomy? Prior benign biopsy could be independently correlated with better surgical and biochemical outcomes after prostatectomy. Further research is needed to validate these findings.,7.1057918207056e-08,0.025450265786948645,0.07271468144044323,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
131,0.5,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does prior benign prostate biopsy influence the outcome for patients undergoing radical perineal prostatectomy? A prior benign biopsy may independently relate to more favorable surgical and biochemical outcomes post-prostatectomy. Additional studies are required to confirm these results.,1.1842986367842661e-07,0.06712513218110239,0.0449595793996269,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
131,0.5,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a prior benign prostate biopsy independently predict outcomes for patients treated with radical perineal prostatectomy? Such a biopsy might be linked to improved surgical and biochemical outcomes following prostatectomy. More research is needed to confirm these findings.,9.474389094274131e-08,0.0012179812952122226,0.07271468144044323,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.5,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is prior benign prostate biopsy associated with outcomes for patients treated with radical perineal prostatectomy? Having had a benign biopsy previously may independently predict better surgical and biochemical outcomes after prostatectomy. Further studies are necessary to confirm these conclusions.,7.1057918207056e-08,0.025450265786948645,0.07271468144044323,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
132,0.5,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Is it possible for neoadjuvant chemotherapy to alter the extent of lymphadenectomy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy may potentially change the extent of lymphadenectomy by reducing tumor size and lymph node involvement, thereby limiting the surgical scope. However, further studies are needed.",2.3685972735685406e-07,0.20246058375523912,0.0016284881299458709,0.018134264647818726,0.19510111321364532,0.009999048185603807,0.018108015409528666,0.2199216019515382,0.004571984280058845,2.3685972735685406e-07,0.21825356602001733,0.0
132,0.5,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Can neoadjuvant chemotherapy influence how extensive lymphadenectomy is in cervical cancer? Answer: Indeed, neoadjuvant chemotherapy might modify lymphadenectomy extent by shrinking tumors and decreasing affected lymph nodes, which could reduce surgery extent. More research is necessary, though.",4.026615365066516e-07,0.28717296009286875,0.0646223152904397,0.030828249901291835,0.30830348295714893,0.05640000000000001,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
132,0.5,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Does neoadjuvant chemotherapy have the potential to adjust the extent of lymphadenectomy in cervical cancer? Answer: Yes, it may decrease tumor burden and lymph node involvement, potentially reducing the surgical area involved in lymphadenectomy. Further investigation is still required.",3.55289591035281e-07,0.19706181144204749,0.09162848812994587,0.02720139697172809,0.25423626168687274,0.05640000000000001,0.027162023114293,0.3136662989925889,0.01922337562475971,3.552895910352811e-07,0.3483066942682149,0.0
132,0.5,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Could neoadjuvant chemotherapy impact the degree of lymphadenectomy performed in cervical cancer cases? Answer: Yes, by potentially shrinking tumors and lowering the number of involved lymph nodes, neoadjuvant chemotherapy might reduce the extent of lymphadenectomy, but additional research is needed.",3.316036182995957e-07,0.20640136248575214,0.06664492468484395,0.025387970506946217,0.22826077528361477,0.05640000000000001,0.025351221573340132,0.28699805191042804,0.01922337562475971,3.316036182995957e-07,0.3209077200800996,0.0
132,0.5,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? Answer: Yes, neoadjuvant chemotherapy could reduce tumor size and lymph node involvement, thus potentially limiting the scope of lymphadenectomy, though more studies are warranted.",4.263475092423369e-07,0.27710451911558165,0.09162848812994587,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.5,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Can the scope of lymphadenectomy be altered by neoadjuvant chemotherapy in cervical cancer patients? Answer: Yes, neoadjuvant chemotherapy might reduce tumor size and lymph node involvement, thereby modifying the extent of lymphadenectomy; however, further research is essential.",4.026615365066516e-07,0.28717296009286875,0.0646223152904397,0.030828249901291835,0.30830348295714893,0.05640000000000001,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
132,0.5,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Does neoadjuvant chemotherapy have the ability to change the extent of lymphadenectomy in cervical cancer? Answer: Yes, it may reduce the tumor and affected lymph nodes, which could decrease the surgical extent, but more research is required.",4.026615365066516e-07,0.24970554492746633,0.09162848812994587,0.030828249901291835,0.30830348295714893,0.05640000000000001,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
132,0.5,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Could the application of neoadjuvant chemotherapy modify lymphadenectomy extent in cervical cancer? Answer: Yes, by potentially reducing tumor size and lymph node involvement, neoadjuvant chemotherapy could lessen the extent of lymphadenectomy, though further studies are needed.",4.263475092423369e-07,0.3156126958133565,0.06387338608912954,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.5,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Is it feasible for neoadjuvant chemotherapy to alter lymphadenectomy extent in cervical cancer? Answer: Yes, neoadjuvant chemotherapy may shrink the tumor and reduce lymph node involvement, thus potentially decreasing the surgical scope, but more research is necessary.",4.026615365066516e-07,0.28717296009286875,0.0646223152904397,0.030828249901291835,0.30830348295714893,0.05640000000000001,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
132,0.5,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Question: Can neoadjuvant chemotherapy change how extensive lymphadenectomy is in cervical cancer treatment? Answer: Yes, it might reduce tumor size and lymph node involvement, potentially limiting lymphadenectomy extent, but additional research is still required.",4.974054274493928e-07,0.3641158961052118,0.09162848812994587,0.038081955760419346,0.42608651861353275,0.05640000000000001,0.038026832360010226,0.4905970071516679,0.01922337562475971,4.974054274493935e-07,0.5306282510621703,0.0
133,0.5,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental factors significant in primary systemic vasculitis? A novel link between farming and PSV has been discovered. Additionally, findings reinforce earlier reported connections with silica, solvents, and allergies.",1.421158364141118e-07,0.19415601444095776,0.0,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
133,0.5,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental influences play a role in primary systemic vasculitis? For the first time, a strong correlation between farming and PSV has been found. The results also confirm previously noted associations with silica, solvents, and allergic reactions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.5,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there an importance of environmental factors in primary systemic vasculitis? A new significant relationship between farming and PSV has been established. The data also uphold prior reported links with silica, solvents, and allergy.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.5,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","How important are environmental factors in primary systemic vasculitis? A significant association between farming and PSV has been identified for the first time, along with support for earlier reported connections with silica, solvents, and allergy.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.5,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental factors relevant to primary systemic vasculitis? For the first time, a substantial association between farming and PSV has been observed. The results also back previous reports linking silica, solvents, and allergy.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
133,0.5,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental factors matter in primary systemic vasculitis? A notable connection between farming and PSV has been found for the first time, supporting earlier reported associations with silica, solvents, and allergy.",9.47438909427412e-08,0.125163142954007,0.0,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
133,0.5,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there a significant role of environmental factors in primary systemic vasculitis? A first-time significant link between farming and PSV has been discovered, alongside confirmation of previously reported associations with silica, solvents, and allergy.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.5,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental influences important in primary systemic vasculitis? A newly identified significant association between farming and PSV has been reported, with results also supporting earlier links to silica, solvents, and allergy.",9.47438909427412e-08,0.125163142954007,0.0,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
133,0.5,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","What is the importance of environmental factors in primary systemic vasculitis? A significant farming-PSV association has been found for the first time, and results also corroborate previous reports involving silica, solvents, and allergy.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
133,0.5,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Can environmental factors be considered important in primary systemic vasculitis? A significant connection between farming and PSV has been identified for the first time, with findings also supporting earlier reported associations with silica, solvents, and allergy.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
134,0.5,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program lower disability rates among the elderly? The program itself does not directly decrease disability in older adults, but it offers financial support to disabled elderly individuals, which can indirectly improve their health by helping them pay for essential medical care, medications, and therapies.",1.8948778188548325e-07,0.019136115312727853,0.12244897959183677,0.014507411718254981,0.03115882342060461,0.08999999999999998,0.014486412327622933,0.08332629667963021,0.05536332179930796,1.8948778188548325e-07,0.13747292640218056,0.018860946745562133
134,0.5,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does Supplemental Security Income reduce disability in seniors? While the program does not directly lessen disability in the elderly, it provides monetary aid to those with disabilities, which can indirectly benefit their health by making medical treatments, drugs, and therapies more affordable.",3.552895910352811e-07,0.17230488647914521,0.09807397959183678,0.02720139697172809,0.19242697101672634,0.08999999999999998,0.027162023114293,0.2484060470390803,0.05536332179930796,3.552895910352811e-07,0.30654925644611364,0.018860946745562133
134,0.5,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Is disability among the elderly reduced by the Supplemental Security Income program? The program does not directly reduce disability but offers financial help to elderly disabled individuals, indirectly supporting their health through access to necessary medical services and treatments.",4.263475092423371e-07,0.21447873586877675,0.12244897959183677,0.03264167636607371,0.2703885124864369,0.08999999999999998,0.0325944277371516,0.3284487547126145,0.05536332179930796,4.263475092423373e-07,0.38878735468308667,0.018860946745562133
134,0.5,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program help reduce disability in older adults? It does not directly reduce disability, but by providing financial assistance to elderly people with disabilities, it indirectly supports their health and well-being by enabling access to medical care and therapies.",3.316036182995957e-07,0.11439527731179533,0.12244897959183677,0.025387970506946217,0.16773435842635465,0.08999999999999998,0.025351221573340132,0.22308823905478858,0.05536332179930796,3.316036182995957e-07,0.28057377004285566,0.018860946745562133
134,0.5,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Can Supplemental Security Income decrease disability in the elderly? This program does not directly lower disability rates but provides financial resources to disabled seniors, which can indirectly enhance their health by covering costs of medical treatments and medications.",4.500334819780224e-07,0.24114698295093762,0.12244897959183677,0.03445510283085558,0.29778748667455224,0.08999999999999998,0.034405229278104466,0.3566196316793113,0.05536332179930796,4.500334819780227e-07,0.4177748915563382,0.018860946745562133
134,0.5,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program directly reduce disability in elderly individuals? No, but it offers financial aid to elderly disabled persons, which can indirectly improve their health by allowing them to afford necessary medical care and therapies.",4.500334819780224e-07,0.24114698295093762,0.12244897959183677,0.03445510283085558,0.29778748667455224,0.08999999999999998,0.034405229278104466,0.3566196316793113,0.05536332179930796,4.500334819780227e-07,0.4177748915563382,0.018860946745562133
134,0.5,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Is there a reduction in elderly disability due to Supplemental Security Income? The program itself does not directly reduce disability, but it provides financial support that indirectly benefits disabled elderly by helping them afford medical treatments and medications.",4.500334819780224e-07,0.24114698295093762,0.12244897959183677,0.03445510283085558,0.29778748667455224,0.08999999999999998,0.034405229278104466,0.3566196316793113,0.05536332179930796,4.500334819780227e-07,0.4177748915563382,0.018860946745562133
134,0.5,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does Supplemental Security Income directly impact disability rates in the elderly? It does not directly reduce disability but supports elderly individuals with disabilities financially, indirectly promoting their health by enabling access to medical treatments and therapies.",4.97405427449393e-07,0.2967168341057498,0.12244897959183677,0.03808195576041933,0.3549459005145006,0.08999999999999998,0.03802683236001021,0.4154601317022446,0.05536332179930796,4.974054274493935e-07,0.47839951337277364,0.018860946745562133
134,0.5,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program lead to less disability among elderly people? The program does not directly reduce disability but offers financial assistance to disabled elderly, indirectly influencing their health by helping with the costs of medical care and medications.",3.789755637709665e-07,0.16318544148122704,0.12244897959183677,0.029014823436509962,0.21774477900101807,0.08999999999999998,0.028972824655245866,0.2743815334423383,0.05536332179930796,3.789755637709665e-07,0.3332175035282745,0.018860946745562133
134,0.5,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Does the Supplemental Security Income program reduce disability in older adults? While it does not directly decrease disability, it provides financial help to elderly disabled individuals, indirectly supporting their health and well-being by enabling access to necessary medical treatments and therapies.",3.789755637709665e-07,0.16318544148122704,0.12244897959183677,0.029014823436509962,0.21774477900101807,0.08999999999999998,0.028972824655245866,0.2743815334423383,0.05536332179930796,3.789755637709665e-07,0.3332175035282745,0.018860946745562133
135,0.5,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Is primary angioplasty a viable substitute for thrombolysis? Answer: Yes, primary angioplasty is regarded as a valid and frequently better option compared to thrombolysis. It typically results in lower death rates, decreased risk of reinfarction, and a reduced likelihood of intracranial bleeding. The decision between",4.737194547137081e-08,0.07913464021248595,0.024190208012743315,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
135,0.5,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Can primary angioplasty be used instead of thrombolysis? Answer: Yes, primary angioplasty is an accepted and often preferred alternative to thrombolysis, generally linked with lower mortality, fewer reinfarction cases, and a smaller risk of intracranial hemorrhage. The selection between",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
135,0.5,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is widely accepted and often considered superior to thrombolysis, commonly associated with decreased mortality, reduced reinfarction risk, and less chance of brain hemorrhage. Choosing between",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
135,0.5,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Could primary angioplasty replace thrombolysis? Answer: Yes, primary angioplasty is an acceptable, and frequently better, alternative to thrombolysis, as it is usually connected with lower death rates, fewer reinfarctions, and less intracranial bleeding. The choice between",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
135,0.5,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Is primary angioplasty a suitable alternative to thrombolysis? Answer: Yes, primary angioplasty is viewed as an acceptable and often superior alternative to thrombolysis, typically linked to lower mortality, reduced reinfarction risk, and diminished chances of intracranial hemorrhage. The decision between",7.105791820705622e-08,0.07715657214167182,0.003460544030479129,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
135,0.5,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Does primary angioplasty serve as an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable and often better alternative to thrombolysis, generally associated with decreased mortality rates, lower risk of reinfarction, and less intracranial bleeding. The choice between",4.737194547137081e-08,0.08458541426017607,0.02631372962604702,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
135,0.5,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Is primary angioplasty a recommended alternative to thrombolysis? Answer: Yes, primary angioplasty is accepted as an alternative and often a superior choice compared to thrombolysis, usually resulting in lower mortality, fewer reinfarctions, and reduced intracranial hemorrhage risk. The decision between",7.105791820705622e-08,0.042499213113674106,0.021417388369294285,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
135,0.5,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Can primary angioplasty be an alternative to thrombolysis? Answer: Yes, primary angioplasty is recognized as an acceptable and often preferable alternative to thrombolysis, commonly linked with lower death rates, decreased reinfarction risk, and less chance of brain hemorrhage. The choice between",4.737194547137081e-08,0.05077335667188576,0.002251250683960135,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
135,0.5,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Is primary angioplasty an effective alternative to thrombolysis? Answer: Yes, primary angioplasty is accepted as an effective and often superior alternative to thrombolysis, generally associated with reduced mortality, fewer reinfarctions, and a lower risk of intracranial hemorrhage. The decision between",7.105791820705622e-08,0.11181393116966865,0.02810598755740803,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
135,0.5,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Question: Is primary angioplasty considered an alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable and often superior alternative to thrombolysis, typically connected with lower mortality rates, reduced reinfarction risk, and less intracranial bleeding. The choice between",1.1842986367842682e-07,0.1685794401405878,0.0319663951243793,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
136,0.5,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Are culture, attitudes, and faith relevant in recovery outcome measures? Yes, these elements should be included as they greatly impact how individuals view and engage with recovery.",2.36859727356853e-07,0.20989787034130325,0.08264462809917354,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
136,0.5,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Do recovery outcome measures have room for culture, attitudes, and faith? Absolutely, because these aspects shape a person's understanding and method of recovery.",3.316036182995942e-07,0.3769519550044702,0.08264462809917354,0.025387970506946314,0.4712172134482806,0.02854671280276816,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
136,0.5,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Is there a role for culture, attitudes, and faith in assessing recovery outcomes? Yes, since these factors profoundly affect a person's recovery perspective and strategy.",2.842316728282236e-07,0.2899405780148405,0.08264462809917354,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
136,0.5,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Should culture, attitudes, and faith be integrated into recovery outcome measures? Yes, they are crucial as they influence how recovery is perceived and approached by individuals.",2.605457000925383e-07,0.2491185834945857,0.08264462809917354,0.019947691112600675,0.337685820823757,0.02854671280276816,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
136,0.5,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Can culture, attitudes, and faith be considered in recovery outcome assessments? Yes, these components significantly shape a person's recovery outlook and approach.",3.552895910352795e-07,0.42347197063936415,0.08264462809917354,0.027201396971728194,0.5200073776177119,0.02854671280276816,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
136,0.5,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Is it important to include culture, attitudes, and faith in recovery outcome measures? Yes, because they play a key role in how recovery is understood and pursued.",2.36859727356853e-07,0.20989787034130325,0.08264462809917354,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
136,0.5,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Do culture, attitudes, and faith have significance in recovery outcome measures? Yes, as they affect the way people perceive and engage with recovery.",3.316036182995942e-07,0.3769519550044702,0.08264462809917354,0.025387970506946314,0.4712172134482806,0.02854671280276816,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
136,0.5,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Are culture, attitudes, and faith factors to consider in recovery outcome measures? Yes, since they impact an individual's view and method of recovery.",3.316036182995942e-07,0.3769519550044702,0.08264462809917354,0.025387970506946314,0.4712172134482806,0.02854671280276816,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
136,0.5,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Does culture, attitudes, and faith matter in recovery outcome measures? Yes, these elements influence how recovery is perceived and approached.",4.026615365066502e-07,0.5235554291963456,0.08264462809917354,0.030828249901291953,0.6253678932755373,0.02854671280276816,0.030783626196198847,0.6931471805599458,0.0,4.0266153650665164e-07,0.7239188392266991,0.0
136,0.5,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Is there a place for culture, attitudes, and faith in recovery outcome measures? Yes, because they significantly shape a person's perception and approach to recovery.",2.842316728282236e-07,0.2899405780148405,0.08264462809917354,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
137,0.5,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is cholecystectomy truly a reason to perform splenectomy simultaneously in mild hereditary spherocytosis? No, cholecystectomy alone does not automatically indicate the need for splenectomy in mild hereditary spherocytosis. Both surgeries are treatment options, but splenectomy is usually reserved for more severe cases and depends on the patient's condition.",1.4211583641411244e-07,0.003959920405923967,0.08654787743004502,0.010880558788691236,0.007217885637957444,0.0916931550327896,0.0108648092457172,0.010748068920493736,0.09688090737240077,1.4211583641411244e-07,0.016929822620292523,0.07939508506616257
137,0.5,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does cholecystectomy warrant a concurrent splenectomy in mild hereditary spherocytosis? No, cholecystectomy is not necessarily an indication for splenectomy in mild hereditary spherocytosis. While both can be treatments, splenectomy is generally considered only in severe cases based on individual patient assessment.",3.079176455639103e-07,0.20228905486483173,0.054510073860709926,0.023574544042164344,0.1988170493030723,0.06228933680014255,0.023540420032387266,0.19480969167922568,0.07058434053529339,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
137,0.5,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is performing a splenectomy alongside cholecystectomy indicated in mild hereditary spherocytosis? No, cholecystectomy does not inherently require a simultaneous splenectomy in mild hereditary spherocytosis. Treatment choices depend on the severity of the disease, with splenectomy reserved for more serious presentations.",3.316036182995956e-07,0.19472680428410083,0.07788479993813871,0.025387970506946217,0.19018194774314834,0.08712498325741062,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
137,0.5,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Should splenectomy be done at the same time as cholecystectomy in mild hereditary spherocytosis? No, having a cholecystectomy is not a definite reason to do a splenectomy concurrently in mild hereditary spherocytosis. Both procedures are options, but splenectomy is typically for severe cases and depends on the patient's specific condition.",9.474389094274162e-08,0.048040422904834124,0.08827459584908273,0.0072537058591274906,0.05103320147081192,0.09259764787631972,0.007243206163811466,0.0542331808602321,0.09688090737240077,9.474389094274162e-08,0.027521939950540197,0.07939508506616257
137,0.5,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is concomitant splenectomy indicated when performing cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy does not automatically indicate the need for splenectomy in mild hereditary spherocytosis. The decision depends on the individual patient's severity, with splenectomy usually reserved for severe disease.",3.316036182995956e-07,0.19472680428410083,0.07788479993813871,0.025387970506946217,0.19018194774314834,0.08712498325741062,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
137,0.5,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does mild hereditary spherocytosis require splenectomy when cholecystectomy is performed? No, cholecystectomy alone is not an indication for splenectomy in mild hereditary spherocytosis. Both treatments are possible, but splenectomy is generally reserved for severe cases depending on patient condition.",3.552895910352809e-07,0.18609170272417686,0.10272044639540678,0.02720139697172809,0.18036876426952286,0.113421550094518,0.027162023114293,0.21239548239371553,0.09688090737240077,3.552895910352811e-07,0.24577139504914092,0.07939508506616257
137,0.5,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is it necessary to perform splenectomy along with cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy is not necessarily an indication for simultaneous splenectomy in mild hereditary spherocytosis. Treatment depends on disease severity, with splenectomy typically reserved for more severe cases.",3.316036182995956e-07,0.19472680428410083,0.07788479993813871,0.025387970506946217,0.19018194774314834,0.08712498325741062,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
137,0.5,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is splenectomy indicated concurrently with cholecystectomy in patients with mild hereditary spherocytosis? No, cholecystectomy does not necessarily require a concomitant splenectomy in mild hereditary spherocytosis. Both are treatment options, but splenectomy is generally reserved for severe presentations based on individual patient factors.",2.8423167282822487e-07,0.10743642277875898,0.10464201323251415,0.02176111757738247,0.10240722279981229,0.113421550094518,0.0217296184914344,0.13235277472018137,0.09688090737240077,2.8423167282822487e-07,0.16353329681216788,0.07939508506616257
137,0.5,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Should splenectomy be performed alongside cholecystectomy in mild hereditary spherocytosis cases? No, cholecystectomy is not by itself an indication for splenectomy in mild hereditary spherocytosis. While both are treatments, splenectomy is usually reserved for severe cases and depends on the patient's individual status.",2.6054570009253947e-07,0.11554083080759314,0.08151701323251415,0.0199476911126006,0.11152666779773046,0.089046550094518,0.019918816950481533,0.10703496673588964,0.09688090737240077,2.6054570009253947e-07,0.1375578104089099,0.07939508506616257
137,0.5,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is a splenectomy required at the time of cholecystectomy in mild hereditary spherocytosis? No, cholecystectomy alone does not warrant a concomitant splenectomy in mild hereditary spherocytosis. The use of splenectomy is typically limited to severe cases and depends on the patient's condition.",2.8423167282822487e-07,0.14124848036704885,0.08036481073415783,0.02176111757738247,0.13706458182780867,0.08843798664941607,0.0217296184914344,0.13235277472018137,0.09688090737240077,2.8423167282822487e-07,0.16353329681216788,0.07939508506616257
138,0.5,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair appropriate for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? It is generally considered justified by doctors, based mainly on the patient's overall health and surgical fitness rather than age alone, weighing risks and benefits.",3.552895910352809e-07,0.12345377478876962,0.14617283950617282,0.02720139697172809,0.18036876426952286,0.113421550094518,0.027162023114293,0.21239548239371553,0.09688090737240077,3.552895910352811e-07,0.24577139504914092,0.07939508506616257
138,0.5,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients aged 80 or older who have experienced aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? Physicians usually justify the procedure, focusing on the patient's general condition and suitability for surgery rather than age, while considering risks and benefits.",3.552895910352809e-07,0.12345377478876962,0.14617283950617282,0.02720139697172809,0.18036876426952286,0.113421550094518,0.027162023114293,0.21239548239371553,0.09688090737240077,3.552895910352811e-07,0.24577139504914092,0.07939508506616257
138,0.5,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is it reasonable to perform aneurysm repair on patients aged 80 and above after aneurysmal subarachnoid hemorrhage? Typically, doctors support this intervention, basing the decision on the patient’s health status and surgical readiness instead of age alone, balancing risks and benefits.",3.079176455639103e-07,0.07216048040121992,0.14617283950617282,0.023574544042164344,0.12772503078410402,0.113421550094518,0.023540420032387266,0.15832826112343934,0.09688090737240077,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
138,0.5,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Should aneurysm repair be conducted on patients 80 years or older after aneurysmal subarachnoid hemorrhage? Medical professionals often justify it, primarily assessing the patient’s overall health and ability to undergo surgery, not merely their age, alongside the associated risks and benefits.",3.079176455639103e-07,0.07216048040121992,0.14617283950617282,0.023574544042164344,0.12772503078410402,0.113421550094518,0.023540420032387266,0.15832826112343934,0.09688090737240077,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
138,0.5,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair justified in patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Physicians generally consider it appropriate, with the decision relying on the patient’s general health and fitness for surgery rather than age, taking into account risks and benefits.",3.079176455639103e-07,0.07216048040121992,0.14617283950617282,0.023574544042164344,0.12772503078410402,0.113421550094518,0.023540420032387266,0.15832826112343934,0.09688090737240077,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
138,0.5,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients aged 80 years or more after aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? The procedure is usually deemed appropriate by physicians, who base their decision on the patient’s overall health and surgical fitness, not just age, while evaluating risks and benefits.",2.6054570009253947e-07,0.023370316231788202,0.14617283950617282,0.0199476911126006,0.0777146102094406,0.113421550094518,0.019918816950481533,0.10703496673588964,0.09688090737240077,2.6054570009253947e-07,0.1375578104089099,0.07939508506616257
138,0.5,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair warranted for patients aged 80 and over after aneurysmal subarachnoid hemorrhage? Doctors typically justify the surgery by focusing on the patient’s general health and readiness for surgery, rather than age alone, considering risks and benefits.",3.789755637709662e-07,0.1501220218709305,0.14617283950617282,0.029014823436509962,0.20776773845763818,0.113421550094518,0.028972824655245866,0.24056635936041237,0.09688090737240077,3.789755637709665e-07,0.2747589319223924,0.07939508506616257
138,0.5,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is it justified to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Medical practitioners usually justify this based on the patient’s health condition and surgical fitness, rather than age, while weighing the risks and benefits.",3.316036182995956e-07,0.09747828838551165,0.14617283950617282,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.5,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Should patients aged 80 or above undergo aneurysm repair after aneurysmal subarachnoid hemorrhage? Physicians often find it justified, with the decision depending largely on the patient’s overall health and fitness for surgery, not merely their age, while considering risks and benefits.",3.079176455639103e-07,0.07216048040121992,0.14617283950617282,0.023574544042164344,0.12772503078410402,0.113421550094518,0.023540420032387266,0.15832826112343934,0.09688090737240077,3.079176455639103e-07,0.19020154389432875,0.07939508506616257
138,0.5,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair advisable for patients aged 80 years or older following aneurysmal subarachnoid hemorrhage? It is generally justified by doctors, who base the decision on the patient’s general health and suitability for surgery instead of age alone, evaluating risks and benefits.",2.8423167282822487e-07,0.04746786781084822,0.14617283950617282,0.02176111757738247,0.10240722279981229,0.113421550094518,0.0217296184914344,0.13235277472018137,0.09688090737240077,2.8423167282822487e-07,0.16353329681216788,0.07939508506616257
139,0.5,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Is there a difference in blood pressure readings in treated hypertensive patients based on whether a physician or a nurse takes the measurement? Systolic blood pressure recorded by nurses in treated hypertensive patients tends to be significantly lower than that recorded by physicians and closely matches ambulatory blood pressure monitoring. Measuring blood pressure by nurses is preferred not only for diagnosis but also for assessing control levels.,7.105791820705622e-08,0.06517881529277059,0.07561959134788218,0.005440279394345618,0.026615601048327164,0.013285447424641588,0.0054324046228586,0.04677942481006081,0.0006991164999823052,7.105791820705622e-08,0.046520015634889056,0.0
139,0.5,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, does blood pressure vary when measured by a physician versus a nurse? Nurses measure systolic blood pressure significantly lower than physicians in these patients, with readings nearly identical to ambulatory blood pressure monitoring. Nurse-led blood pressure measurement is recommended for both diagnosis and control evaluation.",4.974054274493935e-07,0.31011693635191584,0.04882080683209422,0.038081955760419325,0.30820005812252527,0.044023668639053264,0.0380268323600102,0.3553602622881411,0.014921946740128552,4.974054274493935e-07,0.38299225225610467,0.0
139,0.5,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does blood pressure in treated hypertensive patients differ depending on whether a nurse or a physician measures it? Systolic blood pressure readings taken by nurses are significantly lower than those by physicians and closely align with ambulatory blood pressure monitoring. Blood pressure measurement by nurses is beneficial for diagnosis and monitoring control.,4.263475092423373e-07,0.26987899631665746,0.05878811229962591,0.03264167636607371,0.24632465440443774,0.044023668639053264,0.0325944277371516,0.2921813606666088,0.014921946740128552,4.263475092423373e-07,0.31845373111853315,0.0
139,0.5,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For treated hypertensive patients, is there a variation in blood pressure readings based on whether a physician or nurse performs the measurement? Nurses record significantly lower systolic blood pressure than physicians, with values nearly matching ambulatory blood pressure monitoring. Nurse measurements are advantageous for diagnosis and control assessment.",5.210914001850789e-07,0.285770004094815,0.05982116847654792,0.0398953822252012,0.3297062633434886,0.044023668639053264,0.039837633900963065,0.3773391690069161,0.014921946740128552,5.210914001850789e-07,0.4054651081081624,0.0
139,0.5,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does the method of blood pressure measurement—by a nurse or a physician—affect readings in treated hypertensive patients? Nurses obtain systolic blood pressure readings that are significantly lower than physicians’ and closely resemble ambulatory blood pressure monitoring. Measuring blood pressure by nurses is desirable for diagnosis and evaluating control.,5.210914001850789e-07,0.33362831427513884,0.05316194549141448,0.0398953822252012,0.3297062633434886,0.044023668639053264,0.039837633900963065,0.3773391690069161,0.014921946740128552,5.210914001850789e-07,0.4054651081081624,0.0
139,0.5,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In patients treated for hypertension, does blood pressure change depending on whether a nurse or physician measures it? Systolic blood pressure measured by nurses is significantly lower than that recorded by physicians and almost identical to ambulatory blood pressure monitoring. Nurse measurement is preferred for diagnosis and control assessment.",4.974054274493935e-07,0.26325567430034846,0.06166858615257309,0.038081955760419325,0.30820005812252527,0.044023668639053264,0.0380268323600102,0.3553602622881411,0.014921946740128552,4.974054274493935e-07,0.38299225225610467,0.0
139,0.5,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Is there a significant difference in blood pressure readings in treated hypertensive patients when measured by a nurse compared to a physician? Nurses measure systolic blood pressure significantly lower than physicians, with results nearly matching ambulatory blood pressure monitoring. Blood pressure measurement by nurses is recommended for both diagnosis and control evaluation.",4.263475092423373e-07,0.24269675394175572,0.03685900127653849,0.03264167636607371,0.24632465440443774,0.044023668639053264,0.0325944277371516,0.2921813606666088,0.014921946740128552,4.263475092423373e-07,0.31845373111853315,0.0
139,0.5,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Do blood pressure readings in treated hypertensive patients vary depending on whether a nurse or physician takes the measurement? Nurses record systolic blood pressure significantly lower than physicians, with readings closely matching ambulatory blood pressure monitoring. Nurse measurement is beneficial for diagnosis and assessing control levels.",5.684633456564497e-07,0.3323717466407037,0.05587482444006507,0.04352223515476494,0.37415802591432135,0.044023668639053264,0.0434592369828688,0.42280154308367335,0.014921946740128552,5.684633456564497e-07,0.4519851237430563,0.0
139,0.5,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Systolic blood pressure values taken by nurses are significantly lower than those by physicians and closely correspond to ambulatory blood pressure monitoring. Blood pressure measurement by nurses is useful for diagnosis and control evaluation.",4.737194547137081e-07,0.315431727333396,0.06758623893085958,0.03626852929563745,0.2871466489246921,0.044023668639053264,0.03621603081905733,0.33385405706717775,0.014921946740128552,4.737194547137081e-07,0.36101334553732967,0.0
139,0.5,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Does blood pressure measurement by a nurse versus a physician affect readings in treated hypertensive patients? Nurses obtain significantly lower systolic blood pressure readings than physicians, nearly identical to ambulatory blood pressure monitoring. Nurse measurement is desirable for diagnosis and control assessment.",6.632072365991914e-07,0.4326076154866705,0.04680049494305384,0.050775941013892434,0.469468205718647,0.044023668639053264,0.050702443146680265,0.5204400126475912,0.014921946740128552,6.632072365991914e-07,0.5520685823000377,0.0
140,0.5,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The use of audits to identify maternal mortality across various settings raises the question: is it merely a disparity between the wealthy and the poor? The answer is that differences in maternal mortality extend beyond economic status. Recognizing the scale of maternal mortality and mobilizing strong political commitment are crucial. Nonetheless, no universal solution exists to lower maternal mortality, and problem identification remains key.",1.8948778188548325e-07,0.06686396591389432,0.035822605128265864,0.014507411718255009,0.08175244668655601,0.02854671280276816,0.014486412327622933,0.10314141779902108,0.014489619377162637,1.8948778188548325e-07,0.1251631429540092,0.0
140,0.5,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Does the use of audits to detect maternal mortality in different contexts simply reflect a gap between rich and poor? Differences in maternal mortality involve more than economic inequalities. Understanding the extent of maternal mortality and securing political will to address it are vital. However, there is no one-size-fits-all approach to reducing maternal mortality, and identifying specific issues is essential.",2.8423167282822487e-07,0.136008019307436,0.031377105225002505,0.0217611175773825,0.14844382118522859,0.02854671280276816,0.0217296184914344,0.17096401413778128,0.014489619377162637,2.8423167282822487e-07,0.1941560144409591,0.0
140,0.5,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","When using audits to identify maternal mortality in diverse settings, is it just a matter of disparity between the affluent and the underprivileged? Maternal mortality differences go beyond wealth. Acknowledging the severity of maternal mortality and fostering strong political resolve to confront it are important. Still, no single solution can reduce maternal mortality universally, and pinpointing problems is necessary.",3.079176455639103e-07,0.1928473185334938,0.060339761248852,0.023574544042164372,0.16583556389709742,0.02854671280276816,0.023540420032387266,0.1886635912371819,0.014489619377162637,3.079176455639103e-07,0.21217451994363756,0.0
140,0.5,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is the application of audit to uncover maternal mortality in various settings simply a reflection of the divide between rich and poor? Maternal mortality differences are more complex than just economic status. Recognizing the magnitude of the problem and harnessing robust political will are critical steps. However, reducing maternal mortality lacks a universal solution, and problem identification is vital.",3.079176455639103e-07,0.17796721133771198,0.012387511478420682,0.023574544042164372,0.16583556389709742,0.02854671280276816,0.023540420032387266,0.1886635912371819,0.014489619377162637,3.079176455639103e-07,0.21217451994363756,0.0
140,0.5,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to identify maternal mortality in different environments: is it solely an issue of rich versus poor? The disparities in maternal mortality extend beyond economic lines. It is important to acknowledge the scale of maternal mortality and to cultivate strong political will to address it. Nevertheless, there is no single general solution to decrease maternal mortality, and identifying problems is key.",2.3685972735685406e-07,0.10084006980060956,0.03367388069406822,0.018134264647818754,0.11454226950954816,0.02854671280276816,0.018108015409528666,0.13647783806661273,0.014489619377162637,2.3685972735685406e-07,0.15906469462968964,0.0
140,0.5,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is audit use to identify maternal mortality in various settings merely a contrast between the wealthy and the impoverished? Differences in maternal mortality surpass economic distinctions. Recognizing the extent of maternal mortality and mobilizing strong political commitment are essential. Yet, no universal remedy exists to reduce maternal mortality, and identifying the problems remains crucial.",4.263475092423373e-07,0.2495775091097152,0.02342789327690241,0.032641676366073735,0.2576431131502197,0.02854671280276816,0.0325944277371516,0.28218964924800627,0.014489619377162637,4.263475092423373e-07,0.3074846997479632,0.0
140,0.5,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Does auditing maternal mortality in different contexts simply highlight the divide between rich and poor? Maternal mortality disparities are more than economic differences. Acknowledging the magnitude of maternal mortality and fostering strong political will are important. However, there is no single overarching solution to reduce maternal mortality, and problem identification is necessary.",4.737194547137081e-07,0.2904824409667408,0.020354715226170314,0.03626852929563748,0.29686382630350217,0.02854671280276816,0.03621603081905733,0.32219498386170464,0.014489619377162637,4.737194547137081e-07,0.3483066942682176,0.0
140,0.5,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is the use of audit to detect maternal mortality in various settings just a matter of the rich-poor gap? Differences in maternal mortality are more complex than income disparities. Recognizing the scale of maternal mortality and leveraging strong political will are key factors. Still, there is no single general solution to lowering maternal mortality, and identifying issues is important.",3.079176455639103e-07,0.1540655844218506,0.03016833455145143,0.023574544042164372,0.16583556389709742,0.02854671280276816,0.023540420032387266,0.1886635912371819,0.014489619377162637,3.079176455639103e-07,0.21217451994363756,0.0
140,0.5,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The role of audits in identifying maternal mortality across different settings: is it simply a matter of economic disparity? Maternal mortality differences involve more than just wealth gaps. Acknowledging the severity of maternal mortality and securing strong political will are crucial. Yet, there is no universal solution to reduce maternal mortality, and problem identification is essential.",3.789755637709665e-07,0.21027494283862458,0.026273691966756524,0.02901482343650999,0.21990278516737227,0.02854671280276816,0.028972824655245866,0.24372336842021047,0.014489619377162637,3.789755637709665e-07,0.26826398659468076,0.0
140,0.5,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is auditing maternal mortality in different environments just a reflection of the rich-poor divide? Differences in maternal mortality go beyond economic status. Recognizing the magnitude of maternal mortality and harnessing strong political will are important. However, no single solution exists to reduce maternal mortality universally, and identifying the problems is necessary.",4.974054274493935e-07,0.3565643648779169,0.08709372418784307,0.03808195576041935,0.3170665336210208,0.02854671280276816,0.0380268323600102,0.3428142710644404,0.014489619377162637,4.974054274493935e-07,0.36936010346605075,0.0
141,0.5,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is it possible for visceral adipose tissue area measurement at a single level to represent visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,2.3685972735685406e-08,0.002266181631366493,0.011599999999999944,0.0018134264647818726,0.004339744819346958,0.01474622770919079,0.0018108015409528666,0.005591856594737266,0.01626275510204081,2.3685972735685406e-08,0.006090557415993736,0.016900510204081638
141,0.5,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,"Can measuring visceral adipose tissue area at one level indicate visceral adipose tissue volume? Measuring VAT area at a single level, 3 cm above the lower margin of the L3 vertebra, is practical and can indicate changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower",9.474389094274162e-08,0.03660877734572088,0.01944444444444446,0.0072537058591274906,0.0535430937784338,0.011739312040478192,0.007243206163811466,0.04932782794894042,0.01592684955790791,9.474389094274162e-08,0.04843840057857163,0.017538265306122455
141,0.5,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does visceral adipose tissue area measurement at a single level represent visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is possible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,7.105791820705622e-08,0.08823371454313023,0.025425330812854474,0.005440279394345618,0.08323471888572564,0.02158079561042535,0.0054324046228586,0.08092262754331303,0.01992512981523971,7.105791820705622e-08,0.08109050316345101,0.0194439832145876
141,0.5,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can a single-level measurement of visceral adipose tissue area represent the volume of visceral adipose tissue? Measuring VAT area at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,4.737194547137081e-08,0.038556922496021606,0.08158400615148023,0.0036268529295637453,0.014287417910339606,0.014243483492458284,0.003621603081905733,0.012043322428119119,0.0165875358407826,4.737194547137081e-08,0.011397128898221531,0.017538265306122455
141,0.5,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is a single-level measurement of visceral adipose tissue area sufficient to represent visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra at one level is feasible and reflects changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,9.474389094274162e-08,0.04700070885292584,0.11157247212610534,0.0072537058591274906,0.0031323897377104615,0.047707349636993704,0.007243206163811466,0.02365571015042356,0.03443877551020409,9.474389094274162e-08,0.04843840057857163,0.017538265306122455
141,0.5,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can visceral adipose tissue volume be represented by measuring its area at a single level? VAT area measured 3 cm above the lower margin of the L3 vertebra at a single level is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,7.105791820705622e-08,0.00905010027230091,0.039599999999999996,0.005440279394345618,0.00896894954001759,0.03061941798872029,0.0054324046228586,0.005306571482227795,0.03443877551020409,7.105791820705622e-08,0.029746267566417295,0.017538265306122455
141,0.5,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is measuring visceral adipose tissue area at a single level an accurate representation of visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can indicate changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,0.0,0.0,0.0,0.0,4.440892098500626e-16,1.3877787807814457e-17,0.0,0.023901626915860064,0.017202702872469406,0.0,0.024320953703857562,0.017538265306122455
141,0.5,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does a single-level measurement of visceral adipose tissue area accurately represent visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra at one level is feasible and reflects changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,1.1842986367842703e-07,0.02673172549128644,0.11000000000000003,0.009067132323909363,0.0224150599622166,0.04703695586886464,0.009054007704764333,0.04234784316257789,0.03443877551020409,1.1842986367842703e-07,0.06748659554926473,0.017538265306122455
141,0.5,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is it feasible to represent visceral adipose tissue volume by measuring its area at a single level? VAT area measurement 3 cm above the lower margin of the L3 vertebra at a single level is feasible and reflects changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,4.737194547137081e-08,0.029535402775943354,0.04236831987697037,0.0036268529295637453,0.0100335357935184,0.03155006858710558,0.003621603081905733,0.012711934020450677,0.03443877551020409,4.737194547137081e-08,0.011397128898221531,0.017538265306122455
141,0.5,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can visceral adipose tissue volume be estimated from a single-level measurement of visceral adipose tissue area? Measuring VAT area 3 cm above the lower margin of the L3 vertebra at a single level is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,4.737194547137081e-08,0.06245854941188167,0.09792899408284027,0.0036268529295637453,0.03435448949737596,0.04897788207552509,0.003621603081905733,0.012711934020450677,0.03443877551020409,4.737194547137081e-08,0.011397128898221531,0.017538265306122455
142,0.5,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition impact quality of life? Yes, it does. This phase is commonly linked to physical symptoms including hot flashes and sleep problems, as well as psychological challenges such as mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.5,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life affected by the menopausal transition? Indeed, it is. Menopausal transition often brings physical symptoms like hot flashes and sleep disturbances, along with psychological issues like mood swings and depression.",2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
142,0.5,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does going through menopause affect one's quality of life? Yes, menopausal transition influences quality of life, often causing physical symptoms such as hot flashes and sleep problems, as well as psychological effects like mood swings and depression.",1.1842986367842661e-07,0.03331307459281296,0.06866564302857742,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
142,0.5,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is the quality of life influenced by menopausal transition? Yes, it is affected. This transition is frequently accompanied by physical symptoms like hot flashes and sleep disturbances and psychological problems such as mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.5,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition have an effect on quality of life? Yes, it does. Menopausal transition is often associated with physical symptoms including hot flashes and sleep issues, alongside psychological difficulties like mood swings and depression.",1.421158364141119e-07,0.0625841851794462,0.06787403226662558,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.5,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life impacted by the menopausal transition? Yes, it is. The transition often involves physical symptoms such as hot flashes and sleep disturbances, as well as psychological challenges including mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.5,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the transition through menopause affect quality of life? Yes, it does. It is commonly linked to physical symptoms like hot flashes and sleep disturbances and psychological issues such as mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.5,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is the quality of life altered during menopausal transition? Yes, it is affected. Menopausal transition is often accompanied by physical symptoms like hot flashes, sleep problems, and psychological symptoms such as mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.5,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does menopausal transition influence quality of life? Yes, it does. This phase is often marked by physical symptoms including hot flashes and sleep disturbances, as well as psychological problems like mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.5,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life changed by menopausal transition? Yes, menopausal transition affects it, often bringing physical symptoms such as hot flashes and sleep disturbances and psychological issues like mood swings and depression.",2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
143,0.5,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafness—does it always lead to Meniere's disease? We found that not every patient with low-tone sudden deafness experienced endolymphatic hydrops, even if they had vertigo at onset, and that electrocochleography (ECochG) serves as a valuable prognostic indicator.",7.105791820705622e-08,0.03940701666772872,0.0201457993665786,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
143,0.5,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably progress to Meniere's disease? Our conclusion is that not all patients with low-tone sudden deafness have endolymphatic hydrops, even if vertigo occurs initially, and electrocochleography (ECochG) is a useful tool for prognosis.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.5,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the prognosis of low-tone sudden deafness always progression to Meniere's disease? We determined that endolymphatic hydrops does not affect all low-tone sudden deafness cases, even with initial vertigo, and that ECochG is helpful for predicting outcomes.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.5,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily develop into Meniere's disease? Our study shows that not all patients with low-tone sudden deafness have endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) is an effective prognostic method.",2.6054570009253894e-07,0.2922364877603254,0.013544536271808981,0.019947691112600606,0.29026878735828765,0.007174012855831045,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
143,0.5,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Will low-tone sudden deafness inevitably lead to Meniere's disease? We conclude that endolymphatic hydrops is not present in all low-tone sudden deafness patients, even those with early vertigo, and that ECochG is a useful prognostic tool.",2.6054570009253894e-07,0.2922364877603254,0.013544536271808981,0.019947691112600606,0.29026878735828765,0.007174012855831045,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
143,0.5,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease inevitable in low-tone sudden deafness? Findings suggest that not all patients with low-tone sudden deafness exhibit endolymphatic hydrops, even with vertigo at onset, and electrocochleography (ECochG) is beneficial for prognosis.",2.8423167282822424e-07,0.2827805675605046,0.014003673094582187,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
143,0.5,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? Our results indicate that endolymphatic hydrops is absent in some patients despite vertigo attacks, and that ECochG is a valuable prognostic tool.",3.7897556377096544e-07,0.3671703469521619,0.043388429752066124,0.029014823436510004,0.4085601184256267,0.02221074380165289,0.028972824655245914,0.45198512374305766,0.0,3.789755637709665e-07,0.4653632496892328,0.0
143,0.5,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease a certain outcome of low-tone sudden deafness? We found that not all low-tone sudden deafness patients have endolymphatic hydrops, even when vertigo is present initially, and that electrocochleography (ECochG) aids prognosis.",3.0791764556390954e-07,0.3138690871817724,0.013114992252066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
143,0.5,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably evolve into Meniere's disease? We concluded that endolymphatic hydrops does not affect all low-tone sudden deafness patients, even those with vertigo at onset, and that ECochG is a useful prognostic tool.",2.6054570009253894e-07,0.2922364877603254,0.013544536271808981,0.019947691112600606,0.29026878735828765,0.007174012855831045,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
143,0.5,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the development of Meniere's disease unavoidable in cases of low-tone sudden deafness? Our study concludes that endolymphatic hydrops is not universal among these patients despite vertigo attacks, and that electrocochleography (ECochG) provides valuable prognostic information.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
144,0.5,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a correlation between a resident's leadership abilities and their technical skill ratings? Answer: Yes, a resident's leadership abilities can be linked to their technical skill ratings. Strong leaders often possess excellent technical skills because they must comprehend and supervise tasks. Their technical expertise can impact their credibility, decision-making, and leadership effectiveness.",4.737194547137081e-08,0.05262075032202729,0.046460572015319515,0.0036268529295637453,0.015030377622620605,0.01612394835485212,0.003621603081905733,0.013335528443453981,0.018077816224529024,4.737194547137081e-08,0.012561206208669073,0.01922337562475971
144,0.5,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do leadership skills of a resident affect their technical skill ratings? Answer: Yes, a resident's leadership skills may influence their technical skill ratings. Effective leaders typically have strong technical skills since they need to understand and manage the work. Their technical competence can affect their credibility, decisions, and guidance capabilities.",1.1842986367842703e-07,0.09317246666943468,0.035754649554455245,0.009067132323909363,0.022766998915089598,0.05320069444444443,0.009054007704764333,0.04677790788498859,0.037677816224529016,1.1842986367842703e-07,0.0744366099267566,0.01922337562475971
144,0.5,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are a resident's leadership skills connected to how their technical skills are rated? Answer: Yes, leadership skills in residents can be related to their technical skill ratings. Good leaders often demonstrate strong technical skills as they need to grasp and oversee the work. Their technical knowledge can shape their credibility, decision-making, and ability to lead.",0.0,0.04089710142682268,0.004040351634851627,0.0,0.10268847119406699,0.07359999999999998,0.0,0.05231299475924134,0.037677816224529016,0.0,0.026659506944613387,0.01922337562475971
144,0.5,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Does a resident's leadership ability relate to their technical skill evaluation? Answer: Yes, there is a relationship between a resident's leadership ability and their technical skill evaluation. Effective leaders usually excel in technical skills because understanding and managing work is essential. Their technical proficiency influences their credibility, decisions, and leadership.",1.1842986367842703e-07,0.12089835389183268,0.05576791350711306,0.009067132323909363,0.07935044222610532,0.01263591682419661,0.009054007704764333,0.07565904040831928,0.016853914006330732,1.1842986367842703e-07,0.0744366099267566,0.01922337562475971
144,0.5,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a link between leadership skills and technical skill ratings in residents? Answer: Yes, residents' leadership skills can be linked to their technical skill ratings. Successful leaders often have strong technical skills to understand and supervise tasks. Their technical expertise affects their credibility, decision-making, and leadership potential.",1.6580180914979784e-07,0.0715434597724025,0.045233004766532456,0.012693985253473108,0.036147973660150434,0.07359999999999998,0.012675610786670066,0.08933752230378511,0.037677816224529016,1.6580180914979784e-07,0.11792172186649497,0.01922337562475971
144,0.5,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Can a resident's leadership skills impact their technical skill ratings? Answer: Yes, leadership skills in residents can impact how their technical skills are rated. Effective leaders tend to have high technical proficiency since they need to oversee and understand work. This proficiency influences their credibility, decision-making, and ability to guide.",1.1842986367842703e-07,0.0004701578730492706,0.0675246714331991,0.009067132323909363,0.005524722740418486,0.07359999999999998,0.009054007704764333,0.04677790788498859,0.037677816224529016,1.1842986367842703e-07,0.0744366099267566,0.01922337562475971
144,0.5,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do residents with leadership skills tend to have higher technical skill ratings? Answer: Yes, residents who demonstrate leadership skills often have higher technical skill ratings. Leaders must understand and manage work, requiring strong technical skills. Their technical ability affects their credibility, decisions, and leadership capacity.",2.3685972735685406e-07,0.17266474877285987,0.01941239534092601,0.018134264647818726,0.16511932150285125,0.02824852607709749,0.018108015409528666,0.18901820684629156,0.014435185839041492,2.3685972735685406e-07,0.18691459335344662,0.01922337562475971
144,0.5,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are technical skill ratings influenced by a resident's leadership skills? Answer: Yes, a resident's leadership skills can influence their technical skill ratings. Effective leaders usually possess solid technical skills to comprehend and oversee tasks. Their technical competence impacts their credibility, decision-making, and leadership.",2.8423167282822487e-07,0.2238585724046347,0.015410519559431832,0.02176111757738247,0.18163296568493204,0.04980464009518143,0.0217296184914344,0.2044068520885718,0.037677816224529016,2.8423167282822487e-07,0.23570475752287834,0.01922337562475971
144,0.5,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: How do resident leadership skills relate to technical skill ratings? Answer: Resident leadership skills are related to technical skill ratings because effective leaders often have strong technical skills necessary to understand and supervise work. Their technical expertise affects credibility, decision-making, and leadership ability.",2.8423167282822487e-07,0.2238585724046347,0.015410519559431832,0.02176111757738247,0.2146399742830245,0.02609999999999997,0.0217296184914344,0.2044068520885718,0.037677816224529016,2.8423167282822487e-07,0.23570475752287834,0.01922337562475971
144,0.5,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a relationship between a resident's leadership and their technical skill ratings? Answer: Yes, a resident's leadership skills relate to their technical skill ratings. Effective leadership requires technical understanding, which enhances credibility, decision-making, and the ability to guide others.",3.552895910352811e-07,0.30585105510835264,0.008689794889989208,0.02720139697172809,0.2938259477595322,0.022467786705624535,0.027162023114293,0.2803927590664932,0.037677816224529016,3.552895910352811e-07,0.3136662989925889,0.01922337562475971
145,0.5,1,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Can student examiners reasonably replace faculty in an undergraduate OSCE focused on medical emergencies? Student examiners are acceptable substitutes for faculty in such OSCEs, offering useful peer review and assessment, though they may have limitations.",2.6054570009253883e-07,0.11539636141309906,0.11087301406135869,0.019947691112600613,0.0986419322990697,0.13296398891966763,0.019918816950481553,0.13426719415896526,0.11426592797783926,2.6054570009253947e-07,0.17165437940585004,0.09418282548476452
145,0.5,2,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Are student examiners suitable substitutes for faculty during an undergraduate OSCE on medical emergencies? Student examiners can serve as reasonable replacements, providing valuable peer assessments, but some constraints might exist.",3.7897556377096533e-07,0.24071758274980803,0.1350279885511546,0.02901482343651001,0.2629449835903457,0.13296398891966763,0.02897282465524592,0.30416623095436224,0.11426592797783926,3.789755637709665e-07,0.3475450458695142,0.09418282548476452
145,0.5,3,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Is it reasonable for student examiners to act as substitutes for faculty in an undergraduate medical emergencies OSCE? Yes, student examiners can be effective substitutes, contributing meaningful peer review and evaluation, albeit with potential limitations.",2.6054570009253883e-07,0.07462299785074888,0.14008200740387475,0.019947691112600613,0.0986419322990697,0.13296398891966763,0.019918816950481553,0.13426719415896526,0.11426592797783926,2.6054570009253947e-07,0.17165437940585004,0.09418282548476452
145,0.5,4,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","May student examiners serve as adequate substitutes for faculty in an undergraduate OSCE on medical emergencies? They can be considered reasonable substitutes, offering important peer review and assessment, though they might face certain challenges.",2.8423167282822413e-07,0.06370259743808093,0.1694667640613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1660158924735451,0.11426592797783926,2.8423167282822487e-07,0.20444420222884174,0.09418282548476452
145,0.5,5,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Can student examiners be used in place of faculty for an undergraduate OSCE on medical emergencies? Student examiners are reasonable substitutes who provide valuable peer assessment, but they may have some drawbacks.",3.3160361829959473e-07,0.17094212735876546,0.13724454183913648,0.02538797050694625,0.1939521121033949,0.13296398891966763,0.025351221573340174,0.23270726697221855,0.11426592797783926,3.316036182995957e-07,0.2734370737157925,0.09418282548476452
145,0.5,6,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Are student examiners reasonable replacements for faculty in an undergraduate OSCE concerning medical emergencies? They can act as suitable substitutes, delivering beneficial peer review and assessment, with possible limitations.",4.0266153650665063e-07,0.2280056487293569,0.1694667640613587,0.03082824990129189,0.29931262776122036,0.13296398891966763,0.030783626196198795,0.3419065589372092,0.11426592797783926,4.026615365066519e-07,0.38676575902279664,0.09418282548476452
145,0.5,7,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Is it appropriate for student examiners to replace faculty in an undergraduate OSCE on medical emergencies? Student examiners can be reasonable substitutes, contributing valuable peer feedback and evaluation, though some limitations may apply.",3.0791764556390943e-07,0.1377959548898322,0.1382492822715564,0.023574544042164372,0.16116228928040321,0.13296398891966763,0.0235404200323873,0.1988057152965368,0.11426592797783926,3.079176455639103e-07,0.2383457539045235,0.09418282548476452
145,0.5,8,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Could student examiners reasonably substitute for faculty in an undergraduate OSCE on medical emergencies? Yes, they can serve as reasonable substitutes, offering useful peer assessments, but may have certain restrictions.",3.7897556377096533e-07,0.1929143289180879,0.1694667640613587,0.02901482343651001,0.2629449835903457,0.13296398891966763,0.02897282465524592,0.30416623095436224,0.11426592797783926,3.789755637709665e-07,0.3475450458695142,0.09418282548476452
145,0.5,9,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Do student examiners make reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? They are considered reasonable substitutes who provide important peer review and assessment, though some limitations exist.",3.5528959103528003e-07,0.2052225892797357,0.13617306608276178,0.02720139697172813,0.22785366377907668,0.13296398891966763,0.027162023114293048,0.26779858678348756,0.11426592797783926,3.552895910352811e-07,0.3098047178866672,0.09418282548476452
145,0.5,10,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Might student examiners be acceptable substitutes for faculty in an undergraduate OSCE on medical emergencies? Student examiners can be reasonable substitutes, providing valuable peer review and assessment, albeit with potential limitations.",3.5528959103528003e-07,0.2052225892797357,0.13617306608276178,0.02720139697172813,0.22785366377907668,0.13296398891966763,0.027162023114293048,0.26779858678348756,0.11426592797783926,3.552895910352811e-07,0.3098047178866672,0.09418282548476452
146,0.5,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream interventions: does the supplemental security income program decrease disability among the elderly? Answer: Income support policies could be an important tool for enhancing public health, particularly for low-income individuals. Although the results are strong, additional studies are necessary to verify their accuracy. Future research should explore various forms of income support.",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
146,0.5,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream approaches: does the supplemental security income program lower disability rates in older adults? Answer: Income support policies might serve as a crucial mechanism for boosting population health, especially for those with lower incomes. Despite robust findings, more analysis is required to ensure their dependability. Further research should investigate different types of income assistance.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
146,0.5,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream strategies: does the supplemental security income program help reduce disability in elderly populations? Answer: Income support initiatives may represent a valuable strategy for improving health outcomes, particularly among low-income groups. Even though the evidence is strong, further evaluation is needed to confirm its validity. Future studies should assess a range of income support programs.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
146,0.5,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Question: Upstream solutions: can the supplemental security income program decrease disability in seniors? Answer: Income support policies might be a powerful new approach to enhancing public health, especially for economically disadvantaged individuals. While the findings are compelling, additional research is necessary to confirm their reliability. Future investigations should examine multiple forms of income support.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
146,0.5,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream interventions: does the supplemental security income program reduce disability among elderly individuals? Answer: Income support measures could be a significant factor in improving population health, particularly for lower-income persons. Although the findings are strong, further analysis is needed to validate them. Future research should look into diverse income support options.",1.1842986367842703e-07,0.09595304393715409,0.0017487603305785006,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
146,0.5,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Question: Upstream methods: does the supplemental security income program lessen disability in the elderly? Answer: Income support policies may offer a vital means of enhancing health outcomes, especially for those with limited income. Despite robust findings, more research is required to confirm their accuracy. Future studies should consider various income support strategies.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
146,0.5,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program lower disability rates in elderly populations? Answer: Income support programs might be a key lever for improving population health, particularly among low-income individuals. While the findings are solid, additional analyses are needed to confirm their reliability. Future research should explore different income support models.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
146,0.5,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Question: Upstream approaches: does the supplemental security income program reduce disability in senior citizens? Answer: Income support policy could be an important new tool for enhancing population health, especially for lower-income groups. Although the findings are robust, further studies are needed to verify their validity. Future research should examine a variety of income support interventions.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
146,0.5,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream strategies: does the supplemental security income program decrease disability among the elderly? Answer: Income support policies may be a significant approach to improving health outcomes, particularly for low-income populations. Even though the evidence is strong, further research is necessary to confirm its reliability. Future studies should assess different income support programs.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
146,0.5,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Question: Upstream interventions: does the supplemental security income program help reduce disability in older adults? Answer: Income support measures could be a crucial new lever for improving population health, especially among economically disadvantaged individuals. While the findings are compelling, additional research is required to confirm their validity. Future investigations should explore various income support options.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
147,0.5,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone correspond with the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between the transition zone seen on contrast enema and the length of aganglionosis is weak. Therefore, systematic preoperative biopsy via coelioscopy or umbilical incision is essential.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
147,0.5,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease specimens? The link between the transition zone on contrast enema and aganglionosis length is low, making systematic preoperative biopsy by coelioscopy or umbilical incision mandatory.",7.105791820705622e-08,0.012214922288724672,0.041347797501643656,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
147,0.5,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone on contrast enema match the aganglionosis level in Hirschsprung's disease specimens? The correlation is minimal, so systematic preoperative biopsy through coelioscopy or umbilical incision is required.",3.3160361829959463e-07,0.25696549215429787,0.09,0.02538797050694626,0.3616648819601149,0.023242630385487524,0.02535122157334018,0.4054651081081637,0.0,3.316036182995957e-07,0.4177352006999784,0.0
147,0.5,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease? The relationship between the contrast enema transition zone and aganglionosis length is weak, necessitating systematic preoperative biopsy by coelioscopy or umbilical incision.",2.3685972735685343e-07,0.1725757127626406,0.060615243342516056,0.01813426464781874,0.23245315048010795,0.023242630385487524,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
147,0.5,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone correlate with the aganglionosis extent in Hirschsprung's disease specimens? The correlation remains low, thus systematic preoperative biopsy via coelioscopy or umbilical incision is mandatory.",3.7897556377096523e-07,0.32595836364124864,0.09,0.029014823436510018,0.4331238459422586,0.023242630385487524,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
147,0.5,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is there a strong correlation between the radiographic transition zone and aganglionosis length in Hirschsprung's disease? The association is low, so systematic preoperative biopsy by coelioscopy or umbilical incision is essential.",3.3160361829959463e-07,0.25696549215429787,0.09,0.02538797050694626,0.3616648819601149,0.023242630385487524,0.02535122157334018,0.4054651081081637,0.0,3.316036182995957e-07,0.4177352006999784,0.0
147,0.5,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the level of the radiographic transition zone align with the aganglionosis length in Hirschsprung's disease specimens? The correlation is weak, requiring systematic preoperative biopsy through coelioscopy or umbilical incision.",3.5528959103527993e-07,0.29086704382997963,0.09,0.027201396971728138,0.39675620177138393,0.023242630385487524,0.027162023114293055,0.4418327522790384,0.0,3.552895910352811e-07,0.45547552868282537,0.0
147,0.5,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is the radiographic transition zone on contrast enema a reliable indicator of aganglionosis length in Hirschsprung's disease? The correlation is low, making systematic preoperative biopsy by coelioscopy or umbilical incision necessary.",3.3160361829959463e-07,0.25696549215429787,0.09,0.02538797050694626,0.3616648819601149,0.023242630385487524,0.02535122157334018,0.4054651081081637,0.0,3.316036182995957e-07,0.4177352006999784,0.0
147,0.5,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone correspond to the aganglionosis level in Hirschsprung's disease specimens? The correlation remains limited, hence systematic preoperative biopsy via coelioscopy or umbilical incision is mandatory.",3.7897556377096523e-07,0.32595836364124864,0.09,0.029014823436510018,0.4331238459422586,0.023242630385487524,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
147,0.5,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is the radiographic transition zone a dependable marker for aganglionosis length in Hirschsprung's disease? The correlation is low, so systematic preoperative biopsy by coelioscopy or umbilical incision is required.",3.7897556377096523e-07,0.32595836364124864,0.09,0.029014823436510018,0.4331238459422586,0.023242630385487524,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
148,0.5,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in growing children a rare and frequently missed injury? Answer: Isolated sternal fractures in children commonly result from age-specific traumatic events. Ultrasonography serves as an effective diagnostic technique for detecting fractures, while radiography remains the preferred method to assess the degree of dislocation.",9.474389094274162e-08,0.055655721716652895,0.01999167013744273,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
148,0.5,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children uncommon and often unnoticed? Answer: In childhood, isolated sternal fractures typically arise from trauma related to the child's developmental stage. Ultrasonography is a valuable tool for identifying fractures, and radiography is the preferred approach to visualize the extent of dislocation.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856674,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
148,0.5,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is the sternal fracture in children a rare and commonly overlooked injury? Answer: Childhood isolated sternal fractures generally occur due to trauma associated with the child's age. Ultrasonography is helpful for diagnosing fractures, and radiography is the standard method for evaluating dislocation severity.",1.6580180914979784e-07,0.15533640625915934,0.0032509602480447937,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
148,0.5,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children rare and frequently missed? Answer: Isolated sternal fractures in children usually stem from age-related traumatic incidents. Ultrasonography is an effective diagnostic method for detecting fractures, and radiography is the best technique to determine the extent of dislocation.",1.6580180914979784e-07,0.18757581000613355,0.026409281676953476,0.012693985253473108,0.18715768842535052,0.023795359904818555,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
148,0.5,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture a rare and often disregarded injury in growing children? Answer: In children, isolated sternal fractures often result from trauma typical for their age group. Ultrasonography is a useful diagnostic tool to detect fractures, while radiography is preferred to visualize the dislocation extent.",1.1842986367842703e-07,0.0776346284354279,0.01999167013744273,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
148,0.5,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is the occurrence of sternal fractures in growing children uncommon and often overlooked? Answer: Isolated sternal fractures in childhood are typically caused by age-specific traumatic events. Ultrasonography aids in fracture detection, and radiography is the method of choice for assessing dislocation extent.",1.8948778188548325e-07,0.2456485257166583,0.051014247022320575,0.014507411718254981,0.21206028899460883,0.024375,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
148,0.5,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in children rare and frequently unnoticed injuries? Answer: Childhood isolated sternal fractures commonly arise from trauma related to the child's developmental stage. Ultrasonography is valuable for fracture detection, and radiography is preferred to evaluate dislocation extent.",2.6054570009253936e-07,0.2562814813355869,0.0056315985606182235,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
148,0.5,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in growing children an uncommon and often missed injury? Answer: Isolated sternal fractures in children often occur due to typical age-related trauma. Ultrasonography is a useful diagnostic tool for identifying fractures, and radiography is the preferred method for visualizing dislocation extent.",1.4211583641411244e-07,0.10010748428748562,0.01999167013744273,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
148,0.5,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children rare and often overlooked? Answer: Childhood isolated sternal fractures generally result from trauma typical to the child's age. Ultrasonography is effective for fracture diagnosis, and radiography is the method of choice to visualize dislocation extent.",2.1317375462116866e-07,0.20453710908972944,0.0043833298625572704,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
148,0.5,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture a rare and frequently missed injury in growing children? Answer: Isolated sternal fractures in childhood usually stem from age-related traumatic incidents. Ultrasonography helps detect fractures, and radiography is the preferred technique to assess the degree of dislocation.",2.3685972735685406e-07,0.19541766409181127,0.01999167013744273,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
149,0.5,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is Aripiprazole a novel risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might account for the emergence of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could Aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside other documented case reports. The partial agonist effect on dopamine receptors by aripiprazole may explain the development of pathological gambling.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
149,0.5,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated in relation to existing case reports. The dopamine partial agonist properties of aripiprazole could underlie the onset of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is pathological gambling a new risk associated with Aripiprazole? Answer: Adverse drug reactions were reviewed with other published case studies. The mechanism of aripiprazole as a dopamine partial agonist might explain the occurrence of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.5,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole as a novel risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with previously reported cases. The dopamine partial agonist mechanism of aripiprazole may clarify the appearance of pathological gambling.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
149,0.5,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could pathological gambling be a new adverse effect of Aripiprazole? Answer: Adverse drug reactions were compared to other documented cases. The dopamine partial agonist function of aripiprazole could explain pathological gambling.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
149,0.5,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Is Aripiprazole linked to pathological gambling as a new risk factor? Answer: Adverse drug reactions were examined alongside other published case reports. The dopamine partial agonist role of aripiprazole might account for pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is there a new risk of pathological gambling with Aripiprazole? Answer: Adverse drug reactions were confronted with other published reports. The dopamine partial agonist mechanism of aripiprazole could explain pathological gambling.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
149,0.5,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: could it be a new risk factor for pathological gambling? Answer: Adverse drug reactions were assessed with other case reports. The dopamine partial agonist action of aripiprazole might explain the occurrence of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could Aripiprazole contribute to pathological gambling as a new risk factor? Answer: Adverse drug reactions were compared with existing case reports. The dopamine partial agonist mechanism of aripiprazole may explain the development of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
150,0.5,1,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Can preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass surgery? Answer: Yes, studies show that preoperative statins help decrease postoperative atrial fibrillation rates.",2.36859727356853e-08,0.04168988456723399,0.0027888888888888963,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.5,2,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Are preoperative statins effective in reducing atrial fibrillation after coronary artery bypass grafting? Answer: Yes, evidence suggests that taking statins before surgery reduces the occurrence of postoperative atrial fibrillation.",7.10579182070559e-08,0.21583731974344422,0.07638888888888888,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
150,0.5,3,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do statins given before coronary artery bypass surgery reduce atrial fibrillation afterward? Answer: Yes, research supports that preoperative statins diminish the frequency of postoperative atrial fibrillation.",0.0,0.10663802777845355,0.07638888888888888,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.5,4,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Is there a reduction in atrial fibrillation post-coronary artery bypass grafting with preoperative statin use? Answer: Yes, data indicates that preoperative statins lower postoperative atrial fibrillation incidence.",2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.5,5,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Does administering statins before coronary artery bypass grafting decrease atrial fibrillation after surgery? Answer: Yes, findings reveal that preoperative statins reduce postoperative atrial fibrillation rates.",2.36859727356853e-08,0.011965540180375989,0.03645833333333332,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.5,6,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Can atrial fibrillation after coronary artery bypass grafting be reduced by preoperative statin therapy? Answer: Yes, research confirms that preoperative statins decrease the likelihood of postoperative atrial fibrillation.",4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
150,0.5,7,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Are preoperative statins associated with a lower risk of atrial fibrillation following coronary artery bypass grafting? Answer: Yes, studies indicate that preoperative statins reduce postoperative atrial fibrillation.",2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.5,8,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do patients receiving statins before coronary artery bypass grafting experience less postoperative atrial fibrillation? Answer: Yes, evidence shows preoperative statins reduce the rate of atrial fibrillation after surgery.",4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
150,0.5,9,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Is the incidence of atrial fibrillation after coronary artery bypass grafting reduced by preoperative statins? Answer: Yes, research demonstrates that preoperative statins lessen postoperative atrial fibrillation.",0.0,0.10663802777845355,0.07638888888888888,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.5,10,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Question: Do preoperative statins have an impact on reducing atrial fibrillation after coronary artery bypass grafting? Answer: Yes, studies indicate that preoperative statin use reduces the occurrence of postoperative atrial fibrillation.",9.47438909427412e-08,0.24973887141912599,0.07638888888888888,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
151,0.5,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist regarding the clinical significance of certain RBC morphology terms between clinicians and clinical pathologists. Including interpretive comments on CBC reports is the most effective method to guarantee RBC morphology changes are understood as intended by clinical pathologists. Reporting methods should be critically reviewed.,2.3685972735685406e-08,0.0289229721838673,0.03274920999712727,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
151,0.5,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a mismatch between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology? There are notable differences in how clinicians and clinical pathologists view the clinical importance of specific RBC morphology terms. Adding interpretive notes on CBC reports is the best way to ensure that RBC morphology alterations are interpreted correctly by clinical pathologists. Reporting procedures need thorough evaluation.,4.737194547137081e-08,0.011929350116359316,0.03222222222222221,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
151,0.5,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians differ in their reporting and interpretation of red blood cell morphology? Important distinctions exist between clinicians and clinical pathologists concerning the clinical relevance of certain RBC morphology terminology. The clearest approach to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically assessed.,2.3685972735685406e-08,0.06022694767377601,0.08353151010701546,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
151,0.5,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there discordance between clinical pathologists and clinicians in how red blood cell morphology is reported and interpreted? Significant differences about the clinical relevance of some RBC morphology terms exist between clinicians and clinical pathologists. The inclusion of interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are interpreted as the clinical pathologist intends. Reporting practices should be critically examined.,9.474389094274162e-08,0.021216822352577047,0.03121748178980229,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
151,0.5,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? There are important differences in the clinical relevance of certain RBC morphology terms between clinicians and clinical pathologists. Including interpretive comments on CBC reports provides the clearest means to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting methods should undergo critical review.,2.3685972735685406e-08,0.0289229721838673,0.032749209997127264,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
151,0.5,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a difference between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists hold differing views on the clinical significance of particular RBC morphology terms. The best way to guarantee RBC morphology changes are understood as intended by clinical pathologists is to add interpretive comments on CBC reports. Reporting practices warrant critical scrutiny.,0.0,0.07803552045206796,0.08494921514312095,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.5,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians disagree in their reporting and interpretation of red blood cell morphology? There are important discrepancies regarding the clinical relevance of certain RBC morphology terms between clinicians and clinical pathologists. Including interpretive remarks on CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically reviewed.,0.0,0.0462098120373291,0.033293697978596916,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.5,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there inconsistency between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Key differences exist between clinicians and clinical pathologists concerning the clinical importance of certain RBC morphology terms. The inclusion of interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices need careful evaluation.,7.105791820705622e-08,0.004780819371978495,0.03171190540177372,0.005440279394345618,0.04959694113937285,0.0,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
151,0.5,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are there conflicting views between clinical pathologists and clinicians on reporting and interpreting red blood cell morphology? Significant differences about the clinical relevance of specific RBC morphology terms exist between clinicians and clinical pathologists. Adding interpretive comments on CBC reports is the clearest method to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices should be critically assessed.,2.3685972735685406e-08,0.0289229721838673,0.03274920999712727,0.0018134264647818726,0.01680711831638071,0.0,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
151,0.5,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a lack of agreement between clinical pathologists and clinicians regarding red blood cell morphology reporting and interpretation? Important differences exist in the clinical relevance of certain RBC morphology terms between clinicians and clinical pathologists. The clearest way to ensure RBC morphology changes are interpreted as clinical pathologists intend is through the inclusion of interpretive comments on CBC reports. Reporting practices should be critically reviewed.,1.1842986367842703e-07,0.037387496562156564,0.030738221214411676,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
152,0.5,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections contribute to benign paroxysmal positional vertigo? Yes, viral infections may influence benign paroxysmal positional vertigo (BPPV). Viruses can induce inflammation or harm the inner ear, resulting in the displacement of calcium crystals that cause BPPV. However, this is only one factor.",1.8948778188548325e-07,0.07706803164738707,0.06440599173553721,0.014507411718254981,0.09645684685327804,0.05559972516134401,0.014486412327622933,0.09337306643979515,0.060964083175803374,1.8948778188548325e-07,0.12455929174729308,0.04158790170132326
152,0.5,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections be involved in benign paroxysmal positional vertigo? Indeed, viral infections can be involved in benign paroxysmal positional vertigo (BPPV). They might cause inflammation or damage to the inner ear, which leads to the movement of calcium crystals responsible for BPPV. Nonetheless, this is just one possible cause.",4.737194547137081e-08,0.04777168957795519,0.005107897153351665,0.0036268529295637453,0.04544297572398737,0.0032495430330109903,0.003621603081905733,0.04528440554808055,0.002568974675436278,4.737194547137081e-08,0.045071017246912426,0.001800528050742864
152,0.5,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections linked to benign paroxysmal positional vertigo? Yes, viral infections have a potential role in benign paroxysmal positional vertigo (BPPV). Such infections may cause inner ear inflammation or injury, triggering the dislodgement of calcium crystals that result in BPPV. Still, this is only one aspect.",1.1842986367842703e-07,0.0033190414230985787,0.06888104581882545,0.009067132323909363,0.025263508126454504,0.05718434126450968,0.009054007704764333,0.02275549922584119,0.060964083175803374,1.1842986367842703e-07,0.052238630167666944,0.04158790170132326
152,0.5,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is there a connection between viral infections and benign paroxysmal positional vertigo? Yes, viral infections can contribute to benign paroxysmal positional vertigo (BPPV). The viruses might cause inflammation or damage within the inner ear, causing calcium crystals to become dislodged and lead to BPPV. However, this is only one contributing factor.",2.3685972735685406e-08,0.08729540766092603,0.07402544623983777,0.0018134264647818726,0.06240911991656439,0.05899577951060701,0.0018108015409528666,0.06425587776378805,0.060964083175803374,2.3685972735685406e-08,0.03670885584882866,0.04158790170132326
152,0.5,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viruses play a role in benign paroxysmal positional vertigo? Yes, viruses can play a role in benign paroxysmal positional vertigo (BPPV). Viral infections may lead to inflammation or damage in the inner ear, which can cause calcium crystals to dislodge and produce BPPV. This is, however, only one of the causes.",0.0,0.027182242374899523,0.018225436179981624,0.0,0.027725887222397994,0.01937034703260289,0.0,0.028291721655508084,0.020023571145184285,0.0,0.028881132523331132,0.02063432052089896
152,0.5,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can benign paroxysmal positional vertigo be caused by viral infections? Yes, viral infections can cause benign paroxysmal positional vertigo (BPPV). They may induce inflammation or damage to the inner ear, leading to the displacement of calcium crystals that cause BPPV. Yet, this is only one contributing factor.",1.1842986367842703e-07,0.03345587536048722,0.047613191282022446,0.009067132323909363,0.0560700494846742,0.03504678868974288,0.009054007704764333,0.05426218925129378,0.03824910210495426,1.1842986367842703e-07,0.052238630167666944,0.04158790170132326
152,0.5,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections a factor in benign paroxysmal positional vertigo? Yes, viral infections can be a factor in benign paroxysmal positional vertigo (BPPV). They may cause inflammation or injury to the inner ear, resulting in the dislodgement of calcium crystals that cause BPPV. Nonetheless, this is only one of several factors.",2.3685972735685406e-08,0.004117745993732491,0.016012396694214934,0.0018134264647818726,0.022466045049959416,0.0015925692548250936,0.0018108015409528666,0.022387519806204903,0.0012581390464188463,2.3685972735685406e-08,0.022282393560528302,0.000881234101145871
152,0.5,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections influence benign paroxysmal positional vertigo? Yes, viral infections can influence benign paroxysmal positional vertigo (BPPV). They might cause inner ear inflammation or damage, which leads to the displacement of calcium crystals that cause BPPV. However, this is just one of the causes.",1.6580180914979784e-07,0.08338706228357351,0.043780991735537206,0.012693985253473108,0.10439814833894046,0.03299413325176636,0.012675610786670066,0.10228252345882671,0.03716872327098482,1.6580180914979784e-07,0.09986667915692138,0.04158790170132326
152,0.5,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is benign paroxysmal positional vertigo related to viral infections? Yes, benign paroxysmal positional vertigo (BPPV) can be related to viral infections. Viruses may cause inflammation or damage in the inner ear, resulting in the dislodgement of calcium crystals that cause BPPV. This is only one possible cause.",1.1842986367842703e-07,0.09372954323526494,0.0062809917355372,0.009067132323909363,0.0868765908428939,0.013068554453917677,0.009054007704764333,0.05426218925129378,0.03824910210495426,1.1842986367842703e-07,0.052238630167666944,0.04158790170132326
152,0.5,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections trigger benign paroxysmal positional vertigo? Yes, viral infections can trigger benign paroxysmal positional vertigo (BPPV). They may cause inflammation or damage to the inner ear, which leads to the displacement of calcium crystals causing BPPV. However, this is just one contributing cause.",1.6580180914979784e-07,0.11489375230902388,0.02201241842850235,0.012693985253473108,0.10439814833894046,0.03299413325176636,0.012675610786670066,0.10228252345882671,0.03716872327098482,1.6580180914979784e-07,0.09986667915692138,0.04158790170132326
153,0.5,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is there a role for polymorphisms in the beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: Studies indicate a possible involvement of polymorphisms in the beta-adrenergic receptor (ADRB) genes in TTN.,4.73719454713706e-08,0.07931284344063805,0.05658284023668633,0.003626852929563752,0.044774995065926415,0.053854875283446596,0.003621603081905747,0.008373772031363913,0.04081632653061229,4.737194547137081e-08,0.0300445991446745,0.020238297459292842
153,0.5,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could polymorphisms in beta-adrenergic receptor (ADRB) encoding genes influence transient tachypnea of the newborn (TTN)? Answer: Research points to a potential link between ADRB gene polymorphisms and TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.5,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): might polymorphisms in the beta-adrenergic receptor (ADRB) genes play a role? Answer: Evidence suggests polymorphisms in ADRB genes may contribute to TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.5,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: Research indicates a possible role for ADRB gene polymorphisms in TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.5,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Do polymorphisms in beta-adrenergic receptor (ADRB) genes have a role in transient tachypnea of the newborn (TTN)? Answer: Studies suggest a potential involvement of ADRB polymorphisms in TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.5,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): could polymorphisms in the beta-adrenergic receptor (ADRB) genes be implicated? Answer: Research suggests ADRB gene polymorphisms might play a role in TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.5,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is there evidence for polymorphisms in beta-adrenergic receptor (ADRB) genes contributing to transient tachypnea of the newborn (TTN)? Answer: Studies suggest a potential role for ADRB polymorphisms in TTN.,1.894877818854824e-07,0.12071623032995538,0.20964406472648223,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
153,0.5,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): are polymorphisms in beta-adrenergic receptor (ADRB) encoding genes involved? Answer: Research points to a possible role of ADRB gene polymorphisms in TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.5,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could variations in beta-adrenergic receptor (ADRB) genes influence transient tachypnea of the newborn (TTN)? Answer: Evidence supports a potential role for ADRB polymorphisms in TTN.,2.842316728282236e-07,0.02009947904340237,0.24408284023668633,0.021761117577382548,0.05889151782819235,0.22222222222222218,0.021729618491434483,0.14259497333628612,0.1875,2.8423167282822487e-07,0.23145125344609818,0.14268727705112957
153,0.5,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Transient tachypnea of the newborn (TTN): is there a connection with polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: Research suggests a possible involvement of ADRB gene polymorphisms in TTN.,1.658018091497971e-07,0.15621122380002772,0.21078914225808942,0.01269398525347315,0.1303504818103356,0.22222222222222218,0.012675610786670115,0.05411532090976845,0.1875,1.6580180914979784e-07,0.026656840800084236,0.14268727705112957
154,0.5,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.5,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Certainly, parents, their children, and the children's doctors often have varying views on body image. Parents might be shaped by cultural or personal values, children by their self-esteem and peer pressure, and doctors by clinical criteria and health concerns. Therefore, each party",4.737194547137081e-08,0.038371277551590754,0.0018947695229746889,0.0036268529295637453,0.012529249072251503,0.017153368972257988,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
154,0.5,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Indeed, body image perceptions can vary between parents, children, and their physicians. Parents may be guided by cultural or personal beliefs, children by their self-confidence and influence from peers, and physicians by medical guidelines and health considerations. Thus, each group",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.5,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, the way parents, children, and doctors view body image can be quite different. Parents’ perspectives may stem from cultural or personal convictions, children’s from their self-esteem and peer influence, and physicians’ from medical standards and health factors. As a result, each group",7.105791820705622e-08,0.08092262754331303,0.01992512981523971,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
154,0.5,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Affirmative, perceptions of body image differ among parents, children, and their physicians. Parents might be influenced by cultural or personal viewpoints, children by their self-esteem and peer dynamics, and physicians by medical norms and health implications. Consequently, each group",2.3685972735685406e-08,0.01974943600266066,0.0009994164738641592,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
154,0.5,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, parents, children, and physicians may each have distinct perceptions of body image. Parents' opinions can be shaped by cultural or personal beliefs, children's by self-esteem and peer influence, and physicians' by medical criteria and health concerns. Therefore, each group",0.0,0.05041070404072334,0.036188322335046,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
154,0.5,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Absolutely, perceptions about body image often vary between parents, their children, and the children's doctors. Parents’ views may be molded by cultural or personal beliefs, children’s by their self-worth and peer pressure, and physicians’ by medical standards and health priorities. Hence, each group",7.105791820705622e-08,0.033119373711592015,0.014223200298698849,0.005440279394345618,0.031097431661075703,0.016529396361753424,0.0054324046228586,0.030304520734458773,0.017851239669421492,7.105791820705622e-08,0.056089466651043196,0.0
154,0.5,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, there are differences in how parents, children, and their physicians perceive body image. Parents’ perspectives might be influenced by cultural or personal beliefs, children’s by self-esteem and peer influence, and physicians’ by medical guidelines and health concerns. Thus, each group",2.3685972735685406e-08,0.005386464230514587,0.016642011834319514,0.0018134264647818726,0.00638944757401072,0.017799928800284807,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
154,0.5,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Indeed, parents, children, and physicians may each hold different views on body image. Parents' perceptions could be shaped by cultural or personal values, children’s by self-confidence and peer impact, and physicians’ by medical standards and health implications. Accordingly, each group",0.0,0.05041070404072334,0.036188322335046,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
154,0.5,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image between parents, their children, and the children’s physicians can vary. Parents may be influenced by cultural or personal beliefs, children by their self-esteem and peer relationships, and physicians by medical criteria and health considerations. Therefore, each group",4.737194547137081e-08,0.014050323847732749,0.015411815571672607,0.0036268529295637453,0.012529249072251503,0.017153368972257988,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
155,0.5,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain linked to a decline in health-related quality of life six months afterward? Yes, studies indicate that neck pain correlates with poorer health-related quality of life six months later. Ongoing neck pain may lead to emotional distress, reduced physical function, and impaired daily activities, affecting overall health and wellness.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.5,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain relate to a diminished health-related quality of life six months later? Research shows that neck pain is connected to a lower health-related quality of life half a year later. Chronic neck pain can cause emotional strain, limited physical capabilities, and decreased daily activity performance, negatively influencing general health and wellbeing.",7.105791820705622e-08,0.014952553845092975,0.02689376078784081,0.005440279394345618,0.008834427395682631,0.03444964598084129,0.0054324046228586,0.007525303207511769,0.03640832986255729,7.105791820705622e-08,0.006104406581574295,0.03840000000000001
155,0.5,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there an association between neck pain and poorer health-related quality of life six months later? Evidence suggests neck pain is linked to worse health-related quality of life after six months. Persistent neck pain may result in emotional difficulties, restricted physical function, and reduced ability to carry out daily tasks, impacting overall health and wellbeing.",2.3685972735685406e-08,0.05475691067593047,0.051348757091365965,0.0018134264647818726,0.03168334342267132,0.03592218377547097,0.0018108015409528666,0.0327617902235553,0.037176624375240316,2.3685972735685406e-08,0.03390092803212408,0.03840000000000001
155,0.5,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does experiencing neck pain lead to worse health-related quality of life six months later? Research indicates that neck pain is associated with a decline in health-related quality of life six months afterward. Continuous neck pain can contribute to emotional distress, physical limitations, and decreased daily functioning, affecting overall health and wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.5,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain connected with a lower health-related quality of life six months later? Studies suggest that neck pain correlates with worsened health-related quality of life half a year later. Chronic neck pain can cause emotional distress, impair physical abilities, and reduce daily activity performance, impacting overall health and wellbeing.",1.4211583641411244e-07,0.056493610168805386,0.0376158858015109,0.010880558788691236,0.07285682950897909,0.032012098298676725,0.0108648092457172,0.07117044440787978,0.03513345935727792,1.4211583641411244e-07,0.06928330820310658,0.03840000000000001
155,0.5,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain a factor in reduced health-related quality of life six months later? Research supports that neck pain is linked to poorer health-related quality of life six months on. Persistent neck pain may lead to emotional challenges, limited physical function, and decreased capacity for daily activities, affecting overall health and wellbeing.",9.474389094274162e-08,0.0648865978804456,0.004558034561841395,0.0072537058591274906,0.08517611883165399,0.005795085066162581,0.007243206163811466,0.08487728826915619,0.004564083175803348,9.474389094274162e-08,0.08448595883097187,0.0031879017013232494
155,0.5,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain impact health-related quality of life six months later? Evidence shows neck pain is associated with a decline in health-related quality of life after six months. Ongoing neck pain can contribute to emotional distress, physical limitations, and reduced daily activity ability, influencing overall health and wellbeing.",1.8948778188548325e-07,0.10464022749804469,0.03129924068616441,0.014507411718254981,0.11792784675589152,0.03021157024793386,0.014486412327622933,0.11596647300115936,0.03418925619834713,1.8948778188548325e-07,0.1137350707739393,0.03840000000000001
155,0.5,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there a relationship between neck pain and a worsened health-related quality of life six months later? Research suggests neck pain is connected with poorer health-related quality of life six months later. Chronic neck pain can cause emotional distress, restrict physical function, and decrease daily activity performance, affecting overall health and wellbeing.",9.474389094274162e-08,0.0648865978804456,0.004558034561841395,0.0072537058591274906,0.08517611883165399,0.005795085066162581,0.007243206163811466,0.08487728826915619,0.004564083175803348,9.474389094274162e-08,0.08448595883097187,0.0031879017013232494
155,0.5,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain associated with a decline in health-related quality of life six months later? Studies indicate that neck pain correlates with worsened health-related quality of life six months afterward. Persistent neck pain may result in emotional distress, limited physical capabilities, and reduced ability to perform daily tasks, impacting overall health and wellbeing.",7.105791820705622e-08,0.04161206078970636,0.007991102616121654,0.005440279394345618,0.06319891214548301,0.004263286555002299,0.0054324046228586,0.06297707765230687,0.0033555454956994066,7.105791820705622e-08,0.06268784989259002,0.002342417383431425
155,0.5,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain contribute to worse health-related quality of life six months later? Research suggests that neck pain is linked to a decline in health-related quality of life six months later. Ongoing neck pain can lead to emotional distress, physical limitations, and decreased capacity for daily activities, affecting overall health and wellbeing.",9.474389094274162e-08,0.0648865978804456,0.004558034561841395,0.0072537058591274906,0.08517611883165399,0.005795085066162581,0.007243206163811466,0.08487728826915619,0.004564083175803348,9.474389094274162e-08,0.08448595883097187,0.0031879017013232494
156,0.5,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG used as a surrogate tracer for tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia; it primarily measures glucose metabolism in tissues. Specialized tracers like (18)F-fluoromisonidazole are used instead.",1.421158364141119e-07,0.1406315614257938,0.06029478458049889,0.010880558788691243,0.18698294763518453,0.016790123456790124,0.010864809245717214,0.1864428169865202,0.013611111111111143,1.4211583641411244e-07,0.18553079338508116,0.009753086419753088
156,0.5,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG act as a surrogate tracer to assess tumor hypoxia? No, (18)F-FDG is not suitable as a surrogate tracer for tumor hypoxia. It is mainly utilized to evaluate glucose metabolism rates in tissues, while other tracers such as (18)F-fluoromisonidazole are preferred.",0.0,0.11419832261278584,0.12646899202894452,0.0,0.0693147180559941,0.04890393625389013,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914
156,0.5,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a tracer that can substitute for measuring tumor hypoxia? No, (18)F-FDG is not a substitute tracer for tumor hypoxia measurement; it is primarily used to measure tissue glucose metabolism. Other tracers, like (18)F-fluoromisonidazole, are specifically designed for hypoxia imaging.",2.3685972735685406e-08,0.1909418827872842,0.19918367346938776,0.0018134264647818726,0.11331162812769646,0.09876543209876547,0.0018108015409528666,0.08066254137519424,0.0763888888888889,2.3685972735685406e-08,0.04629461402941226,0.05246913580246914
156,0.5,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG serve as a surrogate tracer for detecting tumor hypoxia? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia detection. Its main role is to measure glucose metabolism in tissues, whereas tracers such as (18)F-fluoromisonidazole are specialized for hypoxia.",2.3685972735685406e-08,0.08696980570329327,0.12467673409758352,0.0018134264647818726,0.04221960960872817,0.04763321880439002,0.0018108015409528666,0.0441811108194079,0.05009232205178152,2.3685972735685406e-08,0.04629461402941226,0.05246913580246914
156,0.5,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG employed as a surrogate tracer to measure tumor hypoxia? No, (18)F-FDG is not employed as a surrogate tracer for tumor hypoxia; it is mainly used to assess glucose metabolism rates. Other specialized tracers like (18)F-fluoromisonidazole are utilized for hypoxia measurement.",0.0,0.08038626502449642,0.10276292839999401,0.0,0.03465735902799727,0.024258492726961234,0.0,0.035546009259483924,0.025256675594513445,0.0,0.03648143055578679,0.026172568965361766
156,0.5,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG be used as a surrogate tracer for tumor hypoxia? No, (18)F-FDG cannot be used as a surrogate tracer for tumor hypoxia. It is primarily used to measure glucose metabolism, while other tracers such as (18)F-fluoromisonidazole target hypoxia.",7.1057918207056e-08,0.11572142549077169,0.024365775446494903,0.005440279394345618,0.1641365963501369,0.05732197685024602,0.0054324046228586,0.16594556338395527,0.05888686553358766,7.105791820705622e-08,0.16770887839624438,0.059913798640819076
156,0.5,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a suitable surrogate tracer for tumor hypoxia measurement? No, (18)F-FDG is not suitable as a surrogate tracer for tumor hypoxia; it mainly measures glucose metabolism. Specialized tracers like (18)F-fluoromisonidazole are used for hypoxia imaging.",1.421158364141119e-07,0.061414740790372235,0.11422273596938776,0.010880558788691243,0.10543622051048596,0.04017168209876547,0.010864809245717214,0.10242497691864783,0.046115451388888895,1.4211583641411244e-07,0.09888739581508688,0.05246913580246914
156,0.5,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG function as a surrogate tracer to quantify tumor hypoxia? No, (18)F-FDG does not function as a surrogate tracer for tumor hypoxia. It is primarily utilized to assess glucose metabolism, whereas tracers such as (18)F-fluoromisonidazole are designed for hypoxia.",4.7371945471370706e-08,0.02344003776505632,0.09795918367346935,0.0036268529295637453,0.022108149942921873,0.020398085159989962,0.003621603081905733,0.02094053603777235,0.022511337868480717,4.737194547137081e-08,0.019612536856477902,0.02471403376165281
156,0.5,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a tracer that can measure tumor hypoxia indirectly? No, (18)F-FDG is not used to indirectly measure tumor hypoxia; it mainly measures glucose metabolism in tissues. Other tracers like (18)F-fluoromisonidazole are used for that purpose.",1.421158364141119e-07,0.017802079845050223,0.1706369606666196,0.010880558788691243,0.023889493385786054,0.09876543209876547,0.010864809245717214,0.06041605688471208,0.0763888888888889,1.4211583641411244e-07,0.09888739581508688,0.05246913580246914
156,0.5,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG serve as a surrogate tracer for tumor hypoxia assessment? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia assessment. It is primarily used to measure tissue glucose metabolism, while specialized tracers such as (18)F-fluoromisonidazole are employed for hypoxia evaluation.",4.737194547137081e-08,0.03758671813809089,0.04254787100025195,0.0036268529295637453,0.010622451307136238,0.0401234567901234,0.003621603081905733,0.012411839588333695,0.043209876543209916,4.737194547137081e-08,0.014373280612865358,0.046296296296296315
157,0.5,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain considered a clinically important issue in general adult psychiatry? Our findings indicate that pain is a notable clinical concern among psychiatric patients and appears to be undervalued in psychiatric practice. Patients studied in general adult psychiatry exhibit distinct risk factors.,9.474389094274162e-08,0.06829491416793232,0.017674328113888547,0.0072537058591274906,0.09846084880686945,0.002268582374252811,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
157,0.5,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Does pain represent a clinically significant problem in general adult psychiatry? Evidence suggests that pain is a major clinical issue for psychiatric patients and is often underestimated in psychiatric care. The patients examined in general adult psychiatry have particular risk factors.,1.1842986367842703e-07,0.09467812963771838,0.016465034767369553,0.009067132323909363,0.12466730702264872,0.002908287627211844,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
157,0.5,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain recognized as a clinically relevant issue in general adult psychiatry? Research shows that pain can be a considerable clinical problem in psychiatric patients, which seems to be underappreciated in psychiatry. The patients assessed in general adult psychiatry possess unique risk factors.",7.105791820705622e-08,0.042587264608476616,0.018826530612244874,0.005440279394345618,0.07292293477679124,0.0016600189291508909,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
157,0.5,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically meaningful problem within general adult psychiatry? The evidence reveals that pain is an important clinical issue among psychiatric patients, which appears to be underestimated in the field of psychiatry. Patients in general adult psychiatry display specific risk factors.",9.474389094274162e-08,0.03448285657964245,0.04195153061224489,0.0072537058591274906,0.06380348977887307,0.02271498107084911,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
157,0.5,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain acknowledged as a clinically pertinent problem in general adult psychiatry? Our study found that pain is a significant clinical issue in psychiatric patients and is likely underestimated in psychiatry. The patients involved in general adult psychiatry show particular risk factors.,9.474389094274162e-08,0.06829491416793232,0.017674328113888547,0.0072537058591274906,0.09846084880686945,0.002268582374252811,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
157,0.5,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically relevant concern in the context of general adult psychiatry? Findings demonstrate that pain can be a significant clinical problem for psychiatric patients and tends to be undervalued in psychiatric settings. The patients studied in general adult psychiatry are marked by certain risk factors.,2.3685972735685406e-08,0.08426169685604545,0.04459813555051649,0.0018134264647818726,0.053979545877510304,0.02271498107084911,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
157,0.5,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically important problem in general adult psychiatry? Evidence indicates that pain is a substantial clinical issue among psychiatric patients and is often underestimated within psychiatry. The patients examined in general adult psychiatry have distinct risk factors.,1.6580180914979763e-07,0.14961956708084712,0.013857394809775749,0.012693985253473108,0.17923244641398606,0.004291191768657054,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
157,0.5,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain considered a clinically significant problem in general adult psychiatry? We found that pain can be a major clinical concern for psychiatric patients and seems to be underrecognized in psychiatry. The patients investigated in general adult psychiatry present specific risk factors.,9.474389094274162e-08,0.06829491416793232,0.017674328113888547,0.0072537058591274906,0.09846084880686945,0.002268582374252811,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
157,0.5,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically relevant issue in the field of general adult psychiatry? Our research found evidence that pain can be a notable clinical problem for psychiatric patients and appears to be underestimated in psychiatry. The patients involved in general adult psychiatry are characterized by certain risk factors.,4.737194547137081e-08,0.10640911130971897,0.04505998996952279,0.0036268529295637453,0.07595845259628531,0.02271498107084911,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
157,0.5,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically significant problem in general adult psychiatry? Evidence shows that pain can be a major clinical problem in psychiatric patients and tends to be underestimated in psychiatry. The patients studied in general adult psychiatry are characterized by specific risk factors.,7.105791820705622e-08,0.0755942732065713,0.004679386547518413,0.005440279394345618,0.07292293477679124,0.0016600189291508909,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
158,0.5,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors sufficient for identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors might not be fully reliable for detecting cervical spine fractures in elderly blunt trauma patients with low-energy trauma.,9.47438909427412e-08,0.11337160161350601,0.0008081632653060833,0.007253705859127504,0.10873347009207857,0.0030166257414039332,0.007243206163811487,0.10815599148194055,0.005600545982874655,9.474389094274162e-08,0.10730625979475672,0.008764924821816789
158,0.5,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Can clinical predictors accurately detect cervical spine fractures in geriatric blunt trauma patients experiencing low-energy mechanisms? Answer: Clinical predictors may fall short in adequately identifying cervical spine fractures in geriatric blunt trauma patients with low-energy injuries.,4.73719454713706e-08,0.11605327231889806,0.026318367346938737,0.003626852929563759,0.11525247835421926,0.03265519352137847,0.003621603081905747,0.11668799671466701,0.0348275158482787,4.737194547137081e-08,0.11808054154234604,0.036419379577707536
158,0.5,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors effective in diagnosing cervical spine fractures in older adults with blunt trauma from low-energy mechanisms? Answer: Clinical predictors might not be completely adequate for recognizing cervical spine fractures in older adults with blunt trauma due to low-energy mechanisms.,1.658018091497972e-07,0.2498632958546838,0.028251562499999994,0.012693985253473122,0.24383281968902804,0.029619758640737626,0.012675610786670087,0.2444798804829933,0.0287544623208959,1.6580180914979784e-07,0.2447876671590632,0.026767133410490057
158,0.5,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Do clinical predictors provide sufficient accuracy for cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not fully suffice to identify cervical spine fractures in elderly blunt trauma patients with low-energy trauma.,9.47438909427412e-08,0.11337160161350601,0.000808163265306111,0.007253705859127504,0.10873347009207857,0.0030166257414039332,0.007243206163811487,0.10815599148194055,0.005600545982874655,9.474389094274162e-08,0.10730625979475672,0.008764924821816789
158,0.5,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: How reliable are clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be entirely dependable for detecting cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms.,9.47438909427412e-08,0.11337160161350601,0.0008081632653060833,0.007253705859127504,0.10873347009207857,0.0030166257414039332,0.007243206163811487,0.10815599148194055,0.005600545982874655,9.474389094274162e-08,0.10730625979475672,0.008764924821816789
158,0.5,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors adequate for diagnosing cervical spine fractures in elderly patients with blunt trauma from low-energy events? Answer: Clinical predictors might not be entirely adequate for identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms.,1.184298636784265e-07,0.21979331949875558,0.03893277835587919,0.009067132323909377,0.32569674683009886,0.11837821519140199,0.009054007704764354,0.33017737222367316,0.1236372418790001,1.1842986367842703e-07,0.33461942196994565,0.1275703417461659
158,0.5,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Is the use of clinical predictors sufficient to identify cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be completely sufficient for detecting cervical spine fractures in geriatric blunt trauma patients with low-energy injuries.,1.658018091497972e-07,0.21605123826639305,0.011877627471384017,0.012693985253473122,0.20917546066103077,0.009245562130177493,0.012675610786670087,0.20893387122350937,0.006616355399408275,1.6580180914979784e-07,0.2083062366032764,0.002981693786982237
158,0.5,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Can clinical predictors alone effectively identify cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not fully capture cervical spine fractures in elderly blunt trauma patients with low-energy trauma.,2.36859727356853e-08,0.0001362942427118874,0.009599999999999997,0.0018134264647818796,0.0022715051115631546,0.016272189349112398,0.0018108015409528735,0.003360588860819469,0.019230769230769218,2.3685972735685406e-08,0.004585629698643068,0.022189349112426038
158,0.5,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors alone adequate for cervical spine fracture detection in geriatric patients with blunt trauma from low-energy mechanisms? Answer: Clinical predictors might not be wholly adequate for identifying cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms.,1.421158364141118e-07,0.32153504739093863,0.08507128027681657,0.01088055878869125,0.4611165249007172,0.1967455621301775,0.01086480924571722,0.43178044963663975,0.17751479289940827,1.4211583641411244e-07,0.4005265728558358,0.15532544378698224
158,0.5,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Do clinical predictors provide adequate assessment for cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in elderly blunt trauma patients with low-energy trauma.,1.184298636784265e-07,0.1487013009797873,0.004478478002378189,0.009067132323909377,0.14328959405116626,0.0011900065746219823,0.009054007704764354,0.14284029639666151,0.0013740959894805727,1.1842986367842703e-07,0.14207853848107233,0.004674556213017794
159,0.5,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the interfractional motion of the prostate bed target, assessed using RTOG consensus definitions and daily CT on rails, vary between the superior and inferior parts of the clinical target volume? Answer: No significant motion differences were found between the superior (SUP-CTV) and inferior (INF-CTV) portions. The existing uniform planning target volume (PTV) margins sufficiently cover both areas of the CTV.",9.474389094274162e-08,0.00574402001358898,0.0819867389104402,0.0072537058591274906,0.07064322191685513,0.0011893608989532352,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
159,0.5,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in target motion between the superior and inferior regions of the prostate bed clinical target volume? Answer: There is no statistically significant difference in motion between the superior and inferior CTV regions. The current uniform PTV margins adequately encompass both sections of the CTV.",0.0,0.12160476851928781,0.08535867768595035,0.0,0.0742657693457085,0.05315467749034182,0.0,0.07561605606108524,0.0543639053254438,0.0,0.05134423559703327,0.036982248520710054
159,0.5,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Is there a difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume when using RTOG consensus definitions and daily CT on rails? Answer: Statistically, no motion differences were observed between the superior and inferior CTV. The uniform planning target volume margins currently in use are sufficient for both areas.",0.0,0.07296286111157357,0.051866961709619096,0.0,0.04951051289713915,0.035548546731432915,0.0,0.05041070404072334,0.03631185475258099,0.0,0.025672117798516858,0.01851192595229618
159,0.5,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the prostate bed target exhibit differing interfractional motion between its superior and inferior clinical target volume portions, based on RTOG consensus and daily CT on rails? Answer: No statistically significant motion difference exists between the superior and inferior CTV, and current uniform PTV margins adequately cover both.",2.1317375462116866e-07,0.18097061456560493,0.006546579387273661,0.016320838183036854,0.17994445728120034,0.00341530097330061,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
159,0.5,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: According to RTOG consensus definitions and daily CT on rails, does the interfractional motion vary between the superior and inferior portions of the prostate bed clinical target volume? Answer: There are no statistically significant differences in motion between the superior and inferior CTV, and the uniform PTV margins are sufficient for coverage.",1.1842986367842703e-07,0.14980366962385983,0.04134756657483928,0.009067132323909363,0.15031752868695403,0.040742510330578505,0.009054007704764333,0.1507619542491212,0.03993055555555556,1.1842986367842703e-07,0.12545547010915659,0.020399305555555556
159,0.5,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When assessing prostate bed target motion using RTOG consensus definitions and daily CT on rails, is there a difference between the superior and inferior clinical target volume portions? Answer: No statistically apparent motion differences exist between the superior and inferior CTV, and the uniform PTV margins adequately cover both regions.",1.6580180914979784e-07,0.19328990388827982,0.04435376275211298,0.012693985253473108,0.19365130114247675,0.04311284350638188,0.012675610786670066,0.19389443937124184,0.04158790170132326,1.6580180914979784e-07,0.1683320695588959,0.021266540642722105
159,0.5,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does interfractional motion differ between the superior and inferior parts of the prostate bed clinical target volume as defined by RTOG consensus and evaluated with daily CT on rails? Answer: No significant motion differences were detected between SUP-CTV and INF-CTV, and current uniform PTV margins sufficiently cover both.",2.1317375462116866e-07,0.1232083495189431,0.0350413223140496,0.016320838183036854,0.15044883257652186,0.017851239669421492,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
159,0.5,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using daily CT on rails and RTOG consensus definitions, is there a difference in prostate bed target motion between the superior and inferior clinical target volume segments? Answer: There are no statistically significant motion differences between the superior and inferior CTV, and uniform PTV margins currently in place are adequate.",1.6580180914979784e-07,0.19328990388827982,0.04435376275211298,0.012693985253473108,0.19365130114247675,0.04311284350638188,0.012675610786670066,0.19389443937124184,0.04158790170132326,1.6580180914979784e-07,0.1683320695588959,0.021266540642722105
159,0.5,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Is there a variation in interfractional motion between the superior and inferior portions of the prostate bed clinical target volume when following RTOG consensus definitions and daily CT on rails? Answer: No statistically significant difference in motion was found between the superior and inferior CTV, and uniform PTV margins are sufficient to cover both.",7.105791820705622e-08,0.10811378505662583,0.038558677685950386,0.005440279394345618,0.10877401287332056,0.03854876033057854,0.0054324046228586,0.10940848054026997,0.03840000000000001,7.105791820705622e-08,0.08434065621484965,0.019599999999999992
159,0.5,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the interfractional motion of the prostate bed target differ between the superior and inferior clinical target volume regions according to RTOG consensus and daily CT on rails? Answer: There are no statistically significant motion differences between the superior and inferior CTV, and the current uniform planning target volume margins are adequate for both.",7.105791820705622e-08,0.13378590285514225,0.05658716581589631,0.005440279394345618,0.10877401287332056,0.03854876033057854,0.0054324046228586,0.10940848054026997,0.03840000000000001,7.105791820705622e-08,0.08434065621484965,0.019599999999999992
160,0.5,1,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are laboratories accurately reporting serum quantitative hCG results? The correctness of these reports depends heavily on the individual lab and its compliance with testing procedures. Although most labs deliver trustworthy and precise outcomes, inconsistencies may arise from factors such as equipment calibration, reagent quality, and staff expertise. Ongoing audits and quality control measures are crucial to maintain accuracy.",1.6580180914979784e-07,0.007527568562630371,0.07756391841424877,0.012693985253473108,0.02976434606147116,0.06320022981901754,0.012675610786670066,0.05272244040359286,0.048261993679977015,1.6580180914979784e-07,0.07643754347395681,0.03274920999712727
160,0.5,2,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories report serum quantitative hCG results correctly? The accuracy of these reports is largely contingent on the specific laboratory and its adherence to established testing protocols. Many labs produce reliable and accurate results, but discrepancies can happen due to issues like equipment calibration, the quality of reagents, and the training level of technicians. Regular quality control checks and audits are vital to ensure the results are correct.",7.105791820705622e-08,0.1541137829937842,0.07756391841424877,0.005440279394345618,0.1345387052298035,0.06320022981901754,0.0054324046228586,0.11433164425957276,0.048261993679977015,7.105791820705622e-08,0.09346149332143927,0.03274920999712727
160,0.5,3,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results reported accurately by laboratories? The precision of these results depends on the laboratory's compliance with testing standards. While numerous labs provide dependable and accurate data, errors may occur because of factors including equipment calibration, reagent quality, and technician training. Consistent audits and quality control are necessary to guarantee accuracy.",2.6054570009253947e-07,0.08028692284505956,0.07756391841424877,0.0199476911126006,0.10387231821519283,0.06320022981901754,0.019918816950481533,0.12822999291173875,0.048261993679977015,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.5,4,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting of serum quantitative hCG results by laboratories accurate? The accuracy depends on the specific lab and how well they follow testing protocols. Many laboratories offer reliable and precise results, but discrepancies can arise due to equipment calibration, reagent quality, and the expertise of technicians. To ensure correctness, regular quality control and audits are essential.",1.8948778188548325e-07,0.025227145662030992,0.07756391841424877,0.014507411718254981,0.04778285156414963,0.06320022981901754,0.014486412327622933,0.07107157907178863,0.048261993679977015,1.8948778188548325e-07,0.09512967648611115,0.03274920999712727
160,0.5,5,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do labs report serum quantitative hCG results with accuracy? The reliability of these reports depends on each lab's adherence to testing protocols. Although many labs provide accurate and trustworthy results, discrepancies may occur due to factors like equipment calibration, reagent quality, and technician proficiency. Regular audits and quality control procedures are important to maintain result accuracy.",2.1317375462116866e-07,0.043245651164709464,0.07756391841424877,0.016320838183036854,0.0661319902323454,0.06320022981901754,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.11417787145680425,0.03274920999712727
160,0.5,6,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results being reported correctly by laboratories? The accuracy of these reports largely hinges on the laboratory's adherence to testing protocols. While many labs produce accurate and reliable results, discrepancies can result from equipment calibration issues, reagent quality, and technician training. Ensuring correctness requires ongoing audits and quality control checks.",2.8423167282822487e-07,0.09933511781575266,0.07756391841424877,0.02176111757738247,0.12329040407229552,0.06320022981901754,0.0217296184914344,0.14803262020791852,0.048261993679977015,2.8423167282822487e-07,0.17360129192760532,0.03274920999712727
160,0.5,7,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","How accurately do laboratories report serum quantitative hCG results? The accuracy depends on the specific lab and their compliance with testing protocols. Many labs provide dependable and precise results, but discrepancies might occur due to equipment calibration, reagent quality, and technician training. Regular quality control and audits are essential to ensure the correctness of results.",2.3685972735685406e-07,0.06159478983290523,0.07756391841424877,0.018134264647818726,0.08482412324449973,0.06320022981901754,0.018108015409528666,0.10881190705463606,0.048261993679977015,2.3685972735685406e-07,0.13359595731390694,0.03274920999712727
160,0.5,8,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are laboratories providing correct serum quantitative hCG results? The accuracy of these results is mainly dependent on the lab and their adherence to protocols. Although many labs deliver accurate and reliable data, discrepancies may arise from factors such as equipment calibration, reagent quality, and technician training. Continuous audits and quality control are key to maintaining accuracy.",2.1317375462116866e-07,0.043245651164709464,0.07756391841424877,0.016320838183036854,0.0661319902323454,0.06320022981901754,0.0162972138685758,0.08976371208394296,0.048261993679977015,2.1317375462116866e-07,0.11417787145680425,0.03274920999712727
160,0.5,9,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the accuracy of serum quantitative hCG reporting by laboratories reliable? It depends on the lab and how strictly they follow testing protocols. While many labs report accurate and dependable results, discrepancies can occur due to equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are necessary to ensure accuracy.",2.6054570009253947e-07,0.08028692284505956,0.07756391841424877,0.0199476911126006,0.10387231821519283,0.06320022981901754,0.019918816950481533,0.12822999291173875,0.048261993679977015,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.5,10,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories consistently report serum quantitative hCG results correctly? The accuracy is largely dependent on the specific laboratory and their adherence to testing procedures. Many labs provide reliable and accurate results, but discrepancies can happen due to equipment calibration, reagent quality, and technician expertise. To maintain correctness, regular audits and quality control are essential.",2.6054570009253947e-07,0.08028692284505956,0.07756391841424877,0.0199476911126006,0.10387231821519283,0.06320022981901754,0.019918816950481533,0.12822999291173875,0.048261993679977015,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
161,0.5,1,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis mainly depends on the severity of liver disease and kidney function, but additional factors like systemic inflammation, infections, circulatory issues, and genetic predispositions may also play a role, warranting further investigation.",4.974054274493928e-07,0.4924764850977952,0.0,0.038081955760419346,0.5045560107523945,0.0,0.038026832360010226,0.5172565140962813,0.0,4.974054274493935e-07,0.5306282510621703,0.0
161,0.5,2,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The prognosis of hepatorenal syndrome is largely determined by liver disease severity and renal function, yet emerging evidence indicates that systemic inflammation, infections, circulatory dysfunction, and genetic factors might be overlooked and require more research.",4.737194547137075e-07,0.4626235219481134,0.0,0.03626852929563747,0.47378435208564085,0.0,0.03621603081905735,0.48550781578170144,0.0,4.737194547137081e-07,0.49783842823917857,0.0
161,0.5,3,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","While liver disease severity and kidney function are key to predicting hepatorenal syndrome outcomes, other potential prognostic factors such as systemic inflammation, infection, circulatory problems, and genetic predispositions might be missing and need further study.",4.737194547137075e-07,0.4626235219481134,0.0,0.03626852929563747,0.47378435208564085,0.0,0.03621603081905735,0.48550781578170144,0.0,4.737194547137081e-07,0.49783842823917857,0.0
161,0.5,4,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome prognosis is chiefly assessed through liver disease severity and renal function, but studies propose that factors like systemic inflammation, infections, circulatory dysfunction, and genetics could also influence outcomes and should be further researched.",4.737194547137075e-07,0.4626235219481134,0.0,0.03626852929563747,0.47378435208564085,0.0,0.03621603081905735,0.48550781578170144,0.0,4.737194547137081e-07,0.49783842823917857,0.0
161,0.5,5,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The current prognosis for hepatorenal syndrome focuses on liver disease severity and renal function; however, systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be additional prognostic elements that require more exploration.",5.447773729207634e-07,0.5549968420791287,0.0,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
161,0.5,6,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Prognostic evaluation of hepatorenal syndrome is primarily based on liver and kidney function, but other factors including systemic inflammation, infection, circulatory dysfunction, and genetic predispositions may be overlooked and need further research.",5.447773729207634e-07,0.5549968420791287,0.0,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
161,0.5,7,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Liver disease severity and renal function are the main criteria for hepatorenal syndrome prognosis, yet other factors like systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be missing and should be studied further.",4.974054274493928e-07,0.4924764850977952,0.0,0.038081955760419346,0.5045560107523945,0.0,0.038026832360010226,0.5172565140962813,0.0,4.974054274493935e-07,0.5306282510621703,0.0
161,0.5,8,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","The prognosis of hepatorenal syndrome depends mainly on the severity of liver disease and kidney function, but systemic inflammation, infection, circulatory dysfunction, and individual genetic predispositions may also be important and require more research.",4.974054274493928e-07,0.4924764850977952,0.0,0.038081955760419346,0.5045560107523945,0.0,0.038026832360010226,0.5172565140962813,0.0,4.974054274493935e-07,0.5306282510621703,0.0
161,0.5,9,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Hepatorenal syndrome outcomes are typically predicted by liver disease severity and renal function, but additional factors such as systemic inflammation, infections, circulatory dysfunction, and genetic predispositions may be unaccounted for and need further investigation.",4.974054274493928e-07,0.4924764850977952,0.0,0.038081955760419346,0.5045560107523945,0.0,0.038026832360010226,0.5172565140962813,0.0,4.974054274493935e-07,0.5306282510621703,0.0
161,0.5,10,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","While hepatorenal syndrome prognosis is based mostly on liver disease severity and renal function, other factors like systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be missing and warrant further study.",5.447773729207634e-07,0.5549968420791287,0.0,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
162,0.5,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction using oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most acetabular components in this group remained stable despite limited contact between the component and pelvic bone. However, three out of ten showed migration beyond thresholds indicating future loosening in primary cases.",9.474389094274162e-08,0.07847161544149417,0.0,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
162,0.5,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability achieved in THA for osteoporotic acetabular fractures when using cup-cage reconstruction with oversized cups? In this cohort, the majority of acetabular components were stable even though the contact area with the pelvic bone was minimal. Yet, three of ten components migrated beyond limits associated with later loosening in primary surgeries.",2.3685972735685406e-08,0.0190481949706931,0.0,0.0018134264647818726,0.019418085857102696,0.0,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
162,0.5,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does the use of oversized cups in cup-cage reconstruction provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Most acetabular components in this study were stable despite a small contact surface with the pelvic bone. Nevertheless, three out of ten migrated beyond the limits that predict loosening in primary cases.",4.737194547137081e-08,0.038466280827795796,0.0,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
162,0.5,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can cup-cage reconstruction with oversized cups ensure initial stability in THA for patients with osteoporotic acetabular fractures? The majority of acetabular components showed stability despite limited contact between the implant and pelvic bone, although three of ten migrated past thresholds linked to future loosening in primary procedures.",1.6580180914979784e-07,0.14165051706302645,0.0,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
162,0.5,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability provided by cup-cage reconstruction using oversized cups in THA for osteoporotic acetabular fractures? Most components were stable despite minimal contact with pelvic bone, but three out of ten migrated beyond the limits predictive of later loosening in primary cases.",2.8423167282822487e-07,0.2567198468478131,0.0,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
162,0.5,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does oversized cup usage in cup-cage reconstruction yield initial stability in total hip arthroplasty for osteoporotic acetabular fractures? The majority of acetabular components remained stable despite small contact surfaces with the pelvic bone; however, three of ten migrated beyond limits indicating potential loosening later.",2.3685972735685406e-07,0.2090917978585587,0.0,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
162,0.5,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"In THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups provide initial stability? Most acetabular components were stable despite limited contact with pelvic bone, though three out of ten migrated beyond the thresholds that suggest future loosening in primary cases.",2.8423167282822487e-07,0.2567198468478131,0.0,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
162,0.5,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does the implementation of oversized cups in cup-cage reconstruction offer initial stability in THA for osteoporotic acetabular fractures? Most components maintained stability despite minimal pelvic bone contact, but three of ten migrated beyond the migration limits predictive of loosening in primary surgeries.",2.8423167282822487e-07,0.2567198468478131,0.0,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
162,0.5,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability achieved in total hip arthroplasty using cup-cage reconstruction with oversized cups for osteoporotic acetabular fractures? The majority of acetabular components were stable despite a small contact surface with the pelvic bone, although three of ten migrated beyond limits that forecast later loosening in primary cases.",1.4211583641411244e-07,0.12014431184206309,0.0,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
162,0.5,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Most acetabular components remained stable despite limited contact with the pelvic bone; however, three out of ten migrated beyond the limits that predict subsequent loosening in primary procedures.",2.6054570009253947e-07,0.2326222952687531,0.0,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
163,0.5,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study indicates a potential link between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.15021004549256967,0.005106302021403095,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.5,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does a relationship exist between cervical cord plaques and discopathy in patients with multiple sclerosis? Data from the study points to a possible association between cervical discopathy and cervical MS plaques.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
163,0.5,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques related to discopathy in multiple sclerosis patients? The study's findings suggest a possible correlation between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.5,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any association between cervical cord plaques and discopathy in individuals with multiple sclerosis? Study data indicates a potential connection between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.5,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Can cervical cord plaques be linked to discopathy in multiple sclerosis patients? The data suggests a possible correlation between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.5,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a correlation between cervical cord plaques and discopathy in patients with multiple sclerosis? The study data implies a potential relationship between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.5,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? The research suggests a possible association between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.15021004549256967,0.005106302021403095,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.5,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does cervical cord plaque have any relation to discopathy in patients with multiple sclerosis? The study data indicates a possible correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.059150703620495904,0.033293697978596916,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.5,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques connected to discopathy in patients with multiple sclerosis? The findings suggest a potential link between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.5,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a relationship between cervical cord plaques and discopathy in multiple sclerosis patients? Study data suggests a possible correlation between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.15021004549256967,0.005106302021403095,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
164,0.5,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair on patients aged 80 or above after aneurysmal subarachnoid hemorrhage? The study shows that elderly patients who underwent repair of the ruptured aneurysm had better outcomes compared to those managed conservatively. Therefore, definitive surgery should be offered to elderly patients with aSAH without hesitation.",7.105791820705622e-08,0.033681800587132216,0.01768614608708629,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
164,0.5,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be conducted for patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Findings indicate that repairing the ruptured aneurysm in elderly patients leads to a better prognosis than conservative treatment. Hence, definitive surgery is recommended for elderly aSAH patients.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.5,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified in patients aged 80+ after aneurysmal subarachnoid hemorrhage? The study demonstrated improved prognosis in elderly patients who received aneurysm repair compared to conservative management. Consequently, definitive surgical intervention should be considered for elderly patients with aSAH.",3.316036182995956e-07,0.3255092911822035,0.013454397069846427,0.025387970506946217,0.31365755885504143,0.0,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
164,0.5,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 and above with aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? Results reveal that elderly patients who had the ruptured aneurysm repaired fared better than those treated conservatively, indicating that definitive surgery should be offered to this group.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.5,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study found that elderly patients experienced better outcomes when the ruptured aneurysm was repaired rather than treated conservatively, supporting the use of definitive surgery in these cases.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.5,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it advisable to perform aneurysm repair on patients aged 80+ after aneurysmal subarachnoid hemorrhage? Evidence shows improved prognosis with repair of the ruptured aneurysm in elderly patients versus conservative treatment, suggesting definitive surgery should be offered.",4.026615365066515e-07,0.3344599803367694,0.03767781622452902,0.030828249901291835,0.39589565709201446,0.0,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
164,0.5,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should elderly patients aged 80 or more with aneurysmal subarachnoid hemorrhage undergo aneurysm repair? The study's results indicate better outcomes with repair compared to conservative care, thus definitive surgery is justified for elderly aSAH patients.",4.500334819780221e-07,0.39161839417671773,0.03767781622452902,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
164,0.5,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified in octogenarians after aneurysmal subarachnoid hemorrhage? Data suggests that elderly patients benefit more from repairing the ruptured aneurysm than from conservative treatment, so definitive surgery should not be withheld.",4.974054274493927e-07,0.4522430159931532,0.03767781622452902,0.03808195576041935,0.5172565140962813,0.0,0.03802683236001023,0.5306282510621703,0.0,4.974054274493935e-07,0.5447271754416723,0.0
164,0.5,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair appropriate? The findings show better prognosis when the ruptured aneurysm is repaired rather than treated conservatively, supporting definitive surgery in elderly patients.",4.500334819780221e-07,0.39161839417671773,0.03767781622452902,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
164,0.5,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for patients aged 80+ following aneurysmal subarachnoid hemorrhage? The study demonstrates superior outcomes with repair of the ruptured aneurysm in elderly patients compared to conservative management, indicating that definitive surgery should be offered.",4.026615365066515e-07,0.3344599803367694,0.03767781622452902,0.030828249901291835,0.39589565709201446,0.0,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
165,0.5,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do individuals with episodic migraines selectively focus on headache-related visual cues? Answer: Considering the substantial sample size and previous pilot assessments of the images shown, the findings indicate that episodic migraine sufferers do not specifically attend more to headache-related facial stimuli. Despite some evidence of attentional biases in chronic headache groups, these results suggest otherwise.",1.4211583641411244e-07,0.20038805208836807,0.060964083175803374,0.010880558788691236,0.14666416817971495,0.020823902218198284,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
165,0.5,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are people with episodic migraines more likely to pay attention to headache-related visual stimuli? Answer: Based on the large sample and earlier pilot testing of the images, the data imply that episodic migraineurs do not show a selective attention to headache-related facial images. Although there is some modest evidence of attentional biases in chronic headache populations, these findings do not support that for episodic cases.",3.789755637709665e-07,0.30345932008446264,0.01491829753584499,0.029014823436509962,0.29490235558261446,0.005202838978087427,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
165,0.5,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine patients focus selectively on headache-related visual stimuli? Answer: With a large sample size and prior pilot testing of the images, the results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. While some attentional biases have been observed in chronic headache sufferers, these findings do not confirm such biases in episodic migraineurs.",2.1317375462116866e-07,0.22959625048645593,0.043728010538068685,0.016320838183036854,0.2007313894499898,0.020823902218198284,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
165,0.5,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is there selective attention to headache-related visual stimuli among episodic migraine sufferers? Answer: Given the extensive sample and previous pilot image testing, results indicate that episodic migraineurs do not show selective attention to headache-related facial stimuli. There is limited evidence of attentional bias in chronic headache groups, but these findings do not extend to episodic migraineurs.",1.6580180914979784e-07,0.11938553179676825,0.010041833983959941,0.012693985253473108,0.11460260280718737,0.015487952534382704,0.012675610786670066,0.11316432705570056,0.01851192595229618,1.6580180914979784e-07,0.14165051706302645,0.0
165,0.5,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do individuals with episodic migraines show selective attention to headache-related facial images? Answer: Considering the large sample size and prior pilot testing of the images, the findings suggest no differential attention to headache-related facial stimuli among episodic migraineurs. Although some modest attentional biases exist in chronic headache populations, these results do not demonstrate such bias in episodic cases.",2.1317375462116866e-07,0.18179299665473447,0.009393835241919078,0.016320838183036854,0.1520894820422738,0.014217420095851321,0.0162972138685758,0.15044883257652186,0.017851239669421492,2.1317375462116866e-07,0.17869178874337655,0.0
165,0.5,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are headache-related visual stimuli selectively attended to by episodic migraineurs? Answer: The results, supported by a large sample and earlier pilot testing of the images, suggest that episodic migraineurs do not preferentially attend to headache-related facial stimuli. While modest evidence of attentional biases is found in chronic headache sufferers, these findings do not support this in episodic migraineurs.",2.1317375462116866e-07,0.22959625048645593,0.043728010538068685,0.016320838183036854,0.2007313894499898,0.020823902218198284,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
165,0.5,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine patients exhibit selective attention to headache-related visual stimuli? Answer: Based on a large sample size and previous pilot testing of the images, the evidence suggests that episodic migraineurs do not selectively attend to headache-related facial stimuli. Although attentional biases have been modestly noted in chronic headache groups, these findings do not apply to episodic migraineurs.",2.1317375462116866e-07,0.20569462357059587,0.02652530766559929,0.016320838183036854,0.2007313894499898,0.020823902218198284,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
165,0.5,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is selective attention to headache-related facial stimuli present in episodic migraineurs? Answer: The results, derived from a large sample and pilot-tested images, indicate that episodic migraineurs do not differentially attend to headache-related facial stimuli. Despite some modest evidence of attentional biases in chronic headache sufferers, these findings do not support such biases in episodic migraineurs.",1.4211583641411244e-07,0.0743612919865595,0.02903591682419661,0.010880558788691236,0.12099205038119809,0.0023119762659021027,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
165,0.5,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine sufferers selectively attend to headache-related visual cues? Answer: Considering the large sample and prior pilot testing of the images, the findings suggest that episodic migraineurs do not show selective attention to headache-related facial stimuli. Although modest attentional biases occur in chronic headache populations, these results do not extend to episodic migraine sufferers.",1.4211583641411244e-07,0.12477199602728284,0.006600177850359566,0.010880558788691236,0.14666416817971495,0.020823902218198284,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
165,0.5,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are headache-related facial stimuli selectively attended to by those with episodic migraines? Answer: Given the large sample size and previous pilot testing of the images, results indicate that episodic migraineurs do not differentially attend to headache-related facial stimuli. While modest evidence of attentional biases exists among chronic headache sufferers, these findings do not confirm this for episodic migraineurs.",2.1317375462116866e-07,0.20569462357059587,0.02652530766559929,0.016320838183036854,0.2007313894499898,0.020823902218198284,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
166,0.5,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's distribution of healthcare benefits align with the principles of universal coverage? Although Kenya is working towards universal health coverage, there are still major challenges such as regional disparities, resource limitations, and service delivery gaps. As a result, it does not yet fully adhere to universal coverage principles.",2.1317375462116866e-07,0.025924534703512858,0.10380622837370242,0.016320838183036854,0.07618306323081336,0.07100591715976332,0.0162972138685758,0.1282810847026532,0.03631185475258099,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
166,0.5,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the allocation of health care benefits in Kenya consistent with universal coverage principles? Kenya aims for universal health coverage but continues to face significant obstacles including uneven regional access, scarce resources, and service delivery shortcomings. Hence, it does not completely fulfill universal coverage criteria at present.",2.6054570009253947e-07,0.09862098305969802,0.08207783331197402,0.0199476911126006,0.11966817517055173,0.07100591715976332,0.019918816950481533,0.17273284727348592,0.03631185475258099,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
166,0.5,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the way health care benefits are distributed in Kenya comply with universal coverage principles? Despite efforts to achieve universal health coverage, Kenya struggles with unequal access by region, limited resources, and gaps in service provision, meaning it does not fully satisfy universal coverage standards currently.",2.8423167282822487e-07,0.12126959719930408,0.08159548457204953,0.02176111757738247,0.14214103102260944,0.07100591715976332,0.0217296184914344,0.19572236549818545,0.03631185475258099,2.8423167282822487e-07,0.22564231048239058,0.01851192595229618
166,0.5,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","To what extent does Kenya’s healthcare benefits distribution meet universal coverage principles? Kenya is progressing towards universal health coverage; however, challenges like regional inequalities, resource constraints, and service delivery gaps persist, preventing full compliance with universal coverage principles.",4.737194547137078e-07,0.32367504813258074,0.07680005553419625,0.03626852929563745,0.342811726484761,0.07100591715976332,0.03621603081905733,0.4015744197023343,0.03631185475258099,4.737194547137081e-07,0.43695140414959655,0.01851192595229618
166,0.5,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's health care benefit distribution fulfill the principles of universal coverage? Kenya is advancing towards universal health coverage but faces significant issues such as unequal regional access, limited resources, and service delivery gaps, so it does not fully meet these principles yet.",3.552895910352811e-07,0.15945592732803604,0.10380622837370242,0.02720139697172809,0.2127585982365634,0.07100591715976332,0.027162023114293,0.2680430270778116,0.03631185475258099,3.552895910352811e-07,0.29975028263611403,0.01851192595229618
166,0.5,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits in Kenya aligned with the principles of universal coverage? While Kenya works towards universal health coverage, challenges including regional disparities, resource shortages, and service delivery gaps mean it does not fully meet universal coverage principles now.",3.552895910352811e-07,0.15945592732803604,0.10380622837370242,0.02720139697172809,0.2127585982365634,0.07100591715976332,0.027162023114293,0.2680430270778116,0.03631185475258099,3.552895910352811e-07,0.29975028263611403,0.01851192595229618
166,0.5,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya’s distribution of health care benefits satisfy universal coverage principles? Kenya is striving for universal coverage, but ongoing challenges like unequal access across regions, limited resources, and gaps in service delivery mean it currently falls short of fully meeting these principles.",3.789755637709665e-07,0.18355347890709606,0.10380622837370242,0.029014823436509962,0.2374512108269351,0.07100591715976332,0.028972824655245866,0.2933608350621033,0.03631185475258099,3.789755637709665e-07,0.325725769039372,0.01851192595229618
166,0.5,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","How well does Kenya distribute health care benefits according to universal coverage principles? Kenya is making progress toward universal health coverage, but significant challenges such as regional inequality, resource limitations, and service delivery gaps remain, so it does not yet fully comply.",3.789755637709665e-07,0.18355347890709606,0.10380622837370242,0.029014823436509962,0.2374512108269351,0.07100591715976332,0.028972824655245866,0.2933608350621033,0.03631185475258099,3.789755637709665e-07,0.325725769039372,0.01851192595229618
166,0.5,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the distribution of health care benefits in Kenya conform to universal coverage principles? Kenya is aiming for universal health coverage; however, unequal access by region, resource constraints, and service delivery gaps pose challenges, so it does not fully meet these principles at this time.",3.079176455639103e-07,0.1129359116931421,0.10380622837370242,0.023574544042164344,0.16513054924730897,0.07100591715976332,0.023540420032387266,0.21925286290837986,0.03631185475258099,3.079176455639103e-07,0.2497398620614506,0.01851192595229618
166,0.5,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is Kenya’s distribution of health care benefits consistent with universal coverage principles? Although Kenya is committed to universal health coverage, significant challenges like regional disparities, limited resources, and gaps in service delivery mean it does not currently fully meet these principles.",4.026615365066519e-07,0.20824609149746776,0.10380622837370242,0.030828249901291835,0.26276901881122683,0.07100591715976332,0.030783626196198732,0.3193363214653613,0.03631185475258099,4.026615365066519e-07,0.35239401612153287,0.01851192595229618
167,0.5,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can a new surgical method for the temporomandibular joint enhance access and minimize complications?,8.290090457489868e-07,1.017440328213043,0.19390581717451527,0.06346992626736568,1.1292759542846293,0.16305062458908606,0.0633780539333505,1.2499251200663908,0.1275,8.290090457489886e-07,1.3808512313433954,0.08804283164782867
167,0.5,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is it possible for an innovative surgical approach to the temporomandibular joint to improve accessibility and lower complication rates?,7.105791820705601e-07,0.6920179277784153,0.19390581717451527,0.054402793943456304,0.780969260016414,0.16305062458908606,0.05432404622858612,0.8752316706249803,0.1275,7.105791820705619e-07,0.9753861232352303,0.08804283164782867
167,0.5,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could a novel technique in temporomandibular joint surgery provide better access while reducing complications?,8.290090457489868e-07,1.017440328213043,0.19390581717451527,0.06346992626736568,1.1292759542846293,0.16305062458908606,0.0633780539333505,1.2499251200663908,0.1275,8.290090457489886e-07,1.3808512313433954,0.08804283164782867
167,0.5,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Does a new surgical strategy for the temporomandibular joint offer improved access and fewer complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.5,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Might a cutting-edge surgical approach to the temporomandibular joint enhance access and decrease complications?,8.290090457489868e-07,1.017440328213043,0.19390581717451527,0.06346992626736568,1.1292759542846293,0.16305062458908606,0.0633780539333505,1.2499251200663908,0.1275,8.290090457489886e-07,1.3808512313433954,0.08804283164782867
167,0.5,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can advancements in surgical methods for the temporomandibular joint lead to better access and reduced complications?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,0.5,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is there potential for a novel temporomandibular joint surgery technique to improve access and limit complications?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,0.5,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could innovative surgical approaches to the temporomandibular joint result in improved access and fewer complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.5,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Does employing a novel surgical method on the temporomandibular joint improve access and reduce the risk of complications?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,0.5,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can a new surgical approach targeting the temporomandibular joint enhance surgical access and minimize complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
168,0.5,1,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? Yes, the position of the head can impact the anterior chamber depth in pseudoexfoliation syndrome. Certain positions, like lying flat, may increase anterior chamber depth, which can complicate management. Hence, head position should be taken into account during assessment and treatment of this condition.",1.4211583641411244e-07,0.08342502157105702,0.01848855604865221,0.010880558788691236,0.09357130513539014,0.011111053978994784,0.0108648092457172,0.0926272587484509,0.013318781783310418,1.4211583641411244e-07,0.09154405963226253,0.015673624787111436
168,0.5,2,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Indeed, head positioning can alter anterior chamber depth in pseudoexfoliation syndrome. For example, lying flat may deepen the anterior chamber, potentially complicating treatment. Thus, considering head position is important in evaluating and managing this syndrome.",3.316036182995957e-07,0.22962551740151138,0.02845125119240803,0.025387970506946217,0.21215355899016863,0.045872124553293536,0.025351221573340132,0.2088882910294143,0.05246913580246911,3.316036182995957e-07,0.2381715595546421,0.03566529492455417
168,0.5,3,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can head position change anterior chamber depth in pseudoexfoliation syndrome? Yes, head positioning can affect the anterior chamber depth in pseudoexfoliation syndrome. Specific postures, such as lying flat, can increase the depth, which might complicate disease management. Therefore, head position should be factored into patient assessment and therapy.",2.8423167282822487e-07,0.21039236355228663,0.011618799393524656,0.02176111757738247,0.2266056082060497,0.003687159707430901,0.0217296184914344,0.22503899966909646,0.00812083942604943,2.8423167282822487e-07,0.22315823394520073,0.01295031385370506
168,0.5,4,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the position of the head influence anterior chamber depth in pseudoexfoliation syndrome? Yes, head position does influence anterior chamber depth in pseudoexfoliation syndrome. Positions like lying flat can cause an increase in anterior chamber depth, complicating management. Consequently, head positioning must be considered during diagnosis and treatment.",2.8423167282822487e-07,0.25102092748599736,0.0572120444649388,0.02176111757738247,0.2567424421434388,0.017580694829372107,0.0217296184914344,0.25584554102731616,0.013857394809775776,2.8423167282822487e-07,0.2546649239706529,0.009686178998348324
168,0.5,5,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth in pseudoexfoliation syndrome affected by how the head is positioned? Yes, the anterior chamber depth can be influenced by head positioning in pseudoexfoliation syndrome. For instance, lying flat may increase this depth, potentially complicating management. Hence, head position is a relevant factor in assessment and treatment.",2.3685972735685406e-07,0.10611670859484912,0.05552999966443331,0.018134264647818726,0.12251662449841749,0.047763203405944366,0.018108015409528666,0.1199408050129187,0.05246913580246911,2.3685972735685406e-07,0.14719978134891543,0.03566529492455417
168,0.5,6,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does head positioning have an effect on anterior chamber depth in pseudoexfoliation syndrome? Yes, head positioning can impact anterior chamber depth in pseudoexfoliation syndrome. Certain positions such as lying flat can increase the depth, which may complicate the condition’s management. Therefore, head position should be considered when assessing and treating the syndrome.",1.8948778188548325e-07,0.11714742088912633,0.01961317546783592,0.014507411718254981,0.13599115912202553,0.008831560128443217,0.014486412327622933,0.1348515519233655,0.011726718419037677,1.8948778188548325e-07,0.1335212994534496,0.014841392706355885
168,0.5,7,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can the depth of the anterior chamber in pseudoexfoliation syndrome be influenced by head position? Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Positions like lying flat can increase this depth, possibly complicating management. Thus, head position is important in patient evaluation and treatment planning.",2.8423167282822487e-07,0.12190548943825119,0.07402494703776755,0.02176111757738247,0.13619510639388333,0.06858710562414265,0.0217296184914344,0.16342591695265707,0.05246913580246911,2.8423167282822487e-07,0.19165154391974815,0.03566529492455417
168,0.5,8,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the anterior chamber depth change with head positioning in pseudoexfoliation syndrome? Yes, head position can alter anterior chamber depth in pseudoexfoliation syndrome. Specific postures such as lying flat may increase the depth, complicating management. Therefore, clinicians should consider head position during assessment and therapy.",3.552895910352811e-07,0.25489896792249933,0.026494082840236688,0.02720139697172809,0.23587579093638977,0.045344475238655126,0.027162023114293,0.23241878843960873,0.05246913580246911,3.552895910352811e-07,0.2622691111337021,0.03566529492455417
168,0.5,9,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is the anterior chamber depth in pseudoexfoliation syndrome dependent on head position? Yes, anterior chamber depth can be affected by head positioning in pseudoexfoliation syndrome. Lying flat, for example, can increase the depth and complicate management. Hence, head position is a key consideration in diagnosis and treatment.",3.079176455639103e-07,0.1748309470620244,0.051594136923524936,0.023574544042164344,0.18898055447087803,0.04637636182248976,0.023540420032387266,0.18589877280471478,0.05246913580246911,3.079176455639103e-07,0.21464106214444767,0.03566529492455417
168,0.5,10,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the way the head is positioned influence anterior chamber depth in pseudoexfoliation syndrome? Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Certain positions like lying flat may increase the depth, which can complicate management. Therefore, head position should be considered in the clinical evaluation and treatment of the syndrome.",1.6580180914979784e-07,0.09511565788059029,0.02142844227889669,0.012693985253473108,0.14173983965825254,0.009276180930859634,0.012675610786670066,0.14124306296202427,0.007286409693230321,1.6580180914979784e-07,0.14060432303839887,0.005077122458877266
169,0.5,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? Poor metabolizers with the CYP2D6*4 variant might have reduced activation of procarcinogens, potentially offering protection against carcinogens.",2.36859727356853e-08,0.08460183270840815,0.035665294924554176,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
169,0.5,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer risk? Individuals who are poor metabolizers due to CYP2D6*4 may have decreased conversion of procarcinogens, which might protect them from carcinogens.",4.73719454713706e-08,0.07145896398214369,0.0,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
169,0.5,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What is the association between the CYP2D6*4 allele and breast cancer risk? The CYP2D6*4 poor metabolizer status could lead to lower procarcinogen activation, possibly providing a protective effect against carcinogens.",0.0,0.04780325383172013,0.03443877551020409,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.5,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is there any relationship between breast cancer risk and the CYP2D6*4 allele? Reduced transformation of procarcinogens by CYP2D6*4 poor metabolizers might confer protection against carcinogens.,1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.5,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does carrying the CYP2D6*4 allele affect breast cancer risk? Poor metabolizers with this allele may transform fewer procarcinogens, potentially reducing carcinogen exposure.",1.894877818854824e-07,0.3227733922630516,0.0,0.014507411718255037,0.33647223662121384,0.0,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
169,0.5,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"How does the CYP2D6*4 allele relate to breast cancer risk? CYP2D6*4 poor metabolizers may have decreased procarcinogen metabolism, which could protect against carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.5,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is breast cancer risk associated with the CYP2D6*4 allele? The diminished ability of CYP2D6*4 poor metabolizers to activate procarcinogens might offer a protective effect.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What association exists between the CYP2D6*4 allele and breast cancer risk? A possible reduction in procarcinogen transformation by CYP2D6*4 poor metabolizers may provide carcinogen protection.,1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.5,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Can the CYP2D6*4 allele influence breast cancer risk? Poor metabolizers with CYP2D6*4 might have reduced procarcinogen activation, leading to a protective effect against carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a connection between the CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers could experience decreased procarcinogen transformation, potentially protecting against carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
170,0.5,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' call for a boycott impact the polio vaccination coverage in Kenya in 2015? The boycott call did not significantly affect the campaign. However, if repeated in the future, it could negatively impact polio eradication efforts. Therefore, it is crucial to ensure that",2.6054570009253947e-07,0.01737125526602812,0.24489795918367344,0.0199476911126006,0.10329493800496081,0.1507112648981161,0.019918816950481533,0.16674991483359536,0.07544378698224853,2.6054570009253947e-07,0.2326222952687531,0.0
170,0.5,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the polio vaccination coverage in Kenya in 2015 affected by the boycott called by Catholic bishops? The boycott did not have a major effect on the campaign. Yet, a repeated boycott could pose serious risks to polio eradication, making it important to ensure that",2.8423167282822487e-07,0.07135080114353842,0.22218297811282434,0.02176111757738247,0.12628445622966034,0.1507112648981161,0.0217296184914344,0.19028041224378978,0.07544378698224853,2.8423167282822487e-07,0.2567198468478131,0.0
170,0.5,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the 2015 call for a boycott by Catholic bishops influence polio vaccination rates in Kenya? The boycott did not significantly disrupt the campaign. Still, if such calls recur, they might have adverse effects on polio eradication, so it is vital to ensure that",3.079176455639103e-07,0.06283362934278536,0.24489795918367344,0.023574544042164344,0.14981495363985475,0.1507112648981161,0.023540420032387266,0.2143779638228498,0.07544378698224853,3.079176455639103e-07,0.2814124594381848,0.0
170,0.5,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","In 2015, did the Catholic bishops' boycott call affect polio vaccination coverage in Kenya? The boycott did not significantly impact the campaign, but future repetitions could harm polio eradication efforts. Hence, it is essential to ensure that",4.737194547137077e-07,0.24051480658023738,0.24489795918367344,0.03626852929563745,0.3321365104338092,0.1507112648981161,0.03621603081905734,0.40158950591099574,0.07544378698224853,4.737194547137081e-07,0.47378435208564085,0.0
170,0.5,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call in 2015 impact Kenya's polio vaccination coverage? The campaign was not significantly affected by the boycott. However, if repeated, the boycott could negatively influence polio eradication, so it is important to ensure that",4.263475092423371e-07,0.1864475853099612,0.24489795918367344,0.03264167636607371,0.27656665927899704,0.1507112648981161,0.0325944277371516,0.3444310920710474,0.07544378698224853,4.263475092423373e-07,0.41494385206270756,0.0
170,0.5,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the polio vaccination campaign in Kenya in 2015 significantly affected by the Catholic bishops' boycott call? No, the boycott did not have a major impact. However, future repetitions could have serious negative consequences for polio eradication, making it important to ensure that",3.316036182995957e-07,0.08636412675297978,0.24489795918367344,0.025387970506946217,0.17391250521891477,0.1507112648981161,0.025351221573340132,0.2390705764132215,0.07544378698224853,3.316036182995957e-07,0.30673026742247655,0.0
170,0.5,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott urged by Catholic bishops in 2015 affect polio vaccination coverage in Kenya? The campaign was largely unaffected by the boycott. Yet, if such calls recur, they could significantly hinder polio eradication, so ensuring that is important",4.263475092423371e-07,0.1864475853099612,0.24489795918367344,0.03264167636607371,0.27656665927899704,0.1507112648981161,0.0325944277371516,0.3444310920710474,0.07544378698224853,4.263475092423373e-07,0.41494385206270756,0.0
170,0.5,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","In 2015, did the Catholic bishops' boycott call influence polio vaccination coverage in Kenya? The boycott did not have a significant effect on the campaign. However, repeated calls might negatively impact polio eradication, so it is crucial to ensure that",4.026615365066518e-07,0.16047209890670322,0.24489795918367344,0.030828249901291835,0.24989841219683617,0.1507112648981161,0.030783626196198732,0.31703211788293206,0.07544378698224853,4.026615365066519e-07,0.3867729750960107,0.0
170,0.5,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' call for a boycott in 2015 affect Kenya's polio vaccination coverage? The boycott did not significantly disrupt the campaign. Still, if repeated, it could have serious negative implications for polio eradication, making it important to ensure that",3.789755637709665e-07,0.1351542909224115,0.24489795918367344,0.029014823436509962,0.2239229257935782,0.1507112648981161,0.028972824655245866,0.2903638708007712,0.07544378698224853,3.789755637709665e-07,0.3593740009078954,0.0
170,0.5,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was the 2015 boycott call by Catholic bishops impactful on polio vaccination coverage in Kenya? The campaign was not significantly affected. However, if repeated, the boycott could pose significant risks to polio eradication, so it is important to ensure that",4.026615365066518e-07,0.16047209890670322,0.24489795918367344,0.030828249901291835,0.24989841219683617,0.1507112648981161,0.030783626196198732,0.31703211788293206,0.07544378698224853,4.026615365066519e-07,0.3867729750960107,0.0
171,0.5,1,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",The stretch-sensitive KCNQ1 mutation serves as a connection between genetic and environmental contributors to atrial fibrillation development.,1.1606126640485826e-06,1.0444569158797434,0.3015410245730946,0.08885789677431188,1.212563538939981,0.16447134211463157,0.0887292755066906,1.3060353451877211,0.13888888888888887,1.1606126640485845e-06,1.3833083358261482,0.1262002743484225
171,0.5,2,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",Atrial fibrillation pathogenesis involves the stretch-sensitive KCNQ1 mutation linking genetic factors with environmental influences.,1.2316705822556386e-06,1.2520962806579874,0.3015410245730946,0.09429817616865752,1.4357070902541906,0.16447134211463157,0.09416168012954923,1.5471974020046089,0.13888888888888887,1.2316705822556405e-06,1.64567260029364,0.1262002743484225
171,0.5,3,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",The mutation in KCNQ1 sensitive to stretch links genetic susceptibility and environmental stressors in causing atrial fibrillation.,1.1606126640485826e-06,1.0444569158797434,0.3015410245730946,0.08885789677431188,1.212563538939981,0.16447134211463157,0.0887292755066906,1.3060353451877211,0.13888888888888887,1.1606126640485845e-06,1.3833083358261482,0.1262002743484225
171,0.5,4,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",Genetic and environmental elements in atrial fibrillation are connected by the stretch-sensitive KCNQ1 mutation.,1.2316705822556386e-06,1.2520962806579874,0.3015410245730946,0.09429817616865752,1.4357070902541906,0.16447134211463157,0.09416168012954923,1.5471974020046089,0.13888888888888887,1.2316705822556405e-06,1.64567260029364,0.1262002743484225
171,0.5,5,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",The KCNQ1 mutation that responds to stretch integrates genetic and environmental aspects in atrial fibrillation pathogenesis.,1.184298636784268e-06,1.108995437017314,0.3015410245730946,0.09067132323909377,1.281556410426933,0.16447134211463157,0.09054007704764348,1.3801433173414424,0.13888888888888887,1.1842986367842699e-06,1.4633510434996846,0.1262002743484225
171,0.5,6,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",Stretch-sensitive KCNQ1 mutation acts as a bridge between genetic predisposition and environmental triggers in atrial fibrillation.,1.184298636784268e-06,1.108995437017314,0.3015410245730946,0.09067132323909377,1.281556410426933,0.16447134211463157,0.09054007704764348,1.3801433173414424,0.13888888888888887,1.1842986367842699e-06,1.4633510434996846,0.1262002743484225
171,0.5,7,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","In atrial fibrillation, the stretch-sensitive KCNQ1 mutation connects genetic background with environmental factors such as hypertension.",1.184298636784268e-06,1.108995437017314,0.3015410245730946,0.09067132323909377,1.281556410426933,0.16447134211463157,0.09054007704764348,1.3801433173414424,0.13888888888888887,1.1842986367842699e-06,1.4633510434996846,0.1262002743484225
171,0.5,8,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",The pathogenesis of atrial fibrillation involves a stretch-sensitive KCNQ1 mutation linking genetics and environmental stress.,1.2079846095199534e-06,1.1779883085042662,0.3015410245730946,0.09248474970387564,1.3556643825806542,0.16447134211463157,0.09235087858859635,1.4601860250149787,0.13888888888888887,1.207984609519955e-06,1.5503624204893147,0.1262002743484225
171,0.5,9,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",Atrial fibrillation's genetic and environmental interplay is mediated by the stretch-sensitive KCNQ1 mutation.,1.255356554991324e-06,1.3321389883315238,0.3015410245730946,0.09611160263343939,1.5227184672438208,0.16447134211463157,0.0959724816705021,1.642507581808934,0.13888888888888887,1.2553565549913259e-06,1.7510331159514658,0.1262002743484225
171,0.5,10,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.",The mutation in KCNQ1 that is sensitive to stretch links genetic and environmental causes of atrial fibrillation.,1.1606126640485826e-06,1.0444569158797434,0.3015410245730946,0.08885789677431188,1.212563538939981,0.16447134211463157,0.0887292755066906,1.3060353451877211,0.13888888888888887,1.1606126640485845e-06,1.3833083358261482,0.1262002743484225
172,0.5,1,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? Decompressive surgery has been shown to effectively relieve neurological symptoms in such cases by removing the compression.,3.07917645563909e-07,0.1941936663082129,0.12782951476402715,0.0235745440421644,0.3237278700536126,0.049861495844875335,0.02354042003238733,0.369919098848678,0.025623268698060954,3.079176455639103e-07,0.41871033485818643,0.0
172,0.5,2,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Can decompressive surgery effectively treat spinal cord sarcoidosis when compressive cervical myelopathy is present? Yes, it can help alleviate neurological symptoms by decompressing the affected spinal cord area.",3.316036182995943e-07,0.2323950331789817,0.12651256116787127,0.02538797050694628,0.3614681980364596,0.049861495844875335,0.025351221573340202,0.4091398120019605,0.025623268698060954,3.316036182995957e-07,0.45953232937844124,0.0
172,0.5,3,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Evidence suggests that this surgery can improve neurological outcomes by relieving compression.,4.026615365066502e-07,0.2988338332383327,0.16349480968858132,0.030828249901291918,0.4840705201287925,0.049861495844875335,0.030783626196198823,0.536973183511845,0.025623268698060954,4.026615365066519e-07,0.5930637220029649,0.0
172,0.5,4,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery a viable treatment for spinal cord sarcoidosis with compressive cervical myelopathy? It is considered effective in reducing neurological symptoms through decompression.,4.263475092423355e-07,0.3413934476571283,0.16349480968858132,0.0326416763660738,0.5285222826996265,0.049861495844875335,0.032594427737151696,0.5834931991467389,0.025623268698060954,4.2634750924233726e-07,0.6418538861723961,0.0
172,0.5,5,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can spinal cord sarcoidosis with compressive cervical myelopathy be effectively managed by decompressive surgery? Surgical decompression has been shown to mitigate neurological impairments.,4.500334819780208e-07,0.38584521022796237,0.16349480968858132,0.03445510283085568,0.5750422983345205,0.049861495844875335,0.03440522927810457,0.6322833633161702,0.025623268698060954,4.500334819780226e-07,0.6931471805599463,0.0
172,0.5,6,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Is decompressive surgery effective in cases of spinal cord sarcoidosis associated with compressive cervical myelopathy? Yes, it can alleviate neurological symptoms by removing the compressive lesion.",3.789755637709649e-07,0.25801183871807787,0.16349480968858132,0.02901482343651004,0.44151090570999685,0.049861495844875335,0.02897282465524595,0.4925214209410109,0.025623268698060954,3.789755637709665e-07,0.5465437063680709,0.0
172,0.5,7,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Does decompressive surgery provide relief for spinal cord sarcoidosis when compressive cervical myelopathy occurs? It can be effective by decompressing the spinal cord and improving neurological function.,3.552895910352796e-07,0.2721101394540222,0.1250948096885813,0.02720139697172816,0.40068891118974204,0.049861495844875335,0.027162023114293075,0.4499618065222153,0.025623268698060954,3.552895910352811e-07,0.5020919437972369,0.0
172,0.5,8,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery useful for spinal cord sarcoidosis with compressive cervical myelopathy? Studies indicate it can reduce neurological deficits by relieving spinal cord compression.,4.263475092423355e-07,0.4016671155319065,0.12010637993651518,0.0326416763660738,0.5285222826996265,0.049861495844875335,0.032594427737151696,0.5834931991467389,0.025623268698060954,4.2634750924233726e-07,0.6418538861723961,0.0
172,0.5,9,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Can decompressive surgery treat neurological symptoms in spinal cord sarcoidosis with compressive cervical myelopathy? Yes, by removing the compressive elements, surgery can improve symptoms.",4.263475092423355e-07,0.3413934476571283,0.16349480968858132,0.0326416763660738,0.5285222826996265,0.049861495844875335,0.032594427737151696,0.5834931991467389,0.025623268698060954,4.2634750924233726e-07,0.6418538861723961,0.0
172,0.5,10,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery an effective intervention for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? It has been found to alleviate neurological symptoms through decompression.,4.026615365066502e-07,0.2988338332383327,0.16349480968858132,0.030828249901291918,0.4840705201287925,0.049861495844875335,0.030783626196198823,0.536973183511845,0.025623268698060954,4.026615365066519e-07,0.5930637220029649,0.0
173,0.5,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Question: Do Indigenous Australians age prematurely? Answer: This study, which examines a range of specific conditions, does not strongly support the notion that Indigenous people age prematurely. The existing emphasis and nature of services offered by the aged care sector might not be the",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
173,0.5,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Is premature aging observed in Indigenous Australians? Answer: The concept that Indigenous Australians age prematurely is not strongly backed by this research into various distinct conditions. The current priorities and types of services in the aged care sector may not be the,2.3685972735685406e-08,0.023530497410194418,0.0,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
173,0.5,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Are Indigenous Australians subject to premature aging? Answer: Evidence from this study of several discrete conditions does not robustly support the idea that Indigenous Australians age prematurely. The current focus and types of aged care services may not be the,7.105791820705622e-08,0.10697802060762251,0.02498356344510192,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
173,0.5,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Do Indigenous Australians experience premature aging? Answer: This study analyzing a series of specific conditions does not provide strong support for the claim that Indigenous Australians age prematurely. The present focus and the nature of aged care services might not be the,2.3685972735685406e-08,0.056537506008286,0.023795359904818555,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
173,0.5,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Is there premature aging among Indigenous Australians? Answer: The hypothesis that Indigenous Australians age prematurely is not well substantiated by this study of various discrete conditions. The current focus and type of services in aged care may not be the,7.105791820705622e-08,0.07232066157962613,0.0,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
173,0.5,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Question: Does premature aging occur in Indigenous Australians? Answer: According to this study of several discrete conditions, the idea that Indigenous Australians age prematurely lacks strong support. The current aged care sector's focus and service types may not be the",9.474389094274152e-08,0.09763846956391786,0.0,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
173,0.5,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Are Indigenous Australians aging earlier than expected? Answer: This study on a series of specific conditions does not strongly support the view that Indigenous Australians experience premature aging. The current focus and nature of aged care services may not be the,4.737194547137081e-08,0.0814401065775443,0.024375,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
173,0.5,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Do Indigenous Australians show signs of premature aging? Answer: The study of various discrete conditions does not strongly back the idea that Indigenous Australians age prematurely. The existing emphasis and type of aged care services may not be the,9.474389094274152e-08,0.1331844788234018,0.025623268698060954,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
173,0.5,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Is premature aging a characteristic of Indigenous Australians? Answer: The evidence from this study of discrete conditions does not strongly affirm that Indigenous Australians age prematurely. The current focus and type of services in aged care might not be the,7.105791820705622e-08,0.07232066157962613,0.0,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
173,0.5,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Question: Are Indigenous Australians prone to premature aging? Answer: This study, examining a range of specific conditions, does not provide strong evidence supporting premature aging among Indigenous Australians. The current aged care service focus and type may not be the",9.474389094274152e-08,0.09763846956391786,0.0,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
174,0.5,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate achievable over time? Effective training, adherence to evidence-based protocols, and meticulous documentation contribute to major decreases in CLABSIs. Thoughtful organization can enhance comprehension of what enables a unit to manage peak workloads and maintain exceptional performance long-term.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.5,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained? Comprehensive training, strict adherence to proven guidelines, and detailed record-keeping are linked to notable reductions in CLABSIs. Careful structuring may improve insight into how a unit manages high demand and maintains outstanding performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.5,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero central line-associated bloodstream infection rate? High-standard training, rigorous compliance with evidence-based standards, and thorough documentation correlate with significant CLABSI reductions. Mindful organization helps better understand a unit's capacity to handle peak demand and sustain superior performance long-term.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.5,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero central line-associated bloodstream infection rate maintainable? Quality training, strict observance of evidence-based guidelines, and comprehensive documentation are associated with substantial decreases in CLABSIs. Thoughtful organization may lead to improved understanding of a unit's ability to manage peak demands and sustain exceptional long-term performance.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.5,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infection rates be maintained sustainably? Intensive training, strict guideline adherence, and careful documentation are linked to significant CLABSI reduction. Mindful organizational practices can clarify how a unit copes with peak demands and preserves extraordinary performance over time.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
174,0.5,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is achieving a zero central line-associated bloodstream infection rate sustainable? High-quality training, adherence to evidence-based protocols, and detailed documentation contribute to major CLABSI reductions. Thoughtful organization may foster better understanding of what enables a unit to manage peak demands and maintain exceptional long-term performance.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.5,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero rate of central line-associated bloodstream infections feasible? Effective training, strict compliance with evidence-based guidelines, and comprehensive documentation are associated with significant decreases in CLABSIs. Mindful organizational methods might enhance understanding of how a unit handles peak demand and sustains outstanding performance over time.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.5,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it sustainable to have zero central line-associated bloodstream infections? Quality training, adherence to evidence-based standards, and thorough documentation are linked to marked reductions in CLABSIs. Thoughtful organization may improve insight into a unit's ability to manage peak workloads and maintain extraordinary long-term performance.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.5,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infection rates be upheld? High-quality training, strict adherence to evidence-based guidelines, and meticulous documentation are connected with significant CLABSI reductions. Mindful organizational strategies may lead to a better grasp of how a unit handles peak demands and sustains exceptional performance over time.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.5,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining zero central line-associated bloodstream infection rates over the long term possible? Comprehensive training, strict compliance with evidence-based guidelines, and detailed documentation are linked to substantial decreases in CLABSIs. Thoughtful organization may help better understand a unit's capacity to handle peak demands and sustain outstanding performance in the long run.",4.737194547137081e-08,0.06694660037568045,0.019991670137442734,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
175,0.5,1,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment with estradiol and antagonists before microdose leuprolide enhance IVF results in poor responders compared to oral contraceptive pills? Research shows no significant improvement, though slight benefits may occur in some cases; further research is needed.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
175,0.5,2,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In poor responders undergoing IVF, does estradiol and antagonist pretreatment before microdose leuprolide improve outcomes versus oral contraceptive pills? Studies suggest no major advantage, but minor benefits might exist in particular instances, warranting additional investigation.",6.868932093348761e-07,0.2867041157944441,0.21484375,0.05258936747867432,0.3623117859425027,0.18240000000000006,0.05251324468763315,0.44060272776573095,0.14312130177514798,6.868932093348768e-07,0.5217279216249646,0.09876543209876548
175,0.5,3,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does using estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF success in poor responders compared to oral contraceptives? Evidence indicates no significant enhancement, though some marginal gains could be possible; more studies are required.",6.632072365991908e-07,0.2577165789211926,0.21484375,0.05077594101389244,0.3324588227928209,0.18240000000000006,0.05070244314668028,0.40983106909897726,0.14312130177514798,6.632072365991914e-07,0.4899792233103848,0.09876543209876548
175,0.5,4,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is estradiol and antagonist pretreatment before microdose leuprolide more effective than oral contraceptive pills in improving IVF outcomes for poor responders? Research finds no substantial benefit, but slight improvements might occur in select cases, suggesting the need for further study.",5.684633456564496e-07,0.1495029942809616,0.21484375,0.04352223515476494,0.22123318768259637,0.18240000000000006,0.0434592369828688,0.2954207179212318,0.14312130177514798,5.684633456564497e-07,0.372196187654001,0.09876543209876548
175,0.5,5,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","For poor responders undergoing IVF, does pretreatment with estradiol and antagonists before microdose leuprolide outperform oral contraceptive pills? Data reveals no significant improvement, though minor benefits may be present in some scenarios; further research is recommended.",6.632072365991908e-07,0.2577165789211926,0.21484375,0.05077594101389244,0.3324588227928209,0.18240000000000006,0.05070244314668028,0.40983106909897726,0.14312130177514798,6.632072365991914e-07,0.4899792233103848,0.09876543209876548
175,0.5,6,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment with estradiol and antagonists ahead of microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Studies show no significant difference, but there could be slight advantages in certain cases, requiring more research.",6.158352911278202e-07,0.20214672776638043,0.21484375,0.04714908808432869,0.27530040895287256,0.18240000000000006,0.04708084006477453,0.350990569076044,0.14312130177514798,6.158352911278206e-07,0.42935460149394933,0.09876543209876548
175,0.5,7,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In IVF treatment of poor responders, does estradiol and antagonist pretreatment before microdose leuprolide yield better outcomes than oral contraceptive pills? Research suggests no considerable improvement, though marginal benefits might exist, calling for additional studies.",6.868932093348761e-07,0.2867041157944441,0.21484375,0.05258936747867432,0.3623117859425027,0.18240000000000006,0.05251324468763315,0.44060272776573095,0.14312130177514798,6.868932093348768e-07,0.5217279216249646,0.09876543209876548
175,0.5,8,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is the use of estradiol and antagonist pretreatment prior to microdose leuprolide better than oral contraceptive pills in enhancing IVF outcomes for poor responders? Evidence does not show significant benefits, but some marginal improvements may be possible; further investigation is needed.",5.447773729207643e-07,0.12418518629666986,0.21484375,0.04170880868998307,0.1952577012793384,0.18240000000000006,0.04164843544191593,0.26875247083907094,0.14312130177514798,5.447773729207643e-07,0.34479721346588565,0.09876543209876548
175,0.5,9,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does estradiol and antagonist pretreatment before microdose leuprolide improve IVF results in poor responders compared to oral contraceptive pills? Research indicates no significant benefits, though minor advantages might be found in specific cases, highlighting the need for more studies.",5.921493183921349e-07,0.17547848068421956,0.21484375,0.045335661619546816,0.24790143476475723,0.18240000000000006,0.045270038523821665,0.32281969210934713,0.14312130177514798,5.921493183921352e-07,0.4003670646206978,0.09876543209876548
175,0.5,10,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","For poor responders in IVF, does pretreatment with estradiol and antagonists prior to microdose leuprolide improve outcomes compared to oral contraceptive pills? Studies report no major improvement, but slight benefits could occur, suggesting further research is necessary.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
176,0.5,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count serves as a predictive marker for long-term survival in ESCC, particularly in patients with positive lymph nodes. We suggest that a platelet count of 205 (×10^9/L) is the optimal cutoff for survival prediction in ESCC patients.",0.0,0.0554517744447951,0.04090113955814878,0.0,0.02829172165550764,0.02034311182787588,0.0,0.0,0.0,0.0,0.0,0.0
176,0.5,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? The preoperative platelet count is a significant prognostic factor for long-term survival in ESCC, especially among those with nodal involvement. Our findings propose 205 (×10^9/L) as the ideal threshold for platelet count to forecast survival in ESCC cases.",2.3685972735685406e-08,0.023245450153994263,0.002967809407203287,0.0018134264647818726,0.021798108938381855,0.0008454843178918245,0.0018108015409528666,0.05054903390251164,0.0212665406427221,2.3685972735685406e-08,0.02150620522096336,0.0
176,0.5,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? Yes, it is a predictive factor for long-term survival in ESCC, notably in patients with positive lymph nodes. We determine that 205 (×10^9/L) is the best cutoff point for platelet count to predict survival in ESCC patients.",2.3685972735685406e-08,0.11453254153365977,0.1040595225240512,0.0018134264647818726,0.07678615062853433,0.040742417383431435,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
176,0.5,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the platelet count before surgery a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, particularly in nodal-positive patients. We conclude that 205 (×10^9/L) is the optimal cutoff for platelet count to predict survival in ESCC.",1.8948778188548325e-07,0.16974531168712037,0.0036045278889230425,0.014507411718254981,0.12166478809530323,0.040742417383431435,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
176,0.5,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? It is a prognostic factor for long-term survival in ESCC, especially in patients with lymph node positivity. We recommend 205 (×10^9/L) as the optimal platelet count cutoff for survival prediction in ESCC.",1.6580180914979784e-07,0.03396789449427784,0.11996724615772239,0.012693985253473108,0.09756723651624322,0.040742417383431435,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
176,0.5,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count linked to prognosis in esophageal squamous cell carcinoma? Preoperative platelet count is a predictive factor for long-term survival in ESCC, mainly in patients with positive lymph nodes. We identify 205 (×10^9/L) as the optimal cutoff value for platelet count in survival prediction for ESCC.",7.105791820705622e-08,0.012400818073876607,0.0342222732374248,0.005440279394345618,0.036732292247905196,0.019014022321703038,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,0.5,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can platelet count before surgery serve as a prognostic marker in esophageal squamous cell carcinoma? Yes, it predicts long-term survival in ESCC, particularly in nodal-positive cases. The cutoff point of 205 (×10^9/L) is suggested as optimal for platelet count in predicting survival.",2.1317375462116866e-07,0.08316859732484794,0.1188348765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.5,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the platelet count prior to surgery a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count is a significant predictor of long-term survival in ESCC, especially for patients with positive lymph nodes. We find that 205 (×10^9/L) is the best cutoff for platelet count to predict survival.",4.737194547137081e-08,0.010728003901937289,0.03654320987654329,0.0036268529295637453,0.014910746910446804,0.040742417383431435,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
176,0.5,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? It acts as a predictive factor for long-term survival in ESCC, especially in patients with nodal involvement. We conclude that 205 (×10^9/L) may be the ideal cutoff for platelet count in survival prediction.",1.1842986367842703e-07,0.012927341971233908,0.12099913274155702,0.009067132323909363,0.051047220881349276,0.040742417383431435,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
176,0.5,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the platelet count before surgery a useful prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, particularly in nodal-positive patients. We suggest 205 (×10^9/L) as the optimal cutoff point for platelet count to predict survival in ESCC.",1.6580180914979784e-07,0.11061526347112327,0.02383487654320987,0.012693985253473108,0.09756723651624322,0.040742417383431435,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
177,0.5,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in cases of mild hereditary spherocytosis? The recommendation to carry out a splenectomy alongside cholecystectomy in children with mild HS who have symptomatic gallstones warrants reevaluation. With the advent of minimally invasive surgery, the decision to remove the spleen in these children should be considered independently.",4.737194547137081e-08,0.12538337030533508,0.09639999999999999,0.0036268529295637453,0.06439983492746082,0.01922337562475971,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
177,0.5,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy justify a concomitant splenectomy in mild hereditary spherocytosis? The current guidance for performing splenectomy during cholecystectomy in children with mild HS and symptomatic gallstones should be reconsidered. Given the progress in minimal access surgery, splenectomy should be assessed on its own merits in these cases.",1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,0.5,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it necessary to perform a splenectomy alongside cholecystectomy in mild hereditary spherocytosis? The practice of conducting concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs to be reviewed. In the context of minimally invasive surgery, the indication for splenectomy should be evaluated independently.",1.4211583641411244e-07,0.0318022132170781,0.09639999999999999,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
177,0.5,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy be an indication for simultaneous splenectomy in patients with mild hereditary spherocytosis? The recommendation to do splenectomy concurrently with cholecystectomy in children with mild HS and symptomatic gallstones requires reassessment. With minimal access surgical techniques available, the decision for splenectomy should stand on its own.",1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,0.5,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is concomitant splenectomy warranted during cholecystectomy in mild hereditary spherocytosis? The advice to perform splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones should be revisited. In the era of minimally invasive surgery, the need for splenectomy must be judged independently.",2.6054570009253947e-07,0.1772872052418597,0.07260464009518143,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.5,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis justify splenectomy at the time of cholecystectomy? The traditional recommendation for concomitant splenectomy in children with mild HS undergoing cholecystectomy for gallstones needs reconsideration. With advances in minimal access surgery, splenectomy indications should be evaluated on their own.",2.8423167282822487e-07,0.16837774822282814,0.09639999999999999,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
177,0.5,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is splenectomy truly indicated alongside cholecystectomy in mild hereditary spherocytosis? The current advice to perform a concomitant splenectomy in children with mild HS having cholecystectomy for symptomatic gallstones should be reexamined. Given the rise of minimally invasive surgery, splenectomy should be considered separately.",2.6054570009253947e-07,0.1772872052418597,0.07260464009518143,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.5,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is there a real indication for combined splenectomy during cholecystectomy in mild hereditary spherocytosis? The guidance recommending splenectomy with cholecystectomy in children with mild HS and symptomatic gallstones needs to be reviewed. The necessity for splenectomy should be independently assessed in the era of minimal access surgery.,1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,0.5,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should children with mild hereditary spherocytosis undergoing cholecystectomy also have a splenectomy? The advice to perform splenectomy concurrently with cholecystectomy in these cases requires reevaluation. With minimal access surgery techniques now common, the need for splenectomy should be judged on its own merits.",2.6054570009253947e-07,0.14428019664376812,0.09639999999999999,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.5,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is a splenectomy truly an indication when performing cholecystectomy in mild hereditary spherocytosis? The recommendation for simultaneous splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be reconsidered. In the context of minimal access surgery, the decision for splenectomy should be made independently.",1.8948778188548325e-07,0.10609386651503616,0.0741892561983471,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
178,0.5,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can measuring visceral adipose tissue area at a single level represent the total visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at one level might give an estimate but does not fully represent the total visceral adipose tissue volume, as the distribution of adipose tissue varies across the body and a single measurement may not reflect this variability precisely.",2.3685972735685406e-08,0.05472015450105694,0.0745435340274635,0.0018134264647818726,0.04421971867750907,0.02190552091184622,0.0018108015409528666,0.019525107282946763,0.0016794074835534967,2.3685972735685406e-08,0.01906904986385749,0.0011886152729737587
178,0.5,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is a single-level measurement of visceral adipose tissue area sufficient to represent its volume? Answer: A single-level measurement of visceral adipose tissue area can approximate the volume but cannot completely represent it, due to the variable distribution of adipose tissue throughout the body which a single measurement may miss.",2.6054570009253947e-07,0.019437070245523103,0.4608368034899861,0.0199476911126006,0.12116156759003793,0.16243231986672213,0.019918816950481533,0.21436377086459224,0.002804277529552285,2.6054570009253947e-07,0.2376733922795795,0.016392079556398348
178,0.5,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does a single-level visceral adipose tissue area measurement accurately represent visceral adipose tissue volume? Answer: While a single-level measurement of visceral adipose tissue area may approximate the volume, it cannot fully represent it because adipose tissue is distributed unevenly throughout the body, making one measurement insufficient.",3.316036182995957e-07,0.0980732962229438,0.3142669296515452,0.025387970506946217,0.1164606541903832,0.17093572122726636,0.025351221573340132,0.1643503051584485,0.07935602484631063,3.316036182995957e-07,0.1845673373255563,0.06977572089711641
178,0.5,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Can visceral adipose tissue area measured at one level stand for the entire visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at a single level offers an estimation but cannot fully capture the total volume since adipose tissue distribution varies throughout the body and a single measurement may not be representative.,1.6580180914979784e-07,0.07692226646316103,0.3637366099558917,0.012693985253473108,0.04212695008648071,0.18658892128279878,0.012675610786670066,0.012389858701832068,0.08247100591715975,1.6580180914979784e-07,0.03374444759097317,0.06977572089711641
178,0.5,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is it possible to represent visceral adipose tissue volume by measuring its area at a single level? Answer: Measuring visceral adipose tissue area at one level may provide an approximate value, but it cannot fully represent the volume due to the varying distribution of adipose tissue in the body, which a single level measurement might not accurately reflect.",4.737194547137081e-08,0.25766829468116814,0.5434911593686959,0.0036268529295637453,0.19965453077274997,0.26734303415243643,0.003621603081905733,0.10831844168389182,0.10207100591715974,4.737194547137081e-08,0.061565732213352486,0.06977572089711641
178,0.5,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can the measurement of visceral adipose tissue area at a single level serve as a proxy for visceral adipose tissue volume? Answer: Although a single-level measurement of visceral adipose tissue area can give an approximate idea, it does not fully represent the visceral adipose tissue volume because adipose tissue distribution is heterogeneous throughout the body.",1.1842986367842703e-07,0.010338122030059793,0.09382716049382722,0.009067132323909363,0.009796561383283997,0.05050629945855889,0.009054007704764333,0.025210827637998534,0.04567100591715972,1.1842986367842703e-07,0.047842748326917484,0.0313757208971164
178,0.5,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does measuring visceral adipose tissue area at a single level suffice to represent its volume? Answer: Measuring visceral adipose tissue area at one level may approximate the volume but cannot fully represent it, as adipose tissue distribution varies across different body regions and a single measurement might not capture this variation.",2.1317375462116866e-07,0.05704510700936005,0.48743112947658396,0.016320838183036854,0.017956326819388302,0.20548621439239634,0.0162972138685758,0.11008811590715473,0.04110692274135637,2.1317375462116866e-07,0.13232870715788936,0.02818781919579315
178,0.5,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Can a single-level measurement of visceral adipose tissue area be used to estimate visceral adipose tissue volume? Answer: A single-level measurement can provide an estimate of visceral adipose tissue volume but cannot fully represent it due to the uneven distribution of adipose tissue throughout the body.,3.316036182995957e-07,0.12821013016033245,0.2899353647276085,0.025387970506946217,0.1472671955486029,0.14805798000585213,0.025351221573340132,0.1643503051584485,0.07935602484631063,3.316036182995957e-07,0.1845673373255563,0.06977572089711641
178,0.5,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Is a single-level measurement of visceral adipose tissue area an accurate representation of visceral adipose tissue volume? Answer: It may serve as an approximation, but it cannot fully represent visceral adipose tissue volume because the distribution of adipose tissue varies throughout the body, and a single measurement might not capture this variability.",1.8948778188548325e-07,0.08031964410009973,0.3793320730938879,0.014507411718254981,0.020943354716888685,0.1846208827918922,0.014486412327622933,0.0327361308455103,0.08207933577971702,1.8948778188548325e-07,0.05394715490849178,0.06977572089711641
178,0.5,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can visceral adipose tissue volume be represented by measuring its area at only one level? Answer: Measuring the area of visceral adipose tissue at a single level might approximate the volume, but it cannot fully represent it since adipose tissue is distributed variably throughout the body and a single measurement may not be sufficient.",1.4211583641411244e-07,0.20236073336425342,0.5530666666666666,0.010880558788691236,0.12505963281455745,0.26602035271299673,0.0108648092457172,0.03421046953017015,0.10207100591715974,1.4211583641411244e-07,0.013941820294793406,0.06977572089711641
179,0.5,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT creates a localized pathway for chemotherapeutic drugs to enter brain tissue, offering potential benefits for brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: Laser-induced thermo therapy (LITT) facilitates targeted delivery of chemotherapy agents into brain tissue, which may improve brain tumor therapies.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT promotes localized penetration of chemotherapeutic substances into the brain, which could be valuable in treating brain tumors.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.5,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The use of LITT allows chemotherapeutic agents to pass locally into brain tissue, presenting a promising approach for brain tumor treatment.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
179,0.5,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a localized opening in the blood-brain barrier, enabling chemotherapy drugs to access brain tissue, which is potentially beneficial for brain tumor therapy.",2.3685972735685406e-08,0.021978906718775004,0.0,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
179,0.5,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: By using LITT, chemotherapeutic agents can locally enter brain tissue, offering a new potential strategy for treating brain tumors.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT creates a localized passage for chemotherapy drugs into the brain, which may enhance treatment options for brain tumors.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The application of LITT results in localized delivery of chemotherapeutic agents into brain tissue, which holds promise for brain tumor management.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
179,0.5,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT enables targeted entry of chemotherapy drugs into brain tissue, representing a novel approach for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.5,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT facilitates a localized route for chemotherapeutic agents to penetrate brain tissue, which could be significant for brain tumor therapy.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
180,0.5,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Does a geriatric oncology consultation change the cancer treatment approach for elderly patients?,9.000669639560429e-07,1.1775833706385646,0.17132659131469363,0.0689102056617113,1.2958829737237005,0.13888888888888887,0.0688104585562091,1.4242102552971905,0.10275824770146022,9.000669639560448e-07,1.564436150259803,0.06353305785123965
180,0.5,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Can a geriatric oncology consultation alter the cancer treatment plan for older patients?,9.000669639560429e-07,1.1775833706385646,0.17132659131469363,0.0689102056617113,1.2958829737237005,0.13888888888888887,0.0688104585562091,1.4242102552971905,0.10275824770146022,9.000669639560448e-07,1.564436150259803,0.06353305785123965
180,0.5,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation?,8.763809912203576e-07,1.0975406629650282,0.17132659131469363,0.06709677919692943,1.2088715967340704,0.13888888888888887,0.06699965701525623,1.3289000754928653,0.10275824770146022,8.763809912203594e-07,1.459075634601977,0.06353305785123965
180,0.5,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Does consulting geriatric oncology impact the cancer treatment strategy for elderly patients?,9.237529366917283e-07,1.2645947476281947,0.17132659131469363,0.07072363212649319,1.3911931535280257,0.13888888888888887,0.07062126009716198,1.5295707709550164,0.10275824770146022,9.237529366917302e-07,1.6822191859161868,0.06353305785123965
180,0.5,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Can a geriatric oncology evaluation influence the cancer treatment plan for elderly individuals?,9.000669639560429e-07,1.1775833706385646,0.17132659131469363,0.0689102056617113,1.2958829737237005,0.13888888888888887,0.0688104585562091,1.4242102552971905,0.10275824770146022,9.000669639560448e-07,1.564436150259803,0.06353305785123965
180,0.5,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Does a geriatric oncology consultation lead to changes in cancer treatment plans for elderly patients?,8.526950184846723e-07,1.023432690811307,0.17132659131469363,0.06528335273214755,1.128828889060534,0.13888888888888887,0.06518885547430335,1.2418886985032351,0.10275824770146022,8.526950184846741e-07,1.3637654547976519,0.06353305785123965
180,0.5,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Is the treatment plan for cancer in elderly patients adjusted following a geriatric oncology consultation?,8.526950184846723e-07,1.023432690811307,0.17132659131469363,0.06528335273214755,1.128828889060534,0.13888888888888887,0.06518885547430335,1.2418886985032351,0.10275824770146022,8.526950184846741e-07,1.3637654547976519,0.06353305785123965
180,0.5,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Does a geriatric oncology assessment modify cancer treatment decisions for elderly patients?,9.237529366917283e-07,1.2645947476281947,0.17132659131469363,0.07072363212649319,1.3911931535280257,0.13888888888888887,0.07062126009716198,1.5295707709550164,0.10275824770146022,9.237529366917302e-07,1.6822191859161868,0.06353305785123965
180,0.5,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Can the cancer treatment plan for older patients be modified through a geriatric oncology consultation?,8.526950184846723e-07,1.023432690811307,0.17132659131469363,0.06528335273214755,1.128828889060534,0.13888888888888887,0.06518885547430335,1.2418886985032351,0.10275824770146022,8.526950184846741e-07,1.3637654547976519,0.06353305785123965
180,0.5,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's",Does a consultation in geriatric oncology result in modifications to the cancer treatment plan for elderly patients?,8.053230730133015e-07,0.8899012981867842,0.17132659131469363,0.061656499802583795,0.9857280454198607,0.13888888888888887,0.0615672523923976,1.0877380186759775,0.10275824770146022,8.053230730133034e-07,1.1967113701344854,0.06353305785123965
181,0.5,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be implemented in community palliative care? Answer: Yes, an advance care planning model is practical for community palliative care services. Quality audit procedures are vital to the model, with documentation of advance care planning discussions recognized as a key outcome metric.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
181,0.5,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it possible to apply an advance care planning model in community palliative care? Answer: The advance care planning model is viable within community palliative care services. Integral to the model are quality audit processes, with recording of advance care planning conversations considered an important outcome measure.",0.0,0.02949562470467848,0.021888384889946544,0.0,0.03013683393738864,0.022375274248873853,0.0,0.030806541358219697,0.02213755257476679,0.0,0.03150669002545259,0.02271498107084911
181,0.5,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Does an advance care planning model work in community palliative care? Answer: An advance care planning model can be successfully used in community palliative care services. Quality audits form a crucial part of the model, and documenting advance care planning discussions is an important outcome indicator.",2.3685972735685406e-08,0.056615544623371594,0.027093144044321227,0.0018134264647818726,0.055717054641363895,0.02558815192743763,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.5,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the use of an advance care planning model feasible in community palliative care? Answer: It is feasible to implement an advance care planning model in community palliative care services. Essential to the model are quality audit processes, with established documentation of advance care planning discussions as a significant outcome measure.",9.474389094274162e-08,0.07243580835629304,8.146295294744754e-05,0.0072537058591274906,0.06620950534838199,0.009423028470647549,0.007243206163811466,0.09018744774573095,0.003605878992988247,9.474389094274162e-08,0.08963693449175114,0.0018910788526508258
181,0.5,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can community palliative care adopt an advance care planning model? Answer: Yes, community palliative care services can utilize an advance care planning model. Quality audit processes are key components of the model, with documentation of advance care planning discussions being an important outcome metric.",7.105791820705622e-08,0.08155355311389823,0.017129747991234345,0.005440279394345618,0.07664516186971415,0.00953991063881171,0.0054324046228586,0.040386797368603844,0.020552936471601127,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
181,0.5,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model applicable to community palliative care? Answer: The model of advance care planning is applicable and feasible in community palliative care services. Quality audits are essential to the model, with documentation of discussions on advance care planning serving as an important outcome measure.",2.3685972735685406e-08,0.08358099198180247,0.0485934964845863,0.0018134264647818726,0.08330431197918386,0.04687326782564877,0.0018108015409528666,0.0835919894352144,0.04434829637641968,2.3685972735685406e-08,0.053979545877510304,0.02271498107084911
181,0.5,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it feasible to implement an advance care planning model in community palliative care? Answer: Implementing an advance care planning model in community palliative care services is feasible. The model relies on quality audit processes, with documentation of advance care planning discussions recognized as a key outcome measure.",2.3685972735685406e-08,0.031943538111521175,0.03570389546351088,0.0018134264647818726,0.06417381154420765,0.06058815192743766,0.0018108015409528666,0.0670921802517297,0.06273082319526385,2.3685972735685406e-08,0.06924661955536848,0.06532785057697955
181,0.5,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Could an advance care planning model be used in community palliative care? Answer: An advance care planning model is indeed feasible for community palliative care services. Quality audit processes are a fundamental part of the model, and documenting advance care planning discussions is an important outcome metric.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
181,0.5,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model practical for community palliative care? Answer: Yes, an advance care planning model is practical and feasible for community palliative care services. Quality audit procedures are essential, with documentation of advance care planning discussions established as a critical outcome measure.",4.737194547137081e-08,0.08445766447088454,0.03319987216946674,0.0036268529295637453,0.08195492056885723,0.029263776516523787,0.003621603081905733,0.048328098854266255,0.0020526554379765236,4.737194547137081e-08,0.04802033420753293,0.0010803788339694455
181,0.5,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the implementation of an advance care planning model possible in community palliative care? Answer: The implementation of an advance care planning model is possible in community palliative care services. Quality audit processes are a vital element of the model, with documentation of advance care planning discussions as a key outcome indicator.",1.1842986367842703e-07,0.01020764367950422,0.06562499999999988,0.009067132323909363,0.01979341726705197,0.08219954648526076,0.009054007704764333,0.0006182750398782133,0.07342029866490259,1.1842986367842703e-07,0.025970467595785696,0.058272673250138546
182,0.5,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure indicate fluid responsiveness? Central venous pressure (CVP) is not a reliable predictor of fluid responsiveness. Fluid responsiveness depends mainly on the heart and circulatory system interaction.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.5,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness predicted by central venous pressure? Central venous pressure (CVP) does not consistently forecast fluid responsiveness. The key factor is the interplay between the heart and circulatory system.,1.421158364141118e-07,0.11703025438152714,0.05052216198979591,0.010880558788691277,0.15338265087860803,0.029384756657483937,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.5,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can central venous pressure forecast fluid responsiveness? Central venous pressure (CVP) fails to reliably predict fluid responsiveness. Fluid responsiveness is chiefly influenced by heart and circulatory system dynamics.,1.894877818854824e-07,0.24337443572601725,0.011360937500000015,0.014507411718255037,0.28080963692155647,0.009015243342516074,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
182,0.5,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure serve as a predictor for fluid responsiveness? Central venous pressure (CVP) is not a dependable indicator of fluid responsiveness. The primary determinant is the relationship between the heart and circulation.,4.73719454713706e-08,0.024033109137672426,0.024607139373048918,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.5,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure an accurate predictor of fluid responsiveness? Central venous pressure (CVP) does not reliably indicate fluid responsiveness. Fluid responsiveness is mainly governed by heart and circulatory system interactions.,1.184298636784265e-07,0.12774507294878434,0.018634406887755126,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.5,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does measuring central venous pressure help predict fluid responsiveness? Central venous pressure (CVP) is not a reliable measure for predicting fluid responsiveness. This responsiveness is mainly dependent on the heart-circulation relationship.,1.184298636784265e-07,0.12774507294878434,0.018634406887755126,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.5,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can fluid responsiveness be predicted by central venous pressure? Central venous pressure (CVP) does not reliably predict fluid responsiveness. The main factor is the interaction between the heart and the circulatory system.,9.47438909427412e-08,0.04725479899048457,0.0527387152777778,0.007253705859127518,0.08438977939165726,0.029384756657483937,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
182,0.5,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness reliably predicted by central venous pressure? Central venous pressure (CVP) is not a consistent predictor of fluid responsiveness. The determining factor is the interaction of the heart with the circulatory system.,4.73719454713706e-08,0.01797581089626421,0.0546875,0.003626852929563759,0.019851258254085735,0.029384756657483937,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
182,0.5,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure accurately predict fluid responsiveness? Central venous pressure (CVP) is not a reliable predictor of fluid responsiveness. Fluid responsiveness depends primarily on heart and circulatory system interplay.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.5,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure a reliable indicator of fluid responsiveness? Central venous pressure (CVP) does not reliably predict fluid responsiveness. The key determinant is the interaction between the heart and circulatory system.,9.47438909427412e-08,0.09197397192983603,0.020751662826991688,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
183,0.5,1,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Is it essential to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis?,6.632072365991897e-07,0.34663777711967025,0.24691358024691368,0.05077594101389252,0.44296226592147736,0.22506925207756232,0.050702443146680355,0.5159957926234537,0.20249835634451027,6.632072365991914e-07,0.5926723654876334,0.174375
183,0.5,2,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Should a nasobiliary drainage tube be routinely inserted after endoscopic removal of common bile duct stones in patients with choledocholithiasis-induced cholangitis?,7.579511275419309e-07,0.5289593339136252,0.24691358024691368,0.058029646873020035,0.6340175026841868,0.22506925207756232,0.05794564931049185,0.7166664880856044,0.20249835634451027,7.579511275419328e-07,0.8039814591548389,0.174375
183,0.5,3,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Is the routine insertion of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in cases of choledocholithiasis-induced cholangitis?,7.105791820705603e-07,0.43364915410929994,0.24691358024691368,0.054402793943456276,0.5339340441272054,0.22506925207756232,0.0543240462285861,0.611305972427779,0.20249835634451027,7.105791820705621e-07,0.6927558240446148,0.174375
183,0.5,4,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Do patients with choledocholithiasis-induced cholangitis require routine nasobiliary drainage tube placement after endoscopic clearance of the common bile duct?,8.053230730133017e-07,0.6343198495714506,0.24691358024691368,0.061656499802583795,0.7452431377944109,0.22506925207756232,0.06156725239239759,0.8344495237419882,0.20249835634451027,8.053230730133035e-07,0.9291446021088445,0.174375
183,0.5,5,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Is it mandatory to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients?,7.342651548062456e-07,0.4801691697441939,0.24691358024691368,0.056216220408238156,0.5827242082966366,0.22506925207756232,0.056134847769538976,0.6625992668153291,0.20249835634451027,7.342651548062474e-07,0.7468230453148901,0.174375
183,0.5,6,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","After endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis, is routine nasobiliary drainage tube insertion required?",7.816371002776163e-07,0.5802526283011753,0.24691358024691368,0.059843073337801915,0.6880847239544621,0.22506925207756232,0.05975645085144472,0.7738249019255532,0.20249835634451027,7.816371002776182e-07,0.8646060809712739,0.174375
183,0.5,7,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Should nasobiliary drainage tubes be routinely placed after endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-induced cholangitis?,7.579511275419309e-07,0.5289593339136252,0.24691358024691368,0.058029646873020035,0.6340175026841868,0.22506925207756232,0.05794564931049185,0.7166664880856044,0.20249835634451027,7.579511275419328e-07,0.8039814591548389,0.174375
183,0.5,8,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Is routine placement of a nasobiliary drainage tube necessary following endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis?,6.86893209334875e-07,0.3891973915384659,0.24691358024691368,0.0525893674786744,0.4874140284923114,0.22506925207756232,0.05251324468763323,0.5625158082583477,0.20249835634451027,6.868932093348768e-07,0.6414625296570646,0.174375
183,0.5,9,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Is the routine use of a nasobiliary drainage tube indicated after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis?,7.105791820705603e-07,0.43364915410929994,0.24691358024691368,0.054402793943456276,0.5339340441272054,0.22506925207756232,0.0543240462285861,0.611305972427779,0.20249835634451027,7.105791820705621e-07,0.6927558240446148,0.174375
183,0.5,10,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Is it necessary to routinely use a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis?,6.632072365991897e-07,0.34663777711967025,0.24691358024691368,0.05077594101389252,0.44296226592147736,0.22506925207756232,0.050702443146680355,0.5159957926234537,0.20249835634451027,6.632072365991914e-07,0.5926723654876334,0.174375
184,0.5,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of psychological treatment for depression influence the likelihood of returning to treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of returning to mental health services for certain groups. However, due to the study's design, no causal conclusions can be made. Further investigation, ideally through a randomized controlled trial, is necessary to confirm this.",7.105791820705622e-08,0.07804634346179373,0.019175437823872196,0.005440279394345618,0.0286892385753168,0.01694411414982164,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
184,0.5,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there a connection between the duration of psychological treatment for depression and the probability of re-entering treatment? Answer: The results imply that longer treatment periods may help prevent some groups from returning to mental health care. Nevertheless, the study's design does not allow for causal conclusions. More research, preferably a randomized controlled trial, is required to establish this.",4.737194547137081e-08,0.10744903718274212,0.05246913580246911,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
184,0.5,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the duration of depression treatment affect the likelihood of patients returning for further care? Answer: The study suggests that longer treatment durations could reduce return rates in certain populations. However, the design limits causal interpretation. Additional research, ideally RCTs, is needed to clarify this relationship.",2.6054570009253947e-07,0.14144701023388206,0.05246913580246911,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
184,0.5,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the length of psychological treatment for depression associated with the risk of returning to treatment? Answer: Results show that extended treatment may lower the risk of returning to mental health care in some groups. Yet, no causal inference can be drawn due to study design limitations. Further RCT research is recommended.",1.1842986367842703e-07,0.12548271592000226,0.02391975308641977,0.009067132323909363,0.17507278513552338,0.05859375,0.009054007704764333,0.1507619542491212,0.039930555555555566,1.1842986367842703e-07,0.12545547010915659,0.020399305555555556
184,0.5,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does longer psychological treatment for depression correlate with reduced return to treatment? Answer: The findings suggest that prolonged treatment might prevent some patients from returning to mental health services. However, causal claims cannot be made because of the study design. More research via randomized controlled trials is necessary.",2.1317375462116866e-07,0.09888739581508554,0.05246913580246911,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
184,0.5,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the duration of treatment for depression linked to patients returning for further psychological care? Answer: Evidence indicates that longer treatment durations may help prevent return visits in certain groups, but the study design precludes causal conclusions. Further research, preferably randomized controlled trials, is needed.",2.8423167282822487e-07,0.16342591695265707,0.05246913580246911,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
184,0.5,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of psychological treatment influence the chance of relapse or return to treatment for depression? Answer: The data suggest that longer treatment may reduce the likelihood of returning to care in some groups, though causality cannot be established due to study design. Additional RCT studies are warranted.",1.8948778188548325e-07,0.07826810861234978,0.05246913580246911,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
184,0.5,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there an association between treatment duration for depression and the likelihood of returning to psychological care? Answer: Findings imply that longer treatment might prevent return to mental health services in some groups, but causal inference is limited by the study design. Further randomized controlled trials are needed.",2.1317375462116866e-07,0.09888739581508554,0.05246913580246911,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
184,0.5,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does a longer duration of psychological treatment for depression reduce the chance of patients returning for treatment? Answer: The results indicate that extended treatment could help prevent return to mental health care among certain groups, though no causal relationship can be confirmed due to study design. More RCT research is required.",1.4211583641411244e-07,0.03826277399865141,0.05246913580246911,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
184,0.5,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the time spent in psychological treatment for depression related to the probability of returning for further treatment? Answer: The study suggests that longer treatment duration may reduce return rates in some groups, but causal inference is not possible because of the study design. Further research, ideally randomized controlled trials, is necessary.",1.1842986367842703e-07,0.0455041950861621,0.0332457601777094,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
185,0.5,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to predict discordance between TEOAE and AABR results in newborns? No, the differences in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes cannot be reliably predicted in newborns due to various influencing factors like ear canal debris or background noise.",1.4211583641411244e-07,0.06928330820310658,0.03840000000000001,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
185,0.5,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in TEOAE and AABR outcomes be anticipated in newborn infants? No, predicting the mismatch between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is not feasible, as factors such as ear canal debris or ambient noise can cause variability.",1.4211583641411244e-07,0.06928330820310658,0.03840000000000001,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
185,0.5,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is the mismatch between TEOAE and AABR test results predictable in newborns? No, the discordance in outcomes from Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) in newborns is unpredictable due to influences like debris in the ear canal and environmental noise.",1.8948778188548325e-07,0.1137350707739393,0.03840000000000001,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
185,0.5,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can we forecast discordant results between TEOAE and AABR in newborns? No, the inconsistency between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be reliably predicted because of factors including ear canal debris and ambient noise.",2.3685972735685406e-07,0.16025508640883324,0.03840000000000001,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
185,0.5,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to foresee discordance in TEOAE and AABR outcomes for newborns? No, predicting differences between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is unreliable due to variables such as debris in the ear canal and background noise.",1.6580180914979784e-07,0.09126221492188158,0.03840000000000001,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
185,0.5,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Are discordant TEOAE and AABR results predictable in newborns? No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be predicted because of multiple factors like ear canal debris and ambient noise interference.",2.6054570009253947e-07,0.18435263798789325,0.03840000000000001,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
185,0.5,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in newborn TEOAE and AABR tests be predicted? No, the unpredictability of discordant Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns stems from factors such as debris in the ear canal and environmental noise.",2.6054570009253947e-07,0.18435263798789325,0.03840000000000001,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
185,0.5,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is discordance between TEOAE and AABR results in newborns foreseeable? No, due to factors like ear canal debris and ambient noise, predicting discordant outcomes between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) in newborns is not possible.",2.8423167282822487e-07,0.24370260960626133,0.01341643655489809,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
185,0.5,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can we predict when TEOAE and AABR results will disagree in newborns? No, because of influences such as debris in the ear canal and background noise, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is unpredictable.",1.8948778188548325e-07,0.1137350707739393,0.03840000000000001,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
185,0.5,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it feasible to predict discordance in TEOAE and AABR outcomes in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns cannot be reliably forecasted due to factors like ear canal debris and ambient noise.",1.8948778188548325e-07,0.1137350707739393,0.03840000000000001,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
186,0.5,1,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Present scientific studies do not offer direct proof that laparoscopic cholecystectomy impacts peri-sinusoidal cell activity. Since laparoscopic cholecystectomy targets the gallbladder, it is typically not linked to changes in peri-sinusoidal cells found mainly in the liver.",1.8948778188548325e-07,0.192190077533823,0.01997923145675347,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
186,0.5,2,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Current research lacks direct evidence showing that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The procedure focuses on the gallbladder and is generally unrelated to peri-sinusoidal cells located in the liver.,3.0791764556390996e-07,0.24492988340683786,0.07530256414555499,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
186,0.5,3,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does the procedure of laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Scientific literature to date does not directly support an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity. Because this surgery primarily involves the gallbladder, it is usually not associated with peri-sinusoidal cells within the liver.",1.4211583641411244e-07,0.1287108170437561,0.034491961256328224,0.010880558788691236,0.16285958616403873,0.023242630385487524,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
186,0.5,4,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Can laparoscopic cholecystectomy impact peri-sinusoidal cell activity? There is no direct scientific evidence that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. The surgery mainly concerns the gallbladder and is not commonly linked to peri-sinusoidal cells that reside in the liver.,2.8423167282822466e-07,0.2537570822708477,0.049839601182592015,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
186,0.5,5,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? Current scientific findings do not provide direct evidence that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. This procedure targets the gallbladder and is generally not connected to peri-sinusoidal cells in the liver.,2.3685972735685406e-07,0.19881564482771896,0.05244724114018582,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
186,0.5,6,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there an influence of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Existing scientific literature does not directly demonstrate that laparoscopic cholecystectomy impacts peri-sinusoidal cell activity. Because the procedure is focused on the gallbladder, it is usually unrelated to peri-sinusoidal cells located in the liver.",1.6580180914979784e-07,0.12165907268604714,0.05590778517066495,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
186,0.5,7,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does laparoscopic cholecystectomy modify peri-sinusoidal cell activity? No direct evidence from current scientific literature supports the idea that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The operation centers on the gallbladder and typically does not involve peri-sinusoidal cells in the liver.,2.6054570009253936e-07,0.2259107532749849,0.051176523690685705,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.5,8,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? There is no direct proof in scientific studies that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. Since the procedure mainly targets the gallbladder, it is not generally associated with peri-sinusoidal cells found in the liver.",2.1317375462116866e-07,0.13862037176964304,0.07793373698506115,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.5,9,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Does undergoing laparoscopic cholecystectomy change peri-sinusoidal cell activity? Present scientific literature lacks direct evidence indicating that laparoscopic cholecystectomy alters peri-sinusoidal cell activity. The surgery is primarily focused on the gallbladder and is generally unrelated to peri-sinusoidal cells within the liver.,2.6054570009253936e-07,0.2259107532749849,0.051176523690685705,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.5,10,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.",Is there a connection between laparoscopic cholecystectomy and peri-sinusoidal cell activity? Current scientific research does not provide direct evidence that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The procedure is mainly concerned with the gallbladder and typically does not involve peri-sinusoidal cells located in the liver.,1.4211583641411244e-07,0.1287108170437561,0.034491961256328224,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
187,0.5,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? Yes, it can. By incentivizing healthcare providers to organize their services efficiently, case-mix based reimbursement fosters a process-oriented approach, which can enhance patient outcomes and optimize resource use within the health system.",3.316036182995957e-07,0.18040929450797938,0.07494897959183676,0.025387970506946217,0.2015464160146445,0.06562499999999999,0.025351221573340132,0.22308823905478903,0.05536332179930796,3.316036182995957e-07,0.2544172726632352,0.037677816224529016
187,0.5,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? Indeed, case-mix based reimbursement promotes such development by motivating healthcare providers to deliver services in a structured and efficient manner, leading to better patient outcomes and improved allocation of resources.",3.552895910352811e-07,0.17230488647914521,0.09807397959183678,0.02720139697172809,0.19242697101672634,0.08999999999999998,0.027162023114293,0.24840604703908076,0.05536332179930796,3.552895910352811e-07,0.2803927590664932,0.037677816224529016
187,0.5,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix based reimbursement promote process-oriented care delivery? Yes, it can encourage healthcare providers to adopt efficient and effective service structures, thereby supporting a process-oriented approach that improves patient outcomes and resource management.",5.684633456564489e-07,0.38632899279543675,0.12244897959183677,0.04352223515476497,0.4473192206455159,0.08999999999999998,0.04345923698286883,0.5107703115065703,0.05536332179930796,5.684633456564497e-07,0.5506830888064065,0.037677816224529016
187,0.5,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement drive the development of process-oriented care delivery? Yes, it incentivizes providers to organize care efficiently, fostering a process-oriented system that benefits patient outcomes and resource distribution.",6.395212638635048e-07,0.48476906560869004,0.12244897959183677,0.04896251454911061,0.5491019149554583,0.08999999999999998,0.048891641605727454,0.6161308271643957,0.05536332179930796,6.39521263863506e-07,0.6598823807713972,0.037677816224529016
187,0.5,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is process-oriented care delivery development influenced by case-mix based reimbursement? Yes, this reimbursement model motivates healthcare providers to structure their services effectively, promoting a process-focused approach that enhances patient care and resource allocation.",5.684633456564489e-07,0.38632899279543675,0.12244897959183677,0.04352223515476497,0.4473192206455159,0.08999999999999998,0.04345923698286883,0.5107703115065703,0.05536332179930796,5.684633456564497e-07,0.5506830888064065,0.037677816224529016
187,0.5,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement foster process-oriented care delivery? Yes, by encouraging healthcare providers to deliver services efficiently, it supports a process-oriented framework that can improve patient outcomes and optimize health system resources.",5.921493183921342e-07,0.4180776911100166,0.12244897959183677,0.04533566161954685,0.4801090434685076,0.08999999999999998,0.04527003852382171,0.544671863182252,0.05536332179930796,5.921493183921352e-07,0.5857744086176755,0.037677816224529016
187,0.5,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can the use of case-mix based reimbursement stimulate process-oriented care delivery? Yes, it incentivizes providers to structure their care processes efficiently, which can lead to better patient outcomes and more effective use of resources.",5.447773729207636e-07,0.3975662541626188,0.09217554209183677,0.04170880868998309,0.41557052233093605,0.08999999999999998,0.04164843544191596,0.47798048868357856,0.05536332179930796,5.447773729207643e-07,0.5167815371307247,0.037677816224529016
187,0.5,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement encourage process-oriented care delivery development? Yes, it motivates healthcare providers to organize their services in a way that promotes efficiency and effectiveness, resulting in improved patient outcomes and resource allocation.",5.447773729207636e-07,0.35555733412868307,0.12244897959183677,0.04170880868998309,0.41557052233093605,0.08999999999999998,0.04164843544191596,0.47798048868357856,0.05536332179930796,5.447773729207643e-07,0.5167815371307247,0.037677816224529016
187,0.5,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the advancement of process-oriented care delivery promoted by case-mix based reimbursement? Yes, it incentivizes healthcare providers to adopt efficient processes, which can enhance patient outcomes and optimize resource use.",6.395212638635048e-07,0.48476906560869004,0.12244897959183677,0.04896251454911061,0.5491019149554583,0.08999999999999998,0.048891641605727454,0.6161308271643957,0.05536332179930796,6.39521263863506e-07,0.6598823807713972,0.037677816224529016
187,0.5,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement support the development of process-oriented care delivery? Yes, it encourages healthcare providers to structure their services efficiently, fostering a process-oriented approach that benefits patient outcomes and resource management.",5.921493183921342e-07,0.4180776911100166,0.12244897959183677,0.04533566161954685,0.4801090434685076,0.08999999999999998,0.04527003852382171,0.544671863182252,0.05536332179930796,5.921493183921352e-07,0.5857744086176755,0.037677816224529016
188,0.5,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment a reliable method to rule out aspiration after an acute stroke? Answer: Bedside swallowing assessment does not have sufficient sensitivity to serve as a screening tool in acute stroke cases, and there are doubts regarding videofluoroscopy's role as the definitive standard. The significance of aspiration and bedside assessment in forecasting complications remains a concern.",9.474389094274162e-08,0.13678049920355662,0.07886173469387753,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
188,0.5,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be reliably excluded after acute stroke using bedside assessment? Answer: The sensitivity of bedside swallowing assessment is inadequate for screening in acute stroke, and the validity of videofluoroscopy as the gold standard is questioned. The predictive value of aspiration and bedside assessments for complications is still under scrutiny.",7.105791820705622e-08,0.030073190501009428,0.09639999999999999,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
188,0.5,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment dependable for excluding aspiration post-acute stroke? Answer: Bedside swallowing assessments lack the sensitivity required for screening acute stroke patients, and there are issues with considering videofluoroscopy as the gold standard. The role of aspiration and bedside assessment in predicting complications is a matter of concern.",1.1842986367842703e-07,0.03962993654257563,0.0755760977818017,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
188,0.5,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside assessment effectively exclude aspiration after an acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening tools in acute stroke, and videofluoroscopy’s status as the gold standard is debated. The importance of aspiration and bedside assessments in forecasting complications is questioned.",1.1842986367842703e-07,0.01074880401924494,0.09639999999999999,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
188,0.5,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can bedside swallowing assessment reliably rule out aspiration following acute stroke? Answer: The sensitivity of bedside swallowing assessments is insufficient for acute stroke screening, and concerns exist about using videofluoroscopy as the definitive standard. The relevance of aspiration and bedside assessment in predicting complications is still uncertain.",1.4211583641411244e-07,0.06129783792175658,0.07513345935727789,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
188,0.5,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is it possible to exclude aspiration after acute stroke using bedside assessment? Answer: Bedside swallowing assessment does not provide adequate sensitivity for screening in acute stroke, and the use of videofluoroscopy as the gold standard is controversial. The predictive significance of aspiration and bedside assessments for complications remains a concern.",7.105791820705622e-08,0.030073190501009428,0.09639999999999999,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
188,0.5,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be excluded reliably by bedside assessment after an acute stroke? Answer: Bedside swallowing assessment lacks the needed sensitivity for acute stroke screening, and videofluoroscopy’s designation as the gold standard is questioned. The importance of aspiration and bedside assessment in predicting complications is still debated.",1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
188,0.5,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment a reliable screening method for aspiration after acute stroke? Answer: The sensitivity of bedside swallowing assessments is insufficient for screening acute stroke patients, and videofluoroscopy’s role as the gold standard is controversial. The significance of aspiration and bedside assessment in predicting complications is under discussion.",1.1842986367842703e-07,0.03962993654257563,0.0755760977818017,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
188,0.5,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can bedside swallowing assessment be trusted to exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing does not have the sensitivity required for screening in acute stroke, and there are concerns about using videofluoroscopy as the gold standard. The predictive value of aspiration and bedside assessment regarding complications is still a concern.",0.0,0.0621856012453641,0.07753905325443786,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
188,0.5,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment effective in ruling out aspiration after acute stroke? Answer: Bedside swallowing assessment lacks sufficient sensitivity for use as a screening tool in acute stroke, and the use of videofluoroscopy as the gold standard is debated. The role of aspiration and bedside assessment in predicting complications remains uncertain.",7.105791820705622e-08,0.0023473032786114345,0.07640832986255724,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
189,0.5,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Are musculoskeletal symptoms related to aromatase inhibitors primarily prevented by addressing osteoporosis? Patients using AIs who develop osteoporosis face a higher risk of musculoskeletal symptoms and bone fractures. Co-treatment with calcium and bisphosphonates lowers the risk of osteoporosis and these symptoms. Those previously treated with tamoxifen before AIs showed a reduced chance of developing AI-related musculoskeletal issues. We advise patients on AIs to consider this approach.,9.474389094274162e-08,0.08903660581356299,0.01831053027191412,0.0072537058591274906,0.08764342715623652,0.016661878770468257,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
189,0.5,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is preventing osteoporosis the essential factor in avoiding musculoskeletal symptoms caused by aromatase inhibitors? Individuals on AIs who develop osteoporosis have an elevated risk of musculoskeletal pain and fractures. Combining calcium and bisphosphonates reduces the risk of osteoporosis and related symptoms. Patients who used tamoxifen prior to AIs are less prone to AI-induced musculoskeletal symptoms. We recommend this strategy for patients undergoing AI therapy.,4.737194547137081e-08,0.07843460102211441,0.03317986490984297,0.0036268529295637453,0.05589472884165669,0.016661878770468257,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
189,0.5,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,"Do aromatase inhibitor-induced musculoskeletal symptoms stem from osteoporosis, making its prevention crucial? Patients receiving AIs who develop osteoporosis are more susceptible to musculoskeletal symptoms and fractures. Using calcium and bisphosphonates together decreases the chance of osteoporosis and these symptoms. Those treated with tamoxifen before starting AIs show fewer AI-related musculoskeletal complaints. Our recommendation is for patients on AIs to follow this preventive measure.",2.3685972735685406e-08,0.06207934560472239,0.032924053824406954,0.0018134264647818726,0.03963420796987549,0.016661878770468257,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
189,0.5,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is the prevention of osteoporosis the key to eliminating musculoskeletal symptoms associated with aromatase inhibitors? Osteoporosis development in AI patients increases the risk of musculoskeletal symptoms and bone fractures. Co-administration of calcium and bisphosphonates reduces the incidence of osteoporosis and related symptoms. Patients previously treated with tamoxifen before AIs have a lower likelihood of AI-related musculoskeletal symptoms. We suggest this approach for patients on AIs.,7.105791820705622e-08,0.07286593160398347,0.017831269696523506,0.005440279394345618,0.07189507018810026,0.016661878770468257,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
189,0.5,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Could preventing osteoporosis be the solution to aromatase inhibitor-related musculoskeletal symptoms? Patients on AIs who develop osteoporosis face higher risks of musculoskeletal symptoms and fractures. Co-medication with calcium and bisphosphonates lowers these risks. Patients who had tamoxifen before AIs are less likely to experience AI-related musculoskeletal symptoms. We recommend this preventive strategy for AI patients.,1.6580180914979784e-07,0.053711406406417694,0.0490487514863258,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
189,0.5,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is osteoporosis prevention the key factor in stopping musculoskeletal symptoms caused by aromatase inhibitors? AI patients who develop osteoporosis are at an increased risk for musculoskeletal symptoms and bone fractures. Treatment with calcium and bisphosphonates reduces the risk of both osteoporosis and musculoskeletal symptoms. Patients previously on tamoxifen before AIs tend to have fewer AI-related musculoskeletal symptoms. We recommend this protocol for patients receiving AIs.,7.105791820705622e-08,0.07286593160398347,0.01783126969652351,0.005440279394345618,0.07189507018810026,0.016661878770468257,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
189,0.5,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Are musculoskeletal symptoms from aromatase inhibitors prevented mainly by addressing osteoporosis? Patients on AIs developing osteoporosis are more prone to musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates reduces this likelihood. Those who were treated with tamoxifen before AIs show a decreased risk of AI-related musculoskeletal symptoms. We advise patients on AIs to consider this preventive measure.,9.474389094274162e-08,0.07260704624771641,0.0034203843161433115,0.0072537058591274906,0.07064322191685513,0.0011893608989532352,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
189,0.5,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Does preventing osteoporosis hold the key to eliminating musculoskeletal symptoms linked to aromatase inhibitors? Patients undergoing AI therapy who develop osteoporosis have a higher risk of musculoskeletal symptoms and fractures. Combined treatment with calcium and bisphosphonates reduces these risks. Patients who received tamoxifen prior to AIs are less likely to develop AI-related musculoskeletal symptoms. We recommend this preventive approach for AI patients.,0.0,0.04545227413507824,0.0326598625974369,0.0,0.02310490601866455,0.016661878770468257,0.0,0.0,0.0,0.0,0.0,0.0
189,0.5,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is the key to preventing aromatase inhibitor-related musculoskeletal symptoms found in osteoporosis prevention? Patients on AIs who develop osteoporosis are at greater risk for musculoskeletal symptoms and bone fractures. Co-medication with calcium and bisphosphonates lowers this risk. Those previously treated with tamoxifen before AIs have a reduced risk of AI-related musculoskeletal symptoms. We suggest this preventive strategy for patients on AIs.,2.3685972735685406e-08,0.005439297214077321,0.015755053507728885,0.0018134264647818726,0.006297787702283841,0.016661878770468257,0.0018108015409528666,0.01709443335929972,0.0,2.3685972735685406e-08,0.01739174271186883,0.0
189,0.5,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Could the prevention of osteoporosis be crucial to stopping musculoskeletal symptoms caused by aromatase inhibitors? AI patients developing osteoporosis face increased risks of musculoskeletal symptoms and fractures. Treatment with calcium and bisphosphonates reduces these risks. Patients who had tamoxifen before AIs are less likely to experience AI-related musculoskeletal symptoms. We recommend this approach for patients on AIs.,1.1842986367842703e-07,0.042099018684113254,0.03119751181690431,0.009067132323909363,0.0639064709709638,0.016661878770468257,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
190,0.5,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Do higher depression rates in women result from differences in symptom reporting? Answer: Both men and women in this community sample reported similar depressive symptom patterns. There was no evidence indicating that depressive symptom presentation varies by gender.,4.73719454713706e-08,0.053117365915339665,0.0013130033920054594,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
190,0.5,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the increased incidence of depression in women explained by differences in symptom reporting? Answer: Men and women from this community sample showed comparable patterns of depressive symptoms. No evidence suggests that the way depressive symptoms present differs between genders.,0.0,0.03465735902799638,0.024983563445101917,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
190,0.5,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are elevated depression rates among women due to differential reporting of symptoms? Answer: In this community sample, men and women reported similar depressive symptom patterns. No indication was found that depressive symptom presentation varies by gender.",9.47438909427412e-08,0.10921133332760435,0.0027715385957144123,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
190,0.5,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Does differential symptom reporting explain why women have higher depression rates? Answer: Men and women in this community reported similar depressive symptom patterns. No evidence supports gender differences in depressive symptom presentation.,1.894877818854824e-07,0.23180789107121091,0.006233918344700384,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.5,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates attributable to differences in symptom reporting? Answer: Both genders in this community sample reported similar depressive symptoms, with no evidence of gender differences in symptom presentation.",2.131737546211677e-07,0.30967323647949563,0.0392257112279064,0.01632083818303689,0.30857407650481905,0.033293697978596916,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.5,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Could the higher depression rates in women be due to different symptom reporting? Answer: Men and women reported similar patterns of depressive symptoms in this community sample. No evidence was found for gender-based differences in symptom presentation.,7.10579182070559e-08,0.04330418244171419,0.024983563445101917,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
190,0.5,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the greater prevalence of depression in women explained by how symptoms are reported? Answer: Men and women in the community sample exhibited similar depressive symptom profiles. No evidence indicates gender differences in symptom presentation.,1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.5,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are differences in symptom reporting responsible for higher depression rates in women? Answer: This community sample showed men and women reporting similar depressive symptoms. No evidence was found that symptom presentation differs by gender.,1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.5,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Does the way symptoms are reported account for women's higher depression rates? Answer: In this community sample, men and women had similar depressive symptom patterns, with no evidence of gender-based differences in presentation.",1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.5,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are higher depression rates in women due to variations in symptom reporting? Answer: Men and women in this community sample reported comparable depressive symptoms, with no evidence that symptom presentation differs by gender.",1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
191,0.5,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it possible to implement an advance care planning model in community palliative care? Yes, such a model is feasible in this setting. It promotes early conversations about care preferences, medical choices, and end-of-life desires, helping healthcare providers deliver patient-focused care. Additionally, it improves the",7.105791820705622e-08,0.14051140514095328,0.144375,0.005440279394345618,0.08324288889141185,0.10707911957168353,0.0054324046228586,0.023426752587707433,0.06632653061224489,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
191,0.5,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be effectively used in community palliative care? The answer is yes; it is feasible. This model supports proactive dialogue regarding care preferences, medical decisions, and end-of-life wishes, allowing healthcare professionals to offer care centered on the patient. Furthermore, it enhances the",2.3685972735685406e-08,0.184963167711786,0.144375,0.0018134264647818726,0.1287052629681691,0.10707911957168353,0.0018108015409528666,0.06994676822260137,0.06632653061224489,2.3685972735685406e-08,0.008517171800753065,0.02271498107084911
191,0.5,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model practical within community palliative care? Yes, it is feasible. This model encourages early discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare providers to focus on patient-centered care. It also improves the",1.8948778188548314e-07,0.019883417352335897,0.144375,0.014507411718254981,0.04037106707576399,0.10707911957168353,0.014486412327622933,0.10332495305143485,0.06632653061224489,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
191,0.5,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it feasible to apply an advance care planning model in community palliative care? Yes, it is. This approach facilitates proactive conversations about care preferences, medical decisions, and end-of-life wishes, which helps healthcare professionals provide care that centers on the patient. Moreover, it enhances the",7.105791820705622e-08,0.14051140514095328,0.144375,0.005440279394345618,0.08324288889141185,0.10707911957168353,0.0054324046228586,0.023426752587707433,0.06632653061224489,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
191,0.5,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can community palliative care adopt an advance care planning model? Yes, it is feasible. The model supports proactive discussions about care preferences, medical decisions, and end-of-life wishes, empowering healthcare providers to deliver patient-centered care. Additionally, it improves the",2.3685972735685374e-07,0.032760316133082945,0.144375,0.018134264647818726,0.09443828834604018,0.10707911957168353,0.018108015409528666,0.15889480420624702,0.06632653061224489,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
191,0.5,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is the use of an advance care planning model feasible in community palliative care? Yes, it is. This model encourages early and proactive talks about care preferences, medical decisions, and end-of-life wishes, allowing healthcare professionals to provide care focused on the patient. It also enhances the",4.737194547137081e-08,0.162984260993011,0.144375,0.0036268529295637453,0.10623240711611137,0.10707911957168353,0.003621603081905733,0.04695724999790185,0.06632653061224489,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
191,0.5,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is implementing an advance care planning model in community palliative care feasible? Yes, it is. The model enables proactive discussions about care preferences, medical decisions, and end-of-life wishes, facilitating patient-centered care by healthcare providers. Moreover, it improves the",2.3685972735685374e-07,0.032760316133082945,0.144375,0.018134264647818726,0.09443828834604018,0.10707911957168353,0.018108015409528666,0.15889480420624702,0.06632653061224489,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
191,0.5,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Does an advance care planning model work in community palliative care? Yes, it is feasible. This model promotes proactive conversations about care preferences, medical decisions, and end-of-life wishes, helping healthcare professionals deliver patient-focused care. Additionally, it enhances the",2.3685972735685374e-07,0.032760316133082945,0.144375,0.018134264647818726,0.09443828834604018,0.10707911957168353,0.018108015409528666,0.15889480420624702,0.06632653061224489,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
191,0.5,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model workable in community palliative care? Yes, it is feasible. It supports early discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare providers to offer patient-centered care. Furthermore, it improves the",2.3685972735685374e-07,0.032760316133082945,0.144375,0.018134264647818726,0.09443828834604018,0.10707911957168353,0.018108015409528666,0.15889480420624702,0.06632653061224489,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
191,0.5,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it viable to use an advance care planning model in community palliative care? Yes, it is feasible. This model facilitates proactive talks about care preferences, medical decisions, and end-of-life wishes, allowing healthcare professionals to provide care that centers on the patient. It also enhances the",4.737194547137081e-08,0.162984260993011,0.144375,0.0036268529295637453,0.10623240711611137,0.10707911957168353,0.003621603081905733,0.04695724999790185,0.06632653061224489,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
192,0.5,1,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,Question: Advanced epithelial ovarian carcinoma in Thai women: is it still advisable to perform second-look laparotomy? Answer: The use of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women remains controversial. Although it offers important insights into the disease status...,2.3685972735685406e-08,0.04039559826708672,0.045091826060294576,0.0018134264647818726,0.04221960960872817,0.04763321880439002,0.0018108015409528666,0.0441811108194079,0.05009232205178152,2.3685972735685406e-08,0.04629461402941226,0.05246913580246914
192,0.5,2,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,Question: Should second-look laparotomy be continued for advanced epithelial ovarian carcinoma in Thai women? Answer: The role of second-look laparotomy in managing advanced epithelial ovarian carcinoma in Thai women is debated. It can yield critical information about the disease condition...,4.7371945471370706e-08,0.09422618819011896,0.02916156514641359,0.0036268529295637453,0.05858958049870866,0.005040796274936948,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.5,3,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: In Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy still be utilized? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a debated procedure. It provides valuable data regarding the disease status...",9.474389094274131e-08,0.12093094194564635,0.01223717206790119,0.0072537058591274906,0.04374743294138739,0.043402110299457494,0.007243206163811466,0.001575556861778793,0.0763888888888889,9.474389094274162e-08,0.03826277399865141,0.05246913580246914
192,0.5,4,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is it appropriate to keep offering second-look laparotomy? Answer: The application of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is controversial, as it can deliver important information on the disease's status...",0.0,0.06762411517657974,0.046884083991655584,0.0,0.0693147180559941,0.04890393625389013,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914
192,0.5,5,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy continue to be offered? Answer: Offering second-look laparotomy in cases of advanced epithelial ovarian carcinoma in Thai women is contentious. It can reveal crucial details about the current status of the disease...",4.737194547137081e-08,0.0877307219428074,0.027554058002775966,0.0036268529295637453,0.15441259168332833,0.07497007219394691,0.003621603081905733,0.15664844835311564,0.0763888888888889,4.737194547137081e-08,0.12425615549912283,0.05246913580246914
192,0.5,6,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy remain a standard option for advanced epithelial ovarian carcinoma in Thai women? Answer: The decision to perform second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is debated, though it can provide significant information about disease progression...",0.0,0.03381205758828987,0.023178020362705068,0.0,0.0693147180559941,0.04890393625389013,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914
192,0.5,7,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy justified? Answer: Continuing second-look laparotomy in advanced epithelial ovarian carcinoma for Thai women is a matter of debate, given its potential to offer valuable insight into disease status...",4.7371945471370706e-08,0.0586801789306346,0.0058337605194582615,0.0036268529295637453,0.022108149942921873,0.020398085159989948,0.003621603081905733,0.016526879127630956,0.04938271604938273,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
192,0.5,8,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Is second-look laparotomy still recommended for advanced epithelial ovarian carcinoma in Thai women? Answer: The recommendation for second-look laparotomy in advanced epithelial ovarian carcinoma in Thai women is controversial, despite its ability to provide key information about the disease...",4.7371945471370706e-08,0.09422618819011896,0.02916156514641359,0.0036268529295637453,0.05858958049870866,0.005040796274936948,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.5,9,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy be maintained as a practice for advanced epithelial ovarian carcinoma in Thai women? Answer: Maintaining second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is debated, as it can supply important information regarding the disease's condition...",2.3685972735685406e-08,0.09823383784490325,0.047527038057341056,0.0018134264647818726,0.06441841816972405,0.026667093852791576,0.0018108015409528666,0.0652631808479529,0.02741733948481352,2.3685972735685406e-08,0.06610763146679632,0.027980691187150207
192,0.5,10,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For advanced epithelial ovarian carcinoma in Thai women, is second-look laparotomy still warranted? Answer: The warrant for second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is disputed, although it can offer valuable information about the disease status...",4.7371945471370706e-08,0.023134169671150673,0.018374275636180423,0.0036268529295637453,0.014373280612865358,0.04629629629629633,0.003621603081905733,0.016526879127630956,0.04938271604938273,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
193,0.5,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Yes, it can impair aerobic fitness by lowering maximum aerobic capacity through frequent sleep disruptions, causing daytime tiredness and reduced endurance for aerobic exercises. Additionally, chronic sleep loss harms heart health, further reducing aerobic fitness.",1.6580180914979784e-07,0.042104414110259114,0.08264462809917357,0.012693985253473108,0.13177252289144326,0.0212665406427221,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
193,0.5,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can obstructive sleep apnea influence aerobic fitness? Indeed, it can decrease aerobic fitness by disrupting sleep frequently, which leads to daytime fatigue and diminished stamina for aerobic activities. Prolonged sleep deprivation also negatively affects cardiovascular health, further lowering aerobic fitness.",2.1317375462116855e-07,0.09211483468492254,0.08264462809917357,0.016320838183036854,0.18306581727899296,0.0212665406427221,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
193,0.5,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Yes, obstructive sleep apnea can impair aerobic fitness by causing repeated sleep interruptions that reduce maximum aerobic capacity, resulting in daytime exhaustion and less endurance for aerobic workouts. Chronic lack of sleep also impacts heart health, further decreasing aerobic fitness.",2.3685972735685406e-08,0.03547987148613396,0.04017549229670444,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
193,0.5,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea have an effect on aerobic fitness? Yes, it can reduce aerobic fitness because frequent sleep disturbances lower maximum aerobic capacity, leading to fatigue during the day and decreased stamina for aerobic activities. Long-term sleep deprivation also harms heart function, further impairing aerobic fitness.",4.737194547137081e-08,0.07296491567452756,0.08264462809917357,0.0036268529295637453,0.013989487235059883,0.0212665406427221,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
193,0.5,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can aerobic fitness be influenced by obstructive sleep apnea? Yes, obstructive sleep apnea can negatively affect aerobic fitness by causing frequent awakenings during sleep, which reduces maximum aerobic capacity and leads to daytime tiredness and lower endurance. Chronic sleep loss also impacts cardiovascular health, further diminishing aerobic fitness.",2.3685972735685406e-08,0.03547987148613396,0.04017549229670444,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
193,0.5,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is there a connection between obstructive sleep apnea and aerobic fitness? Yes, obstructive sleep apnea can lower aerobic fitness by causing repeated sleep interruptions that reduce the maximum aerobic capacity, resulting in daytime fatigue and less stamina for aerobic exercise. Prolonged sleep deprivation also affects heart health, further reducing aerobic fitness.",4.737194547137081e-08,0.10089475016878291,0.042714072543618004,0.0036268529295637453,0.04287659944973932,0.0008672350871665457,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
193,0.5,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea reduce aerobic fitness? Yes, it can decrease aerobic fitness by interrupting sleep frequently, which lowers maximum aerobic capacity and causes daytime fatigue and decreased endurance for aerobic activities. Chronic sleep deprivation also negatively affects heart health, further diminishing aerobic fitness.",1.1842986367842703e-07,0.0055236348789953205,0.08264462809917357,0.009067132323909363,0.08298235872201154,0.0212665406427221,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
193,0.5,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","How does obstructive sleep apnea affect aerobic fitness? It reduces aerobic fitness by causing frequent sleep disruptions that lower maximum aerobic capacity, leading to daytime tiredness and reduced stamina for aerobic exercises. Long-term sleep deprivation also impacts cardiovascular health, further decreasing aerobic fitness.",1.4211583641411244e-07,0.018006862531199097,0.08264462809917357,0.010880558788691236,0.10707991030107156,0.0212665406427221,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
193,0.5,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness compromised by obstructive sleep apnea? Yes, obstructive sleep apnea can impair aerobic fitness by causing frequent sleep interruptions that reduce maximum aerobic capacity, resulting in daytime fatigue and less endurance for aerobic activities. Chronic sleep deprivation also affects heart health, further lowering aerobic fitness.",4.737194547137081e-08,0.012691247799749839,0.039256198347107446,0.0036268529295637453,0.013989487235059883,0.0212665406427221,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
193,0.5,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea impair aerobic fitness? Yes, it can affect aerobic fitness by disrupting sleep often, which reduces maximum aerobic capacity and leads to daytime fatigue and decreased stamina for aerobic activities. Persistent sleep deprivation also harms cardiovascular health, further diminishing aerobic fitness.",1.1842986367842703e-07,0.0055236348789953205,0.08264462809917357,0.009067132323909363,0.08298235872201154,0.0212665406427221,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
194,0.5,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for laparoscopic surgery to treat GERD? No, advanced age itself is not a contraindication for GERD laparoscopic surgery. However, the patient's general health, comorbidities, and surgical tolerance are key considerations.",1.8948778188548261e-07,0.16859414136379058,0.029464681375697466,0.014507411718254995,0.15763725250689387,0.04244124394044323,0.014486412327622954,0.1538288332582156,0.049861495844875335,1.8948778188548325e-07,0.19402843238501388,0.025623268698060954
194,0.5,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age disqualify a patient from undergoing GERD laparoscopic surgery? No, being elderly is not a contraindication for laparoscopic surgery for GERD. Still, the patient’s overall health status, presence of other illnesses, and capacity to withstand surgery must be evaluated.",4.737194547137081e-08,0.11624487882103196,0.11687363038714388,0.0036268529295637453,0.051425752190206175,0.07271468144044323,0.003621603081905733,0.018021423668444392,0.049861495844875335,4.737194547137081e-08,0.017097724225934918,0.025623268698060954
194,0.5,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is elderly age a reason to avoid laparoscopic surgery for GERD? No, advanced age alone does not contraindicate GERD laparoscopic surgery. The patient's overall health, other medical conditions, and ability to tolerate surgery are important factors to consider.",1.1842986367842671e-07,0.03828333735132139,0.11687363038714388,0.009067132323909363,0.028616955483327988,0.07271468144044323,0.009054007704764333,0.06421667456852864,0.049861495844875335,1.1842986367842703e-07,0.10165511225399859,0.025623268698060954
194,0.5,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a barrier to laparoscopic surgery for GERD? No, advanced age is not a contraindication for GERD laparoscopic surgery. However, the patient's overall medical condition, other diseases, and surgical fitness are critical factors.",1.8948778188548261e-07,0.08704741423909201,0.08748887372965994,0.014507411718254995,0.11562833247295812,0.07271468144044323,0.014486412327622954,0.1538288332582156,0.049861495844875335,1.8948778188548325e-07,0.19402843238501388,0.025623268698060954
194,0.5,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does being of advanced age prevent one from having GERD laparoscopic surgery? No, advanced age is not a contraindication to GERD laparoscopic surgery, but the patient's overall health, other existing conditions, and surgical endurance must be assessed.",1.42115836414112e-07,0.06613199023234362,0.061510308587835905,0.010880558788691236,0.05678783245002483,0.07271468144044323,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.5,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age an exclusion criterion for GERD laparoscopic surgery? No, advanced age does not exclude patients from GERD laparoscopic surgery. Nevertheless, the patient's general health, presence of comorbidities, and ability to tolerate the procedure are important considerations.",1.1842986367842671e-07,0.036651492979484335,0.06299607936673571,0.009067132323909363,0.028616955483327988,0.07271468144044323,0.009054007704764333,0.06421667456852864,0.049861495844875335,1.1842986367842703e-07,0.10165511225399859,0.025623268698060954
194,0.5,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Can elderly patients undergo GERD laparoscopic surgery or is advanced age a contraindication? Advanced age is not a contraindication for GERD laparoscopic surgery. The overall health status, other illnesses, and surgical tolerance are important factors to evaluate.",1.42115836414112e-07,0.06613199023234362,0.061510308587835905,0.010880558788691236,0.05678783245002483,0.07271468144044323,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.5,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a factor that contraindicates laparoscopic surgery for GERD? No, advanced age is not a contraindication to GERD laparoscopic surgery. The patient's overall health, additional diseases, and ability to endure surgery must be taken into account.",1.1842986367842671e-07,0.0008159221859189714,0.08986745754763771,0.009067132323909363,0.028616955483327988,0.07271468144044323,0.009054007704764333,0.06421667456852864,0.049861495844875335,1.1842986367842703e-07,0.10165511225399859,0.025623268698060954
194,0.5,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is it contraindicated to perform GERD laparoscopic surgery on elderly patients? No, advanced age is not a contraindication for GERD laparoscopic surgery, but the patient's overall health condition, other medical issues, and surgical tolerance are important factors.",1.42115836414112e-07,0.027623813534568775,0.08911852834632755,0.010880558788691236,0.05678783245002483,0.07271468144044323,0.010864809245717207,0.09320421144178015,0.049861495844875335,1.4211583641411244e-07,0.13150807540368037,0.025623268698060954
194,0.5,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age contraindicate GERD laparoscopic surgery? No, advanced age itself is not a contraindication. However, the patient's overall health, presence of other diseases, and ability to tolerate surgery are important considerations.",2.605457000925385e-07,0.1833665437471086,0.08465140816492167,0.019947691112600634,0.21093851227728333,0.07271468144044323,0.019918816950481574,0.2522689060714689,0.049861495844875335,2.6054570009253947e-07,0.29581112669495635,0.025623268698060954
195,0.5,1,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT showed strong correlations with traditional cardiovascular risk factors, but hsCRP was not independently associated with carotid IMT in healthy Korean adults.",7.105791820705622e-08,0.04733512367572068,0.01753776805751861,0.005440279394345618,0.041100963555631864,0.023795359904818555,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
195,0.5,2,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein relate to carotid atherosclerosis among healthy Koreans? While hsCRP levels and carotid IMT were closely connected to conventional cardiovascular risk factors, no independent association was found between hsCRP and carotid IMT in healthy Korean individuals.",1.1842986367842682e-07,0.06761920209085259,0.039575571626853705,0.009067132323909363,0.13121211220645312,0.003210812934687609,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
195,0.5,3,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Korean adults? Both hsCRP and carotid IMT correlated strongly with common cardiovascular risk factors, yet hsCRP did not show an independent link with carotid IMT in this population.",1.4211583641411212e-07,0.05879200322684275,0.06503853458981668,0.010880558788691236,0.12114367122916603,0.023795359904818555,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
195,0.5,4,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Although hsCRP levels and carotid IMT were strongly associated with standard cardiovascular risk factors, hsCRP was not independently related to carotid IMT in healthy Korean adults.",9.474389094274152e-08,0.0753188823544737,0.01565581854043395,0.0072537058591274906,0.06707644995888984,0.023795359904818555,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
195,0.5,5,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT were strongly linked to conventional cardiovascular risk factors, but no independent relationship existed between hsCRP and carotid IMT in healthy Korean adults.",9.474389094274152e-08,0.11086489161395763,0.009179782366595543,0.0072537058591274906,0.14003931107046297,0.028673775897650584,0.007243206163811466,0.1401215692254847,0.027006172839506164,9.474389094274162e-08,0.10536051565782589,0.0
195,0.5,6,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Korean adults? hsCRP levels and carotid IMT were both strongly correlated with traditional cardiovascular risk factors, yet no independent association was observed between hsCRP and carotid IMT in healthy Koreans.",9.474389094274152e-08,0.0753188823544737,0.01565581854043395,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
195,0.5,7,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT showed strong correlations with conventional cardiovascular risk factors, but there was no independent link between hsCRP and carotid IMT in healthy Korean adults.",4.737194547137081e-08,0.10049287179072319,0.08310961355833153,0.0036268529295637453,0.08509787362733423,0.02606613594005678,0.003621603081905733,0.08555642983414735,0.025623268698060954,4.737194547137081e-08,0.051293294387549704,0.0
195,0.5,8,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein associate with carotid atherosclerosis in healthy Koreans? While hsCRP levels and carotid IMT were strongly correlated with established cardiovascular risk factors, hsCRP did not independently associate with carotid IMT in healthy Korean adults.",1.6580180914979742e-07,0.20275626904065502,0.017330292570677155,0.012693985253473108,0.1889229585135741,0.004751352897949604,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.5,9,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Korean adults? Both hsCRP levels and carotid IMT had strong correlations with traditional cardiovascular risk factors, but no independent association was found between hsCRP and carotid IMT in this group.",9.474389094274152e-08,0.03977287309498978,0.040912494134947394,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
195,0.5,10,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there an independent association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Although hsCRP and carotid IMT were strongly linked to conventional cardiovascular risk factors, hsCRP was not independently associated with carotid IMT in healthy Korean adults.",9.474389094274152e-08,0.0753188823544737,0.01565581854043395,0.0072537058591274906,0.06707644995888984,0.023795359904818555,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
196,0.5,1,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux used in perioperative bridging? Yes, fondaparinux plays a role in perioperative bridging and is frequently chosen as an alternative to heparin for high-risk patients.",2.605457000925383e-07,0.227554004543832,0.095345198866921,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.5,2,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a role in perioperative bridging? Indeed, fondaparinux is utilized in perioperative bridging, commonly as a substitute for heparin in patients at high risk.",2.605457000925383e-07,0.227554004543832,0.095345198866921,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.5,3,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux applicable in perioperative bridging? Yes, fondaparinux is often employed in perioperative bridging, serving as an alternative to heparin for patients with elevated risk.",2.842316728282236e-07,0.2706864896659522,0.09368785272115329,0.021761117577382555,0.26142020428941937,0.11238293444328822,0.021729618491434483,0.3129979805707981,0.08740894901144641,2.8423167282822487e-07,0.36796728367518616,0.06035379812695108
196,0.5,4,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Can fondaparinux be used for perioperative bridging? Yes, fondaparinux has a role in perioperative bridging and is often preferred over heparin for patients who are at high risk.",2.131737546211677e-07,0.09514118896290746,0.13527575442247655,0.016320838183036916,0.13881788219708646,0.11238293444328822,0.016297213868575862,0.1851646090609136,0.08740894901144641,2.1317375462116866e-07,0.23443589105066254,0.06035379812695108
196,0.5,5,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is there a use for fondaparinux in perioperative bridging? Fondaparinux is indeed used in perioperative bridging, frequently replacing heparin in high-risk patients.",3.552895910352795e-07,0.4124696344400003,0.08777575442247654,0.027201396971728194,0.40118214666457863,0.11238293444328822,0.027162023114293103,0.45960145476267344,0.08740894901144641,3.5528959103528093e-07,0.5221179635024429,0.06035379812695108
196,0.5,6,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux serve a function in perioperative bridging? Yes, fondaparinux is commonly used for perioperative bridging, particularly as an alternative to heparin in patients with significant risk.",2.36859727356853e-07,0.13288151694575445,0.13527575442247655,0.018134264647818796,0.17803859535036892,0.11238293444328822,0.018108015409528735,0.2259866035811684,0.08740894901144641,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.5,7,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux involved in perioperative bridging? Yes, it is used in perioperative bridging and often selected instead of heparin for patients at increased risk.",3.079176455639089e-07,0.3157575069128655,0.09188732467041041,0.023574544042164434,0.3058719668602534,0.11238293444328822,0.023540420032387356,0.359517996205692,0.08740894901144641,3.0791764556391023e-07,0.41675744784461743,0.06035379812695108
196,0.5,8,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux indicated for perioperative bridging? Yes, fondaparinux plays a role in perioperative bridging, often as a heparin alternative for high-risk patients.",3.552895910352795e-07,0.34645561724381535,0.13527575442247655,0.027201396971728194,0.40118214666457863,0.11238293444328822,0.027162023114293103,0.45960145476267344,0.08740894901144641,3.5528959103528093e-07,0.5221179635024429,0.06035379812695108
196,0.5,9,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux recommended for perioperative bridging? Yes, fondaparinux is utilized in perioperative bridging and is commonly an alternative to heparin for patients at high risk.",2.842316728282236e-07,0.21292422461929172,0.13527575442247655,0.021761117577382555,0.26142020428941937,0.11238293444328822,0.021729618491434483,0.3129979805707981,0.08740894901144641,2.8423167282822487e-07,0.36796728367518616,0.06035379812695108
196,0.5,10,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux part of perioperative bridging strategies? Yes, fondaparinux is frequently employed in perioperative bridging as an alternative to heparin for patients with elevated risk.",2.842316728282236e-07,0.2706864896659522,0.09368785272115329,0.021761117577382555,0.26142020428941937,0.11238293444328822,0.021729618491434483,0.3129979805707981,0.08740894901144641,2.8423167282822487e-07,0.36796728367518616,0.06035379812695108
197,0.5,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors crucial in primary systemic vasculitis? Yes, they significantly influence the condition. Contact with specific infections, drugs, or harmful substances can provoke an abnormal immune reaction.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.5,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors matter in primary systemic vasculitis? Indeed, they have a major impact. Exposure to particular infections, medications, or toxic materials may trigger an unusual immune response.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.5,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the role of environmental factors important in primary systemic vasculitis? Yes, they are key contributors. Being exposed to certain infections, medicines, or hazardous agents can cause an abnormal immune response.",9.47438909427412e-08,0.00284305226695869,0.08740894901144641,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.5,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental influences significant in primary systemic vasculitis? Yes, they play an important role. Contact with specific infections, drugs, or dangerous substances can initiate an abnormal immune reaction.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.5,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors have importance in primary systemic vasculitis? Yes, they are influential. Exposure to some infections, medications, or harmful materials can lead to an abnormal immune response.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.5,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is there a significant role of environmental factors in primary systemic vasculitis? Yes, these factors are important. Exposure to certain infections, drugs, or hazardous materials can induce an abnormal immune response.",9.47438909427412e-08,0.00284305226695869,0.08740894901144641,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.5,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors relevant in primary systemic vasculitis? Yes, they play a significant role. Contact with specific infections, medicines, or toxic substances can trigger an abnormal immune reaction.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.5,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental elements affect primary systemic vasculitis? Yes, they are significant. Exposure to certain infections, medications, or harmful agents can provoke an abnormal immune response.",2.36859727356853e-07,0.2259866035811684,0.08740894901144641,0.018134264647818796,0.3190044255033948,0.0302734375,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
197,0.5,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the impact of environmental factors notable in primary systemic vasculitis? Yes, it is considerable. Exposure to particular infections, drugs, or hazardous materials can cause an abnormal immune reaction.",1.421158364141118e-07,0.07183592375390946,0.08740894901144641,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
197,0.5,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors essential in primary systemic vasculitis? Yes, they are critical. Exposure to specific infections, medications, or dangerous materials can trigger an abnormal immune response.",2.131737546211677e-07,0.1851646090609136,0.08740894901144641,0.016320838183036916,0.2764448110845992,0.0302734375,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
198,0.5,1,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Question: Is the quality of life impacted by menopausal transition? Answer: This long-term study observed no notable impact of menopausal transition on the quality of life in Taiwanese women. The decrease in role limitations due to emotional issues was associated with vasomotor symptoms.,2.3685972735685406e-08,0.007299359038638986,0.02235371466140696,0.0018134264647818726,0.04293150258620804,0.04865220249835634,0.0018108015409528666,0.009339551043704652,0.02498356344510192,2.3685972735685406e-08,0.025975486403257975,0.0
198,0.5,2,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Question: Does undergoing menopausal transition influence quality of life? Answer: According to this longitudinal research, menopausal transition did not significantly affect the quality of life among Taiwanese women. The reduction in role limitations caused by emotional problems was linked to vasomotor symptoms.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
198,0.5,3,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Question: Is there an effect of menopausal transition on quality of life? Answer: This study, conducted over time, showed no significant effect of menopausal transition on the quality of life in Taiwanese women. The decline in role limitations from emotional problems was connected to vasomotor symptoms.",9.474389094274162e-08,0.006681831451492926,0.06072279750164366,0.0072537058591274906,0.0007901097279687797,0.06781677572873293,0.007243206163811466,0.03315966206996945,0.046400951814396206,9.474389094274162e-08,0.06707644995888984,0.023795359904818555
198,0.5,4,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Question: How does menopausal transition affect quality of life? Answer: The longitudinal study found no meaningful impact of menopausal transition on Taiwanese women's quality of life. The observed decrease in role limitations due to emotional problems was related to vasomotor symptoms.,2.3685972735685406e-08,0.02638321546978606,0.0012092933465189942,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.5,5,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Question: Does the menopausal transition alter quality of life? Answer: This longitudinal study revealed no significant alteration in quality of life due to menopausal transition among Taiwanese women. The drop in role limitations related to emotional problems was associated with vasomotor symptoms.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
198,0.5,6,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Question: Is quality of life affected by menopausal transition? Answer: Findings from this longitudinal study indicated no significant effect of menopausal transition on the quality of life of Taiwanese women. The decline in role limitations from emotional issues was linked to vasomotor symptoms.,2.3685972735685406e-08,0.025707649559455703,0.0011522024983563264,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
198,0.5,7,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Question: Does menopausal transition have an impact on quality of life? Answer: This long-term study found no significant impact of menopausal transition on Taiwanese women's quality of life. The reduction in role limitations due to emotional problems was related to vasomotor symptoms.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
198,0.5,8,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Question: What is the effect of menopausal transition on quality of life? Answer: The longitudinal research showed no significant effect of menopausal transition on quality of life among Taiwanese women. The decrease in role limitations caused by emotional problems was associated with vasomotor symptoms.,4.737194547137081e-08,0.07818425831601106,0.08721339282669846,0.0036268529295637453,0.11624487882103196,0.11687363038714388,0.003621603081905733,0.08523780977849604,0.09642074506939374,4.737194547137081e-08,0.05267878269644122,0.07450693937180423
198,0.5,9,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Question: Does the transition through menopause influence quality of life? Answer: This longitudinal study found no significant influence of menopausal transition on the quality of life of Taiwanese women. The decline in role limitations due to emotional problems was linked to vasomotor symptoms.,2.3685972735685406e-08,0.05871465815754817,0.024856842593537785,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
198,0.5,10,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Question: Does menopausal transition change the quality of life? Answer: According to this longitudinal study, menopausal transition did not significantly change the quality of life in Taiwanese women. The decrease in role limitations from emotional problems was connected to vasomotor symptoms.",2.3685972735685406e-08,0.09569793352578015,0.05011322960040913,0.0018134264647818726,0.09640982650326002,0.05113221329437545,0.0018108015409528666,0.06245691695904432,0.026296566837107373,2.3685972735685406e-08,0.026668247082160867,0.0
199,0.5,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Yes, grandmultiparity is recognized as an independent risk factor for negative perinatal outcomes, potentially causing complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean rates.",1.421158364141119e-07,0.11378530095599926,0.029657881883242435,0.010880558788691243,0.11155222504483708,0.03504003058039032,0.010864809245717214,0.10888788769310054,0.04087069166896732,1.4211583641411244e-07,0.10572766404429723,0.0471498651489732
199,0.5,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Indeed, grandmultiparity is an independent risk factor for adverse perinatal outcomes, associated with complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and elevated cesarean section rates.",1.421158364141119e-07,0.005039929997133985,0.11349410352376249,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
199,0.5,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Yes, it is considered an independent risk factor, which may result in complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean delivery rates.",1.894877818854825e-07,0.01419215970808807,0.14204081632653065,0.014507411718255002,0.04985675617422425,0.12244897959183673,0.01448641232762296,0.08739040460656167,0.1012244897959184,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
199,0.5,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Can grandmultiparity be identified as an independent risk factor for adverse perinatal outcomes? Yes, grandmultiparity independently raises the risk of adverse perinatal outcomes and is linked to complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean sections.",9.474389094274131e-08,0.06275077630425496,0.11503464348702448,0.0072537058591274906,0.06792627948215957,0.12244897959183673,0.007243206163811466,0.03397045239770513,0.1012244897959184,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
199,0.5,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent contributor to adverse perinatal outcomes? Yes, it is viewed as an independent risk factor that can cause complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and a greater incidence of cesarean births.",1.421158364141119e-07,0.005039929997133985,0.11349410352376249,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
199,0.5,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently contribute to adverse perinatal outcomes? Yes, it is an independent risk factor associated with complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean rates.",3.316036182995943e-07,0.21486285517023873,0.14204081632653065,0.02538797050694628,0.2574961209524682,0.12244897959183673,0.025351221573340202,0.30250178422350826,0.1012244897959184,3.316036182995957e-07,0.3500880377110809,0.0783673469387755
199,0.5,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Yes, grandmultiparity is independently linked to adverse perinatal outcomes and can lead to complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean deliveries.",1.894877818854825e-07,0.01419215970808807,0.14204081632653065,0.014507411718255002,0.04985675617422425,0.12244897959183673,0.01448641232762296,0.08739040460656167,0.1012244897959184,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
199,0.5,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity independently associated with adverse perinatal outcomes? Yes, it is considered an independent risk factor that may result in complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and elevated cesarean section rates.",2.131737546211678e-07,0.04496381837484176,0.14204081632653065,0.01632083818303688,0.08160545448880407,0.12244897959183673,0.016297213868575834,0.12018022742955337,0.1012244897959184,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
199,0.5,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor affecting perinatal outcomes adversely? Yes, grandmultiparity is recognized as an independent risk factor for adverse perinatal outcomes, potentially causing complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean section rates.",1.1842986367842661e-07,0.04270531281178247,0.05939618822735711,0.009067132323909363,0.03946141811995929,0.06551601356796163,0.00905400770476434,0.035790448037896105,0.07183973313843446,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
199,0.5,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent factor increasing the risk of adverse perinatal outcomes? Yes, it is regarded as an independent risk factor that can lead to complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean delivery rates.",1.1842986367842661e-07,0.034311040583767216,0.11428571428571432,0.009067132323909363,0.03975540251546272,0.12244897959183673,0.00905400770476434,0.004982915524453624,0.1012244897959184,1.1842986367842703e-07,0.03163430659254596,0.0783673469387755
200,0.5,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the estimation of basal metabolic rate accurate for Chinese individuals using current prediction equations? Answer: Currently, the Singapore equation is the most precise BMR prediction model for Chinese people and is valid across a wide BMI spectrum, including overweight and obese groups.",4.737194547137081e-08,0.10994118157070565,0.0464009518143962,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
200,0.5,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are existing equations suitable for estimating basal metabolic rate in Chinese populations? Answer: The newly formulated Singapore equation stands as the most accurate BMR prediction tool for Chinese individuals and applies to a broad BMI range, covering overweight and obese categories.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.5,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Can current prediction formulas accurately estimate basal metabolic rate in Chinese? Answer: The Singapore equation, recently developed, is the most reliable BMR prediction equation for Chinese and works well across a large BMI range, including those who are overweight or obese.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.5,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How effective are current basal metabolic rate prediction equations for Chinese people? Answer: To date, the Singapore equation is the most accurate for predicting BMR in Chinese populations and is suitable for a wide BMI range, including overweight and obese individuals.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.5,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are the present BMR prediction equations valid for Chinese individuals? Answer: The newly created Singapore equation is the most precise BMR prediction method for Chinese and applicable to a broad range of BMI values, including overweight and obese persons.",1.4211583641411233e-07,0.2141928621596434,0.05113221329437545,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
200,0.5,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the basal metabolic rate estimation in Chinese reliable with current equations? Answer: The Singapore equation, developed recently, is the most accurate BMR prediction model for Chinese and is effective across a wide BMI range, including overweight and obese groups.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.5,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Do current prediction equations accurately estimate basal metabolic rate in Chinese? Answer: The Singapore equation is currently the most accurate for BMR prediction in Chinese populations and can be used for a large BMI range, encompassing overweight and obese individuals.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.5,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are the existing equations for basal metabolic rate estimation applicable to Chinese? Answer: The newly developed Singapore equation is the most accurate BMR prediction equation for Chinese and is valid for a broad BMI range, including overweight and obese people.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.5,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How applicable are current basal metabolic rate prediction equations to Chinese individuals? Answer: So far, the Singapore equation is the most accurate BMR prediction tool for Chinese and is suitable for use across a wide BMI spectrum, including overweight and obese individuals.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
200,0.5,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the estimation of basal metabolic rate in Chinese populations accurate using current equations? Answer: The Singapore equation, recently developed, is the most precise BMR prediction equation for Chinese and applies to a large BMI range, including those who are overweight or obese.",4.737194547137081e-08,0.07770177782373144,0.023242630385487524,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
201,0.5,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-induced cholangitis? A routinely placed ENBD tube did not enhance the clinical outcome, although it caused longer procedure times and more discomfort, making its insertion unnecessary.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
201,0.5,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted after endoscopic removal of common bile duct stones in patients with cholangitis caused by choledocholithiasis? Routine insertion of an ENBD tube did not improve patient outcomes and only resulted in longer procedures and added discomfort, thus it is not needed.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
201,0.5,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine insertion of a nasobiliary drainage tube required after endoscopic clearance of the common bile duct in cases of choledocholithiasis-induced cholangitis? Routine ENBD tube placement did not benefit the clinical course but increased procedure duration and discomfort, so it is unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.5,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Must a nasobiliary drainage tube be routinely placed after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? The routine use of an ENBD tube did not improve clinical outcomes, caused longer procedures, and increased patient discomfort, indicating it is not necessary.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
201,0.5,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-associated cholangitis? Routine ENBD tube insertion did not improve clinical progress and led to longer procedures and more discomfort, so it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.5,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Does routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct benefit patients with choledocholithiasis-induced cholangitis? Inserting an ENBD tube routinely did not improve the clinical course and resulted in longer procedure times and discomfort, making it unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.5,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it required to place a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? Routine placement of an ENBD tube did not improve clinical outcomes and increased procedure time and discomfort, thus unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.5,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not improve patient recovery and caused longer procedures and more discomfort, so it is unnecessary.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
201,0.5,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion necessary after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine insertion of an ENBD tube did not improve clinical outcomes but increased procedure duration and discomfort, hence it is not required.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.5,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is inserting a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct necessary in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not improve the clinical course and resulted in longer procedures and increased discomfort, making it unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
202,0.5,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are Pap smears showing glandular cell abnormalities identified through rapid prescreening? Pap smears with glandular cell abnormalities are frequently marked as abnormal by RPS, yielding a sensitivity of 36.4% at the AGC threshold. Notably, certain AGC cases are detected via this method.",1.4211583641411244e-07,0.12002920895190616,0.01165524825128203,0.010880558788691236,0.08400879959098839,0.03991638247160983,0.0108648092457172,0.08148776092423571,0.04434829637641968,1.4211583641411244e-07,0.11509678416642277,0.02271498107084911
202,0.5,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Do rapid prescreening methods detect Pap smears with glandular cell abnormalities? Yes, Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, with a sensitivity rate of 36.4% at the AGC threshold. Importantly, some AGC cases are identified.",1.6580180914979784e-07,0.181915084889396,0.014395502407040212,0.012693985253473108,0.18130727632573596,0.011488942972177146,0.012675610786670066,0.1804261084390668,0.008120839426049457,1.6580180914979784e-07,0.17923244641398606,0.004291191768657054
202,0.5,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Can rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are commonly detected as abnormal by RPS, showing a sensitivity of 36.4% at the AGC cutoff. Significantly, some AGC cases are detected through this process.",1.6580180914979784e-07,0.11260036683340191,0.03450843384684992,0.012693985253473108,0.11021525780676766,0.039276677218650795,0.012675610786670066,0.10746324732749368,0.04434829637641968,1.6580180914979784e-07,0.14176503124858364,0.02271498107084911
202,0.5,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Is rapid prescreening effective in identifying Pap smears with glandular cell abnormalities? RPS often flags these smears as abnormal, resulting in a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are detected this way.",2.6054570009253904e-07,0.1486461644352337,0.08436992969172526,0.0199476911126006,0.18288283318751475,0.06489994591671175,0.01991881695048154,0.21868888243771822,0.04434829637641968,2.6054570009253947e-07,0.2561753824263291,0.02271498107084911
202,0.5,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Pap smears with glandular cell abnormalities are frequently flagged as abnormal by RPS, achieving a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are detected.",2.1317375462116844e-07,0.20402323483231788,0.0060025827529497505,0.016320838183036854,0.164780397198105,0.03789377307720558,0.0162972138685758,0.16153046859776987,0.04434829637641968,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
202,0.5,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Does rapid prescreening detect Pap smears with glandular cell abnormalities? Yes, Pap smears with these abnormalities are often marked abnormal by RPS, with a sensitivity of 36.4% at the AGC threshold. Most importantly, some AGC cases are identified.",2.3685972735685374e-07,0.1961820205779241,0.03049237867131708,0.018134264647818726,0.19322013291859275,0.03714484387589542,0.018108015409528666,0.18970134556446672,0.04434829637641968,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
202,0.5,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are Pap smears with glandular cell abnormalities detected through rapid prescreening? These smears are often flagged as abnormal by RPS, resulting in a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected.",2.8423167282822434e-07,0.17681704140193055,0.08436992969172526,0.02176111757738248,0.21187037006076626,0.06489994591671175,0.021729618491434413,0.2485418455874,0.04434829637641968,2.8423167282822487e-07,0.2869470410930828,0.02271498107084911
202,0.5,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Can Pap smears with glandular cell abnormalities be detected by rapid prescreening? Pap smears with these abnormalities are often flagged as abnormal by RPS, with a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are found.",2.1317375462116844e-07,0.16754180427653065,0.03190079388925612,0.016320838183036854,0.164780397198105,0.03789377307720558,0.0162972138685758,0.16153046859776987,0.04434829637641968,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
202,0.5,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Is rapid prescreening able to detect glandular cell abnormalities in Pap smears? Yes, RPS frequently flags these smears as abnormal, resulting in a sensitivity of 36.4% at the AGC threshold. Importantly, some cases of AGC are detected.",2.6054570009253904e-07,0.1486461644352337,0.08436992969172526,0.0199476911126006,0.18288283318751475,0.06489994591671175,0.01991881695048154,0.21868888243771822,0.04434829637641968,2.6054570009253947e-07,0.2561753824263291,0.02271498107084911
202,0.5,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are glandular cell abnormalities in Pap smears identified by rapid prescreening? Pap smears with these abnormalities are often marked abnormal by RPS, achieving a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are detected.",2.6054570009253904e-07,0.18715434113300855,0.05661482765090893,0.0199476911126006,0.18288283318751475,0.06489994591671175,0.01991881695048154,0.21868888243771822,0.04434829637641968,2.6054570009253947e-07,0.2561753824263291,0.02271498107084911
203,0.5,1,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does treating migraines early reduce the time to peak headache intensity and lessen its severity? Yes, early migraine treatment can shorten the time to headache peak and decrease its severity since early intervention helps medication control symptoms before they worsen.",3.316036182995956e-07,0.19472680428410039,0.07788479993813871,0.025387970506946217,0.21684145468776173,0.06876907372423262,0.025351221573340132,0.2393609929554006,0.05859375,3.316036182995957e-07,0.2730522925272396,0.039930555555555566
203,0.5,2,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment speed up the time to headache peak and diminish its severity? Indeed, early treatment can both shorten the time to peak headache and reduce severity by enabling medications to act before symptoms escalate.",4.026615365066515e-07,0.28069384683421594,0.07365369143320619,0.030828249901291835,0.30220653268665965,0.06651892775857184,0.03078362619619874,0.32391838098346426,0.05859375,4.026615365066519e-07,0.36006366951686974,0.039930555555555566
203,0.5,3,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is the time to headache peak shortened and severity reduced by early migraine treatment? Yes, treating migraines early can shorten the time to headache peak and lower severity because early medication use controls symptoms more effectively.",4.263475092423368e-07,0.3902820116762076,0.016634078789225945,0.032641676366073714,0.4139057499292482,0.007656691549893582,0.03259442773715161,0.4377891842010184,0.0017600481269510818,4.263475092423373e-07,0.434157026968621,0.008713073765753261
203,0.5,4,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does initiating migraine treatment early lead to a shorter time to headache peak and less severe symptoms? Yes, early treatment can reduce both the time to headache peak and its severity by allowing medication to work before symptoms intensify.",3.552895910352809e-07,0.2955359943915372,0.025210784858811744,0.02720139697172809,0.31943051671034484,0.014615813571720648,0.027162023114293,0.3437763205390656,0.003230428200692026,3.552895910352811e-07,0.3408315798116477,0.011383842752787407
203,0.5,5,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early intervention in migraine treatment decrease the time to headache peak and reduce how severe it gets? Yes, early treatment shortens the time to headache peak and reduces severity as the medication acts before symptoms become severe.",3.789755637709662e-07,0.36361559507756436,0.0028189242674858395,0.029014823436509962,0.38845995219335094,0.014309359438660005,0.028972824655245866,0.413756075063346,0.0263671875,3.789755637709665e-07,0.41175743349188787,0.018663194444444434
203,0.5,6,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does early migraine treatment help in reducing the time to headache peak and the severity of the headache? Yes, because early intervention allows medications to control symptoms more effectively, leading to shorter peak times and milder headaches.",4.026615365066515e-07,0.20367749343866626,0.12901701323251416,0.030828249901291835,0.2625981223689484,0.09506564056134,0.03078362619619874,0.32391838098346426,0.05859375,4.026615365066519e-07,0.36006366951686974,0.039930555555555566
203,0.5,7,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is early treatment of migraines effective in shortening the time to headache peak and lowering its severity? Yes, early migraine treatment can achieve both by enabling the medicine to manage symptoms before they become severe.",4.500334819780221e-07,0.2608359072786146,0.12901701323251416,0.034455102830855594,0.3214386223918817,0.09506564056134,0.034405229278104486,0.3845430027998997,0.05859375,4.500334819780227e-07,0.42258402649820326,0.039930555555555566
203,0.5,8,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does starting migraine treatment early shorten the time to headache peak and lessen headache severity? Yes, early treatment helps by allowing medications to act sooner, thus reducing peak time and symptom severity.",5.21091400185078e-07,0.3532092274096299,0.12901701323251416,0.03989538222520123,0.4167488021962069,0.09506564056134,0.03983763390096311,0.482983075613153,0.05859375,5.210914001850789e-07,0.5243667208081457,0.039930555555555566
203,0.5,9,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment shorten the headache peak time and decrease its severity? Yes, because early intervention permits medication to work more efficiently in controlling symptoms before they worsen.",5.921493183921339e-07,0.45499192171957237,0.12901701323251416,0.04533566161954687,0.5221093178540324,0.09506564056134,0.04527003852382173,0.5921823675781437,0.05859375,5.921493183921352e-07,0.6376954061151499,0.039930555555555566
203,0.5,10,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does early treatment of migraines reduce the time to headache peak and the severity of the headache? Yes, early intervention helps medication control symptoms earlier, resulting in a shorter time to peak and less severe headaches.",4.263475092423368e-07,0.3110651910407851,0.07208404720863906,0.032641676366073714,0.2915856592421999,0.09506564056134,0.03259442773715161,0.35377134413314604,0.05859375,4.263475092423373e-07,0.39083532818362343,0.039930555555555566
204,0.5,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does using cup-cage reconstruction with oversized cups ensure initial stability in THA for osteoporotic acetabular fractures? Yes, this technique offers initial stability in Total Hip Arthroplasty for such fractures by minimizing implant migration and encouraging bone ingrowth for durable fixation.",3.316036182995956e-07,0.1424138095248595,0.11157439827587246,0.025387970506946217,0.19018194774314834,0.08712498325741062,0.025351221573340132,0.2393609929554006,0.05859375,3.316036182995957e-07,0.30077817974963716,0.019991670137442734
204,0.5,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Indeed, this approach provides initial stability by reducing implant migration risk and supporting bone ingrowth for long-lasting fixation.",4.737194547137074e-07,0.28038479570299124,0.1324331740702479,0.036268529295637474,0.325550774114022,0.113421550094518,0.03621603081905736,0.41629170111447955,0.05859375,4.737194547137081e-07,0.4830997365435925,0.019991670137442734
204,0.5,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can cup-cage reconstruction with oversized cups provide initial stability in Total Hip Arthroplasty for osteoporotic acetabular fractures? Yes, it helps ensure stability initially by preventing implant migration and fostering bone ingrowth for sustained fixation.",4.737194547137074e-07,0.2383758756690555,0.1627066115702479,0.036268529295637474,0.325550774114022,0.113421550094518,0.03621603081905736,0.41629170111447955,0.05859375,4.737194547137081e-07,0.4830997365435925,0.019991670137442734
204,0.5,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does the use of oversized cups in cup-cage reconstruction offer initial stability in THA for osteoporotic acetabular fractures? Yes, it delivers initial stability by lowering implant migration risk and promoting bone ingrowth for long-term fixation.",4.500334819780221e-07,0.24929627608172344,0.13332185491276397,0.034455102830855594,0.2947791154472683,0.113421550094518,0.034405229278104486,0.3845430027998997,0.05859375,4.500334819780227e-07,0.4503099137206008,0.019991670137442734
204,0.5,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability in THA for osteoporotic acetabular fractures achievable with cup-cage reconstruction using oversized cups? Yes, this method provides initial stability by aiding in implant fixation and encouraging bone ingrowth for lasting results.",4.737194547137074e-07,0.28038479570299124,0.1324331740702479,0.036268529295637474,0.325550774114022,0.113421550094518,0.03621603081905736,0.41629170111447955,0.05859375,4.737194547137081e-07,0.4830997365435925,0.019991670137442734
204,0.5,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction involving oversized cups provide initial stability in Total Hip Arthroplasty for osteoporotic acetabular fractures? Yes, it ensures initial stability by mitigating implant migration and facilitating bone ingrowth for permanent fixation.",4.974054274493927e-07,0.31246923312080677,0.1314891297804456,0.03808195576041935,0.3572994724286018,0.113421550094518,0.03802683236001023,0.44908152393747125,0.05859375,4.974054274493935e-07,0.5170012882192743,0.019991670137442734
204,0.5,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can initial stability be provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? Yes, this technique supports initial stability by reducing implant migration and enhancing bone ingrowth for durable fixation.",4.737194547137074e-07,0.28038479570299124,0.1324331740702479,0.036268529295637474,0.325550774114022,0.113421550094518,0.03621603081905736,0.41629170111447955,0.05859375,4.737194547137081e-07,0.4830997365435925,0.019991670137442734
204,0.5,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability in osteoporotic acetabular fracture THA achieved using cup-cage reconstruction with oversized cups? Yes, it offers initial stability by preventing implant migration and promoting bone ingrowth for long-term fixation.",5.447773729207633e-07,0.37989586751071025,0.129412913591651,0.04170880868998311,0.4239908469272753,0.113421550094518,0.04164843544191598,0.518074395424422,0.05859375,5.447773729207643e-07,0.588460252201418,0.019991670137442734
204,0.5,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction with oversized cups help achieve initial stability in THA for osteoporotic acetabular fractures? Yes, it provides initial stability by lowering the risk of implant migration and aiding bone ingrowth for sustained fixation.",4.500334819780221e-07,0.24929627608172344,0.13332185491276397,0.034455102830855594,0.2947791154472683,0.113421550094518,0.034405229278104486,0.3845430027998997,0.05859375,4.500334819780227e-07,0.4503099137206008,0.019991670137442734
204,0.5,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is it true that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures? Yes, this approach delivers initial stability by reducing implant migration risk and supporting bone ingrowth for long-term fixation.",4.263475092423368e-07,0.21914378596383344,0.13415989876747975,0.032641676366073714,0.26492615229758654,0.113421550094518,0.03259442773715161,0.35377134413314604,0.05859375,4.263475092423373e-07,0.418561215406021,0.019991670137442734
205,0.5,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging required to diagnose appendicitis in children? Yes, imaging is frequently essential for diagnosing appendicitis in children, which may involve an ultrasound or CT scan to detect appendix inflammation.",3.7897556377096533e-07,0.3947502895409074,0.031887755102040796,0.02901482343651001,0.3889717436921529,0.045351473922902494,0.02897282465524592,0.4331238459422586,0.023242630385487524,3.789755637709665e-07,0.4795730802618854,0.0
205,0.5,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do children need imaging to confirm appendicitis? Indeed, imaging such as ultrasound or CT scans is often needed to diagnose appendicitis in children by identifying inflammation of the appendix.",4.0266153650665063e-07,0.3820383555204563,0.06632653061224489,0.03082824990129189,0.4253393878630276,0.045351473922902494,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
205,0.5,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is diagnostic imaging necessary for appendicitis in pediatric patients? Yes, children often require imaging tests like ultrasound or CT scans to confirm appendix inflammation indicative of appendicitis.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
205,0.5,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Should imaging be used to diagnose appendicitis in kids? Imaging, including ultrasound or CT, is commonly necessary to determine if a child's appendix is inflamed, confirming appendicitis.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
205,0.5,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is it necessary to perform imaging to diagnose appendicitis in children? Yes, imaging methods such as ultrasound or CT scans are typically required to detect inflammation of the appendix in children.",3.5528959103528003e-07,0.3130454840335055,0.06632653061224489,0.02720139697172813,0.3538804238808839,0.045351473922902494,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
205,0.5,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do we rely on imaging to diagnose appendicitis in children? Yes, imaging techniques like ultrasound or CT scans are often used to identify appendix inflammation, which signals appendicitis in children.",3.7897556377096533e-07,0.3947502895409074,0.031887755102040796,0.02901482343651001,0.3889717436921529,0.045351473922902494,0.02897282465524592,0.4331238459422586,0.023242630385487524,3.789755637709665e-07,0.4795730802618854,0.0
205,0.5,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging part of the diagnostic process for appendicitis in children? Yes, to diagnose appendicitis in children, imaging tests such as ultrasound or CT scans are commonly utilized to check for appendix inflammation.",3.0791764556390943e-07,0.2918286616809316,0.03510904882244258,0.023574544042164372,0.28718904938221046,0.045351473922902494,0.0235404200323873,0.32776333028443316,0.023242630385487524,3.079176455639103e-07,0.3703737882968947,0.0
205,0.5,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Are imaging studies needed to diagnose appendicitis in children? Yes, diagnosing appendicitis in children often involves imaging like ultrasound or CT scans to observe appendix inflammation.",4.7371945471370653e-07,0.5508188152722555,0.02639597505668933,0.03626852929563753,0.5431224235194119,0.045351473922902494,0.036216030819057415,0.5934664960174385,0.023242630385487524,4.737194547137081e-07,0.6466271649250523,0.0
205,0.5,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is it common to use imaging for diagnosing appendicitis in children? Yes, imaging exams including ultrasound or CT scans are frequently necessary to detect inflamed appendix in children.",4.2634750924233593e-07,0.41840599969133097,0.06632653061224489,0.03264167636607377,0.4630797158458746,0.045351473922902494,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
205,0.5,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Does diagnosing appendicitis in children require imaging? Yes, imaging methods such as ultrasound or CT scans are typically essential to identify inflammation of the appendix in children.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
206,0.5,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Yes, cognitive function indeed predicts frequency compressed speech recognition in individuals with normal hearing and cognition. Working memory and other cognitive skills are crucial for effectively understanding frequency-compressed speech.",2.3685972735685406e-07,0.14878251926743147,0.031242126480221732,0.018134264647818726,0.10872384279722347,0.06420892329311802,0.018108015409528666,0.07265956359081915,0.09448894492785163,2.3685972735685406e-07,0.03460768460910879,0.12705820713899402
206,0.5,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is there a predictive relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? Yes, cognitive abilities, especially working memory, significantly influence the recognition of frequency-compressed speech in such listeners.",4.500334819780222e-07,0.12557057149266315,0.20408163265306123,0.03445510283085559,0.18236641513975327,0.17847485127095727,0.03440522927810448,0.21480059461342815,0.16549486208761494,4.500334819780227e-07,0.24863179092540033,0.15143320713899402
206,0.5,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Can cognitive function forecast how well listeners with normal hearing and cognition recognize frequency compressed speech? Yes, cognitive function, notably working memory, is a key predictor of successful frequency compressed speech recognition in these individuals.",4.737194547137075e-07,0.1953314719282644,0.1746968759955773,0.03626852929563747,0.21221937828943505,0.17847485127095727,0.03621603081905735,0.24557225328018184,0.16549486208761494,4.737194547137081e-07,0.28038048923998016,0.15143320713899402
206,0.5,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function serve as a predictor for frequency compressed speech recognition among listeners with normal hearing and normal cognition? Yes, cognitive function, particularly working memory, plays an important role in recognizing frequency compressed speech.",4.737194547137075e-07,0.1953314719282644,0.1746968759955773,0.03626852929563747,0.21221937828943505,0.17847485127095727,0.03621603081905735,0.24557225328018184,0.16549486208761494,4.737194547137081e-07,0.28038048923998016,0.15143320713899402
206,0.5,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is frequency compressed speech recognition in listeners with normal hearing and cognition predicted by cognitive function? Yes, cognitive abilities, especially working memory, are significant predictors for understanding frequency compressed speech.",5.92149318392134e-07,0.36142605682732354,0.16964285714285715,0.045335661619546865,0.376522429580711,0.17847485127095727,0.04527003852382172,0.4154712900755788,0.16549486208761494,5.921493183921352e-07,0.4562711557036443,0.15143320713899402
206,0.5,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive ability predict the recognition of frequency compressed speech in individuals with normal hearing and cognition? Yes, cognitive function, with a focus on working memory, is predictive of successful frequency compressed speech recognition.",4.974054274493928e-07,0.2684289115834688,0.14372783452611015,0.038081955760419346,0.2863127357411863,0.14725736948115498,0.038026832360010226,0.27732095159476167,0.16549486208761494,4.974054274493935e-07,0.31317031206297186,0.15143320713899402
206,0.5,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is the recognition of frequency compressed speech in listeners with normal hearing and normal cognition influenced by cognitive function? Yes, cognitive function, particularly working memory, contributes significantly to this ability.",5.92149318392134e-07,0.3136228029956034,0.20408163265306123,0.045335661619546865,0.376522429580711,0.17847485127095727,0.04527003852382172,0.4154712900755788,0.16549486208761494,5.921493183921352e-07,0.4562711557036443,0.15143320713899402
206,0.5,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Can cognitive function predict how well frequency compressed speech is recognized by listeners who have normal hearing and cognition? Yes, cognitive abilities, especially working memory, are important predictors of this recognition.",5.684633456564487e-07,0.27972125131992165,0.20408163265306123,0.043522235154764985,0.341431109769442,0.17847485127095727,0.04345923698286885,0.37910364590470413,0.16549486208761494,5.684633456564497e-07,0.4185308277207973,0.15143320713899402
206,0.5,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function predict frequency compressed speech recognition performance in listeners with normal hearing and normal cognitive abilities? Yes, cognitive function, including working memory, is a significant factor in successful recognition.",5.684633456564487e-07,0.27972125131992165,0.20408163265306123,0.043522235154764985,0.341431109769442,0.17847485127095727,0.04345923698286885,0.37910364590470413,0.16549486208761494,5.684633456564497e-07,0.4185308277207973,0.15143320713899402
206,0.5,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Is the ability to recognize frequency compressed speech in listeners with normal hearing and cognition predicted by cognitive function? Yes, cognitive function, particularly working memory, plays a key role in this recognition.",5.447773729207634e-07,0.24693142849692995,0.20408163265306123,0.041708808689983105,0.30752955809376026,0.17847485127095727,0.041648435441915974,0.34401232609343513,0.16549486208761494,5.447773729207643e-07,0.3821631835499226,0.15143320713899402
207,0.5,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest correlation with bone turnover parameters in iliac cancellous bone. However, the iliac crest bone may not fully represent overall bone turnover.",4.737194547137081e-08,0.05158725722269075,0.005690704908203684,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.5,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover accurately reflect bone histomorphometry in 370 postmenopausal women? There was a significant but modest association between bone turnover markers and parameters measured in iliac cancellous bone, suggesting the iliac crest may not perfectly represent total bone turnover.",4.737194547137081e-08,0.026885049110747516,0.09280190362879238,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.5,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"In 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry? Bone turnover markers were significantly, though modestly, linked to bone turnover parameters in iliac cancellous bone, but the iliac crest might not fully capture whole bone turnover.",9.474389094274162e-08,0.10595138713869723,0.011963729892247338,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
207,0.5,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly associated, albeit modestly, with parameters in iliac cancellous bone, indicating the iliac crest may not represent the entire bone turnover.",1.1842986367842692e-07,0.08530793296385264,0.06546505023923549,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
207,0.5,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Is there a representative relationship between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Bone turnover markers correlated significantly but modestly with iliac cancellous bone parameters, and the iliac crest may not perfectly reflect total bone turnover.",9.474389094274162e-08,0.023555465488589,0.09161370008850903,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
207,0.5,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Can biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women? These markers were significantly but modestly associated with bone turnover parameters in iliac cancellous bone, though the iliac crest might not fully represent overall bone turnover.",1.4211583641411222e-07,0.07667283140392867,0.09030069669650356,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
207,0.5,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? There was a modest yet significant association between bone turnover markers and iliac cancellous bone parameters, but the iliac crest may not fully represent total bone turnover.",9.474389094274162e-08,0.023555465488589,0.09161370008850903,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
207,0.5,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant but modest link to bone turnover parameters in iliac cancellous bone, suggesting the iliac crest may not perfectly represent whole bone turnover.",7.105791820705622e-08,0.07840381648300676,0.008748996854200664,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
207,0.5,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"In 370 postmenopausal women, do biochemical markers of bone turnover represent bone histomorphometry? Bone turnover markers were significantly and modestly associated with parameters in iliac cancellous bone, but the iliac crest may not fully represent overall bone turnover.",1.6580180914979753e-07,0.10432706309570561,0.08959109069410477,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
207,0.5,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry findings in 370 postmenopausal women? Bone turnover markers had a significant yet modest association with iliac cancellous bone parameters, indicating the iliac crest may not perfectly reflect total bone turnover.",1.1842986367842692e-07,0.08530793296385264,0.06546505023923549,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
208,0.5,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Does profound hypotension in patients with coronary disease lead to myocardial ischemic events? In individuals with ischemic heart disease and low blood pressure, both symptomatic and silent ischemia appeared closely linked in time to hypotensive episodes, especially affecting diastolic pressures, implying that coronary patients might be vulnerable to ischemic events triggered by hypotension.",7.105791820705622e-08,0.054245544044304594,0.11149557862360629,0.005440279394345618,0.005814178242916412,0.036982248520710054,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
208,0.5,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can severe hypotensive episodes cause myocardial ischemia in patients with coronary disease? Among patients with ischemic heart disease experiencing hypotension, there was a temporal association between hypotension and both symptomatic and silent ischemia, particularly related to diastolic blood pressure, indicating a potential risk for ischemic events due to hypotension in these patients.",9.474389094274162e-08,0.007645215812302375,0.0918955786236063,0.0072537058591274906,0.025616805539096177,0.036982248520710054,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
208,0.5,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Is there a causal relationship between profound hypotension and myocardial ischemic events in coronary disease patients? Patients with ischemic heart disease and hypotension showed symptomatic and silent ischemia occurring in close temporal relation to hypotensive episodes, mainly involving diastolic pressures, suggesting susceptibility to ischemic events induced by hypotension.",1.8948778188548325e-07,0.07634619753174388,0.09022903798088419,0.014507411718254981,0.10899841447814707,0.036982248520710054,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
208,0.5,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Do significant hypotensive events provoke myocardial ischemia in those with coronary disease? In patients suffering from ischemic heart disease and hypotension, ischemic episodes—both symptomatic and silent—were temporally linked to hypotension, especially concerning diastolic pressure, indicating these patients may be prone to ischemia caused by hypotensive events.",2.3685972735685406e-07,0.09033568476680376,0.11149557862360629,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.5,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can profound hypotension trigger myocardial ischemic events in patients with coronary artery disease? In ischemic heart disease patients with hypotension, symptomatic and silent ischemia occurred in a time-related manner with hypotensive episodes, particularly affecting diastolic blood pressure, suggesting that coronary disease patients might be at risk of ischemic events due to hypotension.",9.474389094274162e-08,0.046719268937497116,0.05290182862360629,0.0072537058591274906,0.025616805539096177,0.036982248520710054,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
208,0.5,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Are myocardial ischemic events caused by severe hypotension in coronary disease patients? Symptomatic and silent ischemia in patients with ischemic heart disease and hypotension appeared temporally linked to hypotensive episodes, mainly involving diastolic pressures, suggesting that these patients may be vulnerable to ischemic events resulting from hypotension.",2.1317375462116866e-07,0.0984936119854174,0.08976718356187789,0.016320838183036854,0.13097732119692207,0.036982248520710054,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
208,0.5,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Does hypotension lead to myocardial ischemic events in coronary disease sufferers? In patients with ischemic heart disease experiencing hypotension, both symptomatic and silent ischemia were temporally associated with hypotensive events, particularly diastolic pressure drops, implying susceptibility to ischemic events from hypotension in this group.",2.8423167282822487e-07,0.1680374625905352,0.08825294823811877,0.02176111757738247,0.19997019268387373,0.036982248520710054,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
208,0.5,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Is there evidence that profound hypotension can cause myocardial ischemia in patients with coronary disease? Among those with ischemic heart disease and hypotension, ischemic episodes—symptomatic and silent—occurred in close temporal proximity to hypotension, especially diastolic pressure decreases, suggesting a risk of ischemic events due to hypotension.",2.3685972735685406e-07,0.09033568476680376,0.11149557862360629,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.5,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can myocardial ischemic events be induced by profound hypotensive episodes in coronary disease patients? Patients with ischemic heart disease and hypotension showed a temporal correlation between hypotension and ischemia, both symptomatic and silent, particularly linked to diastolic blood pressure, indicating vulnerability to ischemic events from hypotension.",2.3685972735685406e-07,0.12114222612502346,0.0892848348219534,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.5,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Is myocardial ischemia a consequence of profound hypotension in patients with coronary disease? In ischemic heart disease patients experiencing hypotension, symptomatic and silent ischemic events occurred in a time-related manner with hypotensive episodes, mainly involving diastolic pressures, suggesting these patients might be susceptible to ischemic events caused by hypotension.",1.6580180914979784e-07,0.05467829615256292,0.090671676405408,0.012693985253473108,0.0874922092571837,0.036982248520710054,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
209,0.5,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? The link between cognitive abilities and recognizing frequency compressed speech in noisy environments was not statistically significant. Results might have varied if participants had received training or time to acclimate to frequency-compressed conditions.,1.4211583641411244e-07,0.14987318290452922,0.02307597574902708,0.010880558788691236,0.14963993654674157,0.0212665406427221,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
209,0.5,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive function a predictor of frequency compressed speech recognition in individuals with normal hearing and cognition? No significant statistical relationship was found between cognitive function and recognition of frequency compressed speech-in-noise. Different outcomes may have occurred if participants were given training or time to adapt to the frequency-compressed settings.,1.1842986367842703e-07,0.15636679562165545,0.04245215722350719,0.009067132323909363,0.12797203516756062,0.020823902218198284,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.5,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive function forecast how well normal hearing and cognitively normal listeners recognize frequency compressed speech? The study found no significant statistical association between cognitive function and recognition of frequency compressed speech amid noise. The results could differ if participants had training or time to get used to frequency-compressed conditions.,1.1842986367842703e-07,0.12807507396614737,0.022230491431135254,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.5,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive ability influence recognition of frequency compressed speech in listeners with normal hearing and cognition? There was no statistically significant relationship observed between cognitive function and frequency compressed speech-in-noise recognition. The findings might change if participants were trained or given time to acclimate to frequency compression.,1.8948778188548325e-07,0.16480736621405256,0.0032164691094322163,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
209,0.5,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,"Is there a predictive relationship between cognitive function and frequency compressed speech recognition in normal hearing, cognitively normal listeners? The data showed no significant statistical link between cognitive function and recognizing frequency compressed speech in noise. Different findings might emerge if participants had training or time to adjust to frequency compressed speech.",7.105791820705622e-08,0.20483951781562748,0.14148807404770386,0.005440279394345618,0.14144656979116865,0.05975554549569943,0.0054324046228586,0.08771514212630915,0.020399305555555556,7.105791820705622e-08,0.06062462181643413,0.0
209,0.5,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive functioning predict recognition of frequency compressed speech in listeners with normal hearing and cognition? No significant statistical correlation was found between cognitive function and speech recognition under frequency compressed noise conditions. The outcomes may have been different if participants had training or time to acclimatize to these conditions.,1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.5,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive function predict how well listeners with normal hearing and cognition recognize frequency compressed speech? The study did not find a statistically significant relationship between cognitive function and recognition of frequency compressed speech in noisy settings. The results might differ if participants were provided with training or time to adapt to frequency compression.,2.3685972735685406e-08,0.04533300997287881,0.019165890272232835,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
209,0.5,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive function a predictor for recognizing frequency compressed speech in individuals with normal hearing and cognition? There was no significant statistical evidence linking cognitive function to recognition of frequency compressed speech-in-noise. The findings could have been different if participants had time or training to acclimate to frequency compressed conditions.,1.1842986367842703e-07,0.16704532916787063,0.0859304180930724,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.5,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive function serve as a predictor for frequency compressed speech recognition in normal hearing and cognitively normal listeners? The study found no statistically significant association between cognitive function and recognition of frequency compressed speech amidst noise. Different results might have been observed if participants had training or time to adjust to frequency compression.,2.3685972735685406e-08,0.07148950735249926,0.037888074047703835,0.0018134264647818726,0.04570770191530649,0.01922337562475971,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
209,0.5,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is there a significant relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? The research showed no significant statistical link between cognitive function and recognition of frequency compressed speech in noise. The findings might have changed if participants were given training or time to acclimate to frequency compressed speech.,2.3685972735685406e-08,0.11672445826935851,0.12975962756707077,0.0018134264647818726,0.05832422038339624,0.05536332179930796,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
210,0.5,1,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Answer: The findings suggest that major blunt trauma boosts the migratory ability of circulating neutrophils. This effect appears within 2 hours of admission and might be due to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who subsequently develop ARDS show initially elevated levels.",2.3685972735685406e-08,0.01600034134644357,0.0,0.0018134264647818726,0.016260520871781203,0.0,0.0018108015409528666,0.01652930195121094,0.0,2.3685972735685406e-08,0.01680711831638071,0.0
210,0.5,2,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is enhanced neutrophil migration after major trauma a factor in causing acute respiratory distress syndrome? Answer: Data show that major blunt trauma increases the migratory capacity of circulating neutrophils. This occurs within 2 hours of admission and may result from modifications in interleukin-8 receptor expression, affinity, or signaling pathways. Those who develop ARDS later have initially elevated responses.",9.474389094274162e-08,0.06669137449867257,0.0,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
210,0.5,3,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Could increased neutrophil migration post-major trauma be involved in the etiology of acute respiratory distress syndrome? Answer: Evidence indicates that major blunt trauma heightens the migratory function of circulating neutrophils. This is evident within 2 hours of hospital admission and may be linked to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who go on to develop ARDS initially present with elevated levels.",7.105791820705622e-08,0.04725288485054513,0.0,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
210,0.5,4,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does major trauma-induced neutrophil migratory activity play a role in acute respiratory distress syndrome development? Answer: The data reveal that major blunt trauma enhances neutrophil migration in circulation. This enhancement is seen within 2 hours of admission and may be due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who later develop ARDS show initially increased activity.",4.737194547137081e-08,0.03278982282299214,0.0,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
210,0.5,5,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is the increased migratory activity of neutrophils after major trauma a contributing factor to acute respiratory distress syndrome? Answer: Research indicates that major blunt trauma enhances the migratory capacity of circulating neutrophils, observable within 2 hours of admission, potentially due to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS subsequently have elevated initial levels.",7.105791820705622e-08,0.04959694113937285,0.0,0.005440279394345618,0.05043085362689137,0.0,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
210,0.5,6,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does trauma-induced neutrophil migration increase contribute to the pathogenesis of acute respiratory distress syndrome? Answer: Findings suggest that major blunt trauma augments the migratory ability of circulating neutrophils within 2 hours of admission, possibly due to altered interleukin-8 receptor expression, affinity, or signaling. Patients developing ARDS later show initially raised levels.",2.6054570009253947e-07,0.1953087523207664,0.0,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
210,0.5,7,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Can increased neutrophil migration after major trauma be a factor in the onset of acute respiratory distress syndrome? Answer: Data demonstrate that major blunt trauma increases the migratory capacity of circulating neutrophils within 2 hours of admission, potentially linked to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS initially exhibit elevated levels.",1.1842986367842703e-07,0.0840831172105414,0.0,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
210,0.5,8,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is enhanced neutrophil migratory activity following major trauma implicated in acute respiratory distress syndrome? Answer: The evidence shows that major blunt trauma boosts neutrophil migration in the bloodstream within 2 hours of admission, possibly due to modifications in interleukin-8 receptor expression, affinity, or signaling pathways. Patients who later develop ARDS have initially elevated responses.",1.8948778188548325e-07,0.13815033848081626,0.0,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
210,0.5,9,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Does the increase in neutrophil migratory activity after major trauma contribute to acute respiratory distress syndrome development? Answer: The data indicate that major blunt trauma raises the migratory capacity of circulating neutrophils within 2 hours of admission, which may be attributed to changes in interleukin-8 receptor expression, affinity, or downstream signaling. Patients who develop ARDS later show initially elevated levels.",4.737194547137081e-08,0.03278982282299214,0.0,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
210,0.5,10,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Question: Is neutrophil migration enhancement after major trauma a factor in acute respiratory distress syndrome pathogenesis? Answer: Findings reveal that major blunt trauma increases the migratory function of circulating neutrophils within 2 hours of admission, potentially due to altered interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS subsequently have elevated initial activity.",1.8948778188548325e-07,0.13815033848081626,0.0,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
211,0.5,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",Master of Public Health (MPH) programs play a crucial role in strengthening health systems in low- and middle-income countries by building capacity among local health workers with vital public health skills.,9.711248821631006e-07,0.751490125881856,0.07756546049960925,0.07435048505605685,0.7623741811097529,0.0849609375,0.07424286317906759,0.8014458812974254,0.072021484375,9.711248821631017e-07,0.8421241120470788,0.05859375
211,0.5,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In low- and middle-income countries, MPH programs contribute significantly to health system enhancement by training health professionals in public health practices, policy formulation, and disease prevention.",1.089554745841527e-06,0.8876018706384814,0.11085915847820617,0.08341761737996625,0.9516161807482808,0.0849609375,0.08329687088383195,0.99815617554348,0.072021484375,1.0895547458415287e-06,1.0469185246930928,0.05859375
211,0.5,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",MPH programs are instrumental in boosting health systems in developing countries by equipping local practitioners with necessary skills for healthcare management and public health.,1.1369266913128978e-06,0.9709834795775318,0.11085915847820617,0.08704447030953,1.0386275577379105,0.0849609375,0.0869184739657377,1.089127953749208,0.072021484375,1.1369266913128995e-06,1.142228704497418,0.05859375
211,0.5,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","The impact of MPH programs in low- and middle-income countries includes improving health outcomes through capacity building, policy support, and disease control measures.",1.160612664048583e-06,1.015435242148366,0.11085915847820617,0.08885789677431188,1.0851475733728044,0.0849609375,0.08872927550669057,1.1379181179186393,0.072021484375,1.1606126640485847e-06,1.1935219988849681,0.05859375
211,0.5,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","By providing essential public health training, MPH programs help strengthen healthcare systems and reduce health inequalities in low- and middle-income regions.",1.2079846095199536e-06,1.110745421952691,0.11085915847820617,0.09248474970387564,1.1852310319297858,0.0849609375,0.09235087858859631,1.2432786335764647,0.072021484375,1.2079846095199555e-06,1.3047476339951922,0.05859375
211,0.5,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",MPH programs contribute to health system development in poorer countries by enhancing the skills of local health professionals and supporting effective health policies.,1.160612664048583e-06,1.015435242148366,0.11085915847820617,0.08885789677431188,1.0851475733728044,0.0849609375,0.08872927550669057,1.1379181179186393,0.072021484375,1.1606126640485847e-06,1.1935219988849681,0.05859375
211,0.5,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In low- and middle-income countries, MPH education fosters health system strengthening by focusing on capacity building, healthcare management, and disease prevention.",1.2079846095199536e-06,1.110745421952691,0.11085915847820617,0.09248474970387564,1.1852310319297858,0.0849609375,0.09235087858859631,1.2432786335764647,0.072021484375,1.2079846095199555e-06,1.3047476339951922,0.05859375
211,0.5,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",Strengthening health systems in developing nations is significantly supported by MPH programs that train local health workers and assist in policy and management improvements.,1.1369266913128978e-06,0.9709834795775318,0.11085915847820617,0.08704447030953,1.0386275577379105,0.0849609375,0.0869184739657377,1.089127953749208,0.072021484375,1.1369266913128995e-06,1.142228704497418,0.05859375
211,0.5,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.",MPH programs aid in improving health outcomes and reducing disparities in low- and middle-income countries by building local capacity and enhancing public health interventions.,1.1369266913128978e-06,0.9709834795775318,0.11085915847820617,0.08704447030953,1.0386275577379105,0.0849609375,0.0869184739657377,1.089127953749208,0.072021484375,1.1369266913128995e-06,1.142228704497418,0.05859375
211,0.5,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","The role of MPH programs in low- and middle-income countries includes empowering health professionals with skills for policy development, management, and disease prevention, leading to stronger health systems.",1.0421828003701566e-06,0.810640829502352,0.11085915847820617,0.07979076445040248,0.8715734730747435,0.0849609375,0.0796752678019262,0.9147745666044296,0.072021484375,1.0421828003701579e-06,0.9599071477034631,0.05859375
212,0.5,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): could polymorphisms in the beta-adrenergic receptor (ADRB) genes be involved? Answer: Our findings suggest that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both representing loss-of-function mutations, might increase susceptibility to TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.5,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a connection between transient tachypnea of the newborn (TTN) and polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We determined that homozygosity for beta1Gly49 and the TACC haplotype in the ADRB2 gene, both loss-of-function variants, could contribute to a higher risk of TTN.",1.6580180914979753e-07,0.17327172127403623,0.0,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
212,0.5,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): do polymorphisms in beta-adrenergic receptor (ADRB) genes play a role? Answer: It was concluded that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variants, may predispose infants to TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.5,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes be implicated in transient tachypnea of the newborn (TTN)? Answer: We conclude that both beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, which are loss-of-function variations, may increase the risk of TTN.",1.1842986367842671e-07,0.0937446970410507,0.023795359904818555,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.5,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Our conclusion is that the beta1Gly49 homozygous genotype and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, may predispose to TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.5,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): is there a role for beta-adrenergic receptor (ADRB) gene polymorphisms? Answer: We conclude that homozygosity for beta1Gly49 and the TACC haplotype in the ADRB2 gene, both loss-of-function genetic variants, might predispose newborns to TTN.",7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.5,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: Are polymorphisms in beta-adrenergic receptor (ADRB) genes involved in transient tachypnea of the newborn (TTN)? Answer: We found that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variations, may increase susceptibility to TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.5,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): does the beta-adrenergic receptor (ADRB) gene polymorphism contribute? Answer: We conclude that the beta1Gly49 homozygosity and TACC haplotype of the ADRB2 gene, both loss-of-function variants, could predispose infants to TTN.",2.36859727356853e-08,0.06590715088589016,0.02775510204081633,0.0018134264647818726,0.028170876966696845,0.0,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
212,0.5,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: Is there an association between transient tachypnea of the newborn (TTN) and polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: Our study concludes that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variants, may predispose to TTN.",1.1842986367842671e-07,0.0937446970410507,0.023795359904818555,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.5,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): does polymorphism in beta-adrenergic receptor (ADRB) genes have a role? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, may contribute to TTN susceptibility.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
213,0.5,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic characteristics of child bipolar I disorder: does the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: The RCT sample's generalizability was supported as only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, since RCT subjects had more severe illness, it's uncertain if RCT treatment results apply to children with milder mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.5,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic features of child bipolar I disorder: can the 'Treatment of Early Age Mania (TEAM)' sample be generalized? Answer: Generalization was supported because just 7.8% of Phenomenology participants did not fit RCT criteria. Still, given the greater severity in RCT subjects, applicability of RCT treatment outcomes to less severe mania cases is unclear.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,0.5,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic traits of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: The RCT sample was generalizable since only 7.8% of Phenomenology subjects didn't meet RCT inclusion criteria. Nonetheless, with RCT subjects more severely affected, it's uncertain if RCT treatment findings apply to children with milder mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,0.5,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic indicators of child bipolar I disorder: does the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: Generalization is supported because only 7.8% of Phenomenology subjects were excluded by RCT criteria. Yet, due to higher severity in RCT subjects, the relevance of RCT treatment results to children with less severe mania remains uncertain.",2.3685972735685406e-07,0.08325563922540447,0.1451222789572694,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
213,0.5,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic markers of child bipolar I disorder: can the 'Treatment of Early Age Mania (TEAM)' sample be generalized? Answer: The RCT sample generalizes well since only 7.8% of Phenomenology subjects didn't fit RCT criteria. However, because RCT subjects were more severely ill, it's unclear if the treatment outcomes apply to children with milder mania.",2.3685972735685406e-07,0.08325563922540447,0.1451222789572694,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
213,0.5,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic characteristics of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample representative? Answer: The sample generalizes as only 7.8% of Phenomenology participants failed RCT criteria. Still, since RCT subjects were more severely ill, applicability of treatment findings to less severe mania cases is uncertain.",3.552895910352811e-07,0.18041938767905297,0.1451222789572694,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
213,0.5,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic features of child bipolar I disorder: does the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: Generalization was supported because only 7.8% of Phenomenology subjects did not meet RCT criteria. However, given the greater illness severity in RCT subjects, it's unclear if RCT treatment findings apply to children with less severe mania.",2.3685972735685406e-07,0.08325563922540447,0.1451222789572694,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
213,0.5,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic aspects of child bipolar I disorder: can the 'Treatment of Early Age Mania (TEAM)' sample be generalized? Answer: The RCT sample generalizes since only 7.8% of Phenomenology subjects failed to meet RCT criteria. Nevertheless, due to higher severity in RCT subjects, the applicability of treatment results to children with milder mania is uncertain.",2.3685972735685406e-07,0.08325563922540447,0.1451222789572694,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
213,0.5,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic signs of child bipolar I disorder: does the 'Treatment of Early Age Mania (TEAM)' sample generalize? Answer: Generalization is supported because only 7.8% of Phenomenology subjects did not fulfill RCT criteria. Yet, since RCT subjects were more severely ill, it's unclear if treatment findings apply to children with less severe mania.",2.8423167282822487e-07,0.1209959672082519,0.1451222789572694,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
213,0.5,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic criteria of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: The RCT sample generalizes well as only 7.8% of Phenomenology subjects did not meet RCT criteria. However, because RCT subjects were more severely ill, it's uncertain if RCT treatment findings are applicable to children with less severe mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
214,0.5,1,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy effective for gallbladder carcinoma? It can help alleviate symptoms like pain and obstruction, but it has limited impact on survival due to the disease's advanced stage.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.5,2,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy work well for gallbladder carcinoma? This treatment may relieve symptoms such as pain and blockage, though it offers minimal survival benefit because the cancer is often advanced.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.5,3,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How effective is external palliative radiotherapy in treating gallbladder carcinoma? It is useful for symptom control, including pain and obstruction, but it rarely improves survival given the late progression of the disease.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
214,0.5,4,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy effectively manage gallbladder carcinoma? While it helps reduce symptoms like pain and obstruction, it does not significantly extend survival owing to the advanced disease state.",3.7897556377096523e-07,0.29445167361579827,0.11176857330703485,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
214,0.5,5,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy beneficial for gallbladder carcinoma patients? It can ease symptoms such as pain and obstruction, but its effect on survival is limited because the cancer is usually advanced.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.5,6,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","What is the efficacy of external palliative radiotherapy in gallbladder carcinoma? It provides symptom relief, particularly for pain and obstruction, but survival improvement is generally minimal due to the advanced disease.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.5,7,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy provide effective symptom relief in gallbladder carcinoma? Yes, it can manage pain and obstruction symptoms, but it has limited influence on survival because of the advanced stage of the disease.",2.605457000925387e-07,0.17215754235845804,0.08149513580703485,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
214,0.5,8,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How well does external palliative radiotherapy work for gallbladder carcinoma? It can control symptoms like pain and obstruction, yet it offers little survival advantage given the advanced nature of the cancer.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.5,9,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy a good option for gallbladder carcinoma? It is effective in symptom management, such as reducing pain and obstruction, but has a limited role in enhancing survival due to disease advancement.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
214,0.5,10,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy improve outcomes in gallbladder carcinoma? It helps manage symptoms like pain and obstruction, but survival benefits are limited because the disease is typically advanced.",4.0266153650665053e-07,0.33081931778667295,0.11176857330703485,0.030828249901291897,0.37414596268418343,0.09204470742932283,0.0307836261961988,0.4197727676208891,0.0710059171597633,4.026615365066519e-07,0.4678941211797829,0.04865220249835634
215,0.5,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Can antral follicle count better predict IVF outcomes compared to age and FSH levels? Answer: IVF success is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Among these, antral follicle count predicts IVF results more accurately than age or FSH. It may serve as a unique marker of ovarian age.",3.552895910352811e-07,0.09087925688516751,0.1683052227267014,0.027201396971728173,0.14928470511851533,0.0792541635229362,0.027162023114293013,0.21102609688800023,0.013695987654320991,3.552895910352811e-07,0.23361485118150416,0.0
215,0.5,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle evaluation a superior predictor of IVF success than age and FSH? Answer: The outcome of in vitro fertilization is strongly associated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count outperforms age and FSH as a predictor and may uniquely indicate ovarian aging.",4.737194547137081e-07,0.1849847720977138,0.16042899408284012,0.036268529295637536,0.21434158786470636,0.09619827767275783,0.036216030819057346,0.30117719388229824,0.013695987654320991,4.737194547137081e-07,0.32542240043462645,0.0
215,0.5,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Does antral follicle assessment outperform age and FSH in predicting IVF outcomes? Answer: IVF results correlate significantly with maternal age, day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle count is a better predictor than age or FSH and may reflect ovarian age differently.",6.39521263863506e-07,0.30465055578906464,0.16818827529893396,0.048962514549110644,0.3531780327189238,0.09619827767275783,0.04889164160572741,0.4428277109453247,0.013695987654320991,6.39521263863506e-07,0.4700036292457348,0.0
215,0.5,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Can antral follicle measurement better forecast IVF outcomes than age and FSH? Answer: IVF success correlates with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count is a superior predictor compared to age or FSH and may indicate ovarian age distinctly.",6.158352911278206e-07,0.28262997740180307,0.16995882899702924,0.04714908808432877,0.3321246235210906,0.09619827767275783,0.047080840064774546,0.42132150572436133,0.013695987654320991,6.158352911278206e-07,0.4480247225269598,0.0
215,0.5,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle count a more reliable predictor of IVF outcome than age and FSH? Answer: In vitro fertilization outcomes strongly relate to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count is a better predictor than age or FSH and may mark ovarian aging uniquely.",4.974054274493935e-07,0.23058250372507505,0.13965443786982237,0.03808195576041941,0.2591902182564816,0.0773373309271957,0.03802683236001021,0.32022538885299134,0.013695987654320991,4.974054274493935e-07,0.34484048629172914,0.0
215,0.5,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: How does antral follicle assessment compare to age and FSH in predicting IVF success? Answer: IVF outcome is closely linked to maternal age, day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count predicts IVF results better than age or FSH and may serve as a distinct ovarian age marker.",5.210914001850789e-07,0.19908198634844299,0.17636093537078354,0.03989538222520128,0.2520819158475538,0.09619827767275783,0.03983763390096308,0.33964347471009404,0.013695987654320991,5.210914001850789e-07,0.3646431135879089,0.0
215,0.5,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle assessment a better indicator of IVF success than age and FSH levels? Answer: IVF outcomes are strongly associated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count surpasses age and FSH as a predictor and may uniquely reflect ovarian aging.",5.447773729207643e-07,0.272645072155389,0.1351988823142668,0.041708808689983154,0.298682244079556,0.07659827767275784,0.041648435441915946,0.3594461020062738,0.013695987654320991,5.447773729207643e-07,0.3848458209054275,0.0
215,0.5,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Does antral follicle count provide a better prediction of IVF outcomes than age and FSH? Answer: The success of in vitro fertilization is closely related to maternal age, day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count is a superior predictor compared to age or FSH and may mark ovarian age distinctly.",4.500334819780227e-07,0.16544609411869704,0.1621188024123642,0.03445510283085566,0.2211978012168725,0.07802269468236003,0.03440522927810448,0.2824850608701439,0.013695987654320991,4.500334819780227e-07,0.30637420546393335,0.0
215,0.5,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Can antral follicle assessment serve as a better predictor of IVF outcomes than age and FSH? Answer: IVF outcomes are strongly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count is a more accurate predictor than age or FSH and may provide a unique marker of ovarian aging.",4.026615365066519e-07,0.15137331549230115,0.1476302952086427,0.030828249901291918,0.1602743665944315,0.09619827767275783,0.030783626196198746,0.24611741669926968,0.013695987654320991,4.026615365066519e-07,0.26933293378358325,0.0
215,0.5,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle count more effective than age and FSH in predicting IVF results? Answer: In vitro fertilization success correlates strongly with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Antral follicle count outperforms age and FSH in prediction and may indicate ovarian age distinctly.",5.684633456564497e-07,0.348715887705068,0.09325443786982235,0.04352223515476503,0.37448029066802935,0.0364427321770584,0.04345923698286881,0.4079405309793005,0.006703317901234565,5.684633456564497e-07,0.4054651081081633,0.0
216,0.5,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are the home blood pressure readings reported by stroke patients dependable? This elderly stroke patient group reliably recorded their blood pressures at home. Any bias detected was minimal and unlikely to influence treatment decisions. Given that blood pressure readings taken at a GP's office often do not accurately reflect true blood pressure, GPs might consider utilizing hypertensive patients' home readings.",2.3685972735685406e-08,0.02989859583120502,0.033856571252693125,0.0018134264647818726,0.006509884203991234,0.017236072637734686,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
216,0.5,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients be trusted to report their home blood pressure measurements accurately? This cohort of elderly stroke patients successfully recorded their blood pressures at home with reliability. Any bias present was minor and unlikely to impact clinical management. Since blood pressure measurements in a GP clinic often fail to represent true blood pressure, GPs may want to use readings from hypertensive patients at home.",1.4211583641411244e-07,0.03345752463575824,0.04676162321956463,0.010880558788691236,0.07807878615825725,0.01586888657648284,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
216,0.5,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Do stroke patients provide reliable reports of their home blood pressure readings? Elderly stroke patients in this group were able to reliably record their blood pressures at home. The small bias observed is unlikely to affect treatment decisions. Because blood pressure readings taken in a GP surgery often poorly reflect true blood pressure, GPs might consider relying on hypertensive patients' home measurements.",7.105791820705622e-08,0.004978579491813129,0.032749209997127264,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
216,0.5,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is it reliable when stroke patients report their home blood pressure readings? This group of elderly stroke patients consistently recorded their blood pressures at home with reliability. Any bias was minimal and unlikely to alter management. Since blood pressure readings in a GP office often do not accurately indicate true blood pressure, GPs might consider using hypertensive patients' home readings.",2.3685972735685406e-08,0.02989859583120502,0.033856571252693125,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
216,0.5,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are reports of home blood pressure by stroke patients trustworthy? The elderly stroke patients in this group were able to reliably record their blood pressures at home. Any bias was slight and unlikely to affect management decisions. Given that blood pressure readings in a GP surgery often poorly represent true blood pressure, GPs might consider using hypertensive patients' home measurements.",2.3685972735685406e-08,0.02989859583120502,0.033856571252693125,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
216,0.5,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can home blood pressure readings reported by stroke patients be considered reliable? This group of elderly stroke patients was able to consistently record their blood pressures at home. The bias detected was small and unlikely to impact clinical management. Since blood pressure readings in GP surgeries often do not accurately reflect true blood pressure, GPs might consider using hypertensive patients' home readings.",7.105791820705622e-08,0.017747557575725992,0.049048751486325794,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
216,0.5,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are stroke patients' self-reported home blood pressure readings accurate? The elderly stroke patients in this group reliably recorded their blood pressures at home. Any bias was minimal and unlikely to influence treatment. Because blood pressure readings taken in GP surgeries often poorly indicate true blood pressure, GPs may consider using hypertensive patients' home blood pressure data.",7.105791820705622e-08,0.1634448360092957,0.11149557862360629,0.005440279394345618,0.10541145686730857,0.036982248520710054,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
216,0.5,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is the reliability of home blood pressure readings reported by stroke patients confirmed? This group of elderly stroke patients was able to reliably record their blood pressures at home. The small bias present is unlikely to affect patient management. Since blood pressure readings in GP clinics often do not accurately reflect true blood pressure, GPs might consider using hypertensive patients' home measurements.",7.105791820705622e-08,0.017747557575725992,0.049048751486325794,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
216,0.5,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are home blood pressure readings reported by stroke patients dependable? Elderly stroke patients in this group reliably recorded their blood pressures at home. Any bias was minor and unlikely to influence clinical decisions. Given that blood pressure readings in GP surgeries often poorly represent true blood pressure, GPs might consider using hypertensive patients' home readings.",9.474389094274162e-08,0.14847531737769426,0.05536332179930796,0.0072537058591274906,0.09891585166205008,0.018860946745562133,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
216,0.5,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients reliably report their home blood pressure readings? This group of elderly stroke patients was able to record their blood pressures at home reliably. The small bias observed would unlikely affect management. Since blood pressure readings in GP surgeries often do not accurately indicate true blood pressure, GPs might consider using hypertensive patients' home measurements.",4.737194547137081e-08,0.08460183270840904,0.03566529492455417,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
217,0.5,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering required before scoliosis correction in a patient with myelomeningocele? Typically, untethering is necessary before scoliosis correction in such patients to avoid worsening neurological damage, although the decision varies based on the patient's specific condition.",3.5528959103528056e-07,0.36459662600227416,0.0055658524338374205,0.027201396971728097,0.3904230573081491,0.017851332616568565,0.027162023114293013,0.41670236947534667,0.0302734375,3.552895910352811e-07,0.38441169891033145,0.0
217,0.5,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For a patient with myelomeningocele, is untethering mandatory prior to scoliosis surgery? Generally, untethering is needed before scoliosis correction to prevent further neurological decline, but the choice depends on individual patient factors.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,0.5,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does a patient with myelomeningocele need untethering before scoliosis correction? Usually, untethering is performed before correcting scoliosis to reduce the risk of neurological deterioration, though the approach should be tailored to the patient's condition.",4.0266153650665116e-07,0.3046118950720742,0.07939508506616258,0.030828249901291856,0.36950095199988464,0.040742417383431435,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
217,0.5,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is it essential to untether a patient with myelomeningocele before scoliosis correction? Untethering is commonly required prior to scoliosis surgery to prevent neurological worsening, but the decision should be individualized.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.5,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Should untethering be done before scoliosis correction in myelomeningocele patients? Typically, yes; untethering helps avoid further neurological damage during scoliosis correction, but the necessity depends on the patient's unique clinical situation.",4.7371945471370706e-07,0.3999220748763994,0.07939508506616258,0.036268529295637494,0.46794102481313793,0.040742417383431435,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
217,0.5,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","In patients with myelomeningocele, is untethering necessary before scoliosis correction? It is generally advisable to untether prior to scoliosis surgery to prevent neurological deterioration, though patient-specific factors influence this decision.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.5,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering prior to scoliosis correction necessary for myelomeningocele patients? Usually, untethering is indicated to prevent worsening neurological symptoms during scoliosis correction, but the final decision depends on individual assessment.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.5,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For scoliosis correction in patients with myelomeningocele, is untethering required first? Typically, untethering is performed beforehand to avoid further neurological decline, but the decision must be personalized.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.5,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does scoliosis correction in myelomeningocele patients require prior untethering? In most cases, untethering is needed to prevent neurological deterioration, although the decision should be based on the patient's specific condition.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.5,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering necessary before scoliosis correction in a patient with myelomeningocele? Usually, it is required to prevent neurological worsening during the procedure, but the decision should be tailored to each patient's circumstances.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
218,0.5,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a futile effort? No, this step is vital as it helps prevent spinal cord ischemia and reduces the chance of paralysis, making it an essential component of the surgical approach.",5.447773729207643e-07,0.23855570882808097,0.18026791584483884,0.04170880868998307,0.3294152200973923,0.09566326530612247,0.04164843544191593,0.40510929324430656,0.049048751486325794,5.447773729207643e-07,0.4603217435592093,0.016661878770468257
218,0.5,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is not pointless. It plays a crucial role in protecting the spinal cord from ischemia and lowering paralysis risk, thus forming a key part of the surgery.",6.395212638635055e-07,0.3477670421556853,0.17749637724912443,0.04896251454911056,0.43762880473762333,0.09566326530612247,0.048891641605727405,0.5163349283545311,0.049048751486325794,6.39521263863506e-07,0.5747320947369547,0.016661878770468257
218,0.5,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm surgery is far from a waste of time. It is an important procedure that helps avoid spinal cord ischemia and decreases the likelihood of paralysis, integral to the surgical plan.",5.684633456564496e-07,0.26476216704386024,0.1796282105918798,0.04352223515476494,0.3553907065006503,0.09566326530612247,0.0434592369828688,0.4317775403264674,0.049048751486325794,5.684633456564497e-07,0.4877207177473246,0.016661878770468257
218,0.5,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The process of reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is essential, not a waste. It prevents spinal cord ischemia and reduces paralysis risk, making it a critical surgical step.",7.342651548062467e-07,0.4703635998992919,0.17403399750013845,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.7039438262169617,0.016661878770468257
218,0.5,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a necessary procedure. It safeguards against spinal cord ischemia and minimizes paralysis risk, thereby playing a vital role in the surgery.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
218,0.5,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Is it pointless to reimplant spinal cord arteries in thoracic and thoracoabdominal aneurysm repair? No, this procedure is crucial for preventing spinal cord ischemia and lowering the chances of paralysis, thus it is an important part of the operation.",5.921493183921349e-07,0.29167307474342064,0.17895491245283338,0.045335661619546816,0.38205895358281117,0.09566326530612247,0.045270038523821665,0.45917651451458275,0.049048751486325794,5.921493183921352e-07,0.5158915947140215,0.016661878770468257
218,0.5,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a key procedure that prevents spinal cord ischemia and reduces paralysis risk, so it is definitely not a waste of time.",7.105791820705614e-07,0.43827916248147636,0.17497804178994075,0.0544027939434562,0.5272409634273103,0.09566326530612247,0.054324046228586026,0.6087082484855464,0.049048751486325794,7.105791820705622e-07,0.67004227454128,0.016661878770468257
218,0.5,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During repair of thoracic and thoracoabdominal aneurysms, reimplanting spinal cord arteries is critical. It helps prevent ischemia of the spinal cord and decreases paralysis risk, making it an essential surgical step.",7.816371002776173e-07,0.5377902342891954,0.17195778131134384,0.05984307333780184,0.6256810362405636,0.09566326530612247,0.05975645085144465,0.7104909427954889,0.049048751486325794,7.816371002776184e-07,0.7754027901991054,0.016661878770468257
218,0.5,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is a vital procedure that aids in preventing spinal cord ischemia and reduces the risk of paralysis, thus it is not a waste of time.",6.632072365991908e-07,0.37703815274231856,0.1767047664871726,0.05077594101389244,0.46661634161087484,0.09566326530612247,0.05070244314668028,0.5461878915042129,0.049048751486325794,6.632072365991914e-07,0.6055037534037084,0.016661878770468257
218,0.5,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The act of reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is important. It prevents spinal cord ischemia and lowers the risk of paralysis, forming a significant part of the surgical strategy.",7.105791820705614e-07,0.43827916248147636,0.17497804178994075,0.0544027939434562,0.5272409634273103,0.09566326530612247,0.054324046228586026,0.6087082484855464,0.049048751486325794,7.105791820705622e-07,0.67004227454128,0.016661878770468257
219,0.5,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does undergoing a preoperative medically supervised weight loss program enhance outcomes of bariatric surgery? MSWM seems to offer no extra advantage over the usual preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes following LAGB in our patients.,1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.5,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Is the outcome of bariatric surgery improved by a preoperative medically supervised weight loss program? In our patient group, MSWM does not provide additional benefits compared to the standard preoperative protocol in terms of weight loss and behavioral results after LAGB.",1.1842986367842703e-07,0.09082731196794036,0.01936473293131776,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.5,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery improve bariatric surgery results? Our findings indicate that MSWM does not add any benefit beyond the standard preoperative bariatric approach for weight loss and behavioral outcomes post-LAGB.,2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
219,0.5,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Can a preoperative medically supervised weight loss program improve the results of bariatric surgery? MSWM does not seem to offer further benefits compared to the conventional preoperative bariatric surgery protocol for weight loss and behavioral outcomes after LAGB in our patients.,1.1842986367842703e-07,0.09082731196794036,0.01936473293131776,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.5,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does participating in a medically supervised weight loss program before bariatric surgery enhance surgical outcomes? In our patient population, MSWM shows no additional benefit over the standard preoperative protocol regarding weight loss and behavioral outcomes following LAGB.",2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
219,0.5,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program lead to better bariatric surgery outcomes? MSWM does not appear to provide extra advantages compared to the usual preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patients.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765236,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.5,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a medically supervised weight loss program prior to bariatric surgery effective in improving surgery outcomes? Our patient data suggests MSWM does not confer added benefits beyond the standard preoperative protocol for weight loss and behavioral outcomes post-LAGB.,1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,0.5,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program improve the effectiveness of bariatric surgery? MSWM seems not to provide additional benefit over the standard preoperative bariatric surgery protocol concerning weight loss and behavioral outcomes after LAGB in our patient group.,1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.5,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does engaging in a medically supervised weight loss program before bariatric surgery improve postoperative outcomes? MSWM does not appear to offer any further benefit compared to the standard preoperative protocol in terms of weight loss and behavioral outcomes following LAGB in our patients.,7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.5,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does a preoperative medically supervised weight loss program enhance bariatric surgery results? According to our patient population, MSWM does not confer additional advantages over the standard preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes after LAGB.",1.6580180914979763e-07,0.1804261084390668,0.008120839426049457,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
220,0.5,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving care at a birth center during a woman's initial pregnancy influence her future reproductive outcomes? Answer: In Sweden, the type of care a woman receives during her first pregnancy, including birth center care, does not appear to significantly impact her later reproductive behavior.",2.3685972735685406e-08,0.03762505373517211,0.04268920211505886,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
220,0.5,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Is birth center care during a woman’s first pregnancy linked to her future reproduction? Answer: Care models like birth center care during the first pregnancy do not seem to be a crucial factor affecting subsequent reproduction in Sweden.,1.8948778188548304e-07,0.24657045717368842,0.03890628245699067,0.014507411718254981,0.27067940745689967,0.05387755102040818,0.014486412327622933,0.2391788721599264,0.02775510204081633,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.5,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the care model, such as birth center care, during a woman’s first pregnancy affect her future fertility? Answer: In Sweden, birth center care during the first pregnancy does not seem to play a significant role in influencing later reproductive outcomes.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.5,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can birth center care during a woman’s first pregnancy impact her future reproductive choices? Answer: A woman’s model of care in her first pregnancy, including birth center care, does not appear to meaningfully affect her subsequent reproduction in Sweden.",1.6580180914979774e-07,0.1457612670662516,0.013767732622336298,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
220,0.5,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care in the first pregnancy affect a woman’s later reproduction? Answer: The model of care, like birth center care, during a woman’s first pregnancy does not seem to be an important factor for future reproduction in Sweden.",1.1842986367842703e-07,0.12609500073748947,0.007814735523731478,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.5,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is there an effect of birth center care during the first pregnancy on future reproductive patterns? Answer: In Sweden, birth center care during a woman’s initial pregnancy does not seem to significantly influence her subsequent reproductive outcomes.",2.1317375462116834e-07,0.23971522752891072,0.015549881072907598,0.016320838183036854,0.30015990470975895,0.055363321799307974,0.0162972138685758,0.2684499827465596,0.02854671280276816,2.1317375462116866e-07,0.23483959107740038,0.0
220,0.5,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Does a woman’s first pregnancy care at a birth center influence her future reproductive behavior? Answer: The care model such as birth center care during the first pregnancy does not appear to be a key factor affecting later reproduction in Sweden.,1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.5,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does care at a birth center during a woman’s first pregnancy have an effect on her future reproduction? Answer: In Sweden, a woman’s model of care during her first pregnancy, including birth center care, does not seem to significantly affect her subsequent reproduction.",7.105791820705622e-08,0.04150958647731384,0.018498994102315543,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
220,0.5,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care during the first pregnancy impact a woman’s later reproductive decisions? Answer: The type of care, such as birth center care, during the first pregnancy does not appear to be a significant factor in future reproduction in Sweden.",1.1842986367842703e-07,0.15990705832577934,0.031520799152681994,0.009067132323909363,0.18709775371237747,0.049861495844875335,0.009054007704764333,0.1561739970481013,0.025623268698060954,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.5,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the model of care, like birth center care, during a woman’s first pregnancy influence her future reproduction? Answer: Birth center care during the first pregnancy is not considered a sufficiently important factor to affect subsequent reproduction in Sweden.",1.6580180914979774e-07,0.1457612670662516,0.013767732622336298,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
221,0.5,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia negatively impact the results of colon and rectal surgery? Yes, having anemia before surgery can worsen the outcomes of colon and rectal procedures. Studies indicate it raises the chances of postoperative complications such as infections, extended hospitalization, and increased mortality rates.",2.3685972735685406e-08,0.00631903063618644,0.020625000000000004,0.0018134264647818726,0.05730511085940426,0.02425736961451249,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
221,0.5,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is there a detrimental effect of preoperative anemia on colon and rectal surgery outcomes? Indeed, preoperative anemia can harm the results of colon and rectal surgery. Research demonstrates it is associated with a higher risk of postoperative complications including infections, prolonged hospital stays, and elevated mortality.",2.3685972735685406e-08,0.05607999187920765,0.02367346938775511,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.5,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does anemia before surgery affect the success of colon and rectal operations? Yes, anemia prior to surgery can negatively influence colon and rectal surgery outcomes. Evidence shows it contributes to a greater likelihood of complications after surgery, such as infections, longer hospital admissions, and increased death rates.",4.737194547137081e-08,0.11020485479786402,0.04661157024793387,0.0036268529295637453,0.04689523646551175,0.0010318865838346326,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
221,0.5,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can preoperative anemia worsen the outcomes of colon and rectal surgery? Yes, anemia present before surgery can adversely affect colon and rectal surgery results. Studies reveal it increases the risk of postoperative complications, including infections, extended hospital stays, and higher mortality rates.",7.105791820705622e-08,0.012214922288724672,0.041347797501643656,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
221,0.5,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia linked to poorer outcomes in colon and rectal surgery? Yes, anemia before surgery is associated with worse outcomes in colon and rectal surgery. Research highlights an increased risk of postoperative complications like infections, longer hospitalization, and greater mortality.",9.474389094274162e-08,0.10791285581450483,0.008765432098765458,0.0072537058591274906,0.17203709359539587,0.05314625850340137,0.007243206163811466,0.17304631966855455,0.05246913580246914,9.474389094274162e-08,0.1401215692254847,0.027006172839506164
221,0.5,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does having anemia before colon and rectal surgery lead to worse outcomes? Yes, preoperative anemia can negatively impact the results of colon and rectal surgery. Studies show it raises the risk of complications after surgery, including infections, prolonged hospital stays, and higher mortality rates.",2.3685972735685406e-08,0.03855843438316109,0.04359904818560379,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
221,0.5,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia contribute to adverse outcomes in colon and rectal surgery? Yes, anemia before surgery can lead to worse outcomes in colon and rectal procedures. Evidence suggests it increases the chances of postoperative complications such as infections, longer hospitalization, and increased mortality.",4.737194547137081e-08,0.05252128992545613,0.004182825484764521,0.0036268529295637453,0.11682481800715028,0.0494720510549557,0.003621603081905733,0.11810488222542581,0.049861495844875335,4.737194547137081e-08,0.08555642983414735,0.025623268698060954
221,0.5,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is the presence of anemia prior to colon and rectal surgery harmful to surgical outcomes? Yes, preoperative anemia can negatively affect the outcomes of colon and rectal surgery. Research indicates it elevates the risk of postoperative complications, including infection, extended hospital stays, and higher death rates.",2.3685972735685406e-08,0.08688653323742734,0.045651703623580314,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.5,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does anemia before surgery have a negative effect on colon and rectal surgery outcomes? Yes, preoperative anemia is linked to poorer outcomes in colon and rectal surgery. Studies confirm it increases the risk of complications following surgery, such as infections, longer hospital stays, and greater mortality.",2.3685972735685406e-08,0.08688653323742734,0.045651703623580314,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.5,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can anemia before colon and rectal surgery adversely affect patient outcomes? Yes, having anemia preoperatively can worsen colon and rectal surgery results. Research shows it leads to a higher risk of postoperative complications including infections, prolonged hospitalization, and increased mortality.",1.1842986367842692e-07,0.10123925546526058,0.013611111111111102,0.009067132323909363,0.16433741333177476,0.029226505416981616,0.009054007704764333,0.1642191208045447,0.027006172839506164,1.1842986367842703e-07,0.1300531282481976,0.0
223,0.5,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection required for metastatic carcinoma in cervical nodes when the primary head and neck tumor is unknown? Yes, neck dissection is commonly needed in such cases to manage regional disease, reduce further metastasis, and enhance survival rates, though evaluation on a case-by-case basis is essential to weigh benefits against risks.",4.263475092423373e-07,0.08836844274872258,0.1466049861495845,0.03264167636607371,0.08323120015503838,0.15574022776238844,0.0325944277371516,0.10596271514304156,0.14465989535241613,4.263475092423373e-07,0.12941359096582117,0.13296398891966757
223,0.5,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma found in cervical lymph nodes with an unknown primary tumor in the head and neck, is neck dissection necessary? Yes, it is often recommended to control local disease, prevent spread, and improve patient outcomes, but individualized assessment is important to consider risks and advantages.",5.447773729207643e-07,0.1643704366090537,0.1662049861495845,0.04170880868998307,0.18859171581286427,0.15574022776238844,0.04164843544191593,0.21359337933540656,0.14465989535241613,5.447773729207643e-07,0.23941448618014993,0.13296398891966757
223,0.5,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","In cases of metastatic carcinoma to cervical nodes from an unidentified primary head and neck site, should neck dissection be performed? Yes, performing neck dissection is typically important for controlling regional disease, limiting metastasis, and boosting survival, though each patient’s situation should be carefully assessed.",5.921493183921352e-07,0.240328889205339,0.1434900050787354,0.045335661619546816,0.2340540898896215,0.15574022776238844,0.045270038523821665,0.2601133949703005,0.14465989535241613,5.921493183921352e-07,0.28704253516940437,0.13296398891966757
223,0.5,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Does metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary require neck dissection? Yes, neck dissection is generally needed to manage regional disease, prevent further metastasis, and improve overall survival, with decisions tailored to individual cases.",7.105791820705621e-07,0.3294501869685038,0.1662049861495845,0.05440279394345618,0.35766804585679735,0.15574022776238844,0.054324046228586,0.3868651006094428,0.14465989535241613,7.105791820705622e-07,0.41709566341760196,0.13296398891966757
223,0.5,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection indicated for metastatic carcinoma in cervical nodes originating from an unknown primary in the head and neck? Yes, it is often necessary to control the disease regionally, avoid future metastases, and enhance survival, but each case must be evaluated individually for risks and benefits.",5.447773729207643e-07,0.1643704366090537,0.1662049861495845,0.04170880868998307,0.18859171581286427,0.15574022776238844,0.04164843544191593,0.21359337933540656,0.14465989535241613,5.447773729207643e-07,0.23941448618014993,0.13296398891966757
223,0.5,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Should neck dissection be performed for metastatic carcinoma to the cervical nodes when the primary tumor in the head and neck is unknown? Yes, it is frequently required to control regional disease and improve survival outcomes, though careful individual evaluation is important.",6.632072365991914e-07,0.2794397663938404,0.1662049861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
223,0.5,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma involving cervical lymph nodes from an unknown head and neck primary, is neck dissection needed? Yes, it is commonly necessary to control disease progression, prevent metastasis, and improve survival, with each case assessed individually.",7.81637100277618e-07,0.409492894642038,0.1662049861495845,0.0598430733378018,0.4399061440937704,0.15574022776238844,0.059756450851444605,0.47142248863750646,0.14465989535241613,7.816371002776184e-07,0.5041070404072321,0.13296398891966757
223,0.5,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection necessary for metastatic carcinoma to cervical nodes from an unknown primary head and neck site? Yes, it often plays a critical role in regional disease control, metastasis prevention, and survival improvement, but individual case evaluation is crucial.",7.105791820705621e-07,0.3294501869685038,0.1662049861495845,0.05440279394345618,0.35766804585679735,0.15574022776238844,0.054324046228586,0.3868651006094428,0.14465989535241613,7.105791820705622e-07,0.41709566341760196,0.13296398891966757
223,0.5,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","In metastatic carcinoma cases involving cervical nodes with an unknown primary in the head and neck, is neck dissection required? Yes, it is typically essential for controlling regional disease and improving survival, though each patient’s risks and benefits should be carefully weighed.",6.632072365991914e-07,0.2794397663938404,0.1662049861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
223,0.5,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Does metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary site warrant neck dissection? Yes, neck dissection is often necessary to manage regional disease, prevent metastasis, and improve survival, but decisions should be individualized.",7.579511275419327e-07,0.38209392045392265,0.1662049861495845,0.058029646873019924,0.41173526712707353,0.15574022776238844,0.05794564931049173,0.44243495176425496,0.14465989535241613,7.57951127541933e-07,0.4742540772575503,0.13296398891966757
224,0.5,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is there a concern and a need for improvement regarding 30-day and 1-year mortality rates in emergency general surgery laparotomies? Answer: Emergency laparotomy is associated with a high mortality rate, particularly in patients over 70 years old, highlighting the need for enhanced efforts to improve outcomes in this demographic. This may include boosting acute surgical care staffing and early identification of patients in need.",7.105791820705622e-08,0.026348369793864457,0.015621063240110858,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
224,0.5,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are 30-day and 1-year mortality rates in emergency general surgery laparotomies an area that requires attention and improvement? Answer: Emergency laparotomy has a significant mortality rate, especially among those older than 70, indicating the necessity for improved care strategies, such as increasing acute surgical workforce and early detection of critical patients.",2.3685972735685406e-07,0.17904823144898518,0.0,0.018134264647818726,0.182321556793954,0.0,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
224,0.5,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is the mortality within 30 days and 1 year after emergency general surgery laparotomies a concern that demands improvement? Answer: Emergency laparotomy results in high mortality, notably in patients aged over 70 years, underscoring the importance of enhancing outcomes through measures like expanding acute surgical staffing and prompt patient recognition.",2.6054570009253947e-07,0.19885085874516495,0.0,0.0199476911126006,0.20252426411147262,0.0,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
224,0.5,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Do 30-day and 1-year mortality rates following emergency general surgery laparotomies represent a problem needing improvement? Answer: Mortality rates are elevated in emergency laparotomy cases, particularly for those above 70 years, necessitating improved interventions such as increasing acute surgical manpower and early patient identification.",4.026615365066519e-07,0.35819092028050115,0.02271498107084911,0.030828249901291835,0.33314444652853714,0.0,0.030783626196198732,0.33986782562235085,0.0,4.026615365066519e-07,0.34687094384211115,0.0
224,0.5,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is there a need to improve 30-day and 1-year mortality outcomes in emergency general surgery laparotomies? Answer: The mortality rate for emergency laparotomy is high, especially in patients over 70, indicating a pressing need to enhance care by expanding acute surgical resources and early recognition of at-risk patients.",3.079176455639103e-07,0.26855398578875,0.020823902218198284,0.023574544042164344,0.24419696051204154,0.0,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
224,0.5,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are 30-day and 1-year mortality rates after emergency general surgery laparotomies an area requiring improvement? Answer: Emergency laparotomy carries a significant mortality risk, particularly in individuals older than 70, suggesting the need for better outcomes through increased acute surgical care staffing and early patient detection.",3.789755637709665e-07,0.30421137440299084,0.0,0.029014823436509962,0.3101549283038376,0.0,0.028972824655245866,0.31633732821215643,0.0,3.789755637709665e-07,0.32277339226305113,0.0
224,0.5,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is improvement needed in 30-day and 1-year mortality rates for emergency general surgery laparotomies? Answer: Emergency laparotomy has a high mortality rate, especially in those over 70 years old, pointing to the necessity of measures like augmenting acute surgical manpower and early identification of patients needing care.",3.316036182995957e-07,0.2607262624632525,0.0,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
224,0.5,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Does the high mortality rate at 30 days and 1 year post-emergency general surgery laparotomies indicate a need for improvement? Answer: Emergency laparotomy mortality is notably high in patients over 70, emphasizing the need for enhanced acute surgical staffing and early recognition of patients requiring intervention.",3.552895910352811e-07,0.3123693016216045,0.021728395061728398,0.02720139697172809,0.2876820724517799,0.0,0.027162023114293,0.2933478099874569,0.0,3.552895910352811e-07,0.2992428948528567,0.0
224,0.5,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Are the 30-day and 1-year mortality rates in emergency general surgery laparotomies an issue that needs addressing? Answer: Mortality following emergency laparotomy is high, particularly among patients older than 70, highlighting the importance of increasing acute surgical care capacity and early patient identification.",4.263475092423373e-07,0.3496737484797481,0.0,0.03264167636607371,0.35667494393873156,0.0,0.0325944277371516,0.36396537720141087,0.0,4.263475092423373e-07,0.37156355643248284,0.0
224,0.5,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Question: Is there concern about 30-day and 1-year mortality in emergency general surgery laparotomies that calls for improvement? Answer: Emergency laparotomy is linked with elevated mortality rates, especially in those over 70 years, necessitating improvements such as boosting acute surgical manpower and early recognition of patients in need.",3.316036182995957e-07,0.2607262624632525,0.0,0.025387970506946217,0.2657031657330049,0.0,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
225,0.5,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the visual loss caused by amblyopia permanent? Answer: Amblyopia, commonly called lazy eye, usually begins in childhood. Without treatment, it may result in lasting vision impairment. Nonetheless, early diagnosis and interventions like vision therapy or corrective lenses can frequently reverse the condition, bringing back normal or near-normal sight.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
225,0.5,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia cause permanent vision loss? Answer: Amblyopia, or lazy eye, typically develops during childhood. If not treated, it can cause permanent vision loss. However, early detection and treatment such as vision therapy or glasses often allow for recovery of normal or near-normal vision.",1.1842986367842703e-07,0.17064404424326973,0.045351473922902494,0.009067132323909363,0.14224029896130297,0.023242630385487524,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.5,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is vision loss from amblyopia permanent? Answer: Amblyopia, also known as lazy eye, often appears in childhood. If untreated, it can cause permanent loss of vision. But with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed to restore normal or close to normal vision.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
225,0.5,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia lead to permanent visual impairment? Answer: Amblyopia, or lazy eye, usually starts in childhood. Without proper treatment, it may cause permanent vision loss. However, early diagnosis and treatment methods like vision therapy or corrective glasses can often restore normal or near-normal vision.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
225,0.5,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss from lazy eye permanent? Answer: Lazy eye, medically called amblyopia, often begins during childhood. If left untreated, it can cause lasting vision loss. Yet, early detection and treatment, such as vision therapy or corrective lenses, can frequently reverse the condition and restore normal or near-normal vision.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
225,0.5,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Can amblyopia cause permanent loss of vision? Answer: Amblyopia, known as lazy eye, typically develops in childhood. If untreated, it may result in permanent vision loss. Nevertheless, early detection and treatment, including vision therapy or corrective eyewear, can often reverse the condition and restore normal or near-normal sight.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.5,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss from amblyopia irreversible? Answer: Amblyopia, or lazy eye, commonly starts in childhood. If untreated, it can lead to permanent vision loss. However, with early diagnosis and treatment such as vision therapy or corrective glasses, the condition can often be reversed to regain normal or near-normal vision.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
225,0.5,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does lazy eye cause permanent vision loss? Answer: Lazy eye, medically known as amblyopia, often begins in childhood. If left untreated, it may cause permanent vision loss. Early detection and treatment, including vision therapy or corrective eyewear, can often reverse the condition and restore normal or near-normal vision.",2.3685972735685406e-08,0.07838155224939758,0.04158790170132326,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.5,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is vision loss due to amblyopia permanent? Answer: Amblyopia, also called lazy eye, usually starts during childhood. Without treatment, it can result in permanent vision loss. However, early diagnosis and interventions like vision therapy or corrective lenses can often reverse the condition and restore normal or near-normal vision.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.5,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Can vision loss from amblyopia be permanent? Answer: Amblyopia, commonly referred to as lazy eye, typically develops during childhood. If untreated, it can cause permanent vision loss. Nonetheless, with early detection and treatment such as vision therapy or corrective eyewear, the condition can often be reversed to restore normal or near-normal vision.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
226,0.5,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners serve as reasonable substitutes for faculty in undergraduate OSCEs on medical emergencies? It appears acceptable and justified to allow medical students to act as examiners in formative OSCE assessments in emergency medicine, although this may not be appropriate for summative evaluations.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
226,0.5,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners suitable replacements for faculty during undergraduate OSCEs focused on medical emergencies? Encouraging medical students to participate as examiners in formative emergency medicine OSCEs seems reasonable and justified, but their role in summative assessments is less certain.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.5,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable for student examiners to substitute for faculty in undergraduate OSCEs on medical emergencies? It is apparently permissible and justified to have medical students serve as examiners in formative OSCE testing for emergency medicine, but not necessarily in summative assessments.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
226,0.5,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners act as reasonable substitutes for faculty in undergraduate OSCEs related to medical emergencies? It seems justified and acceptable to involve medical students as examiners during formative emergency medicine OSCEs, although their participation in summative evaluations may not be advisable.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
226,0.5,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can medical students reasonably replace faculty as examiners in undergraduate OSCEs on medical emergencies? It appears justified and acceptable to have students officiate as examiners in formative emergency medicine OSCE testing, but not necessarily for summative assessments.",2.1317375462116823e-07,0.30015990470975895,0.055363321799307974,0.016320838183036854,0.2684499827465596,0.02854671280276816,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.5,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners justified as substitutes for faculty in undergraduate OSCEs on medical emergencies? Encouraging medical students to act as examiners in formative OSCEs for emergency medicine seems reasonable, but this may not extend to summative evaluations.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.5,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is the use of student examiners as substitutes for faculty in undergraduate emergency medicine OSCEs reasonable? It seems acceptable and justified to allow medical students to serve as examiners during formative OSCE testing, though this may not apply to summative assessments.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
226,0.5,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Could student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears justified and appropriate to encourage medical students to officiate in formative emergency medicine OSCEs, but not necessarily in summative assessments.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.5,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners a reasonable alternative to faculty in undergraduate OSCEs on medical emergencies? It seems justified and permissible to have medical students act as examiners during formative OSCE testing, though their involvement in summative assessments is less certain.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.5,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it appropriate for student examiners to substitute for faculty in undergraduate OSCEs on medical emergencies? Allowing medical students to officiate as examiners in formative emergency medicine OSCEs seems justified and acceptable, but this may not hold true for summative evaluations.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
227,0.5,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? At the studied gas flows, HFNC are not louder than BCPAP for preterm infants.",4.73719454713706e-08,0.08517611883165488,0.0057950850661626085,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
227,0.5,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? The gas flows examined show HFNC are not noisier than BCPAP for preterm infants.,0.0,0.10268847119406654,0.07359999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
227,0.5,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Is the noise level of high flow nasal cannulae higher than that of bubble CPAP for preterm infants? According to the gas flows tested, HFNC are not noisier than BCPAP for preterm infants.",1.184298636784265e-07,0.22926580920446593,0.04238251821019768,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
227,0.5,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? At the gas flows studied, HFNC do not generate more noise than BCPAP for preterm infants.",2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.5,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Do high flow nasal cannulae create more noise than bubble CPAP for preterm infants? The data from the studied gas flows indicate HFNC are not noisier than BCPAP for preterm infants.,7.10579182070559e-08,0.16183917481456245,0.04030630202140307,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.5,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Is there more noise from high flow nasal cannulae than from bubble CPAP in preterm infants? The gas flows analyzed show HFNC are not noisier than BCPAP for preterm infants.,4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.5,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae sound levels higher than bubble CPAP for preterm infants? At the tested gas flows, HFNC are not noisier than BCPAP for preterm infants.",0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
227,0.5,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Do high flow nasal cannulae emit more noise than bubble CPAP for preterm infants? The gas flows studied reveal HFNC are not noisier than BCPAP for preterm infants.,0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
227,0.5,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? Based on the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",2.36859727356853e-08,0.011629129321992782,0.035199999999999974,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
227,0.5,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Is the noise produced by high flow nasal cannulae greater than that of bubble CPAP for preterm infants? The gas flows examined demonstrate HFNC are not noisier than BCPAP for preterm infants.,9.47438909427412e-08,0.19611963673553268,0.041377777777777784,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
228,0.5,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? Yes, the coexistence of these two conditions typically worsens depression outcomes in adolescents. The simultaneous occurrence of major depression and alcohol use disorder can intensify depressive symptoms and severity, complicating treatment and potentially causing more severe and enduring effects.",2.6054570009253947e-07,0.12181536232273027,0.04325671595168677,0.0199476911126006,0.1415912135785451,0.03275669097043156,0.019918816950481533,0.16184616665030438,0.021299215893496606,2.6054570009253947e-07,0.18259447766153825,0.009111639660818321
228,0.5,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is comorbidity of major depression and alcohol use disorder in adolescence associated with poorer depression outcomes? Yes, adolescents with both major depression and alcohol use disorder tend to experience worse depression outcomes. The presence of both disorders can amplify depression symptoms and severity, making treatment more difficult and possibly leading to more significant and lasting impacts.",2.3685972735685406e-07,0.10113239476375924,0.04488520408163267,0.018134264647818726,0.12096156224197552,0.03412545398584181,0.018108015409528666,0.1412889429846329,0.022375267538644446,2.3685972735685406e-07,0.16213092094386283,0.009861993679977005
228,0.5,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the combination of major depression and alcohol use disorder in adolescence lead to more severe depression outcomes? Yes, comorbid major depression and alcohol use disorder during adolescence often result in poorer depression outcomes. The dual diagnosis can worsen depressive symptoms and severity, complicating effective treatment and potentially causing more profound and persistent effects.",2.8423167282822487e-07,0.14292939324040344,0.04156923185941046,0.02176111757738247,0.1626514468092095,0.031336565096952915,0.0217296184914344,0.18283245879826637,0.020181517538644472,2.8423167282822487e-07,0.20348439465271406,0.008331438124421449
228,0.5,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Can comorbidity of major depression and alcohol use disorder in adolescence cause poorer outcomes in depression? Yes, having both major depression and alcohol use disorder concurrently in adolescence frequently leads to worse depression outcomes. This comorbidity may intensify symptoms and severity, making treatment more challenging and possibly leading to more lasting and severe consequences.",2.8423167282822487e-07,0.16908589062002433,0.02352259656692017,0.02176111757738247,0.1626514468092095,0.031336565096952915,0.0217296184914344,0.18283245879826593,0.020181517538644472,2.8423167282822487e-07,0.20348439465271406,0.008331438124421449
228,0.5,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the presence of both major depression and alcohol use disorder in adolescence lead to worse depression outcomes? Yes, adolescents suffering from both disorders often face poorer outcomes in depression. The combined effect of these conditions can exacerbate symptoms and severity, hindering effective treatment and resulting in more significant and enduring effects.",3.316036182995957e-07,0.05061318717009655,0.13488520408163265,0.025387970506946217,0.09523413218403842,0.1077254539858418,0.025351221573340132,0.1412910662872653,0.07877526753864447,3.316036182995957e-07,0.1888546147281729,0.048261993679977015
228,0.5,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is the coexistence of major depression and alcohol use disorder during adolescence linked to poorer depression outcomes? Yes, the comorbidity of these disorders often leads to worse depression outcomes in adolescents. The simultaneous presence can heighten the severity of depressive symptoms, complicating treatment and potentially causing long-term negative effects.",4.026615365066519e-07,0.11123780898653068,0.13488520408163265,0.030828249901291835,0.15710953590212595,0.1077254539858418,0.030783626196198732,0.20446996790879757,0.07877526753864447,4.026615365066519e-07,0.2533931358657444,0.048261993679977015
228,0.5,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder in adolescence lead to poorer depression outcomes? Yes, the comorbidity of these disorders in adolescence frequently results in more severe depression outcomes. The presence of both conditions can worsen symptoms and severity, making treatment more difficult and possibly leading to more lasting impacts.",3.316036182995957e-07,0.07779542954499608,0.11528520408163266,0.025387970506946217,0.09523413218403842,0.1077254539858418,0.025351221573340132,0.1412910662872653,0.07877526753864447,3.316036182995957e-07,0.1888546147281729,0.048261993679977015
228,0.5,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Are depression outcomes poorer when major depression and alcohol use disorder co-occur in adolescence? Yes, adolescents with both major depression and alcohol use disorder typically experience worse depression outcomes. The combined disorders may increase symptom severity and complicate treatment, leading to more profound and enduring effects.",4.737194547137081e-07,0.3298090369152007,0.025510204081632654,0.03626852929563745,0.34909426379573105,0.0177254539858418,0.03621603081905733,0.36862945994525287,0.00940026753864448,4.737194547137081e-07,0.3884000245488801,0.0007619936799770008
228,0.5,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the combination of major depression and alcohol use disorder in adolescence result in worse depression outcomes? Yes, the coexistence of these two disorders often exacerbates depression outcomes in adolescents. The presence of both conditions can intensify symptoms and severity, making effective treatment more challenging and potentially causing long-lasting effects.",3.789755637709665e-07,0.09061852178379493,0.13488520408163265,0.029014823436509962,0.1360561267042928,0.1077254539858418,0.028972824655245866,0.1829637626878342,0.07877526753864447,3.789755637709665e-07,0.2314142291469694,0.048261993679977015
228,0.5,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is comorbidity of major depression and alcohol use disorder in adolescence associated with more severe depression outcomes? Yes, the simultaneous occurrence of these disorders in adolescence often leads to poorer depression outcomes. This comorbidity can worsen symptoms and severity, complicating treatment and possibly resulting in more profound and persistent effects.",3.789755637709665e-07,0.11891024343930301,0.1144858985260771,0.029014823436509962,0.1360561267042928,0.1077254539858418,0.028972824655245866,0.1829637626878342,0.07877526753864447,3.789755637709665e-07,0.2314142291469694,0.048261993679977015
229,0.5,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Does profound hypotension in coronary disease patients lead to myocardial ischemic events? Yes, severe hypotension can reduce coronary blood flow, risking myocardial ischemia by depriving heart tissue of oxygen and nutrients.",5.921493183921341e-07,0.4296983394277838,0.12456597222222221,0.04533566161954686,0.5189997453837352,0.0736,0.045270038523821714,0.6119309059972959,0.018860946745562133,5.921493183921352e-07,0.6554068525770984,0.0
229,0.5,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can significant hypotensive episodes cause myocardial ischemia in individuals with coronary disease? Indeed, profound hypotension may lower coronary perfusion, triggering myocardial ischemic events due to insufficient oxygen supply to the heart muscle.",5.684633456564488e-07,0.3969085166047921,0.12456597222222221,0.04352223515476498,0.4850981937080534,0.0736,0.04345923698286884,0.5768395861860269,0.018860946745562133,5.684633456564497e-07,0.6190392084062237,0.0
229,0.5,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Is there a risk of myocardial ischemia from severe hypotension in patients with coronary artery disease? Yes, marked hypotensive events can impair coronary circulation, potentially causing myocardial ischemia by limiting oxygen and nutrient delivery to the heart.",4.500334819780223e-07,0.2858849593316033,0.09681087018140588,0.03445510283085558,0.3309475138807949,0.0736,0.03440522927810447,0.4177748915563382,0.018860946745562133,4.500334819780227e-07,0.45473615711494775,0.0
229,0.5,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Do profound hypotensive events in coronary disease patients result in myocardial ischemic episodes? Yes, such hypotension can diminish coronary blood flow, increasing the likelihood of myocardial ischemia by depriving the myocardium of adequate oxygen and nutrients.",4.737194547137076e-07,0.2755476596005253,0.12456597222222221,0.03626852929563746,0.3599350507540464,0.0736,0.036216030819057346,0.44762785470601996,0.018860946745562133,4.737194547137081e-07,0.48550781578170144,0.0
229,0.5,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can profound hypotension trigger myocardial ischemia in patients suffering from coronary disease? Yes, these events can reduce coronary blood supply, leading to myocardial ischemic conditions due to inadequate oxygenation of the heart muscle.",5.447773729207635e-07,0.36515981829021227,0.12456597222222221,0.0417088086899831,0.4523083708850617,0.0736,0.04164843544191597,0.5429380345103452,0.018860946745562133,5.447773729207643e-07,0.5839478885949547,0.0
229,0.5,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Is myocardial ischemia a possible outcome of profound hypotension in coronary disease patients? Yes, severe hypotensive episodes can lower coronary perfusion, causing myocardial ischemia from insufficient oxygen and nutrient delivery to cardiac tissue.",5.447773729207635e-07,0.40848151707520985,0.09334849043241991,0.0417088086899831,0.4523083708850617,0.0736,0.04164843544191597,0.5429380345103452,0.018860946745562133,5.447773729207643e-07,0.5839478885949547,0.0
229,0.5,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Do patients with coronary disease experience myocardial ischemia due to profound hypotension? Yes, significant drops in blood pressure can decrease coronary blood flow, heightening the risk of myocardial ischemic events.",6.158352911278194e-07,0.46359989110346556,0.12456597222222221,0.04714908808432874,0.5540910651950042,0.0736,0.04708084006477459,0.6482985501681706,0.018860946745562133,6.158352911278206e-07,0.6931471805599454,0.0
229,0.5,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can profound hypotensive events in coronary artery disease patients cause myocardial ischemia? Yes, such events reduce blood flow to the heart, risking myocardial ischemia by failing to supply enough oxygen and nutrients.",5.684633456564488e-07,0.3969085166047921,0.12456597222222221,0.04352223515476498,0.4850981937080534,0.0736,0.04345923698286884,0.5768395861860269,0.018860946745562133,5.684633456564497e-07,0.6190392084062237,0.0
229,0.5,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Are myocardial ischemic events caused by profound hypotension in coronary disease patients? Yes, severe hypotension can compromise coronary circulation, leading to myocardial ischemia from inadequate oxygen and nutrient supply.",6.395212638635047e-07,0.49869121091473456,0.12456597222222221,0.04896251454911062,0.5904587093658789,0.0736,0.04889164160572746,0.6860388781510176,0.018860946745562133,6.39521263863506e-07,0.7323678937132279,0.0
229,0.5,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Does profound hypotension in coronary disease patients lead to myocardial ischemic events? Yes, it can reduce coronary blood flow and increase the risk of ischemia by depriving the heart muscle of necessary oxygen and nutrients.",4.974054274493929e-07,0.3045351964737768,0.12456597222222221,0.03808195576041934,0.3897880139037282,0.0736,0.03802683236001022,0.47839951337277364,0.018860946745562133,4.974054274493935e-07,0.5172565140962813,0.0
230,0.5,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should male HIV-infected patients over 52 with two or more cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was about four times more likely to be positive compared to the general population, suggesting that physicians might recommend more systematic screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.5,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","In male HIV-positive patients older than 52 years who have at least two additional cardiovascular risk factors, screening for silent myocardial ischemia using myocardial SPECT showed a positivity rate approximately four times higher than in the general population, potentially encouraging doctors to advise more routine screening.",4.500334819780227e-07,0.30889889480435695,0.03121748178980229,0.03445510283085558,0.35894509247327333,0.0,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
230,0.5,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it advisable to screen HIV-infected males over 52 with at least two cardiovascular risk factors for silent myocardial ischemia via gated myocardial perfusion SPECT? Such screening was found to be about four times more likely positive than in the general population, which may prompt physicians to recommend more thorough screening.",3.316036182995957e-07,0.20353837914653106,0.03121748178980229,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
230,0.5,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","For male HIV-infected patients above 52 years with two or more cardiovascular risk factors, screening for silent myocardial ischemia using myocardial SPECT was nearly four times more likely to yield positive results compared to the general population, possibly motivating doctors to suggest systematic screening.",4.974054274493935e-07,0.3543612688811142,0.03121748178980229,0.038081955760419325,0.40546510810816727,0.0,0.0380268323600102,0.4135623183407837,0.0,4.974054274493935e-07,0.4219944100593742,0.0
230,0.5,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should screening for silent myocardial ischemia using gated myocardial perfusion SPECT be performed in male HIV-positive patients older than 52 with at least two cardiovascular risk factors? The likelihood of a positive screening in this group was roughly four times that of the general population, which may encourage physicians to implement more routine screening.",2.6054570009253947e-07,0.1452694710225555,0.03121748178980229,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
230,0.5,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","In males infected with HIV who are older than 52 and have two or more cardiovascular risk factors, screening for silent myocardial ischaemia using myocardial SPECT was about four times more likely to be positive than in the general population, potentially motivating physicians to recommend more systematic screening.",4.026615365066519e-07,0.2654137828646186,0.03121748178980229,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
230,0.5,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Screening male HIV-infected patients over 52 years old with at least two cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT was about four times more likely to be positive than in the general population, which may prompt doctors to advise more systematic screening.",4.263475092423373e-07,0.28691998808558195,0.03121748178980229,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
230,0.5,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Among male HIV-infected patients older than 52 years with at least two other cardiovascular risk factors, the likelihood of a positive silent myocardial ischemia screening via myocardial SPECT was about four times higher than in the general population, possibly encouraging physicians to recommend more consistent screening.",4.500334819780227e-07,0.30889889480435695,0.03121748178980229,0.03445510283085558,0.35894509247327333,0.0,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
230,0.5,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should male patients with HIV, aged over 52 and having two or more cardiovascular risk factors, be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Positive screening in this group was about four times more frequent than in the general population, potentially motivating physicians to suggest more systematic screening.",3.316036182995957e-07,0.20353837914653106,0.03121748178980229,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
230,0.5,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","In male HIV-infected patients older than 52 years with at least two additional cardiovascular risk factors, screening for silent myocardial ischemia using myocardial SPECT was nearly four times more likely to be positive compared to the general population, which may encourage physicians to advise more systematic screening.",4.263475092423373e-07,0.28691998808558195,0.03121748178980229,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
231,0.5,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? Yes, it is regarded as less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.5,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Does robotically assisted laparoscopic radical prostatectomy involve less invasiveness than retropubic radical prostatectomy? Yes, it is considered to be less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.5,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Yes, it is seen as less invasive.",1.421158364141118e-07,0.15492204636022278,0.24000000000000005,0.010880558788691277,0.05675098530128997,0.20408163265306126,0.010864809245717241,0.04908820891058685,0.14876033057851235,1.4211583641411233e-07,0.16353329681216788,0.0793950850661626
231,0.5,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Yes, it is considered less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.5,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is there less invasiveness in robotically assisted laparoscopic radical prostatectomy than in retropubic radical prostatectomy? Yes, it is regarded as less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.5,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than the retropubic approach? Yes, it is considered less invasive.",2.605457000925385e-07,0.10290706294187668,0.24000000000000005,0.01994769111260067,0.21518273018235057,0.20408163265306126,0.019918816950481606,0.33677028136236675,0.14876033057851235,2.605457000925391e-07,0.46891494636334974,0.0793950850661626
231,0.5,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the robotically assisted laparoscopic method for radical prostatectomy less invasive than the retropubic method? Yes, it is seen as less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.5,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive relative to retropubic radical prostatectomy? Yes, it is considered less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
231,0.5,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the robotically assisted laparoscopic approach to radical prostatectomy less invasive than the retropubic approach? Yes, it is regarded as less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.5,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is generally considered less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
232,0.5,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
232,0.5,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Is using Nd:YAG laser-induced thermo therapy to locally open the rodent blood-brain barrier for paclitaxel a new adjuvant glioma treatment? Answer: Nd:YAG laser-induced thermo therapy represents an innovative glioma treatment method that locally disrupts the rodent blood-brain barrier to facilitate,1.1842986367842703e-07,0.17169448303326806,0.035953719723183425,0.009067132323909363,0.1682919547501971,0.03340771406718546,0.009054007704764333,0.16433741333177476,0.029226505416981616,1.1842986367842703e-07,0.1267517056391423,0.0
232,0.5,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Does Nd:YAG laser-induced thermo therapy offer a new method to open the rodent blood-brain barrier for paclitaxel in glioma treatment? Answer: This therapy introduces a novel glioma treatment by locally opening the rodent blood-brain barrier using Nd:YAG laser-induced heat to allow,9.474389094274162e-08,0.07430594662807266,0.012954254930606257,0.0072537058591274906,0.07010482778396288,0.017955279883857596,0.007243206163811466,0.10094507507642758,0.00238063831257343,9.474389094274162e-08,0.10008345855698142,0.0
232,0.5,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Can Nd:YAG laser-induced thermo therapy locally open the rodent blood-brain barrier for paclitaxel as a novel adjuvant glioma therapy? Answer: Nd:YAG laser-induced thermo therapy is a new glioma treatment approach that enables localized opening of the rodent blood-brain barrier to permit,9.474389094274162e-08,0.14193006180465284,0.03266581632653065,0.0072537058591274906,0.13941954583995697,0.030948656370032523,0.007243206163811466,0.13649108433591195,0.027889582908887926,9.474389094274162e-08,0.10008345855698142,0.0
232,0.5,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: What is the role of Nd:YAG laser-induced thermo therapy in locally opening the rodent blood-brain barrier for paclitaxel in glioma therapy? Answer: Nd:YAG laser-induced thermo therapy is an innovative technique in glioma treatment that locally disrupts the rodent blood-brain barrier to allow,7.105791820705622e-08,0.1460092248825018,0.050625,0.005440279394345618,0.11134572749075655,0.028603969340660812,0.0054324046228586,0.10939597588864602,0.02661886545938781,7.105791820705622e-08,0.07410797215372344,0.0
232,0.5,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Question: How does Nd:YAG laser-induced thermo therapy serve as a new adjuvant glioma therapy by opening the rodent blood-brain barrier for paclitaxel? Answer: This therapy is a novel glioma treatment strategy that uses Nd:YAG laser-induced heat to locally open the rodent blood-brain barrier, enabling",4.737194547137081e-08,0.011852121473418187,0.04000000000000001,0.0036268529295637453,0.014993045843371355,0.044021415823914375,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
232,0.5,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Is the local opening of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy a new concept for adjuvant glioma therapy with paclitaxel? Answer: Nd:YAG laser-induced thermo therapy offers a new glioma treatment by locally opening the rodent blood-brain barrier to facilitate,7.105791820705622e-08,0.1460092248825018,0.05062500000000003,0.005440279394345618,0.11134572749075655,0.028603969340660812,0.0054324046228586,0.10939597588864602,0.02661886545938781,7.105791820705622e-08,0.07410797215372344,0.0
232,0.5,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Question: Could Nd:YAG laser-induced thermo therapy be considered a new adjuvant glioma therapy by locally opening the rodent blood-brain barrier for paclitaxel? Answer: This method introduces a novel glioma therapy approach by using Nd:YAG laser-induced heat to selectively open the rodent blood-brain barrier, allowing",4.737194547137081e-08,0.02038728227355513,0.01733029257067717,0.0036268529295637453,0.014993045843371355,0.044021415823914375,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
232,0.5,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Question: Is there a novel glioma therapy concept involving Nd:YAG laser-induced thermo therapy to open the rodent blood-brain barrier for paclitaxel? Answer: Nd:YAG laser-induced thermo therapy is a pioneering glioma treatment that locally opens the rodent blood-brain barrier to permit,1.4211583641411233e-07,0.2023441924064815,0.0393853305785124,0.010880558788691236,0.19800912633866563,0.035989452644969486,0.0108648092457172,0.19297762963316822,0.030634920634920654,1.4211583641411244e-07,0.1541506798272576,0.0
232,0.5,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Question: Does the use of Nd:YAG laser-induced thermo therapy to open the rodent blood-brain barrier for paclitaxel represent a new adjuvant glioma treatment? Answer: This therapy is a novel glioma approach that uses Nd:YAG laser-induced heat to locally disrupt the rodent blood-brain barrier, enabling",4.737194547137081e-08,0.011852121473418187,0.04000000000000001,0.0036268529295637453,0.014993045843371355,0.044021415823914375,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
233,0.5,1,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Yes, colorectal cancer in young patients is recognized as a distinct clinical entity. It usually exhibits more aggressive behavior and is frequently diagnosed at later stages. Genetic predisposition,",0.0,0.03554600925948437,0.02420803615563867,0.0,0.0,0.0,0.0,0.037467415165403306,0.026871378180902013,0.0,0.03850817669777484,0.02775510204081633
233,0.5,2,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Yes, colorectal cancer in young patients is regarded as a distinct clinical entity. It tends to be more aggressive and is often identified at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.06441841816972405,0.026667093852791618,0.0018134264647818726,0.02878175029216612,0.001978458049886611,0.0018108015409528666,0.008827198864009844,0.025462962962962975,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
233,0.5,3,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young individuals a distinct clinical condition? Answer: Yes, colorectal cancer in young individuals is considered a distinct clinical entity. It is generally more aggressive and commonly detected at advanced stages. Genetic predisposition,",7.10579182070559e-08,0.13336172156276183,0.03456747404844296,0.005440279394345618,0.13122744784045715,0.03401558750451271,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.5,4,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in younger patients a separate clinical entity? Answer: Yes, colorectal cancer in younger patients is viewed as a distinct clinical entity. It often shows more aggressive characteristics and is diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.0058288376710153855,0.021626297577854642,0.0018134264647818726,0.029626200911009093,0.0020824800508438407,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.5,5,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young people a unique clinical entity? Answer: Yes, colorectal cancer in young people is acknowledged as a distinct clinical entity. It tends to be more aggressive and is frequently found at advanced stages. Genetic predisposition,",0.0,0.03554600925948437,0.02420803615563867,0.0,0.0,0.0,0.0,0.037467415165403306,0.026871378180902013,0.0,0.03850817669777484,0.02775510204081633
233,0.5,6,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer among young patients a distinct clinical entity? Answer: Yes, colorectal cancer among young patients is considered a distinct clinical entity. It usually behaves more aggressively and is often diagnosed at later stages. Genetic predisposition,",4.73719454713706e-08,0.09971817818041284,0.03065488299745442,0.0036268529295637453,0.0986556363940152,0.031007653061224494,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.5,7,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young patients constitute a distinct clinical entity? Answer: Yes, colorectal cancer in young patients constitutes a distinct clinical entity. It tends to be more aggressive and is typically diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.06713402344055774,0.026911224048442928,0.0018134264647818726,0.06709361607641151,0.028152395944603725,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.5,8,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young adults a distinct clinical entity? Answer: Yes, colorectal cancer in young adults is regarded as a distinct clinical entity. It often presents more aggressively and is diagnosed at later stages. Genetic predisposition,",4.73719454713706e-08,0.09971817818041284,0.03065488299745442,0.0036268529295637453,0.0986556363940152,0.031007653061224494,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.5,9,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in younger individuals a unique clinical entity? Answer: Yes, colorectal cancer in younger individuals is considered a distinct clinical entity. It tends to be more aggressive and is frequently diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.0058288376710153855,0.021626297577854642,0.0018134264647818726,0.029626200911009093,0.0020824800508438407,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.5,10,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients classified as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is classified as a distinct clinical entity. It generally exhibits more aggressive behavior and is often diagnosed at advanced stages. Genetic predisposition,",4.7371945471370706e-08,0.042755993834235895,0.05822220315771748,0.0036268529295637453,0.04720656811307311,0.06696137278440792,0.003621603081905733,0.05207288838711488,0.07421831695641223,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
234,0.5,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can analyzing APC mutations aid in making therapeutic choices for familial adenomatous polyposis? Yes, analyzing APC mutations can assist in therapeutic decisions for familial adenomatous polyposis by identifying mutation types, guiding targeted therapy selection, and predicting disease progression to enable personalized treatments.",2.3685972735685406e-07,0.1360438573739784,0.055012462069600296,0.018134264647818726,0.12610294603581673,0.06790709919644694,0.018108015409528666,0.11509176535895049,0.08098765432098766,2.3685972735685406e-07,0.14697145361151165,0.06222222222222222
234,0.5,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Yes, it helps determine the mutation type, informs targeted therapy options, and forecasts disease progression, allowing for tailored treatment plans.",4.7371945471370717e-07,0.28038048923998016,0.15143320713899402,0.03626852929563749,0.34447030043160387,0.11776859504132227,0.036216030819057374,0.41135758150212176,0.08098765432098766,4.737194547137081e-07,0.45235310316269395,0.06222222222222222
234,0.5,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation analysis play a role in therapeutic decision-making for familial adenomatous polyposis? Indeed, it can identify specific mutations, assist in choosing targeted therapies, and predict how the disease will progress, supporting personalized treatment strategies.",3.7897556377096597e-07,0.15901963223571336,0.15143320713899402,0.02901482343650997,0.21930715747759688,0.11776859504132227,0.02897282465524588,0.2821458500221148,0.08098765432098766,3.789755637709665e-07,0.31882171053817165,0.06222222222222222
234,0.5,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can therapeutic decisions in familial adenomatous polyposis benefit from APC mutation analysis? Yes, such analysis helps detect mutation types, directs appropriate targeted therapies, and anticipates disease progression to customize treatment.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.5,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis beneficial for therapeutic planning in familial adenomatous polyposis? Yes, it identifies mutation specifics, guides targeted therapy choices, and predicts disease course, enabling individualized treatment approaches.",5.447773729207631e-07,0.3821631835499226,0.15143320713899402,0.041708808689983126,0.4498308160894293,0.11776859504132227,0.041648435441915994,0.5205568734671124,0.08098765432098766,5.447773729207643e-07,0.5656817884696981,0.06222222222222222
234,0.5,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis influence treatment decisions in familial adenomatous polyposis? Yes, it aids in mutation identification, selection of targeted treatments, and prediction of disease trajectory, facilitating personalized care plans.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.5,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does analyzing APC mutations contribute to therapy decisions in familial adenomatous polyposis? Yes, it helps pinpoint mutation types, assists in targeted therapy selection, and forecasts disease progression to tailor treatments.",5.210914001850778e-07,0.3470718637386536,0.15143320713899402,0.03989538222520125,0.41346317191855464,0.11776859504132227,0.03983763390096312,0.48281654548426545,0.08098765432098766,5.210914001850789e-07,0.5264610753164156,0.06222222222222222
234,0.5,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis inform therapeutic strategies in familial adenomatous polyposis? Yes, it identifies mutation specifics, guides the choice of targeted therapies, and predicts disease development, allowing for personalized treatment plans.",4.974054274493925e-07,0.31317031206297186,0.15143320713899402,0.03808195576041937,0.37837185210728563,0.11776859504132227,0.03802683236001025,0.44644890131339077,0.08098765432098766,4.974054274493935e-07,0.48872074733356863,0.06222222222222222
234,0.5,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis a useful tool for therapeutic decisions in familial adenomatous polyposis? Yes, it helps detect the mutation type, supports targeted therapy selection, and predicts disease progression to customize patient care.",4.5003348197802187e-07,0.24863179092540033,0.15143320713899402,0.03445510283085561,0.31168047760861217,0.11776859504132227,0.0344052292781045,0.37745602982644,0.08098765432098766,4.500334819780227e-07,0.41726178335142494,0.06222222222222222
234,0.5,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can the analysis of APC mutations aid therapeutic decision-making in familial adenomatous polyposis? Yes, it can identify mutation types, guide targeted therapy choices, and predict disease progression, enabling personalized treatment planning.",4.974054274493925e-07,0.31317031206297186,0.15143320713899402,0.03808195576041937,0.37837185210728563,0.11776859504132227,0.03802683236001025,0.44644890131339077,0.08098765432098766,4.974054274493935e-07,0.48872074733356863,0.06222222222222222
235,0.5,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms might compromise their quality of life for experimental therapy.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered when choosing patients for phase I clinical trials? Answer: Older adults with more symptoms enrolled in PICT may trade off quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in deciding patients for phase I clinical trials? Answer: Older adults in PICT with higher symptom burden may give up quality of life for experimental therapies.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.5,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence significant in selecting patients for phase I clinical trials? Answer: Older adults enrolled in PICT experiencing more symptoms might sacrifice their quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom severity matter when enrolling patients in phase I clinical trials? Answer: Older adults with more symptoms in PICT may accept a reduction in quality of life for experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.5,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are patient symptoms relevant when considering phase I clinical trial candidates? Answer: Older adults in PICT who have greater symptom load may compromise their quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom levels influence patient selection for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms might trade quality of life for experimental therapy.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
235,0.5,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms affect the selection of patients for phase I clinical trials? Answer: Older adults participating in PICT with higher symptom counts may sacrifice quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom consideration important for phase I clinical trial patient enrollment? Answer: Older adults in PICT experiencing more symptoms may give up quality of life in exchange for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does the presence of symptoms impact patient eligibility for phase I clinical trials? Answer: Older adults with more symptoms enrolled in PICT might sacrifice quality of life for experimental treatments.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
236,0.5,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does a surgeon's prior experience affect their skill in performing transurethral resection of the prostate? The senior urologist was able to resect tissue at a rate four times higher than less experienced surgeons, suggesting that experience is crucial to minimizing the risk of repeat TURP caused by recurring or incompletely removed adenomas.",1.8948778188548325e-07,0.14571181118139354,0.0,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
236,0.5,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the capability to perform transurethral resection of the prostate dependent on the surgeon's experience? The senior urologist resected tissue four times faster than novice surgeons, indicating that experience may be key to lowering the chance of secondary TURP from recurring or partially excised adenomas.",3.552895910352811e-07,0.2933478099874569,0.0,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
236,0.5,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does previous surgical experience influence the ability to conduct transurethral resection of the prostate? The senior urologist resected four times more tissue per unit time compared to less experienced surgeons, implying that experience helps reduce the risk of repeat TURP due to recurrent or incompletely removed adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.5,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the proficiency in transurethral resection of the prostate affected by the surgeon's prior experience? The senior urologist's tissue resection rate was four times greater than that of inexperienced surgeons, suggesting experience plays a role in decreasing secondary TURP risk from recurring or incompletely resected adenomas.",3.316036182995957e-07,0.2708749541353992,0.0,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
236,0.5,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does a surgeon's experience impact their performance in transurethral resection of the prostate? The senior urologist resected tissue at a rate four times that of less experienced surgeons, indicating that experience may be important to prevent secondary TURP caused by recurring or incomplete adenomas.",3.789755637709665e-07,0.31633732821215643,0.0,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
236,0.5,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the ability to perform transurethral resection of the prostate influenced by prior surgical experience? The senior urologist could resect four times more tissue per time unit than inexperienced surgeons, highlighting the importance of experience in reducing secondary TURP risk due to recurrent or incompletely removed adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.5,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does the surgeon's previous experience affect their ability to perform transurethral resection of the prostate? The senior urologist resected tissue four times faster than less experienced surgeons, suggesting that experience is vital to minimizing the risk of secondary TURP from recurring or incomplete adenomas.",3.789755637709665e-07,0.31633732821215643,0.0,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
236,0.5,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is prior experience a factor in the ability to perform transurethral resection of the prostate? The senior urologist was able to resect four times more tissue per unit time than less experienced surgeons, indicating that experience may reduce the risk of secondary TURP due to recurring or incompletely excised adenomas.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.5,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does the surgeon's experience influence their skill in transurethral resection of the prostate? The senior urologist resected four times more tissue per time unit compared to less experienced surgeons, implying that experience is important in lowering the risk of secondary TURP caused by recurrent or incomplete adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.5,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the effectiveness of performing transurethral resection of the prostate related to the surgeon's experience? The senior urologist resected tissue at a rate four times higher than less experienced surgeons, suggesting that experience may help reduce the risk of secondary TURP due to recurring or incompletely removed adenomas.",2.8423167282822487e-07,0.22738984219566083,0.0,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
237,0.5,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol and an antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not seem to enhance IVF outcomes in the microdose leuprolide protocol versus standard OCP in poor responders. Well-powered randomized trials are warranted to determine the best steroid pretreatment method.,1.4211583641411244e-07,0.16030677249034575,0.04162473246135549,0.010880558788691236,0.1313292907162995,0.021177564178632202,0.0108648092457172,0.10601989389366206,0.0017866941015089038,1.4211583641411244e-07,0.10536051565782412,0.0
237,0.5,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is estradiol and antagonist pretreatment prior to microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Estradiol plus antagonist pretreatment does not improve IVF results in the microdose leuprolide protocol when compared to standard OCP in poor responders. Randomized controlled trials with sufficient sample size are needed to identify the optimal steroid pretreatment strategy.,7.105791820705622e-08,0.03118642625045087,0.012448736926399612,0.005440279394345618,0.004877768200021393,0.0322222222222222,0.0054324046228586,0.02770471655935225,0.016388888888888897,7.105791820705622e-08,0.05129329438754926,0.0
237,0.5,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does using estradiol and antagonist pretreatment before microdose leuprolide enhance IVF outcomes in poor responders versus oral contraceptive pill use? Answer: Estradiol and antagonist pretreatment does not appear to improve IVF outcomes in the microdose leuprolide protocol compared to standard OCP in poor responders. Adequately powered randomized trials are justified to evaluate the best steroid pretreatment approach.,1.4211583641411244e-07,0.1603067724903462,0.04162473246135552,0.010880558788691236,0.1313292907162995,0.02117756417863221,0.0108648092457172,0.10601989389366206,0.0017866941015089038,1.4211583641411244e-07,0.10536051565782412,0.0
237,0.5,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Estradiol and antagonist pretreatment before microdose leuprolide in IVF: does it improve outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not seem to enhance IVF outcomes in poor responders using the microdose leuprolide protocol compared to standard OCP. Randomized trials with enough power are needed to study optimal steroid pretreatment methods.,9.474389094274162e-08,0.12004952265893998,0.037718815301592185,0.0072537058591274906,0.09367708230690219,0.01934802571166211,0.007243206163811466,0.06941741297507864,0.0011493764172335573,9.474389094274162e-08,0.06899287148694988,0.0
237,0.5,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not improve IVF outcomes in the microdose leuprolide protocol relative to the standard OCP in poor responders. Randomized controlled trials with adequate power are warranted to determine the best steroid pretreatment.,1.4211583641411244e-07,0.1359858187864882,0.02503096083505793,0.010880558788691236,0.10657403426773016,0.0034430727023319688,0.0108648092457172,0.10601989389366206,0.0017866941015089038,1.4211583641411244e-07,0.10536051565782412,0.0
237,0.5,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is there an improvement in IVF outcomes in poor responders using estradiol and antagonist pretreatment before microdose leuprolide compared to oral contraceptive pills? Answer: Estradiol and antagonist pretreatment does not appear to improve IVF outcomes in the microdose leuprolide protocol compared to standard OCP in poor responders. Well-designed randomized trials are justified to find the optimal steroid pretreatment method.,9.474389094274162e-08,0.14354603725419235,0.05348155675970233,0.0072537058591274906,0.09367708230690264,0.019348025711662095,0.007243206163811466,0.06941741297507864,0.0011493764172335573,9.474389094274162e-08,0.06899287148694988,0.0
237,0.5,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Estradiol and antagonist pretreatment before microdose leuprolide in IVF: does it offer better outcomes for poor responders versus oral contraceptive pills? Answer: Pretreatment with estradiol plus antagonist does not improve IVF outcomes in poor responders with the microdose leuprolide protocol compared to standard OCP. Randomized trials with sufficient power are needed to explore the best steroid pretreatment approach.,1.1842986367842703e-07,0.020471607683193227,0.0443364920284404,0.009067132323909363,0.03936394427118994,0.0322222222222222,0.009054007704764333,0.0627960363706217,0.016388888888888897,1.1842986367842703e-07,0.08701137698962835,0.0
237,0.5,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol and antagonist prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not seem to enhance IVF outcomes in the microdose leuprolide protocol relative to standard OCP in poor responders. Adequately powered randomized trials are warranted to evaluate optimal steroid pretreatment methods.,1.1842986367842703e-07,0.1638813691783545,0.05562473246135553,0.009067132323909363,0.13664775908662152,0.03755349867489421,0.009054007704764333,0.11230654926776129,0.019276406035665272,1.1842986367842703e-07,0.11221672900999025,0.0181755829903978
237,0.5,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Estradiol and antagonist pretreatment before microdose leuprolide in IVF: is it superior to oral contraceptive pills for poor responders? Answer: Estradiol plus antagonist pretreatment does not improve IVF outcomes in poor responders using the microdose leuprolide protocol versus standard OCP. Randomized controlled trials with sufficient power are justified to identify the best steroid pretreatment strategy.,1.8948778188548325e-07,0.07618888320614436,0.0424634127860635,0.014507411718254981,0.0934311655414648,0.0322222222222222,0.014486412327622933,0.11785581355365027,0.016388888888888897,1.8948778188548325e-07,0.14310084364067155,0.0
237,0.5,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does the use of estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Estradiol and antagonist pretreatment does not appear to improve IVF outcomes in the microdose leuprolide protocol compared to the standard oral contraceptive pill in poor responders. Randomized trials with adequate power are needed to determine the optimal steroid pretreatment method.,2.3685972735685406e-08,0.09083677496320197,0.07211636483446941,0.0018134264647818726,0.027299175309119406,0.03097800759679533,0.0018108015409528666,0.005732515000031135,0.015833333333333317,2.3685972735685406e-08,0.01652930195121094,0.0
238,0.5,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access major surgery in newborns result in less pain? Minimal access major surgery in newborns is typically believed to cause less pain compared to conventional open surgery. This is because,2.36859727356853e-08,0.08205776787134944,0.032876464195145505,0.0018134264647818796,0.08347155215425639,0.03451424948677696,0.0018108015409528735,0.08489168909618305,0.0357444753049149,2.3685972735685406e-08,0.08630909177382762,0.03656714164955924
238,0.5,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Is pain reduced in newborns undergoing minimal access major surgery? Generally, minimal access major surgery in newborns is thought to be less painful than traditional open surgery. This is attributed to",4.73719454713706e-08,0.029881162109572923,0.023683547493071277,0.003626852929563759,0.019662890487660345,0.06122448979591838,0.003621603081905747,0.02342675258770832,0.06632653061224487,4.737194547137081e-08,0.02365571015042356,0.03443877551020409
238,0.5,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Do newborns experience less pain with minimal access major surgery? Minimal access major surgery in newborns is usually regarded as causing less pain than standard open surgery. This is due to,4.73719454713706e-08,0.029881162109572923,0.023683547493071277,0.003626852929563759,0.019662890487660345,0.06122448979591838,0.003621603081905747,0.02342675258770832,0.06632653061224487,4.737194547137081e-08,0.02365571015042356,0.03443877551020409
238,0.5,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is minimal access major surgery less painful for newborns? It is commonly accepted that minimal access major surgery in newborns leads to less pain than open surgery. This is because,7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.06664620128616727,0.024657348146359143,0.005432404622858621,0.06428512718019963,0.029344282091534828,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.5,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access surgery in newborns cause less pain? Minimal access major surgery in newborns is often considered less painful than traditional open surgery. This is attributed to,1.184298636784265e-07,0.15064494844650955,0.013073979591836732,0.009067132323909398,0.09505216153483698,0.05726326530612246,0.009054007704764368,0.08990193271929581,0.06632653061224487,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.5,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Are newborns less hurt by minimal access major surgery? Minimal access major surgery in newborns generally causes less pain than open surgery. This is because,1.894877818854824e-07,0.22991980740511675,0.03980435149266319,0.014507411718255037,0.22460913761272128,0.05227483555405634,0.014486412327622988,0.2177353042291803,0.06632653061224487,1.8948778188548325e-07,0.27497013843133145,0.03443877551020409
238,0.5,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is the pain less severe in newborns undergoing minimal access major surgery? Minimal access major surgery in newborns tends to cause less pain than conventional open surgery. This is due to,4.73719454713706e-08,0.029881162109572923,0.023683547493071277,0.003626852929563759,0.019662890487660345,0.06122448979591838,0.003621603081905747,0.02342675258770832,0.06632653061224487,4.737194547137081e-08,0.02365571015042356,0.03443877551020409
238,0.5,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Does minimal access surgery reduce pain in newborns? Minimal access major surgery in newborns is believed to cause less pain compared to traditional open surgery. This is because,1.184298636784265e-07,0.04795647725244301,0.08546673107112668,0.009067132323909398,0.0417331476456102,0.09566326530612247,0.009054007704764368,0.08990193271929581,0.06632653061224487,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.5,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Is pain minimized in newborns by using minimal access major surgery? Minimal access major surgery in newborns typically results in less pain than open surgery. This is attributed to,9.47438909427412e-08,0.1087761361759525,0.016848979591836705,0.007253705859127518,0.055337055259796486,0.058681016785412425,0.007243206163811494,0.05068121956601335,0.06632653061224487,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
238,0.5,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Do newborns suffer less pain from minimal access major surgery? Generally, minimal access major surgery in newborns is thought to be less painful than traditional open surgery. This is due to",4.73719454713706e-08,0.016328649927756622,0.05612244897959186,0.003626852929563759,0.019662890487660345,0.06122448979591838,0.003621603081905747,0.02342675258770832,0.06632653061224487,4.737194547137081e-08,0.02365571015042356,0.03443877551020409
239,0.5,1,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there a connection between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in patients with hypertension? Research suggests a possible association between ACE-1 gene polymorphism and chronic kidney disease among those with hypertension, though the link is not fully established.",7.1057918207056e-08,0.12581420237119234,0.03274498456790119,0.005440279394345618,0.08920176601933338,0.007754310784613777,0.0054324046228586,0.050421033290631634,0.02102556708958092,7.105791820705622e-08,0.04888364744311113,0.02392242299970098
239,0.5,2,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in hypertensive individuals? Studies show a potential correlation between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, but the relationship remains inconclusive.",4.73719454713706e-08,0.010788655273344716,0.04296875,0.0036268529295637453,0.024525421446334406,0.02155880538337923,0.00362160308190574,0.06168878756909857,0.003230428200692026,4.737194547137081e-08,0.0612410097391578,0.0017267246972318406
239,0.5,3,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in patients suffering from hypertension? Evidence points to a possible connection between ACE-1 gene polymorphism and chronic kidney disease among hypertensive patients, although the association is not definitive.",2.36859727356853e-08,0.07981809075635082,0.07189392301038065,0.0018134264647818726,0.08396250977572084,0.0787646408425629,0.0018108015409528666,0.04884547642885284,0.055363321799307974,2.3685972735685406e-08,0.010620873444459722,0.02854671280276816
239,0.5,4,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is chronic kidney disease among hypertensive patients influenced by angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Research indicates a potential link between ACE-1 gene polymorphism and chronic kidney disease in those with hypertension, but the connection is not completely clear.",2.36859727356853e-08,0.11728550592175369,0.09846619897959183,0.0018134264647818726,0.08396250977572084,0.0787646408425629,0.0018108015409528666,0.04884547642885284,0.055363321799307974,2.3685972735685406e-08,0.010620873444459722,0.02854671280276816
239,0.5,5,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease in hypertensive patients? Studies suggest there may be an association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive individuals, though the exact relationship is uncertain.",4.73719454713706e-08,0.09689508258228452,0.029894770408163268,0.0036268529295637453,0.09587536636857763,0.030130853994490336,0.003621603081905733,0.058120713554252745,0.002894185996838834,4.737194547137081e-08,0.05771084630712098,0.001540539963261995
239,0.5,6,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there evidence that angiotensin-converting enzyme-1 (ACE-1) gene polymorphism causes chronic kidney disease in patients with hypertension? Research indicates a possible association between ACE-1 gene polymorphism and chronic kidney disease among hypertensive patients, but the relationship is not fully understood.",2.36859727356853e-08,0.13822604195952604,0.0759548611111111,0.0018134264647818726,0.14005647718798553,0.08022317604627185,0.0018108015409528666,0.10441532758366501,0.055363321799307974,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
239,0.5,7,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to the development of chronic kidney disease in hypertensive patients? Studies suggest a potential link between ACE-1 gene polymorphism and chronic kidney disease in those with hypertension, although the relationship is not entirely clear.",7.1057918207056e-08,0.1596262599594822,0.05592300493060626,0.005440279394345618,0.15851648407532748,0.056658247038503896,0.0054324046228586,0.12151305180959993,0.02974005310124702,7.105791820705622e-08,0.12184650855468426,0.02854671280276816
239,0.5,8,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can chronic kidney disease in hypertensive patients be attributed to angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Research points to a possible association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive individuals, but the link is not definitive.",2.36859727356853e-08,0.042350675590948406,0.04582400711662077,0.0018134264647818726,0.0069461563801711534,0.02387511478420569,0.0018108015409528666,0.030371344206569173,0.0015696442245671308,2.3685972735685406e-08,0.030152490117890007,0.0008380438547157774
239,0.5,9,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism a factor in chronic kidney disease among patients with hypertension? Studies indicate a potential connection between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients, but the relationship remains uncertain.",2.36859727356853e-08,0.07981809075635082,0.07189392301038065,0.0018134264647818726,0.08396250977572084,0.0787646408425629,0.0018108015409528666,0.04884547642885284,0.055363321799307974,2.3685972735685406e-08,0.010620873444459722,0.02854671280276816
239,0.5,10,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism have a role in causing chronic kidney disease in hypertensive patients? Research suggests a possible link between ACE-1 gene polymorphism and chronic kidney disease in those with hypertension, although the association is not fully established.",4.73719454713706e-08,0.13155244161028135,0.053578317901234546,0.0036268529295637453,0.13142137562806155,0.05538752958900378,0.003621603081905733,0.09460214411003953,0.0290667549622006,4.737194547137081e-08,0.0951782614725234,0.02854671280276816
240,0.5,1,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care during a woman's initial pregnancy affect her subsequent reproductive outcomes? Yes, care at a birth center in a first pregnancy can influence future reproduction by offering thorough prenatal services, encouraging healthy pregnancy behaviors, and lowering complication risks.",1.1842986367842703e-07,0.09221328412603524,0.14182998614958445,0.009067132323909363,0.0670562124929357,0.13017751479289946,0.009054007704764333,0.036905462338642,0.11176857330703485,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
240,0.5,2,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care in a woman's first pregnancy influence her future reproductive health? Indeed, such care supports future reproduction by delivering comprehensive prenatal care, fostering healthy habits during pregnancy, and minimizing complications.",3.3160361829959484e-07,0.1218108221902563,0.16620498614958445,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.2254588021288475,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
240,0.5,3,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an effect of birth center care during a woman's first pregnancy on her later reproductive experiences? Yes, birth center care provides extensive prenatal support, promotes healthy pregnancy practices, and decreases the likelihood of complications, thereby impacting future reproduction.",1.6580180914979774e-07,0.004922902620693392,0.115072772855209,0.012693985253473108,0.02071851245040035,0.10388094795579209,0.012675610786670066,0.01573827114677684,0.11176857330703485,1.6580180914979784e-07,0.04872356224955565,0.09204470742932283
240,0.5,4,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does care at a birth center during a woman’s first pregnancy have consequences for her future reproduction? Yes, it can positively affect future reproductive outcomes by offering complete prenatal care, encouraging healthy habits, and reducing complication risks.",2.3685972735685364e-07,0.004027786533872479,0.16620498614958445,0.018134264647818726,0.06647518013158704,0.13017751479289946,0.018108015409528673,0.10029565917484051,0.11176857330703485,2.3685972735685406e-07,0.13573493923918578,0.09204470742932283
240,0.5,5,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can the care received at a birth center during a woman’s initial pregnancy affect her subsequent reproductive health? Yes, it does by providing comprehensive prenatal care, promoting healthy pregnancy routines, and lowering the chance of complications.",2.6054570009253894e-07,0.032198663500569324,0.16620498614958445,0.019947691112600606,0.09546271700483855,0.13017751479289946,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
240,0.5,6,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is birth center care during a woman’s first pregnancy influential on her future reproductive outcomes? Yes, it impacts future reproduction through thorough prenatal care, encouragement of healthy behaviors, and decreased complication risks.",3.5528959103528014e-07,0.15355952050483612,0.16620498614958445,0.027201396971728124,0.22062585995884554,0.13017751479289946,0.02716202311429304,0.25936035380452926,0.11176857330703485,3.552895910352811e-07,0.30003799053046176,0.09204470742932283
240,0.5,7,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care in a first pregnancy impact a woman’s future reproductive health? Yes, it can, by offering detailed prenatal care, supporting healthy pregnancy habits, and reducing the risk of complications.",3.3160361829959484e-07,0.1218108221902563,0.16620498614958445,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.2254588021288475,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
240,0.5,8,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care during a woman’s first pregnancy affect her future reproductive potential? Yes, it provides extensive prenatal care, promotes healthy pregnancy practices, and reduces complications, thereby influencing future reproduction.",3.7897556377096544e-07,0.18634934332782782,0.16620498614958445,0.029014823436510004,0.2545274116345273,0.13017751479289946,0.028972824655245914,0.29445167361579827,0.11176857330703485,3.789755637709665e-07,0.33640563470133644,0.09204470742932283
240,0.5,9,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an impact of birth center care during a woman’s first pregnancy on her later reproductive outcomes? Yes, it delivers comprehensive prenatal care, encourages healthy habits, and lowers complication risks, affecting future reproduction.",3.0791764556390954e-07,0.09103916352350261,0.16620498614958445,0.023574544042164365,0.156087338821274,0.13017751479289946,0.023540420032387294,0.1926689793058558,0.11176857330703485,3.079176455639103e-07,0.231045119043511,0.09204470742932283
240,0.5,10,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does birth center care during a woman’s first pregnancy have any bearing on her future reproductive health? Yes, it does by providing holistic prenatal care, fostering healthy pregnancy habits, and minimizing the risk of complications.",2.8423167282822424e-07,0.06118620037382083,0.16620498614958445,0.021761117577382486,0.12531568015452033,0.13017751479289946,0.02172961849143442,0.16092028099127598,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
241,0.5,1,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there a link between the CYP2D6*4 allele and breast cancer risk? Yes, multiple studies have found an association between the CYP2D6*4 allele and an increased risk of breast cancer.",0.0,0.11364954710359898,0.14537315689981095,0.0,0.049510512897140035,0.033288888888888826,0.0,0.0,0.0,0.0,0.0,0.0
241,0.5,2,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele influence breast cancer risk? Indeed, research has shown a connection between the CYP2D6*4 allele and breast cancer susceptibility.",1.894877818854824e-07,0.2159528814211269,0.14088426801092205,0.014507411718255037,0.2077449030886518,0.08902739304401353,0.014486412327622988,0.24870941564382276,0.07359999999999998,1.894877818854831e-07,0.31440576623609084,0.03840000000000001
241,0.5,3,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is the CYP2D6*4 allele related to breast cancer risk? Yes, several studies suggest that the CYP2D6*4 allele is associated with breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.5,4,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Can the CYP2D6*4 allele affect breast cancer risk? Yes, evidence from various studies indicates a correlation between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.10776005525117771,0.1522731568998109,0.010880558788691277,0.10613338527923633,0.09353741496598636,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.5,5,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there an association between the CYP2D6*4 allele and the risk of breast cancer? Yes, numerous studies have demonstrated a link between the CYP2D6*4 allele and breast cancer risk.",2.36859727356853e-08,0.0717291910306539,0.14088426801092205,0.0018134264647818796,0.007641700626582093,0.029513888888888867,0.0018108015409528735,0.04168988456723399,0.0027888888888888963,2.3685972735685406e-08,0.041353473708850785,0.001530555555555549
241,0.5,6,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does carrying the CYP2D6*4 allele increase breast cancer risk? Yes, research has identified an association between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.5,7,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is breast cancer risk connected to the CYP2D6*4 allele? Yes, several investigations have found an association between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.047486387376399986,0.19360535644629617,0.010880558788691277,0.04312000522833204,0.13888888888888887,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.5,8,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there any correlation between the CYP2D6*4 allele and breast cancer risk? Yes, multiple studies have reported an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.12425081286987005,0.06977315689981095,0.005440279394345639,0.1925455059424257,0.04861111111111113,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.5,9,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Are there links between the CYP2D6*4 allele and breast cancer risk? Yes, research studies have indicated an association between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.1762680893565669,0.06370667490535112,0.007253705859127518,0.2449199534720119,0.055016928285626404,0.007243206163811494,0.2987488503802247,0.09260498614958453,9.474389094274162e-08,0.30277521092665216,0.09456398891966755
241,0.5,10,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the presence of the CYP2D6*4 allele relate to breast cancer risk? Yes, a number of studies have confirmed an association between the CYP2D6*4 allele and breast cancer risk.",2.36859727356853e-08,0.12123970392779304,0.1741731568998109,0.0018134264647818796,0.11033017182064864,0.10190664036817881,0.0018108015409528735,0.06494814321121956,0.07359999999999998,2.3685972735685406e-08,0.014098300735944314,0.03840000000000001
242,0.5,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Research indicates a significant association exists between hs-CRP and carotid atherosclerosis in this population, with elevated hs-CRP levels serving as a reliable marker.",1.6580180914979742e-07,0.13200868859590598,0.031621299878665715,0.012693985253473108,0.16251735163509773,0.014072951135888197,0.012675610786670073,0.1941728480622058,0.005009756657483936,1.6580180914979784e-07,0.19237189264745602,0.0
242,0.5,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis among healthy Koreans? Studies show a notable relationship, where increased hs-CRP levels are a dependable indicator of carotid atherosclerosis.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.5,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Korean individuals? Evidence suggests a strong association, with higher hs-CRP levels reliably indicating carotid atherosclerosis.",4.50033481978021e-07,0.4219492666107465,0.11426592797783926,0.03445510283085566,0.5031543765599396,0.0710059171597633,0.034405229278104556,0.5887175557577025,0.024375,4.500334819780227e-07,0.6443570163905146,0.0
242,0.5,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Are elevated high-sensitivity C-reactive protein levels linked to carotid atherosclerosis in healthy Koreans? Research supports a significant connection, identifying hs-CRP as a trustworthy marker.",4.737194547137063e-07,0.46450888102954213,0.11426592797783926,0.03626852929563754,0.5476061391307736,0.0710059171597633,0.03621603081905743,0.6352375713925964,0.024375,4.7371945471370807e-07,0.6931471805599458,0.0
242,0.5,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Does research support an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Yes, elevated hs-CRP is a significant and reliable indicator of carotid atherosclerosis.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.5,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Findings suggest a meaningful link, with elevated hs-CRP levels being a reliable marker.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.5,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Can high-sensitivity C-reactive protein levels indicate carotid atherosclerosis in healthy Koreans? Research confirms a strong association, where increased hs-CRP is a dependable indicator.",4.974054274493916e-07,0.5089606436003762,0.11426592797783926,0.03808195576041942,0.5941261547656675,0.0710059171597633,0.0380268323600103,0.6840277355620277,0.024375,4.974054274493934e-07,0.744440474947496,0.0
242,0.5,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is high-sensitivity C-reactive protein a marker for carotid atherosclerosis in healthy Korean individuals? Studies reveal a significant correlation, with elevated hs-CRP levels serving as a reliable sign.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.5,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid",Do elevated high-sensitivity C-reactive protein levels associate with carotid atherosclerosis in healthy Koreans? Evidence indicates a significant and reliable connection.,5.684633456564476e-07,0.6555641177922515,0.11426592797783926,0.04352223515476506,0.7482768345929243,0.0710059171597633,0.04345923698286892,0.8465466650598019,0.024375,5.684633456564495e-07,0.9162907318741551,0.0
242,0.5,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid",Is there a significant relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Research confirms that elevated hs-CRP levels are a reliable indicator of carotid atherosclerosis.,3.789755637709651e-07,0.30416623095436224,0.11426592797783926,0.029014823436510025,0.38055205446760665,0.0710059171597633,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
243,0.5,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Primary eosinophilic esophagitis features a delicate esophageal lining that tears easily with minor trauma during routine endoscopy. This 'crêpe-paper' appearance can help endoscopists recognize the disease even when other mucosal changes are absent. Dilation is an effective treatment.,1.4211583641411244e-07,0.08805554507788438,0.015215399885444382,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
243,0.5,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Does the fragile nature of the esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? In this condition, the esophageal mucosa is so delicate that it tears with minimal trauma during standard diagnostic endoscopy. The 'crêpe-paper' sign may assist endoscopists in identifying the disease when no other mucosal abnormalities are visible. Dilation works well as a therapy.",2.3685972735685406e-08,0.005591856594737266,0.01626275510204081,0.0018134264647818726,0.006509884203991234,0.017236072637734686,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
243,0.5,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is esophageal mucosal fragility an endoscopic hallmark of primary eosinophilic esophagitis? This disease is marked by a fragile mucosal lining that tears easily under slight trauma during otherwise routine endoscopy. The 'crêpe-paper' sign can alert clinicians to the presence of eosinophilic esophagitis when other mucosal signs are missing. Dilation proves to be an effective intervention.,9.474389094274162e-08,0.02365571015042356,0.03443877551020409,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
243,0.5,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Can the fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis is identified by a fragile esophageal mucosa that tears readily with minor trauma during diagnostic endoscopy. The 'crêpe-paper' sign may help endoscopists detect the disease in the absence of other mucosal changes. Dilation is a successful treatment option.,2.3685972735685406e-08,0.018230396287864714,0.0006025468038455134,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
243,0.5,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the delicate nature of the esophageal mucosa a characteristic endoscopic feature of primary eosinophilic esophagitis? The disease causes the mucosa to be fragile and prone to tearing from minor trauma during routine endoscopy. This 'crêpe-paper' sign can alert doctors to the disease even if other mucosal alterations are not present. Dilation is effective in management.,7.105791820705622e-08,0.03051192350258969,0.01626319251980629,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
243,0.5,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Does primary eosinophilic esophagitis present with a fragile esophageal mucosa that serves as a pathognomonic endoscopic sign? The mucosa in this disease is easily torn by minor trauma during otherwise uneventful diagnostic endoscopy. The 'crêpe-paper' sign may indicate the disease when no other mucosal abnormalities are seen. Dilation is a useful treatment.,1.6580180914979784e-07,0.08081412399037369,0.03443877551020409,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
243,0.5,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the fragility of the esophageal mucosa a diagnostic endoscopic hallmark of primary eosinophilic esophagitis? This condition features a fragile esophageal lining that readily tears with minimal trauma during diagnostic endoscopy. The 'crêpe-paper' sign may alert endoscopists to the disease in the absence of other mucosal changes. Dilation is an effective therapeutic approach.,1.4211583641411244e-07,0.06139603813327099,0.03443877551020409,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
243,0.5,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Can fragile esophageal mucosa be regarded as a pathognomonic endoscopic sign of primary eosinophilic esophagitis? The disease is characterized by mucosa that tears easily from minor trauma during routine endoscopy. The 'crêpe-paper' sign can help identify the disease when other mucosal signs are lacking. Dilation is effective for treatment.,2.3685972735685406e-07,0.1703198783301385,0.013614873292005808,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
243,0.5,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Is fragility of the esophageal mucosa a hallmark endoscopic sign of primary eosinophilic esophagitis? In this disease, the mucosa is fragile and tears easily with slight trauma during diagnostic endoscopy. The 'crêpe-paper' sign may help endoscopists detect the disease when other mucosal changes are absent. Dilation is an effective treatment method.",1.8948778188548325e-07,0.10061675128655345,0.03443877551020409,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
243,0.5,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Does the fragile esophageal mucosa represent a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis involves mucosa that tears easily with minor trauma during diagnostic endoscopy. This 'crêpe-paper' sign may alert clinicians to the disease when other mucosal alterations are not evident. Dilation is an effective therapeutic option.,2.1317375462116866e-07,0.14911118025958014,0.014039469954648536,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
244,0.5,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? It may, depending on the patient's health status and the availability of follow-up care. Insufficient home or post-discharge support could lead to higher readmission rates, suggesting a decline in care quality.",3.316036182995957e-07,0.1602463836216983,0.08690828402366867,0.025387970506946217,0.21341630310607274,0.0533997864008544,0.025351221573340132,0.24335041448743988,0.03631185475258099,3.316036182995957e-07,0.2744324746518223,0.01851192595229618
244,0.5,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does early discharge from Winnipeg hospitals compromise care quality? Potentially, as it relies on the patient's condition and the post-discharge support they receive. Lack of adequate home care might increase readmissions, reflecting poorer quality of care.",5.210914001850784e-07,0.36609843782584717,0.08690828402366867,0.039895382225201205,0.4247253967732787,0.0533997864008544,0.03983763390096308,0.4604149197252676,0.03631185475258099,5.210914001850789e-07,0.497576025966032,0.01851192595229618
244,0.5,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Is the quality of care affected by earlier patient discharge from Winnipeg hospitals? It could be, contingent on the patient's medical needs and the follow-up care arrangements. Without proper home or post-discharge support, the chance of readmission rises, indicating lower care quality.",3.789755637709665e-07,0.20787443261095273,0.08690828402366867,0.029014823436509962,0.26220646727550445,0.0533997864008544,0.028972824655245866,0.2933608350621033,0.03631185475258099,3.789755637709665e-07,0.325725769039372,0.01851192595229618
244,0.5,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does releasing patients sooner from Winnipeg hospitals harm care quality? Possibly, depending on individual health and follow-up services. Inadequate home or post-hospital support can elevate readmission risks, showing a decline in care standards.",5.921493183921343e-07,0.45571059651553414,0.08690828402366867,0.045335661619546844,0.517098716904294,0.0533997864008544,0.0452700385238217,0.5557250995295928,0.03631185475258099,5.921493183921352e-07,0.5960160987792853,0.01851192595229618
244,0.5,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does earlier hospital discharge in Winnipeg reduce care quality? It might, based on the patient's condition and the support after discharge. Lack of sufficient home care may lead to more readmissions, implying a decrease in care quality.",4.974054274493931e-07,0.3379275608591503,0.08690828402366867,0.038081955760419325,0.3957378599000272,0.0533997864008544,0.038026832360010206,0.4305619565755858,0.03631185475258099,4.974054274493935e-07,0.4668043672992783,0.01851192595229618
244,0.5,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does discharging patients earlier from Winnipeg hospitals impact care quality negatively? It depends on the patient's health and the follow-up care provided. Without proper home care or post-discharge support, readmission rates may climb, indicating reduced care quality.",4.974054274493931e-07,0.3379275608591503,0.08690828402366867,0.038081955760419325,0.3957378599000272,0.0533997864008544,0.038026832360010206,0.4305619565755858,0.03631185475258099,4.974054274493935e-07,0.4668043672992783,0.01851192595229618
244,0.5,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Can early discharge from Winnipeg hospitals affect the quality of care? Yes, depending on the patient's status and post-discharge support. Insufficient home care can increase readmissions, suggesting a drop in the quality of care.",5.68463345656449e-07,0.5089567779166528,0.026554485896717585,0.043522235154764964,0.5286717173747117,0.022182304611052098,0.043459236982868826,0.5229352767066011,0.03631185475258099,5.684633456564497e-07,0.5621145471036035,0.01851192595229618
244,0.5,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does earlier discharge from Winnipeg hospitals lead to poorer care quality? It potentially does, based on individual patient needs and follow-up care. Without adequate support after discharge, readmissions may rise, reflecting diminished care quality.",5.68463345656449e-07,0.42493893784878045,0.08690828402366867,0.043522235154764964,0.48535001858971416,0.0533997864008544,0.043459236982868826,0.5229352767066011,0.03631185475258099,5.684633456564497e-07,0.5621145471036035,0.01851192595229618
244,0.5,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Is quality of care compromised by earlier discharge from Winnipeg hospitals? It may be, depending on the patient's condition and the availability of post-discharge care. Inadequate home support can increase readmission risk, indicating lower care quality.",5.210914001850784e-07,0.36609843782584717,0.08690828402366867,0.039895382225201205,0.4247253967732787,0.0533997864008544,0.03983763390096308,0.4604149197252676,0.03631185475258099,5.210914001850789e-07,0.497576025966032,0.01851192595229618
244,0.5,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does discharging patients sooner from Winnipeg hospitals adversely influence care quality? Possibly, depending on patient health and follow-up care. Without sufficient home or post-discharge support, readmission risk may increase, signaling reduced care quality.",5.921493183921343e-07,0.45571059651553414,0.08690828402366867,0.045335661619546844,0.517098716904294,0.0533997864008544,0.0452700385238217,0.5557250995295928,0.03631185475258099,5.921493183921352e-07,0.5960160987792853,0.01851192595229618
245,0.5,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a link between androgens and sexual desire in women? The current study found that FT and androstenedione showed a statistically significant correlation with sexual desire across the entire group of women. ADT-G did not demonstrate a stronger correlation than circulating androgens and thus is not a better measure than mass spectrometry of circulating androgens.,2.3685972735685406e-08,0.08944604600095385,0.10928814524741905,0.0018134264647818726,0.03206156537252758,0.036311854752580995,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
245,0.5,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does sexual desire in women correlate with androgens? In this study, FT and androstenedione were significantly correlated with sexual desire among all women studied. ADT-G did not have a stronger correlation than circulating androgens, so it is not a superior method compared to measuring circulating androgens via mass spectrometry.",1.8948778188548325e-07,0.02515655680623352,0.12477609778180175,0.014507411718254981,0.10677487948168984,0.036311854752580995,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
245,0.5,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there an association between androgens and women's sexual desire? The present research showed that FT and androstenedione had a statistically significant correlation with sexual desire in the total female cohort. ADT-G was not more strongly correlated than circulating androgens and therefore not better than measuring circulating androgens by mass spectrometry.,1.4211583641411244e-07,0.010905204207444008,0.10566944444444448,0.010880558788691236,0.06510218308112092,0.036311854752580995,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.5,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are androgens related to sexual desire in women? The study found that FT and androstenedione were significantly correlated with sexual desire in the overall group of women. ADT-G did not correlate more strongly than circulating androgens and is thus not superior to mass spectrometric measurement of circulating androgens.,2.1317375462116866e-07,0.07632008289009296,0.1031308641975309,0.016320838183036854,0.15841791864004184,0.014583459690852597,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
245,0.5,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a relationship between androgens and sexual desire in women? According to the current study, FT and androstenedione showed a statistically significant correlation with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens and is not better than measuring circulating androgens by mass spectrometry.",9.474389094274162e-08,0.022870744387819553,0.06921111111111115,0.0072537058591274906,0.052279090842322073,0.016711854752581003,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.5,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does sexual desire in women correlate with androgen levels? The study demonstrated that FT and androstenedione were statistically significantly correlated with sexual desire in the entire female cohort. ADT-G did not show a stronger correlation than circulating androgens and is therefore not superior to mass spectrometry for measuring circulating androgens.,1.6580180914979784e-07,0.0322395803911828,0.1048575826165686,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.5,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a correlation between androgen hormones and sexual desire in women? The current study found that FT and androstenedione were statistically significantly correlated with sexual desire in the total group of women. ADT-G was not more strongly correlated than circulating androgens and is not a better measurement than mass spectrometry of circulating androgens.,7.105791820705622e-08,0.05050248360208576,0.10792218377547103,0.005440279394345618,0.03233826955493324,0.017088479127821285,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
245,0.5,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are androgen levels linked to sexual desire in women? The study reported that FT and androstenedione had a statistically significant correlation with sexual desire in the whole cohort of women. ADT-G did not correlate more strongly than circulating androgens and thus is not superior to measuring circulating androgens by mass spectrometry.,1.4211583641411244e-07,0.03863109142984156,0.0858444545043006,0.010880558788691236,0.09339390473662901,0.01591254919702544,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.5,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a connection between androgens and sexual desire in women? The present study showed that FT and androstenedione were significantly correlated with sexual desire across the total female cohort. ADT-G did not have a stronger correlation than circulating androgens and therefore is not a better measure than mass spectrometric analysis of circulating androgens.,7.105791820705622e-08,0.05050248360208576,0.10792218377547103,0.005440279394345618,0.005678762610319854,0.036311854752580995,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
245,0.5,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Do androgens correlate with sexual desire in women? In this study, FT and androstenedione were statistically significantly correlated with sexual desire in the entire group of women. ADT-G did not show a stronger correlation than circulating androgens and is not superior to mass spectrometry for measuring circulating androgens.",2.1317375462116866e-07,0.10581570759477144,0.08206694214876038,0.016320838183036854,0.18855475257743093,0.007076574999485129,0.0162972138685758,0.21312809815217548,0.02221074380165289,2.1317375462116866e-07,0.18610227963385917,0.0
246,0.5,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a medically supervised weight loss program before surgery enhance the results of bariatric surgery? Yes, engaging in such a program preoperatively can greatly improve outcomes by boosting physical fitness and reducing surgical risks, resulting in safer operations, fewer complications, and better overall results.",4.737194547137081e-08,0.20098995678900122,0.1694667640613587,0.0036268529295637453,0.14252012451781804,0.13296398891966763,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
246,0.5,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can a preoperative medically supervised weight loss regimen improve the success of bariatric surgery? Indeed, participating in this program prior to surgery significantly benefits outcomes by improving patient fitness and minimizing surgical risk, which leads to safer procedures and fewer complications.",1.1842986367842703e-07,0.1286692952093751,0.1694667640613587,0.009067132323909363,0.06841215236409459,0.13296398891966763,0.009054007704764333,0.005343659020720537,0.09204470742932283,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
246,0.5,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is there an improvement in bariatric surgery outcomes with a medically supervised weight loss program before the operation? Yes, such a program can markedly enhance surgical results by increasing physical fitness and decreasing risks, thereby promoting safer surgeries and reducing complications.",1.1842986367842703e-07,0.1286692952093751,0.1694667640613587,0.009067132323909363,0.06841215236409459,0.13296398891966763,0.009054007704764333,0.005343659020720537,0.09204470742932283,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
246,0.5,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does undergoing a medically supervised weight loss program before bariatric surgery improve the surgery's effectiveness? Yes, this approach can substantially improve outcomes by enhancing patients' physical condition and lowering the risk involved, resulting in safer surgeries and fewer postoperative issues.",1.4211583641411233e-07,0.10335148722508336,0.1694667640613587,0.010880558788691236,0.04243666596083662,0.13296398891966763,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,0.5,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Will a preoperative weight loss program under medical supervision improve bariatric surgery outcomes? Yes, this program can significantly enhance results by improving physical fitness and lowering surgical risks, which leads to safer procedures and a reduction in complications.",1.8948778188548293e-07,0.05070775373966452,0.1694667640613587,0.014507411718254981,0.011630555309439572,0.13296398891966763,0.014486412327622933,0.0768944392162525,0.09204470742932283,1.8948778188548325e-07,0.11228806787292722,0.0710059171597633
246,0.5,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a medically supervised weight loss program prior to bariatric surgery lead to better surgical outcomes? Yes, such a program improves patients' fitness and diminishes surgical risks, contributing to safer operations and fewer complications.",2.8423167282822413e-07,0.06370259743808093,0.1694667640613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1982552962205193,0.09204470742932283,2.8423167282822487e-07,0.2374512108269342,0.0710059171597633
246,0.5,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can bariatric surgery outcomes be improved by a preoperative medically supervised weight loss program? Yes, it can notably improve results by boosting patients' physical fitness and reducing surgical risks, leading to safer surgeries and fewer complications.",2.3685972735685353e-07,0.004862097415147648,0.1694667640613587,0.018134264647818733,0.06878896914938792,0.13296398891966763,0.01810801540952868,0.13573493923918578,0.09204470742932283,2.3685972735685406e-07,0.1729126896893627,0.0710059171597633
246,0.5,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is the outcome of bariatric surgery better when patients participate in a medically supervised weight loss program before the operation? Yes, this program enhances physical fitness and lowers surgical risk, resulting in safer procedures and fewer complications.",2.1317375462116823e-07,0.023308779551549197,0.1694667640613587,0.016320838183036854,0.03980143227613642,0.13296398891966763,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.5,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a medically supervised weight loss program before bariatric surgery improve the surgery's success rate? Yes, it can substantially improve outcomes by enhancing physical fitness and decreasing surgical risks, leading to safer procedures and fewer complications.",2.3685972735685353e-07,0.004862097415147648,0.1694667640613587,0.018134264647818733,0.06878896914938792,0.13296398891966763,0.01810801540952868,0.13573493923918578,0.09204470742932283,2.3685972735685406e-07,0.1729126896893627,0.0710059171597633
246,0.5,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can preoperative medically supervised weight loss improve the results of bariatric surgery? Yes, this program significantly benefits outcomes by increasing physical fitness and reducing surgical risk, resulting in safer surgeries and fewer complications.",3.0791764556390943e-07,0.09447425610483462,0.1694667640613587,0.023574544042164372,0.16116228928040321,0.13296398891966763,0.0235404200323873,0.231045119043511,0.09204470742932283,3.079176455639103e-07,0.271352762502616,0.0710059171597633
247,0.5,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize the diagnostic features of child bipolar I disorder? Yes, the TEAM sample effectively generalizes these characteristics by offering a detailed overview of manic and hypomanic episodes in children, covering a wide range of bipolar I symptoms, which aids in early diagnosis and treatment planning.",2.6054570009253947e-07,0.07501912716162673,0.2102816907015736,0.0199476911126006,0.028155716177177492,0.1530793876824493,0.019918816950481533,0.01643206056336055,0.1262002743484225,2.6054570009253947e-07,0.06249403633992934,0.09719008264462808
247,0.5,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample successfully generalizes the diagnostic traits of child bipolar I disorder by thoroughly analyzing manic and hypomanic episodes in children, illustrating a broad spectrum of bipolar I symptoms and supporting early diagnosis and intervention.",5.684633456564497e-07,0.21489419392493359,0.2041590740020338,0.04352223515476494,0.25952635627460596,0.1530793876824493,0.0434592369828688,0.3106715335612993,0.1262002743484225,5.684633456564497e-07,0.3635991291238492,0.09719008264462808
247,0.5,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample apply to the diagnostic characteristics of child bipolar I disorder? Indeed, it generalizes these features by providing an extensive examination of manic and hypomanic episodes in children, highlighting a wide range of bipolar I symptoms for early diagnosis and treatment.",3.789755637709665e-07,0.026796410626312994,0.20831873522893746,0.029014823436509962,0.0729404006941925,0.1530793876824493,0.028972824655245866,0.1196162967985912,0.1262002743484225,3.789755637709665e-07,0.16785455199775523,0.09719008264462808
247,0.5,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The diagnostic characteristics of child bipolar I disorder are effectively generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which offers a comprehensive analysis of manic and hypomanic episodes in children, demonstrating a broad spectrum of symptoms that facilitate early diagnosis and treatment planning.",4.737194547137081e-07,0.08492665509261155,0.22914263744713573,0.03626852929563745,0.1618878867106881,0.1530793876824493,0.03621603081905733,0.21058807500431787,0.1262002743484225,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
247,0.5,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Is the ""Treatment of Early Age Mania (TEAM)"" sample representative of diagnostic features of child bipolar I disorder? Yes, it generalizes these characteristics by thoroughly assessing manic and hypomanic episodes in children, showcasing a wide array of bipolar I symptoms to aid early diagnosis and treatment.",4.500334819780227e-07,0.09326034059877353,0.20693189364548284,0.03445510283085558,0.13889836848598858,0.1530793876824493,0.034405229278104466,0.18705757759412345,0.1262002743484225,4.500334819780227e-07,0.2368474234847069,0.09719008264462808
247,0.5,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample generalizes the diagnostic features of child bipolar I disorder by providing a detailed evaluation of manic and hypomanic episodes in children, illustrating a comprehensive range of bipolar I symptoms that support early diagnosis and treatment strategies.",4.974054274493935e-07,0.14015557706428527,0.2059000070616482,0.038081955760419325,0.18541838412088252,0.1530793876824493,0.0380268323600102,0.23468562658337788,0.1262002743484225,4.974054274493935e-07,0.2856375876541386,0.09719008264462808
247,0.5,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize the diagnostic characteristics of child bipolar I disorder? Yes, it does by offering an in-depth analysis of manic and hypomanic episodes in children, covering a broad spectrum of bipolar I symptoms, which assists in early diagnosis and treatment planning.",3.789755637709665e-07,0.026796410626312994,0.20831873522893746,0.029014823436509962,0.0729404006941925,0.1530793876824493,0.028972824655245866,0.1196162967985912,0.1262002743484225,3.789755637709665e-07,0.16785455199775523,0.09719008264462808
247,0.5,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The diagnostic features of child bipolar I disorder are generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which delivers a thorough examination of manic and hypomanic episodes in children, reflecting a wide range of bipolar I symptoms that facilitate early diagnosis and intervention.",4.737194547137081e-07,0.11643334511806414,0.20642765637628663,0.03626852929563745,0.1618878867106881,0.1530793876824493,0.03621603081905733,0.21058807500431787,0.1262002743484225,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
247,0.5,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Is the ""Treatment of Early Age Mania (TEAM)"" sample applicable to the diagnostic characteristics of child bipolar I disorder? Yes, it generalizes these traits by providing a comprehensive review of manic and hypomanic episodes in children, highlighting a broad spectrum of bipolar I symptoms to aid in early diagnosis and treatment.",3.316036182995957e-07,0.015180829194874068,0.209150967309693,0.025387970506946217,0.03126770429362358,0.1530793876824493,0.025351221573340132,0.07705668237979468,0.1262002743484225,3.316036182995957e-07,0.12436944005801687,0.09719008264462808
247,0.5,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample effectively generalizes the diagnostic characteristics of child bipolar I disorder by offering a detailed study of manic and hypomanic episodes in children, demonstrating a wide range of bipolar I symptoms that support early diagnosis and treatment planning.",4.737194547137081e-07,0.11643334511806414,0.20642765637628663,0.03626852929563745,0.1618878867106881,0.1530793876824493,0.03621603081905733,0.21058807500431787,0.1262002743484225,4.737194547137081e-07,0.2609449750637669,0.09719008264462808
248,0.5,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese males? Yes, higher carotid artery pulsatility and resistance indexes may signal early vascular abnormalities in young obese males. These measurements, obtained via ultrasound, reflect blood flow changes and might help predict cardiovascular risk.",9.474389094274162e-08,0.06436295494311794,0.08063983078855178,0.0072537058591274906,0.06984851158623773,0.094499716553288,0.007243206163811466,0.07574087425036247,0.10642664539798194,9.474389094274162e-08,0.051271160531809024,0.09454059251246921
248,0.5,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? Indeed, elevated carotid artery pulsatility and resistance indexes can indicate early vascular problems in young obese males. Ultrasound measurement of these indexes reveals blood flow alterations that could forecast cardiovascular risk.",7.105791820705622e-08,0.08910811822061504,0.08333333333333334,0.005440279394345618,0.09397438169080807,0.0966167522985398,0.0054324046228586,0.0991707071694572,0.10779353346345404,7.105791820705622e-08,0.0745894820922457,0.09550045913682277
248,0.5,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can higher carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes are potential early indicators of vascular abnormalities in young obese males. These ultrasound-derived indexes show blood flow changes that may predict cardiovascular risk.",9.474389094274162e-08,0.022280442626874564,0.02831640504770694,0.0072537058591274906,0.018638362527797714,0.036324375410913934,0.007243206163811466,0.0146696275618039,0.043826591314693686,9.474389094274162e-08,0.01034192218463037,0.05084605724106023
248,0.5,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Yes, these elevated indexes in the carotid artery can be early indicators of vascular abnormalities in young obese males. They are measured using ultrasound and reflect changes in blood flow that might signal cardiovascular risk.",2.3685972735685406e-08,0.1640620501734702,0.10666666666666665,0.0018134264647818726,0.16829848993812657,0.11997991493383746,0.0018108015409528666,0.14445511271753775,0.11036250813889031,2.3685972735685406e-08,0.11966049933915812,0.09730098718756564
248,0.5,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an increase in carotid artery pulsatility and resistance indexes an early indication of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can serve as early signs of vascular abnormalities in young obese males. Ultrasound measurement of these indexes can detect blood flow changes that potentially predict cardiovascular risk.",4.737194547137081e-08,0.1019206224791378,0.03184904753320114,0.0036268529295637453,0.1282189679147283,0.05320216049382717,0.003621603081905733,0.1287966564871832,0.05790504122017569,4.737194547137081e-08,0.1293184167026542,0.06102560233388661
248,0.5,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Yes, higher carotid artery pulsatility and resistance indexes may be early signs of vascular abnormalities in young obese males. These indexes, measured by ultrasound, reflect blood flow changes that could indicate cardiovascular risk.",9.474389094274162e-08,0.00660068989645568,0.04470742932281399,0.0072537058591274906,0.010857262176881655,0.05499999999999999,0.007243206163811466,0.015467206375585185,0.06424747174301015,9.474389094274162e-08,0.020464619173589327,0.072562358276644
248,0.5,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can be early markers of vascular abnormalities in young obese males. These indexes are measured through ultrasound and may reveal changes in blood flow that predict cardiovascular risk.",0.0,0.07997852083383927,0.040816326530612235,0.0,0.08154672712469901,0.047941792861006,0.0,0.08317766166719309,0.05355799627337138,0.0,0.08487516496652381,0.05790123456790125
248,0.5,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Yes, elevated carotid artery pulsatility and resistance indexes can indicate early vascular abnormalities in young obese males. These ultrasound-measured indexes reflect blood flow changes that might predict cardiovascular risk.",1.4211583641411244e-07,0.047260237248861525,0.0381462543624706,0.010880558788691236,0.041804266337647,0.049097991689750736,0.0108648092457172,0.03583383663556283,0.059558018007658836,1.4211583641411244e-07,0.02929634206943188,0.0695138888888889
248,0.5,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can be early indicators of vascular abnormalities in young obese males. These indexes, assessed via ultrasound, reveal blood flow changes that may forecast cardiovascular risk.",0.0,0.07997852083383927,0.040816326530612235,0.0,0.08154672712469901,0.047941792861006,0.0,0.08317766166719309,0.05355799627337139,0.0,0.08487516496652381,0.057901234567901236
248,0.5,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do elevated carotid artery pulsatility and resistance indexes serve as early signs of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can act as early markers of vascular abnormalities in young obese males. These indexes are measured using ultrasound and indicate changes in blood flow that could predict cardiovascular risk.",7.105791820705622e-08,0.1254041847070373,0.03472222222222221,0.005440279394345618,0.15078613757571535,0.05570770321361054,0.0054324046228586,0.1508629088478317,0.059963983799981205,7.105791820705622e-08,0.15082744428090322,0.06250000000000001
249,0.5,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection necessary for metastatic carcinoma to cervical nodes from an unknown head and neck primary? Answer: Based on our experience, definitive radiotherapy targeting the neck and possible mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially for",3.079176455639103e-07,0.2227469153330417,0.010011356648788293,0.023574544042164344,0.23737987196399946,0.0181755829903978,0.023540420032387266,0.21570857282668943,0.0,3.079176455639103e-07,0.21936282847430322,0.0
249,0.5,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should neck dissection be performed for metastatic carcinoma in cervical nodes with an unknown head and neck primary? Answer: Our experience shows that definitive radiotherapy to the neck and potential mucosal regions, regardless of preceding neck dissection, provides effective local control in head and neck cancers of unknown primary. The indication for neck dissection, particularly for",3.079176455639103e-07,0.2227469153330417,0.010011356648788293,0.023574544042164344,0.23737987196399946,0.0181755829903978,0.023540420032387266,0.21570857282668943,0.0,3.079176455639103e-07,0.21936282847430322,0.0
249,0.5,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma to cervical nodes from an unknown head and neck primary site, is neck dissection required? Answer: We have found that definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The necessity of neck dissection, especially for",2.1317375462116866e-07,0.14880299255637652,0.006473066092809225,0.016320838183036854,0.1654667758656423,0.01694411414982164,0.0162972138685758,0.14424960884454574,0.0,2.1317375462116866e-07,0.14660347419187403,0.0
249,0.5,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Metastatic carcinoma in cervical nodes from an unknown head and neck primary: is neck dissection needed? Answer: Our experience indicates that definitive radiotherapy to the neck and potential mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",3.316036182995957e-07,0.24211570755109646,0.010975475573377684,0.025387970506946217,0.2561957764103502,0.01851192595229618,0.025351221573340132,0.23440070583884376,0.0,3.316036182995957e-07,0.23841102344499632,0.0
249,0.5,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is there a need for neck dissection in metastatic carcinoma to cervical nodes from an unknown head and neck primary? Answer: According to our experience, definitive radiotherapy to the neck and potential mucosal sites, whether preceded by neck dissection or not, is effective for achieving good local control in unknown primary cancers of the head and neck. The role of neck dissection, especially for",1.1842986367842703e-07,0.058271452147805824,0.012170947962263826,0.009067132323909363,0.0763729787845735,0.0,0.009054007704764333,0.07755823434587317,0.0,1.1842986367842703e-07,0.07878087785311383,0.0
249,0.5,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should patients with metastatic carcinoma to cervical nodes from an unknown head and neck primary undergo neck dissection? Answer: Our experience suggests that definitive radiotherapy to the neck and possible mucosal sites, regardless of prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",3.079176455639103e-07,0.2227469153330417,0.010011356648788293,0.023574544042164344,0.23737987196399946,0.0181755829903978,0.023540420032387266,0.21570857282668943,0.0,3.079176455639103e-07,0.21936282847430322,0.0
249,0.5,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma to cervical nodes with an unknown head and neck primary, is neck dissection necessary? Answer: In our experience, definitive radiotherapy to the neck and potential mucosal areas, whether preceded by neck dissection or not, is effective in achieving good local control in unknown primary head and neck cancers. The indication for neck dissection, especially for",2.6054570009253947e-07,0.18509470692364438,0.008181818181818193,0.0199476911126006,0.20077739104541603,0.017538265306122455,0.019918816950481533,0.1793409286558152,0.0,2.6054570009253947e-07,0.18232155679395312,0.0
249,0.5,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection indicated for metastatic carcinoma to cervical nodes from an unknown head and neck primary site? Answer: Our experience shows that definitive radiotherapy to the neck and possible mucosal sites, with or without preceding neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, particularly for",2.8423167282822487e-07,0.2037444299995057,0.009080706050402995,0.02176111757738247,0.2189112708895289,0.017851239669421492,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
249,0.5,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma to the cervical nodes from an unknown head and neck primary, should neck dissection be performed? Answer: According to our experience, definitive radiotherapy targeting the neck and potential mucosal sites, whether or not preceded by neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The indication for neck dissection, especially for",1.8948778188548325e-07,0.1311373837517893,0.005660321734259684,0.014507411718254981,0.14826804897267376,0.016661878770468257,0.014486412327622933,0.12715517548524602,0.0,1.8948778188548325e-07,0.1292117314800052,0.0
249,0.5,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: In cases of metastatic carcinoma to cervical nodes from an unknown head and neck primary, is neck dissection required? Answer: Our experience indicates that definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, is effective for achieving good local control in unknown primary cancers of the head and neck. The indication for neck dissection, particularly for",1.4211583641411244e-07,0.07470745512840438,0.0116765243502924,0.010880558788691236,0.09237332013101707,0.0,0.0108648092457172,0.09381875521765437,0.0,1.4211583641411244e-07,0.09531017980432477,0.0
250,0.5,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery results in noticeable injury to Kupffer and endothelial cells, indicated by increased postoperative HA serum levels. However, the harm to liver hepatocytes and perisinusoidal cells lacks clinical importance, with the laparoscopic technique itself likely responsible.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.5,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? The laparoscopic approach leads to measurable damage in Kupffer and endothelial cells, evidenced by elevated HA serum levels after surgery. This damage to liver hepatocytes and perisinusoidal cells is clinically insignificant, and the laparoscopic method is probably the cause.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856639,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
250,0.5,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does undergoing laparoscopic cholecystectomy impact peri-sinusoidal cells? Laparoscopic operations cause detectable injury to Kupffer and endothelial cells, as shown by higher postoperative HA serum levels. The liver hepatocyte and perisinusoidal cell damage is not clinically relevant, with the laparoscopic procedure itself being the likely cause.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.5,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Can laparoscopic cholecystectomy alter peri-sinusoidal cell function? Laparoscopic techniques induce noticeable damage to Kupffer and endothelial cells, reflected by increased HA serum levels post-surgery. Damage to liver hepatocytes and perisinusoidal cells is clinically insignificant, probably due to the laparoscopic procedure.",2.6054570009253936e-07,0.2562814813355869,0.00563159856061822,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
250,0.5,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? The laparoscopic method causes detectable injury to Kupffer and endothelial cells, indicated by elevated post-operative HA serum levels. Damage to liver hepatocytes and perisinusoidal cells holds no clinical significance, with the laparoscopic procedure itself likely responsible.",1.1842986367842703e-07,0.1084411697936476,0.0022190736642101576,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.5,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Laparoscopic surgery causes measurable harm to Kupffer and endothelial cells, as reflected by increased HA serum levels after the operation. The damage to liver hepatocytes and perisinusoidal cells is not clinically significant, and the procedure itself is probably the cause.",7.105791820705622e-08,0.034149516495689536,0.019991670137442734,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
250,0.5,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy influence the activity of peri-sinusoidal cells? Laparoscopic procedures lead to detectable damage in Kupffer and endothelial cells, demonstrated by elevated postoperative HA serum levels. The damage to liver hepatocytes and perisinusoidal cells is clinically insignificant, likely caused by the laparoscopic technique.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
250,0.5,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is the activity of peri-sinusoidal cells influenced by laparoscopic cholecystectomy? Laparoscopic surgery results in measurable injury to Kupffer and endothelial cells, shown by raised HA serum levels post-operation. Damage to liver hepatocytes and perisinusoidal cells has no clinical importance, with the laparoscopic procedure probably responsible.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.5,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy impact peri-sinusoidal cell activity? The laparoscopic approach causes detectable damage to Kupffer and endothelial cells, reflected by increased postoperative HA serum levels. The injury to liver hepatocytes and perisinusoidal cells is clinically insignificant, and the laparoscopic procedure itself is likely the cause.",1.4211583641411244e-07,0.1316141743129382,0.002723310933406376,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.5,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? Laparoscopic procedures cause measurable damage to Kupffer and endothelial cells, as indicated by elevated HA serum levels after surgery. The damage to liver hepatocytes and perisinusoidal cells lacks clinical significance, with the laparoscopic technique itself being the probable cause.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856639,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
251,0.5,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does losing consciousness indicate neuropsychological decline after a concussion? The findings of this research question the significance of LOC in forecasting neuropsychological test outcomes in the early recovery stage from mild traumatic brain injury. Cognitive sequelae have been effectively measured by neuropsychological testing methods.,2.6054570009253947e-07,0.22778393087071303,0.0,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
251,0.5,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is loss of consciousness a predictor of neuropsychological impairments following a concussion? This study’s results challenge the relevance of LOC as an indicator of neuropsychological test performance during the acute recovery period after mild traumatic brain injury. Neuropsychological tests are sensitive tools for detecting cognitive aftereffects.,2.1317375462116866e-07,0.21312809815217548,0.02221074380165289,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.5,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Can loss of consciousness predict neuropsychological deficits after a concussion? The study’s findings suggest that LOC may not be a reliable predictor of neuropsychological test results in the initial phase of recovery from mild traumatic brain injury. Neuropsychological assessments have proven sensitive to cognitive consequences.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.5,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does loss of consciousness forecast neuropsychological deterioration post-concussion? The study casts doubt on LOC’s role as a predictor of neuropsychological test performance in the acute phase following mild traumatic brain injury. Neuropsychological testing is sensitive for identifying cognitive sequelae.,3.789755637709663e-07,0.35139788683788886,0.0,0.029014823436509962,0.3593740009078954,0.0,0.028972824655245866,0.3677247801253176,0.0,3.789755637709665e-07,0.37647757123491177,0.0
251,0.5,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is loss of consciousness an indicator of neuropsychological decline after concussion? Research results question the importance of LOC in predicting neuropsychological test scores during early recovery from mild traumatic brain injury. Neuropsychological testing procedures effectively detect cognitive aftereffects.,4.026615365066516e-07,0.37806613392004973,0.0,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
251,0.5,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does experiencing loss of consciousness predict neuropsychological impairments after a concussion? The study’s outcomes raise doubts about LOC’s predictive value for neuropsychological test performance in the acute recovery phase of mild traumatic brain injury. Neuropsychological tests have demonstrated sensitivity to cognitive sequelae.,3.079176455639103e-07,0.27541197985996746,0.0,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
251,0.5,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Can loss of consciousness serve as a predictor for neuropsychological deficits following concussion? Findings from this research undermine the significance of LOC as a predictor of neuropsychological test outcomes during the early recovery period of mild traumatic brain injury. Neuropsychological testing is sensitive to cognitive impairments.,2.1317375462116866e-07,0.24393463951039518,0.04434829637641968,0.016320838183036854,0.21760896965931176,0.02271498107084911,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.5,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is loss of consciousness a reliable predictor of neuropsychological performance after concussion? The results question the predictive importance of LOC for neuropsychological test performance in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing methods are sensitive to cognitive sequelae.,3.079176455639103e-07,0.27541197985996746,0.0,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
251,0.5,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Does loss of consciousness predict cognitive decline after concussion? This study’s results cast doubt on LOC’s role as a predictor of neuropsychological test outcomes during the acute stage of recovery from mild traumatic brain injury. Neuropsychological assessments are sensitive in detecting cognitive sequelae.,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.5,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Is loss of consciousness a significant predictor of neuropsychological deficits following concussion? The findings challenge the importance of LOC in predicting neuropsychological test performance during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing has proven sensitive to cognitive sequelae.,3.079176455639103e-07,0.27541197985996746,0.0,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
252,0.5,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What is the value of PET/CT compared to multidetector CT in preoperative staging of liver metastases from colorectal cancer? PET/CT plays a limited role in staging hepatic lesions of LMCRC. While PET/CT is more sensitive in detecting extrahepatic disease in certain areas, its low positive predictive value limits its effectiveness. It provided additional useful data in only 8% of cases but also...",7.105791820705622e-08,0.026348369793864457,0.015621063240110858,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
252,0.5,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Does PET/CT offer added benefits over multidetector CT in preoperative staging of colorectal carcinoma liver metastases? PET/CT has a restricted role in hepatic staging of LMCRC. Although it shows higher sensitivity for extrahepatic disease detection in some regions, its low PPV reduces reliability. PET/CT contributed extra useful information in 8% of cases but also...",2.6054570009253947e-07,0.19308681779467474,0.0032398835054512753,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
252,0.5,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In preoperative staging of liver metastases from colorectal carcinoma, does PET/CT add value beyond multidetector CT? PET/CT has a limited function in hepatic staging for LMCRC. Despite its greater sensitivity for detecting extrahepatic disease in certain anatomical sites, the low positive predictive value affects its accuracy. PET/CT offered additional helpful insights in 8% of cases but also...",1.8948778188548325e-07,0.11187054323202528,0.015621063240110858,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.5,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","How much does PET/CT improve preoperative staging of colorectal cancer liver metastases compared to multidetector CT? PET/CT’s role is limited in hepatic staging of LMCRC. It has better sensitivity for extrahepatic disease detection in some locations, but the low PPV diminishes its usefulness. PET/CT provided extra valuable information in 8% of cases but also...",2.6054570009253947e-07,0.19308681779467474,0.0032398835054512753,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
252,0.5,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Is PET/CT beneficial in addition to multidetector CT for preoperative staging of liver metastases in colorectal carcinoma? PET/CT is limited in its role for hepatic staging of LMCRC. Though it detects extrahepatic disease with greater sensitivity in some areas, the low positive predictive value restricts its impact. PET/CT added useful information in 8% of cases but also...",1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.5,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What additional benefit does PET/CT provide over multidetector CT in preoperative staging of liver metastases from colorectal cancer? PET/CT plays a minor role in hepatic staging of LMCRC. It is more sensitive in identifying extrahepatic disease in certain anatomical locations, but its low PPV limits its effectiveness. PET/CT contributed extra useful data in 8% of cases but also...",1.6580180914979784e-07,0.11849191983648222,0.001917202066011597,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
252,0.5,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Does PET/CT significantly enhance preoperative staging of liver metastases from colorectal carcinoma compared to multidetector CT? PET/CT has a limited role in hepatic staging of LMCRC. Despite higher sensitivity for extrahepatic disease detection in some regions, its low positive predictive value hampers results. PET/CT provided additional useful information in 8% of cases but also...",2.6054570009253947e-07,0.19308681779467474,0.0032398835054512753,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
252,0.5,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In the preoperative staging of colorectal carcinoma liver metastases, does PET/CT add value beyond multidetector CT? PET/CT’s role is restricted in hepatic staging of LMCRC. Although it shows higher sensitivity for detecting extrahepatic disease in certain anatomical sites, the low PPV limits its diagnostic accuracy. PET/CT offered additional useful information in 8% of cases but also...",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
252,0.5,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","How does PET/CT compare to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? PET/CT has a limited role in hepatic staging of LMCRC. It demonstrates greater sensitivity for extrahepatic disease in some areas, but its low positive predictive value reduces its usefulness. PET/CT provided additional helpful information in 8% of cases but also...",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
252,0.5,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Does PET/CT add significant value to multidetector CT in preoperative staging of liver metastases from colorectal cancer? PET/CT plays a limited role in hepatic staging of LMCRC. Though it detects extrahepatic disease with higher sensitivity in some anatomical locations, its low PPV restricts its utility. PET/CT provided additional useful information in 8% of cases but also...",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
253,0.5,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet in patients identified through screening was excellent. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Therefore, active screening in coeliac disease risk groups appears to be beneficial rather than detrimental.",4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.5,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Does screening for coeliac disease in at-risk populations make sense? Patients detected through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to those without coeliac disease and to the general population. Hence, proactive screening in coeliac risk groups seems justified and not harmful.",2.3685972735685406e-08,0.07735198506164442,0.04097241303836064,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.5,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to screen for coeliac disease among risk groups? Screen-detected patients showed strong long-term dietary adherence. Their quality of life and bone mineral density were comparable to non-coeliac subjects and the general population. Active screening in these risk groups appears reasonable and not harmful.,9.474389094274162e-08,0.0002826433737834755,0.060964083175803374,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.5,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should coeliac disease screening be conducted in risk groups? Patients identified by screening had good long-term compliance with their diet. Their quality of life and bone mineral density were on par with non-coeliac individuals and the general population. Thus, active screening in coeliac disease risk groups seems appropriate and safe.",0.0,0.056583443311015724,0.04056477762024782,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
253,0.5,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening justified in populations at risk? Patients detected through screening demonstrated good long-term dietary adherence. Their quality of life and bone mineral density were similar to those without coeliac disease and the general population. Active screening in these risk groups seems to be a reasonable and non-harmful approach.,2.3685972735685406e-08,0.07735198506164442,0.04097241303836064,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.5,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it reasonable to screen for coeliac disease in groups at risk? Those identified through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density matched that of non-coeliac individuals and the general population. Therefore, active screening in coeliac disease risk groups appears justified and safe.",0.0,0.056583443311015724,0.04056477762024782,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
253,0.5,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does screening for coeliac disease in risk groups make sense? Patients detected by screening adhered well to their diet over the long term. Their quality of life and bone mineral density were comparable to non-coeliac people and the general population. Active screening in these risk groups seems to be a sensible and harmless strategy.,9.474389094274162e-08,0.1371902830283971,0.042103136430241245,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
253,0.5,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease in at-risk groups warranted? Screen-detected patients showed good long-term dietary compliance. Their quality of life and bone mineral density were equivalent to those of non-coeliac subjects and the general population. Active screening in coeliac disease risk groups appears reasonable and not harmful.,7.105791820705622e-08,0.008440570592397112,0.039235688114074976,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.5,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening in risk groups a justified practice? Patients identified through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to non-coeliac individuals and the general population. Active screening in these risk groups seems to be a reasonable and safe measure.,0.0,0.028291721655508084,0.02022166579237194,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
253,0.5,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to conduct coeliac disease screening in risk populations? Those detected through screening had good long-term adherence to their diet. Their quality of life and bone mineral density were comparable to non-coeliac subjects and the general population. Active screening in coeliac disease risk groups appears to be a prudent and non-harmful approach.,9.474389094274162e-08,0.11103378564877664,0.023286266951274358,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
254,0.5,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The insertion allele of the ACE gene I/D polymorphism is examined as a potential candidate gene for insulin resistance. We conclude that the heightened cardiovascular risk associated with the DD genotype is not caused by insulin resistance or fibrinolysis abnormalities. However, we observe increased sensitivity in NIDDM patients carrying the ACE DD genotype.",4.737194547137081e-08,0.06801298065346462,0.020707179930795856,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.5,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Our findings indicate that the elevated cardiovascular risk in individuals with the DD genotype is not linked to insulin resistance or fibrinolysis issues, but we do find increased sensitivity among NIDDM subjects with the ACE DD genotype.",4.737194547137081e-08,0.04135347370885123,0.0015305555555555558,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.5,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Regarding the insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance, our conclusion is that the increased cardiovascular risk of the DD genotype does not result from insulin resistance or fibrinolytic abnormalities. On the other hand, we note greater sensitivity in NIDDM patients with the ACE DD genotype.",7.105791820705622e-08,0.061407687809529765,0.00225273933102655,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
254,0.5,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","We investigated whether the insertion allele of the ACE gene I/D polymorphism is a candidate gene for insulin resistance. Our results show that the DD genotype’s higher cardiovascular risk is not due to insulin resistance or fibrinolysis defects, but NIDDM individuals with the ACE DD genotype exhibit increased sensitivity.",4.737194547137081e-08,0.014251352598789513,0.019106653337357282,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.5,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The ACE gene I/D polymorphism insertion allele was studied as a candidate gene for insulin resistance. We conclude that the DD genotype’s increased cardiovascular risk is not mediated by insulin resistance or fibrinolysis abnormalities, yet NIDDM subjects with the ACE DD genotype show enhanced sensitivity.",1.4211583641411244e-07,0.10388828709054065,0.017215574484706456,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
254,0.5,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Considering the insertion allele of the ACE gene I/D polymorphism as a candidate for insulin resistance, we conclude that the cardiovascular risk linked to the DD genotype is not through insulin resistance or fibrinolysis issues. Conversely, NIDDM patients with the ACE DD genotype demonstrate increased sensitivity.",1.1842986367842703e-07,0.11152182392946974,0.004417740820864116,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
254,0.5,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The insertion allele of the ACE gene I/D polymorphism was evaluated as a possible candidate gene for insulin resistance. Our conclusion is that the DD genotype’s cardiovascular risk elevation is not caused by insulin resistance or fibrinolytic abnormalities, but NIDDM subjects with the ACE DD genotype have heightened sensitivity.",4.737194547137081e-08,0.014251352598789513,0.019106653337357282,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.5,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? We conclude that the increased cardiovascular risk in the DD genotype is not mediated by insulin resistance or fibrinolysis abnormalities. However, we report increased sensitivity in NIDDM individuals with the ACE DD genotype.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.5,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","We examined the insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance. Our findings suggest that the DD genotype’s increased cardiovascular risk is not due to insulin resistance or fibrinolytic abnormalities, but NIDDM patients with the ACE DD genotype exhibit increased sensitivity.",7.105791820705622e-08,0.03591925397797047,0.018664014912833465,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.5,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","The insertion allele of the ACE gene I/D polymorphism was analyzed as a candidate gene for insulin resistance. We conclude that the elevated cardiovascular risk associated with the DD genotype is not driven by insulin resistance or fibrinolytic abnormalities, while NIDDM subjects with the ACE DD genotype show increased sensitivity.",2.3685972735685406e-08,0.049626097839246874,0.021033527620247815,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
255,0.5,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? Answer: This study found that incorporating an endoscope during VPS surgeries did not raise the risk of infection.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.5,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is the incidence of ventriculoperitoneal shunt infection impacted by the concurrent use of a neuroendoscope? Answer: Our research shows that employing an endoscope during VPS operations does not elevate the chance of surgical infection.,2.36859727356853e-08,0.010620873444459722,0.02854671280276816,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
255,0.5,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does simultaneous neuroendoscope use alter the infection rates of ventriculoperitoneal shunts? Answer: The current study indicates that using an endoscope during VPS procedures does not increase infection risk.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.5,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: How does the simultaneous use of a neuroendoscope affect ventriculoperitoneal shunt infection rates? Answer: Findings from this study reveal no increased infection risk when an endoscope is used during VPS surgery.,9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
255,0.5,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.","Question: Does the concurrent use of a neuroendoscope influence ventriculoperitoneal shunt infection occurrence? Answer: According to this study, the use of an endoscope during VPS does not raise surgical infection risk.",1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.5,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is there an impact on ventriculoperitoneal shunt infection rates when a neuroendoscope is used simultaneously? Answer: The study demonstrates that endoscope use during VPS procedures does not heighten infection risk.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.5,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the simultaneous application of a neuroendoscope affect the frequency of ventriculoperitoneal shunt infections? Answer: Results show that using an endoscope during VPS does not increase the likelihood of infection.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.5,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does employing a neuroendoscope at the same time influence ventriculoperitoneal shunt infection rates? Answer: This investigation found no increase in surgical infection risk with endoscope use during VPS.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.5,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the use of a neuroendoscope during VPS surgeries impact the rate of shunt infections? Answer: The present study confirms that endoscope use in VPS does not elevate infection risk.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.5,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does simultaneous neuroendoscope usage affect the incidence of infections in ventriculoperitoneal shunt procedures? Answer: The study concludes that endoscope use during VPS does not increase the risk of surgical infection.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
256,0.5,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can analyzing APC mutations aid in making treatment choices for familial adenomatous polyposis? Since the age of onset and disease progression can vary widely even among individuals with the same germline mutations, treatment decisions should rely on colonoscopy results for each patient instead of mutation location.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999992,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
256,0.5,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Given that both the age at which symptoms appear and disease development can differ significantly even in those with identical germline mutations, treatment should be determined based on colonoscopic observations of the individual rather than mutation site.",7.105791820705622e-08,0.03344237944153461,0.019599999999999992,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
256,0.5,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation testing help inform therapeutic strategies in familial adenomatous polyposis? Because the disease's onset age and progression can vary greatly among carriers of the same germline mutations, treatment decisions ought to be guided by colonoscopy findings specific to each patient rather than mutation position.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999992,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
256,0.5,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can therapeutic decisions in familial adenomatous polyposis be influenced by APC mutation analysis? Since disease manifestation age and progression are quite variable even among patients with the same germline mutations, treatment should be based on individual colonoscopic evaluations instead of the mutation's location.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.5,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is it possible for APC mutation analysis to contribute to treatment planning in familial adenomatous polyposis? As the age at disease onset and its course may differ considerably among carriers of identical germline mutations, therapy should be guided by colonoscopic findings from each patient rather than mutation site.",9.474389094274162e-08,0.05449578863936777,0.019599999999999992,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
256,0.5,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Could APC mutation analysis play a role in therapeutic decision-making for familial adenomatous polyposis? Given the variability in age at manifestation and disease progression even in those with the same germline mutations, treatment choices should depend on individual colonoscopy results instead of mutation location.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999992,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
256,0.5,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does analyzing APC mutations assist in therapeutic decisions for familial adenomatous polyposis? Because the disease's onset and progression can vary widely even among individuals with the same germline mutations, treatment should be based on colonoscopic findings in each patient rather than the mutation site.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999992,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
256,0.5,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis inform treatment decisions in familial adenomatous polyposis? Since the age at which the disease manifests and its course may vary even among carriers of identical germline mutations, therapy should rely on colonoscopic assessments of individual patients rather than mutation location.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999992,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
256,0.5,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation analysis valuable for guiding therapy in familial adenomatous polyposis? Given that both the age of onset and disease course can be quite variable even among patients with the same germline mutations, treatment should be determined by colonoscopic findings in each individual instead of mutation site.",9.474389094274162e-08,0.05449578863936777,0.019599999999999992,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
256,0.5,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation analysis contribute to treatment decisions in familial adenomatous polyposis? Because the age at manifestation and disease progression may vary significantly even among carriers of identical germline mutations, therapeutic choices should be based on colonoscopic findings of the individual patient rather than mutation location.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999992,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
257,0.5,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do the features of general practices affect the adoption of an IT innovation in primary care? The analysis indicates that structural features of a practice do not relate to the adoption of a new IT system, but usage may be impacted by post-graduate training in the relevant clinical area. Specifically for this diabetes system, practice nurses...",7.105791820705622e-08,0.10612797956367492,0.0378411168388924,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
257,0.5,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do characteristics of general practices impact the uptake of an IT innovation in primary care? Findings show that practice structural characteristics are not linked to the adoption of a new IT tool, but its utilization might be influenced by post-graduate education in the pertinent clinical field. In this diabetes system, at least, practice nurses...",1.1842986367842703e-07,0.04234784316257789,0.034438775510204085,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
257,0.5,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Does the nature of general practice affect the adoption of an IT innovation in primary care? The analysis reveals that structural aspects of a practice do not correlate with uptake of a new IT facility, but use may be affected by post-graduate education in the relevant clinical condition. For this diabetes system, practice nurses...",1.1842986367842703e-07,0.06850434054219878,0.015577828764641952,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
257,0.5,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Are general practice characteristics related to the adoption of an IT innovation in primary care? The data show that structural characteristics of a practice are not associated with uptake of a new IT system, though usage could be influenced by post-graduate education in the relevant clinical area. At least for this diabetes system, practice nurses...",9.474389094274162e-08,0.04932782794894042,0.0159268495579079,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
257,0.5,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do general practice features influence the adoption of an IT innovation in primary care? The analyses demonstrate that structural characteristics of a practice do not affect uptake of a new IT facility, but its use may be shaped by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurses...",1.1842986367842703e-07,0.06850434054219878,0.015577828764641952,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
257,0.5,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Can general practice characteristics affect the adoption of an IT innovation in primary care? The study shows that structural characteristics of a practice are not linked to uptake of a new IT system, but use may be influenced by post-graduate education in the relevant clinical field. For this diabetes system, practice nurses...",1.6580180914979784e-07,0.10799636636527321,0.01483877551020409,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
257,0.5,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do the attributes of general practices influence the uptake of an IT innovation in primary care? Analyses indicate that structural characteristics of a practice do not associate with adoption of a new IT facility, but usage might be influenced by post-graduate education in the relevant clinical condition. Regarding this diabetes system, practice nurses...",1.4211583641411244e-07,0.08805554507788438,0.015215399885444375,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
257,0.5,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Does the structure of general practices impact the uptake of an IT innovation in primary care? The analysis suggests that structural characteristics of a practice are not related to uptake of a new IT system, but its use may be influenced by post-graduate education in the relevant clinical area. For this diabetes system at least, practice nurses...",4.737194547137081e-08,0.036798578876688914,0.0012265194143500843,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
257,0.5,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Are the characteristics of general practice influential in the uptake of an IT innovation in primary care? Findings indicate that structural characteristics of a practice do not correlate with uptake of a new IT facility, but usage may be affected by post-graduate education in the relevant clinical condition. For this diabetes system, practice nurses...",1.1842986367842703e-07,0.14697383268106012,0.040529987505206165,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
257,0.5,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Is the uptake of an IT innovation in primary care influenced by general practice characteristics? The analyses reveal that structural characteristics of a practice are not associated with the adoption of a new IT system, but use may be influenced by post-graduate education in the relevant clinical area. Specifically for this diabetes system, practice nurses...",9.474389094274162e-08,0.07499994574745728,0.0025434730105059686,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
258,0.5,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in an urban environment affect the risk of non-communicable diseases in Thailand? Yes, it does. Factors such as pollution, stress, and lifestyle habits in urban areas increase these risks, and rapid urbanization without proper planning worsens the situation, highlighting the importance of timing.",2.8423167282822487e-07,0.13340378381465268,0.06743801652892563,0.02176111757738247,0.16009673330974294,0.051570247933884296,0.0217296184914344,0.18774687065651463,0.035041322314049606,2.8423167282822487e-07,0.21640680036831794,0.017851239669421492
258,0.5,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing important when considering the risk of non-communicable diseases from living in urban Thailand? Absolutely. Urban living exposes individuals to pollution, stress, and unhealthy habits, and if urban growth happens too quickly without adequate health infrastructure, the risk rises significantly.",4.500334819780227e-07,0.3293292904387708,0.04245445308382371,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
258,0.5,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does living in an urban environment in Thailand impact non-communicable disease risk depending on timing? Yes, timing is key. Urban factors like pollution and stress elevate disease risk, and when urbanization occurs rapidly without sufficient health services, these risks increase.",4.73719454713708e-07,0.31998973939506614,0.06743801652892563,0.03626852929563745,0.351151970072451,0.051570247933884296,0.03621603081905733,0.3834914477826086,0.035041322314049606,4.737194547137081e-07,0.4170774958304695,0.017851239669421492
258,0.5,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of urban residence related to non-communicable disease risk in Thailand? Yes, timing plays a critical role. Urban living conditions such as pollution and stress contribute to higher disease risk, especially when urbanization is rapid and unplanned.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.5,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in an urban area influence non-communicable disease risk in Thailand? Indeed it does. Exposure to pollution, stress, and lifestyle factors in cities raises disease risk, and rapid, poorly planned urbanization can worsen these effects.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.5,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing a factor in the risk of non-communicable diseases for urban residents in Thailand? Yes, it is. Urban environments bring risks from pollution and stress, and if urban growth is too fast without proper health services, these risks become more severe.",4.263475092423373e-07,0.2699793188204027,0.06743801652892563,0.03264167636607371,0.2998586756849013,0.051570247933884296,0.0325944277371516,0.33084771429718973,0.035041322314049606,4.263475092423373e-07,0.3630102745601933,0.017851239669421492
258,0.5,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does timing affect the risk of non-communicable diseases associated with urban living in Thailand? Yes, timing matters. Urbanization involves pollution, stress, and lifestyle changes that increase disease risk, particularly when growth is rapid and health services lag behind.",5.210914001850786e-07,0.372633472880485,0.06743801652892563,0.0398953822252012,0.4052191913427272,0.051570247933884296,0.039837633900963065,0.43906129893742074,0.035041322314049606,5.210914001850789e-07,0.47423590967041784,0.017851239669421492
258,0.5,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of living in an urban environment relevant to non-communicable disease risk in Thailand? Yes, it is important. Factors like pollution and stress in cities raise disease risk, and rapid urbanization without adequate planning intensifies these risks.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.5,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of urban residency impact the risk of non-communicable diseases in Thailand? Yes, timing is significant. Urban living conditions such as pollution and stress increase disease risk, and rapid, unplanned urban growth exacerbates these risks.",5.447773729207639e-07,0.4000324470686003,0.06743801652892563,0.04170880868998307,0.43339006830942406,0.051570247933884296,0.04164843544191594,0.46804883581067225,0.035041322314049606,5.447773729207643e-07,0.5040888728200996,0.017851239669421492
258,0.5,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing important in the relationship between urban living and non-communicable disease risk in Thailand? Yes, timing matters. Urban factors like pollution and stress elevate disease risk, especially when urbanization happens quickly without sufficient health infrastructure.",5.684633456564492e-07,0.42820332403529715,0.06743801652892563,0.04352223515476495,0.46237760518267557,0.051570247933884296,0.04345923698286881,0.497901798960354,0.035041322314049606,5.684633456564497e-07,0.5348605314868533,0.017851239669421492
259,0.5,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is anxiety caused by withdrawal in alcoholism linked to beta-endorphin deficiency? Answer: Our findings provide initial proof that reduced beta-endorphin levels during alcohol withdrawal might play a role in the anxiety commonly experienced in this condition.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.5,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Answer: Our results offer the first evidence that decreased beta-endorphin during alcohol withdrawal could contribute to the anxiety frequently observed in this state.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
259,0.5,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal-related anxiety in alcoholism associated with a lack of beta-endorphins? Answer: Our study presents the first evidence that lowered beta-endorphin levels during alcohol withdrawal may be a factor in the anxiety often seen during this phase.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
259,0.5,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety seen in alcoholism withdrawal due to beta-endorphin deficiency? Answer: Our findings provide initial evidence that reduced beta-endorphin during alcohol withdrawal may be linked to the anxiety commonly experienced in this condition.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.5,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does beta-endorphin deficiency cause anxiety during alcohol withdrawal in alcoholism? Answer: Our results give the first indication that decreased beta-endorphin levels during withdrawal might contribute to the anxiety frequently occurring in this state.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.5,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal-induced anxiety in alcoholism related to a deficiency in beta-endorphin? Answer: Our study provides first evidence that lowered beta-endorphin during alcohol withdrawal may be a contributing factor to the anxiety commonly present during this period.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.5,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is anxiety resulting from alcohol withdrawal in alcoholism based on beta-endorphin deficiency? Answer: Our findings offer initial evidence that reduced beta-endorphin levels during withdrawal may contribute to the anxiety often experienced in this condition.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.5,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety caused by alcohol withdrawal in alcoholism due to beta-endorphin deficiency? Answer: Our results present the first evidence that decreased beta-endorphin during withdrawal might be involved in the anxiety commonly observed in this state.,7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.5,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is beta-endorphin deficiency responsible for withdrawal-induced anxiety in alcoholism? Answer: Our study provides the first proof that lowered beta-endorphin levels during alcohol withdrawal may contribute to the anxiety frequently seen during this phase.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.5,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety associated with alcohol withdrawal in alcoholism linked to beta-endorphin deficiency? Answer: Our findings give the first evidence that reduced beta-endorphin during withdrawal could play a role in the anxiety commonly experienced in this condition.,9.47438909427412e-08,0.07694293601234303,0.027006172839506164,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
260,0.5,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts truly exist? Answer: Based on our study's findings and international literature, the concept of the globulomaxillary cyst is no longer valid.",9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.5,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts real? Answer: Our research and global data indicate that the classification of globulomaxillary cysts is no longer supported.,1.658018091497971e-07,0.3536960896479675,0.047500000000000014,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.5,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the existence of globulomaxillary cysts confirmed? Answer: According to our study and international sources, the term globulomaxillary cyst is now considered unjustified.",1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.5,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts actually exist? Answer: Findings from our research and worldwide literature suggest that the globulomaxillary cyst entity is no longer warranted.,1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.5,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a legitimate diagnosis? Answer: Our study results combined with international literature show that the globulomaxillary cyst entity is obsolete.,1.421158364141118e-07,0.24116205681688863,0.0,0.010880558788691277,0.2513144282809079,0.0,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
260,0.5,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is there evidence for globulomaxillary cysts? Answer: Data from our study and global research conclude that the globulomaxillary cyst concept is no longer justified.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.5,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts exist in reality? Answer: According to our findings and international literature, the globulomaxillary cyst entity lacks justification.",1.8948778188548245e-07,0.33647223662121384,0.0,0.014507411718255037,0.3513978868378893,0.0,0.014486412327622988,0.3677247801253176,0.0,1.8948778188548304e-07,0.38566248081198395,0.0
260,0.5,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a real clinical entity? Answer: Our study and international literature confirm that the globulomaxillary cyst is no longer a valid diagnosis.,7.10579182070559e-08,0.2242322341965961,0.0793950850661626,0.005440279394345639,0.17554530070304475,0.04158790170132326,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.5,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts recognized entities? Answer: Based on our research and worldwide data, the globulomaxillary cyst classification is no longer supported.",1.658018091497971e-07,0.28768207245178257,0.0,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.5,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a valid pathological entity? Answer: Evidence from our study and international literature shows that the globulomaxillary cyst is no longer justified.,7.10579182070559e-08,0.2242322341965961,0.0793950850661626,0.005440279394345639,0.17554530070304475,0.04158790170132326,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
261,0.5,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does obstructive sleep apnea impact aerobic fitness? Answer: In general, among a US Air Force cohort, OSA is not a predictor of reduced aerobic fitness based on cycle ergometry testing. Nonetheless, individuals with an apnea-hypopnea index exceeding 20 show a statistically significant decline in aerobic fitness.",4.737194547137081e-08,0.04408378315119643,0.06222222222222221,0.0036268529295637453,0.015506137469618597,0.04246913580246913,0.003621603081905733,0.01431492863344408,0.021728395061728398,4.737194547137081e-08,0.04546237407675724,0.0
261,0.5,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Is aerobic fitness influenced by obstructive sleep apnea? Answer: Overall, within a US Air Force sample, OSA does not forecast diminished aerobic fitness as assessed by cycle ergometry. Yet, patients with an apnea-hypopnea index over 20 exhibit a statistically meaningful reduction in aerobic fitness.",9.474389094274162e-08,0.03187466944508888,0.03950724115137309,0.0072537058591274906,0.029956236607138642,0.04246913580246913,0.007243206163811466,0.06083494426833802,0.021728395061728398,9.474389094274162e-08,0.09309042306601167,0.0
261,0.5,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does obstructive sleep apnea have an effect on aerobic fitness? Answer: In a US Air Force population, OSA generally does not predict lower aerobic fitness measured through cycle ergometry. However, those with an apnea-hypopnea index greater than 20 demonstrate a statistically significant decrease in aerobic fitness.",4.737194547137081e-08,0.04408378315119643,0.06222222222222221,0.0036268529295637453,0.015506137469618597,0.04246913580246913,0.003621603081905733,0.01431492863344408,0.021728395061728398,4.737194547137081e-08,0.04546237407675724,0.0
261,0.5,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Can obstructive sleep apnea affect aerobic fitness levels? Answer: Overall, in a US Air Force group, OSA is not linked to a decrease in aerobic fitness as determined by cycle ergometry. Still, patients with an apnea-hypopnea index above 20 have a statistically significant reduction in aerobic fitness.",2.3685972735685406e-08,0.00659873896280283,0.019753086419753076,0.0018134264647818726,0.0374850441883936,0.04246913580246913,0.0018108015409528666,0.008157927218613636,0.021728395061728398,2.3685972735685406e-08,0.022472855852057716,0.0
261,0.5,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Is there an impact of obstructive sleep apnea on aerobic fitness? Answer: Among a US Air Force population, OSA typically does not predict a decline in aerobic fitness measured by cycle ergometry. However, individuals with an apnea-hypopnea index higher than 20 experience a statistically significant drop in aerobic fitness.",2.3685972735685406e-08,0.07897096311722063,0.041822916666666654,0.0018134264647818726,0.08004465860719012,0.04246913580246913,0.0018108015409528666,0.051643039158352,0.021728395061728398,2.3685972735685406e-08,0.021978906718775004,0.0
261,0.5,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does obstructive sleep apnea influence aerobic fitness? Answer: Generally, in a US Air Force cohort, OSA does not predict reduced aerobic fitness as evaluated by cycle ergometry. Nonetheless, patients with an apnea-hypopnea index greater than 20 show a statistically significant decrease in aerobic fitness.",9.474389094274162e-08,0.00036797941963628844,0.06222222222222221,0.0072537058591274906,0.029956236607138642,0.04246913580246913,0.007243206163811466,0.06083494426833802,0.021728395061728398,9.474389094274162e-08,0.09309042306601167,0.0
261,0.5,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: How does obstructive sleep apnea affect aerobic fitness? Answer: Overall, within a US Air Force population, OSA is not a predictor of decreased aerobic fitness measured by cycle ergometry. However, those with an apnea-hypopnea index over 20 have a statistically significant reduction in aerobic fitness.",7.105791820705622e-08,0.022104876432421428,0.06222222222222221,0.005440279394345618,0.006966718382439119,0.04246913580246913,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
261,0.5,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Is aerobic fitness affected by obstructive sleep apnea? Answer: In a US Air Force group, OSA does not generally predict a decrease in aerobic fitness as assessed by cycle ergometry. Still, patients with an apnea-hypopnea index exceeding 20 exhibit a statistically significant decline in aerobic fitness.",4.737194547137081e-08,0.016189884723581294,0.01883379247015609,0.0036268529295637453,0.015506137469618597,0.04246913580246913,0.003621603081905733,0.01431492863344408,0.021728395061728398,4.737194547137081e-08,0.04546237407675724,0.0
261,0.5,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: Does obstructive sleep apnea reduce aerobic fitness? Answer: Overall, among a US Air Force population, OSA is not associated with decreased aerobic fitness measured by cycle ergometry. However, individuals with an apnea-hypopnea index above 20 have a statistically significant reduction in aerobic fitness.",1.1842986367842703e-07,0.023357497644335812,0.06222222222222221,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.08493249584739804,0.021728395061728398,1.1842986367842703e-07,0.11778303565638337,0.0
261,0.5,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Question: What is the effect of obstructive sleep apnea on aerobic fitness? Answer: In a US Air Force cohort, OSA does not generally predict lower aerobic fitness as measured by cycle ergometry. Yet, patients with an apnea-hypopnea index greater than 20 demonstrate a statistically significant decrease in aerobic fitness.",0.0,0.08664339756999295,0.06222222222222221,0.0,0.05899124940935696,0.04246913580246913,0.0,0.03013683393738864,0.021728395061728398,0.0,0.0,0.0
262,0.5,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts truly exist? Answer: Globulomaxillary cysts were previously believed to be a distinct cyst type originating from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.5,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts real? Answer: It was once assumed that globulomaxillary cysts were a unique cyst type formed along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.5,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the existence of globulomaxillary cysts confirmed? Answer: Globulomaxillary cysts were historically considered a specific cyst type arising at the fusion line between two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.5,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts actually occur? Answer: Previously, globulomaxillary cysts were thought to be a particular cyst type developing from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.5,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts a real phenomenon? Answer: Globulomaxillary cysts were once regarded as a distinct cyst type originating from the fusion line between two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.5,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Can globulomaxillary cysts be considered a genuine entity? Answer: It was once believed that globulomaxillary cysts represented a specific cyst type formed along the fusion line of two embryonic processes. However,",7.10579182070559e-08,0.05706352137059145,0.0322222222222222,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,0.5,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is there evidence supporting the existence of globulomaxillary cysts? Answer: Historically, globulomaxillary cysts were thought to be a unique cyst type arising from the fusion line between two embryonic processes. However,",7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,0.5,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts recognized as a distinct cyst type? Answer: Globulomaxillary cysts were previously assumed to be a cyst type originating from the fusion line of two embryonic processes. However,",4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.5,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts have a confirmed origin? Answer: It was once thought that globulomaxillary cysts were a particular cyst type arising from the fusion line between two embryonic processes. However,",4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.5,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the concept of globulomaxillary cysts valid? Answer: Globulomaxillary cysts were once considered a specific cyst type developing along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
263,0.5,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? For patients undergoing MMT and receiving medical care at various locations, opioid dependence and MMT are documented in the medical records for most, but a significant number of patients lack this documentation. Most of these patients are prescribed medications that may interact with",7.105791820705622e-08,0.05832472573195391,0.0036927867249538504,0.005440279394345618,0.05676954945959212,0.001940926206660469,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
263,0.5,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? Among patients on MMT receiving care at multiple sites, documentation of opioid dependence and MMT is present for the majority, yet a considerable portion of patients do not have this recorded. Most of these patients are on medications that could interact with",9.474389094274162e-08,0.02719669191573626,0.031604857103432596,0.0072537058591274906,0.05027394425433407,0.016180375568487466,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
263,0.5,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Do medical records document opioid dependence and methadone maintenance treatment (MMT)? In patients receiving MMT and care at various sites, the majority have opioid dependence and MMT documented in their medical records, but a notable number of patients lack such documentation. Most of these patients are prescribed drugs that might interact with",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.5,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical records? For patients receiving MMT and medical care at different locations, most have opioid dependence and MMT recorded in their medical records, though a substantial number do not. Most of these patients take medications that potentially interact with",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.5,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) recorded in patients' medical records? Among patients on MMT receiving care at various sites, documentation of opioid dependence and MMT is present for most, but missing in a significant number. Most of these patients are prescribed medications that may interact with",2.3685972735685406e-07,0.15139775702174862,0.02699920392281939,0.018134264647818726,0.17375738342145475,0.013774781671327497,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
263,0.5,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? For patients undergoing MMT and receiving care at different locations, the majority have opioid dependence and MMT noted in their medical records, but a substantial number do not. Most of these patients are on medications that could interact with",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.5,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Do medical records include documentation of opioid dependence and methadone maintenance treatment (MMT)? Among patients receiving MMT and medical care across various sites, opioid dependence and MMT are documented for most patients, though a significant number lack this information. Most of these patients are prescribed drugs that might interact with",2.1317375462116866e-07,0.12959964808336677,0.027844688240711214,0.016320838183036854,0.1520894820422738,0.014217420095851314,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
263,0.5,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical records? Patients receiving MMT and care at multiple sites mostly have opioid dependence and MMT recorded, but a considerable number do not. Most of these patients take medications that potentially interact with",3.552895910352811e-07,0.268115194683364,0.022186153809746444,0.02720139697172809,0.28974675074155787,0.011245962409231043,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
263,0.5,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Among patients treated with MMT and receiving medical care at various sites, documentation of opioid dependence and MMT is present for the majority, but missing for a notable number. Most of these patients are prescribed medications that may interact with",1.4211583641411244e-07,0.06691179819077675,0.03018710562414264,0.010880558788691236,0.0897659700774085,0.015441322314049606,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
263,0.5,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) recorded in medical records? For patients on MMT and receiving care at different sites, most have opioid dependence and MMT documented, but a substantial number do not. Most of these patients are prescribed medications that could interact with",3.079176455639103e-07,0.21978709582909772,0.024238809247722967,0.023574544042164344,0.24172641653402493,0.012326341243200489,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
264,0.5,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the quantity of needles affect acupuncture treatment for neck pain? Answer: For this condition, whether 5 or 11 needles are used does not appear to significantly influence the therapeutic outcome, provided the stimulation duration is identical in both groups.",1.4211583641411244e-07,0.07948827450038065,0.043388429752066124,0.010880558788691236,0.1122943022824554,0.02221074380165289,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
264,0.5,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In acupuncture for neck pain, is the number of needles used a significant factor? Answer: The number of needles, either 5 or 11, does not seem to impact the treatment effectiveness when the stimulation time is consistent across groups.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.5,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the count of needles matter in acupuncture therapy for neck pain? Answer: For this issue, using 5 or 11 needles does not seem to be a critical factor in the treatment effect if the stimulation time is the same in both groups.",7.105791820705622e-08,0.007167612920754518,0.043388429752066124,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
264,0.5,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Neck pain acupuncture treatment: is the needle count important? Answer: The therapeutic effect appears unaffected by whether 5 or 11 needles are used, as long as the stimulation time remains equal between groups.",3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
264,0.5,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Question: Is the number of needles relevant in acupuncture for neck pain relief? Answer: Using 5 or 11 needles does not seem to alter the therapeutic outcome when the duration of stimulation is equal in both groups.,2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.5,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles influence acupuncture treatment results for neck pain? Answer: For this condition, the therapeutic effect is not significantly affected by using 5 versus 11 needles when stimulation time is the same in both groups.",1.8948778188548304e-07,0.13078156888793036,0.043388429752066124,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
264,0.5,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In treating neck pain with acupuncture, does needle quantity matter? Answer: The number of needles, 5 or 11, does not appear to be a crucial variable for therapeutic effect if the stimulation duration is equal in both groups.",1.8948778188548304e-07,0.13078156888793036,0.043388429752066124,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
264,0.5,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Neck pain acupuncture: does the number of needles impact treatment? Answer: The therapeutic effect seems independent of whether 5 or 11 needles are used, assuming equal stimulation time in both groups.",3.5528959103528014e-07,0.3343805241291702,0.043388429752066124,0.027201396971728124,0.3746585667499449,0.02221074380165289,0.02716202311429304,0.41689380393178865,0.0,3.552895910352811e-07,0.42899560551835814,0.0
264,0.5,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is the quantity of needles a key factor in acupuncture treatment for neck pain? Answer: The number, either 5 or 11, does not seem to influence the therapeutic outcome when the stimulation time is consistent in both groups.",1.8948778188548304e-07,0.13078156888793036,0.043388429752066124,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
264,0.5,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles used in acupuncture affect neck pain treatment? Answer: For this pathology, the therapeutic effect is similar whether 5 or 11 needles are used, provided the stimulation time is the same in both groups.",1.8948778188548304e-07,0.13078156888793036,0.043388429752066124,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
265,0.5,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is the formation of endometrial polyps linked to higher levels of vascular endothelial growth factor and transforming growth factor-beta1? Yes, the development of endometrial polyps correlates with elevated expression of these growth factors, which promote angiogenesis and fibrosis, key processes in polyp growth.",2.3685972735685406e-07,0.0669854727857282,0.17472222222222214,0.018134264647818726,0.046939042515590224,0.17500000000000002,0.018108015409528666,0.0263894336873709,0.17132659131469363,2.3685972735685406e-07,0.0019248787369186005,0.15704937537180244
265,0.5,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does endometrial polyp formation involve increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Indeed, these factors are upregulated during polyp formation, contributing to blood vessel formation and fibrotic changes essential for polyp development.",4.026615365066514e-07,0.04932206681204221,0.22222222222222215,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.17132659131469363,4.026615365066519e-07,0.19975062206683658,0.15704937537180244
265,0.5,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Are vascular endothelial growth factor and transforming growth factor-beta1 expression levels increased in endometrial polyp formation? Yes, these growth factors are more highly expressed, facilitating angiogenesis and fibrosis that support polyp formation.",4.974054274493926e-07,0.170682923816309,0.22222222222222215,0.03808195576041936,0.23162358493827284,0.19937500000000002,0.03802683236001024,0.2951941904400921,0.17132659131469363,4.974054274493935e-07,0.3332820146913589,0.15704937537180244
265,0.5,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is there an association between endometrial polyp formation and elevated vascular endothelial growth factor and transforming growth factor-beta1? Yes, increased expression of these growth factors is linked to the angiogenesis and fibrosis that drive polyp development.",4.026615365066514e-07,0.04932206681204221,0.22222222222222215,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.17132659131469363,4.026615365066519e-07,0.19975062206683658,0.15704937537180244
265,0.5,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does the formation of endometrial polyps coincide with enhanced expression of vascular endothelial growth factor and transforming growth factor-beta1? Yes, these growth factors are upregulated, aiding angiogenesis and fibrosis processes involved in polyp formation.",4.50033481978022e-07,0.1081625668349755,0.22222222222222215,0.0344551028308556,0.16708506380070132,0.19937500000000002,0.03440522927810449,0.22850281594141864,0.17132659131469363,4.500334819780227e-07,0.2642891432044081,0.15704937537180244
265,0.5,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is increased expression of vascular endothelial growth factor and transforming growth factor-beta1 related to the development of endometrial polyps? Yes, these growth factors contribute to the angiogenic and fibrotic mechanisms underlying polyp growth.",4.737194547137073e-07,0.18225592428672677,0.19100474043241986,0.03626852929563748,0.19883376211528114,0.19937500000000002,0.03621603081905737,0.26129263876441033,0.17132659131469363,4.737194547137081e-07,0.29819069488008987,0.15704937537180244
265,0.5,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is endometrial polyp formation connected to higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Yes, the increased levels of these factors promote angiogenesis and fibrosis, which are crucial in polyp development.",4.50033481978022e-07,0.1081625668349755,0.22222222222222215,0.0344551028308556,0.16708506380070132,0.19937500000000002,0.03440522927810449,0.22850281594141864,0.17132659131469363,4.500334819780227e-07,0.2642891432044081,0.15704937537180244
265,0.5,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Are elevated levels of vascular endothelial growth factor and transforming growth factor-beta1 associated with endometrial polyp formation? Yes, these growth factors facilitate angiogenesis and fibrosis, playing important roles in the formation of polyps.",4.737194547137073e-07,0.13893422550172918,0.22222222222222215,0.03626852929563748,0.19883376211528114,0.19937500000000002,0.03621603081905737,0.26129263876441033,0.17132659131469363,4.737194547137081e-07,0.29819069488008987,0.15704937537180244
265,0.5,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does the occurrence of endometrial polyps correlate with increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, their higher expression supports angiogenesis and fibrosis essential for polyp development.",5.447773729207632e-07,0.23737429831498247,0.22222222222222215,0.04170880868998312,0.3006164564252236,0.19937500000000002,0.04164843544191599,0.3666531544222358,0.17132659131469363,5.447773729207643e-07,0.40738998684508054,0.15704937537180244
265,0.5,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is the expression of vascular endothelial growth factor and transforming growth factor-beta1 increased during endometrial polyp formation? Yes, these growth factors are upregulated and contribute to angiogenesis and fibrosis involved in polyp growth.",4.737194547137073e-07,0.13893422550172918,0.22222222222222215,0.03626852929563748,0.19883376211528114,0.19937500000000002,0.03621603081905737,0.26129263876441033,0.17132659131469363,4.737194547137081e-07,0.29819069488008987,0.15704937537180244
266,0.5,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification account for the birthweight differences between Australian Aborigines and whites? No, it does not fully account for these differences. Other influences like genetics, maternal health, socio-economic status, and healthcare access also play a role.",1.6580180914979753e-07,0.041314383764178064,0.14583333333333334,0.012693985253473108,0.016484158502581447,0.11426592797783926,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
266,0.5,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification responsible for the birthweight disparity between Australian Aborigines and whites? No, it cannot completely explain the difference. Additional factors include genetic variation, maternal health, socio-economic conditions, and availability of healthcare.",2.605457000925387e-07,0.03562855224816497,0.1728395061728395,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
266,0.5,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can the difference in birthweights between Australian Aborigines and whites be explained by gestational age misclassification? No, this factor alone does not fully explain the disparity. Other contributors include genetics, maternal health, socio-economic inequalities, and access to medical care.",1.4211583641411222e-07,0.10545004601174135,0.1728395061728395,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
266,0.5,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does misclassification of gestational age clarify the birthweight differences seen in Australian Aborigines versus whites? No, it does not entirely explain the difference. Other elements such as genetic factors, maternal health, socio-economic status, and healthcare access are also important.",1.4211583641411222e-07,0.10545004601174135,0.1728395061728395,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
266,0.5,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the birthweight difference between Australian Aborigines and whites due to gestational age misclassification? No, gestational age misclassification does not fully account for the disparity. Other factors like genetics, maternal health, socio-economic disparities, and healthcare access contribute as well.",1.4211583641411222e-07,0.068968615455955,0.14654293933573212,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
266,0.5,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification explain why Australian Aborigines and whites have different birthweights? No, it does not fully explain the difference. Other causes include genetic differences, maternal health, socio-economic status, and access to healthcare.",2.605457000925387e-07,0.03562855224816497,0.1728395061728395,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
266,0.5,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the variation in birthweights between Australian Aborigines and whites explained by gestational age misclassification? No, it is not a complete explanation. Other factors such as genetic makeup, maternal health, socio-economic conditions, and healthcare availability are involved.",1.8948778188548283e-07,0.05138282474146516,0.1728395061728395,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
266,0.5,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does the misclassification of gestational age explain birthweight differences for Australian Aborigines compared to whites? No, it does not fully explain the difference. Other influences include genetics, maternal health, socio-economic disparities, and access to healthcare services.",2.1317375462116813e-07,0.023211947774768316,0.1728395061728395,0.01632083818303686,0.0736425723425298,0.11426592797783926,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
266,0.5,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can gestational age misclassification explain the birthweight differences between Australian Aborigines and whites? No, it does not entirely explain the disparity. Additional factors include genetics, maternal health, socio-economic inequalities, and healthcare access.",3.0791764556390933e-07,0.1428680821688495,0.1406172839506173,0.02357454404216438,0.1988057152965368,0.11426592797783926,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
266,0.5,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? No, it does not fully explain the difference. Other factors such as genetic differences, maternal health, socio-economic status, and access to healthcare also contribute.",1.6580180914979753e-07,0.07878179892958048,0.1728395061728395,0.012693985253473108,0.016484158502581447,0.11426592797783926,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
267,0.5,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the distribution of health care benefits in Kenya align with the principles of universal coverage? Answer: Universal coverage principles demand that health care benefits be allocated based on need. However, Kenya's health sector is evidently inequitable, with benefits not distributed according to need. Focused efforts are necessary to restructure the system.",1.1842986367842703e-07,0.047842748326917484,0.0313757208971164,0.009067132323909363,0.0711977874885843,0.016065294924554177,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
267,0.5,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the allocation of health care benefits in Kenya consistent with universal coverage principles? Answer: Universal coverage requires that everyone receives health care benefits according to their need. The Kenyan health sector is clearly unfair, and benefits are not distributed based on need. Intentional actions should aim at restructuring the system.",1.4211583641411244e-07,0.09548854741949286,0.011181970897116408,0.010880558788691236,0.09154405963226253,0.015673624787111436,0.0108648092457172,0.09030753510148237,0.0181755829903978,1.4211583641411244e-07,0.11778303565638426,0.0
267,0.5,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does Kenya’s health care benefits distribution adhere to universal coverage principles? Answer: The core of universal coverage is that all individuals benefit from health care according to their need. The Kenyan health sector is evidently inequitable, with benefits not allocated by need. Purposeful restructuring efforts are needed.",2.3685972735685406e-07,0.15461110071841766,0.027306585094647277,0.018134264647818726,0.14719978134891543,0.03566529492455417,0.018108015409528666,0.17546534344178966,0.0181755829903978,2.3685972735685406e-07,0.2047944126460135,0.0
267,0.5,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Are health care benefits in Kenya distributed in line with the principles of universal coverage? Answer: Universal coverage principles state that health care benefits should be given based on need. The Kenyan health sector is clearly unequal, and benefits do not reflect need. Deliberate restructuring efforts must be made.",1.8948778188548325e-07,0.1105305982195075,0.029033303513684973,0.014507411718254981,0.1335212994534496,0.014841392706355885,0.014486412327622933,0.1319802315020513,0.0181755829903978,1.8948778188548325e-07,0.16034265007518078,0.0
267,0.5,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the Kenyan health care system distribute benefits following universal coverage principles? Answer: Universal coverage requires health care benefits to be distributed according to need. Kenya’s health sector is evidently inequitable, with benefits not aligned with need. Focused restructuring is necessary.",3.789755637709665e-07,0.29981950149139047,0.021123518398760067,0.029014823436509962,0.2869617237240738,0.03566529492455417,0.028972824655245866,0.31856618708246476,0.0181755829903978,3.789755637709665e-07,0.35139788683788886,0.0
267,0.5,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya in accordance with universal coverage principles? Answer: According to universal coverage, all should receive health care benefits based on need. Kenya’s health sector is clearly unjust, and benefits are not distributed by need. Deliberate restructuring is essential.",2.6054570009253947e-07,0.17739972440480178,0.026387291145050285,0.0199476911126006,0.19998522942591013,0.013454551122901278,0.019918816950481533,0.19793819929384737,0.0181755829903978,2.6054570009253947e-07,0.22778393087071303,0.0
267,0.5,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does Kenya’s allocation of health care benefits satisfy universal coverage principles? Answer: Universal coverage mandates that benefits are distributed according to need. The Kenyan health sector is evidently inequitable, with benefits not aligned to need. Intentional restructuring efforts are required.",4.026615365066519e-07,0.32620271696117653,0.019914225052241073,0.030828249901291835,0.31227953170836553,0.03566529492455417,0.030783626196198732,0.34454167348572273,0.0181755829903978,4.026615365066519e-07,0.37806613392004973,0.0
267,0.5,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Are the principles of universal coverage reflected in Kenya’s health care benefits distribution? Answer: Universal coverage principles require benefits to be allocated based on need. Kenya’s health sector is clearly inequitable, and benefits are not distributed accordingly. Focused efforts to restructure are necessary.",3.316036182995957e-07,0.2490461448195047,0.023374769082720202,0.025387970506946217,0.2381715595546421,0.03566529492455417,0.025351221573340132,0.26855576650780133,0.0181755829903978,3.316036182995957e-07,0.30010459245033916,0.0
267,0.5,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the Kenyan health care benefits distribution meet the standards of universal coverage? Answer: Universal coverage demands that health care benefits be allocated according to need. Kenya’s health sector shows clear inequity, with benefits not distributed by need. Deliberate restructuring efforts should be undertaken.",3.079176455639103e-07,0.2245911991517615,0.024424246974213915,0.023574544042164344,0.24688046589142187,0.012422664539066645,0.023540420032387266,0.2444582149287413,0.0181755829903978,3.079176455639103e-07,0.27541197985996746,0.0
267,0.5,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Answer: The principles of universal coverage require all to benefit from health care according to need. Kenya’s health sector is clearly inequitable, with benefits not distributed based on need. Focused restructuring efforts are needed.",2.1317375462116866e-07,0.13232870715788936,0.02818781919579315,0.016320838183036854,0.12569357612795207,0.03566529492455417,0.0162972138685758,0.15348643672301465,0.0181755829903978,2.1317375462116866e-07,0.18232155679395579,0.0
268,0.5,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: Postictal psychotic episodes may signal an increased risk of interictal psychotic episodes. Frequent occurrences after seizures imply the patient might also have psychotic episodes during interictal periods.,2.3685972735685406e-08,0.005268824097956593,0.019374999999999948,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
268,0.5,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How significant are postictal psychotic episodes II in the long term? Can they forecast interictal psychotic episodes? Answer: Postictal psychotic episodes can be predictive of interictal psychotic episodes. Repeated post-seizure episodes suggest a higher chance of interictal psychosis.,1.6580180914979763e-07,0.14934160894788073,0.05556877162629756,0.012693985253473108,0.1477257563885339,0.01834530108339633,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
268,0.5,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What is the long-term relevance of postictal psychotic episodes II? Are they indicative of interictal psychotic episodes? Answer: Postictal psychotic episodes often indicate a greater probability of interictal psychotic episodes, especially if they frequently follow seizures.",2.1317375462116823e-07,0.2115158147861096,0.04999999999999999,0.016320838183036854,0.24504501301336568,0.011581492100972611,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
268,0.5,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Long-term impact of postictal psychotic episodes II: Do they predict interictal psychotic episodes? Answer: Yes, postictal psychotic episodes can signal an elevated risk for interictal psychotic episodes, particularly when they occur often after seizures.",2.6054570009253883e-07,0.23696161252200643,0.07196605098855358,0.019947691112600613,0.2666776124348127,0.015078036422902494,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
268,0.5,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: Question: What is the enduring significance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes are often a marker for increased likelihood of interictal psychotic episodes if they happen frequently post-seizure.,1.6580180914979763e-07,0.19959272749747115,0.0297893709825528,0.012693985253473108,0.18519317155393722,0.008526077097505684,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
268,0.5,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How do postictal psychotic episodes II relate to long-term outcomes? Can they predict interictal psychotic episodes? Answer: Frequent postictal psychotic episodes after seizures may indicate a higher risk of interictal psychotic episodes.,3.0791764556390943e-07,0.3052312400063846,0.06662826991676574,0.023574544042164372,0.3319082223215615,0.013129251700680293,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
268,0.5,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Question: What is the long-term predictive value of postictal psychotic episodes II for interictal psychotic episodes? Answer: The presence of postictal psychotic episodes can suggest a greater chance of interictal psychotic episodes, especially if these episodes occur repeatedly after seizures.",1.1842986367842703e-07,0.09075202844917207,0.06060956790123452,0.009067132323909363,0.12870662625668094,0.005780739371472957,0.009054007704764333,0.16009538652296218,0.026296566837107373,1.1842986367842703e-07,0.1267517056391423,0.0
268,0.5,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What is the long-term significance of postictal psychotic episodes II? Are they a predictor for interictal psychotic episodes? Answer: Postictal psychotic episodes, when frequent following seizures, may predict the occurrence of interictal psychotic episodes.",2.6054570009253883e-07,0.19618824895965803,0.10078124999999999,0.019947691112600613,0.22466869240087695,0.045351473922902494,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
268,0.5,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Question: Do postictal psychotic episodes II have long-term significance in predicting interictal psychotic episodes? Answer: Yes, frequent postictal psychotic episodes after seizures can indicate a higher likelihood of interictal psychotic episodes.",3.3160361829959473e-07,0.34117236078402735,0.06371173469387753,0.02538797050694625,0.3661886842425317,0.012057775944305578,0.025351221573340174,0.39390428570708913,0.0,3.316036182995957e-07,0.4054651081081637,0.0
268,0.5,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term importance of postictal psychotic episodes II in relation to interictal psychotic episodes? Answer: Recurrent postictal psychotic episodes after seizures may be predictive of subsequent interictal psychotic episodes.,3.3160361829959473e-07,0.34117236078402735,0.06371173469387752,0.02538797050694625,0.3661886842425317,0.012057775944305578,0.025351221573340174,0.39390428570708913,0.0,3.316036182995957e-07,0.4054651081081637,0.0
269,0.5,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness affect microvascular function in healthy adults who are at risk for Type 2 diabetes? Yes, aerobic fitness has a significant impact on microvascular function in these individuals. Engaging in regular aerobic exercise enhances insulin sensitivity and endothelial function, which helps lower the risk of microvascular complications linked to prediabetes or early stages of the disease.",4.737194547137081e-08,0.27473304834874623,0.19523232444631394,0.0036268529295637453,0.2426614479089535,0.14214876033057855,0.003621603081905733,0.24629325071731456,0.14617283950617282,4.737194547137081e-08,0.22435687659514025,0.131358024691358
269,0.5,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is microvascular function influenced by aerobic fitness in healthy adults at risk of developing Type 2 diabetes? Yes, aerobic fitness plays an important role in microvascular function among these adults. Consistent aerobic exercise improves insulin sensitivity and the health of endothelial cells, reducing the chance of microvascular issues related to prediabetes or initial stages of Type 2 diabetes.",4.737194547137081e-08,0.27473304834874623,0.19523232444631394,0.0036268529295637453,0.2674167043575233,0.16000000000000003,0.003621603081905733,0.24629325071731456,0.14617283950617282,4.737194547137081e-08,0.22435687659514025,0.131358024691358
269,0.5,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness have an effect on microvascular function in healthy adults with a risk of Type 2 diabetes? Indeed, aerobic fitness greatly affects microvascular function in such adults. Regular aerobic activity boosts insulin sensitivity and endothelial function, thereby decreasing the likelihood of microvascular complications associated with prediabetes or early Type 2 diabetes.",7.105791820705622e-08,0.14925033242874397,0.1713125713598942,0.005440279394345618,0.1467084039717994,0.14040000000000002,0.0054324046228586,0.1509830709129889,0.14617283950617282,7.105791820705622e-08,0.12719312814149175,0.131358024691358
269,0.5,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness influence microvascular function in healthy adults who are at risk for Type 2 diabetes? Yes, aerobic fitness significantly impacts microvascular function in these individuals. Regular aerobic exercise enhances insulin sensitivity and endothelial function, reducing the risk of microvascular complications related to prediabetes or early-stage Type 2 diabetes.",1.4211583641411244e-07,0.08329805311436456,0.1667138059277954,0.010880558788691236,0.08438489200693411,0.13917609778180173,0.0108648092457172,0.08910766719490137,0.14617283950617282,1.4211583641411244e-07,0.06401422651995947,0.131358024691358
269,0.5,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is there an influence of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? Yes, aerobic fitness markedly influences microvascular function in these adults. Engaging in regular aerobic exercise improves insulin sensitivity and endothelial health, which lowers the risk of microvascular complications associated with prediabetes or early stages of the disease.",0.0,0.2111564187767936,0.17542156789968658,0.0,0.2053769423881322,0.14148807404770386,0.0,0.20925197903696446,0.14617283950617282,0.0,0.18661654861229282,0.131358024691358
269,0.5,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness impact microvascular function in healthy adults at risk of developing Type 2 diabetes? Yes, aerobic fitness significantly affects microvascular function in these individuals. Regular aerobic exercise enhances insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications linked to prediabetes or early-stage Type 2 diabetes.",1.4211583641411244e-07,0.05500633145885647,0.14697831975291534,0.010880558788691236,0.08438489200693411,0.13917609778180173,0.0108648092457172,0.08910766719490137,0.14617283950617282,1.4211583641411244e-07,0.06401422651995947,0.131358024691358
269,0.5,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","How does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? Aerobic fitness has a significant positive influence on microvascular function in these adults. Consistent aerobic exercise improves insulin sensitivity and endothelial function, which helps to reduce microvascular complications associated with prediabetes or early Type 2 diabetes.",9.474389094274162e-08,0.12774130485049495,0.1698381736937808,0.0072537058591274906,0.12636213182812117,0.1400083298625573,0.007243206163811466,0.1307803635954703,0.14617283950617282,9.474389094274162e-08,0.10657384093875599,0.131358024691358
269,0.5,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is microvascular function in healthy adults at risk of Type 2 diabetes influenced by aerobic fitness? Yes, aerobic fitness significantly impacts microvascular function. Regular aerobic activity enhances insulin sensitivity and endothelial function, reducing the risk of microvascular complications related to prediabetes or early stages of Type 2 diabetes.",1.8948778188548325e-07,0.06630536922179209,0.1841684023975434,0.014507411718254981,0.040569576174079636,0.13827160493827162,0.014486412327622933,0.04562255525516301,0.14617283950617282,1.8948778188548325e-07,0.01956246394912675,0.131358024691358
269,0.5,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness play a role in microvascular function among healthy adults at risk of developing Type 2 diabetes? Yes, it does. Aerobic fitness notably affects microvascular function by improving insulin sensitivity and endothelial health through regular aerobic exercise, which decreases the risk of microvascular complications linked to prediabetes or early Type 2 diabetes.",4.737194547137081e-08,0.17031056565940839,0.1727326972333728,0.0036268529295637453,0.19330873220380163,0.16000000000000003,0.003621603081905733,0.17078569820916867,0.14617283950617282,4.737194547137081e-08,0.14739583545901036,0.131358024691358
269,0.5,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness modify microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness significantly modifies microvascular function in these individuals. Regular aerobic exercise enhances insulin sensitivity and endothelial function, thereby lowering the risk of microvascular complications associated with prediabetes or early-stage Type 2 diabetes.",1.6580180914979784e-07,0.060321122440336605,0.1650568321496095,0.012693985253473108,0.06271699062775316,0.13873345935727793,0.012675610786670066,0.06760146197393802,0.14617283950617282,1.6580180914979784e-07,0.04203531980118447,0.131358024691358
270,0.5,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does initiating migraine treatment early reduce the time to reach headache peak and lessen its intensity? Early intervention and triptan use might shorten the duration from migraine onset to peak but do not diminish headache severity at the peak, potentially lowering overall migraine burden by cutting total headache duration.",1.1842986367842703e-07,0.07293440526460904,0.018860946745562133,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
270,0.5,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can early migraine treatment shorten the time until the headache peaks and decrease its severity? Early treatment with triptans may reduce the time from migraine onset to peak but does not reduce the peak headache severity, possibly lessening migraine burden by shortening total headache duration.",2.1317375462116866e-07,0.222959162305143,0.02649052717734036,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.5,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Is the time to headache peak shortened and severity reduced by early migraine treatment? Early administration of triptans can lead to a shorter time from migraine start to peak, though it does not lessen headache severity at the peak, which may reduce the overall migraine burden by decreasing headache duration.",9.474389094274162e-08,0.05231511806187328,0.018860946745562133,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
270,0.5,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does treating migraines early shorten the time to headache peak and reduce how severe it is? Early treatment with triptans may result in a quicker progression from migraine onset to peak without reducing the peak headache severity, potentially lowering migraine burden by shortening total headache duration.",1.8948778188548325e-07,0.13747292640218056,0.018860946745562133,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
270,0.5,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Will early migraine treatment reduce the time to headache peak and its severity? Early use of triptans might decrease the duration from migraine onset to peak but does not alleviate headache severity at peak, which could reduce migraine burden by shortening total headache duration.",2.3685972735685406e-07,0.1829353004789378,0.018860946745562133,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
270,0.5,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does early intervention in migraines shorten the headache peak time and reduce its intensity? Early treatment and triptan use may shorten the interval from migraine onset to peak but do not reduce headache severity at peak, possibly lowering migraine burden by decreasing total headache duration.",2.1317375462116866e-07,0.19145247227969087,0.003854034325286977,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.5,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Can early migraine treatment reduce the time to peak headache and its severity? Early triptan use may lead to a shorter time from migraine start to peak without reducing peak headache severity, potentially decreasing migraine burden by reducing overall headache duration.",3.079176455639103e-07,0.32457068011455803,0.031000549099313202,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
270,0.5,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Is early migraine treatment effective in shortening the time to headache peak and lessening severity? Early treatment with triptans may shorten the duration from migraine onset to peak but does not reduce headache severity at peak, which might lower migraine burden by shortening total headache duration.",1.8948778188548325e-07,0.13747292640218056,0.018860946745562133,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
270,0.5,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Does early treatment of migraines shorten time to headache peak and reduce severity? Early use of triptans may lead to a reduced duration from migraine onset to peak but does not diminish headache severity at peak, potentially decreasing migraine burden by shortening total headache duration.",2.1317375462116866e-07,0.15994578225423828,0.018860946745562133,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.5,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,"Will early migraine treatment shorten the time to headache peak and lessen its severity? Early administration of triptans may shorten the duration from migraine onset to peak but does not reduce headache severity at peak, possibly lowering migraine burden by reducing total headache duration.",2.3685972735685406e-07,0.215174704225912,0.004381683639925391,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
271,0.5,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? The consultation resulted in changes to the treatment plan in over one third of cases. Additional research is necessary to assess if these changes benefit the outcomes for older patients.,1.8948778188548325e-07,0.06873095963088005,0.0749700721939469,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.1534404242706242,0.020823902218198284,1.8948778188548325e-07,0.18658595558041347,0.0
271,0.5,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation alter the cancer treatment plan for elderly patients? More than one third of cases saw modifications in the treatment plan following the consultation. Further studies are required to evaluate whether these adjustments improve outcomes in older patients.,2.1317375462116866e-07,0.09363356020013835,0.07439043209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.5,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients modified after a geriatric oncology consultation? The consultation led to treatment plan changes in over one third of cases. More research is needed to determine if these changes enhance the outcomes for elderly patients.,2.1317375462116866e-07,0.12744561778842822,0.050113229600409114,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.5,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Does consulting geriatric oncology specialists affect the cancer treatment plan for elderly patients? In more than one third of cases, the treatment plan was modified after the consultation. Further investigation is needed to see if these modifications improve patient outcomes.",2.6054570009253936e-07,0.14537793244599584,0.07314216340070451,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.5,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation impact the cancer treatment approach for elderly patients? The consultation caused changes in the treatment plan in over one third of cases. Additional studies are required to confirm if these changes lead to better outcomes for older patients.,1.8948778188548325e-07,0.03572395103278847,0.09876543209876545,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.1534404242706242,0.020823902218198284,1.8948778188548325e-07,0.18658595558041347,0.0
271,0.5,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can consulting a geriatric oncologist modify the cancer treatment plan for elderly patients? The cancer treatment plan was altered in more than one third of cases following the consultation. Further research is needed to determine if these changes improve outcomes.,2.6054570009253936e-07,0.21646995096496413,0.02237654320987656,0.0199476911126006,0.24232183452928968,0.008494947373334234,0.019918816950481533,0.2688693809057372,0.00618227062130788,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.5,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation lead to changes in the cancer treatment plan for elderly patients? Over one third of cases experienced modifications in their treatment plans after the consultation. More studies are necessary to establish if these changes improve patient outcomes.,2.1317375462116866e-07,0.05982150261184849,0.09876543209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.5,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients influenced by a geriatric oncology consultation? The consultation resulted in modifications in more than one third of cases. Further research is needed to assess whether these changes benefit older patients.,3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.5,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation result in adjustments to the cancer treatment plan for elderly patients? The consultation led to treatment plan changes in over one third of cases. Additional studies are needed to evaluate if these adjustments improve outcomes.,2.6054570009253936e-07,0.14537793244599584,0.07314216340070451,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.5,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a consultation with geriatric oncology specialists modify the cancer treatment plan for elderly patients? More than one third of cases had their treatment plans changed after such consultations. Further research is required to determine if these changes improve patient outcomes.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
272,0.5,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,"Can computerized tomography (CT) serve as a substitute for bone scintigraphy in identifying bone metastases originating from breast cancer? CT cannot entirely replace bone scintigraphy in this role, although it is effective in detection.",4.73719454713706e-08,0.2136173527685945,0.16597756281979448,0.003626852929563759,0.18146722433501505,0.16082641395779712,0.003621603081905747,0.1895331632222832,0.1728395061728395,4.737194547137081e-08,0.15206997278741197,0.1508916323731139
272,0.5,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,"Is computerized tomography capable of replacing bone scintigraphy for detecting bone metastases from breast cancer? CT does not fully replace bone scintigraphy, despite its effectiveness in identifying lesions.",1.894877818854824e-07,0.09696449737431623,0.22633136094674555,0.014507411718255037,0.017149558341768678,0.19204389574759942,0.014486412327622988,0.0255782163946634,0.1728395061728395,1.8948778188548325e-07,0.07107357852679774,0.1508916323731139
272,0.5,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can CT scans replace bone scintigraphy when detecting bone metastases in breast cancer patients? CT is effective but cannot completely substitute bone scintigraphy for this purpose.,2.36859727356853e-07,0.03544831820660832,0.18640080539119,0.018134264647818796,0.0628931493317686,0.19204389574759942,0.018108015409528735,0.10895982533371384,0.1728395061728395,2.3685972735685406e-07,0.15808495551642743,0.1508916323731139
272,0.5,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,"Does computerized tomography have the ability to replace bone scintigraphy in the detection of bone metastases caused by breast cancer? CT cannot fully take the place of bone scintigraphy, even though it is effective at detection.",0.0,0.31686728254168894,0.1977846481439774,0.0,0.2854135449364481,0.19204389574759942,0.0,0.2520535202036167,0.1728395061728395,0.0,0.2166084939249835,0.1508916323731139
272,0.5,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can bone scintigraphy be replaced by computerized tomography for detecting bone metastases from breast cancer? CT is useful but cannot entirely replace bone scintigraphy.,2.842316728282236e-07,0.06337815270086367,0.22633136094674555,0.021761117577382555,0.14990452632139828,0.19204389574759942,0.021729618491434483,0.19993160353944184,0.1728395061728395,2.842316728282248e-07,0.25339513532075264,0.1508916323731139
272,0.5,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,"Is it possible for CT to replace bone scintigraphy in the detection of bone metastases in breast cancer cases? CT cannot fully replace bone scintigraphy, despite its detection capabilities.",1.658018091497971e-07,0.08382162864805176,0.19066606602219138,0.012693985253473157,0.054889886324615667,0.19204389574759942,0.012675610786670115,0.01364249675861906,0.1728395061728395,1.6580180914979784e-07,0.03025158400654293,0.1508916323731139
272,0.5,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can computerized tomography fully substitute bone scintigraphy in identifying bone metastases from breast cancer? CT is effective but does not completely replace bone scintigraphy.,2.842316728282236e-07,0.06337815270086367,0.22633136094674555,0.021761117577382555,0.14990452632139828,0.19204389574759942,0.021729618491434483,0.19993160353944184,0.1728395061728395,2.842316728282248e-07,0.25339513532075264,0.1508916323731139
272,0.5,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,"Can CT scans be used instead of bone scintigraphy to detect bone metastases from breast cancer? CT cannot fully replace bone scintigraphy, though it is effective at identifying metastases.",1.658018091497971e-07,0.1333321415451909,0.22633136094674555,0.012693985253473157,0.054889886324615667,0.19204389574759942,0.012675610786670115,0.01364249675861906,0.1728395061728395,1.6580180914979784e-07,0.03025158400654293,0.1508916323731139
272,0.5,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,"Is computerized tomography a complete alternative to bone scintigraphy for detecting bone metastases in breast cancer? CT cannot fully replace bone scintigraphy, despite its effectiveness.",2.605457000925383e-07,0.020818538282068033,0.22633136094674555,0.019947691112600675,0.10545276375056423,0.19204389574759942,0.01991881695048161,0.1534115879045479,0.1728395061728395,2.6054570009253947e-07,0.20460497115132137,0.1508916323731139
272,0.5,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can computerized tomography replace bone scintigraphy in the detection of bone metastases from breast cancer? CT is effective but cannot fully substitute bone scintigraphy.,2.842316728282236e-07,0.06337815270086367,0.22633136094674555,0.021761117577382555,0.14990452632139828,0.19204389574759942,0.021729618491434483,0.19993160353944184,0.1728395061728395,2.842316728282248e-07,0.25339513532075264,0.1508916323731139
273,0.5,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should patients with HIV undergo screening for silent myocardial ischemia utilizing gated myocardial perfusion SPECT? Yes, individuals infected with HIV should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT due to their increased cardiovascular risk from chronic inflammation caused by HIV and antiretroviral therapy. Early identification allows for prompt intervention and improved prognosis.",2.1317375462116866e-07,0.08617351632438908,0.043436405384359264,0.016320838183036854,0.05512965403298331,0.06893419886184904,0.0162972138685758,0.026481863584860488,0.0922134334197271,2.1317375462116866e-07,0.023273323186646877,0.09719008264462808
273,0.5,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it advisable to screen HIV-positive patients for silent myocardial ischemia with gated myocardial perfusion SPECT? Indeed, HIV-positive patients ought to be screened for silent myocardial ischemia using gated myocardial perfusion SPECT because their risk of cardiovascular disease is elevated by the chronic inflammatory effects of HIV infection and antiretroviral drugs. Detecting it early facilitates timely treatment and better health outcomes.",9.474389094274162e-08,0.013440536675421555,0.052126200274348444,0.0072537058591274906,0.03995055291825356,0.0735959900489121,0.007243206163811466,0.06592410387319836,0.09383830752755454,9.474389094274162e-08,0.06853422606647541,0.09719008264462808
273,0.5,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischemia screening via gated myocardial perfusion SPECT be conducted in HIV-infected patients? Yes, screening HIV-infected patients for silent myocardial ischemia with gated myocardial perfusion SPECT is recommended since they are at higher cardiovascular risk due to the persistent inflammation from HIV and its treatment. Early diagnosis enables effective management and improved results.",2.3685972735685406e-07,0.08165113186299777,0.05926314424316802,0.018134264647818726,0.07527492578844885,0.06789752066115698,0.018108015409528666,0.04603306812054608,0.09185100454052952,2.3685972735685406e-07,0.04269140904374957,0.09719008264462808
273,0.5,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is screening for silent myocardial ischemia using gated myocardial perfusion SPECT necessary for HIV-infected individuals? Yes, HIV-infected individuals should be screened for silent myocardial ischemia through gated myocardial perfusion SPECT because the chronic inflammation from HIV infection and antiretroviral therapy increases their cardiovascular disease risk. Early detection supports timely therapeutic intervention and better outcomes.",2.6054570009253947e-07,0.12892166016029227,0.03952902485840144,0.0199476911126006,0.12249165639873372,0.04790863177226812,0.019918816950481533,0.09315613178283488,0.07192402614613053,2.6054570009253947e-07,0.06249403633992934,0.09719008264462808
273,0.5,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should gated myocardial perfusion SPECT be used to screen HIV patients for silent myocardial ischemia? Yes, it is important to screen HIV patients for silent myocardial ischemia with gated myocardial perfusion SPECT given their heightened risk of cardiovascular disease stemming from chronic inflammation caused by HIV and its treatment. Early detection can lead to prompt treatment and improved prognosis.",1.4211583641411244e-07,0.09694622113101214,0.0009541063422933982,0.010880558788691236,0.0942927552941617,0.0038975206611570057,0.0108648092457172,0.06904187126505867,0.022646852291394556,1.4211583641411244e-07,0.042799912596688916,0.042826177319184276
273,0.5,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it recommended to use gated myocardial perfusion SPECT to screen for silent myocardial ischemia in HIV-infected patients? Yes, screening HIV-infected patients with gated myocardial perfusion SPECT is recommended because their chronic inflammatory state from HIV infection and antiretroviral therapy puts them at increased cardiovascular risk. Early identification allows for timely treatment and better outcomes.",2.3685972735685406e-07,0.0303068962659645,0.09552831057380597,0.018134264647818726,0.04911842840882841,0.08661970443662798,0.018108015409528666,0.04603306812054608,0.09185100454052952,2.3685972735685406e-07,0.04269140904374957,0.09719008264462808
273,0.5,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should HIV-infected patients undergo gated myocardial perfusion SPECT screening for silent myocardial ischemia? Yes, HIV-infected patients should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT due to their elevated cardiovascular risk linked to chronic inflammation from HIV and antiretroviral therapy. Early detection promotes early treatment and improved clinical outcomes.",3.079176455639103e-07,0.17354241095976386,0.03533607681755836,0.023574544042164344,0.13825200344075572,0.06454197516545757,0.023540420032387266,0.10708870330224185,0.09067507460973367,3.079176455639103e-07,0.1033160308601837,0.09719008264462808
273,0.5,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is gated myocardial perfusion SPECT screening for silent myocardial ischemia advised in HIV-positive patients? Yes, HIV-positive patients should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT because the chronic inflammation associated with HIV infection and antiretroviral treatment increases their cardiovascular risk. Early detection leads to timely intervention and better outcomes.",2.8423167282822487e-07,0.15098791252094124,0.037470082278595926,0.02176111757738247,0.14400068397698274,0.046434234106154715,0.0217296184914344,0.1140460487740107,0.07114382460973366,2.8423167282822487e-07,0.08269674365744795,0.09719008264462808
273,0.5,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischemia be screened by gated myocardial perfusion SPECT in patients infected with HIV? Yes, patients infected with HIV should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT since they have a higher risk of cardiovascular disease due to chronic inflammatory effects of HIV and its treatment. Early detection facilitates prompt treatment and improved outcomes.",1.1842986367842703e-07,0.05270926229098993,0.018634808074767112,0.009067132323909363,0.002260844318730193,0.05571041503701435,0.009054007704764333,0.04811303437333203,0.09353611485916677,1.1842986367842703e-07,0.05083464896707479,0.09719008264462808
273,0.5,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it beneficial to screen HIV-infected patients for silent myocardial ischemia with gated myocardial perfusion SPECT? Yes, screening HIV-infected patients for silent myocardial ischemia with gated myocardial perfusion SPECT is beneficial because their chronic inflammatory state induced by HIV infection and antiretroviral therapy raises their risk of cardiovascular disease. Early detection enables timely treatment and better outcomes.",1.8948778188548325e-07,0.13972020673666607,0.003929553683925474,0.014507411718254981,0.16140697813213034,0.01694285960140525,0.014486412327622933,0.1613380577827006,0.0156798072498307,1.8948778188548325e-07,0.16116411249367735,0.0141725248700844
274,0.5,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a link between crime and over-the-counter syringe sales at pharmacies? Although no direct connection exists, misuse of syringes can happen, particularly for illegal drug use.",1.658018091497971e-07,0.15439318337712526,0.06035379812695108,0.012693985253473157,0.20353837914652884,0.031217481789802305,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
274,0.5,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does crime correlate with the sale of syringes over the counter in pharmacies? There is no direct association, but syringes may be misused for illicit drug purposes.",1.658018091497971e-07,0.15439318337712526,0.06035379812695108,0.012693985253473157,0.20353837914652884,0.031217481789802305,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
274,0.5,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are over-the-counter pharmacy syringe sales related to crime? While no direct link is found, syringes can be abused for illegal drug use.",2.842316728282236e-07,0.36796728367518616,0.06035379812695108,0.021761117577382555,0.42668193046073855,0.031217481789802305,0.021729618491434483,0.48954822531870645,0.0,2.842316728282247e-07,0.5108256237659901,0.0
274,0.5,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is crime connected to the sale of syringes at pharmacies without prescriptions? There isn’t a direct correlation, though misuse involving illicit drugs can occur.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.5,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does the sale of syringes over the counter in pharmacies contribute to crime? No direct association exists, but syringes might be misused for drug-related activities.",2.131737546211677e-07,0.23443589105066254,0.06035379812695108,0.016320838183036916,0.2869199880855793,0.031217481789802305,0.016297213868575862,0.3429447511268311,0.0,2.1317375462116866e-07,0.35667494393873334,0.0
274,0.5,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there an association between crime and the over-the-counter sale of syringes in pharmacies? Directly, no; however, misuse for illegal drug use is possible.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.5,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are crime rates affected by the sale of syringes over the counter at pharmacies? There is no direct link, but syringes can be used improperly for illicit drugs.",1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.16431766599324638,0.031217481789802305,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
274,0.5,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is crime linked to over-the-counter syringe sales in pharmacies? While no direct connection is evident, syringes can be misused for illegal drug consumption.",2.605457000925383e-07,0.3214472680402922,0.06035379812695108,0.019947691112600675,0.3778917662913073,0.031217481789802305,0.01991881695048161,0.4382549309311563,0.0,2.6054570009253936e-07,0.45675840249571475,0.0
274,0.5,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does over-the-counter pharmacy syringe sales have a connection to crime? No direct association is present, but misuse related to illicit drug use can occur.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.5,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a relationship between crime and the sale of syringes without prescription in pharmacies? No direct link exists, though syringes may be abused for illegal drug use.",1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.16431766599324638,0.031217481789802305,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
275,0.5,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer be considered a novel diagnostic marker for acute appendicitis? Answer: Although research continues, existing studies indicate that D-dimer levels might potentially act as a new",0.0,0.05134423559703327,0.03698224852071005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.5,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer a possible new diagnostic indicator for acute appendicitis? Answer: Research is still underway, but current findings suggest that D-dimer levels could potentially function as a new",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
275,0.5,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer serve as a new diagnostic tool for acute appendicitis? Answer: While studies are ongoing, current evidence points to D-dimer levels potentially being a new",2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.5,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer become a novel diagnostic parameter in acute appendicitis? Answer: Although investigations continue, current research suggests D-dimer levels may potentially be used as a new",2.36859727356853e-08,0.013603907614186284,0.03698224852071005,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.5,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is it possible for D-dimer to be a new diagnostic marker for acute appendicitis? Answer: Research is ongoing, and current studies propose that D-dimer levels might serve as a new",7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
275,0.5,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer be utilized as a new diagnostic parameter for acute appendicitis? Answer: While research is in progress, current data suggests that D-dimer levels can potentially serve as a new",7.10579182070559e-08,0.06428512718019963,0.029344282091534828,0.005440279394345639,0.06139603813327055,0.03443877551020409,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
275,0.5,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Might D-dimer become a new diagnostic indicator for acute appendicitis? Answer: Research continues, but current studies imply that D-dimer levels could potentially act as a new",2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.5,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer be introduced as a new diagnostic marker for acute appendicitis? Answer: Although research is ongoing, current findings suggest that D-dimer levels may potentially serve as a new",4.73719454713706e-08,0.027196691915736704,0.03160485710343262,0.003626852929563759,0.02459745925658252,0.035665294924554176,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
275,0.5,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer likely to become a new diagnostic parameter for acute appendicitis? Answer: While research is still in progress, current studies indicate that D-dimer levels might potentially be used as a new",1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
275,0.5,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer levels be a new diagnostic factor for acute appendicitis? Answer: Although research continues, current evidence suggests that D-dimer levels could potentially function as a new",0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
276,0.5,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in coronary artery disease patients? Current research indicates that bezafibrate, a lipid-lowering PPAR ligand, may possess anti-cancer effects, though definitive studies proving its role in colon cancer prevention are lacking.",7.105791820705622e-08,0.08645840187422271,0.11088203187995288,0.005440279394345618,0.09092707083674023,0.11687363038714388,0.0054324046228586,0.05926232337523807,0.09642074506939374,7.105791820705622e-08,0.02601053561428035,0.07450693937180423
276,0.5,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in individuals with coronary artery disease? Research to date suggests bezafibrate has potential anti-cancer properties, but conclusive evidence for its effectiveness in colon cancer prevention is not yet established.",9.474389094274152e-08,0.06025194365844344,0.11024232662699385,0.0072537058591274906,0.06495158443348226,0.11687363038714388,0.007243206163811466,0.0325940762930772,0.09642074506939374,9.474389094274162e-08,0.0013884385738349714,0.07450693937180423
276,0.5,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer in patients with coronary artery disease? Current studies imply it might have anti-cancer benefits, although specific proof of its preventive effect on colon cancer remains insufficient.",1.1842986367842682e-07,0.03334103595888305,0.10956902848794742,0.009067132323909363,0.03828333735132139,0.11687363038714388,0.009054007704764333,0.0051951021049618795,0.09642074506939374,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
276,0.5,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does bezafibrate, a ligand activating peroxisome proliferator-activated receptors and lowering lipids, prevent colon cancer in coronary artery disease patients? Research suggests potential anti-cancer activity, yet clear evidence for colon cancer prevention is still needed.",2.3685972735685332e-07,0.11326505177917268,0.1055921578250548,0.018134264647818747,0.10689867249317775,0.11687363038714388,0.018108015409528694,0.14433663186600176,0.09642074506939374,2.3685972735685406e-07,0.1837099953677903,0.07450693937180423
276,0.5,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is the lipid-lowering PPAR ligand bezafibrate protective against colon cancer in patients suffering from coronary artery disease? Existing research points to possible anti-cancer properties, but studies confirming its preventive efficacy for colon cancer are limited.",2.1317375462116802e-07,0.08217653215790488,0.10648083866757085,0.016320838183036868,0.07612701382642406,0.11687363038714388,0.01629721386857582,0.11258793355142194,0.09642074506939374,2.1317375462116866e-07,0.15092017254479861,0.07450693937180423
276,0.5,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Can bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, help prevent colon cancer in coronary artery disease patients? Current findings suggest anti-cancer potential, but specific research validating colon cancer prevention is still pending.",2.842316728282239e-07,0.17849566166592146,0.10364337310283259,0.021761117577382506,0.17143719363074927,0.11687363038714388,0.02172961849143444,0.21102800636467522,0.09642074506939374,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
276,0.5,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does the PPAR ligand bezafibrate, known for lowering lipids, prevent colon cancer in those with coronary artery disease? Research indicates it may have anti-cancer effects, though definitive studies on colon cancer prevention are lacking.",2.3685972735685332e-07,0.11326505177917268,0.1055921578250548,0.018134264647818747,0.10689867249317775,0.11687363038714388,0.018108015409528694,0.14433663186600176,0.09642074506939374,2.3685972735685406e-07,0.1837099953677903,0.07450693937180423
276,0.5,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is there evidence that bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevents colon cancer in patients with coronary artery disease? Research suggests it has anti-cancer potential, but conclusive proof for colon cancer prevention is not yet available.",1.6580180914979742e-07,0.022752931453381642,0.10811049328423847,0.012693985253473108,0.017286513803490777,0.11687363038714388,0.012675610786670073,0.05196331173498647,0.09642074506939374,1.6580180914979784e-07,0.0883998155634651,0.07450693937180423
276,0.5,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Does the use of bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, reduce the risk of colon cancer in coronary artery disease patients? Current studies imply it might have anti-cancer properties, but specific evidence for colon cancer prevention is limited.",1.1842986367842682e-07,0.03334103595888305,0.10956902848794742,0.009067132323909363,0.03828333735132139,0.11687363038714388,0.009054007704764333,0.0051951021049618795,0.09642074506939374,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
276,0.5,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Is the lipid-lowering agent bezafibrate, which activates peroxisome proliferator-activated receptors, effective in preventing colon cancer in patients with coronary artery disease? Research suggests it could have anti-cancer benefits, although definitive studies confirming this are still lacking.",1.8948778188548272e-07,0.012415631722303644,0.1358655953250548,0.014507411718254988,0.046274050676742284,0.11687363038714388,0.014486412327622947,0.08181627488466825,0.09642074506939374,1.8948778188548325e-07,0.11917147423021879,0.07450693937180423
277,0.5,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The findings indicate that the R14C KCNQ1 mutation by itself does not cause AF. Instead, we propose a model where a ""second hit,"" such as an environmental factor like hypertension that causes atrial stretch, reveals an inherited ion channel defect (the ""first hit"").",1.1842986367842703e-07,0.08182000813651058,0.0012810193954682567,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
277,0.5,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These results imply that the R14C KCNQ1 mutation alone is not enough to induce AF. We suggest a model where a ""second hit,"" for example hypertension leading to atrial stretch, exposes a genetic ion channel defect (the ""first hit"").",2.1317375462116866e-07,0.1524632300533657,0.002470380294421492,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
277,0.5,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The data imply that the R14C KCNQ1 mutation by itself cannot cause AF. Rather, we propose that an additional factor, such as hypertension causing atrial stretch, unmasks a hereditary ion channel abnormality (the ""first hit"").",3.079176455639103e-07,0.22847545270313097,0.00384251624975971,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
277,0.5,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These observations suggest that the R14C KCNQ1 mutation alone is insufficient for AF development. Instead, a ""second hit,"" like hypertension-induced atrial stretch, reveals a genetic defect in ion channel function (the ""first hit"").",3.552895910352811e-07,0.26876254613419803,0.004610810762442734,0.02720139697172809,0.2670627852490446,0.0,0.027162023114293,0.2719337154836441,0.0,3.552895910352811e-07,0.2769867833350337,0.0
277,0.5,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The evidence suggests that having the R14C KCNQ1 mutation alone does not cause AF. We propose a model where a ""second hit,"" such as hypertension causing atrial stretch, uncovers a genetic ion channel defect (the ""first hit"").",2.6054570009253947e-07,0.189747735574187,0.0031310665772961814,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
277,0.5,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: According to the data, the R14C KCNQ1 mutation by itself is not sufficient to trigger AF. Instead, we suggest that a ""second hit,"" like hypertension that leads to atrial stretch, reveals an inherited ion channel defect (the ""first hit"").",2.1317375462116866e-07,0.1524632300533657,0.002470380294421492,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
277,0.5,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These findings indicate that the R14C KCNQ1 mutation alone does not cause AF. We propose a model where a ""second hit,"" such as hypertension resulting in atrial stretch, unmasks a hereditary ion channel abnormality (the ""first hit"").",2.6054570009253947e-07,0.189747735574187,0.0031310665772961814,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
277,0.5,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The data show that the R14C KCNQ1 mutation alone is not enough to cause AF. Rather, we suggest a model where a ""second hit,"" like hypertension which induces atrial stretch, exposes a genetic defect in ion channel kinetics (the ""first hit"").",1.6580180914979784e-07,0.11651828070938652,0.001855213262734686,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
277,0.5,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The evidence indicates that the R14C KCNQ1 mutation by itself cannot cause AF. Instead, a ""second hit,"" such as hypertension causing atrial stretch, uncovers an inherited ion channel defect (the ""first hit"").",3.789755637709665e-07,0.28953108788482673,0.005018446180555556,0.029014823436509962,0.28768207245178035,0.0,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
277,0.5,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These results suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. We propose a model where a ""second hit,"" like hypertension that promotes atrial stretch, reveals a genetic ion channel defect (the ""first hit"").",2.6054570009253947e-07,0.189747735574187,0.0031310665772961814,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
278,0.5,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors reliably detect cervical spine fractures in geriatric blunt trauma patients with low-energy injuries? Answer: Clinical predictors do not appear to be reliable for evaluating the cervical spine in elderly patients with low-energy trauma.,4.73719454713706e-08,0.14776588842294647,0.05899234693877556,0.003626852929563759,0.10324992977309444,0.03180708532418292,0.003621603081905747,0.10394632060143305,0.031217481789802305,4.737194547137081e-08,0.06252035698133351,0.0
278,0.5,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective for identifying cervical spine fractures in older blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for the assessment of the cervical spine in elderly trauma patients with low-energy injuries.,4.73719454713706e-08,0.10925771172517296,0.03309159251629901,0.003626852929563759,0.06364151945538365,0.003420832103075977,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
278,0.5,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors adequately assess cervical spine fractures in geriatric patients after low-energy blunt trauma? Answer: Clinical predictors appear to be insufficient for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.13076937815654377,0.10801354881182448,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.5,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors sufficient for cervical spine fracture evaluation in elderly blunt trauma patients with low-energy impacts? Answer: Clinical predictors are inadequate for assessing the cervical spine in geriatric trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.14186049357514818,0.03653140943877556,0.005440279394345632,0.09401286366195283,0.004990476327643115,0.005432404622858621,0.09332544715697333,0.0026707689870341424,7.105791820705622e-08,0.09237332013101529,0.0
278,0.5,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for evaluating cervical spine fractures in elderly blunt trauma patients with low-energy trauma? Answer: Clinical predictors seem inadequate for cervical spine assessment in geriatric patients with low-energy mechanisms.,4.73719454713706e-08,0.01072876441767523,0.04591836734693884,0.003626852929563759,0.023221689852812144,0.02813157590472888,0.003621603081905747,0.02121682235257394,0.031217481789802305,4.737194547137081e-08,0.06669137449867346,0.0
278,0.5,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors effectively identify cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear insufficient for cervical spine evaluation in elderly trauma patients with low-energy injuries.,4.73719454713706e-08,0.032592934367321025,0.01747571456566166,0.003626852929563759,0.0679408627921636,0.0038554765460572307,0.003621603081905747,0.06742663438990348,0.0020762161887946107,4.737194547137081e-08,0.06669137449867346,0.0
278,0.5,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors adequate for the diagnosis of cervical spine fractures in older blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate for evaluating the cervical spine in elderly trauma patients with low-energy injuries.,4.73719454713706e-08,0.10925771172517296,0.03309159251629898,0.003626852929563759,0.06364151945538365,0.00342083210307597,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
278,0.5,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide sufficient evaluation of cervical spine fractures in geriatric patients with low-energy blunt trauma? Answer: Clinical predictors do not seem adequate for cervical spine assessment in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.11519407697650497,0.05598441249548734,0.0018134264647818796,0.07309743965520443,0.030969041469467145,0.0018108015409528735,0.07409335745175127,0.031217481789802305,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.5,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors capable of accurately assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear inadequate for cervical spine evaluation in geriatric trauma patients with low-energy injuries.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
279,0.5,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the interfractional motion of the prostate bed target, defined by RTOG consensus and monitored with daily CT on rails, vary between the superior and inferior parts of the clinical target volume?",6.158352911278196e-07,0.3132898844347469,0.18735592812931923,0.04714908808432872,0.3270912316901602,0.19834710743801648,0.04708084006477457,0.36277848302201976,0.1875,6.158352911278206e-07,0.4000583584039057,0.17561983471074377
279,0.5,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using RTOG consensus definitions and daily CT on rails, does the prostate bed target's interfractional motion differ between its superior and inferior sections?",8.290090457489873e-07,0.611515462622227,0.21957815035154143,0.06346992626736564,0.6837661756288935,0.19834710743801648,0.06337805393335044,0.7343420394545026,0.1875,8.290090457489891e-07,0.7878238894126697,0.17561983471074377
279,0.5,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Is there a difference in interfractional motion between the superior and inferior regions of the prostate bed target when assessed by RTOG consensus guidelines and daily CT on rails?,6.868932093348755e-07,0.3703534058053384,0.21957815035154143,0.05258936747867436,0.43245174734798564,0.19834710743801648,0.052513244687633194,0.47197777498701043,0.1875,6.868932093348768e-07,0.5133870437109098,0.17561983471074377
279,0.5,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"According to RTOG consensus and daily CT on rails imaging, does the prostate bed target exhibit varying interfractional motion in its superior versus inferior clinical target volume areas?",7.105791820705608e-07,0.40672104997621306,0.21957815035154143,0.05440279394345624,0.4701920753308326,0.19834710743801648,0.05432404622858607,0.5111984881402929,0.1875,7.105791820705622e-07,0.5542090382311646,0.17561983471074377
279,0.5,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"When using RTOG consensus definitions along with daily CT on rails, does the prostate bed target's interfractional motion differ between the upper and lower parts of the clinical target volume?",6.632072365991902e-07,0.33526208599406937,0.21957815035154143,0.05077594101389248,0.39608410317711096,0.19834710743801648,0.05070244314668032,0.43423744700416345,0.1875,6.632072365991914e-07,0.47416633055762736,0.17561983471074377
279,0.5,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the prostate bed target, evaluated by RTOG consensus criteria and daily CT on rails, show different interfractional motion patterns in the superior compared to the inferior portions of the clinical target volume?",5.921493183921343e-07,0.23682201318081608,0.21957815035154143,0.045335661619546844,0.2943014088671685,0.19834710743801648,0.0452700385238217,0.328876931346338,0.1875,5.921493183921352e-07,0.3649670385926367,0.17561983471074377
279,0.5,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Is there a variation in the prostate bed target's interfractional motion between superior and inferior clinical target volume regions as defined by RTOG consensus and observed with daily CT on rails?,6.395212638635049e-07,0.3013605343183876,0.21957815035154143,0.0489625145491106,0.36099278336584195,0.19834710743801648,0.04889164160572745,0.39786980283328877,0.1875,6.39521263863506e-07,0.43642600257478037,0.17561983471074377
279,0.5,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using daily CT on rails and RTOG consensus definitions, does the interfractional motion of the prostate bed target differ between its superior and inferior clinical target volume segments?",7.105791820705608e-07,0.40672104997621306,0.21957815035154143,0.05440279394345624,0.4701920753308326,0.19834710743801648,0.05432404622858607,0.5111984881402929,0.1875,7.105791820705622e-07,0.5542090382311646,0.17561983471074377
279,0.5,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the interfractional motion of the prostate bed target, based on RTOG consensus and daily CT on rails, differ across the superior and inferior portions of the clinical target volume?",6.632072365991902e-07,0.3830653398257895,0.18513937484133736,0.05077594101389248,0.39608410317711096,0.19834710743801648,0.05070244314668032,0.43423744700416345,0.1875,6.632072365991914e-07,0.47416633055762736,0.17561983471074377
279,0.5,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"According to daily CT on rails imaging and RTOG consensus definitions, is there a difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume?",6.395212638635049e-07,0.3013605343183876,0.21957815035154143,0.0489625145491106,0.36099278336584195,0.19834710743801648,0.04889164160572745,0.39786980283328877,0.1875,6.39521263863506e-07,0.43642600257478037,0.17561983471074377
280,0.5,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders? Yes, mental imagery fMRI can potentially predict recovery by evaluating cognitive function and neural activity, assisting in prognosis formulation, though further research is needed for conclusive results.",4.026615365066519e-07,0.12129868200617544,0.15696350649818733,0.030828249901291835,0.13899273656837918,0.1548211860570394,0.030783626196198732,0.1933095613635527,0.12456597222222221,4.026615365066519e-07,0.24970554492746588,0.09162848812994587
280,0.5,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it possible for mental imagery fMRI to predict recovery in patients with disorders of consciousness? Yes, mental imagery functional MRI may help predict recovery by assessing brain function and neural responses, which supports prognosis, but more research is necessary for definitive conclusions.",3.552895910352811e-07,0.10386517600493139,0.13444706994328923,0.02720139697172809,0.08898231599371575,0.1548211860570394,0.027162023114293,0.142016266976003,0.12456597222222221,3.552895910352811e-07,0.19706181144204704,0.09162848812994587
280,0.5,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can functional magnetic resonance imaging using mental imagery predict recovery in patients suffering from consciousness disorders? Yes, mental imagery fMRI can aid in predicting recovery by evaluating cognitive and neural responses, helping to develop prognoses, although more extensive studies are required for certainty.",3.552895910352811e-07,0.07085816740683892,0.15815171003847067,0.02720139697172809,0.08898231599371575,0.1548211860570394,0.027162023114293,0.142016266976003,0.12456597222222221,3.552895910352811e-07,0.19706181144204704,0.09162848812994587
280,0.5,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery functional MRI have the ability to predict recovery in patients with consciousness disorders? Yes, it has potential by assessing cognitive functions and neural activity, which helps in prognosis, but conclusive evidence depends on further research.",4.737194547137078e-07,0.16460286444788963,0.18194706994328924,0.03626852929563745,0.21903544424191335,0.1548211860570394,0.03621603081905733,0.27554765960052574,0.12456597222222221,4.737194547137081e-07,0.33426293295552956,0.09162848812994587
280,0.5,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI be used to predict recovery in patients with disorders of consciousness? Yes, it can evaluate cognitive function and brain response to assist prognosis, but more comprehensive research is needed for definitive conclusions.",5.210914001850784e-07,0.2201727156027018,0.18194706994328924,0.039895382225201205,0.2761938580818617,0.1548211860570394,0.03983763390096308,0.334388159623459,0.12456597222222221,5.210914001850789e-07,0.394887554771965,0.09162848812994587
280,0.5,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional MRI capable of forecasting recovery in patients with disorders of consciousness? Yes, it can help predict recovery by assessing neural and cognitive responses, aiding prognosis formulation, though additional research is essential for confirmation.",4.974054274493931e-07,0.19200183863600495,0.18194706994328924,0.038081955760419325,0.2472063212086102,0.1548211860570394,0.038026832360010206,0.30453519647377725,0.12456597222222221,4.974054274493935e-07,0.36411589610521133,0.09162848812994587
280,0.5,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can recovery in patients with consciousness disorders be predicted using mental imagery fMRI? Yes, this imaging technique can assess cognitive and neural function to aid prognosis, but more extensive studies are necessary for definitive proof.",5.447773729207637e-07,0.2491602524759533,0.18194706994328924,0.041708808689983085,0.3060468212315435,0.1548211860570394,0.04164843544191595,0.3651598182902127,0.12456597222222221,5.447773729207643e-07,0.42663625308654485,0.09162848812994587
280,0.5,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Yes, it has the potential to do so by evaluating cognitive and neural responses, supporting prognosis, but further research is required for conclusive evidence.",4.500334819780225e-07,0.13793461736572876,0.18194706994328924,0.03445510283085558,0.19163647005379802,0.1548211860570394,0.034405229278104466,0.2473767826338289,0.12456597222222221,4.500334819780227e-07,0.30527539608227805,0.09162848812994587
280,0.5,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI predict recovery in patients with disorders of consciousness? Yes, it can assess cognitive function and neural activity to aid prognosis, though more research is needed to establish definitive conclusions.",5.921493183921343e-07,0.30978487429238877,0.18194706994328924,0.045335661619546844,0.368567178212877,0.1548211860570394,0.0452700385238217,0.42969833942778424,0.12456597222222221,5.921493183921352e-07,0.4933276275852183,0.09162848812994587
280,0.5,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it feasible for mental imagery functional MRI to predict recovery in patients with disorders of consciousness? Yes, it can help by evaluating cognitive and neural responses to support prognosis, but definitive conclusions await further research.",5.210914001850784e-07,0.2201727156027018,0.18194706994328924,0.039895382225201205,0.2761938580818617,0.1548211860570394,0.03983763390096308,0.334388159623459,0.12456597222222221,5.210914001850789e-07,0.394887554771965,0.09162848812994587
281,0.5,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This study shows that hospital management can promote care programme development by incorporating case-mix reimbursement into hospital budgeting. Further research is advised to validate this result and to assess whether care programmes will eventually become established.,2.3685972735685406e-07,0.07293401200320693,0.08842752787389466,0.018134264647818726,0.12505463940106631,0.05436390532544379,0.018108015409528666,0.17912229484749664,0.01851192595229618,2.3685972735685406e-07,0.2090917978585587,0.0
281,0.5,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the use of case-mix based reimbursement foster the growth of process-oriented care delivery? The study indicates that hospital management can drive the creation of care programmes by adopting case-mix reimbursement in budgeting. Additional studies are needed to confirm these findings and to explore if care programmes will be firmly established over time.,9.474389094274162e-08,0.023008803144513035,0.06920415224913495,0.0072537058591274906,0.000108503552939343,0.05436390532544379,0.007243206163811466,0.051288923337613035,0.01851192595229618,9.474389094274162e-08,0.07847161544149417,0.0
281,0.5,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is process-oriented care delivery stimulated by case-mix based reimbursement? Findings from this study suggest that hospital management can encourage care programme development through the integration of case-mix reimbursement in budgeting. Future research should verify this outcome and examine the long-term establishment of care programmes.,3.079176455639103e-07,0.14037529279873917,0.08842752787389466,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
281,0.5,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does implementing case-mix based reimbursement promote process-oriented care delivery? The study demonstrates that hospital management can facilitate care programme growth by using case-mix reimbursement in hospital budgets. Further investigation is recommended to confirm this and to determine if care programmes will become standard practice.,3.079176455639103e-07,0.14037529279873917,0.08842752787389466,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
281,0.5,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Can case-mix based reimbursement drive the development of process-oriented care delivery? This research shows hospital management can stimulate care programme creation by adopting case-mix reimbursement within budgeting processes. More research is needed to validate these findings and to see if care programmes will be established over time.,2.3685972735685406e-07,0.07293401200320693,0.08842752787389466,0.018134264647818726,0.12505463940106631,0.05436390532544379,0.018108015409528666,0.17912229484749664,0.01851192595229618,2.3685972735685406e-07,0.2090917978585587,0.0
281,0.5,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the adoption of case-mix based reimbursement encourage process-oriented care delivery? The study reveals hospital management can promote care programmes by integrating case-mix reimbursement in budgeting. Future studies should confirm this and assess whether care programmes will eventually be implemented.,4.026615365066518e-07,0.27355977162214096,0.06280425917583371,0.030828249901291835,0.2941309694449994,0.05436390532544379,0.030783626196198732,0.35239401612153287,0.01851192595229618,4.026615365066519e-07,0.3867729750960107,0.0
281,0.5,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is the development of process-oriented care delivery influenced by case-mix based reimbursement? This study finds that hospital management can foster care programme development through case-mix reimbursement in budgeting. Additional research is suggested to confirm these findings and to evaluate the long-term establishment of care programmes.,2.8423167282822487e-07,0.11738577457403965,0.08842752787389466,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.5,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement stimulate process-oriented care delivery development? The study indicates hospital management can encourage care programmes by incorporating case-mix reimbursement into budgeting. Further research is required to verify this and to determine if care programmes will eventually be established.,3.789755637709665e-07,0.24735331340636169,0.06344396442879274,0.029014823436509962,0.2681554830417414,0.05436390532544379,0.028972824655245866,0.325725769039372,0.01851192595229618,3.789755637709665e-07,0.3593740009078954,0.0
281,0.5,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Can the use of case-mix based reimbursement enhance the development of process-oriented care delivery? Findings show hospital management can promote care programmes by adopting case-mix reimbursement in budgeting. Future research is recommended to confirm this and to investigate the long-term establishment of care programmes.,3.079176455639103e-07,0.14037529279873917,0.08842752787389466,0.023574544042164344,0.19404751088801797,0.05436390532544379,0.023540420032387266,0.2497398620614506,0.01851192595229618,3.079176455639103e-07,0.2814124594381848,0.0
281,0.5,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement support the growth of process-oriented care delivery? This study demonstrates hospital management can stimulate care programme development by integrating case-mix reimbursement within budgeting. Additional studies should confirm this and explore whether care programmes will be established over time.,3.552895910352811e-07,0.1880033417879936,0.08842752787389466,0.02720139697172809,0.2428376750574497,0.05436390532544379,0.027162023114293,0.29975028263611403,0.01851192595229618,3.552895910352811e-07,0.33270575382573453,0.0
282,0.5,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy harm the kidneys in women who have had multiple pregnancies? Glomerular hyperfiltration, a typical physiological change in pregnancy, generally does not damage the kidneys in women with higher parity. However, if there are pre-existing kidney issues, the elevated filtration rate might worsen the condition. Therefore, routine monitoring is advised.",4.737194547137081e-08,0.04154351581363347,0.0021937499999999735,0.0036268529295637453,0.04135347370885123,0.0015305555555555558,0.003621603081905733,0.041114813894306934,0.0007993055555555635,4.737194547137081e-08,0.04082199452025437,0.0
282,0.5,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage caused by glomerular hyperfiltration in pregnant women with multiple births? Glomerular hyperfiltration is a normal adaptation in pregnancy and usually does not lead to kidney damage in women with more parities. Yet, in cases of existing kidney disease, the increased filtration could aggravate the problem. Hence, regular check-ups are recommended.",2.3685972735685406e-08,0.020986292147961993,0.001117698354852148,0.0018134264647818726,0.07525440174097531,0.039930555555555566,0.0018108015409528666,0.04849442897302669,0.020399305555555556,2.3685972735685406e-08,0.02061928720273576,0.0
282,0.5,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does increased glomerular filtration during pregnancy cause kidney injury in women with many pregnancies? This physiological increase in filtration is common and typically does not harm kidneys in women with several parities. But if kidney disease is present beforehand, the higher filtration rate may worsen it. Routine evaluation is therefore important.",2.3685972735685406e-08,0.006292325383724151,0.018663194444444434,0.0018134264647818726,0.00695734547176885,0.01953125000000001,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
282,0.5,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Can glomerular hyperfiltration in pregnancy damage kidneys in women with multiple pregnancies? This common pregnancy adaptation does not inherently cause kidney damage in women with higher parity. Nonetheless, pre-existing kidney conditions may be aggravated by the increased filtration. So, regular monitoring is essential.",2.1317375462116866e-07,0.1786233045124419,0.011093749999999986,0.016320838183036854,0.1768112218673319,0.015555555555555566,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
282,0.5,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage a consequence of glomerular hyperfiltration in pregnant women with more parities? Glomerular hyperfiltration is a usual physiological adjustment in pregnancy and does not usually harm the kidneys in women with many pregnancies. However, if kidney disease exists before pregnancy, the increased filtration rate might exacerbate it. Thus, routine surveillance is necessary.",4.737194547137081e-08,0.06770001319325392,0.020915933775470984,0.0036268529295637453,0.094672487598078,0.039930555555555566,0.003621603081905733,0.06829705626920646,0.020399305555555556,4.737194547137081e-08,0.04082199452025437,0.0
282,0.5,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does pregnancy-related glomerular hyperfiltration harm kidneys in women who have had several births? This physiological change during pregnancy typically does not cause kidney damage in women with increased parity. But if there are underlying kidney problems, the elevated filtration may worsen them. Therefore, ongoing monitoring is recommended.",1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
282,0.5,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is there kidney damage from glomerular hyperfiltration during pregnancy in women with multiple parities? Glomerular hyperfiltration is a normal pregnancy adaptation and usually does not cause kidney harm in women with more pregnancies. However, existing kidney disease may be aggravated by the increased filtration rate. Hence, routine assessment is advised.",4.737194547137081e-08,0.04333377245552272,0.002370333175803374,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
282,0.5,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Can the kidney be damaged by glomerular hyperfiltration in pregnancy among women with many parities? This common physiological response during pregnancy generally does not damage kidneys in women with higher parity. Yet, if a woman has pre-existing kidney conditions, the elevated filtration can worsen the condition. Therefore, regular check-ups are important.",2.3685972735685406e-08,0.0340182126061217,0.038602079862557266,0.0018134264647818726,0.035249067127276934,0.039930555555555566,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
282,0.5,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration in pregnancy lead to kidney damage in women with multiple pregnancies? This physiological adaptation is common and typically does not cause kidney damage in women with more parities. However, if kidney disease is present before pregnancy, the increased filtration rate may exacerbate it. Thus, routine monitoring is vital.",2.3685972735685406e-08,0.04915944906107139,0.020801335066162566,0.0018134264647818726,0.049626097839246874,0.021033527620247808,0.0018108015409528666,0.050089830593889495,0.021188596145767704,2.3685972735685406e-08,0.05054903390251164,0.0212665406427221
282,0.5,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney injury caused by glomerular hyperfiltration in pregnancy for women with higher parity? Glomerular hyperfiltration is a common adaptation in pregnancy that usually does not harm the kidneys in women with multiple pregnancies. But if pre-existing kidney disease exists, the heightened filtration rate can worsen the condition. Therefore, regular surveillance is essential.",2.3685972735685406e-08,0.020986292147961993,0.001117698354852134,0.0018134264647818726,0.07525440174097531,0.039930555555555566,0.0018108015409528666,0.04849442897302669,0.020399305555555556,2.3685972735685406e-08,0.02061928720273576,0.0
283,0.5,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty, which corrects a deviated septum, does not directly affect the size of compensatory hypertrophy in the middle turbinate.",9.47438909427412e-08,0.12244491871651686,0.0012975246361896509,0.007253705859127518,0.12196881423277617,0.003928926969497065,0.007243206163811494,0.1211537644002374,0.007382467757631295,9.474389094274162e-08,0.1199314161721925,0.011658147000592867
283,0.5,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is the dimension of compensatory hypertrophy of the middle turbinate changed by septoplasty? Septoplasty, a surgery to fix a deviated septum, does not directly modify the dimensions of compensatory hypertrophy in the middle turbinate.",2.36859727356853e-08,0.17030718524730792,0.12301775147928985,0.0018134264647818796,0.21996908278580163,0.1655280803403752,0.0018108015409528735,0.22818149439539992,0.17751479289940827,2.3685972735685406e-08,0.1908060418737647,0.15532544378698224
283,0.5,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does the procedure of septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? Septoplasty, used to correct a deviated septum, does not directly alter these dimensions.",1.658018091497971e-07,0.0956632498869654,0.2130177514792899,0.012693985253473157,0.05565141679255525,0.1967455621301775,0.012675610786670115,0.013070114778453323,0.17751479289940827,1.6580180914979784e-07,0.032337509440445,0.15532544378698224
283,0.5,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can septoplasty change the size of compensatory hypertrophy in the middle turbinate? Septoplasty, a surgical correction for a deviated septum, does not directly change the hypertrophy dimensions of the middle turbinate.",9.47438909427412e-08,0.10860414147013175,0.146691220867045,0.007253705859127518,0.16485070875754593,0.1967455621301775,0.007243206163811494,0.12639880008545745,0.17751479289940827,9.474389094274162e-08,0.08544552621593926,0.15532544378698224
283,0.5,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty influence the dimensions of compensatory hypertrophy in the middle turbinate? Septoplasty, which is performed to correct a deviated septum, does not directly alter the hypertrophy size in the middle turbinate.",7.10579182070559e-08,0.14437524248908007,0.14880847680628156,0.005440279394345639,0.15254244839589814,0.16345186415158058,0.005432404622858621,0.16149011989672646,0.17751479289940827,7.105791820705622e-08,0.12181317038681394,0.15532544378698224
283,0.5,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is compensatory hypertrophy of the middle turbinate dimensionally affected by septoplasty? Septoplasty, aimed at correcting a deviated septum, does not directly change the hypertrophy dimensions.",2.36859727356853e-07,0.022119785769418865,0.2130177514792899,0.018134264647818796,0.06695090529977765,0.1967455621301775,0.018108015409528735,0.11476325673143117,0.17751479289940827,2.3685972735685406e-07,0.16586890206496863,0.15532544378698224
283,0.5,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does the size of compensatory hypertrophy in the middle turbinate change after septoplasty? Septoplasty, a surgery correcting a deviated septum, does not directly impact the hypertrophy size.",1.894877818854824e-07,0.05792292190411841,0.2130177514792899,0.014507411718255037,0.016430703639272792,0.1967455621301775,0.014486412327622988,0.02775187974180149,0.17751479289940827,1.8948778188548325e-07,0.07489712385924063,0.15532544378698224
283,0.5,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty result in changes to the compensatory hypertrophy dimensions of the middle turbinate? Septoplasty, a procedure to fix a deviated septum, does not directly affect these dimensions.",1.658018091497971e-07,0.0956632498869654,0.2130177514792899,0.012693985253473157,0.05565141679255525,0.1967455621301775,0.012675610786670115,0.013070114778453323,0.17751479289940827,1.6580180914979784e-07,0.032337509440445,0.15532544378698224
283,0.5,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is there a change in the dimensions of compensatory hypertrophy of the middle turbinate following septoplasty? Septoplasty, which corrects a deviated septum, does not directly modify these dimensions.",1.658018091497971e-07,0.0956632498869654,0.2130177514792899,0.012693985253473157,0.05565141679255525,0.1967455621301775,0.012675610786670115,0.013070114778453323,0.17751479289940827,1.6580180914979784e-07,0.032337509440445,0.15532544378698224
283,0.5,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty modify the size of compensatory hypertrophy in the middle turbinate? Septoplasty, a surgical intervention for a deviated septum, does not directly alter the hypertrophy dimensions.",1.894877818854824e-07,0.05792292190411841,0.2130177514792899,0.014507411718255037,0.016430703639272792,0.1967455621301775,0.014486412327622988,0.02775187974180149,0.17751479289940827,1.8948778188548325e-07,0.07489712385924063,0.15532544378698224
284,0.5,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research suggests that Indigenous Australians might face some age-related health problems sooner than non-Indigenous Australians because of socio-economic conditions, lifestyle choices, and healthcare availability. However, this does not definitively imply premature aging.",2.842316728282239e-07,0.29497350746144146,0.023242630385487524,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
284,0.5,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Studies show that Indigenous Australians could develop certain health issues linked to aging earlier than their non-Indigenous counterparts, influenced by socio-economic status, lifestyle, and healthcare access. Nonetheless, this does not confirm they age prematurely.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
284,0.5,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Evidence indicates that Indigenous Australians may encounter age-associated health concerns at an earlier stage compared to non-Indigenous Australians, largely due to socio-economic factors, lifestyle, and healthcare accessibility. Still, this should not be interpreted as premature aging.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
284,0.5,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians might experience some age-related health challenges earlier than non-Indigenous Australians, influenced by socio-economic elements, lifestyle, and healthcare access; however, this does not necessarily mean they age prematurely.",3.552895910352798e-07,0.39675620177138393,0.023242630385487524,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
284,0.5,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research points out that certain aging health issues may appear earlier in Indigenous Australians than in non-Indigenous Australians, attributed to socio-economic factors, lifestyle, and healthcare availability, but this does not equate to premature aging.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
284,0.5,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians may develop some age-related health problems earlier than non-Indigenous Australians because of socio-economic conditions, lifestyle habits, and access to healthcare, though this does not imply they age prematurely.",3.316036182995945e-07,0.3616648819601149,0.023242630385487524,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
284,0.5,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Findings suggest that Indigenous Australians could suffer from certain health issues associated with aging earlier than non-Indigenous Australians due to socio-economic influences, lifestyle, and healthcare access, but this does not mean they age prematurely.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
284,0.5,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians are likely to face some age-related health issues sooner than non-Indigenous Australians, as a result of socio-economic status, lifestyle, and healthcare accessibility, yet this does not necessarily indicate premature aging.",2.842316728282239e-07,0.29497350746144146,0.023242630385487524,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
284,0.5,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research indicates that age-related health problems might occur earlier among Indigenous Australians compared to non-Indigenous Australians, driven by socio-economic factors, lifestyle, and healthcare access; however, this does not confirm premature aging.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.5,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","It has been observed that Indigenous Australians may experience certain health issues related to aging earlier than non-Indigenous Australians, influenced by socio-economic and lifestyle factors as well as healthcare availability, but this does not mean they age prematurely.",1.4211583641411212e-07,0.1180427993023625,0.023242630385487524,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
285,0.5,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Is there a discrepancy between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Answer: Yes, discrepancies often exist between clinical pathologists and clinicians regarding red blood cell morphology reporting and interpretation, due to differences in training, interpretation skills, and communication gaps. Clinicians may miss or misinterpret subtle changes that experienced pathologists detect.",9.474389094274162e-08,0.03433551245895394,0.022879740131346665,0.0072537058591274906,0.006550064587928173,0.04421419049114017,0.007243206163811466,0.003295064999875752,0.048457409720656985,9.474389094274162e-08,0.025952990550476507,0.033608189056906976
285,0.5,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Are clinical pathologists and clinicians discordant in their reporting and interpretation of red blood cell morphology? Answer: Yes, discordance can frequently occur between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology, often because of variations in training, interpretative abilities, and communication. Clinicians might fail to recognize or misinterpret subtle morphological changes that a skilled pathologist would identify.",9.474389094274162e-08,0.14251757895056505,0.05258198963994916,0.0072537058591274906,0.1640588674563972,0.06899408284023666,0.007243206163811466,0.16383992260829805,0.06931496057944819,9.474389094274162e-08,0.14078545745033377,0.05246913580246911
285,0.5,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Does disagreement exist between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Answer: Yes, there can be frequent disagreement between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This is often due to differences in training, interpretation expertise, and communication gaps. Clinicians may overlook or misinterpret subtle changes that experienced pathologists notice.",4.737194547137081e-08,0.08421687170324388,0.034254339557894184,0.0036268529295637453,0.08418133709666265,0.035180307330032606,0.003621603081905733,0.0840949681989902,0.035578162396491704,4.737194547137081e-08,0.06045600799223738,0.018612564549775987
285,0.5,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Is there a gap between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Answer: Yes, a gap often exists between clinical pathologists and clinicians in how red blood cell morphology is reported and interpreted, stemming from differences in training, interpretation skills, and communication. Clinicians may miss or misread subtle changes that a trained pathologist would detect.",0.0,0.02310490601866455,0.01515120493028399,0.0,0.046993029190506075,0.03247487845066195,0.0,0.04780325383172013,0.03386941030748274,0.0,0.024320953703857562,0.017427813488419507
285,0.5,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Answer: No, clinical pathologists and clinicians often show discordance in reporting and interpreting red blood cell morphology, due to differences in training, interpretation skills, and communication barriers. Clinicians might misinterpret or overlook subtle morphological changes that an experienced pathologist would recognize.",7.105791820705622e-08,0.010725137557286768,0.04152249134948101,0.005440279394345618,0.038024079650488485,0.06309429643938227,0.0054324046228586,0.041192957244991835,0.06726407525096924,7.105791820705622e-08,0.018895639841298717,0.05246913580246911
285,0.5,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Is there often a discordance between clinical pathologists and clinicians regarding red blood cell morphology interpretation and reporting? Answer: Yes, discordance is common between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may result from differences in training, interpretation skills, and communication gaps, with clinicians sometimes missing subtle changes that pathologists identify.",7.105791820705622e-08,0.010725137557286768,0.04152249134948101,0.005440279394345618,0.013268823201919133,0.045488165680473355,0.0054324046228586,0.015987605224630386,0.04912780348878605,7.105791820705622e-08,0.006776477957218141,0.033957209850172934
285,0.5,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Do clinical pathologists and clinicians differ in their reporting and interpretation of red blood cell morphology? Answer: Yes, differences often arise between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology, mainly due to varying training, interpretation expertise, and communication gaps. Clinicians may overlook or misinterpret subtle changes seen by pathologists.",1.4211583641411244e-07,0.051449068280942534,0.035953719723183425,0.010880558788691236,0.021239420325692926,0.060094082840236644,0.0108648092457172,0.016350664330302855,0.06621628261660734,1.4211583641411244e-07,0.03826277399865141,0.05246913580246911
285,0.5,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Is there a frequent mismatch between clinical pathologists and clinicians in red blood cell morphology reporting and interpretation? Answer: Yes, frequent mismatches occur between clinical pathologists and clinicians in this area, often because of differences in training, skills in interpretation, and communication. Clinicians might miss or misinterpret subtle morphological details that a seasoned pathologist would catch.",9.474389094274162e-08,0.01517500043818476,0.05690119184928877,0.0072537058591274906,0.006550064587928173,0.044214190491140185,0.007243206163811466,0.02896718279839261,0.03007633644205908,9.474389094274162e-08,0.052109487930096954,0.014791319577940096
285,0.5,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Are there differences between clinical pathologists and clinicians in the way red blood cell morphology is reported and interpreted? Answer: Yes, differences frequently exist between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology, attributed to training disparities, interpretation skills, and communication gaps. Clinicians may fail to notice or misinterpret subtle changes that pathologists recognize.",4.737194547137081e-08,0.006731214081280523,0.026912725874663646,0.0036268529295637453,0.008384657576308463,0.029585798816567976,0.003621603081905733,0.010151045422323257,0.032039871840512636,4.737194547137081e-08,0.013165925531228861,0.016157281049888124
285,0.5,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Question: Is discordance common between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology? Answer: Yes, discordance is common due to differences in training, interpretation skills, and communication, leading clinicians to potentially overlook or misinterpret subtle changes that experienced pathologists would identify.",3.789755637709665e-07,0.10221077413585533,0.14532871972318342,0.029014823436509962,0.15186172604538983,0.11649408284023667,0.028972824655245866,0.20326525768374948,0.08543965824136704,3.789755637709665e-07,0.25651634001866874,0.05246913580246911
286,0.5,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better clinical outcomes? Individuals diagnosed with type 2 diabetes exhibiting lower initial blood sugar levels, possibly indicating an earlier disease stage, experienced fewer negative health events despite comparable glycemic advancement. Most of these patients are asymptomatic when diagnosed, hence proactive case identification is important.",7.105791820705622e-08,0.05470323687720402,0.0018087236718610442,0.005440279394345618,0.05441355041844975,0.000939510352663115,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
286,0.5,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is there a connection between lower fasting plasma glucose at type 2 diabetes diagnosis and improved health outcomes? Patients with type 2 diabetes who have lower initial glucose levels, suggesting an earlier phase of the disease, tend to have fewer adverse clinical events even though their glycemic progression is similar. Since many are asymptomatic at diagnosis, active screening is crucial.",7.105791820705622e-08,0.05470323687720402,0.0018087236718610442,0.005440279394345618,0.05441355041844975,0.000939510352663115,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
286,0.5,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Do lower fasting plasma glucose values at the diagnosis of type 2 diabetes correlate with better outcomes? Individuals presenting with type 2 diabetes with reduced initial glycemia, potentially indicating an earlier stage of the condition, experience fewer negative clinical outcomes despite similar patterns of glycemic progression. As most are symptom-free at diagnosis, active case detection is recommended.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
286,0.5,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are lower fasting plasma glucose readings at type 2 diabetes diagnosis associated with more favorable outcomes? People diagnosed with type 2 diabetes who have lower initial blood glucose, possibly reflecting an earlier disease phase, show fewer adverse clinical results despite similar glycemic trajectories. Because most are asymptomatic upon diagnosis, proactive case finding is advised.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.5,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is there an association between lower fasting plasma glucose at the time of type 2 diabetes diagnosis and better clinical outcomes? Patients with type 2 diabetes who present with lower initial glycemia, likely earlier in their disease course, have fewer adverse outcomes despite comparable glycemic progression. Given that most are asymptomatic at diagnosis, active case identification is important.",2.3685972735685406e-08,0.0185681825888242,0.000623972610504564,0.0018134264647818726,0.01846860107447057,0.0003243433209763093,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
286,0.5,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Do lower fasting plasma glucose levels at the point of type 2 diabetes diagnosis relate to improved clinical outcomes? Individuals with type 2 diabetes who exhibit lower initial blood sugar, possibly indicating an earlier stage of disease, tend to experience fewer negative outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active screening is essential.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
286,0.5,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are reduced fasting plasma glucose levels at diagnosis of type 2 diabetes linked to better health outcomes? People with type 2 diabetes who have lower initial glycemia, potentially earlier in their disease course, demonstrate fewer adverse clinical events even with similar glycemic progression. Because most are asymptomatic at diagnosis, proactive case detection is necessary.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.5,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is lower fasting plasma glucose at type 2 diabetes diagnosis associated with improved outcomes? Individuals presenting with type 2 diabetes with lower initial blood glucose, suggesting an earlier disease stage, experience fewer adverse clinical outcomes despite similar glycemic progression. Most are asymptomatic at diagnosis, so active case finding is important.",1.6580180914979784e-07,0.14060432303839887,0.005077122458877266,0.012693985253473108,0.13980795482754882,0.002648319227800483,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
286,0.5,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are decreased fasting plasma glucose levels at the diagnosis of type 2 diabetes connected to better outcomes? Patients with type 2 diabetes showing lower initial glycemia, possibly earlier in their disease course, have fewer adverse clinical events despite similar glycemic progression. Since most are asymptomatic when diagnosed, active case identification is recommended.",1.1842986367842703e-07,0.09838002986348426,0.0034850590946045243,0.009067132323909363,0.09783071500636176,0.0018160871470449327,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
286,0.5,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is a lower fasting plasma glucose level at type 2 diabetes diagnosis related to improved clinical outcomes? People with type 2 diabetes who present with lower initial blood sugar levels, likely at an earlier disease stage, experience fewer adverse outcomes despite similar glycemic progression. As most are asymptomatic at diagnosis, active screening is advised.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
287,0.5,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.5,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do parents, their children, and children's doctors differ in perceiving body image? Answer: A significant number of children underestimated how overweight they were, a misperception also held by their parents and doctors. This highlights the importance of better educating physicians to identify obesity and overweight in order to advise children and their families effectively.",0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.5,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are there differences in body image perception among parents, their children, and the children's physicians? Answer: Many children did not accurately perceive their overweight status, and this misunderstanding was also common among their parents and doctors. The study underscores the need to improve physician education on recognizing obesity to provide better counseling to children and families.",2.3685972735685406e-08,0.043223857523040365,0.0181755829903978,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,0.5,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and children's physicians have differing views on body image? Answer: Numerous children underestimated their overweight condition, with similar misperceptions found in their parents and attending physicians. This research points to the necessity of enhancing physician training to identify obesity and overweight for better guidance of children and their families.",7.105791820705622e-08,0.030884114630681303,0.0181755829903978,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
287,0.5,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do body image perceptions vary between children, their parents, and their physicians? Answer: Many children underestimated their overweight levels, a view shared by their parents and physicians. The findings suggest a need for improved physician education to recognize and address obesity and overweight in children and provide appropriate counseling.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,0.5,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Is there a difference in how parents, children, and physicians perceive body image? Answer: Many children underestimated their overweight status, a misperception also held by their parents and doctors. This study highlights the importance of educating physicians to better detect obesity and overweight so they can support children and families effectively.",9.474389094274162e-08,0.050302200487784,0.0181755829903978,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
287,0.5,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and their children's doctors perceive body image differently? Answer: A large number of children underestimated their overweight status, with parents and physicians sharing this misjudgment. The study indicates a need to educate physicians more thoroughly to recognize obesity and provide counseling to affected children and their families.",1.1842986367842703e-07,0.09783071500636176,0.0018160871470449327,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,0.5,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are perceptions of body image different among children, their parents, and physicians? Answer: Many children underestimated their overweight degree, a misunderstanding also common among parents and physicians. This research emphasizes the need to educate doctors to better identify obesity and overweight for effective family counseling.",2.3685972735685406e-07,0.17546534344178966,0.0181755829903978,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
287,0.5,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do children, parents, and physicians differ in perceiving body image? Answer: Many children underestimated how overweight they were, a misconception also held by their parents and doctors. The study calls for improved physician education to recognize obesity and overweight, enabling better counseling of children and their families.",1.6580180914979784e-07,0.11092682230421813,0.0181755829903978,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
287,0.5,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and children's physicians see body image differently? Answer: Many children underestimated their overweight status, and this misperception was shared by their parents and doctors. The findings highlight the necessity of educating physicians to identify obesity and overweight to counsel children and families appropriately.",2.1317375462116866e-07,0.15348643672301465,0.0181755829903978,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
288,0.5,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it justified to screen for coeliac disease in at-risk groups? Yes, screening is warranted as it facilitates early diagnosis and management, helping to avoid complications such as malnutrition, osteoporosis, and lymphoma. Individuals with family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are particularly considered.",4.737194547137081e-08,0.09978591187697106,0.10072314049586772,0.0036268529295637453,0.07296491567452756,0.08264462809917357,0.003621603081905733,0.04500176217429708,0.06353305785123965,4.737194547137081e-08,0.015821905303945005,0.043388429752066124
288,0.5,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should coeliac disease screening be done in risk groups? Indeed, screening in these groups is justified because it enables early detection and treatment, preventing issues like malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are especially targeted.",7.105791820705622e-08,0.0782797066560077,0.10072314049586772,0.005440279394345618,0.05098600895575256,0.08264462809917357,0.0054324046228586,0.02252890632223936,0.06353305785123965,7.105791820705622e-08,0.007167612920754518,0.043388429752066124
288,0.5,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in high-risk groups justified? Yes, it is justified since early detection and treatment can prevent complications including malnutrition, osteoporosis, and lymphoma. People with family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are particularly considered.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
288,0.5,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Does screening for coeliac disease in risk populations make sense? Yes, it is justified because it helps with early diagnosis and treatment, thereby preventing complications such as malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially included.",4.737194547137081e-08,0.09978591187697106,0.10072314049586772,0.0036268529295637453,0.07296491567452756,0.08264462809917357,0.003621603081905733,0.04500176217429708,0.06353305785123965,4.737194547137081e-08,0.015821905303945005,0.043388429752066124
288,0.5,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening justified for risk groups? Yes, it is, as it promotes early detection and intervention, preventing complications like malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are particularly considered.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
288,0.5,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it appropriate to screen for coeliac disease among at-risk groups? Yes, screening is justified as it supports early diagnosis and treatment, reducing the risk of complications such as malnutrition, osteoporosis, and lymphoma. Those with family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially targeted.",2.3685972735685406e-08,0.12083932107480422,0.10072314049586772,0.0018134264647818726,0.09447112089549092,0.08264462809917357,0.0018108015409528666,0.06698066889307208,0.06353305785123965,2.3685972735685406e-08,0.03829476115600272,0.043388429752066124
288,0.5,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening in risk groups warranted? Yes, it is warranted because it enables early detection and management, preventing complications like malnutrition, osteoporosis, and lymphoma. People with family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
288,0.5,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should individuals in risk groups be screened for coeliac disease? Yes, screening is justified since it allows for early diagnosis and treatment, helping to avoid complications such as malnutrition, osteoporosis, and lymphoma. Those with family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are particularly considered.",4.737194547137081e-08,0.09978591187697106,0.10072314049586772,0.0036268529295637453,0.07296491567452756,0.08264462809917357,0.003621603081905733,0.04500176217429708,0.06353305785123965,4.737194547137081e-08,0.015821905303945005,0.043388429752066124
288,0.5,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease justified in those at risk? Yes, it is justified because it aids early detection and treatment, preventing complications like malnutrition, osteoporosis, and lymphoma. Individuals with family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially targeted.",1.4211583641411244e-07,0.010838425860475454,0.10072314049586772,0.010880558788691236,0.018006862531199097,0.08264462809917357,0.0108648092457172,0.048088660891714596,0.06353305785123965,1.4211583641411244e-07,0.07948827450038065,0.043388429752066124
288,0.5,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening in high-risk groups justified? Yes, it is justified as it facilitates early diagnosis and intervention, preventing complications including malnutrition, osteoporosis, and lymphoma. Those with family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are particularly considered.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
289,0.5,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is family practice at residency teaching sites representative of community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to those reported in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,0.5,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Do family practice residency teaching sites mirror community practice? Answer: The residency training locations of Northeastern Ohio Universities College of Medicine deliver patient care opportunities akin to those identified in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.5,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice during residency at teaching sites reflect what is seen in community practice? Answer: Patient care opportunities at the residency training sites of Northeastern Ohio Universities College of Medicine are similar to those found in a national survey of family and general practitioners.,1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
289,0.5,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Are family practice residency teaching sites representative of community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities that align with those found in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,0.5,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is the family practice at residency teaching sites reflective of community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care opportunities similar to those reported in a national survey of family and general practitioners.,2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
289,0.5,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice at residency teaching sites correspond to community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care experiences comparable to those in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.5,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Are the family practice experiences at residency teaching sites consistent with community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care opportunities that resemble those found in a national survey of family and general practitioners.,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
289,0.5,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Does family practice at residency teaching sites reflect the nature of community practice? Answer: The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those identified in a national survey of family and general practitioners.,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
289,0.5,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Is family practice at residency teaching sites aligned with community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine deliver patient care opportunities comparable to those in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.5,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Question: Do residency teaching sites for family practice reflect community practice? Answer: The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care opportunities similar to those documented in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
290,0.5,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does measuring end-tidal carbon dioxide correlate with arterial carbon dioxide levels in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30-50 mmHg. Monitoring end-tidal CO2 can assist in tracking or screening abnormal PaCO2 values in these infants in their first week of life.,7.105791820705622e-08,0.08443410949988772,0.12055170821791317,0.005440279394345618,0.03805753737221629,0.06127385111529162,0.0054324046228586,0.026348369793864457,0.015621063240110858,7.105791820705622e-08,0.04879016416943571,0.0
290,0.5,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is end-tidal carbon dioxide measurement correlated with arterial carbon dioxide in extremely low birth weight infants during the first week of life? Studies show good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring is useful for trending or detecting abnormal PaCO2 values in this population during the first week.,9.474389094274162e-08,0.04500943947092617,0.10384243354490487,0.0072537058591274906,0.0009291205671040359,0.04488496222640273,0.007243206163811466,0.042877671745075396,0.015621063240110858,9.474389094274162e-08,0.06559728248581642,0.0
290,0.5,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement correspond with arterial CO2 levels in extremely low birth weight infants within their first week? There is a strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants when EtCO2 is between 30-50 mmHg. End-tidal CO2 monitoring can help trend or screen for abnormal PaCO2 values in these infants early in life.,2.1317375462116866e-07,0.0017227607313725635,0.13301038590386358,0.016320838183036854,0.06372515693772574,0.06127385111529162,0.0162972138685758,0.12988904873470375,0.015621063240110858,2.1317375462116866e-07,0.15415067982725983,0.0
290,0.5,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants during the initial week of life? Good correlation and agreement exist between end-tidal CO2 and arterial CO2 in ELBW infants with EtCO2 values from 30 to 50 mmHg. End-tidal CO2 monitoring aids in trending and screening for abnormal PaCO2 values in the first week.,1.1842986367842703e-07,0.027282716207692292,0.10280086180363188,0.009067132323909363,0.005267714549224145,0.06127385111529162,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.5,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement correlate with arterial CO2 in extremely low birth weight infants during their first week? There is strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring is beneficial for trending or screening abnormal PaCO2 in this group during the first week.,2.3685972735685406e-07,0.04160067830602099,0.11465192181705877,0.018134264647818726,0.1069490144607661,0.04309826812489382,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
290,0.5,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,"Is end-tidal carbon dioxide measurement in good agreement with arterial carbon dioxide in extremely low birth weight infants during the first week of life? Yes, there is good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring can be valuable for trending and identifying abnormal PaCO2 values in this early period.",4.737194547137081e-08,0.12287478487921488,0.13683422642811088,0.0036268529295637453,0.05405787871865986,0.06127385111529162,0.003621603081905733,0.010087848922083253,0.015621063240110858,4.737194547137081e-08,0.03226086221822477,0.0
290,0.5,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does measuring end-tidal CO2 align well with arterial CO2 levels in extremely low birth weight infants during their first week? A good correlation and agreement exist between end-tidal and arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. End-tidal CO2 monitoring can assist in trending or screening for abnormal PaCO2 values during the first week.,1.8948778188548325e-07,0.019953157019237278,0.13361293270770908,0.014507411718254981,0.046025579838325115,0.06127385111529162,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
290,0.5,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a reliable correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants during the first week of life? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants in the EtCO2 range of 30-50 mmHg. Monitoring end-tidal CO2 can help trend or screen abnormal PaCO2 values in these infants early on.,7.105791820705622e-08,0.06242943710115911,0.10485147839889564,0.005440279394345618,0.03805753737221629,0.06127385111529162,0.0054324046228586,0.026348369793864457,0.015621063240110858,7.105791820705622e-08,0.04879016416943571,0.0
290,0.5,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,"Does end-tidal carbon dioxide monitoring correlate well with arterial CO2 in extremely low birth weight infants in their first week? Yes, there is good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring can be helpful for trending or screening abnormal PaCO2 values in this period.",1.6580180914979784e-07,0.014361300424500012,0.11735017760566828,0.012693985253473108,0.05253546404231635,0.04403777847755694,0.012675610786670066,0.09417096613262466,0.015621063240110858,1.6580180914979784e-07,0.11778303565638559,0.0
290,0.5,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is end-tidal CO2 measurement a good indicator of arterial CO2 in extremely low birth weight infants during the first week? There is good correlation and agreement between end-tidal and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring can be useful for trending or screening abnormal PaCO2 values in the first week of life.,1.6580180914979784e-07,0.009135214170751471,0.10061369168898752,0.012693985253473108,0.05253546404231635,0.04403777847755694,0.012675610786670066,0.09417096613262466,0.015621063240110858,1.6580180914979784e-07,0.11778303565638559,0.0
291,0.5,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? It serves as a valuable method for forecasting IVF success. Although age and FSH are important markers, the antral follicle count may more accurately reflect ovarian reserve and response, thus providing a better prediction. Using all these indicators together might yield the most thorough prediction.",3.789755637709665e-07,0.1505795831997121,0.08789948411062862,0.029014823436510045,0.20615466749234823,0.027006172839506164,0.02897282465524588,0.2474081733138398,0.0,3.789755637709665e-07,0.2513144282809048,0.0
291,0.5,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle assessment better predict IVF results than age and FSH? This assessment is a helpful tool for anticipating IVF outcomes. While age and FSH are significant factors, antral follicle count potentially offers a more precise measure of ovarian reserve and responsiveness, leading to improved prediction accuracy. A combination of these factors could offer the best overall forecast.",4.026615365066519e-07,0.1684842412002272,0.08731727985311769,0.030828249901291918,0.22354641020421706,0.027006172839506164,0.030783626196198746,0.2651077504132404,0.0,4.026615365066519e-07,0.26933293378358325,0.0
291,0.5,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle evaluation outperform age and FSH in predicting IVF success? It is an effective predictor for IVF results. Although age and FSH are critical, the antral follicle count might give a more accurate insight into ovarian reserve and response, enhancing prediction reliability. Integrating all these variables may provide a more comprehensive outlook.",5.210914001850789e-07,0.3154580738812869,0.04678729234791151,0.03989538222520128,0.34201346640195274,0.007782797214746454,0.03983763390096308,0.3586338084240648,0.0,5.210914001850789e-07,0.3646431135879089,0.0
291,0.5,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is the antral follicle count a better predictor of IVF outcomes than age and FSH? It is a useful predictive tool for IVF success. Age and FSH remain important indicators, but antral follicle assessment may more precisely reflect ovarian reserve and responsiveness, offering superior prediction. Combining these factors may yield the most complete forecast.",5.210914001850789e-07,0.26314507912204643,0.08407823913879273,0.03989538222520128,0.31535395945733935,0.027006172839506164,0.03983763390096308,0.3586338084240648,0.0,5.210914001850789e-07,0.3646431135879089,0.0
291,0.5,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle count be considered a better predictor of IVF outcomes than age and FSH levels? It is an important method for predicting IVF success. Although age and FSH are key, the antral follicle count could provide a more accurate representation of ovarian reserve and response, thus improving prediction quality. Using all these markers together might provide the most comprehensive prediction.",3.316036182995957e-07,0.1611546820117722,0.05650520894904046,0.0253879705069463,0.2184629278539969,0.0062875251390907515,0.025351221573340146,0.21292199724267125,0.0,3.316036182995957e-07,0.21622310846963533,0.0
291,0.5,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is assessing antral follicles a more reliable predictor of IVF outcomes compared to age and FSH? It serves as a valuable tool for predicting IVF results. While age and FSH are essential markers, antral follicle count may offer a more precise measure of ovarian reserve and responsiveness, leading to better prediction. Combining these factors may provide the most thorough forecast.",3.789755637709665e-07,0.1505795831997121,0.08789948411062862,0.029014823436510045,0.20615466749234823,0.027006172839506164,0.02897282465524588,0.2474081733138398,0.0,3.789755637709665e-07,0.2513144282809048,0.0
291,0.5,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle assessment offer better prediction of IVF success than age and FSH? It is a useful tool for forecasting IVF outcomes. Though age and FSH are important, antral follicle count potentially reflects ovarian reserve and responsiveness more accurately, resulting in improved prediction. Using all these indicators together might offer the most comprehensive outlook.",4.974054274493935e-07,0.24348418694768448,0.0847738068426117,0.03808195576041941,0.29630576448664625,0.027006172839506164,0.03802683236001021,0.3392157225669621,0.0,4.974054274493935e-07,0.34484048629172914,0.0
291,0.5,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is the antral follicle count a superior predictor of IVF success compared to age and FSH? It is an effective method for predicting IVF outcomes. Age and FSH are important, but antral follicle assessment may provide a more accurate reflection of ovarian reserve and response, enhancing prediction accuracy. A combination of these factors might yield the best overall forecast.",4.026615365066519e-07,0.1684842412002272,0.08731727985311766,0.030828249901291918,0.22354641020421706,0.027006172839506164,0.030783626196198746,0.2651077504132404,0.0,4.026615365066519e-07,0.26933293378358325,0.0
291,0.5,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle evaluation better forecast IVF results than age and FSH? It is a helpful tool for predicting IVF success. While age and FSH are key, antral follicle count may offer a more precise measure of ovarian reserve and responsiveness, leading to better prediction. Integrating all these factors may provide the most comprehensive prediction.",4.974054274493935e-07,0.24348418694768403,0.08477380684261168,0.03808195576041941,0.29630576448664625,0.027006172839506164,0.03802683236001021,0.3392157225669621,0.0,4.974054274493935e-07,0.34484048629172914,0.0
291,0.5,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle count a more accurate predictor of IVF outcomes than age and FSH? It serves as a valuable tool for anticipating IVF success. Although age and FSH are significant indicators, antral follicle assessment potentially provides a clearer representation of ovarian reserve and responsiveness, resulting in superior prediction. Combining these markers may offer the most complete forecast.",4.263475092423373e-07,0.18671463748809192,0.08671473304927214,0.03264167636607379,0.24124598730361768,0.027006172839506164,0.03259442773715161,0.2831262559159189,0.0,4.263475092423373e-07,0.287682072451779,0.0
292,0.5,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Patients and their carers found the reorganization of care to provide primary angioplasty acceptable. Satisfaction was generally high regardless of care type, except for discharge and aftercare.",2.1317375462116802e-07,0.25190751070815187,0.012192798185603794,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.5,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty serve as an acceptable alternative to thrombolysis? The restructuring of services to include primary angioplasty was well received by patients and carers. Satisfaction levels remained high across care types, except when it came to discharge and aftercare.",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
292,0.5,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is it acceptable to use primary angioplasty instead of thrombolysis? Patients and carers approved the care reorganization to offer primary angioplasty. Satisfaction was high for all care types except in discharge and aftercare.,2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.5,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does primary angioplasty represent an acceptable alternative to thrombolysis? Care reorganization to provide primary angioplasty was favorably accepted by patients and carers. Satisfaction was high for all care types, with the exception of discharge and aftercare.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
292,0.5,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is offering primary angioplasty a suitable alternative to thrombolysis? Patients and carers accepted the care changes to provide primary angioplasty, with high satisfaction across care types except for discharge and aftercare.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.5,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty considered an acceptable alternative to thrombolysis? The care system was reorganized to include primary angioplasty, which patients and carers accepted. Satisfaction was high regardless of care type, except in discharge and aftercare.",2.1317375462116802e-07,0.17036078358345197,0.046400951814396206,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.5,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be an acceptable substitute for thrombolysis? Patients and carers found the reorganization of care to offer primary angioplasty acceptable. Overall satisfaction was high, except for discharge and aftercare.",3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.5,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a preferred alternative to thrombolysis? Patients and carers accepted the shift to provide primary angioplasty, with high satisfaction levels except in discharge and aftercare.",4.026615365066504e-07,0.4386247701781314,0.046400951814396206,0.030828249901291904,0.5187937934151678,0.0,0.03078362619619881,0.5355182363563626,0.0,4.026615365066519e-07,0.5533852381847866,0.0
292,0.5,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an approved alternative to thrombolysis? The reorganization of care to provide primary angioplasty was acceptable to patients and carers, with high satisfaction except in discharge and aftercare.",3.316036182995945e-07,0.37722873204486085,0.011962176304192114,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
292,0.5,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? Patients and carers found the reorganization of care to provide primary angioplasty acceptable, with satisfaction high across care types except discharge and aftercare.",3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
293,0.5,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better outcomes? Yes, lower fasting plasma glucose levels at diagnosis typically suggest superior glycemic control and correlate with enhanced outcomes. This includes a decrease in diabetes-related complications and an overall improvement in health, resulting in a more favorable patient prognosis.",2.3685972735685406e-08,0.17822316379870884,0.12606721508892,0.0018134264647818726,0.15668802813987037,0.11747618437353154,0.0018108015409528666,0.13437181461673653,0.10598948056186047,2.3685972735685406e-08,0.13738777974203753,0.10979363760775446
293,0.5,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there an association between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved patient outcomes? Yes, having lower fasting plasma glucose levels when diagnosed with type 2 diabetes usually reflects better glycemic control and is connected to improved outcomes such as fewer complications from diabetes and better overall health, leading to a more positive prognosis.",4.737194547137081e-08,0.18874463569894262,0.09627610152085674,0.0036268529295637453,0.19048778799026422,0.10306378527572309,0.003621603081905733,0.19223407366186684,0.10800200186183531,4.737194547137081e-08,0.19493140131733222,0.11084143024211636
293,0.5,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes correlate with better health outcomes? Yes, lower fasting plasma glucose levels at diagnosis are generally indicative of improved glycemic control and relate to better outcomes, including reduced diabetes-related complications and enhanced overall health, which contribute to a better prognosis for patients.",7.105791820705622e-08,0.11122081330170319,0.10503113521579427,0.005440279394345618,0.08932602577411997,0.09645061728395062,0.0054324046228586,0.06667180142348261,0.08507354678638948,7.105791820705622e-08,0.06937479908857291,0.0890864576769586
293,0.5,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are improved outcomes linked to lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis? Yes, lower fasting plasma glucose levels at diagnosis often signify better glycemic control and are associated with favorable outcomes like fewer diabetes complications and improved overall health, resulting in a better prognosis for the patient.",9.474389094274162e-08,0.08965757050604672,0.10328146687667648,0.0072537058591274906,0.06781699819587095,0.09497621961783721,0.007243206163811466,0.045238239584809214,0.08391175129069005,9.474389094274162e-08,0.048040422904834124,0.08827459584908273
293,0.5,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Does having lower fasting plasma glucose levels at the diagnosis of type 2 diabetes predict improved outcomes? Yes, lower fasting plasma glucose levels at diagnosis commonly indicate superior glycemic control and are connected to better outcomes, including a reduction in diabetes-related complications and enhanced general health, leading to a better patient prognosis.",1.1842986367842703e-07,0.06762580749751068,0.10146620006561571,0.009067132323909363,0.04583979150969997,0.09344442110667693,0.009054007704764333,0.02333802896795989,0.08270321361058611,1.1842986367842703e-07,0.02624231396645227,0.0874291115311909
293,0.5,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there a relationship between lower fasting plasma glucose levels at diagnosis of type 2 diabetes and improved outcomes? Yes, lower fasting plasma glucose levels at diagnosis generally reflect better glycemic control and are linked to improved outcomes such as fewer diabetes complications and better overall health status, resulting in a more favorable prognosis.",7.105791820705622e-08,0.0850643159220823,0.086984499923304,0.005440279394345618,0.06266651882950747,0.0777738656114995,0.0054324046228586,0.0394895590485822,0.0658040102313872,7.105791820705622e-08,0.041648911866175364,0.06926146773681473
293,0.5,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are lower fasting plasma glucose levels at type 2 diabetes diagnosis associated with better health outcomes? Yes, typically, lower fasting plasma glucose levels at diagnosis suggest improved glycemic control and correlate with positive outcomes including fewer diabetes-related complications and enhanced overall health, leading to a better prognosis.",2.3685972735685406e-07,0.05033138655016467,0.09126798786633294,0.018134264647818726,0.07184334069141363,0.08479667452501084,0.018108015409528666,0.09393754033423818,0.07585052105765655,2.3685972735685406e-07,0.09047512369516308,0.08261606141811795
293,0.5,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do patients with lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis experience improved outcomes? Yes, lower fasting plasma glucose levels at diagnosis generally indicate better glycemic control and are associated with improved outcomes like reduced diabetes complications and better overall health, resulting in a more favorable prognosis.",1.1842986367842703e-07,0.06762580749751068,0.10146620006561571,0.009067132323909363,0.04583979150969997,0.09344442110667693,0.009054007704764333,0.02333802896795989,0.08270321361058611,1.1842986367842703e-07,0.02624231396645227,0.0874291115311909
293,0.5,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is a diagnosis of type 2 diabetes with lower fasting plasma glucose levels linked to improved outcomes? Yes, lower fasting plasma glucose levels at diagnosis usually point to better glycemic control and are associated with improved outcomes, including fewer complications related to diabetes and enhanced overall health status, which leads to a better prognosis.",7.105791820705622e-08,0.13737731068132364,0.12337834442260623,0.005440279394345618,0.11598553271873335,0.11536345452769163,0.0054324046228586,0.09385404379838258,0.10451694276723078,7.105791820705622e-08,0.09710068631097046,0.10902534309507142
293,0.5,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are better outcomes observed in type 2 diabetes patients diagnosed with lower fasting plasma glucose levels? Yes, lower fasting plasma glucose levels at diagnosis typically signify improved glycemic control and are connected to better outcomes such as decreased diabetes-related complications and improved overall health, culminating in a more positive patient prognosis.",1.4211583641411244e-07,0.07283084318623922,0.11895202237185391,0.010880558788691236,0.07995718977075672,0.13209708878940807,0.0108648092457172,0.05871277420841725,0.1228433945681912,1.4211583641411244e-07,0.06295116981528093,0.12901701323251416
294,0.5,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head posture affect anterior chamber depth in pseudoexfoliation syndrome? In patients with clinically evident unilateral pseudoexfoliation, the lens appears more mobile in the affected eye, causing a shallower anterior chamber when the head is prone. This mobility may potentially cause transient pupillary block during certain activities.",3.079176455639103e-07,0.2320398521635081,0.012128176190964735,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
294,0.5,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? For patients with unilateral pseudoexfoliation that is clinically visible, the lens tends to be more mobile in the affected eye, leading to a shallower anterior chamber in the prone position. This might cause transient pupillary block during some activities.",2.3685972735685406e-07,0.1953075599156029,0.006885846130738303,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
294,0.5,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the position of the head impact anterior chamber depth in cases of pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the lens in the affected eye seems more mobile, resulting in a shallower anterior chamber when the head is prone. This could potentially cause transient pupillary block when performing certain tasks.",2.1317375462116866e-07,0.1739731837318641,0.006073984302862434,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
294,0.5,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Can head positioning alter anterior chamber depth in pseudoexfoliation syndrome? Patients with clinically apparent unilateral pseudoexfoliation have a more mobile lens in the affected eye, which leads to a shallower anterior chamber when the head is placed prone. This may cause transient pupillary block during certain activities.",3.079176455639103e-07,0.2320398521635081,0.012128176190964735,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
294,0.5,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is there an effect of head position on anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation cases, the lens in the affected eye shows increased mobility, resulting in a shallower anterior chamber when the head is prone. This condition might lead to transient pupillary block during some activities.",2.6054570009253947e-07,0.1882245363306536,0.013032669034494848,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
294,0.5,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","How does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, causing a shallower anterior chamber when prone. This may potentially induce transient pupillary block during activities.",4.500334819780227e-07,0.3763223196292742,0.008873007807591211,0.03445510283085558,0.3968813644167746,0.0,0.034405229278104466,0.4054651081081637,0.0,4.500334819780227e-07,0.41443377809092397,0.0
294,0.5,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does changing head position affect anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the affected eye's lens is more mobile, which causes the anterior chamber to become shallower in the prone position. This might result in transient pupillary block during certain activities.",3.552895910352811e-07,0.27786147082240475,0.011141590181844022,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
294,0.5,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth impacted by head positioning in pseudoexfoliation syndrome? The lens mobility in the affected eye of patients with unilateral pseudoexfoliation increases, leading to a shallower anterior chamber when the head is prone. This could potentially cause transient pupillary block during some activities.",3.552895910352811e-07,0.27786147082240475,0.011141590181844022,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
294,0.5,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the anterior chamber depth vary with head position in pseudoexfoliation syndrome? In unilateral pseudoexfoliation patients, the lens in the affected eye is more mobile, resulting in a shallower anterior chamber in the prone position. This may cause transient pupillary block during certain activities.",3.789755637709665e-07,0.3338231065156001,0.012544380561703067,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
294,0.5,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is there a relationship between head positioning and anterior chamber depth in pseudoexfoliation syndrome? Patients with clinically evident unilateral pseudoexfoliation have a more mobile lens in the affected eye, causing a shallower anterior chamber when prone. This might lead to transient pupillary block during some activities.",3.316036182995957e-07,0.25468846630311415,0.01164582745104024,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
295,0.5,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission enhance driving performance in elderly drivers? Yes, automatic transmission can greatly enhance driving performance in elderly drivers by simplifying the driving process and removing the need to manually shift gears.",7.10579182070559e-08,0.1081786010261152,0.012002743484225031,0.005440279394345639,0.10421074826202092,0.008254316294676059,0.005432404622858621,0.10371196381111192,0.005972732485293793,7.105791820705622e-08,0.10292162785997583,0.003221293720401787
295,0.5,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission improve the driving habits of older drivers? Indeed, automatic transmission can improve the driving habits of older drivers by making the driving experience easier and eliminating manual gear changes.",9.47438909427412e-08,0.25323198837067284,0.1510416666666667,0.007253705859127518,0.18768230041627731,0.04276856578145302,0.007243206163811494,0.18860365290729497,0.04171720779020869,9.474389094274162e-08,0.18923071963380345,0.039788435369961024
295,0.5,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is driving behavior better in older drivers with automatic transmission? Yes, automatic transmission can improve driving behavior in older drivers by simplifying gear changes and making driving less complex.",1.658018091497971e-07,0.17363303841707145,0.03328888888888884,0.012693985253473157,0.1595478035218174,0.050426700490736366,0.012675610786670115,0.15439318337712526,0.06035379812695108,1.6580180914979784e-07,0.20353837914652884,0.031217481789802305
295,0.5,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does using automatic transmission benefit older drivers' driving behavior? Yes, automatic transmission benefits older drivers by simplifying the driving process and removing the necessity of manual gear shifting.",1.894877818854824e-07,0.11281337949356196,0.10190664036817881,0.014507411718255037,0.14594389590763113,0.08740894901144641,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.5,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission positively affect how older drivers drive? Yes, automatic transmission positively affects older drivers by making driving easier and eliminating the need to manually change gears.",1.894877818854824e-07,0.2155018506876285,0.029513888888888867,0.014507411718255037,0.1992629097968579,0.0490089490114464,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.5,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission aid older drivers in driving more effectively? Yes, automatic transmission aids older drivers by simplifying gear changes and improving overall driving behavior.",2.605457000925383e-07,0.2947767096462357,0.056244260789715325,0.019947691112600675,0.26854621799996403,0.08740894901144641,0.01991881695048161,0.3214472680402922,0.06035379812695108,2.6054570009253947e-07,0.3778917662913073,0.031217481789802305
295,0.5,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Will automatic transmission improve older drivers' driving skills? Yes, automatic transmission improves older drivers' skills by making driving simpler and removing manual gear shifting.",2.842316728282236e-07,0.3423591297212645,0.05272108843537414,0.021761117577382555,0.3129979805707981,0.08740894901144641,0.021729618491434483,0.36796728367518616,0.06035379812695108,2.842316728282248e-07,0.42668193046073855,0.031217481789802305
295,0.5,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is driving easier for older drivers with automatic transmission? Yes, automatic transmission makes driving easier for older drivers by eliminating manual gear changes and simplifying the process.",2.131737546211677e-07,0.312485527436281,0.009871441689623478,0.016320838183036916,0.35151993239530155,0.030359646029875856,0.016297213868575862,0.3499604211439853,0.02229082997222246,2.1317375462116866e-07,0.34719365596035745,0.012170947962263826
295,0.5,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission help older drivers drive better? Yes, automatic transmission helps older drivers drive better by simplifying the driving task and removing the need for manual gear shifts.",1.658018091497971e-07,0.17363303841707145,0.03328888888888884,0.012693985253473157,0.1595478035218174,0.050426700490736366,0.012675610786670115,0.15439318337712526,0.06035379812695108,1.6580180914979784e-07,0.20353837914652884,0.031217481789802305
295,0.5,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can older drivers benefit from automatic transmission in terms of driving behavior? Yes, older drivers benefit from automatic transmission as it simplifies driving and removes the requirement to manually change gears.",1.184298636784265e-07,0.18715768842535185,0.021111111111111136,0.009067132323909398,0.22795761926952096,0.04699105098855355,0.009054007704764368,0.22881674991482015,0.04524620187304896,1.1842986367842703e-07,0.22926580920446593,0.04238251821019768
296,0.5,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Does the use of provider service networks lead to reduced costs compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to lower PMPM costs, with Demonstration PSNs showing slightly more cost reduction than Demonstration HMOs. PSNs may be an effective model for Medicaid care delivery.",1.1842986367842703e-07,0.01844621624671694,0.05157024793388431,0.009067132323909363,0.06748659554926473,0.017538265306122455,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
296,0.5,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Are provider service networks associated with lower expenditures than HMOs or primary care case management within Florida's Medicaid program? Florida's Medicaid Demonstration appears to reduce PMPM spending, and Demonstration PSNs produce marginally greater savings than Demonstration HMOs. PSNs look promising for Medicaid enrollee care.",3.552895910352811e-07,0.25977741785224984,0.028327617548396786,0.02720139697172809,0.28106069584732474,0.017538265306122455,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
296,0.5,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Do provider service networks result in decreased spending relative to HMOs or primary care case management in Florida Medicaid? The Medicaid Demonstration in Florida seems to lower PMPM expenses, with Demonstration PSNs achieving somewhat larger cuts than Demonstration HMOs. PSNs represent a promising approach for Medicaid care.",2.8423167282822487e-07,0.19023356724713203,0.029841852872155912,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
296,0.5,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Is spending lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows reduced PMPM expenditures, with Demonstration PSNs delivering slightly better reductions than Demonstration HMOs. PSNs could be a beneficial model for Medicaid care.",3.316036182995957e-07,0.2360551859060287,0.0288552668630352,0.025387970506946217,0.2575301984371303,0.017538265306122455,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
296,0.5,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Do provider service networks reduce expenditures more than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to lower PMPM costs, with Demonstration PSNs generating slightly greater expenditure reductions than Demonstration HMOs. PSNs seem to be a promising care delivery model for Medicaid.",2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.5,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows decreased PMPM expenditures, and Demonstration PSNs have slightly larger reductions compared to Demonstration HMOs. PSNs appear to be an effective Medicaid care model.",3.079176455639103e-07,0.2128821813867381,0.02935950413223142,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
296,0.5,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Do provider service networks cut costs more effectively than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to reduce PMPM spending, with Demonstration PSNs yielding marginally better reductions than Demonstration HMOs. PSNs seem promising for delivering Medicaid care.",3.079176455639103e-07,0.1820756400285184,0.05157024793388431,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
296,0.5,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Is there a cost advantage to provider service networks over HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration results in lower PMPM expenditures, with Demonstration PSNs achieving slightly greater reductions than Demonstration HMOs. PSNs may be a promising Medicaid care model.",3.079176455639103e-07,0.2128821813867381,0.02935950413223142,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
296,0.5,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Do provider service networks lead to lower PMPM expenditures compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to reduce costs, with Demonstration PSNs generating somewhat larger savings than Demonstration HMOs. PSNs seem to offer a promising approach for Medicaid care.",2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.5,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Are provider service networks more cost-effective than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows lower PMPM expenditures, and Demonstration PSNs produce slightly greater reductions than Demonstration HMOs. PSNs appear to be a promising model for Medicaid service delivery.",3.316036182995957e-07,0.2360551859060287,0.0288552668630352,0.025387970506946217,0.2575301984371303,0.017538265306122455,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
297,0.5,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers secrete GABA? We have presented strong evidence supporting the existence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal remains unclear, though it might play a role in development. Additional data indicate that this GABAergic signal is",2.3685972735685406e-08,0.07355644462982047,0.0008001435587828842,0.0018134264647818726,0.08548623590296245,0.045351473922902494,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
297,0.5,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers responsible for releasing GABA? Our findings provide convincing proof of a GABAergic signal originating from mossy fibers. The exact physiological purpose of this mossy fiber GABAergic signal is not well understood but could be important during development. Further evidence points to this GABAergic signal as,4.737194547137081e-08,0.09658708873422706,0.0011292514009150906,0.0036268529295637453,0.10746514262173745,0.045351473922902494,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
297,0.5,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Is GABA released by mossy fibers? We have demonstrated compelling evidence that mossy fibers emit a GABAergic signal. The physiological significance of this mossy fiber GABAergic signal is uncertain but may have developmental relevance. Other studies suggest this GABAergic signal is,1.1842986367842703e-07,0.06387158827949868,0.03818133580295334,0.009067132323909363,0.09316061699719658,0.019728205224841543,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.5,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers produce a GABAergic signal? We have supplied strong evidence indicating the presence of a GABAergic signal from mossy fibers. While the physiological role of this mossy fiber GABAergic signal is unknown, it may be crucial during development. Additional findings imply that this GABAergic signal is",4.737194547137081e-08,0.037595839324870095,0.04283872595087333,0.0036268529295637453,0.07732830868434881,0.023623078861174096,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
297,0.5,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Can mossy fibers release GABA? We have provided convincing evidence for a GABAergic signal in mossy fibers. The functional role of this mossy fiber GABAergic signal is unclear but might be significant in developmental processes. Other research suggests this GABAergic signal is,9.474389094274162e-08,0.08406258024591873,0.03730342873998292,0.0072537058591274906,0.0669541587814173,0.020367910477800576,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
297,0.5,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Is there a GABA release from mossy fibers? Our evidence strongly supports a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal remains uncertain, although it may be important for development. Further evidence indicates that this GABAergic signal is",4.737194547137081e-08,0.031122981367698088,0.031332168352171355,0.0036268529295637453,0.01649336441601079,0.045351473922902494,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
297,0.5,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers emit GABA? We have gathered compelling evidence that mossy fibers have a GABAergic signal. The physiological importance of this mossy fiber GABAergic signal is not fully understood but could be vital for development. Other data suggest this GABAergic signal is,7.105791820705622e-08,0.044787731848351164,0.017036914488065394,0.005440279394345618,0.04141624475133909,0.020976473922902493,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.5,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are GABA signals released by mossy fibers? We have demonstrated strong evidence for a mossy fiber GABAergic signal. The physiological role of this mossy fiber GABAergic signal is unclear but may be relevant during developmental stages. Additional evidence shows that this GABAergic signal is,4.737194547137081e-08,0.051193823631774826,0.004001875781494163,0.0036268529295637453,0.04952065278017326,0.0021485260770975137,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
297,0.5,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers discharge GABA? We have presented compelling proof that mossy fibers carry a GABAergic signal. The physiological function of this mossy fiber GABAergic signal is uncertain, though it may have developmental significance. Other evidence supports that this GABAergic signal is",9.474389094274162e-08,0.07130043039800293,0.015328150207385455,0.0072537058591274906,0.0669541587814173,0.020367910477800576,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
297,0.5,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers a source of GABA? We have established convincing evidence of a GABAergic signal from mossy fibers. The exact physiological role of this mossy fiber GABAergic signal is unknown but might be important in development. Further research suggests that this GABAergic signal is,2.3685972735685406e-08,0.005658763762911967,0.028554431885782258,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
298,0.5,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always lead to Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily develop into Meniere's disease. Although it can be a symptom of Meniere's disease, it may also result from other causes, such as viral infections.",1.1842986367842703e-07,0.032009275274421434,0.05842691707332719,0.009067132323909363,0.060020770609720664,0.04134296716714297,0.009054007704764333,0.0891212977631648,0.02271498107084911,1.1842986367842703e-07,0.12361395596717584,0.0
298,0.5,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is progression from low-tone sudden deafness to Meniere's disease inevitable? Answer: No, low-tone sudden deafness does not inevitably progress to Meniere's disease. It is a symptom associated with Meniere's, but can also stem from other factors like viral infections.",1.6580180914979774e-07,0.12103360845095734,0.03069023068279464,0.012693985253473108,0.11313813652506033,0.04002996377513751,0.012675610786670066,0.14176503124858364,0.02271498107084911,1.6580180914979784e-07,0.17768117723745203,0.0
298,0.5,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always evolve into Meniere's disease? Answer: No, low-tone sudden deafness isn't guaranteed to advance to Meniere's disease. While it can be a sign of Meniere's, it might also be caused by other reasons, including viral infections.",1.4211583641411244e-07,0.05839249074420749,0.0572176237268082,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.5,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is Meniere's disease a certain outcome of low-tone sudden deafness? Answer: No, low-tone sudden deafness does not always lead to Meniere's disease. It is one symptom of Meniere's disease but can also be triggered by various other factors such as viral infections.",9.474389094274162e-08,0.006301625714965731,0.05957911957168352,0.0072537058591274906,0.0006707989913525836,0.06632653061224489,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
298,0.5,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Will low-tone sudden deafness inevitably become Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily become Meniere's disease. Although it is a symptom of Meniere's, other causes like viral infections can also be responsible.",2.6054570009253894e-07,0.24143439626586938,0.022118182071683534,0.019947691112600606,0.22865570464184826,0.03694177395476095,0.019918816950481547,0.2561753824263291,0.02271498107084911,2.6054570009253947e-07,0.29546421289383584,0.0
298,0.5,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always indicate future Meniere's disease? Answer: No, low-tone sudden deafness does not always indicate progression to Meniere's disease. It can be a symptom of Meniere's but may also be caused by other factors including viral infections.",1.4211583641411244e-07,0.09304984977220432,0.0325721801998793,0.010880558788691236,0.08622722882549994,0.040703261914183934,0.0108648092457172,0.11509678416642277,0.02271498107084911,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.5,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is Meniere's disease an unavoidable progression from low-tone sudden deafness? Answer: No, low-tone sudden deafness does not unavoidably progress to Meniere's disease. It is a symptom of Meniere's disease but can also arise from other causes like viral infections.",1.6580180914979774e-07,0.08548759919147342,0.055946906277308084,0.012693985253473108,0.07665670596927399,0.06632653061224489,0.012675610786670066,0.14176503124858364,0.02271498107084911,1.6580180914979784e-07,0.17768117723745203,0.0
298,0.5,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness inevitably result in Meniere's disease? Answer: No, low-tone sudden deafness does not inevitably result in Meniere's disease. While it can be a symptom, other factors such as viral infections may also cause it.",2.1317375462116834e-07,0.2543763899849374,0.024756817928316466,0.016320838183036854,0.2462484573328747,0.016318097486928654,0.0162972138685758,0.23694329272110703,0.005831731731919049,2.1317375462116866e-07,0.23483959107740038,0.0
298,0.5,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is low-tone sudden deafness a definite precursor to Meniere's disease? Answer: No, low-tone sudden deafness is not a definite precursor to Meniere's disease. It may be a symptom of Meniere's but can also be due to other causes like viral infections.",1.1842986367842703e-07,0.16725750562758135,0.034961696754847116,0.009067132323909363,0.16399284769371247,0.03243890148652058,0.009054007704764333,0.1602133162821331,0.02841723222352634,1.1842986367842703e-07,0.16009538652296218,0.026296566837107373
298,0.5,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always lead to Meniere's disease? Answer: No, low-tone sudden deafness does not always lead to Meniere's disease. It is one symptom among others and can also be caused by different factors including viral infections.",1.8948778188548304e-07,0.2227782198546966,0.021479190804808646,0.014507411718254981,0.21572719854764344,0.014123296377374459,0.014486412327622933,0.2076721821344738,0.00504012096996722,1.8948778188548325e-07,0.20585205420414887,0.0
299,0.5,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is it possible for mental imagery functional magnetic resonance imaging to forecast recovery in patients suffering from disorders of consciousness? Answer: The mental imagery fMRI paradigm shows strong agreement with the subsequent clinical progression of patients in a vegetative state (VS). All five VS patients exhibiting notable ROI activation experienced a positive clinical outcome by the end.,0.0,0.04864190740771601,0.03493087049634666,0.0,0.024755256448570684,0.01785123966942149,0.0,0.0,0.0,0.0,0.0,0.0
299,0.5,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI predict recovery outcomes in patients with consciousness disorders? Answer: The mental imagery fMRI paradigm highly correlates with the later clinical development of patients in a vegetative state. Each of the five VS patients who showed significant region of interest (ROI) activation had a favorable clinical progression until the end.,9.474389094274162e-08,0.052109487930096954,0.014791319577940096,0.0072537058591274906,0.07601222264976437,0.0013721359553382217,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
299,0.5,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Does mental imagery functional MRI have predictive value for recovery in disorders of consciousness? Answer: The mental imagery fMRI paradigm demonstrates a high level of concordance with the subsequent clinical course in patients diagnosed with a vegetative state. All five VS patients with marked ROI activation showed a positive clinical trajectory through to the end.,4.737194547137081e-08,0.012039426489132588,0.03429355281207131,0.0036268529295637453,0.011612387722303552,0.01785123966942149,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
299,0.5,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can the mental imagery fMRI paradigm be used to predict recovery in patients with disorders of consciousness? Answer: There is a strong correlation between mental imagery fMRI results and the clinical progression of patients in a vegetative state. All five VS patients who exhibited significant activation in regions of interest had a favorable clinical outcome by the conclusion of the study.,9.474389094274162e-08,0.09533318331525553,0.01971992580534184,0.0072537058591274906,0.07064322191685601,0.0011893608989532317,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
299,0.5,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is mental imagery functional magnetic resonance imaging effective in predicting recovery for patients with consciousness disorders? Answer: Mental imagery fMRI shows high concordance with the later clinical course of patients in a vegetative state. All five patients in VS with significant ROI activation experienced a positive clinical course until the end.,1.4211583641411244e-07,0.11980950112335043,0.006124614197530888,0.010880558788691236,0.08857342885843345,0.01785123966942149,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
299,0.5,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI serve as a predictor for recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm aligns closely with the clinical progression of patients in a vegetative state. Each of the five VS patients who demonstrated significant ROI activation had a favorable clinical outcome through to the end.,7.105791820705622e-08,0.032448595755735,0.015486887281759058,0.005440279394345618,0.056461018114078776,0.0010097070761406444,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
299,0.5,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Does mental imagery functional MRI accurately predict recovery in patients suffering from disorders of consciousness? Answer: The mental imagery fMRI paradigm is highly consistent with the subsequent clinical course of patients in a vegetative state. All five VS patients with significant activation in regions of interest showed favorable clinical progression until the end.,9.474389094274162e-08,0.025952990550476507,0.033608189056906976,0.0072537058591274906,0.049352715705150985,0.01785123966942149,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
299,0.5,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI be used to forecast recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm exhibits strong concordance with the later clinical course of vegetative state patients. All five VS patients who showed significant ROI activation had a positive clinical outcome by the end.,1.6580180914979784e-07,0.11351717573962672,0.012538580246913546,0.012693985253473108,0.13706785783146014,0.0025480658861340676,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
299,0.5,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is mental imagery functional magnetic resonance imaging a reliable predictor of recovery in patients with disorders of consciousness? Answer: The fMRI mental imagery paradigm demonstrates high agreement with the clinical progression of patients in a vegetative state. All five VS patients exhibiting significant ROI activation had a favorable clinical course until the conclusion.,9.474389094274162e-08,0.025952990550476507,0.033608189056906976,0.0072537058591274906,0.049352715705150985,0.01785123966942149,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
299,0.5,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI predict the recovery trajectory in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm shows a high level of agreement with the clinical course of patients in a vegetative state. All five patients in VS with significant ROI activation experienced a positive clinical outcome through to the end.,7.105791820705622e-08,0.05812071355425141,0.002894185996838848,0.005440279394345618,0.056461018114078776,0.0010097070761406444,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
